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R2405 Microbiological characteristics of follow-up blood cultures
at seven university-afﬁliated hospitals in Korea
S. Kim*, J. Shin, E. Kim, S. Koo, N. Lee, H. Jung (Jinju, Busan, Seoul,
Daejeon, Changwon, KR)
Objectives: The aims of this study were to evaluate the patterns of the
request of repeated blood culture and analyze the microorganisms
detected in follow-up cultures.
Methods: The frequency and intervals of repeated blood cultures
during January and February 2010 were analyzed at seven university-
afﬁliated hospitals in Korea. The microbiological culture results were
categorized according to the isolated pathogens or skin contaminants
during the ﬁrst and follow-up cultures.
Results: Among 3072 patients who underwent repeated blood culture,
53.5% were requested to undergo two repeated cultures, while 16.3%
were requested to undergo more than four repeated cultures. For the
5241 events of repeated blood cultures, intervals of 1, 2, and 3 days
were noted between the ﬁrst and repeat cultures in 23.1%, 21.4%, and
15.0%, of the patients, respectively. Persistent growth of pathogens
isolated in the ﬁrst culture was noted in 2.6% of the repeat cultures,
clearance of pathogens in the follow-up culture in 8.5%, new pathogens
in the follow-up culture in 5.2%, growth of contaminants in 7.6%, and
no growth of microorganisms at any time in 76.1%.
Conclusion: Two or three follow-up cultures were most commonly
requested, with the interval between the initial and repeat culture being
<3 days in most cases. Among follow-up cultures, 16.3% showed either
persistence or clearance of the original pathogen or a new pathogen.
Follow-up culture should be considered after receiving the ﬁrst result,
which takes at least 3–4 days.
R2406 Reduction in interleukin-2 serum levels but lack of
evidence of the Th1 to Th2 cytokine shift during the
course of HIV infection
S. Souﬁan, A. Ramezani*, A. Aghakhani, M. Banifazl, A. Eslamifar,
M. Mohraz (Arak, Tehran, IR)
Objectives: Infection with human immunodeﬁciency virus (HIV)
results in dysregulation of the cytokine proﬁle. A switch from a T
helper 1 (Th1) to a Th2 cytokine has been proposed as an important
factor in progression of HIV infection to AIDS. The aim of the present
study was to assess the levels of Th1 and Th2 cytokines in treatment
naı¨ve and under treatment HIV infected individuals in order to identify
the switch from Th1 to Th2 cytokines.
Methods: This study was carried out in 140 HIV infected patients (21
treatment naı¨ve and 119 under treatment) and 35 matched healthy
controls. The serum samples were checked with enzyme-linked
immunosorbent assay (ELISA) for interleukin (IL)-2, IL-4, IL-10 and
interferon (IFN)-gamma.
Results: A total of 140 HIV positive patients with mean age
36.9 ± 9.2 years and 35 matched controls were enrolled in the study.
IL-2 level was relatively higher and IL-10, IL-4 and IFN-gamma levels
were relatively lower in the treatment naı¨ve group than the under
treatment group. Except for IL-2, all of the other cytokines exhibited a
negative correlation with the CD4 cell counts and IFN-gamma levels
showed the strongest negative correlation.
Conclusion: Our observations did not demonstrate switching of the
type 1–2 T helper cells cytokine proﬁle in HIV infected patients and
suggested more complex changes in Th1 to Th2 cytokine patterns in
HIV infection.
R2407 Last situation of Crimean-Congo haemorrhagic fever in
Iran and its public health importance
S. Chinikar*, M. Moradi, S. Khakiﬁrouz, F.S. Rasi Varaie, M. Raﬁgh,
A. Hassanzehi (Tehran, Zahedan, IR)
Objectives: Crimean-Congo Haemorrhagic Fever (CCHF) is a viral
zoonotic disease. The virus is from Nairovirus genus, Bunyaviridae
family. Humans are infected by tick bite, handling of infected blood or
tissues and nosocomially. The disease is asymptomatic in livestock
(only mild fever) but in human mortality rate could be 50%. CCHF has
been observed for decades in Iran but since 2000, as a public health
importance, has been extensively studied.
Methods: Since 2000, the laboratory of Arboviruses and Viral
Haemorrhagic Fevers of the Pasteur Institute of Iran, as the National
Reference Laboratory, has performed advanced laboratory diagnosis
consisting of speciﬁc Elisa for IgM and IgG detection and also gel-
based and Real time RT-PCR for detection of a fragment of CCHFV
genome in the sera of CCHF probable patients.
Results: From June 2000 to 20 September 2011, 2382 serum samples
from CCHF probable patients have been collected from different
provinces of Iran and transferred according to safety procedures to the
Laboratory of Arboviruses and Viral Haemorrhagic Fevers (National
Reference Laboratory).We conﬁrmed (serologically and/or molecularly)
the disease of 853 patients, and between conﬁrmed cases we have 122
death cases.Our data showed the disease has been seen in Iran 23 out of 30
provinces in Iran, but we observed the most infected province in Iran is
Sistan-Baluchistan, this province is near to Afghanistan and Pakistan
(endemic area) and the genome isolates from different part of Iran have
close relationship to Matin (Pakistan) strain, and also we found some
isolated from central part of Iran which are near to Iraq strain.
Conclusion: By representing a major public health problem, CCHF is
in the most important rank of viral hemorrhagic fevers in Iran and it is
important to expand control program in all country especially in
infected province by public awareness and also information to high risk
group. Our phylogenetic study showed that rather than Matin strain we
have another strains such as Iraq strain in Iran. As Iran is one of the
CCHF infected countries in the world, so our experiences on different
aspects on CCHF can be very useful for prevention and public health in
this regard in the region and also in the world.
R2408 Pathogenesis of coxsackievirus B3 isolate from clinical
and environmental specimen in Swiss albino mice
D. Shukla*, M. Ohri, A. Kumar, R. Nawal, S. Srivastava,
T. Dhole (Lucknow, IN)
Objective: Coxsackievirus B3 causes asymptomatic infection to more
severe disease like myocarditis, aseptic meningitis, encephalitis and
neonatal sepsis like illness. Environmental surveillance of sewage is a
suitable method for detection of enterovirus serotypes circulating in the
community. The present study was undertaken to compare the
pathogenesis of predominant coxsackievirus serotype isolated from
environmental and clinical specimen.
Methods: Coxsackievirus B3 (CB3) isolates in this study was isolated
from cerebrospinal ﬂuid and sewage. Fifteen days old Swiss albino
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mice were infected with oral route and intracerebral route with 0.2 mL
of 107 TCID50/mL of virus of different origin. Sterile PBS was
inoculated in age and sex matched control mice. Mice were sacriﬁced at
5, 10, 15 and 20 days after post inoculation. Isolation of virus in heart,
spleen, thymus, pancreas, brain, small intestine, large intestine and
blood was done in RD cell line and virus titres was determined by
Karber method. Histopathological changes of infected tissues were
studied.
Results: Virus was isolated from several organs (heart, pancreas,
spleen, thymus, small and large intestine) on different days depending
on the route of infection but not their origin. Organs became negative
for virus isolation after 20 days with the exception of spleen tissue in
intracerebral route and large intestine by oral route. Histopathology
showed mild inﬂammation and necrosis in heart, intestine and pancreas
tissue of all infected mice.
Conclusions: It is concluded that the pathogenesis of coxsackie b3
does not depend on their source but depend on the route of infection.
These observations suggest the prominence of environmental
surveillance of the enterovirus which might be latent in nature until
they get a suitable host to infest their pathogenesis.
R2409 Prevalence of PAPI-1 in clinical isolates of Pesudomonas
aeroginosa
N. Sadeghifard*, Z. Rasaei, M.R. Zolfaghari, S. Ghafourian
(Ilam, Qom, IR)
Objectives: The aims of this study were to evaluate frequency of
PAPI-1 in Pseudomonas aeroginosa isolated in References laboratory
of Ilam, Milad and Emam Khomaini hospital in Iran and to study
frequency of extended spectrum b-lactamases (ESBLs) among isolates
which were positive and negative for PAP-1.
Methods: Forty-eight clinical isolates of P. aeroginosa were obtained
during April 2010 to September 2010. The isolates were evaluated for
ESBLs by screening and conﬁrming disk diffusion methods and for
PAPI-1 by PCR methods.
Results: The results of the current study showed that 31.5% (n = 15)
of 48 isolates of P. aeruginosa isolates were positive for ESBLs by
screening and conﬁrming disk diffusion methods. In this study, of 48 P.
aeruginosa isolates in all laboratories, 10 isolates were resistant to
azteronam and 3rd generation of cephalosporin and produced ESBLs,
While in Imam Khomaini hospital 4 and in References laboratory of
Ilam 5 isolates were ESBLs positive. Generally, 15 isolates were
ESBLs positive that also conﬁrmed by conﬁrming disk diffusion
methods. The results of PAPI-1 detection showed 35.4% (n = 17) of
isolates were positive for PAPI-1, which 42.1% (n = 8) were found in
isolates in milad hospital, 29% (n = 5) of PAPI-1 positive were
detected in References laboratory of Ilam and 23.5% (n = 4) in Imam
khomaini hospital. Interestingly, all the PAPI-1 were ESBLs positive
and no PAPI-1 detected in non-ESBLs P. aeroginosa.
Conclusion: This was ﬁrst study of prevalence of PAPI-1 in clinical
isolates of P. aeroginosa which showed most of PAPI-1 positive strains
had high levels of resistance and produced ESBLs. It is suggested that
PAPI-1 maybe has an important role in antibiotic resistance of P.
aeroginosa.
R2410 Colistin in management of multidrug-resistant
Acinetobacter baumannii infections
F. Simsek*, T. Yildirmak, H. Gedik, N. Iris, Ç. Arabaci,
M. Erso¨z (Istanbul, TR)
Objective: In this study, it is aimed to evaluate the outcome of colistin
therapy as monotherapy vs. combination therapy in the multidrug-
resistant Acinetobacter baumanii infections.
Methods: This case-control study was conducted at a 800-bed training
hospital in Istanbul, Turkey, from August 2008 to May 2011. Patients,
who received colistin as monotherapy or combinated with one of other
antimicrobials <24 hour or received antimicrobial regimens without
colistin were excluded from the analysis. Response to colistin treatment
was deﬁned as clinical and microbiologic evaluation.
Results: Totally 44 patients, who were treated with colistin as a
monotherapy or combinated with one of those antibiotics including
carbapenems, rifampicin and tigecycline due to their 44 attacks with
A. baumannii and fulﬁlled the study criteria, were included into the
study. Of those, 31 patients (70%) were male, mean age was
51.71 ± 18.82 years (14–87), length of stay at hospital prior to A.
baumannii infection was 19.25 ± 17.51 days (3–95 days) and also 39
patients were supported with mechanic ventilation during
38.58 ± 29.96 days (2–205 days) in intensive care unit (ICU).
Comorbid conditions were reported in 15 patients, and also 26
patients had been treated with other antibiotics due to accompanying
another infections. There was no signiﬁcant difference between
colistin monotherapy and colistin combinated therapy in treatment of
VAP and blood stream infection in terms of clinical and
microbiologic response (p > 0.05). Microbiologic response was
found signiﬁcantly higher in 31 of 44 patients than clinical
response that achieved in 18 of 44 patients in overall response
(p = 0.005, Table 1). Ten-day mortality rates was found 27% (12/44),
30-day mortality was found 38% (17/44). Mortality rates were found
similar in patiens that received colistin within 72-hour of identiﬁed A.
baumannii infection and in patients that received colistin after 72-hour
of identiﬁcation (57% vs. 58%, p = 0.651). Mortality rate was
signiﬁcantly higher in patients, who were supported with mechanic
ventilation more than 10 days (n: 20, 31%, OR = 9.09; 95% CI
0.940–87.95; p = 0.023).
Conclusion: Colistin should be thought as a monotherapy for
treatment of A. baumannii infections decreasing the cost and drug
burden compared to combination therapy that did not decrease
mortality. Patients with prolonged duration of ventilation are likely
more to have increased mortality.
R2411 The effect of oxygen on the growth characteristics and
virulence of Clostridium difﬁcile
L. Green*, T. Worthington, A. Hilton, P. Lambert (Coventry,
Birmingham, UK)
As an obligate anaerobe Clostridium difﬁcile cannot tolerate oxygen
within the environment. This intolerance may be due to an inability to
either prevent damage from reactive oxygen species (ROS) through
neutralisation mechanisms e.g. catalase or efﬁciently repair the damage
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which ROS have caused. Whilst the effect of oxidative stress has been
investigated in other anaerobic microorganisms, the area has not been
well researched in C. difﬁcile. Our research to date has investigated
oxygen tolerance in C. difﬁcile and also how characteristics such as
sporulation are inﬂuenced by changes in redox potential.
Five C. difﬁcile PCR ribotypes (001, 017, 027, 078, 106) and NCTC
11204 were grown overnight in Wilkins-Chalgren anaerobe broth and
adjusted to a density of 107 CFU/mL. These cultures were then to
inoculate sterile volumes of Wilkins-Chalgren anaerobe broth and
incubated in concentrations of between 1% and 15% oxygen at 37C for
48 hours. Samples were taken at the beginning of the incubation period
and periodically throughout the experiment, diluted accordingly and
spread onto both Wilkins-Chalgren anaerobe agar and fastidious
anaerobe agar supplemented with 0.1% (w/v) sodium taurocholate
and 5% (v/v) horse blood. Agar plates were then incubated for 48 hours
at 37C in anaerobic conditions and following incubation, colonies
quantiﬁed. At each time point, samples were also taken and malachite
green staining used to visualise spore formation.
Each of the PCR ribotypes investigated in this study grew in the
presence of up to 2% oxygen with no observable detrimental effects.
Above concentrations of 2% oxygen however, growth was less
consistent across separate observations. Above concentrations of 3%
oxygen, growth began to become inhibited and the numbers of
vegetative cells present in the samples began to decline. Although
growth was inhibited in higher concentrations of oxygen, vegetative
cells were found to survive in 15% oxygen for 24 hours. PCR ribotypes
017 and 078 appeared to posses a greater tolerance to oxygen compared
with the other PCR ribotypes tested, growing in concentrations of 3%
oxygen and surviving for over 24 hours in atmospheric conditions.
Although regarded as a strict anaerobe, C. difﬁcile can grow in the
presence of small amounts of oxygen. The results here also suggest that
oxygen tolerance may vary between different PCR ribotypes and strains
and therefore further studies into the mechanisms behind this are clearly
warranted.
R2412 Analysis on the diversity of vaginal microbiota in healthy
chinese women
X. Bingbing*, L. Qinping (Beijing, CN)
Objectives: PCR-denaturing gradient gel electrophoresis (PCR-
DGGE) has been used to analyze the vaginal microbiota of healthy
Chinese women in different physiological states. Our research provided
a basis for the development of vaginal probiotics adapted to Chinese
female population.
Materials: Women were enrolled during routine gynecologic
examinations in the Peking University 1st Hospital from October
2009 to January 2010, and included 30 cases of reproductive age, 30
cases of post menopause age, 90 cases for routine prenatal care (ﬁrst
trimester: 30 cases, second trimester: 30 cases, third trimester 30 cases),
as well as 30 cases for 6–8 weeks postpartum. Vaginal discharge was
collected and total bacterial DNA was extracted.
Methods: Universal bacterial primers were used to amplify the V3
region of 16S rDNA gene. PCR products were analyzed by denatured
gradient gel electrophoresis (DGGE).
Results: (i) Vaginal ﬂora of healthy Chinese women in their
reproductive age is relatively simple. The most common bacteria
include: Lactobacillus crispatus, Lactobacillus iners, and Lactobacillus
gasseri. L. iners is the predominant vaginal bacteria that cannot be
recognized by traditional method. (ii) The vaginal ﬂora of pregnant
women includes: Lactobacillus iners, Lactobacillus crispatus,
Lactobacillus delbrueckii, Lactobacillus gasseri (ﬁrst trimester);
Lactobacillus iners, Lactobacillus crispatus (second trimester);
Lactobacillus crispatus, Lactobacillus iners, Streptococcus anginosus
(third trimester). (iii) The vaginal ﬂora of postpartum women is mostly
represented by Lactobacillus iners, Prevotella spp., Streptococcus
anginosus, Lactobacillus crispatus, Streptococcus agalactiae,
Streptococcus gallolyticus, Lactobacillus gasseri, Veillonella sp.,
Anaerococcus lactolyticus, Megasphaera spp. (iv) The vaginal ﬂora
of post-menopause women is more complex than in the reproductive
age; the most common bacteria include: Lactobacillus iners,
Lactobacillus crispatus, Escherichia coli, Streptococcus agalactiae,
Streptococcus gallolyticus, Veillonella spp., Streptococcus intermedius,
Streptococcus anginosus, Prevotella spp., Anaerococcus lactolyticus
and Bacteroides fragilis.
Conclusions: (i) The most common vaginal bacteria of Chinese
healthy women are Lactobacillus crispatus, Lactobacillus iners, and
Lactobacillus gasseri. (ii) Dominant vaginal ﬂora of healthy women
during pregnancy and reproductive age is similar, whilst the
postmenopausal and postpartum ﬂora is more complex. (iii) PCR-
DGGE is a useful tool for analyzing the vaginal microbiota.
R2413 Signiﬁcance of anti-Chlamydophila pneumoniae IgA and
IgG determination in patients with acute and post-acute
ischaemic stroke
C. Contini*, M. Maritati, S. Scivales, S. Seraceni,
E. Fainardi (Ferrara, IT)
Objectives: Accumulating evidence indicates that recent acute
infections and chronic infectious diseases are important triggers or
risk factors for ischemic stroke (IS) mediated by atherogenic process in
the arteries. Chlamydophila pneumoniae (Cp) has been associated with
ﬁrst IS by enhancing atherosclerosis. Serological data however are
limited and results often contradictory. We aimed to investigate the
seroprevalence of C. pneumoniae antibodies in patients with acute IS
and its impact on admission and follow-up.
Methods: We evaluated in a retrospective case-control study performed
between January 2007 and October 2011 anti-Cp IgA and IgG (BU/mL)
serum samples from 78 consecutive patients (mean age, 66.7, range 35–
82 year) with ﬁrst IS at different times (admission, 0–9 hour), 7 and
90 days after, in relation to age, sex, NIHSS score (mean values on
admission vs. 90 days after), CT scan and stroke subtype (TOAST).
Results: Anti-Cp IgA have shown statistically signiﬁcant values in
53.8% (42/78) IS patients vs. 10.5% (9/85) age and sex matched
controls (p < 0.021), compared to Cp IgG (71.7%, 61/78) vs. 84% (72/
85); p < 0.38). IgA titres were evaluated according to the following
score: low (10–30), intermediate (30–60), elevated (>60), more elevated
(>90). Of IS patients, 12 (15.3%) had intermediate IgA titres on
admission which became more elevated 90 days after (Group 1;
NIHSS, 10 vs. 4.08, p < 0.022); 10 (12.2%) had more elevated IgA
titres on admission but decreased at 90 days (Group 2; NIHSS, 10.7 vs.
4.4, p < 0.063); 6 (7.6%) had intermediate IgA titres on admission but
low 90 days after (Group 3; NIHSS, 11 vs. 5.2, p < 0.091); 4 (5%) had
low/intermediate titres on admission but increased at 90 days (Group 4;
NIHSS, 7.3 vs. 1.7, p < 0.014); 6 (7.6%) had negative IgA titres on
admission that slightly increased at 7 and 90 days (Group 5; NIHSS, 11
vs. 1.2, p = 0.000053); 4 (5%) patients had low titres on admission and
intermediate at 7 days but was negative 90 days after (Group 6, NIHSS,
12.3 vs. 5.5, p < 0.274). All patients showed intermediate Cp IgG titres
from admission to 90 days.
Conclusions: Patients from Group 1, 4 and 5 showed a NIHSS score
statistically signiﬁcant after 90 days. Positive or negative IgA values at
IS onset which increase and become elevated at 90 days, appear to be
associated with clinical and neuroradiological improvement. No
signiﬁcant statistical difference in achieving of good outcome was
seen between IgA in relation to age, sex or TOAST.
R2414 Ability of greater omentum (omentum majus) to eradicate
Klebsiella bioﬁlm from surgical biomaterials implanted to
Wistar female rats – initial evaluation
M. Bartoszewicz, B.M. Maczynska*, D. Smutnicka, A. Junka,
A. Domanasiewicz, P. Barc, A. Secewicz, M. Rzeszutko, J. Nowicka,
A. Janczura, B. Kowalska-Krochmal (Wroclaw, Trzebnica, PL)
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Introduction: Metal or silicone implants used to recover bone
structure and function after fractures or osteomyelitis often serve
Klebsiella as a scaffold for bioﬁlm establishment. Inability of physical
removing these bioﬁlm covering implants lead to chronic infections,
resistant to treatment with antibiotics. The only solution are alternative
methods, such as covering wounds with different types of pedicled or
vascularised ﬂaps. The aim of this study was in vitro assessment of
Klebsiella strains ability to form bioﬁlm on surgical implants and in
vivo (animal model) evaluation of greater omentum inﬂuence on the
Klebsiella bioﬁlm on this implants.
Materials and Methods: Quantitative cultures, crystal violet staining
and modiﬁed Richard’s technique were used to in vitro assess the ability
of 30 clinical Klebsiella strains to form bioﬁlm on silicone tendon
endoprostheses, surgical steel screws, polypropylene surgical meshes
and vascular prostheses. In vivo assessment covered 100 Wistar female
rats. In experimental group, omentum greater was closed around
infected biomaterials, whereas in control group, this biomaterials were
implanted into subcatenous tissue, periosteum or left in abdomen.
Implants were restored in day 2, 5, 9, 14, 30 after implantation. Bioﬁlm
was removed from it’s surface using mechanical and chemical methods.
Rats’ lungs, kidneys, livers, pancreas, spleens and greater omentum
were uptaken for histopathological assessment.
Resuts: Among investigated Klebsiella pneumoniae strains, 53% of
them proved to be effective bioﬁlm–formers in vitro, however level of
bacterial adhesion was associated with the type of biomaterial. The
Klebsiella strain (K66), which was able to very effectively form bioﬁlm
structure on all tested biomaterials, was chosen to be used in research in
vivo. In experimental group, after 2 days from implantation, number of
cfu was reduced 1000-fold. Between 14 and 30 day after experiment
beginning, implant was sterile. In control group, in 1–5 day from
implantation, number of cfu was 10 times higher than on the begining
of experiment.
Conclusions: Obtained results indicate high ability of greater omentum
to erradicate Klebsiella bioﬁlm from surgical implants.
Histopathological assesments indicated that number of organs
pathologies related to bacterial activity (necrosis, ulcers) was lower in
experimental group than in control group. Studies were granted by
Ministry of Education and Science (grant No N401038138).
R2415 The skin as a key organ by its innate immunity in Lyme
disease transmission
B. Jaulhac*, A. Kern, C. Barthel, E. Collin, S. De Martino,
N. Boulanger (Strasbourg, FR)
Objectives: The skin is a key organ in the transmission of arthropod
borne diseases like Lyme disease. We investigated whether a speciﬁc
cutaneous innate immunity might explain a part of the organotropism of
some Borrelia burgdorferi sensu lato strains, and which factors in the
skin might inﬂuence the outcome of the disease, responsible of multi-
systemic disorder.
Methods: Using different clinical isolates (human pathotypes) of B.
burgdorferi ss inoculated to C3H/HeN mice, we compared the
transmission and the dissemination of these B. burgdorferi ss strains
and measured the induction of antimicrobial peptides (AMPs),
chemokines and cytokines in kinetics of skin inﬂammation.
Results: Different inﬂammatory proﬁles were observed in the skin,
with induction of AMPs in the course of infection. A strong induction
of MCP-1, IL 6 and TNF-alpha at day 7 was observed that corresponds
to a peak of intense bacterial multiplication whatever the strain. We also
evidenced that the surface lipoprotein OspC, was essential in the
inﬂammation.
Conlusion: The skin is an essential interface in the development of
Lyme disease by its skin innate immunity, represented by an induction
of AMPs and MCP-1 that might play a role in the dissemination of B.
burgdorferi ss strains. OspC and BBK-32 are two bacterial lipoproteins
with a critical role in the skin pathogenesis.
Bioﬁlm
R2416 Inhibitory effect of coral-associated bacterial extracts on
methicillin-resistant and susceptible Staphylococcus
aureus bioﬁlms
S. Gowrishankar*, S. Karutha Pandian (Karaikudi, IN)
Objectives: Bioﬁlms are biotic and abiotic surface-associated, sessile
bacterial communities entrench themselves in an exopolysaccharide
matrix. Bioﬁlm- associated bacteria renders huge tolerance towards
antibiotics and host immune defence mechanism, leaving behind their
planktonic counterparts. In this study, ethyl acetate extract of three
Coral Associated Bacteria (CAB) were assessed for their ability to
modify the adhesion properties, such as cell surface hydrophobicity
(CSH), and to inhibit synthesis of bioﬁlm in vitro by clinical strains of
methicillin resistant (MRSA) and susceptible Staphylococcus aureus
(MSSA).
Methods: Five clinical strains each from MRSA and MSSA along with
two reference strains MRSA ATCC 33591 and S. aureus ATCC 11632
were taken for the study and their ability of slime production was
evaluated using Congo red agar (CRA). CAB extracts were tested for
antibacterial activity prior to antibioﬁlm activity using agar well
diffusion method. Subsequently, the extracts showing no bactericidal
action were assayed qualitatively and quantitatively for antibioﬁlm
activity respectively, through CLSM and spectrophotometry at 570 nm
against all test strains. The percentage hydrophobicity and reduction in
slime production of test strains with and without extracts were assessed
by microbial adhesion to hydrocarbon assay (MATH) and CRA plate
method respectively.
Results: Out of nine CAB screened, three have shown excellent
antibioﬁlm activity (79–87%) against MRSA and MSSA bioﬁlms.
CLSM images also revealed the potential of CAB extracts in effective
disruption and reduction of bioﬁlms. MATH assay revealed that the
hydrophobicity of MRSA was comparatively high upto 44–62% with
that of MSSA showing a maximum of 33%. Two extracts were able to
strongly decrease the hydrophobic property of both MRSA and MSSA
cell surfaces. Classic black color appearance of bioﬁlm forming test
strains were highly reduced and changed to pink on CRA plate
incorporated with three extracts individually. This proves that all three
CAB extracts have a signiﬁcant role in reducing the slime production of
bioﬁlm forming S. aureus isolates.
Conclusion: This study unveils that coral ecosystem remains an
untapped resource with surplus biotechnologically potent bacteria in
marine environment. Characterization of lead molecules from these
extracts may end up with novel bioactive agents which can be targeted
to these dreadful bioﬁlm forming pathogens.
R2417 A fatal case of Trichosporon asahii endocarditis two and a
half years after aortic valve replacement
C. Tsamadou, T. Chatzitheodorou*, E. Perivolioti, M. Nepka,
E. Protopapadakis, B. Koubouli, H. Belesiotou (Athens, GR)
Objectives: Trichosporon species is a yeast like ubiquitous fungus
extensively distributed in nature. Here we present a case of
Trichosporon asahii endocarditis in a 57-year old woman, occuring
two and a half years after aortic valve replacement.
Methods and Results: A 57-year old woman who had undergone
aortic valve replacement in the past, presented herself at a peripheral
Hospital with high fever, right hemiparesis and aphasia. A brain CT
scan revealed thrombotic infarctions at the left temporal lobe and the
left cerebellum hemisphere. A yeast like but unidentiﬁable fungus was
isolated in ﬁve consecutive blood cultures and so antifungal
chemotherapy was added to the antimicrobial treatment (Table I). An
intraesophageal U/S performed 2 days after, revealed an aortic
pseudoaneurysm of 2.4 cm close to the metallic prosthetic valve as
well as a large vegetation measuring 1.5 · 0.9 cm. Using the Vitek 2
System method we isolated and identiﬁed Trichosporon asahii in nine
consecutive blood culture sets and with the same method we determined
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the susceptibility proﬁle of the microorganism who appeared to be
sensitive in vitro to Fluconazole, Amphotericin B and Flucytosine with
an MIC of 0.5, 2 and 1 lg/mL respectively. Despite intravenous and
pos combined antifungal chemotherapy (Table II) the patient showed no
signs of improvement and ﬁnally expired on March 19, 2011 because of
sepsis. It is important to underline that the patient was not considered at
any time during her hospitalization able to undergo any surgical
operation for her underlying disease.
Conclusion: T. asahii has already been reported as a cause of
endocarditis in patients who have undergone heart valve replacement,
therefore it is important to be suspected as a possible pathogen when
clinical manifestations of endocarditis are observed. Due to the small
number of cases reported so far, our data concerning mortality and
epidemiology is quite poor. However, it emerges that Trichosporon spp.
endocarditis presents much higher mortality rate than that observed in
other infective endocardites. It is also acknowledged that chemotherapy
alone is unable to control deep mycosis infections and that patient’s
rescue can only be achieved when antifungal treatment is followed by
effective management of the underlying disease. Nevertheless, early
detection of the pathogen may improve the prognosis of the patient in
terms of improving patient’s clinical condition so that further surgical
treatment can be offered.
R2418 Evaluating the ability of in vitro bioﬁlm formation of
Escherichia coli isolated from urine samples and analysis
of inhibition of bioﬁlm growth by Lactobacillus species
V. Aslan, G. Ozel, G. Bahar*, O. Gurbuz, H. Saltas,
M. Cagatay (Ankara, Yozgat, TR)
Objectives: To investigate the ability of bioﬁlm formation of urinary
E. coli isolates and how they are affected after treating the surfaces with
Lactobacillus plantarum, Lactobacillus fermentii and Lactobacillus
casei species.
Methods: Eighty-two E. coli strains isolated from urine specimens
were identiﬁed by standard microbiological methods, and investigated
for bioﬁlm production. The study consisted of two phases; in the ﬁrst
phase, adhesion capabilities of isolates to polystyrene microwells were
evaluated and accepted as bioﬁlm formation capability of bacteria.
Crystal violet microtiter plate based bioﬁlm assay described by
Christensen and colleagues was used for quantiﬁcation of bioﬁlm
formation. The optical densities (OD) of microwells were measured at
550 nm. Spectrophotometrically using an enzyme linked
immunosorbent assay reader. Bacteria were classiﬁed as non-bioﬁlm
formers, moderate bioﬁlm formers, and strong bioﬁlm formers
according to their abilities of bioﬁlm formation. In the second phase,
polystyrene microwells were coated with L. casei, L. plantarum and L.
fermenti spp. by incubation at 37C for 48 hours with suspensions of
these bacteria, and bioﬁlm formation of urinary E. coli isolates were
evaluated thereafter. Quantitation of bioﬁlm formation was performed
by ultrasonication and colony counting methods.
Results: In the ﬁrst phase of the study; 11 (13.42%) E. coli were
detected as strong, 39 (46.34%) E. coli as moderate, and 32 (40.24%) E.
coli as non- bioﬁlm forming strains. In the second phase; microwells
coated with Lactobacillus spp. were detected as 93% less bioﬁlm
formation allowing compared to the plates in the ﬁrst phase of the
study. The decrease in bioﬁlm formation was statistically signiﬁcant.
Conclusion: Although the results of our study indicated the fact that,
coating inorganic surfaces with Lactobacillus spp. suspension may
reduce E. coli colonization signiﬁcantly, we would like to underline the
need for further studies before accepting this as a strategy for the
prevention of bioﬁlm formation of urinary devices.
R2419 Decreasing antifungal susceptibility of different phases of
bioﬁlms formed by Candida albicans and Candida
parapsilosis
N. Kulkova*, H. Bujdakova (Trnava, Bratislava, SK)
Objectives: Mature Candida bioﬁlm, with its typical 3D structure
consisting of cells, hyphae/pseudohyphae and matrix, can strongly and
effectively protect cells against antifungal drugs. Bioﬁlms are often
resistant to commonly used antifungal agents and are formed on
catheters and surfaces of other medical devices thus acting as clinical
complication. The aim of this study was to evaluate susceptibility of
different phases of bioﬁlms formed by C. albicans and C. parapsilosis.
Methods: Six strains of C. albicans (two strains) and C. parapsilosis
(four strains) clinical isolates were included and bioﬁlm formation
under impact of ﬂuconazole (FLU) and caspofungin was evaluated.
Bioﬁlms were formed in 96-well microtiter plates. Antifungals were
added to forming bioﬁlm (i) in the beginning, (ii) after 90 minutes (after
adherence phase) and (iii) after 24 hours. Effect of added antifungals
was evaluated using XTT-reduction assay.
Results: Adding of antifungal in the very beginning of bioﬁlm
formation led to its full inhibition with MIC¢s maintained mostly on
low level. Higher MIC¢s both in FLU and CAS arm were consequence
of antifungals added to bioﬁlm after adherence phase. When antifungals
were added to preformed 24-hrs old bioﬁlm, any inhibition of its
forming did not occurred. Increase of MIC¢s is shown in Table 1 below.
Conclusion: Direct adding of FLU or CAS to cells with ability of
bioﬁlm formation can lead to full inhibition of its forming. Adding
antifungals in later phase of bioﬁlm formation has no inhibiting effect.
R2420 Expression of ALS1, ALS3 and CPAG_05056 genes in
dispersal cells and in bioﬁlm formed by Candida
parapsilosis and Candida albicans
N. Kulkova*, L. Cernakova, A. Soltysova, H. Drahovska,
H. Bujdakova (Trnava, Bratislava, SK)
Objectives: Adherence is the ﬁrst and critical step in process of bioﬁlm
formation and is associated with change in gene expression. There are
eight ALS genes involved in adherence of C. albicans and, previously,
some of them were proved to be upregulated during bioﬁlm formation.
In C. parapsilosis, ﬁve genes were described as ALS adhesins. In this
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study we aimed to evaluate the expression of one of those gene in C.
parapsilosis as well as expression of ALS1 and ALS3 in C. albicans
during different phases of bioﬁlm formation.
Methods: Real-time PCR was used to determine the level of gene
expression in three C. albicans strains and three C. parapsilosis strains.
We focused on expression of ALS1 and ALS3 genes in C. albicans and
CPAG_05056 gene in C. parapsilosis, compared to expression of
ACT1 gene as houskeeping gene. Primers for ACT1, ALS1 and ALS3
were prepared according to published data. Primers for CPAG_05056
were designed by our team. Expression was monitored in yeast cells, in
mature bioﬁlm and in dispersal cells detached from bioﬁlm. Obtained
data were evaluated using delta-delta-Ct method.
Results: ALS1 expression was higher in dispersal cells (6–26-times)
than in bioﬁlm or yeasts. Expression of ALS3 was considerably higher
in one C. albicans isolate dispersal cells, but was also increased in
bioﬁlm (3–24-times and 34-times respectively). C. parapsilosis
CPAG_05056 expression was considerably high in dispersal cells and
was increased in bioﬁlm cells too in case of two strains. Unfortunately
third C. parapsilosis strain showed no increase in expression.
Conclusion: In these experiments, we found out that expression of
adherence genes is high dispersal cells derived from bioﬁlm and in
bioﬁlm of C. albicans and C. parapsilosis, too. Our results suggest that
dispersal cells detached from bioﬁlm are, in some way, adapted to form
bioﬁlm in advance. We suppose, that more experiments should be done
to evaluate expression of other ALS genes in C. parapsilosis.
R2421 Dynamic in vitro of urogenital E. coli bioﬁlm by oestradiol
inﬂuence
A. Farinati, M. Quinteros, M. Arcos*, M. Marques, L. Sibert,
N. Rosiere, J. Garcia, A. Farinati (Martinez, AR)
Bacterial bioﬁlms are associated with a large number of persistent and
chronic infections like recurrent urinary tract infections (RUTI) in
posmenopausic women. The uropathogenic E. coli (UPEC) adherence
to perineal areas and vaginal mucosa is one of the ﬁrst steps to initiate
RUTI. The patients with this pathology were subjected to different
prophylactic antibiotic regimens but not always the improvement
occurs. Despite signiﬁcant advances in the understanding of UPEC
biology, it is not clear which factors are involved in the recurrence and
how to control the RUTI. In previous works we demonstrated the
different estrogen activity against vaginal and urogenital bioﬁlms.
Aim: To study the in vitro inﬂuence of Estradiol Hemisuccinate (EH)
on the E. coli BF dynamic as a model for non antibiotic strategy of
RUTI control.
Methods: one-Qualitative assay: we study 30 E. coli isolates from
urinary tract infections (UTI). The UPEC BF was investigated using a
previously described method. Brieﬂy, each UPEC were placed in six
tubes with Trypticase Soy Broth (TSB). After overnight incubation at
36C, one glass coupon (GC) was placed in each tube as an abiotic
surface. EH was added to four tubes (200 lg/mL) from the beginning
(2) and after 12 hours (2). The other two were used as controls. All
glass coupons were stained with crystal violet and readed at 12 and
24 hours after incubation at 36C, by optical microscope. Two-
Quantitative assay: we used microtiter assay (MA) to study the early
stage of BF formation and the EH concentrations (200–25 lg/mL)
inﬂuence. Following 12 and 24 hours of incubation and the remotion of
planktonic bacteria, the crystal violet coloration was employed. For
reading a RT-2100C microprocessor (absorbance mode with lambda
450 nm) was employed.
Results: EH improves UPEC BF in the early stage: is more thick and
homogeneous than the ones without EH, but at 24 hours fragmentation
and dispersion was shown in all isolates tested mainly in presence of
exuberant exopolisacharide. The EH activity could not be concentration
dependent because the different dilutions have not shown inﬂuence on
BF quantiﬁcation.
Conclusions: E. coli BF detachment and dispersion are factors to
consider as possible strategy to control postmenopausal RUTI. The
possibility of local estradiol application on women perineal area is
important to restrict the BF development, and the selective pressure due
to continuous employ of antibiotics in these patients.
R2422 Antimicrobial activity in catheter model E. coli bioﬁlm
susceptibility to adamant containing compound AM-166
Z. Suvorova*, N. Vrynchanu (Kiev, UA)
Purpose: Study of adamant derivative AM-166 potency to disturb
mature bioﬁlms developed by E. coli clinical isolate, received from a
patient with pyoinﬂammatory disease.
Materials and Methods: Compound’s Minimum Inhibitory
Concentration (MIC) was found by serial micro-dilutions in Mueller-
Hinton Broth (Guidelines MUK 4.2.1890–04). Catheter Dialock
Hemodialysis Access system was used to investigate aminoadamantan
derivative effect on E. coli ﬁlm forming disturbance. Test
microorganisms were incubated in Trypticase Soy Broth (TSB,
bioMe´rieux SA, France), subsequently diluted to 5–60 CFU/0.1 mL
in TSB. Of 0.15 mL of the broth with test microorganisms was
introduced in the catheter lumina and the catheter was incubated
overnight at 37C. After completion of the incubation, 1.0 mL of AM-
166 was introduced with syringe to the catheter. The catheter distal end
was then sealed and incubated in ﬂat position for 72 hour at 37C. After
completion of the incubation, the catheter surfaces were treated with
alcohol. Clip opened, liquid from the catheter was transferred to a sterile
test tube. The catheter was washed with 0.1 mL of TSB and the ﬂuid
was transferred to a sterile test tube. From the central part of the
catheter, a section (approximately 5 cm) was aseptically cut out and put
into a sterile test tube with 3 mL of TSB. After ultrasonication during
1 minute and shaking during 15 second, colour density was assessed by
Adsorbance Microplate Reader Elx808 (BioTeK, USA). AM-166 was
studied at 1.0 MIC, 2.0 MIC, and 5.0 MIC.
Results: Our experiments have shown, that MIC of AM-166 with
respect to E. coli is 0.39 lg/mL. Experimental results evidence, that all
studied AM-166 concentrations cause damage to mature E. coli bioﬁlms.
It was established that the compound’s efﬁciency at 5.0MICwas 94%, at
2.0 MIC – 86%, and at 1.0 MIC – 42% with respect to control.
Conclusion: So, aminoadamantan derivative causes dose-dependent
damage to E. coli bioﬁlm. In future, the task will be to investigate
inhibitory effect of AM-166 with respect to bioﬁlms developed by
various microorganisms, speciﬁcally by S. aureus, P. aeruginosa. In the
longer term, it is necessary to investigate in order to establish effect of
catheter chemical composition on bioﬁlms formation and AM-166
efﬁciency with various composition catheters.
R2423 Bioﬁlm and virulence factors in Proteus bacteria from
catheter-associated urinary tract infections
T. Peroutkova*, V. Hola (Brno, CZ)
Objectives: The number of the catheter associated urinary tract
infections (CAUTIs) increases every year. Over 40% of nosocomial
infections are infections of the urinary tract, especially infections of
catheterised patients. With the inserted catheter, the bacteria can more
easily attack urinary tract. For effective combat with CAUTIs, it is
necessary to understand virulence factors and possible linkages among
their production. In this work we focused on the proof of bioﬁlm
formation in various conditions and selected virulence factors in the
bacteria of the genus Proteus.
Methods: From the CAUTIs we isolated 102 strains of the genus
Proteus. As a control group we included 50 strains of the genus Proteus
isolated from stool of healthy people. With isolated strains we
performed tests for virulence factors: bioﬁlm formation in Brain
Heart Infusion (BHI) and in BHI with addition of 4% of glucose (BHI-
g), tests for swarming, swimming and twitching motility, the ability to
attach to various types of catheters, the ability to swarm over various
types of catheters, the production of urease, and the susceptibility to
selected antibiotics.
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Results and conclusion: There were differences between the group of
strains isolated from CAUTIs and control group in several virulence
factors – the bioﬁlm formation in BHI with and without glucose
supplementation (p << 0.001; t = 5.105 and p << 0.001; t = 6.859,
respectively), the twitching motility (p = 0.012; t = 2.548), and the
swarming over one type of catheter – the Argyle Catheter (p = 0.023;
t = 2.297). The ability of the isolates to swarm over particular catheters
was different in both tested groups of isolates (H [6,
N = 714] = 233.7864; p << 0.01; H [6, N = 350] = 81.07407;
p << 0.01, respectively). The differences may be caused by different
hydrophobicity of the catheters. The surface hydrophobicity varies even
in catheters from same material, but from different suppliers. The
results of this study show, that genus Proteus is well adapted to the
survival in the host body. Identifying and understanding of particular
virulence factors is necessary for prevention and treatment of CAUTIs.
The choice of the catheter based on the knowledge of its properties,
especially as the bacterial adherence and swarming ability are
concerned, could lead to decrease of risk of CAUTI in patients,
which is an important aim. The research was funded by grants IGA MZ
9678 and MSMT INGO LA10037.
R2424 Evaluation of relationships among virulence factors of
Pseudomonas aeruginosa strains isolated from catheter-
related infections
K. Olejnickova*, V. Hola, F. Ruzicka (Brno, CZ)
Modern health care is associated with increasing ratio of invasive
surgery and immunocompromised patiens, which are highly susceptible
to nosocomial infections. Pseudomonas aeruginosa is common noso-
comial pathogen. Due to the high antibiotic resistance these infections
are difﬁcult to eradicate. P. aeruginosa is equipped with a large arsenal
of cell associated and secreted virulence factors. The aim of this study
was to evaluate production of selected virulence factors of 80 catheter-
related isolates and to ﬁnd potential relationships among them.
Antibiotic resistance was evaluated by disc diffusion method, assay for
detection of beta-lactameses was performed as double-disc synergy test
(metallo-beta-lactamase secretion was conﬁrmed by spectrophotometric
assay). Formation of submersial bioﬁlm was tested in microtiter plate,
whereas air-liquid interface (A–L) bioﬁlm was observed in test tube.
Effectiveness of the antibiotic lock technique (with amikacin, ciproﬂ-
oxacine or ethanol) against selected bioﬁlm-positive strains was tested
as well. Different types of motility were detected by plate test with
medium solidiﬁed with different amount of agar. Elastolytic activity of
the strains was tested by elastin-congo red assay. Haemolysins were
evaluated by spectrophotometric assay as the amount of released
haemoglobin. Siderophores occurence was observed by plate test.
Production of hemolysins, LasB elastase, pyoverdine and bioﬁlm
formation (both submesial and A-L) were commonly observed among
strains. All strains further showed one or more types of motility. In
contrast, secretion of pyocyanine and pyochelin was poor. Colistine and
amikacin were the most effective antibiotics. One day bioﬁlm was
eradicated by the solution of 30% ethanol with 4% trisodium citrate,
amikacin 1 and 1 mg/mL ciproﬂoxacine. Positive correlation was
observed among production of several extracelular virulence factors
(LasB elastase and haemolysins, pyochelin and pyocyanine; pyocya-
nine and LasB elastase) and between submersial and A-L bioﬁlm
formation. On the other hand we detected negative correlation between
submesial as well as A-L bioﬁlm and LasB elastase production.
Interestingly, siderophores sectetion was negatively correlated with
submersial bioﬁlm and positively with A-L bioﬁlm. All correlations
were signiﬁcant at p = 0.05 and correlation coefﬁcient gamma > 0.50.
This work was supported by the Grant Agency IGA MZ CR 9678 and
INGLO LA 10037.
R2425 Antibiotic susceptibility patterns of bioﬁlms of
vancomycin resistant and susceptible enterococci under
conditions of oxygen limitation in vitro
J.K. Hart*, D. Hewson, M. Petrou, C. Thomas (London, UK)
In-vitro studies of bioﬁlms (BF) of pathogenic microorganisms are
typically carried out under standard aerobic conditions, however this
does not always reﬂect the true nature of in-vivo infections & the
possible effects of reduced oxygen environments encountered through-
out the body. Furthermore, the interior of mature bioﬁlms have been
shown to be anaerobic in nature. Previous studies have established that
planktonic forms of enterococci can exhibit increased resistance the
aminoglycosides under anaerobic conditions, but whether a similar
trend exists for BF of the organism has yet to be examined. A study was
therefore carried out to establish whether BF of enterococci exhibit
altered antibiotic resistance patterns when cultured and exposed under
reduced oxygen environments in-vitro. Twelve clinically derived
isolates obtained from active infections comprising three each of
VRE-faecium, VRE-faecalis, VSE-faecium and VSE-faecalis were
cultured as BF using an established 96-well microtitre plate platform
under strict aerobic, microaerophilic and anaerobic conditions. The
isolates were chosen from a larger pool of 90 organisms due to the fact
that they produced BF of similar mass, to minimise any effect this may
have on antibiotic response. Forty-eight hour old BF were exposed to
eight antibiotic agents commonly used against enterococci for clinical
infections (amikacin, gentamicin, rifampicin, tetracycline, imipenem,
meropenem, ampicillin and linezolid) for a period of 24 hours. The
resultant reduction in metabolic activity was measured against untreated
BF using the XTT assay. Testing was also carried out against the same
organisms in planktonic form using NCCLS methodology. Variance in
antibiotic response to the aminoglycosides was noted for planktonic
forms of the organism under anaerobic conditions, as was expected,
however no variance in activity to any of the antibiotics was observed
against BFs regardless of atmosphere. This suggests that the mecha-
nisms contributing to altered antibiotic resistance for planktonic forms
of the organism do not exist in BF state, or the variances were too small
to be measured against the higher antibiotic concentrations using in BF
testing. These results indicate that a range of antibiotics, including the
aminoglycosides, may be suitable for use against BFs in environments
where reduced oxygen concentrations are encountered, or in applica-
tions such as in antibiotic lock therapy.
R2426 Microbial bioﬁlm on laryngeal voice prosthetic devices
B. Ticac*, T. Rukavina, R. Ticac (Rijeka, HR)
Objectives: The durability of voice prostheses after their implantation
is variable, and the most frequent reason for replacing a voice prosthesis
is leakage of ﬂuids into the trachea due to valve insufﬁciency, which
mainly is caused by bioﬁlm formation. The physiological ﬂora of the
neopharynx and the tracheostoma created in laryngectomized patients
are predisposing factors for adherence of microorganisms to the surface
of voice prostheses. The aim of this presentation was to characterize
with great precision the presence of individual microorganisms and the
most frequent microbial combinations in the bioﬁlm of the indwelling
voice prosthesis in situ.
Methods: The study was performed by retrospective analysis of data
archived at medical documentation of the Clinical Medical Centre and
the Teaching Institute of Public Health in Rijeka. During the analyzed
period, voice rehabilitation in laryngectomized patients was performed
by implanting a Provox2 voice prostheses (Provox2; Atos Medical AB,
Sweden). In total 100 implanted prostheses were microbiologically
processed. The bioﬁlm was removed from the valve by scraping and
rigorous homogenization in saline. The composition of the microﬂora
found in the bioﬁlm was determined by plating 0.1 mL of the
homogenate on nutritional substrates for cultivation of fungi Sabouraud
agar, chromagar Candida plate (CHROMagarTM Candida, BD
Diagnostics, USA), and the blood agar for the culture of bacteria.
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Identiﬁcation of isolated strains was performed using standard
laboratory protocols and commercial kits (API bioMerieux, France).
Results: Out of the total of 292 isolates, 67% were bacteria and the
remaining 33% were yeasts. Simultaneous presence of bacteria and
fungi was established in 83% of the processed voice prostheses; in 16%
of samples the bioﬁlm contained only one or more bacterial species.
The most frequently found yeast species on voice prostheses bioﬁlms
was C. albicans, followed by C. krusei and C. tropicalis. The most
frequently isolated bacteria included Staphylococcus aureus,
Pseudomonas aeruginosa, Escherichia coli, Proteus mirabilis and
Streptococcus agalactiae. The median lifetime of the voice prosthetic
devices was 180 days.
Conclusion: Dividing the prostheses in four groups according to the
composition of bioﬁlm revealed that the device lifetimes varied
signiﬁcantly between groups. The longest lifetime of voice prostheses
was associated with the presence of single fungal isolate in combination
with bacteria.
R2427 Detection of autoﬂuorescence in bioﬁlms formed by
rapidly growing mycobacteria
M.C. Mun˜oz-Egea*, M. Garcı´a-Pedrazuela, M.J. Garcı´a,
J. Esteban (Madrid, ES)
Objectives: To study the distribution and the behaviour of the
autoﬂuorescence in a bioﬁlm formed by rapidly growing mycobacteria.
Methods: Mycobacterium fortuitum ATCC 6841 and Mycobacterium
abscessus DSM 44196 were used in the experiments. The bioﬁlm
development test was made using hydrophobic, uncoated sterile 2 · 4-
well plates, which were incubated at 37C on an orbital shaker (80 rpm)
during 24, 48, 72 and 96 hour. The medium was changed daily until the
end of the experiment. The wells were stained using Live/deadª
BacLightª and Nile Redª stains and analysed with a confocal laser
scanning microscope. One set of wells was used to study both
autoﬂuorescence and Nile Redª stain, and the other one to analyse the
proportion of live and dead mycobacteria. Thickness was measured
eight times/well in predeﬁned points of each well. All experiments were
performed in triplicates for each strain.
Results: Both strains increased their thickness according to the
incubation time: M. fortuitum bioﬁlm reached a maximum thickness
at 72 hours (23.11 ± 4.35 lm), whileM. abscessus bioﬁlm reached it at
96 hours (13.60 ± 6.21 lm). The sample standard deviation of M.
abscessus is higher because its bioﬁlm surface is more irregular than
that of M. fortuitum. Percentage of covered surface at 96 hour was also
higher for M. fortuitum (43.15 ± 15.34%) than for M. abscessus
(39.10 ± 32.24%). The highest value of covered surface proportion was
achieved at 48 hour in M. fortuitum (69.35 ± 1.63%), while achieved at
96 hour in M. abscessus. Mature bioﬁlm of both strains tends to be
detached partly at long incubation times, a fact that could explain these
ﬁndings.
The detection of autoﬂuorescence in both species is similar, being
higher when the percentage of covered surface is lower. There is a
concordance between the Nile Redª stained bacteria and those who
emitted autoﬂuorescence. At the same time, the proportion of live and
dead mycobacteria in the bioﬁlm showed that all bacteria were alive.
We also detected the presence of autoﬂuorescence outside bacterial
cells in both species, with irregular distribution inside the bioﬁlm.
Conclusions: Mycobacterial bioﬁlms showed the presence of
autoﬂuorescence not only inside the cells but also in the extracellular
matrix. Detection of autoﬂuorescence could be useful for future studies
of the mycobacterial bioﬁlm structure.
R2428 The effects of different physico-chemical stressors on
bioﬁlm-associated Legionella pneumophila survival
C. Vatansever, I. Tu¨retgen* (Istanbul, TR)
Objective: The aim of this study was to evaluate the survival against
different physical and chemical stressors of bioﬁlm-associated
Legionella pneumophila, which is the etiologic agent of
Legionnaires’ disease. Legionnaires’ disease is usually seen as a
serious form of pneumonia that carries with it a fatality rate in the order
of 10–15%.
Methods: Heterotrophic mixed bioﬁlms were allowed to develop for six
months on glass coupons in a bench-scale bioﬁlm reactor, which was
experimentally infected by L. pneumophila ATCC 33152 strain.
Coupons have been analyzed for L. pneumophila bacteria using BCYE
plating, after 24 hours exposition to different conditions of temperature
(4 and 60C), pH (pH 3, 5 and 11), osmotic stress (ultra pure water and
3 M salt solution) and disinfectant (2, 500, 1000 ppmmonochloramine).
Results: Legal dose of 2 ppm of monochloramine was found
ineffective against bioﬁlm-associated L. pneumophila, whereas shock
treatment (500 and 1000 ppm) was found signiﬁcantly successful to
ﬁght against this bacterium where applicable. Exposure to 60C was
inefﬁcient to kill all L. pneumophila, which is generally used as heat
treatment method in man-made water systems for decontamination.
Signiﬁcant amount of L. pneumophila bacteria also resists pH 11 and
3 M salt solution. But the acid-tolerant bacteria showed signiﬁcant
decrease on exposure to pH 3, whereas pH 2.2 acid solution is widely
used to isolate this bacterium from mixed microﬂora. No signiﬁcant
change was observed after exposure to 4C, ultra pure water, pH 3 and 5.
Conclusion: Bioﬁlm is essential for the survival and multiplication of
L. pneumophila. Interestingly, the growth of other environmental
organisms stimulates the growth of L. pneumophila in aquatic
environments. An infectious dose level for L. pneumophila has not
been established, however low numbers of this bacterium possess risk
for public health. Since man made water systems are ideal incubators, L.
pneumophila could multiply in a very short time. The prolonged
persistence of pathogen bacteria in aquatic bioﬁlms serves as a reservoir
and detachment through shear forces or another mechanisms permits
continuous pathogen intrusion into bulk water. Due to the problem of
resistance and potential environmental impacts, alternative strategies for
Legionella control need to be investigated and put to practice.
R2429 The prevalence of implant-associated bioﬁlm infections
S. Eickhardt*, A. Gheorghe, M. Alhede, C. Moser, S. Sørensen,
L. Hansen, M. Givskov, H. Hougen, N. Høiby,
T. Bjarnsholt (Copenhagen, DK)
Objectives: Currently, the presence of an implant associated bioﬁlm
infection is primarily suspected when the patient shows clinical
symptoms of infection or repeated positive cultures with low virulent
microorganisms. However, since bioﬁlms may consist of extremely
slowly growing persisters and/or microorganisms only inducing minor
inﬂammation, we believe that the actual amount of such infections may
be underestimated. Therefore, the present study was designed to
investigate the prevalence of bioﬁlm on implants and in the surrounding
tissue of deceased humans.
Methodology: Implants and implant-associated material from
deceased humans without a history of implant failure or inﬂammation
associated with the implant were included in the study. From each case
the following was collected; tissue adjacent to the implant and if
possible the implant itself as well as control tissue from an unrelated
part of the body. The collected samples were subjected to Peptide
Nucleic Acid – ﬂuorescent in situ Hybridization (PNA-FISH) and
visualized by Confocal Laser Scanning Microscopy (CLSM) to
determine the presence of any microbial infections. To determine the
presence of an immune response, HE (Hematoxylin and Eosin) stained
samples was also included in the study. To identify the present
microorganisms, part of the 16 second and the D2 LSU rRNA genes
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were sequenced and the results compared to validated databases. When
deemed necessary and when possible, deep sequencing was performed
to get a more accurate description of the infecting microorganisms.
Results: Including controls, our preliminary study consisted of 42
tissue samples and eight implants from a total of 21 cases. We found an
infection rate of approximately 52% (11 out of 21), when correcting for
suspected post mortem contamination. Interestingly, the microbial
ﬁndings were almost solely pathogenic and non – pathogenic fungi,
which is in contrast with what is seen after revision surgery where
ﬁndings primarily are bacterial.
Conclusion: The data from the present study on post-mortem material
shows that there is a much higher incidence of implant colonization
than initially anticipated, especially with fungi.
R2430 Antibioﬁlm and quorum quenching activity of
bio-emulsiﬁer from coral-associated Streptomyces sp.
A. Padmavathi*, S. Karutha Pandian (Karaikudi, IN)
Objectives: Emergence of multidrug resistant pathogens made the
world to switch over to post antibiotic era. Bioﬁlm formation is an
important mechanism for microbial survival and resistance to many
antibiotics. Pathogens living in bioﬁlms are more resistant to antibiotics
than their planktonic counterparts. Bioﬁlm formation on medical
devices causes severe nosocomial infections and poses critical threats to
human wellbeing. Bioﬁlm infection can be minimized by inhibiting the
initial stage of bioﬁlm formation and subsequent growth. Novel
antibioﬁlm compounds are required to combat bioﬁlm related
infections. Coral ecosystem, an untapped reserve for novel bacteria
was explored for bio-emulsiﬁer producers anticipating that
biomolecules from such bacteria will be of new type.
Methods: Antibacterial activity of Coral Associated Streptomycetes sp.
(CAS) was tested against representative Gram negative bacteria
(Chromobacterium violaceum, Pseudomonas aeruginosa ATCC
10145 and Serratia marcescens), since an ideal quorum quenching
agent should not possess any bactericidal activity. Quorum quenching
activity of CAS was tested against C. violaceum (QS reporter strain).
Quorum quenching and antibioﬁlm activity of CAS was evaluated by
quantitative and qualitative methods. The bio-emulsiﬁer extracted was
characterized by TLC and FTIR spectroscopy. Minimum bioﬁlm
inhibitory and disruption concentrations were determined.
Results: Out of 23 coral associated bacteria screened, seven isolates
were found to be bio-emulsiﬁer producers. Bio-emulsiﬁer from strain
U23 was tested for antibioﬁlm activity against representative Gram-
negative bacteria (C. violaceum, P. aeruginosa ATCC 10145 and S.
marcescens). 16S rRNA gene sequence analysis revealed that strain
U23 is Streptomyces sp. (JN315778). CAS completely inhibited
violacein production of C. violaceum. Bio-emulsiﬁer from CAS has
shown inhibition of bioﬁlm formation and disruption of mature bioﬁlms
at signiﬁcantly lower concentrations (200 lg/mL). It inhibits the QS
controlled virulence factors like swarming, bioﬁlm formation,
production of pigment and extracellular enzymes in S. marcescens
and disrupts EPS in P. aeruginosa.
Conclusion: Bio-emulsiﬁer from coral associated Streptomycetes sp.
thus effectively acts as potent antibioﬁlm agent. Further puriﬁcation and
characterization will reveal the nature of the antibioﬁlm agent.
R2431 Combined activity of colistin with human
polymorphonuclear neutrophils against Pseudomonas
aeruginosa bioﬁlms
A. Chatzimoschou*, C. Antachopoulos, T.J. Walsh,
E. Roilides (Thessaloniki, GR; New York, US)
Background: Chronic Pseudomonas aeruginosa (PA) airway
infection constitutes the primary cause of bronchial inﬂammation and
respiratory deterioration in cystic ﬁbrosis (CF) patients. It is
predominantly caused by bioﬁlm (BF)-producing strains frequently
resistant to multiple antibiotics. Little is known about the effects of
polymorphonuclear neutrophils (PMNs) against PA BFs in combination
with clinically useful antibiotics. Our aim was to examine the activity of
PMNs alone and in combination with colistin (CST), an antibiotic
active against multi-resistant PA, against PA BF in comparison to their
activities against planktonic cells (PL).
Methods: Two clinical PA isolates from CF patients were used, one
resistant (CLSI MIC 4 mg/L) and one susceptible (1 mg/L) to CST.
Both strains were grown in Muller-Hinton broth. BFs were grown in
96-well plates at 37C for 48 hour. CST (1, 4, 16 mg/L) and human
PMNs (E:T ratios 1:20 or 1:10), alone or in combination, were
incubated with BF or PL at 37C 5% CO2 for 24 hour. BF formation
and antibacterial activities were assessed by metabolic XTT assay.
ANOVA was employed (n = 6). Synergy was deﬁned when the
observed bacterial damage produced by the combinations of PMNs and
CST was signiﬁcantly higher than the expected sum of damages
produced by PMNs or CST alone; additivity was deﬁned when the
observed damage produced by the combination was signiﬁcantly higher
than the damages produced by PMNs or CST alone.
Results: PMNs damaged PL and BF in an E:T ratio-dependent pattern;
however, PMN-induced damage of BF was signiﬁcantly lower than that
of PL even when PMNs were combined with CST for both strains.
When PMNs at 1:20 were combined with 16 mg/L CST for BF of R or
4 mg/L for BF of S strain, synergistic effects were noted. By
comparison, additive effects were noted when PMNs were combined
with 1 or 4 mg/L CST for BF of R strain. At E:T 1:10, PMNs combined
with CST (1 and 4 mg/L) had synergistic effects on BF of S strain. No
signiﬁcant interaction was noted between PMNs and CST on PL
damage for both strains at all conditions tested. At all conditions tested
(CST alone or combined with PMNs), no signiﬁcant differences in BF
damage were noted between the two clinical isolates (S and R).
Conclusions: BFs of PA strains that are either S or R to CST are
signiﬁcantly less susceptible than PL to the activities of PMNs and CST
alone or in combination. However, PMNs and CST combinations tested
exhibit additive or synergistic effects on BFs of PA.
R2432 Interactions of the triple combination of voriconazole,
amikacin and polymorphonuclear neutrophils against
mixed bioﬁlms of Candida albicans and Pseudomonas
aeruginosa
A. Chatzimoschou*, M. Simitsopoulou, C. Antachopoulos, T.J. Walsh,
E. Roilides (Thessaloniki, GR; New York, US)
Objectives: Candida albicans (CA) forms multispecies microbial
communities, known as mixed bioﬁlms (MBF), with various bacterial
species including Pseudomonas aeruginosa (PA). CA and PA also
interact with each other to cause mixed infections in humans. The
establishment of MBF of CA and PA has important clinical
implications requiring vigorous treatment as microorganisms exhibit a
high level of resistance to antimicrobials and are protected from host
defenses. Our aim was to study the combined activities of PMN with
two antimicrobial agents, AMK and VRC, against MBF of CA and PA
in comparison to their corresponding planktonic cells (PL).
Methods: CA-M61, a BF-producing CA strain, and a clinical PA
isolate from a cystic ﬁbrosis patient were used. MBF were grown in 96-
well plates in RPMI at 106 cells/mL at 37C/48 hour. PL of CA and PA
were grown in RPMI or in Muller-Hinton broth, respectively, at 37C/
24 hour. PL and BF were then incubated for 24 hour with twofold
dilutions of amikacin (AMK) (1–64 mg/L for PL and 4–256 mg/L for
BF) and VRC (0.125–64 mg/L for PL and 0.5–256 mg/L for BF) and
PMNs. PMNs from healthy donors at E:T ratios 1:1 or 1:2 were
incubated further for 24 hour alone or in combination with AMK and
VRC, simultaneously in a checkerboard format. Damage induced by
both antimicrobial agents to PL and MBF was assessed by XTT assay.
The interactions between AMK combined with VRC and PMNs were
analyzed using the Bliss surface model. Synergy was concluded when
the observed damage was signiﬁcantly higher than the expected sum of
damages; whereas, additivity was deﬁned when the observed damage
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was signiﬁcantly higher than each component but where synergy was
not achieved. ANOVA (n = 6) with Dunnett’s test was performed.
Results: Against PL, a synergistic interaction was observed when 8–
64 mg/L of AMK were combined with 0.125–4 mg/L of VRC in the
absence of PMN or in the presence of PMN at E:T 1:1. At E:T 1:2, a
synergistic interaction was observed when 16–64 mg/L of AMK were
combined with 0.25–1 mg/L of VRC. Against BF, the above drug-drug
and drug-PMN combinations demonstrated indifferent interactions.
Conclusions: The triple combination of voriconazole (VRC) with
AMK and polymorphonuclear neutrophils (PMN) against PL mixtures
exhibits synergistic interactions. By comparison, the interactions
against MBF are indifferent. These in vitro interactions between an
antipseudomonal and an antifungal agent with PMN suggest differential
interactive effects of these antimicrobial agents in the treatment of
mixed infections.
R2433 Phenotypic and genotypic characterisation of coagulase
negative staphylococci isolated in blood cultures from
patients with haematological malignancies
W. Achour*, O. Bouchami, M.A. Mekni, R. Baaboura, H. Ksouri,
A. Ben Hassen (Tunis, TN)
Introduction: We studied the production of bioﬁlm in coagulase
negative staphylococci (CNS) isolated from bacteremia in patients
hospitalized in the bone marrow transplant centre of Tunisia during 10-
year period (1998–2007). In addition, we analyzed the relationship
between bioﬁlm production and detection of adherence and
antimicrobial resistance genes.
Material and Methods: Forty nine CNS were isolated in 45 patients
with bacteraemia: 13 catheter related bacteraemia (CRB) and 36 non
CRB (NCRB). Quantitative determination of bioﬁlm production was
performed by using a microtiter assay. PCR was used to detect the
presence of icaA, icaB, icaC, atlE, aap gene and 13 antimicrobial
resistance genes. The chromosomal DNA of methicillin resistant
isolates was digested with SmaI and was separated by pulsed-ﬁeld gel
electrophoresis (PFGE).
Results: CRB did not differ signiﬁcantly from NCRB isolates in their
ability to form bioﬁlm but they were signiﬁcantly more resistant to
tetracycline (p < 0.01) than NCRB isolates. In addition, the ica A, B
and C genes were signiﬁcantly (p < 0.05) more prevalent in CRB than
were in NCRB isolates. Resistance to clindamycin (50% vs. 20%,
p < 0.001) and rifampin (64.3% vs. 48.6%, p < 0.05) was
comparatively higher among bioﬁlm producers than non-bioﬁlm
producers. In addition, there was a signiﬁcant association
(p < 0.0001) between the strong bioﬁlm-producer phenotype and
harboring the ica operon and atlE and aap concomitantly.
Among the erythromycin-resistant strains the most prevalent macrolide
determinant was msr(A) (53.6%). The most important gene coding for
aminoglycoside resistance, aac(6¢)-Ie-aph(2¢¢), was detected in 77.6% of
the isolates. Seven out of eight tetracycline-resistant strains harboured
the tet(K) gene and one strain carried tet(K) and tet(M) genes.
Conclusion: Signiﬁcant association between bioﬁlm production and
resistance to antimicrobials (clindamycin and rifampin) and between
strong bioﬁlm-producer phenotype and harboring concomitantly ica
operon and atlE and aap. Moreover, signiﬁcantly higher resistance to
tetracycline and higher prevalence of the ica A, B and C genes in CRB
than in NCRB isolates.
R2434 The effect of low molecular weight chitosan upon bioﬁlm
formation by C. albicans and E. faecalis
P.A. Ramalho*, A. Silva-Dias, R. Rocha, I. Pina-Vaz, M.F. Carvalho,
C. Pina-Vaz, A.G. Rodrigues (Porto, PT)
Objectives: The use of the antimicrobial properties of chitosan in
dentistry is at present the subject of several studies. We aim the
development of new formulations of this compound to prevent the
growth of microorganisms responsible for pulpal and periapical
inﬂammation and disease.
Methods: In this work, we have determined the minimal inhibitory
concentration (MIC) accordingly to the reference protocols CLSI (M27-
A3 for yeasts and M07-A8 for bacteria) and the minimal lethal
concentration (MLC) on planktonic cells of C. albicans ATCC 90028
and E. faecalis ATCC 2912 of 5 diferent chitosans. The chitosans used
were: low molecular weight (LMW), medium molecular weight
(MMW), high molecular weight (HMW), a mixture in equal parts of
high and medium molecular weight (H + M) and a mixture in equal
parts of high and low molecular weight (H + L). The effect of LMW
chitosan was also accessed upon adhesion, bioﬁlm formation and
disaggregation using a model that simulated the teeth – hidroxyapatite
discs, and in RPMI medium.
Results: The results showed that MIC for all simple chitosans samples
is similar. Since low molecular weight chitosan has been described to
be more biocompatible and with less secondary effects, we decided to
use this compound in subsequent studies. The results showed a
reduction in adhesion of 56%, 37% and 26% for 7.5, 3.75 and
0.029 mg/L of LMW chitosan respectively. The effect upon bioﬁlm
formation was at MIC and over MIC concentrations, higher ((90%).
These concentrations managed to inhibit almost completely bioﬁlm
formation. Preliminary results on disaggregation also showed the
efﬁciency of this compound.
Conclusions: Our results show the potential of LMW chitosan on
blocking the formation and on removing teeth bioﬁlm, preventing the
development of periapical and pulpal diseases.
R2435 Phenotyping and genotyping of 57 S. epidermidis isolates
from colonized CVC. Is strain ability to produce slime
related to microscopic bioﬁlm characteristics?
F. Tessarolo*, M. Lorenzato, F. Piccoli, M. Cavallo, L. Fracchia,
G. Nollo, P. Caciagli, E. Geat, I. Caola (Trento, Novara, IT)
Objectives: To test if a relation is present between phenotypic or
genotypic characteristics of Staphylococcus epidermidis strains isolated
from colonized central venous catheters (CVC) and
micromorphological features of bioﬁlm formed on catheter tips in
patients.
Methods: Of 57 S. epidermidis strains were isolated, in a signiﬁcant
load, from 57 CVC tips (Cleri method). Immediately after cultural test,
CVC tips were washed twice in HEPES buffer and stored in 2.5%
glutaraldehyde in HEPES. A 5 mm long segment was then aseptically
isolated with a scalpel from the distal portion of the tip, dehydrated in
ascending alcohol, dried, gold sputtered and observed by scanning
electron microscopy (SEM). Each lumen and the external surface of the
segment were checked for the presence of the following
micromorphological features: ﬁbrin network (FN), white blood cells
(WBC), and microbial bioﬁlm (MB) (Fig. 1). Phenotypic characteristics
of the isolated strains were assessed by congo red agar test (tryptone soy
agar, 36 g/L dextrose, 0.8 g/L congo red) according to the colorimetric
scale proposed by Arciola et al. (2002). Almost black, black, and very
black colony former strain were considered as slime producer. Speciﬁc
primers for icaA, icaB, icaC, icaR, icaD were used for the identiﬁcation
of the genes encoding for slime synthesis. Strains were considered
positive to ica locus when all genes were detected. Contingency tables
comparing each SEM feature to phenotypic and genotypic
characteristics were realized and Fisher’s exact test was performed for
statistical signiﬁcance.
Results: Positive percents for phenotypic and genotypic tests were
28.0% (16/57) and 52.6% (30/57) respectively. Strains exhibited the
following colonies colour: very red (22.8%), red (29.8), bordeaux
(19.3%), almost black (15.8%), black (5.3%), very black (7.0%). All
bordeaux colonies were ica positive. None of the tested ica genes was
present in ica negative strains. FN, WBC and MB were found in 40, 21
and 31 catheters respectively. However, no statistically signiﬁcant
relation was found between any of the three micromorphological
features and the strain phenotype or genotype.
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Conclusion: Microscopic features, as FN, WBC and MB, are
frequently observed by SEM on CVC removed from patients but no
signiﬁcant relation to the strain ability of producing slime was found. A
larger number of samples is desirable for considering biologic
variability of bioﬁlm and patients.
R2436 Bioﬁlm producing ability of Salmonella Typhimurium
BK4, isolated From Turkey
B. Karaca*, F.N. Yuksel, O. Gunay, M. Diani, M.N. Badali, B. Yavas,
N. Akcelik, M. Akcelik (Ankara, TR)
Objectives: The bioﬁlm forming characteristics of 140 Salmonella
strains (99 serotyped and 41 genus level identiﬁed), originated from
Turkey was investigated. Salmonella strains were evaluated for their
bioﬁlm morphotype properties on Congo Red agar plates. Additionally,
all strains evaluated according to their pellicle structure forming,
physical differences of pellicle, and the alterations in the media along
with the pellicle forming and for cellulose existence in the bioﬁlm
matrix.
Methods: One hundred and fourty strains were tested for bioﬁlm
forming characteristics on Congo Red (CR) agar plates. Also, all
Salmonella strains were screened on LB agar wo/NaCl containing
200 lg/mL calcoﬂour for screening absence or presence of cellulose
under UV light. For pellicle production, overnight cells were diluted
(1:100) in fresh LB agar wo/NaCl and incubated at 20C for eight days.
The strains were visually examined according to their pellicle forming
abilities and classiﬁed. Furthermore, effects of temperature (5, 20 and
37C), pH (4.5, 5.5, 6.5, and 7.4), NaCl concentration (0.5%, 1.55,
5.5%, and 10.5%) on bioﬁlm forming was assessed in microtiter plates.
Same parameters were also tested on stainless steel surfaces. All
experiments were performed in triplicate.
Results: Turkey originated Salmonella Typhimurium BK4 strain was
determined as the strongest bioﬁlm producer (OD: 3.418). The optimum
temperature for bioﬁlm producing was determined as 20C for
Salmonella Typhimurium BK4. When NaCl concentration increased
in the growht media, bioﬁlm production of BK4 was dramatically
decreased. On the other hand, pH values exhibited variable effects on
bioﬁlm forming feature of BK4 on both polystyrene and stainless steel
surfaces.
Conclusion: Salmonella Typhimurium BK4 strain can adhere and
form bioﬁlms on both polystyrene and stainless steel surfaces. Bioﬁlm
formation is signiﬁcantly inﬂuenced by pH, NaCl concentration and
temperature.
R2437 Multi-drug resistance in canine pyoderma isolates of
Staphylococcus pseudintermedius associated to bioﬁlm
formation and to IS256 insertion element
P. Casagrande Proietti*, A. Bietta, M.L. Marenzoni, M. Coletti,
F. Passamonti (Perugia, IT)
Objectives: Staphylococcus pseudintermedius is the most frequent
staphylococcal species isolated from canine pyoderma. The control of
S. pseudintermedius infection is often difﬁcult due to the expanded
antimicrobial resistance phenotypes. Antibiotic resistance in
staphylococcal pathogens is often associated to bioﬁlm formation and
to mobile genetic elements such as the insertion sequence IS256 that
was ﬁrst described as a part of the transposon Tn4001, which confers
aminoglycoside resistance in S. aureus and in S. epidermidis. The
present study was carried out to determine the prevalence of antibiotic
resistance, the bioﬁlm formation and the presence of IS256 aspects not
yet investigated in S. pseudintermedius.
Methods: Thirty-six S. pseudintermedius isolates from canine
pyoderma were identiﬁed using RFLP assay. Susceptibility to a panel
of fourteen antimicrobial agents was determined by the disk diffusion
method in Mueller-Hinton agar and MRSP isolates were detected by
subculture on screening agar base medium. Bioﬁlm formation was
investigated by the tissue culture plate method. The presence of IS256
insertion element was characterized by PCR.
Results: All S. pseudintermedius isolates showed multidrug-resistance
((6 antibiotics); in particular the highest antibiotic resistances were
observed toward to penicillin and trimethoprim-sulfamethoxazole
(94%) and clindamycin (92%). Noteworthy MRSP rate (56%) was
higher than elsewhere reported (Fig. 1). Interestingly all isolates showed
bioﬁlm production and PCR analyses detected the presence of IS256 in
61% S. pseudintermedius isolates. Statistical analysis revealed a strict
association between the presence of IS256 and gentamicin- and
oxacillin- resistance (v2 p-Value <0.05).
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Conclusion: To our knowledge this is the ﬁrst report showing the
bioﬁlm formation and the detection of IS256 in S. pseudintermedius
isolates. Our preliminary results suggest that multi-drug resistance may
be related to bioﬁlm formation also in S. pseudintermedius as reported
in S. epidermidis and S. aureus. Moreover the association between the
presence of IS256 and the resistance to gentamicin and oxacillin
indicate that S. pseudintermedius may acquire antibiotic resistance
genes through mobile genetic elements which may play an important
role in the dissemination of multi-drug resistance.
R2438 Kinetics of the bioﬁlm formation of ATCC 27853
Pseudomonas aeruginosa strain on silicone catheter under
the effect of aminoglycosides: evaluation with the
scanning electron microscopy
V. Bayrakal*, H. Baskin, I. Bahar, N. Hoiby on behalf of the Study
Group for Bioﬁlms – ESGB
Objective: Pseudomonas aeruginosa is adapted to the changing
conditions of microenviroment and survived by bioﬁlm forming,
deﬁned as a phenotypic change. At the beginning of bioﬁlm formation,
bacteriae interact with the signal molecules Quorum Sensing (QS)
systems by reorganizing the presentation of virulence factors. In
planning the therapy it is getting necessary to identify the relationship
between the host (in vitro system) and the Pseudomonas following the
exposure of the decreasing concentrations of antibiotics (subminimal
inhibitory concentrations) mimicking tissue concentrations.
Methods: In our study, following the determinations of minimum
inhibitor concentrations (MICs) of gentamicin, netilmicin and amikacin;
las and rhl systems responses of standard ATCC 27853 Pseudomonas
aeruginosa strain, which was exposed to MIC and 50% MIC of these
antibiotics, were determined at the 12th and 15th hours by micro AHL
method. The MIC and 50% MIC concentrations of gentamicin,
netilmicine, amikacin together with bacterial suspensions prepared in
the appropriate sizes (1 · 1 cm) of silicone urinary catheter (Rusch,
Germany) in the Eppendorf tubes were incubated for 12 and 15 hours at
37C. Bioﬁlm formation on the silicone urinary catheter was examined
with ‘‘Scanning Electron Microscope’’ (SEM, Izmir Institute
Technology) at 12th and 15th hours of bacteriae exposures.
Results: Signal molecules of las and rhl systems were present under
MIC and 50% concentrations at 12th and 15th hours. Bioﬁlm formation
started at 12th hours of infection instead of MIC and 50% MIC
concentrations of aminoglycosides. Bioﬁlm formation started at 12th
hours of infection instead of MIC and 50% MIC concentrations of
aminoglycosides. Silicone surface had no ‘‘preventive’’ effect on
Pseudomonas aeruginosa attachment.
Conclusion: MIC and 50% MIC concentrations of different
aminoglycosides have different ‘‘architectual’’ effects on bioﬁlm
formation of ATCC 27853 Pseudomonas aeruginosa. According to
control experiments, at the 12th hour bacteriae formed bioﬁlm while
bacteriae seemed to be in dispersal phase at the 15th hour of exposure
but in aminoglycoside exposured bacteriae showed different cell wall
types, probably because of the differences in lipopolysaccharide
formation. Natural (gentamicin) and semi-synthetic (amikacin,
netilmicine) aminoglycosides have same effect on QS but different
effects on the bioﬁlm formation and morphology of Pseudomonas
aeruginosa.
R2439 Candida bioﬁlms, sodium metasilicate and antifungal
drug susceptibility
S. Basu*, D. Chakraborty, S. Shukla, P. Borkakoty, S. Dey,
S. Das (Kolkata, IN)
Objectives: Slime or bioﬁlm represents a structured community of
fungal cells embedded in a self-produced polymorphic matrix adherent
to the artiﬁcial surface. It is also a fact that antifungal agents frequently
fails to eradicate these bioﬁlms despite the use of drugs with proven in
vitro activity. This experiment was done to ﬁnd out whether bioﬁlm
produced by susceptible strains are less organized and can be removed
easily by sodium meta silicate.
Methods: Using a modiﬁed tube adherence test the bioﬁlms produced
by 24 different Candida species including two international strains were
treated with 4/8% sodium metasilicate solutions for 30 minutes and
then the cell suspension in the tubes were poured or aspirated out and
the walls of the tubes were stained with 1% safranin and scoring of the
bioﬁlms were done before and after treatment by use of pair tubes.
Although in some previous experiments sodium metasilicate has been
used in removing bioﬁlms but it is used only as a minor component of
chemical formulations in very low concentrations which is not properly
effective. Antifungal sensitivity patterns were studied according to
M27-A2, NCCLS protocols and then the bioﬁlm removal scores were
analysed in relation to the antifungal sensitivity patterns.
Results: Strong slime production was seen in C. tropicalis and weak in
C. glabrata. Micafungin and amphotericin-B were more effective
against bioﬁlm producing Candida spp. than ﬂuconazole. Original
mean bioﬁlm score of 1.481 became only 0.3 after application of
sodium metasilicate solution even in amphotericin B antifungal drug
resistant C. tropicalis bioﬁlm.
Conclusion: In this study we observed a deﬁnite Candida bioﬁlm
lowering activity of sodium metasilicate even up to 70% in antifungal
drug resistant Candida strains. Sodium metasilicate can be removed
easily by washing and it is nontoxic, thus simple occasional washing
with this chemical is sufﬁcient to prevent Candida bioﬁlm in many
medical devices.
R2440 Mapping and bacterial diagnosis of bioﬁlms on central
venous catheters
W.L. Niehaus*, E. Calton, D.A. Johnston, A. Page, J. Jefferies,
P. Thurner, J.C. Gray, L. Hall-Stoodley, J.S. Webb, C. Loose,
S.C. Clarke, A. Davies, S.N Faust, P. Stoodley (Southampton, UK;
Cambridge, US)
Objectives: Central venous catheters (CVCs) are widely used in adult
and paediatric medicine for medium to long-term vascular access.
Complications include thrombus and infection. Diagnosis of CVC
infection is conventionally done by blood and roll-tip culture, but is
suspected of producing a high rate of false negatives, in part because
Bioﬁlm 727
bacteria can be present as bioﬁlms. We aimed to develop methods to
map the distribution of bioﬁlm and thrombus on the surface of
peripherally inserted CVCs (PICC) from adults, and subcutaneously-
tunnelled or totally-implanted CVCs in paediatric patients using high
resolution imaging and sonication-culture.
Methods: CVCs from 11 Peripherally Inserted Central Catheters
(PICC) (adult) and 24 tunnelled or implanted (paediatric) patients were
collected, of which twenty six were removed for end of treatment (EOT),
three for blockage, two for exit site infection and four for other reasons.
Four 1 cm sections were cut from each of the tip, middle and entry site
regions. One section from each region was (i) cultured following
sonication, (ii) examined with scanning electron microscopy (SEM) and
c) confocal microscopy to visualise bioﬁlm and proteins in situ (Fig. 1).
Results: SEM showed that all catheters contained some degree of
deposit in the lumen. Based on the images we developed a scoring
system for semi-quantiﬁcation. Paediatric CVCs had a median scoring
of 3 (small occlusions or 50–80% surface cover) compared to a score of
2 (10–50% surface cover) for adult PICCs. SEM revealed bacterial and
yeast bioﬁlm in the lumen of one adult catheter which, interestingly,
was culture-negative (Fig. 1 B). Confocal microscopy suggested that
bacteria might be obscured by overlying protein (Fig. 1 A). Paediatric
CVCs had a higher culture-positive rate than adult CVCs (10 of 23 vs. 1
of 10, one excluded from each patient population due to possible
contamination). Bacteria were recovered most commonly (eight of 11)
from non-tip CVC sections.
Conclusion: The CVC tip is not necessarily the most reliable section
for the detection of infection. Sonication-culture was more sensitive for
detecting bacteria than SEM. For all CVCs combined culture found 11
of 20 positive for bacteria compared to 1 of 20 for SEM (p < 0.05 by
McNemar’s test). Even though most paediatric CVCs were removed for
EOT there was evidence of bacteria suggesting that CVCs from
paediatric oncology patients might be more commonly contaminated
than currently realised.
R2441 Production of bioﬁlm on different substrates by
Acinetobacter baumannii isolates
L. Drago*, C.L. Romano`, L. Cappelletti, R. Mattina, E. De
Vecchi (Milan, IT)
Objectives: Acinetobacter spp. mainly Acinetobacter baumannii-
Acinetobacter calcoaceticus cluster, are emerging as problematic
opportunistic pathogens due to the rapid increase in multidrug
resistance. Bioﬁlm formation is an important feature of most clinical
isolates of A. baumannii allowing for persistence on colonized surfaces
and reducing antibiotics’ activity.
This study aimed to evaluate bioﬁlm production by clinical isolates of
A. baumannii on different substrates.
Methods: Eight isolates of A. baumannii from hospitalized patients
affected by different infections were used. They were identiﬁed by
biochemical methods and pyrosequencing. Four of them were isolated
from urines, and one each from blood, low respiratory tract, wound and
cerebrospinal ﬂuid. Bioﬁlm production was evaluated on polystyrene,
polypropylene, polyethylene and titanium. Aliquots (about 5–
7 · 108 CFU/mL) from a 24 hours in Brain Heart Infusion broth
were used to inoculate wells of a polystyrene microtitre plate,
polypropylene tubes, and polyethylene and titanium coupons
(diameter: 20 mm; thickness: 6 mm) placed in a six wells plate. After
overnight incubation, the medium was refreshed in order to remove
non-adherent bacteria and samples incubated for 72 hour until a visible
bioﬁlm was formed. Detection of bioﬁlm on each substrate was carried
out by a spectrophotometric method, involving crystal violet staining
and reading at 595 nm. Each test was performed in triplicate, means of
OD595 were calculated and used to classify the isolates as strong
producers, moderate producers or not producers of bioﬁlm as compared
to negative controls consisting of not inoculated substrates.
Results: Production of bioﬁlm was observed in all the tested isolates
but with differences among isolates and materials. The ability to form
bioﬁlm was greater on polyethylene followed by polystyrene,
polypropylene and titanium.
The greater amount of bioﬁlm on all the substrates was showed by the
wound isolate, followed by isolates from CSF, blood and respiratory
tract; all of them resulted strong producers. Production of bioﬁlm varied
in urinary isolates being two of them strong producers and the rest
moderate producer.
Conclusion: Production of bioﬁlm characterized A. baumannii
isolates, but it seemed to depend on the abiotic substrate and on
isolate. More studies are needed to better elucidate the links between
infection site and production of bioﬁlm.
R2442 Mechanical properties and disruption of dental bioﬁlms
A. Rmaile*, L. Capretto, D. Carugo, X. Zhang, J. Wharton,
P.J. Thurner, M. Ward, M. Aspiras, P. Stoodley (Southampton, UK;
Seattle, US)
Objectives: The aim of our research was to characterize and quantify
the inﬂuence of a high velocity water microdrop impact on the structure
and detachment of dental bioﬁlms from the interproximal space of a
typodont model using high speed imaging, and image analysis with
focus on the viscoelastic parameters and cohesive and adhesive failure.
Methods: General Bacterial Growth Conditions: S. mutans bioﬁlms
were grown on coupons, typodont teeth and human deciduous teeth and
imaged with confocal and epiﬂuorescent microscopy. High speed
videography: a high-speed camera was used to record the impact of a
high velocity water droplet of 114 lL, burst from a Philips ‘‘AirFloss’’
device, on bioﬁlm detachment from both model and human teeth.
Compressive testing: uni-axial compression testing using a small scale
mechanical tester was conducted on bioﬁlms while submerged.
Computational Fluid Dynamics CFD: CFD simulations based on the
ﬁnite element method (FEM) were performed utilizing ANSYS Fluent
software to calculate the shear distribution caused by the drop around a
tooth geometry.
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Results: The water droplet had an exit velocity of 60 m/second leaving
the ‘‘AirFloss’’ nozzle. We estimated that 90% of the water was ejected
in the ﬁrst 10 ms. At this time scale the water behaved initially as a
continuous jet before breaking up into nanodrops. On impact there was
initial cohesive failure as the water burst through the bioﬁlm and
subsequent adhesive failure as the shear caused the bioﬁlm to ﬂow over
the tooth surfaces. Of 90% of the bioﬁlm was removed from the IP
space and confocal microscopy showed that there were no bioﬁlm at the
device tip but small patches of bioﬁlm remained on the prominences at
the back of the teeth. Mechanical testing showed that the S. mutans
bioﬁlms were viscoelastic with an elastic modulus of 179 kPa and a
relaxation time of 10 second. The CFD simulations predicted lowest
shear at posterior aspect of the teeth and were consistent with the
experimental observations.
Conclusion: Bioﬁlms made from S. mutans were grown on different
surfaces, including human teeth. The impact of the water drop was high
enough to cause adhesive and cohesive viscoelastic failure contributing
to the detachment process. High velocity water microdrops can
effectively remove viscoelastic bioﬁlms with minimal volume and time.
R2443 Comparison of various antifungal agents as catheter lock
solutions in an in vitro model of Candida spp. bioﬁlm
A. Pen˜a-Monje, R. Ga´lvez, F. Anguita, J. Badiola, M. Ruiz-Ruigo´mez,
D. Parra, J. Herna´ndez-Quero, J. Parra-Ruiz* (Granada, Oviedo, ES)
Objectives: Candida spp. is one of the main causative agents
bacteraemia. Most of them are originated as catheter-related fungemia
(CRF). The antibiotic lock technique (ALT) has been used to treat
bacterial catheter colonization. Current guidelines recommends removal
of the catheter when the infectious organism is Candida spp., however,
removal is not always possible. Our objective was to evaluate the
efﬁcacy of different antifungal lock solutions using an in vitro model of
CVC infection.
Methods: The following lock solutions were evaluated: ﬂuconazol
(FLU) 10 mg/mL, anidulafungin (AND) 1 mg/mL, caspofungin (CAS)
1 mg/mL and liposomal amphotericin B, Ambisome (AMB) 1.5 mg/
mL, all alone and combined with doxicycline (DOX) 5 mg/mL, and
Ethanol (ETA) 35%. PBS was used as control. Experiments were
performed on full introcan Safety 14G catheters (Braun Medical,
Spain) inoculated with two clinical strains of C. albicans and two
clinical isolates of C. parapsilosis. AL solutions were exchanged every
24 for 72 hour. After 72 hour, catheters were reincubated another
24 hour with fresh media. Catheters were drained, ﬂushed and
sonicated at 0, 4, 8, 24, 48, 72 and 96 hour to assess CFU/mL.
Scanning electron microscopy was performed to evaluate persistence of
bioﬁlm at 0, 72 and 96 hour.
Results: All antifungals resulted in signiﬁcant reductions (p < 0.05) of
log10 CFU/mL at 72 hour for both C. albicans compared with controls,
although FLU did not achieve reductions bigger than 2 log10 CFU.
AND and AMB were the most active agents and resulted in signiﬁcant
reductions of log10 for both organism vs. CAS and FLU (p = 0.001).
Both AND and AMB were able to reduce logCFU below the limit of
detection at 72 hour, however neither AND nor AMB prevent regrowth
after 24 hour of ALT removal. ETA and DOX combinations showed
similar results, but prevented regrowth with AMB and AND. Only
AND and AMB resulted in signiﬁcant reductions of log10 CFU/mL at
72 hour for both strains of C. parapsilosis. Neither FLU nor CAS were
able to achieve reductions >2 log10 CFU/mL compare to initial
inoculum. ETA and DOX combinations did not resulted in a faster
sterilization of the lumen but did prevent regrowth after 24 hour of ALT
removal.
Conclusion: Our CVC model demonstrated that ALT with 1 mg/mL
of AND and 1.5 mg/mL of AMB with either ETA or DOX eradicated
bioﬁlm and prevented regrowth suggesting it possible role in ALT and
should be explored in clinical trials
R2445 Relationship between multiple arthroplasty revisions for
aseptic failure and bioﬁlm-associated infection
M. Fernandez-Sampedro, M. Fakkas Fernandez, R. Garcia Renedo,
C. Salas-Venero, C. Farin˜as-Alvarez, J. Figols, J. Gomez, L. Martinez-
Martinez, M.C. Farin˜as* (Santander, ES)
Background: Prosthetic joint infection (PJI) is a bioﬁlm-related
disease. Vortex-sonication is used to dislodge bioﬁlm bacteria. The
aging population makes that patients will be undergoing multiple
arthroplasty revisions (MAR) and it may increase the risk of implant
infection. We evaluate the risk of infection when repeated revisions are
performed at the affected joint and whether sonication improves the
microbiological diagnosis in PJI.
Methods: From February 2009 to September 2011 all consecutive
patients undergoing partial or total removal of hip or knee implants
(index surgery) were included. We study patients with MAR at the
affected joint, whom all of the revisions were performed due to aseptic
failure (AF). Retrieved implants were vortexed and sonicated in
400 mL Ringers solution (sonicate ﬂuid). PJI was diagnosed if (1 of the
following was present: intraoperative purulence, histopathologic acute
inﬂammation, sinus tract, positive synovial ﬂuid culture or at least two
peri-implant tissue cultures positive (same organism) and sonicate ﬂuid
culture (100 cfu on either plate.
Results: Of 199 patients with no prior revisions were studied; 46 had
PJI (Hip 32, Knee 14) and 153 AF (Hip 94, Knee 59). Sensitivities of
peri-implant tissue and sonicate ﬂuid cultures were 48% and 74%
(p = 0.01), respectively. Sixty-three patients with MAR (1–8) on the
affected joint were studied; 25 had PJI (Hip 19, Knee 6) and 38 AF (Hip
24, Knee 14). Sensitivities of peri-implant tissue and sonicate ﬂuid
cultures were 68% and 80% (p = 0.33), respectively. The infection rate
increased from 23.2% to 33.3% to 54.6% to 57.1% as the number of
revisions increased from zero to three or more (p = 0.002). The risk of
PJI in the index surgery was 2.4-fold times higher in patients with two o
more revisions than among patients with no prior revisions (RR = 2.4;
95% CI 1.5–3.9) (p = 0.003).
Conclusion: Bioﬁlm-sampling technique is useful for the
microbiologic diagnosis of PJI. There was a tendency of higher risk
of PJI in patients with prior revisions. Two revisions performed at the
affected joint is the cutoff point associated with a signiﬁcant increased
risk of PJI in the index surgery.
R2446 Alpha-toxin neutralisation decreases Staphylococcus
aureus bioﬁlm density and increases vancomycin efﬁcacy
in a rat endocarditis infection model
M. Pulse*, K. Peterson, W. Weiss, P. Nguyen, J. Pierce, P. Renick,
D. Valtierra, J. Simecka (Fort Worth, US)
Objectives: Our lab has previously demonstrated that alpha-toxin
(Atox), a cytotoxin, inﬂuences Staphylococcus aureus bioﬁlm
formation on plastics. Further experiments were performed to
investigate the effects of Atox neutralization on in vitro and in vivo
S. aureus bioﬁlm formation. The following describes the results of Atox
neutralization on S. aureus bioﬁlm formation and the effects of Atox
neutralization on vancomycin (VAN) treatment of S. aureus bioﬁlms in
vitro and in a rat endocarditis (REI) model.
Methods: In vitro bioﬁlm assays were performed with a MBEC assay
device that was inoculated with S. aureus, treated with the anti-Atox
antibody or serum control, and crystal violet stained. MBEC assay
bioﬁlms were also treated with titers of VAN, and well-associated cells
were harvested and plated to determine VAN susceptibility. The mouse
bioﬁlm model involved pre-treating S. aureus overnight cultures with
the anti-Atox antibody or serum control, infecting Teﬂon catheter
segments, and subcutaneously implanting infected catheters into female
mice. The REI model utilized aortic catheterized male rats that were
intravenously challenged with S. aureus cells pre-treated with the anti-
Atox antibody or the serum control. Rats were administered VAN at 6,
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24, and 48 hours after infection, and hearts were removed and
processed for S. aureus counts.
Results: Crystal violet staining of 24-hour bioﬁlms indicated that the
density of anti-Atox antibody treated S. aureus bioﬁlms was
signiﬁcantly less (p Value <0.0001) than the density of serum control
treated bioﬁlms. In the mouse bioﬁlm model, 48-hour CFU counts of
catheters infected with anti-Atox antibody treated S. aureus were 2.6
log10 CFU lower than the counts associated with serum control treated
S. aureus infected catheters. VAN susceptibility of 24-hour in vitro S.
aureus bioﬁlms was increased by eightfold after pre-treatment with the
anti-Atox antibody, and when compared to animals infected with serum
control treated S. aureus, VAN treatment in the REI model reduced 72-
hour heart counts by 4.7 log10 in animals infected with anti-Atox
antibody treated S. aureus.
Conclusions: Neutralizing Atox decreased the densities of in vitro and
in vivo S. aureus bioﬁlms. Furthermore, anti-Atox antibody treatment
increased the susceptibility of S. aureus bioﬁlms to VAN, which
suggests that the anti-Atox antibody could be utilized in combination
with antibiotics to treat S. aureus bioﬁlm infections.
R2447 In vitro activity of tigecycline, fosfomycin and colistin
against ESBL-producing Escherichia coli bioﬁlm
investigated by microcalorimetry
S. Corvec*, U. Furustrand Taﬁn, O. Borens, B. Betrisey,
A. Trampuz (Nantes, FR; Lausanne, CH)
Background: Prosthetic joint infections caused by quinolone-resistant
Gram-negative rods are considered difﬁcult to treat. We investigated the
activity of tigecycline (TIG), fosfomycin (FOS) and colistin (COL)
against planktonic and bioﬁlm ESBL-producing E. coli by using
conventional microbiological tests and measuring the growth-related
heat production (microcalorimetry).
Methods: An ESBL-producing, ciproﬂoxacin-resistant E. coli clinical
strain (kindly provided by Pr. Nicolas-Chanoine). In vitro susceptibility
testing were performed by macrobroh dilution. E. coli bioﬁlm was
formed on porous sintered glass beads (diameter 4 mm, pore size
60 lm) in Luria broth (LB) at 37C. After 24 hour, beads were washed
with 10 mL normal saline 3 · and incubated in 2 mL of LB containing
serial dilution of TIG, FOS and COL (0.12–256 lg/Ml) for 24 hour.
After three washes, beads were placed in ampoules containing 3 mL LB
to detect residual bacteria by measuring growth-related heat production
at 37C with a 48-channel batch calorimeter (thermal activity monitor,
model 3102 TAM III; TA Instruments, New Castle, DE, USA). The
calorimeter measures the heat ﬂow at 37C controlled to within
0.00001C and had a sensitivity of 0.25 lW. All experiments were
performed in triplicate. The minimal heat inhibition concentration
(MHIC) was deﬁned as the lowest antibiotic concentration delaying
heat production by >24 hour.
Results: Table summarizes MIC, MBClog, MBCstat and MHIC (in
lg/mL) for tested antibiotics.
Conclusions: TIG exhibited a bacteriostatic activity, whereas FOS and
COL were bactericidal in the logarithmic and stationary growth-phase.
A complete inhibition of bioﬁlm heat production was observed with
FOS, while COL and TIG inhibit heat production only at high
concentrations. As an alternative to Calgary device method, a
challenge/recovery antibiotic activity detection against bioﬁlm with
calorimetry seems a repeatable and easy-to-use method. Antibiotic
activity against bioﬁlm (alone or in combination) may be evaluated by
calorimetry to determine the optimal strategy for eradication of bacteria
bioﬁlms
R2448 Staphylococcus aureus bioﬁlm formation on fresh, fresh-
frozen and processed human cancellous bone grafts
L. Sessa*, M. Clauss, U. Furustrand Taﬁn, A. Bizzini, T. Illchmann,
A. Trampuz (Lausanne, Liestal, CH)
Objective: Bone grafts are often used for ﬁlling bone defects. We
investigated the characteristics of Staphylococcus aureus bioﬁlm
formation on fresh, fresh-frozen and processed human bone grafts.
Methods: Standardised cylinders (6.5 · 10 mm) of human cancellous
bone grafts were used. Fresh bone grafts were harvested from femoral
heads during total hip replacement and transferred in PBS within
2 hour. Fresh-frozen bone graft were frozen at -80C for 10 days before
investigation. Processed BG was sterilized by chemical treatment
(osmolysis, NaOH, H2O2 and acetone). S. aureus (ATCC 29213)
bioﬁlm was formed by inoculation of approximately 106 CFU in 3 mL
TSB containing bone graft sample at 37C under static conditions for
24 hours. Bioﬁlm characteristics were investigated by sonication at
40 kHz, 0.2 W/cm2 for 5 minute (morphology and enumeration of
removed bioﬁlm bacteria in sonication ﬂuid) and by isothermal
microcalorimetry (heat analysis of bone grafts with bioﬁlms). All
experiments were performed in ﬁve replicates.
Results: Bioﬁlm density was lower on fresh bone grafts
(6.7 ± 0.2 CFU/mL) than on fresh-frozen (7.8 ± 0.2 CFU/mL) or
processed bone graft (7.6 ± 0.2 CFU/mL) (p < 0.01). While fresh-
frozen and processed bone grafts grew only one colony morphology,
fresh bone grafts grew additional small-colony variants. After re-plating
the different colonies, the morphology reverted to normal colony-size.
In microcalorimetry, fresh bone grafts showed a double peak
corresponding to the two morphologies (Figure), but only one peak
was observed with fresh-frozen and processed bone grafts.
Conclusion: Despite structural similarities in the architecture of the
three tested bone grafts, marked differences in S. aureus bioﬁlm
formation was observed. Fresh bone graft was more resistant to bioﬁlm
formation than fresh-frozen or processed bone graft, possibly reﬂecting
the presence of host factors such as serum, bone marrow, ﬁbrous tissue
and viable bone cells. Observation of small-colony variants in fresh
bone graft reﬂects the interaction between S. aureus, viable bone and
other host factors. Microcalorimetry might be used for further
investigation and understanding of bioﬁlm formation on bone grafts.
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R2449 Antibiotic resistance and bioﬁlm in Stenotrophomonas
maltophilia isolates from cystic ﬁbrosis and non-cystic
ﬁbrosis patients
A. Pompilio, V. Savini, S. Pomponio, V. Crocetta, V. Di Vincenzo,
D. D’Antonio, E. Fiscarelli, E. Toniato, S. Martinotti, G. Di
Bonaventura* (Chieti, Pescara, Rome, IT)
Objective: To assess antibiotic resistance, bioﬁlm formation ability/
efﬁciency, and their possible relationship among S. maltophilia isolates
collected from cystic ﬁbrosis (CF) and non-CF patients.
Methods: 86 S. maltophilia isolates were investigated: 40 from the
sputa of CF patients, and 46 from different sites of non-CF patients.
Antimicrobial sensitivity to nine antibiotics was carried out with the
agar disk-diffusion technique according to CLSI. Bioﬁlm formation on
polystyrene was quantitatively determined by using cristal violet
colorimetric assay.
Results: Overall, resistance to erythromycin, imipenem, meropenem,
ciproﬂoxacin, rifampicin, piperacillin/tazobactam, chloramphenicol,
levoﬂoxacin and cotrimoxazole was observed in 100%, 98.8%,
87.2%, 80.2%, 72.1%, 50.0%, 47.7%, 26.7% and 18.6% of isolates,
respectively. Compared to non-CF strains, CF ones exhibited
signiﬁcantly (p < 0.01) higher resistance rates to meropenem (78.6%
vs. 63%), rifampicin (78.6% vs. 21.7%), piperacillin/tazobactam
(85.7% vs. 71.7%), and chloramphenicol (85.7% vs. 28.3%). Most
isolates showed a high level of multidrug resistance (i.e. >50% of
strains showed multi-resistance to (6 antibiotics), although no
differences in multi-resistance level were found between CF and non-
CF groups. CF and non-CF strains showed comparable capabilities of
bioﬁlm formation (90% vs. 97.8%, respectively), although the mean
bioﬁlm formed by CF strains was signiﬁcantly lower (OD492,
mean ± SD: 0.504 ± 0.350 vs. 0.903 ± 0.813, respectively; p < 0.05).
Cotrimoxazole, rifampicin, chloramphenicol, levoﬂoxacin,
ciproﬂoxacin, piperacillin/tazobactam, and meropenem-susceptible
strains produced signiﬁcantly (p < 0.01) more bioﬁlm than resistant
ones. Multidrug-resistance level was negatively associated with mean
bioﬁlm formed (Spearman r = -0.253; p < 0.05).
Conclusions: Our results suggest that: (i) high-level of resistance to
meropenem, rifampicin, piperacillin/tazobactam, and chloramphenicol
appears to be a trait among CF isolates; (ii) bioﬁlm formation is not a
trait among CF strains, although their reduced efﬁciency in forming
bioﬁlm suggests an adaptation to a stressed environment such as CF
lung; (iii) high efﬁciency in forming bioﬁlm may be considered as an
alternative strategy adopted by antibiotic-susceptible strains to escape
antimicrobial treatments and survive within the host.
R2450 Bioﬁlm production ability of carbapenem-resistant
Acinetobacter baumannii lineages and blaOXA-24/40-
plasmids
F. Grosso*, M.L. Costa, H. Ferreira, C. Vuotto, S. Quinteira,
G. Donelli, L. Peixe (Porto, PT; Rome, IT)
Objectives: Bioﬁlm formation ability has been associated with
persistence of Acinetobacter baumannii (AB) in the hospital
environment and propensity to cause infection, despite the lack of
evidences of this feature in epidemic AB carbapenem-resistant (CRAB)
lineages. In this study we investigated the ability to form bioﬁlm of
disseminated CRAB lineages and the possibility for this feature to be
encoded by blaOXA-24/40-carrying plasmids.
Methods: Of 17 isolates producing carbapenem-hydrolyzing Class D
b-lactamases (CHDL) were selected from a collection of 213
Portuguese CRAB clinical isolates. They were obtained from
bronchial secretions (8); urine (2); catheter (4); intraperitoneal ﬂuid
(2) and others (1). Isolates belonged to two different lineages: ST2/
ST92-carrying blaOXA-23 (5; 2006–2008) and ST2/ST98-carrying
blaOXA-40 (12; 2001–2007). They were resistant to all b-lactams; and
presented variable susceptibility to aminoglycosides, tigecycline and
colistine. The study also included two transformants harbouring
blaOXA-24/40-carrying plasmids and the receptor strain A. baylyi
ADP1. blaOXA-24/40-carrying plasmids were characterized by a PCR
mapping strategy and further sequencing. Adherence was tested with
LB Broth cultures incubated in 96-well plates. Bioﬁlm production was
conﬁrmed with ultramicroscopic analysis (CLSM and FESEM).
Results: Only one OXA-40 producing AB was classiﬁed as non-
adherent. The remaining isolates comprising OXA-40 producers and the
OXA-23 producers were classiﬁed as strongly adherent Conﬁrmation of
a complex structure compatible with bioﬁlm production was observed
by ultramicroscopic analysis in one blaOXA-24/40-carrying isolate.
Nevertheless, transformants of A. baylyi ADP1 with plasmids encoding
for blaOXA-24/40 and ton-B-dependent receptor (virulence
determinant involved in iron uptake) demonstrated identical
adherence values (moderately adherent) to A. baylyi ADP1 receptor
strain.
Conclusion: Isolates of globally disseminated AB (CRAB) lineages
demonstrated strong adherence properties and ability to form bioﬁlms
in abiotic surfaces which might contribute to their emergence and
persistence. In this study we also demonstrate that blaOXA-24/40-
carrying plasmids do not contribute to improve adherence and bioﬁlm
formation in A. baumannii.
R2451 In vitro effect of antimicrobial agents incorporated into
resilient denture relines on the C. albicans bioﬁlm
K.H. Neppelenbroek*, M.G. Bueno, V.C. Porto, S. Soares, L. Pinto,
V.M. Urban (Bauru, Pelotas, Ponta Grossa, BR)
Denture stomatitis associated with Candida is prevalent in 65% of
denture wearers. To extend the clinical longevity of resilient denture
relines and reduce bioﬁlm accumulation, incorporation of antimicrobial
agents into these materials has been suggested. Advantages of this
method of drug delivery include no need for patient compliance,
simultaneous treatment of injured denture-bearing tissues and candidal
infection and reduced application frequency.
Objectives: This study evaluated the antimicrobial action on Candida
albicans bioﬁlm and determined the minimum inhibitory concentration
(MIC) of drugs for treatment of Candida-associated denture stomatitis
incorporated into temporary denture relines.
Methods: For MIC determination, C. albicans (SC5314) bioﬁlm was
formed on disc specimens (10 · 1 mm) of the relines Trusoft and
Softone (n = 6) modiﬁed (experimental) or not (control) by the
addition of one of the ﬁve tested drugs (nystatin, miconazole,
ketoconazole, itraconazole, and chlorhexidine diacetate). For this
procedure, standardized C. albicans cell suspension (107 cells/mL)
was applied to the surfaces of the samples placed in 24-well tissue
culture plates. The cells were allowed to adhere for 90 minute at 37C
and non-adherent cells were then removed by washing with PBS. The
samples were submerged in RPMI-1640 and incubated at 37C for 24,
48 hour, 7 or 14 days for bioﬁlm formation. Different dosages of the
antimicrobials were tested and cellular viability was determined by
spectrophotometric using the XTT [2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide sodium salt] assay at the
time periods. The spectrophotometric measurements were converted to
percentage reduction in candidal growth and the MICs were determined
as the concentrations necessary to inhibit 90% or more of fungal
viability.
Results: MICs of the antimicrobials incorporated into both materials
were: 0.032, 0.256, 0.128, 0.256 e 0.064 g/mL for nystatin,
miconazole, ketoconazole, itraconazole and chlorhexidine,
respectively. No fungal inhibition was observed in control specimens.
Conclusion: The incorporation of all tested drugs inhibited the C.
albicans bioﬁlm on the materials up to 14 days. The lowest MIC values
were exhibited by nystatin followed by chlorhexidine. Within the
limitations of this in vitro study, it can be concluded that the addition of







R2452 Optimal dosing of Daptomycin in the morbidly obese:
which body weight is it?
A. Farkas* (Nyack, US)
Objectives: Dosing Daptomycin (DAP) based on total body weight is
expected to result in higher drug exposure in the obese patient
compared to patients with normal body weight. Prior analysis of
patients from a randomized trial suggested the use of lean body weight
for dosing of DAP in the obese, but provided no analysis for the
population of morbidly obese. The objective of our study was to assess
for the bases of optimal dosing of DAP in the morbidly obese.
Methods: Published DAP pharmacokinetic data of matched morbidly
obese patients with subjects of normal body weight was used in this
analysis. Dosing of DAP based on total (TBW), ideal (IBW), adjusted
(ABW), lean (LBW), and fat free (FFW) weight of 4 and 6 mg/kg doses
were evaluated with Monte Carlo Simulation (MCS, n = 10000) to
assess for the magnitude of drug exposure using the simulated AUC0-
24 values. The dosing method that results in the AUC0-24 most similar
to that of the matched normal body weight patients was then compared
with the exposure achieved by the patients in the randomized trial of
bacteremia and endocarditis.
Results: Dosing based on ABW best approximates the exposure
provided by DAP at the dose of 4 mg/kg in the morbidly obese when
compared to the matched subjects. Simulated mean AUC0-24 values of
dosing DAP based on IBW, LBW, and FFW were up to 20% smaller in
the morbidly obese. Simulated exposure provided by DAP 6 mg/kg
based on ABW in the morbidly obese provides mean ± sd AUC0-24
similar or slightly higher when compared to the population of the
bacteremia and endocarditis clinical trial.
Conclusion: We conclude that dosing of DAP based on IBW, LBW,
and FFW would result in sub–optimal exposure based on the simulated
AUC0-24 values. Since the pharmacodynamic index most predictive of
outcomes is the ratio of AUC/MIC, dosing of DAP based on IBW,
LBW or FFW should be avoided in this population. Instead, dosing
based on ABW should be considered in the morbidly obese.
R2453 PK/PD research of linezolid in different weight Chinese
male volunteers
Y. Cai*, D. Chai, E. Falagas, K. Vouloumanou, R. Wang, N. Bai,
B. Liang (Beijing, CN; Athens, GR)
Study design: This is an open-label phase 1 study involving 20 healthy
male participants. The study participants were assigned to two groups
according to their body weight: low-weight group (LW): 50 kg < body
weight £ 55 kg, and high-weight group (HW): body weight (80 kg.
The study participants were administered an intravenous single-dose of
linezolid (600 mg/30 minute) at constant speed. Seventy-two hour
later, all participants were administered an intravenous single-dose of
linezolid (10 mg/kg/30 minute) at constant speed.
Objective: Primary, to study features of pharmacokinetics after single
dose administration of linezolid injections in different body weight
healthy Chinese subjects. Secondary, to obtain serum bactericidal
activity at different times after single administration of linezolid
injections.
Methods: The study participants were hospitalized for a 9-day/8-night
period starting on study Day 1. Testing ﬁeld located at Unit of Phase I
Clinical Trial of National Institute of Clinical Trial For Drugs in PLA
General Hospital. Twenty healthy subjects, 10 in LW group and 10 in
HW group. HPLC-MS-MS to detect serum concentration of linezolid.
Monte Carlo simulation to evaluated probability of target attainment
(PTA) of these two linezolid regimens. Main criteria for inclusion:
subjects must sign informed consent, male, healthy, aged 18–45 years
of age, body mass index (BMI) in the range of 18.0–30.0 kg/m2,
50 kg < low weight group £55 kg, high weight group(80 kg, haven’t
taken any medicine for at least 4 weeks.
Results: In 600 mg regimen, plasma concentrations (from 0.5 to
16 hour) in LW group were much higher than that in HW group (Cmax:
12002.8 ± 2580.24 vs. 19462.71 ± 3667.33 ng/mL). A persistent
inhibitory effect of linezolid trough 7 hour timepoint was observed in
LW group. However, inhibitory effect reduced obviously in HW group.
PTAs of HW group were much lower than LW group (67.43% vs.
99.76%). While in 10 mg/kg regimen, both HW and LW groups got
similar plasma concentrations at each time point (Cmax:
15299.537 ± 1929.733 vs. 16941.891 ± 4704.375 ng/mL). HW and
LW groups got similar inhibitory effect. PTAs of HW and LW also
showed no difference (98.33% and 97.8%).
Conclusion: Our ﬁndings suggest that 10 mg/kg regimen of linezolid
may appropriate dosage for different weight patients. However, safety
issues should be further evaluated for dosing regimen according to the
weight. Register number: ChiCTR-TRC-10001174.
R2454 Voriconazole is stable at high temperatures and released
from cement spacers
E. Denes*, F. Fiorenza, F. Saint-Marcoux, M. Megherbi, M. Dupon,
P. Weinbreck (Limoges, Bordeaux, FR)
Objectives: Voriconazole can be useful for the treatment of prosthetic
joint infections due to Candida especially if it can be placed in a spacer.
However, its stability at high temperature is not known, and it is an
important data, as during cement polymerisation, the temperature can
rise up to 80C.
Methods: We had the opportunity to make in vivo dosage of
voriconazole in a patient who presented prosthetic joint infections
due to Candida glabrata in his both hips. For several reasons
(anaesthesia and surgery technique) both removals and spacer
insertions were spaced of 1 week. After removal, the surgeon inserted
a custom made spacer where he mixed voriconazole powder and
cement. The loading voriconazole doses were 600 mg in the right
spacer and 400 mg in the left one. The difference was due to the size of
the spacer. One week after the second insertion, a needle puncture was
performed in both hips, namely 1 week after the insertion of the right
spacer and 2 weeks after the left one. The patient did not received
intravenous voriconazole during this period. Voriconazole
concentrations were measured using high-performance liquid
chromatography coupled with a diode array detector method.
Results: Voriconazole was found in both samples. Concentrations
were respectively 0.1 mg/L at week 1 and 0.04 mg/L at week 2. The
second aspiration needed the instillation of 1 mL of physiological
serum, meaning that the concentration measured is far lower than the
reality.
Conclusion: (i) Voriconazole was found in the liquid surrounding the
spacer, meaning that the heat, produced by the exothermic reaction
during polymerisation, did not destroyed it. (ii) Voriconazole is released
by the cement spacer. (iii) The concentration observed after 1 week is
equivalent to the MIC of some Candida species such as C. albicans, C.
parapsilosis or C. tropicalis. One could then hypothesise that during the
ﬁrst week the concentrations were over the MIC and thus that the local
concentrations obtain could help to cure the patient, in combination
with systemic administration of the molecule.
R2455 Simpliﬁed oral ﬂucloxacillin absorption test for patients
requiring long-term treatment
A.C. Dijkmans*, J. Den Hartigh, J.T. Van Dissel,
J.J. Burggraaf (Leiden, NL)
Introduction: The absorption of oral ﬂucloxacillin is highly variable
between patients. Therefore an oral absorption test is common practice
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in our hospital to ensure efﬁcacious continuation of continuous
intravenous therapy with an intermittent oral dose regimen. We
explored if the test could be simpliﬁed
Patients and Methods: In the usual test an oral dose of ﬂucloxacillin
is administered while continuous iv ﬂucloxacillin is interrupted (test A)
while in the alternative test the iv administration was continued (test B).
In both tests serum concentrations of ﬂucloxacillin were measured
before and at 1 and 2 hour after the oral test dose. Adequate absorption
was deﬁned as an increase in ﬂucloxacillin of at least 10 mg/L after 1
gram at either 1 or 2 hour after oral administration.
Results: The tests were performed in 43 patients with a wide age range
(Test A: n = 20; test B n = 23) and identiﬁed 10% of the patients as
poor absorbers. There was no inﬂuence of age, diagnosis, renal function
or pre-dose ﬂucloxacillin concentration.
Conclusion: The oral ﬂucloxacillin absorption test without interrupting
continuous iv therapy performs well and is simple to implement. The
test can be considered in applicable cases to guide transition from iv to
oral therapy.
R2456 Pharmacokinetics of high-dose daptomycin in
haemodialysis
G. Beraud*, C. Floriot, S. Belmouaz, N. Venisse, O. Tribut,
M. Bauwens, F. Roblot, F. Bridoux (Poitiers, Vesoul, Rennes, FR)
Objectives: Pharmacokinetics of daptomycin in patient on
haemodialysis has been validated at 4 and 6 mg/kg three times a
week. We report two cases where daptomycin at 8 and 10 mg/kg three
times a week in patients on haemodialysis was used with concentration
monitoring.
Methods: Both patients had conventional haemodialysis during
4 hours three times a week on central venous catheter for chronic
kidney failure. Patient A was admitted in the infectious disease ward for
a methicillin resistant Staphylococcus aureus (MRSA) bacteraemia
associated to infected orthopaedic device. Because of multiple
arteriovenous ﬁstula thrombosis, CVC had to be saved, and
daptomycin was administered at 500 mg (10 mg/kg for a weight of
50 kg) after dialysis three times a week for 14 days with oral rifampicin
at 20 mg/kg/day. Patient B was admitted in intensive care unit for a
MRSA bacteraemia associated to left endocarditis and spondylodiscitis.
Daptomycin was administered at 1 g (8 mg/kg for a weight of 120 kg)
after dialysis three times a week for 14 days. Peak concentration,
concentration before dialysis (trough before dialysis), concentration
after dialysis, area under the concentration curve (AUC) between two
doses and minimum inhibitory concentration (MIC) are reported.
Results: The mean (SD) peak/trough were 115.6 (21.2)/16.3 (6.1) and
109.5 (4.5)/19.2 (2.3) lg/mL for patient A and B, respectively. MIC for
daptomycin were 0.094 and 0.38 lg/mL for patient A and B. The
AUC0-48 hour was 2254 lg/hour/mL for patient A and 2013 lg/hour/
mL for patient B. AUC0-72 hour was 2376 lg/hour/mL for patient A
and 2971 lg/hour/mL for patient B. The mean reduction ratios due to
haemodialysis were 33.5% and 47.5% for patient A and B, respectively.
There was no adverse effect, and no increase of CPK. Patients fully
recovered from their infection.
Conclusion: In this two patients we reached the recommended target
for the peak (approximately 100 lg/mL) and for the 24-hour AUC
(approximately 600 lg/hour/mL). The trough was under the
recommended limit of 24.5 lg/mL and far above the MIC.
Daptomycin could probably be used at high dose in haemodialysis.
R2457 Which is easier to manage? – anxiety of gentamicin-
induced nephrotoxicity or gentamicin-induced
nephrotoxicity: A surveillance study from a tertiary care
cardiac centre in northwest England
T. Al-Badawi*, R. Bagi, M. Hassan, K. Mattam, A. Guleri (Blackpool,
UK)
Background: Aminoglycosides have long been recognised for drug-
induced nephrotoxicity. Clear recognition of patient and treatment
related risk factors including age, pre-existing renal impairment, dose/
duration/frequency and therapeutic monitoring [TDM] have improved
the situation since early 1980s. However, variation still exists in
practice and data on the real impact of this phenomenon. Lancashire
cardiac centre [LCC] has 1800 cardio-thoracic [CT] surgeries annually
and serves 1.5 million inhabitants in northwest England. We present
ﬁnding from a prospective study over 3-weeks undertaken to assess
gentamicin use, gentamicin TDM and renal functions in emergency and
elective cardiac and thoracic surgeries.
Methods: Prospective study of 89 CT surgeries over 3-weeks
[September 2011]; gentamicin use, TDM and renal functions [pre and
postop]. This study complemented the new prophlaxis policy in CT
surgery that replaced previous practice of variable combinations/
durations of cefuroxime ± teicoplanin use (subject to surgeon
variation), with use of ﬂucloxacillin or teicoplanin, plus gentamicin
(3 mg/Kg) at induction/cover over 1st 24 hour postop.
Results: Review of 89 patients included 70.7% [63/89] cardiac and
29.2% [26/89] thoracic surgeries of whom 82.5% [52/63] cardiac/23%
[6/26] thoracic patients received gentamicin. Documentation of reason
for ommission was missing. No gentamicin detected in blood for 40.3%
[22/52] cardiac and 66.6% [4/6]thoracic patients. Remaining thoracic
patients and 42.3% [22/52] cardiac patients had a trough <1 mg/L, with
4.5% [1/22] had marginal raise in creatinine. Of 9.6% [5/52] cardiac
patients had trough level between 1 and 2 mg and 7.6% [4/52] between
2 and 4 mg/L. Of 13.5% [7/52] had no elevation in creatinine. One
patient with gent not detected had elevated creatinine. Four patients had
deranged creatinine pre and postoperatively.
Conclusions: The revised guidance on antibiotic prophylaxis for CT
surgery followed a drive to reduce use of C. difﬁcile driving agents
including cefuroxime. None of the patients had any ototoxicity which is
the irreversible side effect with aminoglycosides. Elevation in creatinine
was reversible when it did increase in patients. There was limited non
compliance with using gentamicin as a single dose at induction,
documenting reason for omission and missing gentamicin when
elevated preoperative creatinine. The results indicate that use of
gentamicin as an adjunct with ﬂucloxacillin or teicoplanin in absence of
pre-existing renal impairment is safe.
R2458 Factors inﬂuencing minimum colistin plasma
concentrations in patients with multidrug-resistant Gram-
negative bacterial infections
S. Luque*, L. Sorlı´, N. Berenguer, J. Horcajada, F. Alvarez-Lerma,
H. Knobel, M. Montero, C. Segura, S. Grau (Barcelona, ES)
Objectives: Colistin use has re-emerged for treating multidrug resistant
Gram-negative (MDR-GNB) infections but there is a lack of
information about which factors can inﬂuence its pharmacokinetics.
The aim of this study was to correlate the value of the colistin minimum
plasma concentration at steady state (Cminss) with patients’
characteristics, colistimethate sodium (CMS) dosage and maximum
colistin plasma concentration at steady state (Cmaxss).
Methods: Prospective observational pharmacokinetic study performed
at a tertiary care hospital in hospitalized patients with MDR-GNB
infections treated with different CMS dosages. Cminss (before next
CMS dose) and Cmaxss (30 minute after the end of the CMS infusion)
were obtained and quantiﬁed using a validated HPLC method.
Correlations between Cminss and the following variables were
analysed: age, body weight, body mass index (BMI), Acute
Physiology and Chronic Health Evaluation II score (APACHE II),
CMS daily dose (mg/day), serum creatinine and glomerular ﬁltration
rate at the beginning of CMS treatment (SCr0, GFR0), at day 3 of CMS
treatment (SCr3, GFR3) and at day 4–5 of treatment (just before colistin
sample extraction after the steady state had been achieved) (SCr5,
GFR5) and Cmaxss. Bivariate correlations were studied by performing
the Spearman’s rho test (r).
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Results: Of 85 patients were included. The bivariate correlations are
showed in the table:
Conclusions: Factors inﬂuencing minimum colistin plasma
concentration at steady state were CMS dosage and age and renal
function, mainly after the third day of treatment. These factors should
be considered when individual CMS dosage schedule has to be decided.
On the contrary, other patients¢ characteristics such as body weight,
body mass index or severity status did not inﬂuence colistin minimum
plasma concentration. Minimum and maximum colistin plasma
concentration showed a strongly correlation. These ﬁndings also
suggest the need to closely monitor colistin plasma concentrations in
patients treated with CMS.
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R2459 Characterisation of IncFIA, IncFIB, IncF11 and IncN
plasmids carrying the CTX-M-15, TEM-1, OXA-1 beta-
lactamase genes and the acc (6¢)-IB-cr gene in Escherichia
coli
J. Dimude*, P. Kolima, J. Dave, S. Amyes (Edinburgh, London, UK)
Objective: Plasmids have been associated with dissemination of
antimicrobial resistance genes in Escherichia coli and several studies
have shown the association between speciﬁc resistance mechanisms and
certain plasmid types. We present the distribution and characterisation
of Inc F plasmids using the replicon sequence typing scheme (FAB
formula) and Inc N.
Methods: Seven cefotaxime resistant E. coli strains isolated from blood
cultures in the Royal inﬁrmary Edinburgh were examined. Detection of
the resistance gene was performed by PCR ampliﬁcation and subsequent
sequencing of the gene. The genetic environments of the CTX M-15
gene were determined by PCR. Plasmids were classiﬁed according to
their compatibility groups using the PCR replicon typing scheme.
Plasmid numbers and sizes were assessed by the alkaline lysis method
and S1 nuclease digested linearised plasmid DNA was examined by
Pulsed-ﬁeld electrophoresis (PFGE) proﬁling. Genotyping of the strains
was determined by PFGE with Xba1 restriction.
Results: All isolates were found to have bla(CTX-M-15), bla(TEM-1),
bla(OXA-1), and aac (6¢)-IB-cr genes. Insertion sequence Isecp1 was
found upstream of the bla(CTX-M-15) gene and, in two of the isolates,
IS26 was inserted into ISecp1 between bla(CTX-M-15) gene and its
normal promoter. Plasmid replicon typing showed four different
replicon types; IncF1A (n = 7), IncF1B (n = 5), Inc F11 (n = 7) and
IncN (n = 7). On the basis of replicon sequence type (FAB formula) the
plasmid groups in two isolates were F2:A1: B-and in the rest
F33:A1:B26. PFGE shows that the isolates are genetically divergent.
S1 nuclease and alkaline lysis extraction plasmid analysis revealed that
all isolates contained detectable plasmid, four of these had seven
plasmids but one had eight and two had four plasmids. The plasmid
sizes ranged from 3to 194 kb.
Conclusion: Plasmids play a signiﬁcant role in the dissemination of
these genes in E. coli since the PFGE showed that these isolates were
genetically divergent. These genes were probably mobilised by these
plasmids, which can readily spread causing horizontal dissemination of
these resistance gene. The co-existence of these resistance determinants
in a single isolate increases the selection by one or more of the
antimicrobials used in clinical practice.
R2460 Disruption of blaOXA-51-like in clinical isolates of
Acinetobacter baumannii
P.G. Higgins*, E. Zander, A. Ferna´ndez, H. Seifert (Cologne, DE; La
Corun˜a, ES)
Objectives: Speciation of Acinetobacter baumannii using phenotypical
methods can be difﬁcult, therefore molecular methods are increasingly
used for species identiﬁcation. One proposed method is the
conﬁrmation of blaOXA-51-like, which is intrinsic to this species.
We encountered three putative A. baumannii clinical isolates that did
not amplify blaOXA-51-like when tested by an established OXA-
multiplex PCR (Woodford et al., 2006, IJAA). We investigated this
phenomenon.
Methods: The isolates were speciated using gyrB multiplex PCR and
rpoB sequencing. Susceptibility to imipenem was investigated by Etest.
The epidemiological relatedness of the isolates was investigated by rep-
PCR (DiversiLab). Analysis of published A. baumannii genome
sequences allowed the design of primers to amplify and sequence the
region surrounding blaOXA-51-like.
Results: Molecular methods conﬁrmed the isolates as A. baumannii.
The isolates had originated from different countries (Table). Strains 508
and 653 had similar rep-PCR patterns (94.8% similarity) but were
considered unrelated. Strain 511 showed <70% similarity to strains 508
or 653. Sequencing blaOXA-51-like revealed that insertion elements
had integrated into the gene. In-silico removal of the IS elements
allowed the identiﬁcation of the OXA-51 variants. Two isolates had the
novel ISAba19 inserted in blaOXA-78 at nucleotide number 380.
ISAba19 is 1309 bp in size, shows 91% DNA homology to ISAba2 and
encodes three putative ORFs with 94–97% amino acid identity to those
in ISAba2. In strain 511, ISAba15 was inserted in blaOXA-66 at
nucleotide number 436. In all strains, the ORF of blaOXA-66 and
blaOXA-78 had premature stop codons. The ISAba19 isolates were
susceptible to imipenem. Strain 511 (ISAba15 insert) was imipenem-
resistant but this strain also possessed an acquired blaOXA-23.
Conclusions: These data show that speciation of A. baumannii based
on the presence of blaOXA-51-like may not always be reliable,
therefore additional methods should be employed. These data also show
that in clinical isolates, insertional inactivation of the intrinsic blaOXA-
51-like is not lethal. Furthermore, a functioning blaOXA-51-like is not
necessary for imipenem-resistance.
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R2461 Biological ﬁtness cost of macrolide-lincosamide-
streptogramin B resistance in Clostridium difﬁcile
F. Wasels*, P. Spigaglia, F. Barbanti, P. Mastrantonio (Rome, IT)
Objectives: Antimicrobial therapy plays a central role in the
development of C. difﬁcile infection (CDI), as this pathogen can
colonise the human gut if the normal intestinal microbiota is
signiﬁcantly altered. Clindamycin (CLI), which is part of the
macrolide-lincosamide-streptogramin B (MLSB) group, has been
recognised as one of the major risk factors for CDI. In C. difﬁcile,
ermB genes located on mobile elements generally mediate macrolide-
lincosamide-streptogramin B (MLSB) resistance. The acquisition of
resistance genes also carries a ﬁtness cost inﬂuencing the rate of
development of resistance, its stability and the rate of its decrease if the
antibiotic use is reduced. Here, we evaluated the ﬁtness cost of different
mobile elements conferring resistance to MLSB in C. difﬁcile.
Methods: Three different macrolide-lincosamide-streptogramin B
(MLSB) elements were transferred from resistant clinical isolates to
the susceptible C. difﬁcile CD13 strain by ﬁlter-mating experiments.
Minimum inhibitory concentrations (MICs) to CLI and erythromycin
(EM) were determined by Etest. Fitness cost of the different elements
was assessed by comparison of growth rates of transconjugants and
wild-type strain, as well as by competitive growth in vitro. To
determine growth curve data, 18 hour cultures of each strain were
diluted to an OD600 of 0.05 in BHl, and incubated at 37C. OD600 was
monitored over 12 hours. For competitive assays, 24 hour cultures of
one transconjugant and recipient strain were mixed together in a ratio of
1:1. The mixed culture was transferred to fresh BHI broth every
24 hour over 3 cycles. To calculate the competition index, cfu ratio of
each strain was determined by plating aliquots on selective and drug-
free BHI agar after each cycle.
Results: All mobile elements were transferred to C. difﬁcile CD13.
Transfer efﬁciency ranged from 6.1 · 10-7–2.1 · 10-9 per donor. All
transconjugants were highly resistant to EM and CLI (MIC ( 256 g/L).
The acquisition of these elements signiﬁcantly affected the ﬁtness of the
recipient strain, reducing the growth capacities, independently from the
genetic organisation of the element acquired.
Conclusion: Results indicate that resistance to macrolide-lincosamide-
streptogramin B (MLSB) mediated by ErmB determinant leads to a
metabolic cost with a ﬁtness reduction. This could explain the
increasing number of ermB-negative isolates resistant to macrolide-
lincosamide-streptogramin B (MLSB) circulating in hospitals. At our
knowledge, this is the ﬁrst time that the ﬁtness cost of antibiotic
resistance in C. difﬁcile is assessed.
This study was funded by the Marie Curie European Project number
237942 CLOSTNET.
R2463 Is daptomycin susceptibility breakpoint appropriate for
enterococci?
J.M. Munita, D. Panesso, L. Diaz, T.T. Tran, J. Reyes, A. Wanger,
C.A. Arias* (Houston, US)
Background: The clinical utility of daptomycin (DAP) for the
treatment of serious enterococcal infections may be compromised by
the emergence of DAP resistance during therapy. The current
breakpoint for DAP is £4 lg/mL; however, recent data suggest that
mutations in genes encoding the LiaFSR system (a three-component
regulatory system that orchestrates the cell envelope response to
antibiotics) produces slight decrease in DAP susceptibility (MIC
between 3 and 4 lg/mL) that may be associated with treatment
failures. Our aim was to evaluate the presence of liaFSR mutations in
clinical isolates of enterococci exhibiting MICs between 3 and 4 lg/
mL.
Methods: Enterococcal isolates recovered from bacteremic episodes
were collected from two large hospitals in the Texas Medical Center,
Houston, TX. Enterococcal species were conﬁrmed by multiplex PCR
and DAP susceptibility testing was performed by Etest following the
manufacturer’s speciﬁcations. The liaFSR genes were sequenced in
their entirety in all clinical strains with DAP MICs between 3 and 4 lg/
mL and in six isolates with MICs £ 2 lg/dL. Additionally, DAP MICs
were determined in 12 isolates whose genomes have been sequenced
and are publically available.
Results: A total of 80 isolates were included in the study. E. faecium
and E. faecalis corresponded to 47% and 53% of the isolates,
respectively. The MIC90 for all isolates was 3 lg/mL. A total of
eight E. faecium and one E. faecalis isolate exhibited MICs between
three and 4 lg/mL. Mutations in liaFSR system were found in 75% of
isolates with MIC 3 and 4 lg/mL, whereas none were found in six
clinical isolates with MICs < 2 lg/mL or in any of the sequenced
strains of enterococci with MICs < 2 (p < 0.001). The most common
substitutions were Thr120 for Ala in LiaS and Trp73 for Cys in LiaR.
Conclusions: Clinical isolates of enterococci with DAP MICs between
3 and 4 lg/mL are likely to have mutations in genes encoding the
LiaFSR system, which is an important mediator of DAP resistance in
vivo. Our data suggest that DAP susceptibility breakpoints should be
re-assessed.
R2464 Mechanisms of carbapenem resistance in multidrug-
resistant Klebsiella pneumoniae isolates
S. Tsiplakou, V. Papaioannou, A. Stylianakis*, D. Argyris,
I. Papadakis, P. Papanikolaou, E. Chatziandreou, K. Mouta (Athens,
GR)
Objectives: The aim of the present study was to determine the
mechanisms of carbapenem resistance among multidrug resistant
Klebsiella pneumoniae clinical isolates in a tertiary hospital.
Methods: During a 3 year period (December 2008–November 2011),
394 multidrug resistant Klebsiella pneumoniae isolates were tested for
the detection of KPC-carbapenemase and metallo beta -lactamase
(MBL) production. K. pneumoniae clinical isolates were collected from
blood (76), urine (42), pus (103), catheters (58) and bronchial secretions
(192) cultures of patients hospitalized in different wards of our hospital,
mainly in ICUs. Identiﬁcation and susceptibility testing were performed
by the Vitek 2 automated system (bioMe´rieux, France) and MICs were
determined by E-test (AB Biodisk, Sweden) when necessary.
Phenotypic screening for the presence of carbapenemases was
performed with the cloverleaf test. The imipenem-EDTA MBL E-test
was used to test for production of MBLs and the boronic acid disc test
in combination with meropenem was performed to screen for KPC
producers.
Results: All K. pneumoniae isolates were multidrug resistant, being
resistant to beta-lactams, aminoglycosides, ﬂuoroquinolones and
trimethoprim/sulfamethoxazole. The majority of the isolates were
susceptible to gentamicin, colistin and tigecycline. Forty-eight
(12.2%) isolates were resistant to gentamicin, 148 (37.5%) were
resistant to colistin and 64 (16.2%) were resistant to tigecycline. The
isolates exhibited various susceptibilities to imipenem and meropenem
ranging from 0.5 to 32 mg/L. All isolates were resistant to ertapenem. It
should be noted that 37 (9.4%) isolates were initially identiﬁed as
susceptible to imipenem and meropenem by the Vitek 2 system, but
were classiﬁed as resistant by the Vitek EXPERT software and were
considered ‘possible carbapenemase producers’. Of 108 (27.4%) of 394
isolates were MBL producers and the rest 286 (72.6%) were KPC
producers. Correlation of MIC values with the two mechanisms of
resistance showed that isolates with imipenem and meropenem MICs of
£1 mg/L produced MBL and KPC at 54% and 46% respectively, while
for MICs of >1 mg/L 80% of the isolates were KPC producers.
Conclusion: Multidrug resistant Klebsiella pneumoniae isolates, that
produce different carbapenemases, pose a most serious therapeutic
problem. Isolates with low carbapenem MICs should be routinelly
tested so as to accurately detect the presence of carbapenemases and
discriminate between the two enzyme types.
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R2465 Characterisation of mefA and msrA/msrB multi-drug
efﬂux pumps associated with blaTEM-1 b-lactamase in
Enterococcus faecalis
C. Chouchani*, A. El Salabi, R. Marrakchi, L. Ferchichi,
T.R. Walsh (Hammam-Lif, TN; Cardiff, UK; Kasserine, TN)
Objectives: Enterococcus faecalis is thought to possess a great deal of
intrinsic resistance to several antimicrobial agents, in this study, we
found ampicillin- and erythromycin-resistant clinical isolates of E.
faecalis. We attempt to identify the resistance mechanisms among these
isolates.
Methods: Twelve isolates of E. faecalis collected from 12 different
patients were found. Identiﬁcation and susceptibility pattern were
carried out using Phoenix automated phenotypic identiﬁcation criteria.
PCR ampliﬁcation and sequencing were used to detect b-lactamases
production. Colony blotting was performed in order to screen multidrug
efﬂux pumps production. Extraction and N-terminal sequencing of the
multidrug efﬂux pumps were established.
Results: E. faecalis isolates shows high resistance to erythromycin and
ampicillin with MICs > 16 lg/mL. PCR ampliﬁcation and sequencing
showed that isolates produced TEM-1 beta-lactamase. Colony blotting
showed that these isolates harbored multi-drug efﬂux pumps genes.
Multi-drug efﬂux pumps extraction, puriﬁcation and sequencing
showed the distribution of mefA and msrA/msrB efﬂux pumps.
Conclusion: Two resistance mechanisms among E. faecalis are
described, the production of TEM beta-lactamase and mefA and
msrA/msrB efﬂux pumps, these results are very interesting because this
is the ﬁrst report of the co-existence of these resistance mechanisms
among E. faecalis strains.
R2466 Detection of hlyA and clyA haemolysin genes in clinical
isolates of Escherichia coli resistant or susceptible to
quinolones from blood cultures
A. Ma´rquez-Lo´pez*, S. Garcia Rubio, L. Martı´nez-
Martı´nez (Santander, ES)
Objectives: Haemolysins are relevant virulence factors of E. coli, but
most quinolone-resistant clinical isolates of E. coli do not produce these
proteins. In this study, the phylogenetic group and the presence of genes
hlyA and clyA, coding for alpha -haemolysin and cytolisin A
respectively, was determined in E. coli isolates (resistant or
susceptible to quinolones) from blood cultures.
Methods: Four hundred and sixteen isolates of E. coli obtained
consecutively from blood cultures in our laboratory from January 2006
to December 2008 were studied. Identiﬁcation was done with
MicroScan WalkAway. Susceptibility to nalidixic acid (NAL) was
determined by disk-diffusion (CLSI guidelines). Haemolysis production
was assessed in 5% sheep blood agar. Phylogroups were determined by
multiplex PCR (Clermont et al.). The presence of hlyA and clyA was
investigated by PCR using primers hlya-1 GAACTAAAGC
TGCAGCAGGTGTTGA, hlyA-2 GCAGCAAGTAAACTGTCACCA
TCGT, clyA-1 TAAAATCAGGAAGGAAGCGTATGCC and clyA-2
CGTGTTAGACAGGGTGGTAAAGAAA. Data analysis was
performed by SPSS software.
Results: Resistance to NAL was observed in 186 (44.7%) isolates.
hlyA and clyA were detected in 88 (21.1%) and 216 (52%) out of the
416 isolates respectively and in another 5 (1.2%) isolates containing
both genes (hlyA/clyA). hlyA was detected in 8 (4.3%) NAL-Resistant
(R) and in 80 (34.9%) NAL-susceptible (S) isolates (p < 0.01). On the
other hand, clyA was detected in 127 (68.4%) NAL-R and in 89
(38.7%) Nal-S strains (p < 0.01). These values indicate an association
between the presence of clyA and NAL-R (p < 0.01). The ﬁve isolates
with both genes corresponded to 1 (0.5%) NAL-R and 4 (1.7%) NAL-S
isolates. The 107 isolates lacking hlyA and clyA corresponded to 50
(26.8%) NAL-R and 57 (24.7%) NAL-S isolates (p = 0.62). The results
of the relationship between phylogroups, NAL testing and haemolysin
genes are presented in the Figure 1.
Conclusion: E. coli from blood cultures produce more frequently clyA
than hlyA. In addition, resistance to nalidixic acid is associated with the
presence of clyA and not associated with the presence of hlyA. clyA
was most frequently detected in isolates of phylogroups A/B1/D than in
those of phylogroup B2 which usually contain hlyA and are susceptible
to nalidixic acid.
R2468 A study on variable behaviour of Clostridium difﬁcile
strains to in vitro induction of antibiotic resistance
I. Moura*, P. Spigaglia, F. Barbanti, P. Mastrantonio (Rome, IT)
Objectives: In order to better understand the inﬂuence of metronidazole
(MZ), an antibiotic used for treatment, and erythromycin (ERY) or
clindamycin (CM), inducing agents of Clostridium difﬁcile infection
(CDI), on the development of higher MICs on different isolates and
different colonies of C. difﬁcile strains, in vitro induction assays were
performed.
Methods: Twelve C. difﬁcile clinical isolates belonging to six different
PCR-ribotypes 027, 018, 078, 012, 001, 010, fully susceptible to MZ,
ERY and CM were selected for this study. Induction of resistance in
presence of MZ was performed in all twelve strains, and in presence of
ERY and/or CM in six isolates belonging to the most frequent PCR-
ribotypes 001, 027, 078 and 018. The MIC values were ﬁrstly evaluated
by the Etest method. A further investigation was performed on four
parental strains and the respective induced strains, analysing the single
colonies’ behaviour towards MZ by agar dilution method (ADM),
according to CLSI, and by agar incorporation method (AIM) as
described by Freeman et al. (2005).
Results: Seven strains belonging to different PCR-ribotypes showed
an increase of MIC to MZ after induction but only one achieved a MIC
of 8 mg/L by ADM that according to EUCAST is consistent with
resistance to MZ. Higher MICs to ERY and CM were easily reached
after induction with each of the two antibiotics used separately. All the
strains analysed showed a signiﬁcant MIC increase towards CM, with
strains belonging to PCR-ribotype 078 and 027 achieving fully
resistance values to this antibiotic. Heterogeneity in the MIC values
of the selected colonies studied was found by using the three methods;
however a higher diversity of MICs was observed by the ADM. In
particular, several colonies showed MICs higher than those detected in
the original strains.
Conclusion: These experiments showed that in vitro exposition of
susceptible C. difﬁcile strains to MZ or ERY/CM can lead to increase of
MICs or, in some cases, to resistance. The heterogeneous MICs to MZ
observed in isolated colonies of C. difﬁcile strains suggest how a
recurrent and/or prolonged in vivo administration of this antibiotic
could be related with an increase of colonies with higher MICs and with
the risk of failure in the treatment of CDI.
This study was funded by the Marie Curie European Project number
237942 CLOSTNET.
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R2469 Development of azithromycin resistant-mutant of
Escherichia coli and Shigella spp. in presence of phe-arg-
beta-naphthylamide
C. Gomes*, D. Durand, A. Lluque, S. Mosquito, M.J. Pons, A. Prada,
T.J. Ochoa, J. Ruiz (Barcelona, ES; Lima, PE)
Objective: To develop and analyse azithromycin(Azm)-resistant
mutants of Escherichia coli and Shigella spp. in presence of Phe-
Arg-beta-Naphtylamyde (PAN), an efﬂux pump inhibitor.
Methods: Eight clinical isolates of E. coli (4) and Shigella spp. (4)
were spread onto Mueller-Hinton plates containing Azm from 2 to 64
and 20 mg/L of PAN. Previously was evaluating that PAN doesn’t
affect the viability of the microorganisms. Twenty eight mutants were
selected, analyzing the stability of the resistance (20 passages without
antibiotic pressure) and the presence of cross-resistance with ampicillin,
chloramphenicol, nalidixic acid and tetracycline. Moreover, the
mechanisms involved in the development of Azm-resistance like
efﬂux pumps, mutations in the rplD, rplV and rrlH (23S rRNA) genes
were searched.
Results: The frequency of mutation ranged between 5.22 · 10-7 and
<6.99 · 10-10 for E. coli and 1.23 · 10-7 and <9.99 · 10-10 for Shigella
spp. E. coli mutants showed an increase in the Azm MIC of fourfold
with one strain achieving a MIC of 256 mg/L. Moreover, Shigella spp.
presented increases of up to ﬁvefold in MIC levels. All the strains
obtained but one (Ec 2.7) showed a stabled Azm resistance. The
insertion of six amino acids (IMPRAS) was observed in the rplV gene
of Ec 2.7 mutant, which has a MIC of 256 mg/L. This insertion
disappears after 20 passages without antibiotic pressure (MIC level
decreases to 8 mg/L). No cross resistance with other antibiotics was
found. The substitutions H165-Q (rplD) and L46-Q (rplV) were found
concomitantly in ﬁve Shigella spp. mutant strains.
Conclusions: Highly resistant mutants were selected in a single step
more easily in E. coli than in Shigella spp. A low frequency of
acquisition of Azm-resistance was found in presence of PAN.
Furthermore, the insertion IMPRAS could explain the high MIC level
of the E. coli mutant Ec 2.7. This insertion reverted in absence of
antibiotic pressure.
The association between detected mutations in rplV and rplD genes and
resistance to Azm is need to be conﬁrmed by further experiments.
R2470 Characterisation of mobile genetic elements harbouring
extended-spectrum b-lactamases and AmpC b-lactamases
in clinical Salmonella enterica isolates
M. de Toro*, Y. Sa´enz, I. Rodrı´guez, B. Rojo-Bezares, R. Helmuth,
C. Torres, B. Guerra (Logron˜o, ES; Berlin, DE)
Objective: To carry out the plasmid characterization of extended-
spectrum-b-lactamases (ESBL) and AmpC beta-lactamase-producing S.
enterica isolates recovered in three Spanish hospitals during 2003–
2009.
Methods: Nine ESBL-positive and two AmpC-positive S. enterica
isolates [serovars Virchow, 4; Enteritidis, 2; Bredeney, 2; Livingstone,
1; Gnesta, 1 and Salmonella spp., 1] were recovered from clinical faecal
samples. Seven of these ESBLs were previously characterised.
Susceptibility testing to 21 antibiotics was performed by disc-
diffusion and microdilution methods (CLSI). The presence of
blaCTX-M, blaTEM, blaOXA, blaCMY and blaSHV genes, the
blaCTX-M genetic environment and integrons were studied by PCR
and sequencing. Clonal relationship among the isolates was studied by
PFGE (XbaI and SpeI digestion) and by MLST. Plasmids were
analysed by alkaline lysis and S1-PFGE followed by hybridization
experiments (blaCTX-M, blaTEM, blaCMY, blaSHV and dfrA12
probes) and typed by PBRT method.
Results: The 11 S. enterica isolates of this study carried the genes
encoding b-lactamases CTX-M-9, CTX-M-10, CTX-M-14, CTX-M-
15, SHV-2, SHV-12 and CMY-2. MIC ranges of beta-lactams detected
in ESBL-positive isolates were: cefotaxime (16 to >128 mg/L),
ceftazidime (4 to >128 mg/L), aztreonam (4 to >128 mg/L) and
cefoxitin (£8 mg/L). The gene encoding CMY-2 was found in the two
AmpC-positive S. Bredeney isolates and they showed the following
MIC values: cefotaxime (32 mg/L), ceftazidime (>64 mg/L), aztreonam
(8–16 mg/L) and cefoxitin (64 mg/L). PFGE and MLST experiments
revealed high clonality and the same ST among S. enterica isolates of
the same serotype. Table shows the b-lactamases, mechanisms of
resistance and integrons detected among the 11 strains. Replicon type
and size of plasmids, as well as hybridization results, are also indicated.
Conclusion: ESBL-positive S. enterica isolates contain different
plasmids, some of them non typable, although the most frequent
incompatibility groups are IncF and IncI1. ESBL genes have been
detected in high sized plasmids in S. enterica isolates of different
serotypes.
R2471 High polymorphism in CMY variants of clonally-diverse
clinical and commensal Citrobacter freundii and
Citrobacter braakii isolates
N. Porres-Osante*, C. Torres, B. Rojo-Bezares, C. Aspiroz, C. Seral,
Y. Sa´enz (Logron˜o, Zaragoza, ES)
Objectives: To analyze the polymorphisms of blaCMY gene, probably
chromosomally located, in C. freundii and C. braakii clinical and faecal
isolates and to determine their antimicrobial resistance phenotype and
genotype as well as their clonal relationship.
Methods: Of 28 C. freundii and two C. braakii isolates from faecal
samples of healthy humans (n = 12) and clinical samples (n = 18) were
studied. Antibiotic susceptibility patterns to 25 antibiotics were
determined by disc diffusion and agar dilution methods. B-lactam
resistance genes (blaTEM, blaSHV, blaCTX-M and blaCMY), blaCMY
surrounding regions and characterization of integrons were studied by
PCR and sequencing. The presence of 13 resistance genes to
quinolones, aminoglycosides and sulfonamides were analysed by
PCR. Clonal relationship among isolates was studied by PFGE-XbaI
and REP-PCR.
Results: The antibiotic MIC ranges in isolates were as follows (faecal/
clinical, in mcg/mL): cefotaxime (0.06 to 0.12/0.125 to 64; ceftazidime
0.025 to 1/0.5 to >256; and cefoxitin 4 to 128/32 > 256. The
percentages of resistance to nalidixic acid, ciproﬂoxacin,
trimethoprim, sulphonamides and streptomycin were: 20%, 3.3%,
13.3%, 13.3% and 10%, respectively. All but two Citrobacter isolates
presented unrelated PFGE patterns. The blaCMY gene was ampliﬁed in
all strains, and 26 of them were completely sequenced, detecting 22
new blaCMY variants that were registered at Lahey database. The
identity range among detected blaCMY genes was 89–99% (94–99% in
case of translated CMY protein). Only the blaCMY-79 variant
presented a conservative mutation in H10 helix, whereas none of the
remaining variants showed mutations either in Ser84 or Lys87, being
these important residues very preserved. The blaCMY-2 variant was
found in only one C. freundii isolate, and the blaCMY-48, blaCMY-67
and blaCMY-70 variants were detected each one, at least in two
isolates. The surrounding regions detected upstream and downstream of
all blaCMY genes were ampR and blc genes, respectively. Four strains
presented an additional B-lactamase gene (blaTEM in three strains and
blaSHV in other one), 11 strains ampliﬁed a qnrB gene and two strains
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carried a class 1 integron harbouring dfrA12 + orfF+aadA2 and
dfrA1 + aadA1 arrangements, respectively.
Conclusion: A high polymorphism was detected in the blaCMY gene
of clinical and commensal Citrobacter isolates with high clonal
divergence among them. The variant blaCMY-2 was infrequently
detected in the studied collection.
R2472 Utilising population analysis to investigate piperacillin/
tazobactam differences between broth microdilution and
agar dilution for a set of Escherichia coli
C. Shubert, J. Slaughter, D. Creely*, G. Zambardi,
D. Shortridge (Hazelwood, US; La Balme, FR)
Objective: An abbreviated population analysis (PA) was done on 42
Escherichia coli (EC) isolates, in order to determine if heterogeneity of
resistance expression was a factor in piperacillin/tazobactam (TZP)
MIC differences between agar dilution (AD) and broth microdilution
(BMD), observed for some of the isolates.
Methods: BMD and AD testing for TZP was performed in triplicate
for 42 EC isolates, and a composite MIC (i.e. voted based on the three
results) was determined for each method. PA was performed utilizing a
range of agar plates prepared with piperacillin at doubling-dilutions
from 1 to 256 mcg/mL and tazobactam at a ﬁxed concentration of
4 mcg/mL. PCR for tem, shv, oxa, plasmid-mediated ampC, and ctx-m
b-lactamases was done on all isolates.
Results: Twenty EC isolates differed by interpretive category between
BMD and AD, utilizing the composite MICs for comparison. When
BMDandADwere not in agreement, higherMICswere usually observed
for BMD. Seventeen isolates were TZP resistant (R) by both BMD and
AD, and ﬁve were TZP susceptible (S) by both BMD and AD. Of the 20
isolates that differed between BMD and AD, 85% (17/20) were
heterogeneous, and three were homogeneous, by PA. Of the 17 R by
both BMD and AD, 65% (11/17) were homogeneous, and six were
heterogeneous, by PA. Of the ﬁve S by both BMD and AD, three were
heterogeneous, and two (including QC EC ATCC 35218) were
homogeneous. For the 22 total in category agreement between BMD
and AD, 13 were homogeneous (59%), and nine were heterogeneous
(41%). The rates of heterogeneity and homogeneity for the respective sets
(BMD vs. AD not in agreement, and BMD vs. AD in agreement) were
signiﬁcantly different based on Chi-square analysis p-values of 0.003 and
0.010, respectively. Most isolates (28 of 42) harbored only tem-1.
Conclusion: The majority of isolates with differences between BMD
and AD demonstrated heterogeneous growth by PA. When BMD and
AD were in agreement, the majority of isolates demonstrated
homogeneous growth. PA data support the conclusion that TZP MIC
differences between BMD and AD are primarily due to heterogeneity of
resistance expression. Further study of the mechanism of TZP
resistance for EC harboring tem-1 is in progress.
R2473 Analysis of the mechanisms of resistance to azithromycin
and its transferability in clinical isolates of Escherichia
coli and Shigella spp. clinical isolates from Lima, Peru
C. Gomes*, D. Durand, A. Lluque, S. Mosquito, M.J. Pons, A. Prada,
T.J. Ochoa, J. Ruiz (Barcelona, ES; Lima, PE)
Objective: To analyse the mechanisms of resistance to azithromycin
(AZM) and its transferability in Escherichia coli and Shigella spp.
clinical isolates from Lima, Peru.
Methods: The Minimal Inhibitory Concentration (MIC) to AZM was
determined in 71 clinical isolates (62 E. coli and nine Shigella spp.)
exhibiting a halo to AZM <15 mm. The role of efﬂux pumps was tested
establishing the MIC levels in presence of Phe-Arg-beta-Naphtylamyde
(PAN), an inhibitor of efﬂux pumps. Point mutations in rplD and rplV
genes were observed by PCR and sequencing. The presence of 10
established mechanisms of resistance to macrolides (ereA, ereB, msrA,
ermA, ermB, ermC, mefA, mefB, mphA and mphB) was searched.
Conjugations assays were performed in order to evaluate if plasmid
mechanisms are transferable.
Results: The MICs of AZM ranged between 32 and >256 mg/L among
E. coli isolates and 4 e 8 mg/L among Shigella spp. When PAN was
added to the media the MICs levels decreased from 1 to eightfold. In
seven strains were found substitutions in the rplV gene (K82-N, D-94H,
K98-N; L46-Q in two isolates; S101-T, I103-L; I4-L, K6-Q and P80-S
in two isolates of Shigella spp.). The most frequent plasmid mediated
gene was mphA (present in 59% of E. coli isolates and 11% of Shigella
spp.). Also the genes mphB, ermA, ermB, ereA and mefA were found
among the isolates. The conjugation assays showed that 25.8% of E.
coli isolates were able to transfer the AZM-resistance. Thus three genes
(mphA, ermA and ermB) were present within conjugative elements.
One E. coli isolate without any of the searched transferable AZM-
resistance mechanisms was able to transfer the AZM-resistance to
recipient strain.
Although no analysed plasmid mediated mechanism of resistance was
found among Shigella spp.
Conclusions: PAN-inhibitible efﬂux pumps play a role in development
of AZM resistance. The possible association between detected
mutations in rplV gene and resistance to azithromycin may not be
ruled out and need to be conﬁrmed by further experiments. In the area
several transferable AZM-resistance mechanisms are present, being the
mphA the most disseminated. The AZM should be carefully used in
Lima.
R2474 Phenotypic and molecular characterisation of CMY-46
and CMY-50, two novel plasmid-mediated AmpC beta-
lactamase carried by Escherichia coli
V. Manageiro*, D. Louro, E. Ferreira, M. Caniça (Lisbon, PT)
Objectives: The identiﬁcation of isolates containing AmpC b-
lactamases is epidemiologically and clinically relevant. With this
study we performed the phenotypic and molecular characterization of
two new CMY-2-types, designated CMY-46 and CMY-50, encountered
among a total of 1664 clinical non-duplicate isolates of various
Enterobacteriaceae species.
Methods: E. coli INSRA1169 and INSRA3413 were isolated from the
urine of patients with 77 years and 7 months old, hospitalized in the
ward and in pediatrics, respectively. The blaCMY genes were cloned in
the plasmid pBK-CMV and transformed into electrocompetent E. coli
DH5 alpha delta ampC by electroporation. Antimicrobial susceptibility
(MIC) was determined by a microdilution method. E. coli INSRA6015,
a CMY-2-producer, was used for phenotype comparison. PCR-mapping
of the genetic environment of new blaCMY genes was performed using
primers for known antibiotic and mercury resistance genes.
Results: Antimicrobial susceptibly tests showed that all isolates and
respective transformants were nonsusceptible to amoxicillin,
amoxicillin plus clavulanic acid, cephalothin, cefoxitin, ceftazidime
and cefotaxime. INSRA1169 and INSRA6015 were also nonsusceptible
to ciproﬂoxacin and to trimethoprim. Regarding gentamycin, only
INSRA1169 was resistant. Its noteworthy that the transformants
EcDH5a(pBK-CMY-2) and EcDH5a(pBK-CMY-46) exhibited higher
values for extended-spectrum cephalosporins than the respective
isolates. All strains were susceptible to cefepime and imipenem,
showing synergy between cloxacilin and cefoxitin and/or ceftazidime.
No phenotypic alterations were found comparing the new CMY-type
with the parental CMY-2. The genetic characterization of CMY-46 and
CMY-50-encoding genes revealed a Citrobacter freundii chromosome-
type structure, encompassing a blc-sugE-blaCMY-2-type-ampR
platform in both isolates. In addition, a sul1-type class 1 integron and
a truncated mercury resistance operon were encountered.
Conclusion: Although the CMY-type enzymes studied conferred
resistance to extended-spectrum cephalosporins, the susceptibility to
cefepime lead us to assume that those enzymes are not extended-
spectrum cephalosporinases. Otherwise, the presence of three genetic
resistance-encoding regions is of great concern, namely the truncated
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mercury resistance operon, which may help to promote antibiotic
resistance through indirect selection.
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R2475 First report of KPC beta-lactamase in Klebsiella
pneumoniae isolate from Croatia
B. Bedenic*, A. Mazzariol, V. Plecko, Z. Bosnjak, D. Sijak,
G. Cornaglia (Zagreb, HR; Verona, IT)
Objectives: The aim of the study was to characterize carbapenem
resistance in K. pneumoniae from Zagreb, Croatia.
Material and Methods: In February 2011. A 78 old male patient was
admitted to Clinical Hospital Center Zagreb with subdural haematoma.
He was previously diagnosed with acute myeloblastic leukemia. After
surgical removal of haematoma he developed purulent meningtis. K.
pneumoniae with reduced susceptibility to carbapenems was isolated.
The patient died from intracerebral bleeding in April 2011.
The antimicrobial susceptibility to a wide range of antibiotics was
determined by broth microdilution method in Mueller-Hinton broth and
96 well microtiter plates according to CLSI guidelines. A double-disk-
synergy test was performed to detect ESBLs.
Modiﬁed Hodge Test (MHT) was used to screen for production of
carbapenemases. MBL E-test was used to screen for production of
metallo-b-lactamases. The transferability of meropenem resistance was
determined by conjugation (broth mating method) employing E. coli
A15R-strain resistant to rifampicin. Transconjugant was selected on the
combined plates containing meropenem (1 mg/L) and rifampicin
(128 mg/mL). The presence of genes encoding ESBLs (blaSHV,
blaTEM, blaCTX-M), plasmid mediated ampC b-lactamases and
carbapenemases blaKPC, blaOXA-48, blaOXA-NDM, blaVIM and
blaIMP was determined by PCR.
Results: The isolate showed resistance or intermediate susceptibility to
expanded-spectrum cephalosporins, beta-lactam combinations with
inhibitors, carbapenems and gentamicin but remained susceptible only
to ciproﬂoxacin and colistin. Modiﬁed Hodge test was consistent with
the activity of carbapenemases. The MBL test for metallo-beta-
lactamase was negative indicating the absence of metallo beta-
lactamase. Imipenem resistance was not transferred to E. coli
recipient strain by conjugation. PCR revealed the presence of
blaKPC, blaTEM genes and blaSHV genes. Sequencing of blaKPC
gene revealed the presence of KPC-2 beta-lactamase. Neither plasmid-
mediated AmpC beta-lactamase nor OXA-48 beta-lactamase were
found. The strain was found belong to ST37 clone by MLST.
Conclusions: Infection control efforts limited the spread of KPC-
producing clone of K. pneumoniae in our hospital so far. KPC-2 beta-
lactamase with similar properties was previously reported from USA,
United Kingdom, Israel and Greece. To our best knowledge, this is the
ﬁrst report of KPC beta-lactamase from Croatia.
R2476 Evaluation of the antimicrobial resistance of Pseudomonas
aeruginosa at a clinical hospital Osijek, Croatia
V. Atalic*, M. Bogdan, D. Vukovic (Osijek, HR)
Objectives: Pseudomonas aeruginosa (PA) is an important
nosocomial pathogen causing a wide varriety of infections. The aim
of this study is to evaluate the resistance rate of PA isolates between
years April 2003 and October 2009, from patients hospitalised at the
Clinical Hospital Osijek (1250 beds), Croatia.
Methods: Of 1.531 isolates of PA were tested during 2003/2004, and
1.369 during 2009/2010. The antimicrobial susceptibility was
determined by the Kirby-Bauer disc diffusion method and E-test
when necessary. Results were interpreted according to CLSI. The
isolates were tested for amikacin (AN), gentamicin (GM), ciproﬂoxacin
(CIP), piperacillin/tazobactam (TZP), ceftazidime (CAZ), imipenem
(IPM) and meropenem (MEM). The statistical analysis was performed
using the chi-square test.
Results: After comparing the resistance rate of PA in the period of
April 2003–October 2009, the increasing rate of resistance with
statistical signiﬁcance for tested antimicrobial agents were found as
follows: AM 10.84%/18.19% (p < 0.01), CIP 25.08%/30.39%
(p < 0.05), CAZ 1.82%/3.21% (p < 0.05), IMP 6.92%/19.28%
(p < 0.01), MEM 6.92%/17.82% (p < 0.01), TZP 1.96%/6.72%
(p < 0.01). The resistance decreased only for GM 45.33%/39.01%
(p < 0.05).
Conclusion: According to the mentioned ongoing increasing
resistance rate, we can conclude that the number of therapeutic
options has continuously been decreasing. Ceftazidime is still the best
therapeutic agent for PA infections, due to its low resistance rate. On
the other hand, ﬂuoroquinolones and karbapenems show substantional
resistance increase which we can contribute to the excessive and
irrational usage of broadspectrum antibiotics. The decrease in
gentamicine resistance was because gentamicine was not used in the
therapy of PA and it was generally used less in last few years because of
its high resistance, so it recovered susceptibility. Although there is the
increasing rate of resistance, we can still be satisﬁed that the resistance
rate for PA is lower if compared to some other European countries. It is
important to continue the monitoring of the antimicrobial resistance in
treatment of pseudomonas infections with effective infection control
measures, in order to limit the development and spreading of resistance,
followed by good clinical practise.
R2477 Fluoroquinolone-resistant urinary isolates of Escherichia
coli from nosocomial vs. community-acquired infections
S. Baka, I. Tsouma, E. Kouskouni* (Athens, GR)
Objectives: Community-acquired (CA) and healthcare-associated
(HA) urinary tract infections (UTI) have been associated with high
rates of morbidity, and pose a signiﬁcant economic burden to healthcare
systems all over the world. Escherichia coli is the primary causative
agent of UTI but its susceptibility proﬁle has changed over the last
decade. Fluoroquinolones, such as levoﬂoxacin, norﬂoxacin or
ciproﬂoxacin, are now recommended for the empirical treatment for
UTI. However, the increased use of ﬂuoroquinolones has resulted in the
rapid emergence of ﬂuoroquinolone-resistant E. coli, making the
medical community skeptic as to whether ﬂuoroquinolones should
remain the drugs of choice for UTI. The purpose of this study was to
evaluate the prevalence of ﬂuoroquinolone-resistant E. coli in CA-UTI
and compare it to cases of HA-UTI.
Methods: We studied all episodes of CA-UTI and HA-UTI, diagnosed
in our hospital, due to E. coli during the period January 2009 to
September 2011. HA-UTI was deﬁned as those UTI affecting patients
hospitalized for two or more days. Urine samples were obtained from
clean-catch mid-stream urine or from urinary catheters and cultured on
Blood agar and MacConkey agar followed by incubation for 24 hour at
37C. Positive urine cultures were deﬁned by bacterial grow (105
colony forming units/mL. Patients with polymicrobial urine cultures
were excluded from the study. Identiﬁcation of E. coli was performed
by means of standard methods and susceptibilities to ciproﬂoxacin,
norﬂoxacin and levoﬂoxacin were tested by agar disk diffusion method
according to the CLSI criteria. Intermediate and resistant E. coli strains
to either of the antimicrobials studied were grouped together for data
analysis.
Results: We obtained 119 E. coli isolates from an equal number of
hospitalized patients and 321 from patients attending the Outpatient
Clinic of our hospital. Out of the 119 E. coli strains isolated from HA-
UTI, the resistance to ciproﬂoxacin, norﬂoxacin and levoﬂoxacin was
16.8%, 15.1% and 17.6%, respectively. The respective percentages for
the 321 E. coli strains isolated from CA-UTI were 14.0%, 14.0% and
13.1%, respectively.
Conclusion: Although ﬂuoroquinolones are considered an optimal
therapeutic choice in UTI, care should be given before initiating
empirical treatment with these agents, at least until antimicrobial
susceptibility tests become available for the clinicians.
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R2478 Resistance to ciproﬂoxacin and gentamicin in
Pseudomonas aeruginosa isolated from ear
A. Gil-Setas*, A. Mazon-Ramos, I. Polo-Vigas, C. Martin-Salas,
X. Beristain-Rementeria, C. Ezpeleta-Baquedano (Pamplona, ES)
Objective: Pseudomonas aeruginosa is a major cause of otitis externa.
The aim of this work is to know the susceptibility to ciproﬂoxacin end
gentamicin in Pseudomonas aeruginosa isolated from ear.
Methods: All P. aeruginosa isolated in our Hospital from January
2006 to October 2011 in ear swab samples were tested to ciproﬂoxacin
and gentamicin. Data of susceptibility of the strains and age and sex of
the patients were recorded on LIS. Susceptibility testing were made by
disk diffusion method following annual criteria published by CLSI.
Results: Of 635 P. aeruginosa were isolated from ear during the six
year period. Of 273 (43%) from females and 362 (57%) from males.
Ninety-ﬁve were isolated from elderly people 331 from adults and 209
from infants. The global rate of resistance was 6.1% to ciproﬂoxacin
and 1.7% to gentamicin. For infants, only four strains (1.9%) were
resistant to ciproﬂoxacin and none to gentamicin. For adults these
percentages were 6% and 1.5% and 15.8% and 6.3% in elderly people.
During 2006 to 2011 the global data of resistance were 13.3%, 9.6%,
3%, 5.8%, 2.3% and 5.1% to ciproﬂoxacin and 2.6%, 4.1%, 1%, 0.8%,
1.6% and 1% for gentamicin. For children 5.9%, 6.3%, 0%, 0%, 1.9%
and 0% for ciproﬂoxacin and 0%, 0%, 0%, 0%, 0%, 0% for gentamicin.
Adults: 5.4%, 8.7%, 5.6%, 9.1%, 3.4% and 4% for ciproﬂoxacin and
1.8%, 4.3%, 1.9%, 0%, 1.7% and 0% for gentamicin. Elderly: 37.5%,
18.2%, 0%, 7.1%, 0% and 15% for ciproﬂoxacin and 8.3%, 9.1%, 0%,
7.1%, 6.3% and 5% for gentamicin.
Conclusion: The rate of resistance to gentamicin both global and
stratiﬁed by age group remains largely unchanged during the study
period but for ciproﬂoxacin data show a tendency to decrease ﬁrst and
then to stabilize. These data do not match those contained in our records
of P. aeruginosa isolated from other locations. Mostly of P. aeruginosa
isolated from ear are from the community unlike in other locations
isolated from hospital environment, nursing homes or from patients
with underlying diseases. The data presented indicate that both
ciproﬂoxacin and gentamicin are useful in the treatment of otitis
externa, and we have to investigate possible causes of differences in
antibiotic susceptibility between P. aeruginosa isolated from ear and
the rest of them.
R2479 Prevalence and antimicrobial resistance pattern of
urinary tract pathogens in northern Cyprus
K.H. Suer, M. Guvenir*, A. Arikan, E. Guler, T.O. Guler (Mersin, CY)
Objective: Antimicrobial resistance is the major problem for the
treatment of urinary tract pathogens (UTPs) in the worldwide. The aim
of this study was to determine prevalence and antimicrobial resistance
pattern of urinary tract pathogens in North Cyprus.
Methods: This cohort study was performed on positive urine culture
samples which were evaluated in the microbiology laboratory of Near
East University Hospital between September 2010 and September
2011. Urine samples were cultured on blood agar and EMB mediums.
Colonies were counted after 24 hours at 37C and samples having
colony count more than 100 000/mL were considered to be positive.
BD Phoenix 100 (Becton Dickinson, USA) system were used for
bacterial identiﬁcation and antimicrobial susceptibility. Commercially
available statistical software package was used for analysis.
Results: A total of 174 urine samples were found to be culture
positive. One hundred and thirty one patients (75.3%) were female
while 43 (24.7%) were male. The mean age of the patients was 40.8.
The ﬁve most common organisms isolated were: Escherichia coli
(60.9%), Proteus mirabilis (9.8%), Klebsiella pneumoniae (9.2%),
Pseudomonas aeroginosa (5.2%) and Klebsiella oxytoca (3.4%). E. coli
was found to have higher resistance to Trimethoprim-Sulfamethoxazole
(45.8%), Ampicillin-Sulbactam (37.7%) and Ciproﬂoxacin (34.9%) and
no resistance to Imipenem (0%). K. pneumoniae showed equal
resistance to Trimethoprim-Sulfamethoxazole (31.3%) and
Piperacillin-Tazobactam (31.3%).
Conclusion: Antimicrobial resistance for common UTPs was found to
be lower than expected in this study. We suggest that the low resistance
ratio is due to limited usage of wide spectrum antibiotics here in North
Cyprus. To our knowledge this study is the ﬁrst report in English
literature for the prevalence of UTPs in North Cyprus. More studies are
needed to explore whether this resistance pattern will change in the
following years.
R2480 Optimal empirical therapy for male urinary tract
infections in Dutch general practices
C.D.J. den Heijer*, G.A. Donker, J. Maes,
E.E. Stobberingh (Maastricht, Utrecht, NL)
Objectives: To optimize empirical treatment of male urinary tract
infections (UTIs) in Dutch general practices, we determined the
antimicrobial susceptibility of Gram-negative uropathogens, including
extended-spectrum beta-lactamase (ESBL) prevalence, and the
antimicrobial prescription rates for male urinary tract infections (UTIs).
Methods: From January 2009 to June 2011, general practitioners
(GPs) participating in the Dutch Sentinel General Practice Network
(n = 42) collected urinary samples from male patients ((18 years) with
symptoms indicative of UTI and recorded prescribed antimicrobial
treatment. Uropathogens were identiﬁed and antibiotic susceptibility of
Gram-negative uropathogens was determined.
Results: Of 603 urinary samples were collected, of which 390 (65%)
were positive ((103 CFU/mL). The majority (83%) of the isolated
uropathogens was Gram-negative with Escherichia coli being the most
commonly isolated (51% of all uropathogens) followed by non-
fermenters (10%), Klebsiella pneumoniae (6%) and Proteus mirabilis
(5%). High susceptibility rates were observed to ciproﬂoxacin,
norﬂoxacin and nitrofurantoin (94%, 92% and 89% respectively),
whereas amoxicillin (52%), co-amoxiclav (77%) and co-trimoxazole
(82%) showed lower rates. One ESBL (0.3%) was found. An
antimicrobial agent was prescribed to 379 (63%) men.
Fluoroquinolones (30%) and co-amoxiclav (27%) showed highest
prescription rates followed by nitrofurantoin (22%) and co-trimoxazole
(15%).
Conclusions: Based on current susceptibility rates, ﬂuoroquinolones
are the antimicrobial agents of ﬁrst choice for male UTIs in Dutch
general practices. ESBL prevalence was low. Antimicrobial
susceptibility to co-trimoxazole and co-amoxiclav should be carefully
monitored, given their low susceptibility rate and relatively high
prescription rates. Nitrofurantoin showed high susceptibility rates,
although the appropriateness of this antimicrobial agent for male UTIs
still needs to be established in clinical trials.
R2481 Trends in the antimicrobial resistance of Streptococcus
pyogenes during 2007–2011 in a Kuwait hospital
E. Draghijeva* (Kuwait, KW)
Objective: To examine select antimicrobial susceptibilities for
Streptococcus pyogenes (S. pyogenes) responsible for acute tonsillitis
among the patients in a Kuwait hospital for the years 2007–2011. This
study was conducted to evaluate the trends in the antimicrobial
resistance of S. pyogenes isolates and its implications for empiric
therapy.
Methods: Antimicrobial susceptibility of 162 strains of S. pyogenes
isolated from throat cultures during 2007–2011 was performed by disc
diffusion method and results interpreted using CLSI (M2, M7, M100,
2010) breakpoint criteria. The results were compare for 2007–2008,
2009–2010 and 2011 (up to month of October).
Results: The prevalence of resistance for the respective periods were
as follow: penicillin 6.7% and 5.6%; ampicillin 33.4% and 50%;
erythrom ycin 19.1%, 26.7% and 38.9%; clindamycin 7.2% and 23.1%;
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ciproﬂoxacin 13.4% and 25%. The data of intermediatidy were as
follow: penicillin 14.3%, 6.7% and 38.9%; amoxicillin/clavulanic acid
9.5%, 13.3% and 11.1%; erythromycin 47.6%, 26.7% and 11.9%;
clindamycin 7.7% and 16.7%; ciproﬂoxacin 53.3%, 50% and 62.5%.
All isolates were susceptible to cefuroxime, ceftriaxone and cefotaxime.
Conclusions: Monitoring of drug resistance of local isolates of S.
pyogenes is important, since most streptococcal infections are treated on
an empirical basis, with increasing reliance upon second, third-
generation cephalosporines and beta-lactam/beta-lactamase inhibitor
combinations. Continued longitudinal comparisons of worldwide
monitored and important pathogen – S. pyogenes and changing
susceptibility proﬁles are critical elements in guiding empiric
therapies and epidemiologic interventions.
R2482 Frequency and antimicrobial susceptibility of
Pseudomonas aeruginosa isolated from Makkah hospitals,
Saudi Arabia
A. Asghar* (Makkah, SA)
Objectives: Pseudomonas aeruginosa is the most prevalent pathogen
that cause nosocomial infection associated with higher mortality rate in
hospitalized patients. This pathogenic bacteria produces different
enzymes including metallo-b-lactamases (MBLs) and extended
spectrum-b-lactamases that reduce the effectiveness of antibiotics.
The aims of this study were to determine the frequency of P.
aeruginosa isolated from various clinical specimens in different wards
of Makkah hospitals. In addition, antimicrobial susceptibility patterns
and types of MBLs were also determined.
Methods: A total of 478 P. aeruginosa clinical isolates were collected
during a period of six months starting September 2009 from clinical
wards of Al-Noor Specialist Hospital, Hera General Hospital and King
Abdul-Aziz Hospital. All clinical isolates were investigated by routine
microbiological methods and antibiotic susceptibility was performed by
using automated instruments; Phoenix 100 BD, USA and MicroScan
Walkaway 96, Siemens, Germany. MBLs production was determined
according to Clinical and Laboratory Standards Institute and conﬁrmed
using double disk synergy test. Types of MBLs were detected by using
polymerase chain reaction.
Results: A 31% of P. aeruginosa were isolated from intensive care
unit followed by male medical ward (15.9%). The majority of infections
caused by P. aeruginosa were respiratory tract infection (52%)
followed by wound infection (26%) and urinary tract infection (12%).
Higher susceptibility of P. aeruginosa was shown against piperacillin
(65%), amikacin (64%), merobenem (62%) and imipenem (61%).
MBLs producing strains were identiﬁed in 31 out of 148 (21%) of P.
aeruginosa and the most frequent MBLs types found were IMP
(22.6%) and VIM (19.4%).
Conclusion: P. aeruginosa cause a several nosocomial infection in
patients who are hospitalized in different hospital wards in particular
intensive care units of Makkah hospital. Antibiotic resistance is
increasing overtime rendering the difﬁculties for patient’s treatment.
Continuous monitoring of antimicrobial susceptibility is recommended
to help to reduce its resistance to antibiotics problem in the future.
R2483 Clarithromycine resistance of Helicobacter pylori:
prospective study among patients in the northern center
of Morocco
S. Alaoui*, M. Mahmoud, A. Amarti, D. Benajah, M. Lahbabi, M. El
Abkari, A. Ibrahimi, A. Souleimani, K. El Ghazi, C. Nejjari,
J. Raymond, B. Bennani (Fe`s, MA; Paris, FR)
Objective: The aim of our study is to determine the clarithromycine
resistance rate of H. pylori strains isolated in Moroccan patients with
gastric pain.
Method: A prospective and randomized study including adults
consenting patients (n = 486) who underwent endoscopy in gastro-
enterology unites has been conducted. H. pylori detection has been
done using Polymerase chain reaction (PCR), histological examination,
rapid urease test and culture, directly from collected gastric biopsies. H.
pylori clarithromycine resistance assessment has been performed on
bacterial cultures by disc diffusion technique. A reel times PCR has
been done on 41 biopsies randomly selected to conﬁrm our results
(detection and clarithromycine sensibility separately).
Results: H. pylori infection has been detected by PCR in 65% of cases.
From the 144 obtained cultures, 25% were clarithromycine resistant
using agar diffusion technique. Only 41 specimens were tested by reel
time PCR. The obtained results conﬁrmed those obtained both in
detection (by simple PCR) and in clarithromycine resistance. Samples
free from H. pylori by PCR and positives by histological examination
and/or rapid urease test were also negatives by reel time PCR.
Conclusion: The rate of clarithromycine resistance (25%) is
concordant with that determined in France (26%) but steel higher
than Tunisian one (14.6%). This rate will be conﬁrmed by reel time
PCR in larger sampling.
R2484 Aetiological agents of infective endocarditis in Saint
Petersburg, Russia
E.P. Barantsevich*, N.E. Barantsevich, L.V. Ivanova, I.V. Churkina,
E.N. Kolobova (Saint-Petersburg, RU)
Objectives: The aim of the present study was to evaluate the spectrum
of microorganisms – causative agents of infective endocarditis, and
their resistance to antibiotics.
Materials and Methods: Cardiac valves of patients with infective
endocarditis were removed during cardiosurgical operations. Valves
were homogenized in aseptic conditions and examined microscopically.
The cultures were obtained with BactAlert (BioMerieux, France).
Identiﬁcation of bacteria was performed with traditional bacteriological
methods and sequencing of 16sRNA gene (ABI Prism 3130, MicroSeq
ID v2.0 Software, MicroSeq ID 16s rDNA500 Library v2.0).
Susceptibility to antibiotics was tested by agar-dilution method on
Muller-Hinton agar (Oxoid, GB).
Results: Totally 51 bacterial strains were isolated from valves (four
mitral and 46 aortic), obtained during cardiosurgical operations in
patients with endocarditis. In the majority of cases a single bacterial
species was isolated, in one case – two species. Staphylococcus
epidermidis was the most frequent isolate – and was revealed in 24
(47.05%) cases. Other gram-positive cocci were presented with
Staphylococcus aureus in 9 (17.64%), Micrococcus luteus in 3
(5.88%), Streptococcus saprophyticus in 2 (3.92%), Enterococcus
faecalis in 2 (3.92%), Streptococcus salivarius in 2 (3.92%),
Streptococcus mitis in 3 (5.88%) cases. Gram-negative rods were
isolated in 2 (3.92%) cases – Enterobacter cloacae in 1 and
Acinetobacter baumannii in 1. Anaerobes were presented with
Propionibacterium acne in 2 (3.92%) cases. Rare bacteria were
Rothia amarae in 1 (1.96%) and Neisseria subﬂava in 1 (1.96%) case.
Resistance to antibiotics was detected in 25 (49.02%) strains.
Polyresistant were 7 (13.72%) isolates. The majority of strains were
resistant to 1 (23.52%) or 2 (11.76%) antibiotics. Sensitive to all
antibiotics were 26 (50.98%) isolates. All Enterococcus strains were
susceptible to vancomycin. No resistance to meticillin was observed in
Staphylococcus aureus. Meticillin-resistant were 6 (25.0%) of
Staphylococcus epidermidis isolates.
Conclusions: (i) The majority of bacteria, isolated from the excised
valves of patients with infective endocarditis, were Staphylococcus spp.
(ii) Resistant to antibiotics was half (49.02%) of bacterial strains. (iii)
Polyresistance to antibiotics was observed rarely. Resistance to
meticillin was present in ¼ of S. epidermidis isolates.
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R2485 Helicobacter pylori resistance to metronidazole and
clarithromycin in dyspeptic patients in Iran
F. Haghi*, A. Mohabati Mobarez, H. Zeighami (Zanjan, Tehran, IR)
The resistance of H. pylori to the recently available antibiotic treatment
regimens has been a growing problem. The prevalence of high
antibiotic resistance of H. pylori is the most common reason of its
eradication failure. The purpose of the present study is to determine the
prevalence of antibiotic resistance among H. pylori strains isolated from
Iranian patients. We investigated the prevalence of H. pylori resistance
to metronidazole, clarithromycin, amoxicillin, and tetracycline among
128 H. pylori isolates from Iranian patients. After the culture of biopsy
specimens and identiﬁcation, susceptibility tests was performed with
Modiﬁed Disk Diffusion Method (MDDM) and E-test. Resistance rates
to metronidazole, clarithromycin, amoxicillin and tetracycline were
64%, 23%, 2.5% and 0%, respectively. Seventy two percent of the
metronidazole resistance strains had MIC>256 mg/mL (High-Level-
Resistance). Due to the increasing rate of antibiotic resistance in H.
pylori strains and in order to decrease the treatment cost, testing of
susceptibility to metronidazole and clarithromycin is recommended.
R2486 Spectrum and antibiotic resistance dynamics of
uropathogens isolated from pregnant women with
community-acquired urinary tract infections in Russia:
2002–2011
I. Palagin*, M. Sukhorukova, M. Edelstein, R. Kozlov, A. Shevelev,
A. Dekhnich on behalf of the ‘‘DARMIS’’ Study Group
Objectives: To evaluate the dynamics of the resistance of Escherichia
coli isolates from pregnant women with community-acquired urinary
tract infections (CAUTIs) in different regions of Russia during the 9-
year period.
Methods: A total of 152 and 186 uropathogens were isolated from
urine samples from pregnant women with signiﬁcant bacteriuria
(>105 CFU/mL) as a part of two multicenter studies in 2010–2011
and 2002, respectively. Susceptibility of strains was determined by agar
dilution and interpreted according to the EUCAST criteria (2011).
Results: Among the identiﬁed microorganisms the most frequent were
Enterobacteriaceae members [135 isolates in 2010–2011 (88.8%) and
158 isolates in 2002 [83.2%]) out of which there were 100 (65.8%) and
117 (61.6%) E. coli strains, respectively. Resistance rates of E. coli in
2010–2011 and 2002 are summarized in the Table.
Conclusions: A statistically signiﬁcant increase in resistance rates to
ampicillin (from 31.7% to 48.0%; p < 0.05), cefotaxime (from 2.6% to
17.0%; p < 0.05), ceftazidime (from 1.8% to 16.0%; p < 0.05) and
ciproﬂoxacin (from 6.0% to 15.0%; p < 0.05) was observed between
the two study periods. A dramatic growth of ESBL production rate
(from 1.9% to 16.0%; p < 0.05) was also noted. The changes in
susceptibility to other drugs were statistically non signiﬁcant.
R2487 Prevalence of hGISA heterogeneous glycopeptide
intermediate-resistant Staphylococcus aureus isolates in
Italy
N. Girometti*, J. Richards, V.E. Daniel, M. Wootton,
R.A. Howe (Cardiff, UK)
Objectives: S. aureus is an important clinical pathogen causing,
bacteriaemia, endocarditis and wound infections in hospitals and
community. Glycopeptide Intermediate resistance in Staphylococcus
aureus (GISA) is associated with treatment failure but is rare.
Heterogeneous (h) GISA is more common; prevalence of 0.7%,
0.2%, 7.5%, 0.7%, 6% and 1.1% in UK, France, USA, Belgium, Israel
& Italy. It is important to determine the prevalence of hGISA within
local and national S. aureus strains to inform treatment options. This
study investigates the prevalence of hGISA in a local hospital in
Bologna, Italy.
Methods: Of 74 strains of MRSA were collected from S. Orsola
University Hospital in Bologna, Italy. Strains were screened using
10 lL of McFarland 0.5 inoculum onto a Mueller Hinton agar plate
containing 5 mg/L teicoplanin (MHA5T). All isolates were tested with
GRD strips using manufacturer’s instructions. Any screening plate or
GRD positives were conﬁrmed with population analysis proﬁle-area
under curve (PAP-AUC) method.
Results: Out of the 74 isolates tested two isolates showed positive
results for GRD, with one of these also resulting in a positive MHA5T
test (Table). Geometric means for vancomycin and teicoplanin are 1.02
and 0.92 respectively. Both screen positive isolates were conﬁrmed
hGISA by PAP-AUC ratio of 1.05 and 1.22. Further screening for
second line antibiotic therapies through E-tests, demonstrated a fully
sensitive proﬁle of the strains for Daptomycin, Linezolid and
Quinupristin/Dalfopristin.
Conclusions: Of 2.7% of MRSA strains tested were conﬁrmed as
hGISA. The prevalence in this hospital is similar to those observed in
Northern Italy and has implications for the treatment of hGISA
infections.
R2488 Coexistence of extended-spectrum beta-lactamase (ESBL)
and ampC plasmidic beta-lactamase in Escherichia coli,
Klebsiella pneumoniae and Proteus mirabilis in a two-year
period
M.P. Palacia´n, I. Ferrer, N. Nantomil, M.I. Cameo, G. Martı´n,
M.J. Revillo, A. Rezusta* (Zaragoza, ES)
Objective: To study the coexistence of the ESBL and ampC plasmidic
(ampCp) beta-lactamase in the Escherichia coli, Klebsiella pneumoniae
and Proteus mirabilis strains isolated from tract urinary infections. To
document antibiotics susceptibility in the treatment of urinary tract
infections caused by extended-spectrum beta-lactamase (ESBL)
producing E. coli, Kl. pneumoniae and P. mirabilis.
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Method: Retrospective study of ESBL producing E. coli, K.
pneumoniae y P. mirabilis strains isolated from urinary clinical
samples of patients from Hospital Miguel Servet from 2010 to 2011.
Isolates were identiﬁed and tested using MicroScan-WalkAway. ESBL
production was conﬁrmed by the double-disk diffusion method
according to CLSI. AmpCp beta-betalacmases were conﬁrmed by the
use of boronic acid in disk diffusion test according to CLSI in the ESBL
strains with cefoxitin concentrarion equal or superior to 16.
Result: In 2010, 4977 E. coli, 813 K. pneumoniae and 439 P. mirabilis
were recovered. Of 248 (4.98%) 33 (4.05%) and 2 (0.45%) isolates
were positive for ESBL. We tested 16 strains of ESBL E. coli with CMI
of cefoxitin equal or superior to 16 to ﬁnd one strain with AmpC
plasmidic beta-lactamase. Ciproﬂoxacin and norﬂoxacin were resistant
in 73.14% and 68.19%. Of 9.18% of the strains were resistant to nalidix
acid with quinolones sensible. Fosfomycin was sensible in 86.92%.
Gentamicin and tobramycin were sensible in 71.73% and 55.83%.
Trimethoprim/sulfamethoxazole was resistant in 69.25%. From January
1, 2011 to October 31, 2011, 4181 E. coli, 618 K. pneumoniae and 262
P. mirabilis were recovered. Of 250 (5.97%), 29 (4.69%) isolates were
positive for ESBL. We tested 28 strains of ESBL E. coli with cefoxitin
equal or superior to 16 to ﬁnd ﬁve strains with AmpCp beta-lactamase.
Ciproﬂoxacin was resistant in 78.13% and norﬂoxacin in 73.47%.
Nalidixic acid resistant with quinolones sensible was found in 6.81%.
Fosfomycin was sensible in 92.11%. Gentamicin was sensible in
64.15% and tobramycin 51.97%. Trimethoprim/sulfamethoxazole was
resistant in 56.99%.
Conclusion: ESBL strains remains similar in our study. E. coli has
been the only specie with positive result to AmpCp beta-lacmase in a
strain which presented a cefoxitin concentration superior to 16. More
further studies are obliged to conclude if the presence of AmpC
betalactamases is increasing. Most of the ESBL strains were resistant to
quinolones. Fosfomycin remains as an good therapeutic option.
R2489 Activity of moxiﬂoxacin tested against 14 930 clinical
isolates of Enterobacteriaceae from Europe
D. Farrell, H. Sader*, R. Flamm, R. Jones (North Liberty, US)
Objective: To determine the activity of moxiﬂoxacin and selected
antimicrobial agents tested against Enterobacteriaceae (ENT) isolated
from Europe (EU) over a ﬁve year period. Moxiﬂoxacin is a broad-
spectrum bactericidal ﬂuoroquinolone (FQ) with potent activity against
Gram-positive and -negative pathogens.
Methods: Of 14 930 ENT were analyzed from the SENTRY
Antimicrobial Surveillance Program platform collected from 13
countries (2005–2009). The distribution of isolates by infection type
(n) was: blood stream infection (12 126), intra-abdominal infection
(854), respiratory tract infection (1690), hospital-acquired pneumonia
(878), ventilator-associated pneumonia (262), urinary tract infection
(1671), and complicated skin and skin structure infection (1114).
Isolates were tested for susceptibility by CLSI broth microdilution
methods (M07-A8 and M100-S21). Susceptibility interpretations were
determined using EUCAST (2010) and CLSI breakpoints.
Results: The table shows the cumulative percentage MIC frequency
against the species/groups tested. Against all ENT, 20.8% of isolates
were resistant (R) to moxiﬂoxacin compared to 17.8 and 19.3% for
levoﬂoxacin (LEV) and ciproﬂoxacin (CIP), respectively. R against all
ENT was lowest for imipenem (0.4%) and meropenem (0.3%). Against
E. coli, 23.2% of isolates were R to moxiﬂoxacin compared to LEV
(22.6%) and CIP (22.9%). R to ceftazidime (CAZ) and ceftriaxone
(CRO; surrogate markers for ESBL production) were 5.2 and 8.9%,
respectively. Against K. pneumoniae, 19.5% of isolates were R to
moxiﬂoxacin compared to 16.1% for LEV and 18.4% for CIP (18.4%)
with 20.2% R to CAZ and 23.9% R to CRO.
Conclusions: Similar to LEV and CIP, moxiﬂoxacin demonstrated a
stable susceptibility and MIC distribution pattern in ENT clinical
isolates from EU patients over a 5 year period (2005–2009).
R2490 Extended-spectrum b-lactamases are differentially
expressed in specimens from normally sterile and non-
sterile sites, in a hospital setting
G. Marques*, C. Chaves, T. Reis, M. Pereira, R. Tome´, L. Boaventura,
G. Ribeiro (Coimbra, PT)
Objectives: To compare the prevalence of extended spectrum beta-
lactamase (ESBL)-producing strains in isolates from normally sterile
samples and non-sterile sources, in a Hospital setting.
Methods: We reviewed all cultures of blood or urine (‘‘B/U’’),
spontaneously expectorated sputum or bronchial aspirates (‘‘sputum’’)
performed in our Lab, between January 2008 and October 2011,
selecting all 12668 positive samples for Escherichia coli (EC) or
Klebsiella pneumoniae (KP). Excluding duplicates, we obtained 10205
isolates, and compared the ratio of ESBL-producing E. coli (EPE) and
K. pneumoniae (EPK) in each type of sample.
Results: We obtained 6351 EC-positive isolates from urine, 1044 from
blood and 307 from sputum, and 1632 KP-positive isolates from urine,
429 from blood and 442 from sputum. Considering the EC isolates, we
found that 668 urine samples (10.5%), 114 blood samples (10.9%) and
76 sputum samples (24.8%) were positive for EPE (p < 0.001), while
in the KP isolates, 746 urine samples (45.7%), 200 blood samples
(46.6%) and 168 sputum samples (38.0%) were positive for EPK
(p = 0.01). In both, the differences between urine and blood were not
signiﬁcant. The observed high incidence of EPK reﬂected a constant
upward trend in the period considered, with isolates in B/U climbing
from 22.1% in 2008 to 45.4% in 2009 and 53.5% in 2010 (p < 0.001),
with a similar increase in sputum, from 27.7% in 2008 to 37.1% in
2009 and 45.4% in 2010 (p = 0.03). By contrast, EPE plateaued in B/U
during the same period (9.1% in 2008, 10.6% in 2009 and 10.8% in
2010, p = NS).
Discussion: We found that the prevalence of EPE was identical in
blood and urine (11%), but increased 2.3-fold in bronchial samples
(25%). Conversely, the prevalence of EPK was 17% lower in bronchial
samples than in blood and urine (38% vs. 46%). Considering that
ESBL-producing strains are more frequent in the nosocomial setting
than in the community, and that EC is part of the endogenous ﬂora, our
results suggest that, in our series, isolates resulting from colonization
with Hospital ﬂora colibacilli are more frequent in bronchial samples,
while bacteriuria and bacteraemia are due to autologous strains in a
higher percentage of cases. On the other hand, the presence of KP in
blood and urine is typically of nosocomial origin; the lower percentage
of EPK in bronchial samples suggests that a higher proportion of these
specimens reﬂect colonization of the patient’s respiratory tract by
strains acquired in the community.
R2491 Emerging carbapenemase-producing Klebsiella
pneumoniae infections in a Greek hospital: clinical and
laboratory features
A. Kyratsa, N. Charalambakis, I. Grafakos, A. Arvaniti, A. Karaiskou,
F. Klouva, E. Trikka-Graphakos* (Athens, GR)
Objectives: To analyze clinical and laboratory data in 31 infections
due to Klebsiella pneumoniae isolates with reduced susceptibility to
carbapenems.
Methods: All nosocomial infections due to K. pneumoniae strains with
reduced susceptibility to carbapenems (MIC in meropenem: (1) were
recorded in our hospital from November 2010 through November 2011,
according to a National Surveillance Study for the management of
multi-drug resistant Gram-negative pathogens. Of 31 clinical isolates
were recovered from 25 patients in our laboratory. Susceptibility tests
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were performed by Kirby-Bauer method, MIC determination by
automated system (Phoenix, BD) and E-test method (Biomerieux SA,
France) according CLSI standards. Preliminary phenotypic detection
was based on the boronic acid disk test, a simple phenotypic algorithm
employing three combined-disc tests consisting of meropenem alone
and with phenylboronic acid (PBA), EDTA, and both PBA and EDTA.
Genotypic conﬁrmation for the presence of the bla-KPC gene by PCR
and molecular typing by PFGE.
Results: Of 12 cases of bacteremia, seven catheter related infections,
three surgical site infections, two lower respiratory tract infections, ﬁve
ventilator-associated pneumonia and two urinary tract infections were
identiﬁed. Twenty-three infections were recorded in ICU, four in
Surgical and four in Internal Medicine unit respectively. Ninteen out of
25 patients were mechanically ventilated, 21 had central venous
catheter and 25 urinary-bladder catheter. The crude mortality, 28 days
after the ﬁrst positive culture, was 32%.
Multidrug resistance characterized the studied isolates with an MIC
range to meromenem £1 to (32, with colistin, gentamicin and
tigecycline being the most active agents. Boronic acid disk test was
able to differentiate 26 KPC, 3 MBL producers and two co-producers of
both carbapenemases. PCR conﬁrmed that all 26 isolates produce KPC-
2 b-lactamases and belong to the same dominant genotype in Greece.
Conclusion: In Greek hospitals, carbapenem resistance among
Klebsiella pneumoniae clinical isolates, is alarming and poses a
unique challenge for clinical microbiologists and clinicians.
Continuation of antibiotic policy and proper infection control
practices and barriers to prevent further spread, is mandatory.
Boronic acid disk test provides a simple algorithm for phenotypic
detection of carbapenemase production and for the differentiation of
KPC and MBL enzymes
R2492 Carbapenemase-producing Enterobacteriaceae isolates
collected in Portuguese hospitals
V. Manageiro*, E. Ferreira, D. Louro, M. Caniça, on behalf of
ARSIP Antibiotic Resistance Surveillance Program in Portugal
Objectives: In Portugal, little is known on carbapenemase (CARB)-
producing Enterobacteriaceae. The aim of this study was to identify the
resistance mechanisms of Enterobacteriaceae isolates, identiﬁed at
hospital laboratories as carbapenem (CA) non-susceptible.
Methods: This study included 61 Enterobacteriaceae isolates (26
Klebsiella spp., 15 Escherichia coli, nine Enterobacter spp., six
Morganella morgannii, four Proteus mirabilis, one Serratia
marcescens), collected between April 2006 and September 2011 and
sent to the NIH-Lisbon for CA susceptibility conﬁrmation.
Antimicrobial susceptibility of clinical isolates was performed by disk
diffusion method (CA-SFM). Clinical isolates showing synergism
between CA and boronic acid (BOR) (and/or clavulanic acid, CLAV) or
with EDTA were considered presumptively CARB-producers from
class A or Class B, respectively. PCR and sequencing were applied to
detect and identify CARB-encoding genes; the respective genetic
environment was revealed by sequencing using PCR mapping. Direct
transfer of the CA resistance phenotype was attempted by mating-out
assays. Antibiotics susceptibility (MIC) of transconjugants and
respective isolates were tested by microdilution.
Results: The majority of isolates were collected from the urine (57.4%)
of elderly ((65 years old) male patients (54.1%), admitted at the
emergency room/ambulatory (24.6%) and at internal medicine (18.0%)
wards. Among all isolates, 50.8% were nonsusceptible to at least one
CA, being 67.2% multidrug-resistant; 16 isolates showed synergy
between CA and BOR (and/or CLAV). Among those, ﬁve were KPC-3-
producers (four Klebsiella pneumoniae and one Enterobacter clocae),
collected in 2010 (2) and 2011 (3). The blaKPC-3 genes were
conﬁrmed to be carried by plasmids. Genetic environment of blaKPC-3
gene revealed the presence of a Tn4401 transposon in all but one isolate
(E. cloacae), suggesting that this last gene was included in other
Tn4401-like isoform. We also detected a VIM-2-producing Klebsiella
oxytoca, collected in 2009, among the seven isolates that showed
synergy between imipinem and EDTA. No blaGES, blaNDM or
blaIMP were detected.
Conclusion: This study provides new data regarding the molecular
epidemiology of CARB-producing Enterobacteriaceae in Portugal.
Overall, our results emphasize the need of a concerted action to manage
CA use. This is supported by EARS-Net, which reported an increase in
CA nonsusceptibility of K. pneumoniae isolates from 0.72% in 2008 to
1.58% in 2010.
R2493 Susceptibility comparison of uropathogens isolated from
adults with complicated and uncomplicated community-
acquired urinary tract infections in Russia, 2010–2011
I. Palagin*, M. Sukhorukova, M. Edelstein, R. Kozlov, A. Shevelev,
A. Dekhnich, on behalf of ‘‘DARMIS’’ Study Group
Objectives: To compare the resistance of Escherichia coli isolates
from adults with complicated and uncomplicated community-acquired
urinary tract infections (CAUTIs) in Russia.
Methods: A total of 282 and 196 uropathogens from adults with signs of
complicated and uncomplicated CAUTI in 17 cities of Russia (Moscow,
St. Petersburg, Chelyabinsk, Irkutsk, Kazan, Krasnodar, Omsk, Rostov-
on-Don, Samara, Seversk, Smolensk, Surgut, Tomsk, Tyumen, Ufa,
Yakutsk, Yekaterinburg) were collected during 2010–2011. The MICs
for antibiotics (amikacin – AMK, amoxicillin/clavulanate – AMX/CLV,
ampicillin – AMP, cefotaxime – CTX, ceftazidime – CTZ, cefepime –
CFPM, ciproﬂoxacin – CPX, co-trimoxazole – TMP/SMX, ertapenem –
ERT, fosfomycin – FSF, gentamicin – GNT, imipenem – IPM,
nitrofurantoin – NTF) were determined by agar dilution and interpreted
according to the EUCAST criteria (2011).
Results: Among the identiﬁed microorganisms the most frequent were
Enterobacteriaceae members (225 isolates [79.8%] in the group of
complicated CAUTI and 160 isolates in the group of uncomplicated
CAUTI [81.6%]) out of which there were 173 (61.3%) and 129 (65.8%)
E. coli strains, respectively. Resistance rates of E. coli in both study
groups are summarized in the Table. A statistically signiﬁcant
difference in resistance rates to ampicillin (37.9% and 53.1%;
p < 0.05), cefotaxime (2.3% and 13.8%; p < 0.05), ceftazidime (3.0%
and 13.8%; p < 0.05), cefepime (3.0% and 11.0%; p < 0.05), co-
trimoxazole (21.8% and 32.4%; p < 0.05) and ciproﬂoxacin (10.8%
and 27.7%; p < 0.05) was observed between the groups of adults with
uncomplicated CAUTIs and complicated CAUTIs, respectively. A
signiﬁcant distinction in ESBL production rate (2.3% and 13.8%;
p < 0.05) was also noted. The changes in susceptibility to other drugs
were statistically non signiﬁcant.
Conclusions: The resistance rates of E. coli to ampicillin, co-
trimoxazole, III-IV generation cephalosporins and ciproﬂoxacin were
signiﬁcantly higher in the group of adults with complicated CAUTIs
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than in uncomplicated ones. There were no signiﬁcant differences in
resistance to other antimicrobials tested.
R2494 Empiric therapy for sepsis needs adaptation due to
increased resistance rates
M.A. Leverstein van Hall*, J. Muilwijk, J. Alblas, N. van de Sande on
behalf of the ISIS-AR participants
Introduction: In 2011 the Dutch Society of Antibiotic Policy (SWAB)
issued a new guideline on sepsis therapy. For hospital acquired (HA)
sepsis of unknown origin it recommends combination therapies of
piperacillin-tazobactam (PTZ), cefuroxim (CEF), cefotaxim or
ceftriaxon (CFT) with aminoglycoside (AG) or ciproﬂoxacin (CIP),
for community-acquired (CA) sepsis monotherapy with CEF or CFT or
amoxi-clav (AMC) with AG, and for ESBL high risk patients
carbapenems. In the present study, we investigated the distribution of
species causing sepsis and to what extent the recommended empiric
therapy covers sepsis caused by Enterobacteriaceae (ENT).
Materials and Methods: Antimicrobial Susceptibility Test (AST)
results, ﬁrst isolate per patient, from 2008 to 2010 were collected from
the Infectious Diseases Surveillance and Information System for
Antibiotic Resistance (ISIS-AR) at the RIVM, representing 27
laboratories covering 50% of the hospital beds. The distribution of
species and the % I or R Enterobacteriaceae for the recommended
regimens was calculated. E. coli (ECO) or K. pneumoniae (KPN) I or R
to 3rd generation cephalosporins were deﬁned ESBLs. Hospital
acquired was deﬁned as a blood culture (BC) obtained from an
admitted patient and community acquired was deﬁned as a BC obtained
at the outpatient department or emergency room.
Results: Of 35.113 (34% ENT) HA and 9.456 (36% ENT) CA isolates
were included. The distribution of species was stable over the years,
except for a signiﬁcant decrease among HA and CA pneumococci and
increase among HA E. faecium. (Intermediate) resistance rates for ENT-
BC isolates from 2008 to 2010 are shown in the Figure. Co-resistance
rates among HA and CA ESBLs were, respectively: tobramycin
(TOBR) 47% and 46%, gentamicin (GENT) 36% and 33%, for
amikacin (AMIK) 9% and 5%, CIP 58% and 63%, carbapenems 0.2%
and 0%.
Conclusion: From 2008 to 2010 the distribution of species causing
sepsis was stable, except for a decrease among pneumococci and
increase of HA E. faecium. Although the resistance rates among CA-
ENT were stable, the increasing resistance rates among HA-ENT
causing sepsis are worrisome. The recommendations of the SWAB
guideline are greatly supported by our data, except for CEF-CIP therapy
for HA sepsis and CEF or CFT monotherapy for CA sepsis since
resistance rates in 2010 were above 5%, the consensus resistance rate
above which a drug is no longer eligible for empiric sepsis therapy.
R2495 Bloodstream infections caused by extended-spectrum
beta-lactamase producing Escherichia coli and Klebsiella
spp. and associated factors
O. Kaya*, F. Akcam, O. Unal, T. Ceylan (Isparta, TR)
Objectives: Antibiotic resistance is an important problem in treatment
of Gram negative bacterial infections. Extended spectrum b-lactamases
(ESBL) are heterogenous bacterial enzymes that result in clevage and
inactivation of extended spectrum cephalosporins, monobactams, and
penicillins. These enzymes are found most commonly in the
Enterobacteriaceae family, especially Esherichia coli and Klebsiella
spp. (EK). We analysed the clinical characteristics of the bloodstream
infections (BSI) caused by ESBL positive EK strains, and compared
them with those caused by ESBL negative EK strains.
Methods: This retrospective study was conducted at the tertiary-care
teaching hospital in Isparta, Turkey. Hospital records were searched in
order to identify all adult inpatients (18 years old) diagnosed with BSI
caused by ESBL positive/negative EK strains between January 2007–
October 2011. BSI caused by ESBL positive/negative EK in at least one
blood culture specimen from a patient with systemic inﬂammatory
response syndrome (e.g. fever, tachycardia, tachypnea, and
leukocytosis). Detection of ESBL was performed by using disk
diffusion method. Nosocomial acquisition of infection was considered
when the infection ocurred >48 hour after admission to the hospital,
while community-acquired bacteremia when it occurred <48 hour after
admission to the hospital. Data obtained included age, sex, underlying
diseases, surgical interventions performed within 30–90 days prior to
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the episode of bacteremia, antibiotic use within 30–90 days prior to the
episode of bacteremia, site of infection, intensive care unit stay, invasive
procedures and survival. Statistically analyses were performed using
SPSS 15.0. The chi-square test was used to compare dischotomous data
unless the cell size was <5, in which case Fisher’s exact test was used.
Results: We analysed the records of 145 adult inpatients with BSI due
to EK (n = 113 Escherichia coli, n = 32 Klebsiella spp.) diagnosed
between 2007 and 2011. Demographic, clinical, laboratory
characteristics of patients with bloodstream infection due to ESBL
positive and negative EK cases were seen table 1. Central venous
catheterisation, surgical interventions within 30 and 90 days prior to the
episode of bacteremia, antibiotic use in 30 and 90 days and urinary
pathology were statistically signiﬁcant.
Conclusion: In conclusion, surgery interventions and previous use of
antibiotics is associated factor for bacteremia by ESBL producing
organisms.
R2496 Antibiotic sensitivity patterns of Pseudomonas aeruginosa
strains isolated from various clinical specimens: a
comparative study between two periods, 1999 vs. 2011
N. Lassoued, S. Sammoud, M.S. Asli, M. Ben Moussa,
F. Barguellil* (Tunis, TN)
Objective: Pseudomonas aeruginosa is an opportunistic human
pathogenic bacterium that is highly prevalent in hospital environment.
The use of new generation of broad-spectrum antibiotics has been
responsible for the selection of many multi-resistant strains. We
undertook this study to describe the resistance proﬁle of this germ in the
Military hospital of Tunisia, to determine its phenotypes and study its
distribution among hospital departments. We also compared the recent
resistance proﬁle with resistance described from 1990 to 1999 in the
same hospital.
Materiel and method: The present study is a retrospective analysis of
all positive cultures of Pseudomonas aeruginosa found between
October 2010 and November 2011 in the Military hospital of
Tunisia. Information about resistance proﬁles, site of sampling and
department origin were provided. We have focused on susceptibilities
to betalactam family and aminoglycosides family, ciproﬂoxacin,
colistin and fosfomycin. Drug susceptibilities had been evaluated by
disk-diffusion method on Mueller-Hinton agar in accordance with the
criteria of CA-SFM 2010.
Results: Sampling was taken from patients belonging to many
departments and distributed as the following: 35.5% are isolated from
ICU, 13.5% from cardiovascular and cardiothoracic surgery, 8.8% from
other surgery departments, 8.8% from neonates, 8.5% from urology,
and 10.5% from other departments. We included 14.4% emanated from
outpatients as well. The site of sampling was also variable, including
37.8% from deep and superﬁcial wounds, 17.5% from tracheal aspirate,
16.3% from urine, 9.3% from auricular infection, 6.4% from blood,
4.7% from catheters, 4.7% from other material and 3.3% from other
samplings. Pseudomonas aeruginosa was highly resistant to large
spectrum penicillin and large spectrum cephalosporin (Table 1). Both of
enzymatic and non-enzymatic mechanisms were involved. Resistance
to carbapenem was above all related to porin-D2 mutation, whereas the
existence of carbapenemase was found rare.
Conclusions: Our results showed relatively high rates in the presence
of Pseudomonas aeruginosa resistant to beta-lactam, amino-glycosides,
ﬂuoroquinolones and fosfomycin. Different mechanisms are involved to
induce these resistances, including non enzymatic reactions. Treatment
options are currently limited. Colistin is known to be still efﬁcient
against this germ, even though it is recommended to be used as an
ultimate treatment.
R2497 Antimicrobial resistance phenotypes in Staphylococcus
spp. isolates from mastitis milk of sheep dairy farms in
Sicily
M.C. Emanuele*, D. Vicari, A. Vella, M. La Giglia, M. Bivona,
R. Bosco, M. Vitale (Palermo, IT)
Objectives: Antimicrobial agents are commonly applied to dairy farm
to control bacterial infection in lactating sheep. The testing and the
monitoring of drug resistance in the main pathogens involved in
mastitis represent an important tool to guide veterinarian in selecting the
most effective agents for the therapeutic interventions and to avoid the
potential resistance spreading through the dairy products and food
chain.
Methods: Of 40 strains of Staphylococcus (36 S. aureus, two S.
intermedius and two CNS) used to prepare autogenous vaccine at the
IZS of Sicily and isolated during 2009 from mastitis milk of 30 dairy
farms were tested for antimicrobial susceptibility by disk diffusion test
against the following agents: ampicillin (AMP 30 mcg),
amoxicillin + clavulanate (AMC 30 mcg), clindamycin (DA 2 mcg),
enroﬂoxacin (ENR 5 mcg), erythromycin (ER 15 mcg), penicillin (P
10 UI), tetracycline (TE 30 mcg), vancomycin (VA 30 mcg), oxacillin
(OX 1 mcg), oxytetracycline (OT 30 mcg) according to CLSI
guidelines. MIC values for the strains exibiting ER and DA and
methicillin resistance were also detected by E-test. Inducible DA
resistance was investigated by DD test. The presence of mecA gene was
investigated by PCR.
Results: Of the total 40 strains analyzed 11 were coming from
previous tested ﬂocks. The isolates conﬁrmed the same resistance/
sensitivity proﬁle except for two farms in which new resistance
regarding ER and TE showed up. Of 50% showed resistance to TE and
OT and some had multidrug resistance, as showed in the Table 1. The
resistance to ER and DA (20% and 15% respectively), was frequently
associated with other drugs. High resistance rate for P, AMC, AMP and
TE was found. Inducible DA resistance was not observed. The majority
of resistant clones to both ER and DA showed low MIC (4–8 mcg/mL),
the CNS exhibited high MIC (>256 mcg/mL). The presence of mecA
gene resulted in a 2.5% of positive clones holding multiple resistance.
None of the tested strains showed resistance to VA and ENR.
Conclusion: The results conﬁrm the widespread of antibiotic
resistance clones in the animals for food productions and highlight
the major risk for the increasing drug resistance due to the selective
pressure acting in the ecosystem. The ﬁnding of phenotipically resistant
clones to ER and DA can be related to the frequent therapeutic use of
tylosin for the relevant and endemic mycoplasmosis (contagious
agalaxia) affecting Sicilian dairy farms. Multiresistant clones mecA+
have been reported in sheep.
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R2498 Detection of aminoglycoside-resistance genes among
multidrug-resistant clinical isolates of Acinetobacter
baumannii from Krakow, Poland
P. Nowak, P. Paluchowska, I. Skiba, A. Budak* (Krakow, PL)
Objectives: Acinetobacter baumannii is an increasingly important
nosocomial pathogen often causing outbreaks in hospital environment.
Many clinical isolates are resistant to almost all antibiotics including
aminoglycosides. Inactivation of these antimicrobial agents by
enzimatic modiﬁcations is the main mechanism. Different types of
aminoglycoside acetyltransferases (ACC), nucleotidylotransferases
(ANT) and phosphotransferases (APH) are synthetized by clinical
isolates of A. baumannii. The aim of the study was detection of selected
ACC and APH encoding genes.
Methods: The study included the total of thirty nine strains of
multidrug-resistant A. baumannii. These isolates were obtained from
patients hospitalized in Specialized Hospital in Krakow between 2005
and 2010. A. baumannii identiﬁcation and susceptibility testing (Vitek-
2 Compact, bioMe´rieux, Poland) were performed by standard criteria
(CLSI). PCR detection of genes encoding: AAC (6¢)-Ih, AAC (3)-Ia,
AAC (3)-IIa, AAC (6¢)-Ib, APH (3¢)-Ia and APH (3¢)-VI used in this
study was described by Noppe-Leclercq et al. (1999) and Nemec et al.
(2004).
Results: PCR analysis showed the occurence of at least one of the
following aminoglycoside-resistance genes in 97.4% (38) strains:
aph(3¢)-VI (66.7%; 26), aac(3)-Ia (64.1%; 25), aph(3¢)-Ia (43.6%;
17), aac(3)-IIa (15.4%; 6), aac(6¢)-Ih (10.3%; 4) and aac(6¢)-Ib (5.1%;
2). A combination of two to four different resistance genes was
observed in 66.7% (26) of strains, with a total of eight different
combinations. Among analysed isolates the most frequent combination
was: aac(3)-Ia + aph(3¢)-VI (18%; 7), and the least frequent
combinations were: aac(3)-Ia + aac(3)-IIa and aac(6¢)-Ib + aph(3¢)-
Ia + aph(3¢)-VI (2.6%; 1).
Conclusions: Our results support that: (i) aminoglycoside-resistance in
A. baumannii strains might be associated with the production of
aminoglycoside-modyﬁng enzymes, (ii) aminoglycoside-resistant
strains frequently contain more than one aminoglycoside resistance
gene.
R2500 Otitis-related invasive pneumococcal disease in children:
susceptibility and clonal proﬁle of Streptococcus
pneumoniae isolates
J. Picazo*, J. Ruiz-Contreras, J. Casado-Flores, A. Delgado, M. Ruiz-
Gimenez, L. Aguilar, C. Mendez and the HERACLES group
Objectives: Otic foci have been described as signiﬁcant source of
secondary bacteremia in children. Conjugate vaccines, such as the 7-
valent conjugate vaccine (PCV7), alter serotype nasopharyngeal
carriage in children, potentially increasing cases of otitis media by
non-vaccine serotypes. This study analyses isolates from otitis-related
Invasive Pneumococcal Disease (IPD) in children.
Methods: A prospective laboratory-conﬁrmed (by culture and/or PCR)
surveillance of IPDs was performed (May 2007–April 2010) in all
hospitals with Pediatric department in Madrid (28 centres), a region
(6 million inhabitants) where PCV7 was included in the vaccination
calendar in 2006. Serotypes, sequence types (STs) of 19A isolates, and
antibiotic susceptibility following CLSI recommendations for all
isolates from otitis-related IPDs were analysed.
Results: Among 499 IPDs (including 161 bacteremic pneumonia, 60
primary and eight secondary bacteremias), 26 (5.2%) were otitis-
related: 18 mastoiditis and eight bacteremias (ﬁve secondary to otitis,
and three to mastoiditis). Median hospital stay was 8.0 days. All cases
(but one mastoiditis) were culture-conﬁrmed (25 isolates): 18 (72%)
isolates were serotype 19A (12 from ST320, four from ST276, one
from ST63 and one from ST1201), two were serotype 11A, and one
serotype 5, 8, 10A, 19F and 24B each. Serotype 19A caused 75% (six
out of eight) otitis-related bacteremia. Intermediate/resistance (%) in
19A isolates was: 0.0/94.4 to erythromycin, 0.0/72.2 to clindamycin,
22.2/72.2 to oral penicillin, 55.6/0.0 to parenteral penicillin, 44.4/0.0
to cefotaxime and 0.0/0.0 to levoﬂoxacin. Intermediate/resistance (%)
in ST320 was: 8.3/91.7 to oral penicillin, 83.3/0.0 to parenteral
penicillin and 66.7/0.0 to cefotaxime. All ST276 isolates were
susceptible to parenteral penicillin and cefotaxime. The phenotype
for macrolide resistance was inducible in all ST276 (all ermB
genotype) and constitutive in all but one ST320 (ermB/mefE in all but
two).
Conclusions: After PCV7 inclusion, 72% otitis-related IPDs were
caused by 19A. The proportions of otitis-related IPDs among total IPDs
(5.2%), of otitis-related bacteremias among non-pneumonic bacteremias
(eight out of 68; 11.8%), and of multiresistant ST320 among 19A
(66.7%) indicate the beneﬁt of the 13-valent PCV (including serotype
19A among others) for preventing otitis-related IPDs within prevention
strategies.
R2501 Molecular epidemiology of imipenem-non-susceptible
Acinetobacter baumannii: a 5-year study in Daejeon,
Korea
S. Koo*, G. Sung, H. Cho, K. Kwon, J. Lim, S. Shin (Daejeon, KR)
Objectives: Acinetobacter baumannii has emerged globally as an
increasingly important nosocomial pathogen. The recently discovered
clonal complex 92 (CC92) has been reported as the most prevalent
clonal complex in many parts of the world. In this study, we
investigated molecular epidemiology and various genes involved in
resistance to carbapenems, aminoglycosides, and ﬂuoroquinolones in
52 imipenem-non-susceptible A. baumannii isolates.
Methods: This study included 52 imipenem-non-susceptible A.
baumannii isolated in a university hospital in Daejeon, Korea from
January 2007 to October 2011. The minimum inhibitory concentrations
(MICs) of seven antibiotics were determined by the agar dilution
method and E-test. PCR and DNA sequencing were used to identify the
genes that potentially contribute to each resistance phenotype.
Multilocus sequence typing (MLST) was performed to determine the
epidemiological relationships. And pan-European clonal lineages were
identiﬁed by sequence type multiplex PCR.
Results: The 52 imipenem-non-susceptible A. baumannii isolates were
classiﬁed into seven STs (ST92, ST75, ST137, ST138, ST358, ST69
and ST109) and four allelic proﬁles. The six STs (except ST109 and
four allelic proﬁles) were clustered into CC92 and the pan European
clonal lineage II. ST138 (22 isolates) was the most commonly observed
ST and followed by ST137, which was identiﬁed in 15 isolates.
Interestingly, ST 138 was positive for the ISAba1/blaOXA-51-like and
ISAba1/blaOXA-23, which may contribute to carbapenem resistance,
whereas ST137 was positive for only ISAba1/blaOXA-51-like. In
addition, the armA and aac(6¢)-Ib was the most prevalent genes
involved in aminoglycoside resistance in 52 isolates, but aph(3¢)-Ia was
detected only in ST138.
Also, in resistance to ﬂuoroquinolone, ST138 had Ser83–>Leu and
Ser80–>Leu mutations in gyrA and parC, whereas ST137 had Ser83–
>Leu and Ser80–>Typ mutations.
Conclusions: Imipenem-non-susceptible A. baumannii emerged in
Daejeon, Korea, over 5 year period was associated with the spread of
global epidemic CC92 and European clonal lineage II. Epidemiological
surveillance may require to promptly identify the spread of epidemic
strains and to adopt adequate containment measures.
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R2502 High genetic diversity and over-expression of the
SmeABC efﬂux pump in ciproﬂoxacin-resistant
Stenotrophomonas maltophilia
S.Y. Shin*, S.H. Koo, J.Y. Sung, H. Cho, J. Lim, K.C. Kwon (Seoul,
Daejeon, KR)
Objectives: Stenotrophomonas maltophilia, a non-fermentative Gram-
negative bacillus, is one of the multiresistant opportunistic nosocomial
pathogens and is being isolated worldwide with increasing frequency.
The SmeABC and SmeDEF are tripartite efFLux pumps of which
contribution to antimicrobial resistance has been suggested. We aimed
to analyze the levels of expression of the SmeABC and SmeDEF and
their correlation with antimicrobial susceptibility.
Methods: A total of 33 S. maltophilia isolates were collected from a
tertiary hospital located in central Korea. The minimum inhibitory
concentrations(MICs) of 11 antimicrobials were determined by the agar
dilution method or E-test. Real-time PCR was performed to assess the
expression of Sme efﬂux systems. The multilocus sequence typing
(MLST) was performed.
Results: The majority of the isolates were resistant to beta-lactams and
aminoglycosides; cefepime (90.9%), meropenem (100.0%), aztreonam
(97.0%), amikacin and gentamicin (each 93.91%), while for
ciproﬂoxacin (54.5%). Most of the isolates were susceptible to
ticarcillin/clavulanic acid (97.0%), levoﬂoxacin (87.9%),
trimethoprim/sulfamethoxazole (93.9%), and minocycline (97.0%).
Overexpression of smeB and smeF were found in 21 (63.6%) and 19
(57.5%) of the 33 clinical isolates. Fifteen (45.4%) isolates
overexpressed both smeB and smeF. The MICs of ciproﬂoxacin and
levoﬂoxacin (MIC50 = 4; 6.83-fold and 1; 3.60-fold increase,
respectively) were signiﬁcantly higher for the isolates with detectable
smeB and/or smeF than those without. Overexpression of the SmeABC
efﬂux pump was statistically related to the MICs of ciproﬂoxacin
(p = 0.033) and levoﬂoxacin (p = 0.034). The MLST showed a high
degree of genetic diversity among the S. maltophilia isolates: three STs
and 23 allelic proﬁles. The MLST clustering supportively demonstrated
the association of SmeABC efﬂux pump with multidrug resistance, in
particular with ciproﬂoxacin resistance, as the group A and A’ isolates
harboring smeB showed high-level resistance to ciproﬂoxacin and the
group B isolates showed high-level ceftazidime and cefepime resistance.
Conclusion: The SmeABC efﬂux pump was considered to play an
important role for resistance of S. maltophilia to ciproﬂoxacin. The
MLST scheme was thought to be useful for studying the population
structure of S. maltophilia, which demonstrated a discriminatory typing
of groups with resistances to ciproﬂoxacin and beta-lactams.
R2503 Aminoglycoside-modifying enzymes in metallo-beta-
lactamase producing Pseudomonas aeruginosa isolated in
Daejeon, Korea
S.Y. Shin*, S.H. Koo (Seoul, Daejeon, KR)
Background: Carbapenem resistant Pseudomonas aeruginosa has
emerged as a serious opportunistic pathogen presenting signiﬁcant
therapeutic challenges. Concurrent resistance to aminoglycoside can
lead to a multi-drug resistance threat for nosocomial infections. In the
present study, we investigated the prevalence of aminoglycoside
resistance and its association with various aminoglycoside modifying
enzymes (AMEs) and 16S rRNA methylases in imipenem-resistant P.
aeruginosa isolates.
Methods: A total of 59 imipenem-resistant P. aeruginosa clinical
isolates from a tertiary hospital in central Korea were subjected. PCR
and sequence analyses for eight AMEs genes including aac(3)-I, aac(3)-
II, aac(3)-III, aac(3)-IV, aac(6¢)-I, aac(6¢)-II, ant(2¢¢)-I, ant(4¢)-II and
aph(3¢)-VI, 16S rRNA methylases including rmtA, rmtB, rmtC and
armA, class 1 integrons and three MBL genes, namely, blaIMP-1,
blaVIM-2 and blaSIM-1, were performed.
Results: Three types of AME genes [aac(6¢)-I, ant(2¢¢)-I and aph(3¢)-
VI] were detected in 30 isolates (50.8%). Most strains harboring
ant(2¢¢)-I gene (17/18) showed the high-level resistance
(MIC ( 1024 lg/mL) to gentamicin. Eighteen strains had two or more
types of AME genes and showed resistance to amikacin and
gentamicin. Eight strains with AME genes simultaneously had MBL
genes; blaIMP-1 (7/8) or blaVIM-2 (1/8), and showed signiﬁcantly high
resistance to imipenem, meropenem, amikacin and gentamicin
(MIC ( 1024 lg/mL). Seven strains contained class 1 integron, which
had AME genes. aac(3)-I, aac(3)-II, aac(3)-III, aac(3)-IV, aac(6¢)-II,
ant(4¢)-II, rmtA, rmtB, rmtC or armA were not detected.
Conclusion: AME genes were frequently harboured in imipenem-
resistant P. aeruginosa and associated with high resistance to
aminoglycoside. In particular, simultaneous presence of AME and
MBL genes showed signiﬁcantly high resistance to aminoglycoside and
carbapenem.
R2504 Continuing control of Clostridium difﬁcile ribotype 027 in
England using long term surveillance: the Clostridium
difﬁcile ribotyping network for England and N. Ireland
(CDRN)
M. Wilcox*, W. Fawley, A. Birtles, M. Cairns, M. Curran, S. Green,
K. Hardy, P. Hawkey, P. Hawtin, B. Patel, A. Sails, M. Shemko,
N. Shetty (Leeds, Manchester, London, Cambridge, Southampton,
Birmingham, Newcastle, UK)
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Objectives: To describe the key epidemiological ﬁndings concerning
CDI in England in 2010–2011 vs. the previous 3 years as determined
by The Clostridium difﬁcile Ribotyping Network for England and N.
Ireland (CDRN).
Methods: CDRN provides ribotyping, and enhanced DNA
ﬁngerprinting, to identify cross-infection, reduce transmission,
optimise management of outbreaks and determine the epidemiology
of C. difﬁcile.
Results: In November 2010 CDRN processed 7026 faecal samples
from 152 health care facilities, which was a 23% increase over 2009/10
when 5720 samples were received from 172 health care facilities. The
main reasons provided for submission to CDRN in 2010/2011 were
suspected CDI case clusters (68%), increased CDI rate (19%), and
severity of symptoms (13%). The number of reports of C. difﬁcile
recorded by the mandatory C. difﬁcile surveillance scheme in England
has decreased from 55 498 to 36 095 to 25 604 to 21 698 (in the
ﬁnancial years 2007/2008, 2008/2009, 2009/2010 and 2010/2011).
Thus, on average samples were received by CDRN from 1 in 3.1 and 1
in 4.5 reported CDI cases in England in November 2010 and October
2009, respectively. C. difﬁcile could not be cultured from 10% to 12%
of samples in each of the 4 years. Marked changes in ribotype
prevalence have occurred in the 4 years since CDRN was launched in
2007 (Table). There was a striking progressive decrease in the
prevalence of C. difﬁcile ribotype 027 (from 55% to 13%), with
‘‘compensatory’’ increases in the other main types, including ribotypes
002, 015, 014, 005 and 078. Ribotype 106 has also declined markedly
but remains the 4th most common type.
Conclusions: Since CDRN was introduced in 2007 there has been a
marked decrease in incidence of CDI and associated deaths in England.
The changes coincided with a 77% decrease in the relative prevalence
of ribotype 027 cases. The improvements may reﬂect the success of
control measures to reduce cross-infection in hospitals caused by
epidemic strains. Continued access to timely typing data appears to help
to reduce the prevalence of epidemic C. difﬁcile strains.
R2505 Molecular characterisation of aminoglycoside resistance
in plasmid-mediated AmpC- (pAmpC) and
carbapenemase-producing Enterobacteriaceae
E. Miro´*, F. Navarro, M. Ferna´ndez, G. Bou, M. Conejo, N. Larrosa,
J. Oteo, L. Zamorano, L. Martı´nez-Martı´nez and members of
REIPI
Objectives: Bacterial resistance to antimicrobial agents has become an
increasing problem in clinical medicine, limiting the agents available
for treatment of many types of infections. Aminoglycosides are widely
used in clinical practice and resistance to these drugs may be due to
several mechanisms amongst which aminoglycoside-modifying
enzymes (AME) are particularly important. We report here the
prevalence of the AME present in plasmid-mediated AmpC (pAMPC)
and carbapenemase-producing Enterobacteriaceae and which of them
were implicated in this resistance.
Methods: A total of 315 pAmpC- or carbapenemase-producing
Enterobacteriaceae strains were selected from a collection of 635
clinical pAmpC- and 43 carbapenemase-producing isolates obtained
between February and July of 2009. The susceptibility to
aminoglycosides (amikacin, gentamicin, kanamycin, netilmicin,
neomycin and tobramycin) was determined by the disk diffusion
method. The identiﬁcation of the modifying-enzymes was done by
PCR. Some representative amplicons were sequenced.
Results: One hundred twenty three out of the 315 pAmpC- or
carbapenemase-producing strains were aminoglycoside-resistant, being
the most affected drug kanamycin (K) (111/123; 90.2%), followed by
tobramycin (T) (80/123; 65%), gentamicin (G) (64/123; 52%),
netilmicin (N) (24/123; 19.5%), and amikacin (A) (18/123; 14.6%).
The most frequent enzyme found was APH(3¢)-Ia (KNm) (48/123;
39%), AAC(3)-IIa (KGTN) (36/123; 29.3%), AAC-6¢-Ib (KTAN) (31/
123; 25.2%), ANT-2¢¢-Ia (KGT) (21/123; 17.1, APH(3¢)-IIa (KNm) (2/
123; 1.6%) and AAC(3)-IVa (TGN) (1/123; 0.8%). Thirty percent of
the strains presented more than one enzyme. Finally, 13 strains remain
to be concluded. The frequency of the different enzymes found was
similar between pAmpC- and carbapenemase-producing strains, with
one exception, AAC(3) type enzymes were not been found in
carbapenemase-producing strains.
Conclusions: The prevalence ofAME in pAMPCs- and carbapenemase-
producing strains was 31.4% and 7%, respectively. APH(3¢)-Ia was the
most frequent enzyme found followed by AAC(3)-IIa.
R2507 Diversity of plasmids in CTX-M-producing Klebsiella
pneumoniae and Escherichia coli in a tertiary medical
care centre in the city of Ribeirao Preto, Brazil
L. Neves Andrade, J. Mucedola Longo, J. Cristina Ferreira,
R. Martinez, A.L. Costa Darini* (Ribeirao Preto, BR)
Objectives: The aim of this study was to search the diversity of
plasmids in extended spectrum beta-lactamase CTX-M-producing
Klebsiella pneumoniae and Escherichia coli in the University
Hospital of the Faculty of Medicine of Ribeirao Preto-University of
Sao Paulo (HCFMRP-USP), a tertiary medical care centre, in the city of
Ribeirao Preto, Brazil, from April to August of 2007. These bacteria
were collected during the outbreak of KPC-2-producing Klebsiella
pneumoniae in the same hospital.
Methods: Seventy four K. pneumoniae and 37 E. coli resistant to
broad spectrum cephalosporins and/or aztreonam and susceptible to
carbapenems were investigated. The blaCTX-M, KPC and SPM genes
were investigated using PCR. The PCR-Based Replicon Typing
(PBRT) scheme was performed to search replicons of the major
plasmid incompatibility groups (Inc) among Enterobacteriaceae.
Results: All bacteria were negative to KPC and SPM-enconding genes.
In 59 (79.7%, 59/74) K. pneumoniae and 25 (67.5%, 25/37) E. coli was
ampliﬁed CTX-M-enconding gene. IncHI1 (n = 1), I1 (n = 1), N
(n = 3), FIC (n = 1), A/C (n = 14) and F (n = 1) were detected in K.
pneumoniae. IncHI1 (n = 1), I1 (n = 9), N (n = 2), FIA (n = 3), FIB
(n = 17), P (n = 3), A/C (n = 9) and F (n = 21) were detected in E.
coli. No plasmid of the IncHI2, X, L/M, W, Y, T, FIIAs, K and B/O
was found. In 38 K. pneumoniae and one E. coli were not ampliﬁed
replicons of plasmids, using PBRT scheme. However, more than one
plasmid was ampliﬁed in the most of E. coli. IncFIIAs plasmids were
not found in this study, seems to be more related to clones of KPC-2
producing-K. pneumoniae, mainly the ST258, as previously reported in
the same hospital.
Conclusion: There is a diversity of Inc plasmids in K. pneumoniae and
E. coli in the HCFMRP-USP. The data found suggest that there is a
common dissemination of IncA/C plasmids in both bacteria and a
prevalence of FIB and F plasmids in E. coli. Further studies will be
performed to determine the plasmids and clones that carrying CTX-M-
encoding genes. These data will contribute to knowledge of
dissemination of CTX-producing Enterobacteriaceae.
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R2508 First outbreak of carbapenem-resistant OXA-48-
producing Klebsiella pneumoniae in Russia
M. Sukhorukova*, J. Savochkina, I. Alexandrova, A. Timohova,
M. Edelstein (Smolensk, Moscow, RU)
Background and Objectives: An increase in the incidence of
carbapenem-resistant Klebsiella pneumoniae (Kp) was detected in a
300-bed neurosurgery hospital in Moscow, Russia since August 2010.
The aim of this study was to determine the mechanisms of resistance
and genetic relatedness among the carbapenem-resistant Kp isolates
collected during a suspected outbreak.
Methods: Seventeen carbapenem-non-susceptible Kp isolates were
collected from 15 ICU patients between August 2010 and April 2011.
All isolates were nosocomial and were obtained from respiratory
(n = 11), urine (n = 3) and central nervous system (n = 3) specimens.
Susceptibility testing was performed by agar dilution and interpreted by
EUCAST criteria. Carbapenemase production was screened by
modiﬁed Hodge test. Real-time PCR with speciﬁc primers and probes
was used to detect carbapenemase (VIM, IMP, NDM-1, KPC, OXA-48-
like) and ESBL (TEM, SHV, CTX-M) genes. The association of
blaOXA-48 gene with IS1999 was determined using PCR mapping and
direct sequencing of ampliﬁcation products. Isolates were typed by
ERIC-PCR and RAPD. MLST and plasmid analysis are currently
ongoing.
Results: All the isolates studied were resistant to ertapemen (MICs 4–
32 mg/L); sixteen were resistant (MICs 4–32 mg/L) and one was
borderline susceptible (MIC 1 and 2 mg/L) to imipenem and
meropenem. All were also resistant to cefotaxime, ceftazidime,
cefepime, ciproﬂoxacin and fosfomycin, ten to co-trimoxazole and
gentamicin, four to amikacin, and one to colistin. The blaOXA-48 gene
ﬂanked by the IS1999 was found in all isolates. The blaCTX-M gene
was detected as resistance determinant to oxyimino-cephalosporins.
The ERIC-PCR and RAPD typing similarly divided the isolates into
two groups of ten and six members each, and one single strain. The
infection control intervention was implemented which has led to the
containment of the outbreak since April 2011.
Conclusions: This study reports the ﬁrst outbreak of carbapenem-
resistant OXA-48-producing Kp in Russia. Results indicate that
dissemination of OXA-48 was due to both clonal spread and
horizontal transfer. Consistent with other reports, a co-production of
OXA-48 carbapenemase with CTX-M ESBL leading to pan-beta-
lactam resistance was noted.
R2509 Genetic analysis of the ﬁrst outbreak of carbapenem-
resistant Klebsiella pneumoniae in Saudi Arabia
H. Balkhy*, T. Uz Zaman, M. Al Drees, S. Al Juhaini, A. Al Qahtani,
M. Al Ahdal (Riyadh, SA)
Objectives: Klebsiella pneumoniae has recently surfaced as one of the
most antibiotic-resistant organisms in localized outbreaks. Loss of an
Outer Membrane Protein (OMP) expression has been implicated for
resistance to cephalosporins and carbapenems in certain strains of
bacteria. A ﬁrst documented Carbapenem-resistant Klebsiella
pneumoniae (CRKP) outbreak involving 23 cases in a tertiary care
health facility in Riyadh, Saudi Arabia (King Abdulaziz Medical City,
National Guards Health Affairs) was investigated.
Methods: CRKP isolates were identiﬁed using standard laboratory
methods. Pulse-ﬁeld gel electrophoresis (PFGE) was done to determine
the clonality of the isolates. OXA-A, B, C and D group of OXA b-
lactamases were investigated by PCR ampliﬁcation of their respective
gene targets and subsequent sequencing using speciﬁc primers. OMP-
35 and -36 were also analyzed by PCR ampliﬁcation and sequencing.
Nested primers were designed to sequence and map the whole OMP-36
gene along with the insert.
Results: The isolates were genetically related (77%) by PFGE analysis.
All the 23 isolates presented a normal OMP-35 gene sequence.
However, there was an interruption in the OMP-36 gene in all isolates.
Five out of 23 isolates (22%) showed an insertion of IS-903 in their
OMP-36, whereas the remaining 18 showed mutation/deletion of a few
nucleotides. This might have resulted in the non-functional OMP-36
protein. Isolates with the insert IS-903 presented A1/A3 PFGE pattern.
All 23 isolates were positive for OXA-48, and negative for OXA-A and
OXA-D group of enzymes.
Conclusion: This is the ﬁrst report on the molecular epidemiology of
CRKP from Saudi Arabia. The presence of insert in OMP-36 might be
responsible in carbapenem resistantnce as is observed in other
countries, and same clone may be disseminating in this region
R2510 Diversity of antimicrobial and biocide susceptibility
patterns among equine methicillin-resistant staphylococci
N. Couto*, A. Belas, A. Fessler, S. Costa, P. Tilley, I. Couto, K. Kadlec,
S. Schwarz, C. Pomba (Lisbon, PT; Neustadt-Mariensee, DE)
Objectives: Antimicrobial and biocide susceptibility characterization
was performed in 14 methicillin-resistant staphylococci isolates (eight
Staphylococcus sciuri, two S. aureus, one S. lentus, one S. ﬂeurettii, one
S. haemolyticus and one S. cohnii cohnii) previously isolated from 71
sick and healthy horses.
Methods: MICs of the study strains towards several antimicrobial
agents, biocides and dyes were determined by broth microdilution
according to the CLSI standard. Beta-lactamase production was tested
after cephalosporin induction by using the nitroceﬁn test. PCR
ampliﬁcation was used to detect antimicrobial resistance and plasmid-
encoded efﬂux-pump genes. S. sciuri strains were subjected to PFGE.
All isolates were characterized by dru-typing.
Results: Beta-lactamase production was detected in three strains and
conﬁrmed by the presence of the blaZ gene. Only the S. lentus isolate
was resistant to chloramphenicol due to the presence of the gene cat
pC221. Likewise only one S. aureus showed a high MIC (>256 mg/L)
to trimethoprim and the dfrK gene was detected. Eight strains were
resistant to tetracycline due to the presence of the genes tet(K) (n = 7)
and tet(M) (n = 1). The erm(C) gene was seen in two isolates, which
showed resistance to both, erythromycin and clindamycin. High MICs
to gentamicin and kanamycin were observed in two strains which were
encoded by the bifunctional enzyme aacA-aphD (n = 2), and also by
aph(3¢)-IIIa (n = 1). Fusidic acid resistance and the gene fusC were
detected in a single S. aureus strain. Two strains had high MICs to
ethidium bromide ((64 mg/L), benzalkonium chloride (2 mg/L) and
triclosan (2 mg/L) and carried qac genes (S. haemolyticus harbouring
qacA and S. cohnii cohnii carrying both qacB and a qacH-like gene).
The same S. sciuri clone, with an undistinguishable PFGE proﬁle, was
isolated from different horses. The dru type dt11a was the most
frequently identiﬁed type (n = 7), two single strains (S. lentus and S.
haemolyticus) harboured novel dru types one S. aureus had dt10q and
three strains were non-typeable.
Conclusions: This study showed that methicillin-resistant
staphylococci are important reservoirs of antimicrobial and biocide
resistance genes, which circulate in different staphylococcal species,
including MRSA. These bacteria/genes seem to be disseminated in the
equine population and can be transmitted to humans in close contact,
which raises the question of potential interspecies and zoonotic spread.
R2511 Prevalence of plasmid-mediated quinolone resistance
determinants (qnr) and aac(6‘)Ib-cr in
Enterobacteriaceae from blood cultures in a Greek
university hospital
A. Margaritis*, I. Galani, T. Panagea, H. Giamarellou, G. Petrikkos,
M. Souli (Athens, GR)
Objectives: To determine the prevalence of plasmid-mediated
quinolone resistance determinants in blood culture isolates of
Enterobacteriaceae recovered in Attikon University Hospital, Athens,
Greece.
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Methods: Over an 18-month period (Dec 2008 to May 2010) a total of
147 Enterobacterial isolates were recovered from blood cultures of
single hospitalized patients. Thirty-seven Escherichia coli, 32
Klebsiella pneumoniae, 13 Enterobacter spp., eight Serratia
marcescens, two Morganella morganii, two Stenotrophomonas
maltophilia, one Proteus vulgaris and one Providencia stuartii
isolates were retrieved from the laboratory collection and tested.
Isolates were screened for the presence of qnrA, qnrB and qnrS by
multiplex PCR, using universal primers for each gene amplifying all
related alleles. Gene aac(6¢)-Ib was screened by PCR and the aac(6¢)-Ib-
positive PCR products were digested with BtsCI to identify the aac(6¢)-
Ib-cr variant. The qnr and aac(6¢)-Ib-cr positive isolates were
additionally tested for extended-spectrum b-lactamases (ESBL),
metallo-b-lactamases (MBL) and K. pneumoniae carbapenemase
(KPC).
Results: Among the 96 Enterobacterial isolates tested, ﬁve isolates
(5.2%) were positive for qnr genes, all harbouring the qnrS determinant.
The aac(6¢)Ib gene was detected in 21 isolates (21.9%), with four
isolates containing the mutated variant aac(6¢)Ib-cr (4.2%). Two
Enterobacter spp. and one S. maltophilia isolates harboured only the
qnrS. One E. coli isolate harboured only the aac(6¢)-Ib-cr, while one K.
pneumoniae and oneM. morganii isolates harboured simultaneously the
qnrS and the aac(6¢)-Ib-cr. Aac(6¢)Ib was signiﬁcantly more prevalent
among K. pneumoniae isolates (50%), but only one harboured the
aac(6¢)-Ib-cr (3.1%). Isolates carrying only the qnrS had MICs to
nalidixic acid ranging from 4 to 8 mg/L and to ciproﬂoxacin from 0.032
to 3 mg/L, while qnrS and aac(6¢)-Ib-cr –positive isolates were resistant
to both antimicrobials (MIC >32 mg/L). Trimethoprim/
sulfamethoxazole was active against the qnrS-positive isolates but not
against those carrying aac(6¢)-Ib-cr probably due to co-existing
resistance mechanisms. Only the K. pneumoniae isolate was an ESBL
producer.
Conclusions: This epidemiological survey of the three known qnr
determinants and of aac(6¢)-Ib-cr shows their presence among
Enterobacteriaceae responsible for bloodstream infections in patients
hospitalized in a Greek tertiary-care hospital, with the qnrS gene being
identiﬁed at 5.1% and aac(6¢)-Ib-cr at 4.2%.
R2512 First report of a quinolone resistance mutation in the
Chlamydia trachomatis gyrA gene from clinical sample
I. Edelstein*, E. Shipitsyna, T. Khusnutdinova, A. Savicheva,
M. Edelstein, R. Kozlov (Smolensk, St. Petersburg, RU)
Objectives: Genital Chlamydia trachomatis (CT) infection is the most
prevalent STI worldwide. So far, mutational resistance to
ﬂuoroquinolones (FQs), which are used, along with macrolides and
tetracyclines, for treatment of CT infection, has not been described in
clinical CT isolates, although selection of FQ resistance mutations in
primary target (GyrA) has been shown in vitro. In Russia, FQs are used
widely and available over-the-counter thus potentially exerting
signiﬁcant selective pressure for resistance development in STI
pathogens. This study aimed to assess the presence of FQ resistance
mutations in quinolone resistance determining regions (QRDRs) of the
CT gyrA and parC genes in clinical samples.
Methods: Two sets of urogenital samples (cervical swabs from
females and urethral swabs from males) were screened for mutations
in the CT gyrA and parC genes using a newly designed real-time PCR
assays. One set comprised 33 samples collected in St. Petersburg in
2006–2008 from 16 patients with posttreatment recurrence of CT
infection. The other consisted of 557 consecutive CT positive samples
from gynaecological and urological patients collected in Smolensk in
2009–2011 and St. Petersburg in 2010–2011 during routine testing by
PCR. The presence of mutations was inferred by postampliﬁcation
melting temperature (Tm) analysis of ﬂuorescent probes
complementary to the sequences encoding amino-acids 80–87 of
GyrA and 80–85 of ParC (Escherichia coli numbering). Samples
showing altered probe Tm as compared to a wild type control (CT L2)
were further characterized by sequencing of QRDR containing
fragments.
Results: Of the 590 CT positive samples, 551 and 543 were positive in
the PCR assays targeting the gyrA and parC genes, respectively. No
samples were found to contain mutations in parC, but ﬁve samples
revealed the presence of mutations in gyrA. Three of them had only
silent substitution at gyrA codon for His80. Two samples, both obtained
from the same patient in the group of patients with posttreatment CT
recurrence, had Ser83-Gly substitution, which is known to be associated
with FQ resistance in various Gram-negative bacteria, and two
additional mutations, Val61-Ala and His129-Gln, outside the gyrA
QRDR.
Conclusion: The results of our study indicate that, although extremely
rare, gyrA mutations associated with FQ resistance may occur in
clinical CT isolates. Clinical relevance of these ﬁndings is to be
assessed.
R2513 Diversity of carbapenem-resistant bacteria in untreated
drinking water in Portugal
I. Henriques*, S. Arau´jo, J. Azevedo, A. Pereira, A. Correia (Aveiro,
PT)
Objectives: The emergence of resistance to carbapenems in clinical
settings may seriously compromise the therapeutic usefulness of these
antibiotics. However, the current status of dissemination of carbapenem
resistance in natural environments remains unknown. The aim of this
study was to assess the prevalence, phylogenetic diversity and antibiotic
resistance trends of heterotrophic carbapenem-resistant bacteria (CRB)
in untreated drinking waters in Portugal.
Methods: Potable water was collected from ten public fountains located
in the North and Central regions of Portugal. Prevalence of CRB was
estimated in PCA and R2A media with or without imipenem (4 lg/mL).
Clonal relatedness of CRB isolates was established by REP-PCR and
phylogenetic analysis was based on the 16S rRNA gene. Antimicrobial
susceptibility to 16 antibiotics was assessed by disc diffusion methods.
Detection of genes encoding b-lactamases was done by PCR.
Results: CRB were detected in all fountains, ranging from 0.1% to
15.9%. A total of 36 non-clonal carbapenem-resistant isolates were
identiﬁed as Stenotrophomonas (n = 19), Pseudomonas (n = 3),
Janthinobacterium (n = 3), Chryseobacterium (n = 2), Sphingobac-
terium (n = 2), Acidovorax (n = 1), Caulobacter (n = 1), Cupriavidus
(n = 1) and Sphingomonas (n = 1). Seventy two per cent of the isolates
were resistant to at least six beta-lactams. From those, 22% displayed
additional resistances to at least two non-beta-lactam antibiotics. Apart
from beta-lactams, resistances to nalidixic acid (22% of the isolates),
streptomycin (22%) and kanamycin (19%) were most frequently
detected. Common acquired beta-lactamase genes (blaTEM, blaSHV,
blaIMP, blaVIM and blaOXA) were not detected.
Conclusions: Carbapenem resistance in untreated drinking waters was
mainly represented by genera previously described as intrinsically
resistant to these antibiotics and acquired mechanisms of resistance to
beta-lactams were not detected. These results suggest that the
dissemination of anthropogenic-derived carbapenem resistance in the
environment may be at an earlier stage. Therefore this presents an
opportunity to start implementing monitoring strategies to follow this
dissemination. Also, the high variability in carbapenem-resistance
prevalence justiﬁes efforts to identify factors accounting for these
differences.
R2514 Characterisation of blaOXA-48 in Enterobacter cloacae
strains in southern Spain
F. Galan-Sanchez*, B. Ruiz del Castillo, P. Marin-Casanova,
L. Martinez-Martinez, M. Rodriguez-Iglesias (Cadiz, Santander, ES)
Objectives: The oxacillinase OXA-48 was ﬁrst identiﬁed in a
Klebsiella pneumoniae but recently it has been described in other
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enterobacteria. We report the characterization and genetic environment
of OXA-48 carbapenemase in Enterobacter cloacae isolated from two
patients hospitalized in Cadiz, Southern Spain.
Methods: Identiﬁcation and antimicrobial susceptibility tests were
determined by a commercial microdilution system. MICs of
carbapenems were conﬁrmed by Etest. Phenotypic detection of
carbapenemases was determined by the modiﬁed Hodge’s test
(MHT). Molecular analysis of plasmid-encoded b-lactamases genes
was performed using Check Carba ESBL. The conﬁrmation of OXA-48
was determined by PCR and sequencing. Outer membrane protein
(OMP) analysis was performed. The genetic relationship between the
strains was studied by Rep-PCR. Plasmids were characterized by PCR-
based replicon typing. The genetic environment of the blaOXA-48 gene
was determined by PCR and sequencing using blaOXA-48 and Tn1999
transposon primers.
Results: Both strains were resistant to all beta-lactams tested. MICs of
imipenem and meropenem were 8 and 16 mg/L, respectively, for the
ﬁrst strain, and 2 and 8 mg/L, respectively, for the second one. MHT
was positive. blaSHV-like, blaCTX-M9 group and blaOXA-48 in both
strains were detected. Rep-PCR suggests that the strains were clonally
related. Both strains expressed three outer membrane proteins in the
range of the porins size (OmpF, OmpC and OmpA). A approximately
70 kb plasmid in both strains was detected. Hybridization analysis
showed the relationship between OXA-48 and a plasmid of
incompatibility group P. Replicons of incompatibility groups Y, T,
and R were also detected in both isolates, while IncHI2 was detected
only in one. The blaOXA-48 gene was ﬂanked by two copies of
IS1999, and the presence of an IS1R element truncating the IS1999
insertion sequence upstream from blaOXA-48 allowed identiﬁcation of
a Tn1999.2 type transposon.
Conclusion: OXA-48 has begun to spread since the ﬁrst outbreak in
Turkey, in particular in the Eastern and Southern Mediterranean region
being the Tn1999.2 transposon implicated. We describe two clonally
related isolates of E. cloacae carrying Tn1999.2. Environmental isolates
harboring blaOXA-48 in Morocco suggests that OXA-48 producers
may lead to community-acquired infections in the Mediterranean area,
with a threatening risk of dissemination to other European countries.
R2515 Biocides and multi-drug resistance associated with the
ﬁrst extended-spectrum beta-lactamase-producing
nontyphoidal Salmonella strain isolated in Portugal
P. Antunes*, J. Mourao, T. Alves, J. Campos, C. Novais,
L. Peixe (Porto, PT)
Objectives: Extended-spectrum b-lactamases (ESBLs) in Salmonella
is a newly emerging threat worldwide though their distribution is
uneven in different geographical regions. This study characterizes the
ﬁrst ESBL-producing Salmonella identiﬁed in Portugal and the nature
of the co-mobilized genes that can confer selective advantages in the
animal setting.
Methods: Susceptibility to antibiotics and b-lactamase production was
tested by disk diffusion method and to b-lactams conﬁrmed by E-test.
Clonality was established by PFGE (XbaI) and MLST. Search of arsB
(arsenic), terF (tellurium), copD (copper), merA (mercury), and silA
(copper/silver) genes encoding resistance to compounds found in the
animal setting (feed, disinfectants and environmental pollution),
antibiotic resistance genes, plasmid and integron backbones (PCR,
RFLP and/or sequencing), transferability and genomic location (I-CeuI/
S1 nuclease hybridization) was performed.
Results: In February 2011, a Salmonella (ST142) isolate with a
positive double disk synergy test, carrying an ESBL identiﬁed as
blaCTX-M-nine gene, was identiﬁed from a hospitalized child with
gastrointestinal infection. It was resistant to ampicillin (MIC > 256 mg/
L), cephalotin (MIC > 256 mg/L) and cefotaxime (MIC = 4 mg/L), but
not to ceftazidime (MIC = 0.5 mg/L), cefepime (MIC = 1 mg/L),
aztreonam (MIC = 1 mg/L) and carbapenems (MIC = 0.008–
0.38 mg/L). Resistance to gentamicin, kanamycin, tobramycin,
streptomycin and sulfamethoxazole was also detected and a class 1
integron carrying aadB-aadA2-qacEd1-sul1 was found. The blaCTX-
M-9 gene and the class 1 integron were located on a conjugative IncHI2
(99% homology with pR478) plasmid of 240 kb, also carrying the arsB
(arsenic resistance) and terF (tellurium resistance) genes. The ISEcp1
was not detected upstream of the blaCTX-M-9 gene and merA, silA and
copD genes described in the early antibiotic resistance IncHI2 plasmid
pR478 (reference IncHI2 plasmid) were not detected in our strain.
Conclusion: This is the ﬁrst description of Salmonella harbouring
genes encoding ESBL, conferring resistance to therapeutically
important broad-spectrum b-lactams, in Portugal. The ﬁnding of
blaCTX-M-9 gene in a conjugative plasmid IncHI2 carrying genes
that confer resistance to antibiotics and biocides (arsenic and tellurium)
that could be extensively used in animal production setting is
worrisome, as persistence of this b-lactamase and its emergence in
other Salmonella strains could be anticipated.
R2516 Characterisation of multidrug-resistant
Enterobacteriaceae producing NDM-1 and OXA-48
carbapenemases from Oman
Y. Pfeifer*, W. Witte, Z. Al Maskari, A. Al Jardani, S. Al Busaidy,
L. Abdullah Al Balushi (Wernigerode, DE; Muscat, OM)
Objectives: The successful worldwide dissemination of
carbapenemase-producing Enterobacteriaceae is of special concern
because of limited therapeutic options and higher mortality. While the
dissemination of carbapenemase KPC is predominantly bound to
distinct Klebsiella pneumoniae strains, spread of OXA-48 and NDM-1
enzymes is mainly due to conjugative transfer of different plasmids
carrying these carbapenemase genes and facilitating the transmission
among many enterobacterial species. Here we report on molecular
analysis of multidrug-resistant Enterobacteriaceae isolates from
hospitals in Oman.
Methods: Carbapenem resistant isolates of species K. pneumoniae spp.
(n = 13), Escherichia coli (n = 4) and Enterobacter cloacae (n = 1)
were collected from three hospitals in Oman between September 2010
and February 2011. All patients were Omani whereby three patients
recently travelled to India and Pakistan before their admission to the
hospital. Relevant resistance genes were identiﬁed by PCR and
sequencing. Conjugation experiments and strain-typing by PFGE
analysis were performed.
Results: The carbapenemase OXA-48 was identiﬁed in ﬁve isolates. In
ten K. pneumoniae isolates we identiﬁed metallo-beta-lactamase NDM-
1 and the OXA-48-related enzyme OXA-181 was identiﬁed in two
isolates. XbaI-macrorestriction analysis revealed seven closely related
NDM-1-producing K. pneumoniae isolates and three identical E. coli
isolates with OXA-48 indicating several events of clonal transmission
of carbapenemase producing strains in two hospitals. Furthermore we
detected additional extended spectrum b-lactamases (ESBL) CTX-M-
15 (n = 14) and CTX-M-24 (n = 3) as well as other b-lactamases
(TEM-1, SHV-11, OXA-1, OXA-9) in the majority of isolates. The
blaOXA-48 genes were successfully transferred into recipients and
plasmids of ca. Of 60 kb size were isolated from transconjugants. The
blaNDM-1 genes were found to be located on conjugative plasmids of
different size. The reduced carbapenem MIC values of transconjugants
indicate the occurrence of further carbapenem resistance mechanisms
like increased production of efﬂux pumps or loss of porins (outer
membrane proteins, OMPs) in the clinical isolates.
Conclusion: We identiﬁed various carbapenemase-producing
Enterobacteriaceae as colonizers or cause of urinary tract infections
or severe blood infections in patients from Oman. There is an urgent
need of surveillance to prevent further spread of these multidrug-
resistant pathogens.
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R2517 Prevalence and mechanism of carbapenem resistance in
Acinetobacter baumannii isolates from Thailand
T. Chatsuwan*, P. Samarnthai (Bangkok, TH)
Objectives: To investigate the prevalence of carbapenem resistance
and mechanism of carbapenem resistance in A. baumannii.
Methods: A total of 200 A. baumannii isolated from King
Chulalongkorn Memorial Hospital during May 2008 to April 2009
were included in this study. Antimicrobial susceptibility testing of
imipenem and meropenem was determined by agar dilution method.
Oxa-type carbapenemase and metallo-beta-lactamase genes were
determined by PCR. The presence of ISAba1, ISAba2 and ISAba3
upstream the blaOXA-like genes was detected by PCR and DNA
sequencing. Carbapenem efﬂux pump was determined by using CCCP,
the effux pump inhibitor. The loss or decrease of outer membrane
protein (OMP) was analysed by SDS-PAGE.
Results: The prevalence of imipenem and meropenem resistance was
both 92.5%. All carbapenem-resistant A. baumannii isolates had
carbapenemase activity by modiﬁed Hodge test. However, metallo-
beta-lactamase enzymes by EDTA-disk synergy were not detected in
any isolates. The presence of carbapenemase genes including blaOXA-
23, blaOXA-24, blaOXA-51, blaOXA-58, blaIMP, blaVIM, blaGIM,
blaSPM and blaSIM was screened by multiplex-PCR. Of 185
carbapenem-resistant A. baumannii isolates, 182 (98.4%) carried
blaOXA-51-like with blaOXA-23-like and 3 (1.6%) had blaOXA-51-
like with blaOXA-23-like and blaOXA-58-like. The blaIMP, blaVIM,
blaGIM, blaSPM and blaSIM metallo-beta-lactamase genes were not
found in any isolates. ISAba1 was found in the upstream region of
blaOXA-23-like in all 25 representative isolates and ISAba3 was
present upstream blaOXA-58-like in all three isolates. The effux pump
inhibitor, CCCP, could not reduce the MIC of imipenem and
meropenem equal or more than fourfold. The result showed no efﬂux
pump mechanism in all of the carbapenem-reststant isolates. The
reduction of 43 kDa OMP was detected in two of the 10 representative
carbapenem-resistant A. baumannii isolates.
Conclusion: High resistance rate of carbapenems was found in
Acinetobacter baumannii isolates from Thailand and carbapenem
resistance mechanism was attributed to the production of OXA-23
carbapenemases and the decrease of 43 kDa OMP. ISAba1 and ISAba3
play an important role in the expression of the blaOXA genes in our
isolates.
In vitro antibacterial susceptibility and drug
interaction studies
R2518 More than a Gram-positive agent: in vitro activity of
dalbavancin against Moraxella catarrhalis
L. Koeth*, A. Windau, B. Goldstein (Westlake, Shefﬁeld, Wayne, US)
Objectives: Dalbavancin is a semisynthetic lipoglycopeptide antibiotic
with in vitro activity to a variety of Gram positive organisms, including
one of the primary respiratory tract infection (RTI) pathogens, S.
pneumoniae. Unlike other lipoglycopeptide antibiotics (vancomycin
and teicoplanin), dalbavancin has previously demonstrated some in
vitro activity against another key respiratory pathogen, M. catarrhalis.
Since this initial testing with M. catarrhalis was done, the broth
microdilution (BMD) method was modiﬁed to include preparation of
the stock solution in DMSO and subsequent dilution in cation adjusted
Mueller Hinton broth (CAMHB) containing 0.002% polysorbate 80
(P80). This study was performed to assess the activity of dalbavancin
against M. catarrhalis using the current BMD procedure.
Methods: Of 10 Moraxella catarrhalis (including nine beta lactamase
producing strains) and a quality control strain, S. aureus (ATCC
29213), were tested by broth microdilution using CAMHB with and
without 0.002% P80.
Results: With addition of 0.002% P80 dalbavancin MIC results
decreased one dilution for all study isolates. Using the current BMD
method, the dalbavancin MIC was 2 mg/L for nine strains and 1 mg/L
for one strain.
Conclusion: Using the current susceptibility method, dalbavancin has
demonstrated good in vitro activity to M. catarrhalis. In addition to its
superior PK/PD proﬁle, dalbavancin stands apart from other
lipoglycopeptides with its activity against M. catarrhalis, providing a
potential option in a regimen to treat community acquired RTI.
R2519 Prevalence of anaerobic bacteria and evaluation of its
resistance to antibiotics by E test method
L. Llorca*, D. Domingo, J. Martia´n˜ez, M. Espı´nola, T. Alarco´n,
M. Lo´pez-Brea (Madrid, ES)
Introduction: Infections caused by anaerobic bacteria are common,
and may be serious and life-threatening. Anaerobes are the predominant
components of the bacterial ﬂora of normal human skin and mucous
membranes, and are therefore a common cause of bacterial infections of
endogenous origin.
Objective: the aim of this study was to evaluate the anaerobic bacteria
isolated from clinical samples, and to study the pattern of susceptibility
to antibiotics from clinical samples since March 2009 until November
2011 in the ‘‘Hospital Universitario de la Princesa’’, in Madrid.
Methods: Of 382 strains were isolated from different clinical samples:
abscesses (34.82%), peritoneal ﬂuid (18%), biopsies (17%), drainage
(9.4%), wound/pus/tissue (7.32%), ascitic ﬂuid (3.67%), bile (5.24%),
and other sites (4.55%). Samples were cultured on blood, phenyl ethyl
alcohol (PEA), Schaedler (SCS) and Schaedler Kanamycin
Vancomycin agar with 5% sheep blood and all plates were incubated
in an anaerobic jar (Gas Pak, Becton Dickinson) for 48 hour. The
identiﬁcation of the microorganisms was carried out through
conventional tests and conﬁrmed by Rapid ID32A (bioMe´rieux)
gallery. In 84 strains susceptibility test was performed. The minimum
inhibitory concentrations (MICs) for amoxicillin/clavulanate,
piperacillin/tazobactam, meropenem, clindamycin and metronidazole
were determined by E-test (AB Biodisk) according to Clinical
Laboratory Standard Institute (CLSI) recommendations.
Results: The microorganisms more frequently isolated were:
Bacteroides sp. (40.58%), Propionibacerium sp. (18.06%), Prevotella
sp. (13.09%), Clostridium perfringens (7.59%) and Clostridium other
than perfringens (5.50%). We isolated a total of 44 different species.
From all the species, Bacteroides fragilis group was the most prevalent.
The global percentage of susceptibility were as follows: clindamycin
(58%), amoxicilline/clavulanic acid (74.02%), piperacillin tazobactam
(84.2%), meropenem (90.50%) and metronidazole (98.10%)
Conclusions: Nearly half of the strains belonged to Bacteroides sp. We
obtained a high percentage of resistance to amoxicillin/clavulanate and
clindamycin among the isolates studied. These ﬁndings emphasize the
need to know the susceptibility patterns of anaerobic bacteria in any
context.
R2520 Determination of MIC values of tigecycline against
multidrug-resistant Gram-negative bacteria isolated from
bacteraemic episodes by using agar dilution and Etest
methods
S. O¨zko¨k*, F. Timurkaynak, A. Yesilkaya, O¨. Azap, H. Arslan (Ankara,
TR)
The aim of this study is to determine in-vitro susceptibility of
tigecycline against multi-drug resistant gram negative bacteria which
are isolated from bacteremic patients using agar dilution and E-test
methods while evaluating the correlation between the two test methods.
Two hundred and six ESBL producing E. coli, K. pneumoniae and
multi drug resistant (MDR) A. baumannii strains which had been
obtained from blood culture of patients hospitalized in service and
intensive care units in our hospital between January 2008 and October
2010 were included. MIC50/MIC90 values determined by using agar
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dilution and E-test methods were 0.5/0.5 and 0.25/0.5 lg/mL for E.
coli, 1/2 lg/mL and 0.75/2 lg/mL for K. pneumoniae, and 4/4 and 2/
4 lg/mL for A. baumannii, respectively. It’s observed that the
correlation between MIC values measured by agar dilution and E-test
methods is high for K. pneumoniae (R = 0.776; p < 0.001) and A.
baumannii (R = 0.759; p < 0.001) while it is low for E. coli
(R = 0.299; p < 0.001). It is observed that the correlation between
two tests decreases as MIC values, 1 and 2 lg/mL for E. coli ve
Acinetobacter spp., respectively. Consequently, tigecycline is consid-
ered an appropriate agent for treating bacteremia caused by E. coli, as
the MIC values are less than serum concentration of tigecycline. On the
other hand, MIC values for A. baumanni strains which are much higher
than the serum concentration, eliminates the use of tigecyline in the
treatment of bacteremia due to A. baumanni. Lastly, because K.
pneumoniae strains with high MIC values are emerging; the decision of
using tigecycline should be made after determining the MIC value of
the causative strain. As the results of E-test and agar dilution used to
determine tigecycline susceptibility are correlated, E-test which is easier
to use could be utilized for daily use. However, due to the decrease in
the correlation between test results for E. coli and A. B baumannii with
high MIC values, the susceptibility test should be repeated by using
either AD or broth microdilution which are the golden standards if the
MIC value is found to be high.
R2521 Susceptibility of urinary coliforms to fosfomycin
trometerol in Wales
L. Davies*, M. Wootton, R.A. Howe (Cardiff, UK)
Objectives: Urinary tract infections (UTIs) are among the commonest
types of bacterial infections, with antibiotic treatment for UTIs
associated with important medical and economic implications.
Antibiotic agents such as beta-lactams, trimethoprim, and
cotrimoxazole have been used for the treatment of UTIs. However
the emergence of uropathogens, mainly Escherichia coli, exhibiting
high rates of resistance associated with the production of extended-
spectrum b-lactamases (ESBLs) is worrisome. Fosfomycin trometerol is
a broad-spectrum bactericidal antibiotic agent that inhibits the synthesis
of the bacterial cell wall and has a pharmacokinetic proﬁle which
encourages use for UTIs; mean peak urinary concentration of an oral
single dose of 3 g fosfomycin trometerol (FOS) occurs within 4 hour,
while concentrations sufﬁcient to inhibit the majority of the urinary
pathogens are maintained for 1–2 days. This study aims to evaluate the
susceptibility of 500 recent urinary coliform isolates to fosfomycin
trometerol for use as an alternative therapy in uncomplicated UTIs.
Methods: Susceptibilities of 500 urinary Coliforms, including E. coli
(n = 413), Enterobacter, Citrobacter and Klebsiella species (KES)
(n = 63) and Proteus species (n = 24) to fosfomycin were determined.
Minimum inhibitory concentrations (MICs) were determined using agar
dilution incorporating 25 mg/L glucose-6-phosphate to potentiate
fosfomycin trometerol activity and categorised using BSAC
breakpoints. Any isolate with raised MICs were tested against other
agents.
Results: Of 490 (98%) of isolates showed susceptible MICs to
fosfomycin trometerol with the mean GeoMIC 0.43 mg/L. Of 2% (10
isolates) exhibited ‘‘resistant’’ FOS MICs of >32 mg/L. The
frequency of isolates with FOS MICs can be seen in Fig. 1. Of the
resistant isolates three were E. coli and seven KES; all exhibited
susceptible MICs to gentamicin, 3rd generation cephalosporins and
mecillinam.
Conclusions: Fosfomycin trometerol is active against Gram negative
uropathogens. Of 98% of isolates were susceptible with resistant
isolates all proving susceptible to alternative therapies.
R2522 Synergistic effect of linezolid in combination against
multidrug-resistant and drug-susceptible isolates of M.
tuberculosis
E. Rey Jurado*, G. Tudo´, J. Gonza´lez Martı´n (Barcelona, ES)
Objective: To evaluate the in vitro effectiveness of two combinations
of three drugs: (i) linezolid, levoﬂoxacin and amikacin; (ii) linezolid,
levoﬂoxacin and ethambutol against multidrug-resistant (MDR) and
drug-susceptible isolates of M. tuberculosis.
Methods: Clinical isolates were collected in the Hospital Clinic of
Barcelona: nine MDR, 11 drug-susceptible isolates and H37Rv
reference strain. The individual MICs of the isolates studied were
evaluated with the proportional method in 7H11 solid medium. The
abovementioned combinations were studied crossing three
concentrations of each antibiotic (corresponding to their MIC and two
lesser dilutions), with an adaptation to a three-antibiotic chequerboard
assay in 7H11 medium. The fractional inhibitory concentration (FIC)
was calculated as: FIC index = MICA in combination/MICA
alone + MICB in combination/MICB alone + MICC in combination/
MICC alone where A, B and C were the three respective antimicrobial
agents tested. The FIC index was interpreted as FIC index £ 0.75,
synergistic activity, FIC>0.75–4, indifference and FIC>4 antagonistic
activity. As a control a 1/100 inoculum was seeded in antibiotic-free
medium. All the plates were incubated at 37C, being read after
21 days.
Results: The individual MIC of the isolates studied was 0.5–1, 0.5,
2.5 and 2.5–5 lg/mL for linezolid, levoﬂoxacin, amikacin and
ethambutol, respectively. In the MDR and drug-susceptible isolates
the MICs of linezolid, amikacin and ethambutol in combination
decreased two dilutions compared to their individual MIC. In the MDR
and drug-susceptible isolates the MIC of levoﬂoxacin in combination
was either maintained or decreased from one to two dilutions in
combination A, with most of the isolates in combination B being
decreased two dilutions compared to their individual MIC. Eight and
19 out of the 21 MDR and drug-susceptible isolates showed synergism
(FIC = 0.75) in combinations A and B, respectively. Comparing each
isolate with the two combinations, 12 MDR and drug-susceptible
isolates displayed synergism with (FIC = 0.75) combination A but not
with combination B.
Conclusion: The two combinations studied showed indifference or
synergism against MDR as well as susceptible isolates of M.
tuberculosis. The combination including linezolid was more
synergistic than that with amikacin, suggesting that it may be useful
in MDR treatment.
R2523 In vitro susceptibility trends for MSSA bloodstream
isolates over a 3.5 year period in Detroit
M. Perri*, S. Donabedian, R. Ziegler, P. Hartman, S. Arshad,
D. Moreno, A. Shoyinka, M. Zervos (Detroit, US)
Objectives: In this study, we evaluated in-vitro susceptibility of
clinical methicillin-susceptible Staphylococcus aureus (MSSA)
bloodstream isolates over a 3.5 year period, in Detroit, MI. The study
was done to evaluate in vitro susceptibility changes over time to
vancomycin (V), and daptomycin (D) and Linezolid (L).
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Methods: We evaluated 418 MSSA consecutive bloodstream isolates
from patients in urban Detroit from July 2007 to December 2010 to
determine susceptibility trends using susceptibility methods for MIC by
manual microbroth dilution and Etest (bioMerieux, Inc.) to V, D and
susceptibility to L by Etest. The geometric mean was determined for
each year and analysed over time.
Results: Statistical analysis was performed using t-test, and signiﬁcant
statistical increases or decreases are described in the following table:
Conclusion: Over a 3.5 year period in urban Detroit, we found a
signiﬁcant decrease in MIC’s by Etest from 2008 to 2009, yet a
signiﬁcant increase by manual microbroth of these MSSA bloodstream
isolates to V the same time. There was a signiﬁcant decrease in D MIC
by Etest from 2007 to 2008, yet an increase from 2008 to 2009 by Etest
to D. A signiﬁcant decrease was seen in the MIC’s by Etest to L from
2007 to 2008. With increasing reports of vancomycin failure in
methiciillin -susceptible Staphylococcus aureus, it is important to
monitor susceptibilities of other relevant treatment options such as
linezolid and daptomycin, to determine MIC creep of these agents.
R2524 In vitro activity of tigecycline against Gram-positive and
Gram-negative isolates at a tertiary care hospital
S. Al Johani*, M. Younan, A. Muhanna, F. Al Dughaishim,
A. Alothman (Riyadh, SA)
Objectives: Tigecycline (TIG) is a member of the glycylcycline class
of antibiotics with a broad spectrum of activity which includes several
Gram-positive and Gram-negative bacteria. It is one of the last resort
antibiotics for multidrug resistant pathogens like MRSA and ESBL. In
this study we evaluate the in-vitro activity of TIG against multiple gram
positive and gram negative isolates including ESBL and MRSA. We
also evaluate his activity at our Pseudomonas isolates.
Methods: A total of 506 carbapenem resistant isolates of
Acinetobacter spp.; 50 g positive including 14 MRSA and 5 VRE
isolates as well as 80 g negative isolates (12 ESBL, 12 Pseudomonas
aeroginosa) isolated in our centre were studied. Isolates were recovered
from blood cultures, body ﬂuids, pus, bronchial secretions and urine
samples in a two year period, from January 2010 till November 2011.
The identiﬁcation and susceptibility testing was performed via the
MicroScan Walkaway (Siemens). The TIG susceptibility testing
performed using Etest strips (AB Biodisc, Sweden) according to
CLSI guidelines. The EUCAST Enterobacteriaceae breakpoints were
used to interpret Tigecycline MIC results for A. baumannii.
Results: Of the 506 isolates, 420 isolates exhibit an MIC less the 4 mg/
L (Susceptible range) which represent 83.00%. There are 86 resistant
isolates (16.99%). Of the resistant strains; there were eight samples
exhibit very high level of resistance MIC 256 mg/L, and 12 isolates has
MIC equal to 4 mg/L and the rest fall between 6 and 24 mg/L. In our
study, all these isolates have susceptibility to amikacin at 21%, to
cefepime at 0.6%, to imipenem 2.00% and to colistin 98.00%.
Among the 12 pseudomonas isolates; there are 10 isolates resistant to
tigacycline with MIC ( 8 and two were susceptible MIC £ 1. Of the 12
ESBL isolates there were 11 susceptible to TIG and one are resistant
with MIC of 24 mg/L. ALL gram positive isolates including (MRSA,
VRE, S. pnemoniae, S. pyogenes and enterococci) were susceptible to
TIG with MIC 0023–0.125 mg/L
Conclusion: Tigecycline maintains potent in vitro activity against
gram positive pathogens and some of highly resistant Acinetobacter
spp. As for A. baumannii, there is a decreased susceptibility but it may
be an alternative treatment option when other agents are excluded due
to multidrug resistance. TIG shows no activity against Pseudomonas
isolates.
New antimicrobials
R2525 Antagonistic activity of Lactobacillus spp. against
methicillin-resistant staphylococci
M. Sukhina*, V. Zhukhovitsky, M. Sukhina (Moscow, RU)
Summary: Lactobacillus spp. strains isolated from faeces were
divided into three groups depending on the degree of antagonism
against methicillin resistant Staphylococcus aureus (MRSA) and S.
epidermidis (MRSE). Lactobacilli with high antagonistic activity may
appear to alternative to antibiotics in the control on methicillin resistant
staphylococci.
Aim: Assessment of degree of antagonistic effect of lactobacilli on the
growth of methicillin resistant staphylococci.
Methods: Nine Lactobacillus spp. strains isolated from faeces, one
strain L. plantarum 38 isolated from ofﬁcinal probiotic ‘‘Lactobacterin
dry’’ (‘‘Microgen’’, Russian Federation) and 13 strains of methicillin
resistant staphylococci (12 – MRSA, 1 – MRSE), isolated from blood
under bacteriaemia were studied. For semi-quantitative assessment of
the antagonistic action of lactobacilli in vitro the original technique,
based on the phased cultivation of cultures of lactobacilli and
staphylococci on a combined solid medium was developed. The
result of the antagonistic effect of lactobacillar culture on the
staphylococcal culture was assessed by the size of the zone of growth
inhibition: high antagonistic activity corresponded to 25–40 mm,
medium – 15–25 mm, low – 5–15 mm, absence of antagonism –
<5 mm.
Results: All 12 MRSA strains and one strain of MRSE only included
in the study were sensitive by antagonistic action of strain L. plantarum
38. Three strains of lactobacilli (33.3%) had no antagonistic activity on
all 13 methicillin resistant staphylococci strains studied. Two strains of
lactobacilli (22.2%) showed no antagonism against single MRSE strain,
preserving at the same time antagonistic activity varying degree on
different (1–10) MRSA strains. The remaining four strains of
lactobacilli (44.5%) demonstrated antagonistic activity against single
MRSE strain and the majority (83.3%) of MRSA strains; their activity
against MRSE strain was medium and low only, for MRSA strains –
predominantly high degree of expressiveness.
Conclusion: Most of the investigated strains of lactobacilli possess
antagonistic activity against MRSA and/or MRSE. The presence of
antagonistic activity of lactobacilli against methicillin resistant
staphylococci opens some possibilities for development of a new
generation of drugs aimed to these microorganisms, exhibit a high
degree of resistance to the vast majority of modern antibiotics.
R2526 Activity of strawberry (Fragaria vesca) leaf phenolic
extracts on metallo-beta-lactamase VIM-2 producers
Pseudomonas aeruginosa
F.A. Pereira, T. Santos, S.G. Pereira*, M.T. Amaral, O. Cardoso,
M.T. Batista (London, UK; Coimbra, PT)
Objectives: Pseudomonas aeruginosa (PA) is at present the fourth most
common nosocomial pathogen, causing a wide variety of serious
infections on compromised hosts and is characterized by an intrinsic
resistance to various antimicrobial agents and for the ability to easily
develop multi-drug resistance (MDR) under antibiotic pressure. Metallo-
b-lactamases (MBLs) confer a MDR proﬁle to the bacteria that present
them, since they hydrolyse all beta-lactams, except aztreonam. At
present, there is no available inhibitor of MBLs, which augments the risk
of infections caused by MBLs producing bacteria. Some polyphenols are
generally recognised as quite potent antibiotics. The aim of this studywas
to challenge clinical isolates ofMBLVIM-2 producers PAwith an extract
and polyphenol-rich fractions from strawberry (Fragaria vesca) leaves,
in order to screen for antimicrobial activity,with the intent to ﬁnd possible
future therapeutic alternatives to treat MBL producing PA infections.
Methods: Fragaria vesca leaves (Fv) were extracted with ethanol
(EtOH) and 50% aqueous EtOH. Three fractions from that crude extract
were obtained on a Sephadex LH-20 column by elution with 50% and
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75% aqueous methanol (Fa and Fb, respectively) and 70% aqueous
acetone (Fc). Fifteen MBL VIM-2 producers PA clinical isolates were
used. Standard microplate assays were performed to determine MICs of
extract (0.78–50 mg/mL) and fractions (0.39–25 mg/mL).
Results: Crude extract presentedMIC50 = 10.35 mg/mL andMIC90 =
20.7 mg/mL. Fraction Fa presented MIC50 and MIC90 of 25 mg/mL;
fraction Fb presented MIC50 = 6.25 mg/mL and MIC90 = 12.5 mg/
mL; fraction Fc presented MIC50 and MIC90 of 12.5 mg/mL.
The more active fraction was fraction Fb, essentially constituted by
tannins: proanthocyanidins and ellagitannins. Curiously, an exacerba-
tion of the pigment in all isolates was detected with this fraction.
Conclusion: A fraction of a crude extract obtained from Fragaria
vesca leaves presented an interesting activity against MBL VIM-2
producers PA clinical isolates. One or more polyphenols of this fraction
can constitute a signiﬁcant potential for the development of novel
antibacterial therapies against these bacteria. Further studies are
required to address this possibility.
For an approach to antimicrobial efﬁcacy, MDR clinical isolates should
be used and not only ATCC strains, since they represent more
accurately the pathovars of the species, which confers higher interest to
the obtained results.
R2528 Screening for bio-active and anti-bioﬁlm substances of
Bacillus and Paenibacillus species
M. Klinger, O. Makarewicz*, P.M. Keller, R. Borriss,
M.W. Pletz (Jena, Berlin, DE)
Objectives: Soil living bacteria are known to produce compounds that
promote plant growth and confer resistance to plant diseases caused by
different pathogens (1, 2). The rhizosphere can be colonized by bioﬁlm
formation by various species, thus antimicrobials ensure also survival
advantage against competing commensals. For example, B.
amyloliquefaciens strain FZB42 secrets at least 12 known antibiotics,
which inhibit growth and destroy bioﬁlms of other microorganisms and
that belong to different chemical classes: lipopetides, polyketides and
small peptides (3). The aim of our efforts is to scrren culture
supernatants of soli living Gram+ for novel substances with activity
against bioﬁlms of multidrug resistant major bacterial human pathogens
involved into catheter- and device associated infections.
Methods: We used supernatants of B. amyloliquefaciens (n = 5), B.
pumilus (n = 1), B. licheniformis (n = 1) and P. polymyxa (n = 3) that
were ﬁltered, lyophilized and resuspended in 1/10 volume in sterilized
water. Supernatants were used in disc diffusion tests against multidrug
resistant isolates ofE. coli (n = 3),K. pneumoniae (n = 2),P. auruginosa
(n = 4) S. aureus (n = 3), E. faecalis (n = 2) and P. mirabilis (n = 1) as
indicator strains. A more detailed analysis of active compounds was
performed using bioautography based on thin layer chromatography.
Results: Supernatants of P. polymyxa strains exhibited strongest
antimicrobial activity against Gram+ and Gram- pathogens. B.
amyloliquefaciens FZB 42 showed also high activities against all
indicator strains. B. pumilus and B. licheniformis inhibited mainly
growth of Gram+.
Conclusion: Gram-positives soil living bacteria secrete a wide
spectrum of bio-active secondary metabolites, which can inhibit the
growth of human pathogens. Further experiments will concentrate on
identiﬁcation of particular substances with antimicrobial activity and
analyze their anti-bioﬁlm activities.
1. Verhagen BW, Trotel-Aziz P, Couderchet M, Hofte M, Aziz A.
2010 J Exp Bot. 61: 249–60.
2. Ko HS, Jin RD, Krishnan HB, Lee SB, Kim KY. 2009 Curr
Microbial. 59: 608–15
3. Chen XH, Koumoutsi A, Scholz R, Eisenreich A, Schneider K, et al.
2007 Nat Biotechnol. 25: 1007–14.
R2529 In vitro activities of telavancin and three comparator
agents against Staphylococcus aureus
K. Chalvatzi*, M. Pilavidou, E. Protonotariou, S. Metallidis,
F. Tsiapara, E. Diza (Thessaloniki, GR)
Objectives: Staphylococcus aureus is becoming increasingly resistant
to antibiotics. The worldwide prevalence of methicillin- resistant
Staphylococcus aureus (MRSA) poses a particular threat due to
difﬁculties in treatment not only with existing ß-lactams, but also with
quinolones. Telavancin (TLV) is a novel semisynthetic
lipoglycopeptide with a broad spectrum of activity against aerobic
and anaerobic gram-positive bacteria, including methicillin-resistant
Staphylococcus aureus (MRSA). The objective of the current study was
to evaluate the in vitro activity of TLV in comparison with vancomycin
(VAN), daptomycin (DPC), and linezolid (LZD) against MRSA and
MSSA isolates from various clinical specimens of our hospital.
Methods: Thirty six non-duplicate Staphylococcus aureus isolates (28
MRSA and eight MSSA) were recovered from blood, bronchoalveolar
secretions, urine, trauma, pus and central venus catheter samples. The
samples were isolated from patients hospitalized in surgical and internal
departments of AHEPA University Hospital in Greece. Bacterial
identiﬁcation and initial susceptibility testing was performed using
Vitek2 system (bioMe´rieux, France). Minimum inhibitory
concentrations (MICs) of TLV, VAN, DPC, and LZD were
determined with E-test strips (AB Biodisk, bioMe´rieux, France).
Results: MICs for 50% (MIC50) and 90% (MIC90) for TLV, VAN,
DPC, and LZD against MRSA, and MSSA are shown in the table.
Based upon MIC90 comparisons, TLV was two to threefold more
potent than VAN, and up to twofold more potent than LZD against
MRSA isolates. Comparing the MIC values of TLV, and DPC against
MRSA revealed almost similar results. Signiﬁcantly elevated MIC90
was observed for TLV (threefold), VAN (16-fold), and LZD (sixfold)
against MSSA in contrast to DPC.
Conclusion: Our results conﬁrm the potent in vitro inhibitory activity
of telavancin against important and emerging antimicrobial-resistant
Staphylococcus aureus pathogens. Based upon MIC90 comparisons,
telavancin was consistently more active than vancomycin, and linezolid
against all organisms tested and showed potency equal to or greater than
daptomycin against MRSA, but lower against MSSA strains. These data
highlight the potential therapeutic use of TLV in the treatment of
Staphylococcus aureus infections.
R2530 Hybrid nanostructurated materials for bio-interface
application in developing new antimicrobial strategies
A.M. Grumezescu, E. Andronescu, C. Saviuc, A. Ficai, B.S. Vasile,
L. Marutescu*, M.C. Chiﬁriuc, V. Lazar (Bucharest, RO)
Objectives: The present work aims to describe the synthesis and
characterization of functionalized magnetite nanoparticles for
stabilizing essential oils aiming to obtain an efﬁcient antimicrobial
strategy for bioﬁlm related fungal infections.
Materials and Methods: The Eugenia caryophyllata buds essential oil
microwave assisted extraction was performed in a Neo-Clevenger type
apparatus and its chemical composition was settled by GC-MS analysis.
The fungal strains were isolated from different clinical specimens and
were identiﬁed by Vitek II automatic system. Fe3O4/Cn (n = 12, 14, 16,
18) – nanoparticles (core/shell) were synthesized and characterized by
HR-TEM, XRD, FT-IR and BET. The nanoparticles were used to
achieve a core/shell/adsorption-shell based on essential oil nanosystem
for covering treatment of the prosthetic devices represented by
catheters.
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The obtained modiﬁed surfaces were subsequently used for the in vitro
study of the fungal bioﬁlm development. The bioﬁlm architecture was
assessed by Scanning Electron Microscopy (SEM).
Results: The results proved that the nanostructurated materials (core/
shell/adsorption-shell) show a signiﬁcant antibioﬁlm activity,
highlighting the opportunity of using them for the developing of
efﬁcient antibioﬁlm strategies as coating modiﬁed biomaterials
(prosthetic devices), as well as for the controlled release of different
antimicrobial substances for further clinical applications.
Epidemiology of MRSA, VRE and other
Gram-positives
R2531 Molecular characterisation of methicillin-resistant
Staphylococcus aureus with emergence of epidemic clone
of sequence type (ST) 772 and novel ST 2129 in southern
India
S. Karutha Pandian*, S. Gowrishankar (Karaikudi, IN)
Background: The emergence of community-acquired MRSA (CA-
MRSA) has changed the current epidemiology of Staphylococcus
aureus, in particular methicillin-resistant S. aureus (MRSA).
Objectives: The aim of the work was to study the molecular
epidemiology of MRSA strains isolated from throat swab of
pharyngitis patients attending Thoracic Science Department of
Government Rajaji Hospital, Madurai, Tamil Nadu, India.
Methods: In total, 63 non-repeated MRSA were isolated in the
prospective study carried out between December 2009 and March 2010.
These isolates were subjected to two conventional multiplex PCR
assays including pvl, mecA, nuc genes detection and SCCmec typing.
The antimicrobial susceptibility was determined by disk diffusion
method. The clonal relationship between the selected strains was
determined by Multilocus Sequence Typing (MLST). Based on the
PVL prevalence, SCCmec types and difference in antibiotic resistant
proﬁles, 26 isolates were selected for MLST.
Results: Almost all MRSA showed a multidrug resistant phenotype.
The prevalence of antibiotic resistant was moderately high: Kanamycin
(96.8%), Tobramycin (85.7%), Gentamicin (87.3%), Trimethoprim
(85.7%), Ciprorﬂoxacin (59.5%), Co-Trimoxazole (55.7%),
Erythromycin (58.7%) and Clarithromycin (47.6%). Of the 65
isolates showing resistance to oxacillin and cefoxitin disks, 63 were
conﬁrmed to be mecA and nuc gene positives and 69.8% of the isolates
harbored PVL toxin gene as determined by multiplex PCR assay.
SCCmec typing by multiplex PCR assay revealed that type V was the
most predominant type at 50.8% (n = 32) followed by SCCmec type III
at 44.4% (n = 28). SCCmec types I, II and IVa were found to be least at
1.6% (n = 1) each. MLST analysis resulted with 12 different Sequence
Types for 26 selected MRSA, including a newly assigned ST 2129 with
PVL positive, SCCmec type III. Ten strains of SCCmec type V, PVL
positives were found to be ST 772 (38.5%). Three strains belonging to
ST 368 (11.5%) followed by two strains each found to be STs 1137,
1713 and 217 (7.7%) and one strain each found to be the STs 571,
2129, 474, 585, 1801, 672 and 240 (3.8%).
Conclusion: This study unveils that many CA-MRSA have
successfully been established themselves in hospital of South India.
The results of the study also give a hint that SCCmec V ST 772, which
has recently been believed to be the native of Asia, may emerge as a
dominant global epidemic MRSA strain in the coming years.
R2532 Community-acquired methicillin-resistant Staphylococcus
aureus in a university clinical hospital, Mostar – our ﬁrst
experience
M. Ostojic, T. Petrovic* (Mostar, BA)
Objectives: Infections caused by community-acquired methicillin-
resistant Staphylococcus aureus (CA-MRSA) have been recognized
as a major public health problem worldwide. CA-MRSA producing
Panton-Valentine leukocidin (PVL) causes mostly skin and soft tissue
infections, but it can also cause severe invasive diseases, including
necrotizing pneumonia. Infections with PVL-positive MRSA have been
described in most European countries, but no cases of CA-MRSA
infections have previously been reported in University Clinical Hospital
Mostar, Bosnia-Herzegovina.
Methods: During the ﬁrst six months of 2010, we have collected 25
isolates of MRSA. Antibiotic susceptibility testing was performed using
disk-diffusion method, according to Clinical Laboratory Standards
Institute (CLSI) guidelines. Methicillin-resistance was conﬁrmed by
molecular dipstick assay GenoTipeMRSA (Hain Lifescience, Nehren,
Germany) by detection of mecA gene. At the same time, we detected a
speciﬁc fragment of PVL gene. The isolates were further analyzed by
spa-sequence typing, according to SeqNet.org protocol.
Results: All isolates were resistant to penicillin, all were susceptible to
sulfamethoxazole/trimethoprim, amikacin, vancomycin, teicoplanin and
linezolid. Two of them were uncommonly susceptible to erithromycin,
azithromycin, gentamicin, clindamycin and ciproﬂoxacin. All isolates
in the study were positive to mecA gene. Two uncommonly susceptible
isolates were found positive to PVL gene, while the other 23 were
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negative. MRSA isolates from 10 patients have belonged to spa type
t001, from four patients to spa type t008, and from one patient to spa
type t041. Above described susceptible isolates have belonged to spa
type t008. The residual of 10 isolates failed to be typed by spa-typing
method. (See Table 1.)
Conclusion: Community-associated MRSA isolates cannot be
discriminated from hospital MRSA only by spa typing. The
possession of PVL gene in two isolates, which have belonged to spa
type t008, suggests that the other two in the present study might belong
to the transatlantic strains. The transmission of those strains has been
previously described in literature.
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R2533 Impact of acute kidney injury on clinical and economic
burden in patients with methicillin-resistant
Staphylococcus aureus infection: a retrospective,
multicentre and observational study
E.J. Joo*, J. Kim, S. Park, Y. Kim, Y. Song, S. Lee, S. Ryu, C. Moon,
C. Lee, K. Park, K. Peck (Seoul, Pyonchon, Daegue, Pusan, Chonbuk,
Chonnam, KR)
Objectives: Acute kidney injury (AKI) associated with treatment of
methicillin-resistant Staphylococcus aureus (MRSA) infection is
considered to be a major factor for mortality and morbidity.
However, the clinical outcomes and economic burden caused by
MRSA and antibiotic related adverse events have not been well
evaluated among hospitalized patients.
Methods: A retrospective, multicenter and observational study was
performed in eight hospitals in South Korea between March 2010 and
February 2011. The risk factors for mortality and kidney injury were
evaluated in patients with MRSA infections. To assess resource
utilization that results from MRSA infections, direct costs charged on
each patient during treatment were summed up according to the
respective resource category.
Results: A total of 335 patients were identiﬁed to have MRSA
infections. One-hundred and thirty-ﬁve patients (40.3%) experienced
AKI during 1st line antimicrobial treatment and seventy-seven (20.3%)
patients died during the study period. Male gender, underlying renal
disease, gastrointestinal and central-venous catheter infections and
increase of Pitt bacteremia score were independently associated with
development of AKI. As for mortality, solid tumor, increase in Pitt
bacteremia score, and AKI were shown to be independent risk factors.
The estimated mean total medical cost per patient was KRW 5 435 361
(USD 4868) ± SD 5 492 96. In the multivariate regression analyses for
hospital charges, male gender, increase in Pitt bacteremia score, and
AKI were related to increased hospital costs. The mean increase in
hospital costs per patient when AKI occurred was KRW 2 474 600
(USD 2216) higher than that without AKI (p < 0.001).
Conclusion: Kidney injury occurring during treatment for MRSA
infections was signiﬁcantly associated with worse clinical outcomes
and higher hospital costs than patients who retained baseline renal
function.
R2534 Dear Director of Finance of NHS Hospital: it is possible to
close beds and achieve savings from reduction in health-
care associated infections!
A. Guleri*, A. Kehoe (Blackpool, UK)
Objectives: According to the National Audit Ofﬁce Report [January
20, 2011], NHS caters to a population of 51 million, employs more than
1.3 million and deals with a million patients every 36 hours. The
Government aims to deliver £20 billion (4%) efﬁciency savings in the
NHS by the end of 2014–2015. Blackpool Teaching Hospitals [BTH] is
a large 844 bed teaching hospital with two tertiary centres. Its share of
saving is approximately £50 M over 3–4 years. The trust board is
committed to reducing costs by improving quality and driving
efﬁciency, through clinical engagement, with key priority – quality
and safety in patient care. We [CEO of the hospital and Microbiologist]
present a case for taking costs out of the system through signiﬁcant
reductions in HAI and other quality initiatives within this teaching
hospital.
Methods: Using reductions in HAI and other quality initiatives such as
patient falls; pressure ulcers; medication errors, etc to take costs out of
the system by closing a 24 bedded ward. This realised a cost saving of
over £970 K.
Results: Reductions in acute trust (post 48 hour) HAI over ﬁnancial
years [2007/2008; 2008/2009; 2009/2010; 2010/2011; 2011/2012
(projected)]: MRSA bacteraemias – 90% [28; 5; 3; 3; 2 or 3 resp]; C.
difﬁcile infections 90% [323; 207; 134; 101; 64]. Reductions in total
MRSA infections 48.9% [883 in 2007–2008 to 451 in 2009–2010] incl.
Of 80% reduction in bacteraemias [1.33 to 0.27/10 K bed days as
compared to national and regional reduction from 1.19 and 1.09 to 0.5/
10 K bed days] & 39.1% reductions in wound infections.
Savings from closure of 24 bedded ward included Stafﬁng [£960 K];
Clinical and general supplies and services [£9754].
Conclusions: The challenge facing all NHS trusts and healthcare
professionals is to balance increasing demand from patients with the
requirement for efﬁciency and productivity, whilst maintaining
excellent quality. This requires dynamic leadership from CEO,
commitment from trust board, clinical engagement, continuous
endeavours to recognise innovative ideas of work differently, more
efﬁciently, identifying savings and taking costs out of the system.
R2535 USA300 CA-MRSA clone responsible for an outbreak of
skin and soft tissue infections in a hospital newborn
nursery in Italy
A. Sanchini, M.G. Spitoni, M. Monaco*, A. Raglio, A. Grigis, V. Petro`,
M. Menchini, A. Pesenti, A. Goglio, A. Tempra, A. Pantosti (Rome,
Bergamo, IT)
Objectives: Community-acquired methicillin-resistant Staphylococcus
aureus (CA-MRSA) is a well-established human pathogen that emerged
in the 1990s, becoming responsible for severe infections in previously
healthy people in the community in different areas of the world. CA-
MRSA is able to cause outbreaks in groups with close interpersonal
contacts and recently appeared in hospital causing outbreaks in USA
and Europe. Here we describe an hospital outbreak of skin and soft
tissue infections (SSTI)s occurred in an hospital newborn nursery
caused by USA300 CA-MRSA clone.
Methods: In October 2010, SSTIs due to MRSA were observed in
nine neonates born in a hospital in northern Italy. Of these three were
severe infections (a mastitis and two deep abscesses) that required
admission to the neonatal intensive care unit of a tertiary-care hospital.
Besides, four mothers had post-partum mastitis and four family
members had SSTI. To control the outbreak, a screening for MRSA
nasal carriage was performed on 217 neonates and babies, six family
members and 69 hospital staff-members. Identiﬁcation and antibiotic
susceptibility of the isolates were obtained by Vitek 2, disk-diffusion
method and E-test. EUCAST breakpoints were applied. The presence of
mecA, and of the genes for PVL and ACME was investigated by PCR.
Molecular characterization included SCCmec typing, spa typing, PFGE
and MLST.
Results: All MRSA isolates were resistant to erythromycin and
ciproﬂoxacin besides beta-lactam antibiotics and had identical
molecular characteristics: the outbreak strain was characterized by
SCCmec type IV, spa type t008, ST8 and was positive for the PVL
genes and ACME. PFGE revealed an identical pulsotype, highly related
to that of USA300 in all the isolates. Isolates from post-partum mastitis
and family members shared the same proﬁle of the outbreak strain. Nine
healthy neonates and babies, two family members and 10 hospital staff
members were found colonized by the outbreak strain.
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Conclusion: To our knowledge, this is the ﬁrst report of an outbreak
caused by the USA300 CA-MRSA clone in a hospital newborn nursery
in Europe. The large number of neonates involved, the severity of some
cases, and the spread to mothers and other family members conﬁrms the
high virulence, transmissibility and persistence of the USA300 clone.
Hence, it is important to reinforce infection control especially in high-
risk groups, such as neonates, to prevent USA300 from becoming
endemic in European hospitals.
R2536 Molecular epidemiology of methicillin-resistant
Staphylococcus aureus nasal colonisation in a university
hospital in Rio de Janeiro
F. Cavalcante, D. Ferreira, S. Nouer*, K. Santos (Rio de Janeiro, BR)
Introduction: Methicillin-resistant Staphylococcus aureus (MRSA) is
the main pathogen involved in healthcare-associated infections. Nasal
colonization is the most risk factor to the development of MRSA
infections. The methicillin resistance is due to presence of a
Staphylococcal Chromosome Cassette (SCCmec).
Objectives: The aim of this study was to characterize MRSA isolates
from nasal colonization in patients from a university hospital in Rio de
Janeiro city, between October 2005 and August 2006.
Methods: The isolates were evaluated to SCCmec types, clonal
proﬁles, ST (sequence type) and presence of PVL genes.
Results: Of a total of 83 recovered isolates, 41 (49%) carried SCCmec
IV, 36 (43%) the type III, 3 (4%) the type II and 3 (4%) the type V. The
41 type IV MRSA isolates were included in ﬁve genotypes. The
genotypes associated to USA400/ST1 and USA800/ST5 were related to
92.7% of type IV isolates. All MRSA isolates from dermatology were
USA800, while 53% of isolates from medical clinic were USA400.
Two isolates USA400 and one USA800 present the PVL genes. Type
III MRSA isolates belonged to seven genotypes, but 64% of them were
related to the Brazilian epidemic clone (BEC)/ST239. This clone was
associated to 29% of isolates from medical clinic and 50% of isolates
from infectious disease clinic. In intensive care unit, 33% of isolates
belonged to SCCmecIII/clone N/ST239 lineage. The others 10 isolates
recovered in ICU belonged to six different clonalities, included a type
IV isolate that belonged to ST97 and that presented PVL genes. Among
14 MRSA isolates from patients who have been transferred, 6 (43%)
showed genomic proﬁles that was never found in patients of our
hospital. Horizontal transmission events involving 19 patients showed
that the USA400/type IV clone was isolated from 42% of them. In
addition, one speciﬁc USA400 isolate was transmitted three times in the
same ward.
Conclusion: Each ward of hospital showed spread of a speciﬁc MRSA
lineage. In ICU was observed a great clonal diversity of isolates,
probably because this unit receives patients of all wards of hospital.
SCCmec IV/USA400/ST1 was the most found lineage in our hospital at
time of study. Moreover, that lineage was the main involved in
horizontal transmission, indicating how easy it is the transmission of
isolates of this genetic proﬁle, justifying the gradual substitution of
clonal types well established in hospitals.
R2537 Highly successful community-associated S. aureus
resistant to methicillin and ﬂuoroquinolones in
northwestern Spain
A. Moreno-Flores*, C. Potel-Alvarellos, M.A. Pallares, L. Constenla-
Carames, M. Alvarez-Fernandez (Pontevedra, Vigo, ES)
Objectives: The current selection of a successful S. aureus clone
resistant to methicillin and ﬂuoroquinolones (MRSA-FQ) is studied. Its
clonal relationship with other S. aureus only resistant to methicillin is
analysed.
Methods: A total of 750 MRSA isolated at the Pontevedra Hospital in
2009, 2010, and 2011 were studied by the WIDER system. The
antimicrobials studied included: oxacillin (OX), erythromycin,
clindamycin, gentamicin, tobramycin, amikacin, levoﬂoxacin (LE),
and trimethoprim-sulfamethoxazole. The MRSA strains that were only
OX resistant and OX-LE resistant were selected and PFGE studied,
SCC-mec classiﬁed, and spa-typed. The arcA (ACME) and PVL genes
were PCR studied. The strains were classiﬁed as community-onset
MRSA (CO-MRSA) when the strain was isolated in a non-hospitalized
patient. In any other cases the strains were classiﬁed as healthcare
associated MRSA (HA-MRSA).
Results: Thirty-one (4%) strains were OX (R) and 97 (13%) were OX-
LE (R). The prevalence of the OX-LE (R) was 7% in 2009, 13% in
2010, and 22% in 2011. The 65% of the OX-LE (R) isolates were
identiﬁed as CO-MRSA. By PFGE/spa-type, ﬁve clones (A/t008, B/
t148, C/t002, D/t1133, and E/t024) were identiﬁed in the OX (R)
strains, while in the OX-LE (R) strains only one clone (C/t002) was
identiﬁed being identical to the PFGE-C/t002 identiﬁed in the OX (R)
isolates. All strains were identiﬁed as SCC-mec IV (2B). The ArcA
(ACME) and PVL genes were not identiﬁed in any of the strains.
Conclusions: A successful MRSA-FQ resistant clone t002 was
identiﬁed. The MRSA-FQ clone has its ancestor in a t002 MRSA
clone susceptible to FQ. The clone MRSA-FQ resistant t002 was
isolated more frequently in the community. Surveillance studies are
essential to identify new successful MRSA clones, being this
information highly outstanding for clinicians and epidemiologists.
R2538 Variability of resistance and virulence genes in human
isolates of MRSA ST398 in Austria
A.J. Grisold*, K. Krziwanek, S. Johler, G. Feierl, E. Leitner,
U. Wagner-Eibel, M. Gehrer, C. Kittinger, E. Marth, G. Zarfel (Graz,
Linz, AT; Zurich, CH)
Background: Methicillin-resistant Staphylococcus aureus (MRSA) of
sequence type 398 (ST398) has gained particular attention because of
its association with pig farming and its ability to colonize people, when
in close contact to these animals. MRSA ST398 can mainly be assigned
to the speciﬁc spa-types (like t011or t034). Typically, in addition to the
resistance to Methicillin, MRSA ST398 isolates are resistant to
tetracycline only. There are reports that MRSA ST398 are less
virulent than other known MRSA types.
Objectives: MRSA ST398 from both MRSA reference centres were
studied to determine relatedness, resistance and virulence genes in
human MRSA ST398 in Austria.
Methods: From 2004 to 2008 41 MRSA ST398 were detected at the
two MRSA reference centres in Austria, the Elisabethinen Hospital,
Linz and the Institute of Hygiene, Medical University of Graz. To
determine involved resistance and virulence genes from these two
different regions a chip based microarray on the IdentiBac System
(Alere Technologies GmbH) was used. IdentiBac gene proﬁles were
compared using SplitsTree4 software. Additional spa- and SCCMec
Type was determined.
Results: Spa typing assigned 36 (87.8%) to spa type t011, two to t034,
two to t2346 and one t1451. All strains belonged to SCCmec type V.
Analysis of the resistance genes (additional to Methicillin resistance)
exhibited that 40 (97.6%) MRSA ST398 were positive for blaZ ß-
lactamases and tetM tetracycline resistance genes. The tetK gene was
present in 28 (68.3%) strains. Genes for Erythromycin and Clindamycin
resistance ermC was found in 12 (29.3%). Three strains (7.3%)
harboured the vga (strepotomycin) gene, two (4.9%) the aacA-aphD
gene (gentamicin, tobramycin) and one (2.4%) the ﬂexA
(chloramphenicol) gene.
Whereas different sets for hemolysines could be identiﬁed, in none of
the MRSA ST398 enterotoxins, toxic shock syndrome toxin gene
(TSST) and panton valentine leukocidin toxin (PVL) could be detected.
SplitsTree analyses offered that although MRSA ST398 originating
from two different regions clustered together, but MRSA ST398 from
2005 to 2006 were much more related than MRSA ST398 detected in
2007–2008.
Conclusion: Since 2004 a single MRSA ST398 clone (with only small
variations in resistance and virulence genes) is responsible for the most
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human MRSA ST398 in Austria. Only two MRSA ST398 (4.9%)
differed signiﬁcantly from the isolates.
Absence of TSST- and PVL genes was in accordance with the known
less virulence of MRSA ST398.
R2539 Detection and characterisation of methicillin-resistant
Staphylococcus aureus strains isolated from pigs in
Lithuania – a cross-sectional study
N. Couto*, M. Ruzauskas, A. Belas, M. Virgailis, I. Klimiene,
R. Siugzdiniene, C. Pomba (Lisbon, PT; Kaunas, LT)
Objectives: To investigate methicillin-resistant Staphylococcus aureus
(MRSA) occurrence among pigs in Lithuania and to characterize
isolated strains.
Methods: Between January 2011 and December 2011, 120 nasal
swabs were taken from randomly selected breeding pigs from six
different farms and additionally 40 nasal swabs were obtained from
ﬁnishing pigs from two other farms at two slaughter houses just before
slaughtering. MRSA was screened on BrillianceTM MRSA 2 Agar
(Oxoid) and chromIDTM MRSA medium (bioMe´rieux) and conﬁrmed
by PCR for the presence of the mecA gene. MRSA isolates were
subjected to spa typing, SCCmec typing, ST398 PCR, and underwent
PFGE analysis with Cfr9I. Isolates were also tested for the lukF/lukS
genes encoding Panton–Valentine leukocidin (PVL). Antimicrobial
susceptibility testing was performed using the broth microdilution
method (MicroScan PM21; Dade Behring Siemens) and interpreted
according to CLSI guidelines. The presence of tetK, tetM, ermA, ermB,
ermC, vgaA, vgaC and dfrK genes was studied by PCR.
Results: Four nasal swabs out of 160 (2.5%) were MRSA-positive. The
isolates were obtained from animals of the same farm at slaughterhouse.
The strains were CC398, spa type t011 and SCCmec V. None of the
MRSA isolates carried the PVL genes. Analysis obtained by PFGE
revealed that two isolates had similar proﬁles, while the other two
clustered differently. Susceptibility testing revealed resistance to
tetracycline in all MRSA isolates, attributed to tetK and tetM genes.
All tested isolates were resistant to erythromycin and clindamycin
owing to the presence of ermB gene. One MRSA strain was resistant to
trimethoprim/sulfamethoxazole and carried the dfrK resistance gene. All
isolates were susceptible to ﬂuoroquinolones, mupirocin, fosfomycin,
fusidic acid, rifampicin, chloramphenicol, gentamicin, netilmicin,
linezolid, nitrofurantoin, teicoplanin and vancomycin.
Conclusions: This study is the ﬁrst report on the prevalence and
characteristics of livestock-associated MRSA isolated in pigs in
Lithuania. Since the MRSA strains were isolated just before
slaughtering, pigs can potentially be reservoirs of bacteria that may
enter the food chain. Furthermore, MRSA ST398 shows low host
speciﬁcity and can colonize various animal hosts as well as humans,
which raises the question of potential interspecies and zoonotic
transmission.
R2540 Clinical outcome of patients with methicillin-resistant
Staphylococcus aureus bacteraemia, 2004–2008
T. Crawford, L. Danziger*, K. Rodvold, B. Booth,
W.M. Janda (Chicago, US)
Objective: Objective of this study was to compare clinical outcomes of
patients diagnosed with methicillin-resistant Staphylococcus aureus
(MRSA) bacteremia that received vancomycin from 2004 to 2008.
Methods: Single-center retrospective chart review of 93 patients
diagnosed with MRSA bacteremia from 2004 to 2008 was conducted.
Hospitalized patients were included if they had two positive MRSA
blood cultures collected within 24 hours of each other and received
intravenous vancomycin within 48 hours of drawing blood cultures.
Subsequent infections were not included in the analysis. Treatment
failure was deﬁned as one of the following: addition of an antimicrobial
for treatment of MRSA bacteremia, change in antimicrobial therapy,
recurrence of MRSA bacteremia within 60 days of discontinuation of
vancomycin, discontinuation of vancomycin £10 days due to adverse
effect, or MRSA isolates obtained (10 days after initiation of
vancomycin but before completion of therapy. Logistic regression
was used to identify association of treatment failure and 30-day
mortality between study years. ANOVA test was utilized to identify
statistical difference of vancomycin dose and mean vancomycin
concentration between study years.
Results: Number of patients with MRSA bacteremia was similar during
the study period (2004: n = 15, 2005: n = 20, 2006: n = 17, 2007:
n = 21, 2008: n = 20). Majority of patients included were male (59.1%),
African American (54.8%), and immunocompromised (67.7%). The
median age was 53 years old. Of 22.6% of patients were admitted to an
intensive care unit at the time of infection. There was no difference in
mean dose (mg/kg) between each study year (2004: 15.2, 2005: 13.3,
2006: 13.4, 2007: 16.1, 2008: 13.5; p = 0.25). There was no signiﬁcant
change in mean concentration (mg/L) of vancomycin among study years
(2004: 11.8, 2005: 12.7, 2006: 17.2, 2007: 14.6, 2008: 18.1; p = 0.10).
Incidence of 30-day mortality was not signiﬁcantly different by study
year (2004:n = 2, 2005:n = 2, 2006:n = 0, 2007:n = 1, 2008:n = 4;
OR=1.13, 95% CI: 0.71–1.78). Incidence of treatment failure was not
associated with study year (2004:n = 4, 2005:n = 5, 2006:n = 0,
2007:n = 2, 2008:n = 5; OR = 0.893, 95% CI: 0.61–1.32).
Conclusion: Over a ﬁve year period, there was no change in the
incidence of MRSA bacteremia. The dose of vancomycin and
vancomycin concentration were similar during the study period.
There was no difference in 30-day mortality and treatment failure
from 2004 to 2008.
R2541 Microbiological and molecular characterisation of human
clinical isolates of methicillin-resistant Staphylococcus
hominis: evidence of new SCCmec
S. Mendoza*, R. Morﬁn-Otero, G. Gonza´lez, E. Rodrı´guez-Noriega,
J. Llaca-Dı´az, E. Garza-Gonza´lez (Monterrey, Guadalajara, MX)
Objectives: To characterise bioﬁlm formation, antibiotic resistance,
SCCmec type and genetic relatedness in Staphylococcus hominis
clinical isolates.
Methods: Fifteen clinically relevant isolates of S. hominis were
included. Bioﬁlm formation was evaluated using crystal violet
staining. Drug susceptibility was determined by the broth
microdilution method. Methicillin resistance was evaluated with the
cefoxitin disk test and mecA gene was detected by PCR. Genetic
relatedness was determined by pulsed-ﬁeld gel electrophoresis (PFGE)
and SCCmec was typed by multiplex PCR using two different
methodologies described for Staphylococcus aureus.
Results: Of 20% (3/15) S. hominis isolates were categorised as strong
producers of bioﬁlm and 33.3% (5/15) as weak producers. All isolates
showed high resistance to ampicillin, erythromycin and trimethoprim
(>72%). Among all isolates, 80% (12/15) were methicillin resistant and
mecA positive. PFGE analysis revealed 15 different proﬁles with
homologies that ranged from 0% to 95%.
SCCmec type III was detected in one isolate with the structure of
cassette assumed as described for S. aureus. Furthermore, two isolates
ampliﬁed SCCmec type III, mec complex A, ccrAB1; two isolates
typed SCCmec III, mec complex A, ccrC1; and three isolates typed
SCCmec III, mec complex A, ccrAB1 + ccrC1; one isolate typed
SCCmec III, mec complex B, ccrC1.
Conclusions: The S. hominis isolates analysed in this study showed
moderate production of bioﬁlm, a high methicillin resistance, resistance
to other antimicrobials, and low clonality. The results of this study
suggest that S. hominis harbors new SCCmec structural elements that
might be a reservoir of ccrAB1, ccrC1, and mec complex A for the
assembly of the SCCmec types.
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R2542 Genetic lineages, resistance and virulence factors of
Staphylococcus aureus isolates from nasal samples of
healthy companion animals in Tunisia
H. Gharsa, R. Ben Sallem, K. Ben Slama, C. Lozano, E. Go´mez-Sanz,
N. Klibi, P. Go´mez, M. Zarazaga, L. Messadi, A. Boudabous,
C. Torres* (Tunis, TN; Logron˜o, ES; Sidi Thabet, TN)
Objective: To study the carriage rate, resistance mechanisms,
virulence traits and genetic lineages of nasal S. aureus of healthy
companion animals in Tunisia.
Methods: Nasal swabs of healthy animals (100 dogs and 30 cats) were
obtained in National School of Veterinary Medicine and several
veterinary clinics that receive animals from all Tunisia (2010–2011).
Samples were inoculated into Baird Parker and ORSAB plates for S.
aureus and methicillin-resistant S. aureus (MRSA) recovery,
respectively. Isolates were identiﬁed by biochemical methods and
nuc-gene PCR. Antibiotic susceptibility proﬁle to 18 antibiotics was
determined by disk diffusion method. The presence of nine resistance
genes (tetL, tetM, tetK, blaZ, ermA, ermB, ermC, msrA and ant(6)-Ia),
18 staphylococcal enterotoxin genes and lukF/lukS-PV (encoding
Panton-Valentine leucocidin, PVL), lukE-lukD, lukM, eta, etb and tsst1
genes were studied by PCR. S. aureus isolates were typed (spa, agr,
MLST and SmaI-PFGE).
Results: Six S. aureus were detected (one/sample) from the 130 tested
samples (4.6%), representing 4% in dogs and 6.6% in cats. All S. aureus
were methicillin-susceptible (MSSA). Four different spa-types (t189,
t279, t582 and t701) and four sequence-types (ST6 [CC6], ST15 [CC15]
and ST188 [CC22], including a new sequence-type named ST2121
[CC30]) were identiﬁed among our MSSA isolates. They were ascribed
to agr type I (4 isolates), II (1) and III (1). MSSA isolates showed
susceptibility to the tested antibiotics with the following exceptions (%
of resistance, resistance gene): penicillin (100%, blaZ), tetracycline
(16.6%, tetM), erythromycin (16.6%, ermA), streptomycin (16.6%,
ant(6)-Ia) and ciproﬂoxacin (16.6%). Virulence genes carried by MSSA
were (number of isolates): lukF/lukS-PV (2, from cats), hla (6), hld (6),
hlb (4), lukED (5), sea (3), ser (3), sei (2), see (2), ser (1), hlg (1), hlgv(1)
and a variant of egc-cluster-like [sen-sem-sei-seu-seg] (1, from dog).
The remaining virulence genes tested were negative among our isolates.
Conclusions: The nares of healthy companion animals could be a
reservoir of PVL-positive community-associated-MSSA with
implications in public health.
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R2543 Characterisation of carbapenem-resistant Acinetobacter
baumannii clinical isolates in a tertiary care hospital in
Saudi Arabia
B. Abdalhamid*, A. Itbaileh, H. Hassan (Dammam, SA)
Background: Acinetobacter baumannii is an opportunistic gram
negative organism causing a variety of healthcare-associated
infections. Carbapenems have been used widely to treat the emerging
multi-resistant A. baumannii. However, carbapenem-resistant A.
baumannii (CRAB) has been documented worldwide. The aim of this
study was to molecularly characterize CRAB clinical isolates in a
tertiary care hospital in Saudi Arabia.
Methods: A. baumannii isolates were obtained from August 2010 to
September 2011 in the hospital. The vitek 2 system was used to detect
A. baumannii isolates and their susceptibility to carbapenem. In
addition, E-test method was used to detect the isolate susceptibility to
carbapenem. The multiplex PCR was performed for the detection of
bla(OXA-23), bla(OXA-24), bla(OXA-51), bla(OXA-58), bla(IMP),
and bla(VIM).
Results: A total of 132 A. baumannii strains were detected and
characterized with 90 (68%) of them were CRAB isolates. In addition
to carbapenem resistance, all strains were resistant to ciproﬂoxacin and
105 (79.5%) strains were resistant to aminoglycosides. All strains were
susceptible to colistin and 92 (69.7%) strains were susceptible to
tigecycline. All CRAB isolates studied were positive for bla(OXA-51)
which was used as a marker for A. baumannii detection. In addition,
bla(OXA-23) was detected in 105 (79.5%) strains. No bla(IMP) neither
bla(VIM) was detected in any strain.
Conclusions: To our knowledge, this is the ﬁrst comprehensive
molecular study characterizing carbapenem resistance in A.
baumannii in the Eastern Province of Saudi Arabia. Bla(OXA-23) is
the most common gene associated with CRAB in this region.
R2544 Prevalence and antimicrobial susceptibility of extended-
spectrum beta-lactamase-producing Escherichia coli and
Klebsiella pneumoniae in a tertiary care hospital
S. Aljohani*, M. Younan, H. Balkhy (Riyadh, SA)
Background: The prevalence of extended-spectrum b-lactamases
(ESBLs) varies between countries and institutions. We studied the
prevalence of ESBL among clinical isolates of Escherichia coli and
Klebsiella pneumoniae and analyzed patterns of susceptibilities to
different antimicrobial agents at King AbdulAziz Medical City in
Riyadh, Saudi Arabia between July 2007 and July 2011
Methods: Between July 2007 and October 2011; a total of 20268
clinical isolates of E. coli and 9126 K. pneumoniae were screened and
conﬁrmed for ESBL production by MicroScan walkaway 960 system.
All isolates were from inpatients and outpatients who attended King
AbdulAziz Medical City. The samples collected from all age groups.
The minimum inhibitory concentration to imipenem, meropenem,
piperacillin-tazobactam, cefepime, ciproﬂoxacin, gentamicin and
amikacin were determined by the MicroScan MIC panels.
Results: Of the 20268 isolates of E. coli and 9126 of K. pneumoniae
tested, there were –18.3% and 19.9% produced ESBL respectively. The
majority of these isolates were from urine (57.5%) and wounds (17%).
Only 7% of the blood culture isolates were ESBL-producing. Overall,
carbapenems (imipenem and meropenem) had good activity against the
ESBL-producing isolates tested (99% of E. coli isolates and over 92%
K. pneumoniae of were susceptible). There was no difference in the
activity of imipenem and meropenem against the ESBL-producing E.
coli or K. pneumoniae. Over 86% and 68% of E. coli and K.
pneumoniae respectively were susceptible to piperacillin-tazobactam.
Susceptibilities of the isolates to amikacin varied, ranging from 95% for
E. coli to 75% for K. pneumoniae. Gentamicin, ciproﬂoxacin and
cefepime were active against 73%, 67% and 60% of the isolates,
respectively.
Over the past 5 years the epidemiology of ESBL are start to change
gradually and more ESBL producing isolates appear among E. coli over
K. pneumoniae. ESBL (Table 1)
Conclusion: We conclude that there is increasing incidence of
infection with ESBL-producing bacteria, and the high rates of
antimicrobial resistance encountered among them. Clinicians should
be familiar with the clinical importance of these enzymes and potential
strategies for dealing with them.
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R2545 Emergence of carbapenem-resistant Klebsiella
pneumoniae infection among patients hospitalised in
intensive care unit of a Warsaw infectious diseases
hospital
A. Bednarska*, E. Czekalska-Lachowicz, D. Lipowski,
A. Horban (Warsaw, PL)
Objective: The spread of multidrug-resistant Gram-negative pathogens
like carbapenemase producing Kl. pneumoniae is one of the major
hazards for patients requiring long-term hospitalization or
hospitalization in intensive care units (ICU).
Methods: Of the 12 patients hospitalized in ICU of Warsaw Infectious
Diseases Hospital from June 2009 to April, 2010, infected with Kl.
pneumoniae epidemic strain that coproduced carbapenemases were
included in the study. Identiﬁcation of isolated bacteria and MIC
determination were performed using an automated system (Vitec 2
Compact, BioMe´rieux) or standard microbiological plates. Results were
interpreted according to Clinical Laboratory Standards Institute. Clinical
data were retrospectively collected from medical documentation.
Results: The infection with KPCs producing Kl. pneumoniae was
detected in 12 out of 107 (11%) studied patients. Seven of them (7/12)
were severely immunocompromised (lymphoma in one case, HIV
infection in two cases, chronic immunosuppressive treatment in four
cases) comparing with 19/95 patients without KPC + Kl. pneumoniae
infecton (p < 0.05). KPCs producing strains were detected in urine
obtained from seven patients, in bronchial ﬂuid obtained from three
patients and in blood of four patients. The ﬁrst biological material from
which the pathogen was cultured appeared urine in seven cases,
bronchial ﬂuid in three cases and blood in two cases. In two patients
with KPCs producing Kl. pneumoniae present in blood, urinary tract
could be assumed as the source of invasive infection. In one of this
patients the infection was fatal. In one patient emergence of resistance
to tigecyline following treatment with this antibiotic was observed.
Conclusions: Immunocompromised patients can be more likely to
inquire infection with carbapenems resistant Kl. pneumoniae. Urinary
tract seems to be the most frequent site of KPCs Kl. pneumoniae
infection and can be the source of invasive infection.
R2546 Molecular detection and antibacterial susceptibility of
enteropathogenic Escherichia coli and shigatoxigenic
Escherichia coli strains isolated from healthy and
diarrhoeic dogs
T. Zahraei Salehi*, M. Askari Badouei, I. Mehdizadeh Gohari,
O. Madadgar (Tehran, Garmsar, IR)
Animal contacts have been regarded as an emerging rout of Shiga toxin-
producing Escherichia coli (STEC) infection in humans. Diarrhoeic and
asymptomatic dogs have been recognised as a reservoir of atypical
enteropathogenic Escherichia coli (EPEC), and STEC in some
investigations. In this study E. coli isolates from 100 faecal samples
of healthy (n = 50) and diarrhoeic (n = 50) dogs were screened by
polymerase chain reaction (PCR) for the presence of determining
virulence genes of STEC and EPEC pathotypes including stx and eaeA.
The conﬁrmed virulence-positive strains were subjected to antimicro-
bial susceptibility testing against 12 antibacterial using disc diffusion
method. Resistance proﬁles were also determined for the STEC and
EPEC strains. Ten isolates from 10 dogs (10%) were shown to possess at
least one of the tested virulence genes. Six of these isolates (6%)
harboured only the eaeA gene and were considered as EPEC. Four
isolates (4%) were stx+ and regarded as STEC, of which two were stx+/
eae+. The resistance was specially observed against penicillin, ampicil-
lin, sulfomethoxazole, streptomycin and oxytetracyclin. Altogether, nine
resistance proﬁles were observed among 10 isolates. In conclusion, dogs
can act as a reservoir for EPEC and STEC strains, and close contacts of
children with companion animals can be a potential risk factor in
development of diarrhoea and haemolytic uremic syndrome. In rural
areas shepherd dogs can also be a transient carrier of STEC strains that
they may acquire from ruminants. To our knowledge this is the ﬁrst study
which reports the faecal shedding of STEC and EPEC from dogs in Iran.
R2547 Multidrug-resistant Acinetobacter baumannii carrying the
carbapenemase NDM-1 encoding gene introduced into the
Czech Republic
L. Krizova*, R.A. Bonnin, L. Poirel, P. Nordmann, A. Nemec (Prague,
CZ; Paris, FR)
Objective: Carbapenem-hydrolysing ß-lactamases have emerged as the
most clinically signiﬁcant mechanism responsible for carbapenem
resistance in Acinetobacter baumannii. The aim of this study was to
assess the mechanism of high-level carbapenem resistance in an A.
baumannii isolate imported to a Czech hospital.
Methods: Strain ANC 4097, which had been imported from Egypt,
was recovered from the sputum of a patient hospitalized in the Czech
Republic in July 2011. Antimicrobial susceptibility was determined by
disc diffusion while the production of metallo-ß-lactamases was
assessed using Etest MBL strips. Resistance genes were characterized
by PCR and sequencing. The location and genetic background of
blaNDM-1 were analyzed by hybridization of genomic DNA with a
blaNDM-like probe and primer walking strategy. The strain was
genotyped by multilocus sequence typing (MLST).
Results: ANC 4097 belonged to sequence type (ST) 1 which is typical
of the ‘‘European clone I’’ epidemic lineage. It showed high level
resistance to all ß-lactams and other antimicrobial agents except
colistin, tobramycin, netilmicin, doxycycline and tigecycline. The
positive MBL test suggested the production of a metallo-ß-lactamase.
The strain harboured the blaNDM-1, blaOXA-23 and intrinsic blaOXA-
51-like carbapenemase genes. Insertion sequence ISAba1 was identiﬁed
upstream of the blaOXA-23 and blaOXA-51-like genes. The blaNDM-
1 gene was located onto the chromosome of ANC 4097 and inside
composite transposon Tn125.
Conclusions: This study reports on the ﬁrst blaNDM-1 positive A.
baumannii strain in the Czech Republic. The high level of carbapenem
resistance in this strain is likely to result from the production of
chromosomally encoded NDM-1 and overproduction of OXA-23 and
OXA-51-like.
R2548 Multidrug-resistant Gram-negative rods in
ophthalmological patients
G. Broniek, M. Sybilska, M.M. Wroblewska* (Warsaw, PL)
Objectives: The aim of the study was to assess the frequency of
isolation of multidrug-resistant (MDR) pathogens from eye infections in
hospitalised ophthalmological patients.
Antimicrobial therapy of such infections poses a challenge as many
agents do not penetrate into the eye in sufﬁcient concentration to inhibit
bacterial growth.
Methods: Specimens for bacteriological culture were obtained from
patients hospitalized in ophthalmological hospital (2005–2010).
Samples were cultured and isolates identiﬁed according to standard
microbiological methods.
Results: In total 1988 specimens were cultured, including swabs from
conjunctiva, cornea, throat, nose, wounds and cornea conservation
medium. The samples yielded 377 isolates, comprising 343 strains of
bacteria and yeast-like fungi. Enteric rods comprised 11.31% (38/336)
of all strains, while non-fermenting rods – (24/336) (7.14%). Among
alarm pathogens there were extended-spectrum beta-lactamase
producing – ESBL(+) enteric rods – 5.26% (2/38), and ESBL(+)
Gram-negative nonfermenting rods – 16.67% (4/24). Among enteric
rods the most numerous were strains of S. marcescens and Klebsiella
spp. (27.5% each), E. cloacae and E. coli (12.5% each), M. morganii
(10.0%) and P. mirabilis and C. koserii (5.0% each). ESBL(+) strains
were S. marcescens (1) and E. cloacae (1). Among Gram-negative
nonfermenting rods predominated strains of P. aeruginosa – 57.69%,
followed by S. maltophilia – 15.38%, Acinetobacter spp. – 7.70%, A.
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faecalis – 7.69%, A. denitriﬁcans – 7.69% and S. paucimobilis – 3.85%.
Three out of four strains of S. maltophilia were ESBL(+).
Conclusion: In this study there was a high percentage (16.67%) of
ESBL(+) Gram-negative nonfermenting rods. Three out of four strains
of S. maltophilia were ESBL(+). Multidrug-resistant strains represented
opportunistic pathogens, belonging to the genus Stenotrophomonas,
Pseudomonas, Serratia and Enterobacter.
R2549 Bloodstream infections due to carbapenem-resistant
Klebsiella pneumoniae, Pseudomonas aeruginosa and
Acinetobacter baumannii clinical isolates in a tertiary
hospital: epidemiology and outcome
V. Papaioannou, A. Stylianakis*, S. Tsiplakou, E. Lamprianidou,
K. Kafantogia, K. Ntetsika, K. Tsopelas, K. Mouta (Athens, GR)
Objectives: Dissemination of carbapenemase-producing Gram-
negative bacteria is a major public health concern. The aim of this
study was to evaluate the epidemiology and outcome of infections
associated with carbapenem-resistant Klebsiella pneumoniae,
Pseudomonas aeruginosa and Acinetobacter baumannii isolates
derived from blood cultures in a tertiary hospital.
Methods: A total of 74 strains of K. pneumoniae, 38 of P. aeruginosa
and 72 of A. baumannii recovered from blood cultures were studied.
Isolates derived from 94 hospitalized patients (ICUs and surgical and
medical wards), during one year, from November 1, 2010 to October
31, 2011. All isolates had meropenem and/or imipenem MICs > 1 mg/
mL. The identiﬁcation and susceptibility testing were performed via the
Vitek II automated system (Biomerieux, France), and when necessary
susceptibility results were conﬁrmed with the use of E-test strips (AB
Biodisc, Sweden) according to CLSI guidelines. Metallo-beta -
lactamase (MBL) production was evaluated using disks containing
meropenem with and without EDTA and KPC-production with boronic
acid combined-disk tests, using disks containing meropenem with and
without boronic acid.
Results: The mean age of patients was 56.5 years, ranging from 18 to
95 years. The majority of them were male (65%). Most of the patients
(66%) were hospitalized at ICUs, while the rest were hospitalized
mostly at surgical departments. With reference to diagnosis at
admission, 37% were trauma patients, 8% had various infections, 7%
had subarachnoid hemorrhage, 5% had burns and the rest several other
conditions. The mortality rate was 52%. All isolates were multidrug
resistant. K. pneumoniae, P. aeruginosa and A. baumannii isolates
revealed 7%, 68% and 49% resistance to gentamicin, 5%, 100% and
39% resistance to tigecycline and 46%, 3% and 3% to colistin
respectively. All K. pneumoniae isolates were producing KPC and 95%
P. aeruginosa isolates were producing MBL.
Conclusion: It is crucial to monitor the emergence and prevalence of
carbapenem resistant Gram-negative bacteria depending not only on
susceptibility testing but on phenotypic detection of carbapenemase
production as well, especially in critically ill patients, because in
combination with other risk factors, it is associated with high
mortality.
R2550 Characterisation of outbreak CTX-M plasmid from
Enterobacteriaceae
I. Freire Martin*, M. AbuOun, M.J. Woodward, R.M. La
Ragione (Addlestone, UK)
Aims: The CTX-M family of b-lactamases confers resistance to most
beta-lactams and is often carried within large promiscuous plasmids.
These CTX-M plasmids are increasingly prevalent within animal and
human bacterial isolates. Our aim was to characterise the spread of
CTX-M plasmids amongst Enterobacteriaceae strains isolated from an
outbreak of cephalosporin resistant Salmonella in pigs. Furthermore, we
aimed to assess the phenotypic effect of plasmid carriage on the
outbreak strains.
Methods: Six E. coli, one Klebsiella and two Salmonella strains were
selected from a well characterised group of isolates. CTX-M plasmids
from these strains were extracted and transformed into NEB10B (E. coli
K12) and characterised by plasmid proﬁling, PCR based replicon typing
(PBRT), conjugation studies, antibiotic resistance proﬁling and
miniaturised DNA strip array (virulence and antimicrobial resistance
genes). To assess relatedness among the characterised plasmids
restriction analysis was also performed.
Results: The ﬁrst type of plasmid identiﬁed was conﬁned to two E. coli
strains, was approximately 50 kb and harboured CTX-M-14, but could
not be typed by PBRT. The second type of plasmid, present in all three
genera, was approximately 100 kb, harboured CTX-M-1. These
plasmids were typed by PBRT and found to belong to the IncI
plasmid group. A representative CTX-M-1 plasmid was selected for full
sequence analysis and found to encode additional resistance genes
(chloramphenicol and sulphonamide resistance) as well as genetic
addiction systems. All the plasmids studied were shown to readily
conjugate into other Enterobacteriaceae strains.
Conclusions: Most of the resistance to beta-lactams found in this study
was conferred by the spread of a plasmid encoding CTX-M-1. The
presence of additional antibiotic resistance genes in the plasmid may
indicate that co-selection played a role in its spread. Furthermore,
genetic addiction systems that prevent plasmid loss even in the absence
of selection may have also inﬂuenced its prevalence. The studies
reported here demonstrate that three related, but distinct genera of
Enterobacteriaceae harboured the same IncI CTX-M-1 plasmid. The
presence of a CTX-M gene in such promiscuous plasmids magniﬁes
the risk of widespread beta-lactam resistance. Future work will include
the construction of plasmid-less derivatives that will be compared to the
plasmid carrying strains using a number of phenotypic studies.
R2551 Intestinal Colonisation with multidrug-resistant
Enterobacteriaceae in travellers, immigrants and ‘visiting
friends and relatives’: dominance of E. coli producing
CTX-M enzymes
A. Valverde, M.C. Turrientes, F. Norman, J.A. Pe´rez Molina, T. Coque,
F. Baquero, R. Canto´n*, R. Lo´pez-Ve´lez (Madrid, ES)
Objective: To study the faecal carriage of ESBL and carbapenemases
producing Enterobacteriaceae among travellers, inmigrants and
‘‘visiting friends and relatives’’ (VFR) that include people who had
travelled to their country of origin to visit their friends and family.
Methods: Forty two faecal samples from 36 travellers, two inmigrants
and four VFR were studied (September–October 2011). One faecal
sample per individual was requested on return or arrival to our country.
Samples were seeded in selective media (MacConkey-ceftazidime and
MacConkey-cefotaxime, 2 mg/L). One isolate per morphotype was
selected for further studies. Positive isolates were conﬁrmed for ESBL
(double disk synergy test) and carbapenemase (Hodge test) production.
Bacterial identiﬁcation and susceptibility patterns were determined
using the MALDI-TOF MS (Bruker) and the semi-automated WIDER
system (Fco. Soria Melguizo). blaESBLs were characterized by PCR
and sequencing. Population structure was characterized by XbaI-PFGE
and phylogrouping. Presence of qnr genes was detected by PCR assay.
Results: Individuals enrolled in this study travelled to or from
countries of Africa (47.6%), Latin America (28.6%) and Asia
(23.8%). Of 28.6% (12/36) of them (11 travellers and one immigrant)
were faecal carriers of ESBL-producing Enterobacteriaceae. No fecal
carriage with carbapenemases producing organisms was detected. A
total of 17 isolates (16 E. coli and one K. pneumoniae) was further
studied. E. coli isolates belonged to phylogroups A0 (37.5%), A1
(25%), D1 (25%) and D2 (12.5%). Of 64.7% (11/17) of the ESBLs
were CTX-M-types and 81.8% (9/11) of them belonged to the CTX-M-
1 cluster, most of them being CTX-M-15 (66.6%). Presence of qnr
genes was not detected. High resistance rates to different antimicrobials
were detected: 94.1% to ciproﬂoxacin; 88.2% to cotrimoxazol and
82.3% of the isolates were resistant to one or more aminoglycosides.
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Conclusions: Individuals with contact with foreign countries had high
rates of intestinal colonization by Enterobacteriaceae producing CTX-
M-types, especially those of the CTX-M-1 cluster. Our study points out
the importance of ecological surveillance studies of faecal carriers of
multi-drug resistance organisms to establish epidemiological measures
that would allow controlling the dissemination of these organisms.
R2552 Detection of blaIMP-22 in a Klebsiella pneumoniae clinical
isolate in an acute care hospital in Portugal
D. Gonçalves*, F. Branca, C. Igle´sias, A. Faustino, F. Mota-Garcia,
A. Estrada, H. Ferreira (Porto, Braga, PT)
Objectives: Carbapenem resistance in Enterobacteriaceae is one of the
actual major therapeutic concerns. Routine procedures of the hospital
clinical microbiology laboratory, alerted for the need of extensive study
of some Enterobacteriaceae isolates in order to better understand the
resistance proﬁle, namely in isolates that showed reduced susceptibility
or resistance to, at least, one type of carbapenem. With that purpose,
isolates were selected for genotypic approach by PCR and sequencing.
Methods: In a set of 13 Enterobacteriaceae showing reduced
susceptibility to carbapenems, collected since September 2010 till
September 2011, a Klebsiella pneumoniae blood culture isolate,
showed resistance to oxiimino-beta-lactams, resistance to meropenem,
reduced susceptibility to ertapenem, and susceptibility to imipenem,
with MICs of 16, 4 and 2 lg/mL respectively, and susceptibility to
aminoglycosides and ﬂuoroquinolones. Identiﬁcation and susceptibility
testing were performed by Vitek2 (bioMe´rieux) and WalkAway
(Dadebehring) systems. Total DNA of this Klebsiella pneumoniae,
was subjected to ampliﬁcation by multiplex PCR using primers for
blaVIM, blaIMP and blaKPC and sequencing of the ampliﬁed fragment,
using ABI-PRISM 3100 automatic genetic analyzer, showing the
presence of blaIMP-22.
Results: In this study, we detected blaIMP-22, in a clinical isolate of
Klebsiella pneumoniae. According to the CLSI guidelines, extended-
spectrum b-lactamases production was not detected. Metalo-b-
lactamases detection, by Etest MIC determination for imipenem and
imipenem plus EDTA, was negative, highlighting the need of adequate
phenotypic detection of this particular resistance threats. Genotypic
determination of this resistance mechanism, seems useful in these
situations of Imipenem susceptibility, masking carbapenemase
production. This is an important issue to interpret hospital resistance
epidemiology and to guide infection control procedures, to avoid
outbreak installation.
Conclusions: As far as it seems, this is the ﬁrst report of blaIMP-22 in
a Klebsiella pneumoniae clinical isolate. The acquired metallo-b-
lactamases represent a signiﬁcant clinical threat due to their hydrolysis
spectrum and infection control challenge. These atypical
carbapenemase-producers may be overlooked in routine clinical
microbiology laboratory testing, emphasizing the importance to
survey and control the spread of such resistance determinants in
nosocomial pathogens.
R2553 Characterisation of antibiotic resistance determinants in
multidrug-resistant Moraxella osleonsis, an opportunisitic
human pathogen
L.M. Bishop*, M.T. Mafura, T. Hunt, A.P. Roberts,
M.F. Anjum (Weybridge, London, UK)
Objectives: To characterise the antimicrobial resistance determinants
present in Moraxella osloensis, isolated from human clinical trial
studies.
Methods: Four M. osloensis isolates from the skin of two participants,
one a placebo and one part of a clinical trial study undergoing
antimicrobial treatment of Minocycline (EU ANTIRESDEV Project)
were characterized using an antimicrobial resistance (AMR) gene
microarray chip (Clondiag TM GmbH). Phenotypic characterisations
were determined by antimicrobial disk diffusion assays and Phenotype
Micro (PM) arrays from Biolog.
Results: Three of the four M. osloensis isolates from the skin trunk of
human volunteers showed multiple resistance, both geno- and pheno-
typically to sulphonamide, beta- lactamase and tetracycline and
produced positive signals for antibiotic resistance genes sul2, sul3,
blaCMY, blaPER, blaOXA2 and tet37 with the microarray. The fourth
strain was sensitive to all antibiotics tested and did not produce any
positive signals with the AMR gene array. Biochemical characteristics
determined using the PM arrays showed differences between the AMR
resistance and sensitive strains.
Conclusion: Moraxella osloensis is an opportunistic human pathogen
known to cause diseases such as endocarditis, osteomyelitits, septic
arthritis, catheter infection and meningitis. At present all diseases have
been treatable and currently there is no record in the literature of M.
osloensis with multiple antibiotic resistances. The present discovery of
multiple drug resistance in isolates of human origin is worrying and
follows a growing trend of multiple resistances acquired in bacterial
pathogens.
R2554 Screening of antibiotic-resistant Gram-negative
organisms in hospital settings from Bucharest, Romania
M.C. Chiﬁriuc, I. Czobor, A.I. Cotar, L. Marutescu, M. Popa*,
O. Banu, E. Borcan, V. Lazar (Bucharest, RO)
The purpose of this study was to establish the main resistance
phenotypes and their genetic determinants in Gram-negative bacilli
(GNB) isolated from intensive care units (ICU).
Material and Methods: A number of 531 GNB strains (334
Enterobacteriaceae and 197 Pseudomonadaceae) were isolated from
1166 positive clinical samples collected from patients hospitalized
during 2011, in the ICUs of two big hospital from Buhcarest, Romania.
Their resistance phenotypes were established using: disk diffusion test,
double-disk diffusion test (DDST) with amoxicillin-clavulanic acid
(AMC), cefotaxime (CTX) and ceftazidime (CAZ), DDST with AMC
plus EDTA, imipenem (IPM) and IMP plus EDTA, Modiﬁed Hodge
Test (MHT) and E-test ESBL, MBL and AmpC. The genetic support of
the antibiotic resistance was investigated by simple and multiplex PCR
reactions for class A Ser- b-lactamases (PSE, CARB, TEM genes
families), class B – metallo-b-lactamases -MBL (IMP, VIM, SPM gene
families), class C – AmpC and ESBL, as well as ciproﬂoxacin resistance
genes (gyrA, parC) as well as the presence of mexB, mexD, mexF and
mexY genes, encoding for multi-drug efﬂux pumps. In accordance with
the recommended deﬁnitions of the degree of multidrug resistance, 32%
of the GNB exhibited a multi-drug resistance (MDR) phenotype
(Escherichia sp., Klebsiella sp., Serratia sp., Acinetobacter sp.,
Pseudomonas sp.), 13.2% were extended-drug resistant (XDR)
(Klebsiella sp., Acinetobacter sp.) and 5.6% pan-drug resistant (PDR)
(Enterobacter sp. and Klebsiella sp.). The gyrA gene, as well as the
mexB, mexD, mexF si mexY genes, encoding for the efﬂux pumps
mexAB-oprM, mexEF-oprN10 si mexCD-oprJ were detected in
ciproﬂoxacin resistant strains and also correlated with the phenotypic
resistance to aminoglycosides and carbapenems. The ESBL phenotype
was correlated with the presence of blaSHV, blaTEM and blaPSE
genes, while the MBL phenotype with the presence of blaVIM gene.
Conclusion: The increasing resistance in GNR provides an important
signal that we need to improve our understanding of the genetic and
biochemical basis of resistance mechanisms in the bacterial strains
circulating in our geographical area, by using phenotypic and resistance
genotyping tools.
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R2555 Clinical impact and cost analysis of multidrug-resistant
nosocomial Acinetobacter baumannii bacteraemia: a case-
control study
T. Aslan Gulen, R. Guner, G.R. Yilmaz*, S. Keske,
M.A. Tasyaran (Ankara, TR)
Objectives: Acinetobacter baumannii is an important nosocomial
pathogen that causes high mortality, morbidity and medical cost
because of its increasing resistance to antimicrobial agents. The aim of
this study was to investigate clinical impact and cost analysis of
multidrug resistant nosocomial A. Baumanni bacteremia.
Methods: A case-control study was carried out in the intensive care
unit of the Atatu¨rk Education and Research Hospital of Ankara, Turkey,
from January 2007 through December 2010. Risk factors associated
with multidrug resistance (MDR) and mortality and cost analysis were
evaluated in patients with A. baumannii bacteremia. We selected
patients who had bacteremia caused by the other gram-negative
microorganisms during the study period as control group.
Results: Of the 86 patients were included in the study. Forty-one
patients were in the case group, and 45 patients were in the control
group. In the univariate analysis we found that arterial line (p = 0.01),
higher SAPS II score (p = 0.02), lower albumin level (p = 0.02), the
previous use of carbapenem (p < 0.001), quinolone (p = 0.04),
glycopeptide (p = 0.02), aminoglycosid (p = 0.001), and
metronidazole (p = 0.01) were risk factors for MDR A. baumannii
bacteremia. In the multivariate analysis it was found that previous use
of carbapenem (p < 0.001, OR: 11.9, 95% CI: 3.3–43.3), quinolone
(p < 0.02, OR: 6.7, 95% CI: 1.3–34.4) and metronidazole (p = 0.007,
OR: 31.8, 95% CI: 2.6–391.2, and high SAPS II score (p = 0.01, OR:
1.1, 95% CI: 1.0–1.1) were independent risk factors. The length of time
spent at hospital, hospitalization costs and expense of antimicrobial
therapy were not found statistically different between the two groups
(case and control). There was no statistical signiﬁcance in 14-day
mortality, 28-day mortality or infection related mortality between the
two groups in multivariate analysis, immunosuppression (p = 0.027,
OR: 4.7, 95% CI: 1.2–18.4) and high SAPS II score (p < 0.001, OR:
1.1, 95% CI: 1.0–1.2) were independently associated with mortality in
the case group.
Conclusion: The rationale use of the antibiotics is particularly
important to prevent bacteremia caused by MDR A. baumannii.
R2556 Carbapenem resistant Klebsiella pneumoniae at the Lagos
University teaching hospital, Lagos, Nigeria
P. Oshun*, F. Ogunsola (Lagos, NG)
Objective: Carbapenem use is still low in Nigeria because they are
expensive, not readily available and are reserved for life threatening
gram negative infections. While carbapenem resistant Klebsiella
pneumoniae is increasingly reported worldwide, there is limited data
from Africa. The Lagos University Teaching hospital is a 761 bed
referral hospital with an inpatient population of about 11 000 annually.
Klebsiella pneumoniae has been identiﬁed as a major health care
associated pathogen with reports of increasing resistance to various
antibiotics. This study was undertaken to identify the risk factors for
infection with carbapenem resistant K. pneumoniae (CRKP).
Methods: The study was conducted over a 6 month period and all in-
patients with microbiological conﬁrmation of carbapenem resistant
Klebsiella pneumoniae infection were recruited as cases. Controls were
in-patients with carbapenem susceptible Klebsiella pneumoniae
infections. Carbapenem resistance was determined using disc
diffusion tests and carbapenemase production was conﬁrmed using
the modiﬁed Hodge test. Patient data as well as data on antibiotic use
and hospital stay were collected using a simple questionnaire. Bivariate
and multivariate analyses were carried out to determine the association
between potential risk factors and carbapenem resistance.
Results: Klebsiella pneumoniae was isolated from 153 in-patients of
which eight were carbapenem resistant. Bivariate analysis showed that
the use of three or more antibiotics (p = 0.03) and previous hospital
admission (p = 0.05) were associated with CRKP infections. The use of
three or more antibiotics (odds ratio [OR], 9.0 95% conﬁdence interval
[CI], 1.12–90.25) was an independent risk factor for the development of
CRKP infections using multivariate analysis. Only four out of the eight
CRKP isolates could be identiﬁed by the modiﬁed Hodge test (MHT) as
carbapenemase producers. Resistance rates to other commonly used
antibiotics were > 50% except for amikacin to which resistance rate was
25%.
Conclusion: Infections with CRKP are an emerging clinical threat and
these ﬁndings highlight the need to institute antibiotic stewardship to
promote rational antibiotic use as well as good infection control
programmes to limit their transmission within the hospital.
Antibiotic usage
R2557 Drug-speciﬁc indicators assessing outpatient antibiotic
use: a cross-sectional study of French general
practitioners
C. Pulcini*, C. Lions, B. Ventelou, P. Verger (Nice, Marseille, FR)
Objectives: Quality indicators assessing the use of antibiotics among
General Practitioners (GPs) would be useful to target antibiotic
stewardship interventions. We wanted to: (i) adapt at an individual
physician level a set of 12 drug-speciﬁc quality indicators of outpatient
antibiotic use developed at the European level to compare data between
countries; (ii) describe the differences in antibiotic prescriptions
between GPs in South-Eastern France; and (iii) study the factors
associated with total antibiotic prescriptions at the GP level.
Methods: We performed a cross-sectional study analysing antibiotic
prescriptions made by GPs in adults in South-Eastern France in 2009,
using data from the outpatient reimbursement database of the General
Health Insurance Fund.
Results: The 4971 included GPs practicing in South-Eastern France
prescribed 19.1 million DDD of antibiotics to 997 437 adult patients in
2009. The 12 indicators showed wide variations of antibiotic
prescriptions between GPs. The factors associated with total antibiotic
use in multivariate analysis were: (i) GP’s age; (ii) proportion of
patients (70 yo, of patients exempt from copayments and of patients
covered by the public supplementary health insurance program, total
annual patient encounters and total pharmaceutical expenses; and (iii)
other drug-speciﬁc indicators assessing prescribing of penicillins’
combinations and of ﬂuoroquinolones, and seasonal variation of
quinolone prescriptions. A high amount of pharmaceutical expenses
was one of the factors that inﬂuenced the most the quantity of
antibiotics prescribed.
Conclusion: A set of 12 indicators could be calculated using
reimbursement data to describe outpatient antibiotic use at the
individual level. The observed heterogeneity in antibiotic
prescriptions among French GPs could justify feeding back their
results to each GP to try to change their prescribing behaviour.
R2558 Design of a set of quality indicators evaluating general
practitioner’s antibiotic use: a cross-sectional study
C. Pulcini*, C. Lions, B. Ventelou, P. Verger (Nice, Marseille, FR)
Objectives: Our objective was to design quality indicators of
outpatient antibiotic use that could be calculated at the individual GP
level using reimbursement data only and to describe the differences in
antibiotic prescriptions between GPs regarding these indicators in
South-Eastern France.
Methods: Based on a literature review, we designed a set of quality
indicators, assessing the quality of antibiotic prescriptions. We
performed a cross-sectional study of antibiotic prescriptions in adults
in South-Eastern France in 2009, using data from the outpatient
reimbursement database of the General Health Insurance Fund. We
carried out a cluster analysis to group GPs according to their antibiotic
prescribing behaviour.
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Results: The 4971 included GPs practicing in South-Eastern France
prescribed 19.1 million DDD of antibiotics to 997 437 adult patients in
2009. Seven quality indicators were calculated at the GP level despite
the lack of diagnosis reported in the information system. We noted wide
variations in practice regarding all these indicators. High
pharmaceutical expenses, high quinolone use and high seasonal
variation of quinolone use were associated with antibiotic misuse in
the cluster analysis.
Conclusion: The observed heterogeneity in antibiotic use among
French GPs could justify feeding back their results to each GP to try to
change their prescribing practices.
R2559 General practitioner’s habits on antibiotic prescriptions,
do they follow the recommendations?
S. Labrousse-El Alaoui, E. Denes* (Limoges, FR)
Objectives: In France, general practitioners (GP) deliver about 80% of
all the antibiotic prescriptions. However, due to the amount of
knowledge needed in such a speciality, the physician could not be up
to date even with continuous medical education and the publication of
several guidelines. We wanted with this study to make a snapshot of
GP’s habits concerning the prescription of antibiotics.
Methods: We performed a prospective study from December 2010
through March 2011. Rather than a poll, the point of call was the
prescriptions that we retrieved from pharmacies. When antibiotics were
prescribed, we called on the phone or interviewed directly, as soon as
possible, the GP to ask him the reason of the prescription. Several data
about the patient, the suspected infection and the GP’s activity were
collected.
Results: Our study included 100 prescriptions done by 22 GPs. A
majority of GP were more than 50 years old and the mean delay of
practice was 23 years. All the GPs said that they are aware of the
guidelines and of their content. They also are conﬁdent when they
prescribe antibiotics. Infections were as follow: ENT: 42%, lower
respiratory tract: 31%, UTI: 16% and skin structure: 11%. The
comparison with the French guidelines for these kinds of infection, and
taking into account the molecule, the dosage and the length of treatment
led to the following rate of adequacy: 36.6% for skin infections, 56.2%
for UTI, 6.4% for lower respiratory tract and 28.5% for ENT infections.
One of the major mistake was a lower dosage compared to the one
proposed particularly for skin and respiratory tract infections (in up to
80%). Another discrepancy was a lower length of treatment mainly in
ENT (85%) and respiratory tract infections (61%). There was also a
lack of knowledge of bacteria usually in cause of the suspected disease.
This is of importance mostly in empirical prescription, which is the case
for GPs. Another practice, which is not recommended, is the use of
corticosteroids in association with antibiotics mainly in lung infections
(51%).
Conclusion: Even if GPs tell that they know the recommendations and
follow them, it seems that they do not widely stick to them. Among the
wrong uses, there are still a lot of viral infections that are treated with
antibiotics. There are still a lot of things to propose to increase the
knowledge of antibiotherapy to preserve its efﬁcacy and to limit the
emergence of resistant bacteria, due to inappropriate treatments.
R2560 Clostridium difﬁcile associated diarrhea in cancer patients
as a result of antibiotic and/or cytostatic therapy
I. Klyuchnikova, N. Dmitrieva*, I. Petukhova,
Z. Grigoryevskaya (Moscow, RU)
Objective: To analyse the isolation rate of toxigenic strains of
Clostridium difﬁcile, causing diarrhea and/or Clostridium difﬁcile
associated diarrhea (CDAD) in cancer patients treated with cytostatics
and/or antimicrobials.
Materials and Methods: From September 2007 till October 2011, 205
patients with grade I-III diarrhea were examined to detect toxins A and
B of C. difﬁcile with an analyzer ‘‘MiniVidas’’.
Results: In 24 (11.7%) of 205 patients (female – 67%, male – 33%,
mean age – 45 years [14–73 years]), toxins A and B were positive.
According to NCI CTC criteria 14 (58%) patients had grade I diarrhea, 5
(21%) patients – grade II and 5 (21%) patients – grade III diarrhea.
Diarrhea was acute in all cases. Mild form of CDAD was observed in 18
(75%) patients, moderate form – in 5 (21%) patients and severe form in
1 (4%) patient. Moderate/severe cases were accompanied by fever and/
or leukocytosis >9000/lL and/or abdominal pains. Three patients
received only cytostatic therapy and 21 patients – antibiotic therapy with
or without cytostatics. Antimicrobials contributing to CDAD
development were: cefepime (17%), cefoperazone/sulbactam (13%),
imipenem (11%), metronidazole (10%), moxiﬂoxacin (8%), ceftazidime
(6%), levoﬂoxacin (6%), meropenem (5%), amikacin (5%),
sulfamethoxazole/trimethoprim (5%), ceftriaxone (3%), ciproﬂoxacin
(3%), doxycycline (3%), linezolid (3%), piperacillin/tazobactam (2%).
Thus, cephalosporins accounted for 39% of diarheas, ﬂuoroquinolones –
17%, carbapenems -16%, other – 28%. Some of them were administered
in combinations. Total of 20 patients received chemotherapy with
etoposide, doxorubicin, cyclophosphamide, cisplatin, cytosine
arabinoside, 5-ﬂuorouracil, paclitaxel, irinotecan, ifosfamide,
methotrexate, vincristine, rituximab prior to CDAD development.
Treatment of CDAD included vancomycin PO 1.5–2.0 g/day in 17
patients or metronidazole PO 1.5 g/day – seven patients. The duration of
treatment was 10 days. Clinical response and negative controls for fecal
toxins A and B of C. difﬁcile were seen in all cases. Further long-term
probiotic therapy was administered. No recurrences were seen.
Conclusion: CDAD due to antimicrobials and/or cytotoxics use was
revealed in 11.7% of hospitalized patients with diarrhea.
Cephalosporins caused CDAD most frequently. Oral treatment of
CDAD with vancomycin or metronidazole was equivalent and clinical
and microbiological effect was achieved in all patients.
R2561 An observation study of antimicrobial prescribing in
general paediatric patients at Birmingham Children’s
Hospital
J. Aston*, U. Nusgen, J.W. Gray, M. Patel (Birmingham, UK)
Objective: To identify changes that may be made to current paediatric
practice to optimise antibiotic prescribing.
Method: Fifty consecutive emergency General Paediatric admissions
during July and August 2011, from whom a blood culture was
requested, were followed daily by an antimicrobial pharmacist and/or
medical microbiologist, who did not intervene in patient management.
Antibacterial treatment, laboratory results and clinical observations
were reviewed retrospectively, and a consensus view on the
appropriateness of each patient’s antibacterial management was
determined.
Results: Twenty-eight (56%) patients were aged <12 months, 5 (10%)
aged 12–24 months, 7 (14%) aged 25–36 months and 10 (20%) aged
>36 months. The commonest indications for empiric therapy were
generalised sepsis (n = 25), respiratory tract infection (n = 9),
meningitis (n = 5) and urinary tract infection (n = 4). Twenty-nine
(58%) patients had a ﬁnal diagnosis of conﬁrmed/probable bacterial
infection. Eleven (22%) had a positive culture: six Escherichia coli
(urine), two Neisseria meningitidis (1 blood, 1 blood + CSF), one
Staphylococcus aureus (wound), one Group A streptococcus (sputum)
and one Bordetella pertussis (nasal). Hospital empiric antibiotic
prescribing guidelines were followed in all cases. However, treatment
was inappropriate in some way in 26/50 (52%) patients: treatment not
indicated (n = 1); treatment could have been discontinued within
48 hour on the basis of laboratory results (n = 13); treatment could
have been de-escalated based upon susceptibility testing (n = 8);
treatment duration inadequate (n = 4). In 15/50 (30%) patients the
instruction to await culture results prior to stopping antibiotics was
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documented. This includes 7/13 (54%) patients whose therapy could
potentially have been discontinued earlier. In 5/13 (38.5%) patients
whose therapy could have been discontinued earlier a repeat C-reactive
protein may have aided the decision to stop therapy.
Conclusions: Empirical broad spectrum antibiotics were appropriately
prescribed. However, opportunities for timely reappraisal of therapy
were frequently missed resulting in over-treatment. Measures such as
repeating CRP measurement after 18–24 hour and consideration of the
negative predictive value of negative blood cultures at 24–36 hour
could substantially reduce antibacterial usage in hospitalised children.
R2562 The probable impact of antibiotic use on nosocomial
Pseudomonas aeruginosa resistance
M.C. Sonmezer, G. Tuncer Ertem*, N. Tulek, F.S. Erdinc, C. Ataman
Hatipoglu, A. Adiloglu, A.P. Demiro¨z (Ankara, TR)
Objectives: Emergence of resistance in nosocomial bacteria is known
to be inﬂuenced by antimicrobial use. The aim of the study was to
evaluate the probable impact of previous antibiotic use on beta lactam
resistant Pseudomonas aeruginosa infections at intensive care units
(ICUs).
Methods: A retrospective case-control study was performed between
January 2008 and July 2011. Our hospital is a 670-bed tertiary-care
teaching hospital. The patients with nosocomial infection caused by P.
aeruginosa at three different ICUS (Neurology, Neurosurgery and
Anesthesia-Reanimation) were included to the study. The patients with
P. aeruginosa resistant to selected antibiotics were deﬁned as case
groups and the patients with P. aeruginosa sensitive to the related
antibiotic were deﬁned as control groups. The selection of the control
patients was constituted regardless of whether the isolate is sensitive to
other beta lactams or not. The case and control groups were made for
each of imipenem, meropenem, ceftazidime and piperacillin-
tazobactam. Previous antibiotic use was deﬁned as at least 48 hours
antibiotic usage in the period of 30 days before the isolation of P.
aeruginosa. The investigated antibiotics to be used were cefazolin,
vancomycin, teicoplanin, ciproﬂoxacin, amikacin and forementioned
beta lactams. Case and control groups were compared and univariate
and multivariate logistic regression analysis was carried out using SPSS
v.15.0 software.
Results: Total of 120 patients (30 at Neurology, 34 at Neurosurgery
and 56 at Anesthesia-Reanimation ICU) with P. aeruginosa infection
were evaluated. The mean age was 58.4 ± 19.2 years, 50.8% were
male. The results of univariate analysis of antibiotic use are shown in
Table. Multivariate analysis revealed previous cefazolin or meropenem
use was found as an independent risk factor for the development of
imipenem resistance (OR = 3.31, 95% CI = 1.20–9.14, p = 0.021;
OR = 4.60, 95% CI = 1.62–13.00, p = 0.004, respectively). Previous
meropenem use was found as an independent risk factor for the
development of meropenem resistance (OR = 8.04, 95% CI = 2.84–
22.74, p < 0.001).
Conclusion: Previous antibiotic use has a probable effect on
emergence of resistance in P. aeruginosa. In case of empirical
therapy of nosocomial pseudomonal infections, history of previous
antibiotic use should be taken into account.
R2563 Antibiotics: over-the-counter dispensing vs. prescriptions
A. Abasaeed*, J. Vlcek, M. Abuelkhair, R. Andrajati,
A. Elnour (Hradec Kralove, CZ; Abu Dhabi, AE; Jakarta, ID; Al-Ain,
AE)
Objectives: To study the pattern of dispensing antibiotics (with and/or
without prescription OTC)
intermsof deﬁned daily dose DDD, frequency, costs and indications
reasons for dispensing.
Methodology: Cross-sectional study conducted in n = 24 randomly
selected community pharmacies out of n = 240 located in Abu Dhabi
city during the study period. A structured-closed developed to examine
the impact of demographic characteristics age, gender and years of
practice experience of the pharmacist with respect to dispensing
antibiotics with or without prescription in terms of legalization
rationality and safety. Questionnaire permitted studying the DDD
frequency costs and reasons. Data were entered and analyzed by using
SPSS version 17. Descriptive statistics. Odds ratios (OR) signiﬁcance
and 95% CI were calculated. Logistic regression conducted.
Results: Participated pharmacists dealt with a total of n = 1645
transactions with antibiotics, dispensed with prescriptions n = 1211
(73.6%) as OTC n = 434 (26.4%) customers. Only one pharmacist has
not dispensed OTC antibiotic during the study period. Male pharmacists
are dispensing more of OTC antibiotics. Gender of the Individuals
p = 0.012 and their socioeconomic status p = 0.001 signiﬁcantly affect
the Individuals’ manner in acquiring OTC antibiotics hence females and
individuals with low socioeconomic status tend to get OTC
antibiotics.co-amixoclav in addition with cefuroxime and
clarithromycin, were the most dispensed antibiotics with prescription
(66.4%, 91.3%, and 91.5% respectively) coamoxiclav amoxicillin and
ceftriaxone were the frequent OTC dispensed antibiotics 33.6, 47.8 and
53.3% respectively. Prescribed antibiotics frequently dispensed with
duration 7.5 and 10 days; while the OTC are frequently dispensed with
duration 7.5 and 3 days. coamoxiclav was prescribed for sore throat as
OTC Results reveal that ceftriaxone is mostly prescribed by doctors for
Sexually Transmitted Diseases (STD) and also shows a threefold
increase in dispensing as OTC. The total of dispensed DDD’s is
16468.31 within this result 12771.68 (77.6%) were been dispensed with
prescriptions and 3696.64 (22.4%) were dispensed as OTC.
Conclusion: Prevalence of dispensing of antibiotic over the counter is
alarming such research and patients interviews will allow the collection
of additional information on patient perception, knowledge and
prescribing behavior which may be useful to develop interventions to
change behavior of both prescribers and dispensers.
R2564 Use of tigecycline in intensive care: a French prospective
observational study
P. Montravers*, H. Dupont, J.-P. Bedos on behalf of the Tigecycline
Group
Objectives: Little information is available on tigecycline activity in
patients (pts) with serious underlying disease or organ failure. This
prospective observational study aimed at describing tigecycline
prescribing patterns and pt outcomes in French ICUs.
Methods: Data of all adult pts treated with tigecycline alone or in
combination for suspected or documented infection in 26 ICUs were
collected over 7 days. Response to treatment was classiﬁed as cure (no
other treatment or surgery), failure (persistent/relapsing infection,
infection-related death >48 hour after tigecycline start, discontinuation
due to adverse effects), or undetermined (death <48 hour, tigecycline
<4 days due to de-escalation, antibiotics for another infection). We
distinguished the less (SOFA £ 7) from the most (SOFA>7) severely
ill pts.
Results: Of the 156 pts were included (September 2008 to April 2010):
64% male, age 60 ± 15 year, SAPS II on admission 42 ± 16. At
tigecycline start, 45% had a SOFA>7 (median 11 [8–24]); 34% had
fatal underlying disease, 10% chronic renal failure, 33% were
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immunosuppressed and 19% diabetic. Of 93% had received antibiotics
in the past 30 days.
Tigecycline was given in ﬁrst-line in 47% of pts, mostly in combination
(67%), for intra-abdominal (IAI, 56%), skin and soft tissue (SSTI,
19%), or other infections (36%, mainly pulmonary 24%), and for
10 ± 9 days in average. Of 84% of infections were hospital-acquired
and 12% of pts had bacteremia. Tigecycline was stopped prematurely in
52% of pts, whatever the severity of illness, mainly due to resistant
strain (n = 13), clinical failure (n = 14), de-escalation (n = 20), death
(n = 14) or new infection (n = 4). Response to treatment is shown in
the table. The cure rate was 60% at the end of treatment and 53% at
7 days (SSTI 63%, IAI 54%, other infections 46%). Failure at the end
of treatment was due to persistent infection (n = 12), infection-related
death >48 hour (n = 4) or clinical failure (n = 12), and at day 7 to
relapse (n = 32). At both time points, the cure rate was similar with
tigecycline alone or in combination; in Gram-positive, Gram-negative
and anaerobic infections; and in mono or polymicrobial infections. It
was similar in the less and the most severely ill patients at the end of
treatment but not 7 days later (Table).
Conclusion: In this severe ICU population, the success rates were
comparable to those obtained in clinical studies using other antibiotics
in ICU. Tigecycline is a valuable alternative for the management of
serious infections in ICU.
R2567 Pharmacologic assessment of guidelines on gentamicin use
in infective endocarditis
G. Beraud*, A. Elsendoorn, C. Landron, C. Plouzeau, G. Le Moal,
C. Godet, F. Roblot (Poitiers, FR)
Objectives: To assess the relevance of guidelines on aminoglycosides
use in the treatment of infective endocarditis.
Methods: Patients with a Streptococcus spp., Staphylococcus spp. or
Enterococcus spp. bacteraemia were included, excluding critically ill
patients. Endocarditis treatment was initiated as recommended by
European guidelines (gentamicin at 3 mg/kg/day, once daily dosing for
Streptococcus spp., twice daily dosing for Staphylococcus spp. or
Enterococcus spp.). If endocarditis wasn’t conﬁrmed, gentamicin was
discontinued. Peak (Cmax), Trough (Cmin) and Minimum Inhibitory
Concentration (MIC) were measured as well as creatinine level.
Gentamicin regimen was considered efﬁcient when inhibitory quotient
(Cmax/MIC) was superior or equal to 12.
Results: Aminoglycosides were administered during [median (min -
max)] 10 (1–15) days. Among the 20 included patients, 50 peaks and
136 troughs were obtained. Modiﬁcation of the initial regimens was
required in 13/20 patients, because of insufﬁcient peak (n = 8) or
excessive trough (n = 5). At 3 mg/kg/day, 17.9% (n = 5/28) of
measured peaks (2/18 of patients) allowed an inhibitory quotient (12
[median (min - max) = 4 (0–79)]. At 5 mg/kg/day, 40% (8/20) of
measured peaks (2/6 of patients) allowed an inhibitory quotient (12
[median (min - max) = 10.5 (2–12.5)]. The only peak measured at
7 mg/kg/day had an inhibitory quotient <12. There was no signiﬁcant
association between once or two daily dosing and obtaining an
inhibitory quotient (12. Of 19/136 (eight patients) troughs were superior
to 1. There was no signiﬁcant association between once or two daily
dosing and obtaining a trough superior to one. Age, sex, weight or
severity status weren’t associated with inhibitory quotient (12 or
elevated trough. Three patients had a worsening of their renal function,
and all three had nephrotoxic medication concomitant to gentamicin.
Conclusion: Because of effective inhibitory quotients rarely obtained,
recommended guidelines for gentamicin dosing regimens in infective
endocarditis are inappropriate, as an effective inhibitory quotient is
rarely obtained. Higher doses seem to be more appropriate to obtain
efﬁciency from gentamicin. Dosing (3, 5 or 7 mg/kg) may be more
important than frequency of administration (once or twice daily).
Studies with sufﬁcient number of patients are required to improve
gentamicin prescribing recommendations.
R2568 Systematic post prescription review of carbapenem use in
hospitals: impact on the duration of therapy
P. Lesprit*, G. Lars, A. De Farcy, J. Zahar, M. Postaire (Cre´teil,
Paris, FR)
Objectives: To describe the impact of an early review of carbapenems
prescriptions in hospital using unsolicited infectious disease physician
counselling (IDPC).
Methods: Prescriptions of four carbapenems from ICU, medical (M) or
surgical (S) wards of two university hospitals were screened daily by the
pharmacy using antimicrobial order forms or a computer-generated alert
system. After inital delivery of the drug for up to 3 days, prescriptions
where then reviewed by IDPs during a 5 month period to identify those
likely needing counselling. Improved antibiotic use was sought by
encouraging wards physicians to withdraw or de-escalate therapy.
Results: Of 327 prescriptions (adults = 254; 77.7%) were included
(ICU = 131, 40.1%; M = 148, 45.2%; S = 48, 14.7%). Imipenem
(n = 257; 78.6%) was the most carbapenem used while meropenem
(n = 28, 8.6%), ertapenem (n = 23, 7.0%) or doripenem (n = 19, 5.8%)
were less frequently used. The most common types of infection treated
were urinary tract infection (n = 83, 25.4%), pneumonia (n = 74,
22.6%), gastrointestinal infections (n = 40, 12.2%) or primary
bacteraemia (n = 31, 9.5%). Microbiologically documented infections
and extended-spectrum be´ta-lactamase producing Enterobacteriacae
accounted for 67.3% (n = 220) and 41.9% (n = 137) of prescriptions,
respectively. Median time between delivery of the drug and review by
the IDP was 2 days (IQR, 2–4 days). Overall, 142 prescriptions
(43.4%) were stopped or de-escalated. The overall duration of
carbapenem therapy was short (median, 2 days; IQR, 2–4 days).
Conclusions: A strategy using antimicrobial order form followed by
an unsolicited antibiotic review of carbapenem prescriptions by IDP
was successfully implemented in our hospitals and was associated with
high rates of counselling and physicians’ compliance, resulting in short
courses of carbapemen therapy. The impact of this strategy on sparing
hospital carbapenem use will require a longer follow-up.
R2569 Linezolid in the treatment of methicillin-resistant
Staphylococcal post-neurosurgical meningitis
A. Rodriguez-Guardado*, A. Blanco, M. Alvarez, F. Pe´rez, A. Fleites,
J. Ruiz, V. Carcaba, J. Carton (Oviedo, ES)
Background: Linezolid is a bacteriostatic antibiotic with good
cerebrospinal ﬂuid penetration. The aim of this study was to evaluate
the efﬁcacy of linezolid in methicillin-resistant staphylococcal
(methicillin-resistant Staphylococcus aureus [MRSA] and methicillin-
resistant coagulase-negative Staphylococcus [MRCoNS]) meningitis.
Methods: All adult patients (age >18 years) with culture-proven
MRSA or MRCoNS meningitis treated with linezolid (600 mg/
12 hours intravenous) between January 2006 and September 2011
were retrospectively reviewed. Nosocomial meningitis was deﬁned
according to the CDC deﬁnitions. Samples of CSF were obtained
through an intraventricular catheter if present and by lumbar puncture in
the rest. The identiﬁcation of Staphylocccus spp was conﬁrmed using a
commercial identiﬁcation system. Antimicrobial susceptibilities were
tested using a microdilution commercial system. An empirical
antimicrobial therapy was considered as adequate if it included at
least an effective antibiotic. Cure was achieved when two successive
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cultures were negative and clinical signs of infection were absent. To
assess survival, patients were followed-up until they died in the hospital
or were discharged.
Results: Of the 11 cases (9 MRCoNS, 2 MRSA) fulﬁlled the inclusion
criteria (82% males, mean age 66 years, limits 51–80). All patients had
hospital-acquired meningitis and had undergone neurosurgery. The
most frequent underlying diseases were brain haemorrhage (82%), and
brain neoplasms and head trauma (both 10%). The mean time that
elapsed between the surgery and the onset of the infection was
19.60 days (limits 6–49). All cases had a intraventricular catheter. The
mean permanence of intraventricular catheter before the diagnosis of
the meningeal infection was 16.7 days (limits 6–27) All the patients had
received empirical antibiotic treatments that were adequate in 100% of
the cases. Five patients received linezolid monotherapy . In three cases,
a combined parenteral therapy was used with linezolid and rifampicina.
Three patients received a rescue therapy with iv linezolid due to
inefﬁcay vancomicin treatment. In 91% cases, treatment was associated
with the removal of the intraventricular catheter. Cure of the meningeal
infection was reported in all cases. No patients died. There were no
severe adverse events.
Conclusions: Our experience with linezolid suggests that it can be
useful and safe the treatment of MRCoNS- and MRSA-related
meningitis.
R2570 Antimycotic consumption in VINCat hospitals, Catalonia:
stratiﬁed data by hospital size
S. Grau*, E. Fondevilla, S. Mojal, J. Valle´s, M. Palomar, F. Gudiol on
behalf of the VINCat Antimicrobial Program Group
Objectives: VINCat is a nosocomial infection surveillance program in
Catalonia (7.5 million of population), Spain. The aim of the study is to
assess the evolution of the antimycotic consumption in 49 acute care
hospitals stratiﬁed by hospital size.
Methods: Annual analysis on antimycotic use from 2007 to 2010.
Hospitals were stratiﬁed in three groups: I (more than 500 beds; N = 7),
II (200–500 beds; N = 13) and III (<200 beds; N [2007] = 19,
N [2010] = 29). Deﬁned daily doses per 100 occupied bed-days (DDD/
100 OBDs) were used to calculate the average of antimycotic
consumption rate among all hospitals. Data in intensive care units
(ICU), medical and surgical wards were analyzed separately. Trends of
consumption and their differences between hospital groups were
statistically analyzed using a linear mixed model with hospital as a
cofactor. p Values <0.05 were considered statistically signiﬁcant.
Results: Differences of antimycotic consumption between hospital size
were statistically signiﬁcant (p < 0.001). Global hospital DDD/100
OBDs 2007, 2008, 2009, 2010; group I: 3.78, 4.10, 4.30, 4.03 (increase
of 6.61%; p = 0.558); Group II: 1.96, 1.98, 1.98, 2.20 (+12.24%;
p = 0.887); Group III: 0.84, 1.28, 1.29, 1.14 (+35.71%; p = 0.204).
ICU DDD/100 OBDs 2007–2010; group I: 19.32, 15.67, 14.52, 15.23
(-21.17%; p = 0.467); Group II: 15.05, 12.04, 12.01, 14.26 (-5.25%;
p = 0.795); Group III (2008–2010): 12.64, 14.35, 16.02 (+26.74%;
p = 0.809). Medical wards DDD/100 OBDs 2008–2010; group I: 4.97,
4.92, 4.84 (-2.62%; p = 0.643); Group II: 2.65, 2.33, 2.22 (-16.23%;
p = 0.661); Group III: 1.95, 1.95, 1.26 (-35.38%; p = 0.843). Surgical
wards DDD/100 OBDs 2008–2010; group I: 1.80, 2.16, 1.79 ()0.56%;
p = 0.274); Group II: 0.55, 0.71, 1.14 (+107.27%; p = 0.840); Group
III: 0.47, 0.49, 0.49 (+4.26%; p = 0.913). Higher consumption in large
hospitals was observed when global data was compared by hospital size
(p < 0.001) (Figure 1). These differences mainly came from medical
and surgical wards.
Higher consumption increases were observed in voriconazole
(p = 0.001), micafungin (p < 0.001) and anidulafungin (p < 0.001)
mainly due to ICU.
Conclusions: (i) A different proﬁle in antimycotic consumption was
observed by hospital size. The larger hospital size was, the bigger
antimycotic consumption was. (ii) A high and sustained antifungal
consumption in large hospitals was observed, with a non signiﬁcant
increase along the years. (iii) In all size groups, the antifungal
consumption came mainly from ICU.
R2571 Contrasted effect of an antimicrobial stewardship
programme on antimicrobial use and on antimicrobial
resistance in the intensive care unit setting
S. Cheriﬁ*, P. Gottignies, J. Massaut, J. Devriendt, C. Theunissen,
G. Mascart (Brussels, BE)
Objectives: To improve healthcare quality and trying to reduce broad
spectrum antimicrobial use, an infectious diseases team started in
January 2005 quality rounds twice a week and, a close monitoring of
antibiotic consumption. The present study evaluates the impact of this
intervention between 2007 and 2010 in the intensive care units (ICU)
setting with 24 beds of mixed medical and surgical intensive care.
Methods: The antibiotic consumption in Deﬁned Daily Doses (DDD)/
1000 patientdays was collected by the pharmacy. The antimicrobial
resistance data of the Enterobacteriaceae and Pseudomonas aeuginosa
were obtained from the laboratory survey. Bacterial resistances were
given as percentages of resistant and intermediate isolates.
Results: The overall antibiotic use decreased in the ICU setting from
2136 in 2007 to 1092 DDD/1000 patientdays in 2010, being lower than
the national mean consumption. The most signiﬁcant reduction was
observed with broad spectrum antibiotics, particularly with cefepime
(decreased by 89%), aminoglycosides (decreased by 64%) and
piperacillin/tazobactam (decreased by 61%). Cefuroxime remained
stable whereas ceftazidime increased from 54 in 2008 to 88 DDD/1000
patientdays in 2010. A decrease in antibiotic resistance for
Enterobacteriaceae was observed in 2010 only for cefuroxime and
cefepime. Unfortunately, the piperacillin/tazobactam resistance rate
increased for Enterobacteriaceae as for P. aeruginosa, respectively from
11% in 2007 to 24% in 2010, and from 13% in 2007 to 27% in 2010.
The most signiﬁcant reduction was observed in the aminoglycosides P.
aeruginosa resistance from 26% in 2007 to 7% in 2010.
Conclusions: The intervention of the infectious diseases team resulted
in a signiﬁcant decrease in total antibiotic consumption but was
associated with limited beneﬁts in overall rate of resistance. Antibiotic
resistant in ICU remains complex.
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R2572 Vancomycin vs. linezolid in the treatment of methicillin-
resistant Staphylococcus aureus meningitis: a
retrospective cohort study
O. Sipahi, S. Bardak-Ozcem*, T. Turhan, B. Arda, M. Ruksen,
H. Pullukcu, S. Aydemir, T. Dalbasti, T. Yurtseven, H. Sipahi, M. Zileli,
S. Ulusoy (Izmir, TR)
Objectives: In this study it was aimed to compare vancomycin and
linezolid in the treatment of methicillin-resistant Staphylococcus aureus
(MRSA) meningitis.
Methods: This study was performed at a tertiary-care general teaching
hospital with an active neurosurgery ward containing 78 beds, 16 of
which are in an intensive care unit. We extracted data and outcomes for
all adult patients (age > 18 year) with culture-proven MRSA meningitis
who received vancomycin or linezolid between January 2006 and July
2011. Demographic, clinical, and laboratory ﬁ ndings and predisposing
factors, as well as information on response to treatment and outcome
were obtained prospectively. A deﬁnite diagnosis of meningitis was
based on the isolation of MRSA in at least one CSF culture. Typical
CSF ﬁndings included a leukocytosis with a predominance of
polymorphonuclear cells and classic clinical manifestations of
meningitis. Samples were routinely centrifuged and the pellet was
Gram-stained. S. aureus isolates were identiﬁed using routine
microbiological methods. Antibacterial susceptibility tests were
performed using the Kirby – Bauer disk diffusion method, as
described by the Clinical and Laboratory Standards Institute (CLSI).
Linezolid was given as 600 mg ·2 and vancomycin as 500 mg ·4
intravenously.
Results: There were a total of eight cases (ﬁve male, three female, aged
61.6 ± 13.2) received linezolid and nine cases (seven male, two female,
aged 59.1 ± 15.6) received vancomycin, who fulﬁlled the inclusion
criteria. One case in the linezolid group had MRSA and methicillin-
resistant coagulase-negative staphylococci coinfection. All strains were
susceptible to vancomycin and linezolid. All patients had hospital-
acquired meningitis and had undergone neurosurgery. Microbiological
success (Clearance of MRSA from CSF on day 5) with linezolid or
vancomycin were 7/9 and 2/8 (p: 0.044 Fisher Exact Test). There were
no severe adverse events in both arms. One month survival in the
microbiologically successfully treated cases were 1/2 in vancomycin
group (one died due to another nosocomial infection) and 5/7 in
linezolid group in which two cases died due to other reasons (one
additional nosocomial infection, one sudden cardiac death). In four of
six failures with vancomycin, vancomycin minimum inhibitory
concentration data was available and 2 mg/L (Etest; AB BIODISK,
Solna, Sweden).
Conclusion: Although this is a retrospective cohort study, these data
suggest that linezolid may be a good option in the treatment of MRSA
meningitis.
R2573 Surgical prophylaxis compliance at a West London
district general hospital
R. Amin* (London, UK)
Prophylactic antimicrobial use has an important part to play in the
prevention of post-operative wound and deep site infections. However,
the key principle in this use is to have a high concentration of the
antimicrobial agent(s) in the relevant tissues at the time of the operation,
when bacteria may contaminate the tissues. For most operations, this
requires only a single dose of the antimicrobial(s) at induction of
anaesthesia1. The aim of the audit is to determine the hospital
compliance to the Surgical Prophylaxis Policy, to investigate outcomes
and to agree on the necessary actions. A total of 196 patients were
identiﬁed (172 included in the compliance study due to cancelations
and inability to obtain the medical notes or required information). The
plan was to gather information over one calendar week with provision
to extend if a minimum of 100 patients was not achieved. All audited
cases were reviewed by consultant microbiologist to assign compliance.
Reasons for non-compliance are listed in table I. The audit has provided
a snapshot of the surgical prophylaxis prescribing. The following are
recommended; staff education, guidelines review, user friendly guide-
lines presentation, laminated wall poster for theatres, and monitoring
initiatives.
1. Department of Health. Saving Lives: reducing infection, delivering
clean and safe care, Antimicrobial Prescribing. Department of
Health. 2007. Available at http://www.safetypatient.com/documen-
tos/DH_076587buenaspracticasprescripcionantibioticos.pdf
R2574 Results from an observational study: daptomycin is
effective in the treatment of catheter-related bacteraemia
P. Nikolaidis*, M. Allen, A. Robb, A. Beiras-Fernandez, R. Utili,
B. Almirante Gragera, A. Gonzalez-Ruiz, N. Kro¨ger, K. Bouylout,
Y. Yin, R. Chaves (Thessaloniki, GR; Camberley, Newcastle upon
Tyne, UK; Frankfurt, DE; Naples, IT; Barcelona, ES; Dartford, UK;
Hamburg, DE; Basel, CH; East Hanover, US)
Objective: Catheter-related bloodstream infections are frequently
caused by Gram-positive organisms, many of which are resistant to
commonly used antibiotics. Daptomycin has rapid in vitro bactericidal
activity against Staphylococci independent of methicillin susceptibility
and against vancomycin susceptible or resistant Enterococci. The aim of
this analysis was to assess the efﬁcacy and safety of daptomycin in this
indication.
Methods: The European Cubicin Outcomes Registry and Experience
(EU-CORE) is a retrospective non-interventional multicenter study to
assess characteristics and clinical outcomes of patients receiving
daptomycin. Patients with catheter-related bacteraemia who were
treated with at least one dose of daptomycin were evaluated in this
cohort. Treatment success was assigned by investigators using protocol
criteria and deﬁned as cured, improved, failure or non-evaluable
following daptomycin therapy.
Results: The EU-CORE registry study included 487 patients with
catheter-related bacteremia (of 4592 enrolled from January 2006 to June
2011). In this cohort 64% patients were male and 41% aged 65 years or
more. Positive cultures of pathogens were reported in 415 patients (94%
Gram positive, 6% Gram negative) and the most common pathogens
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were coagulase-negative staphylococci (50%) and S. aureus (30% of
which 59% were MRSA). The most frequently used initial dose of
daptomycin was 6 mg/kg (66.3%; range <4–10 mg/kg). The median
duration of daptomycin therapy was 10 days (range: 1–173 days). Of
348 (72%) patients received concomitant antibiotics, most frequently
carbapenem (32%), penicillin (21%) and aminoglycoside (13%). The
clinical success with daptomycin was achieved in 92% of patients (65%
cured and 27% improved) and only 9% experienced failure.
Daptomycin treatment was associated with high success rate against
most of the pathogens including MRSA (82%) S. epidermidis (86%)
and other coagulase-negative staphylococci (87%) (Fig. 1). Mild to
moderate adverse effects (AEs) were observed in 27 (7%) patients. Five
(1%) patients developed serious AEs classiﬁed as possibly related to
daptomycin therapy by the investigator.
Conclusion: Daptomycin exhibited good efﬁcacy and safety results
conﬁrming its role as a therapeutic agent for the treatment of catheter-
related bacteraemia caused by Gram-positive pathogens.
R2575 Patterns of antibiotic usage in pregnant women in Russia
S. Ratchina*, R. Kozlov, S. Yurjev, E. Batseykina, V. Djagileva,
L. Kozhuchova (Smolensk, Tomsk, RU)
Background: In pregnancy antibiotic (AB) present a special concern
due to the threat of potential harmful effects on fetus and neonate.
Although studies of AB usage are not uncommon in Russia there is a
serious lack of comprehensive and valid data concerning the patterns of
their prescription during pregnancy.
Objectives: To investigate the patterns of AB usage among pregnant
women.
Methods: A population-based cohort study was conducted among
obstetrician-gynecologists in two Russian cities. They were asked to
recruit women with a pregnancy of (35 gestation weeks regularly
attending prenatal clinics. AB exposure (patterns of AB use,
indications, duration of treatment) throughout the pregnancy was
recorded and evaluated with regard to teratogenic properties of drugs.
Results: Overall, 150 women aged from 16 to 39 years, mean age
25.7 ± 4.9 years were enrolled. Complicated course of pregnancy was
registered in 71/150 (47%) of cases. Concomitant diseases were
observed in 60/150 (40%) of women. Average number of AB
prescriptions was 1.1 ± 0.3 per woman, length of treatment varied
from 1 to 20 days; 16% of drugs were administered in the ﬁrst trimester
of pregnancy. The most frequently prescribed AB were macrolides
(47%) and penicillins (41%), followed by cephalosporins (6%) and
fosfomycin (4%); ﬂuoroquinolones and nitroimidazoles were given in
2/163 and 1/163 of cases, respectively. AB were prescribed mostly by
obstetrician-gynecologists (65%) and general practitioners (30%);
indications to AB use were as follows: urogenital (47%), urinary tract
(36%), respiratory tract (16%) and skin and soft tissue infections (1%).
A total of 59% AB prescriptions belonged to Category B of the FDA
pregnancy risk classiﬁcation, 3% – to Category C; 39% of them were
unclassiﬁed due to lack of data. Admitted possibility of additional AB
use for self-medication was reported by 17% of pregnant women.
Conclusions: In general, majority of prescribed AB belonged to
category B. The main concern causes the high rate of usage of drugs
with undeﬁned teratogenic risk and common practice of AB self-
prescription.
R2576 Outcomes of antimicrobial stewardship intervention in a
Spanish university hospital
M. Lightowler*, S. Grau, F. Alvarez-Lerma, L. Sorlı´, N. Sandoval,
J. Horcajada, M. Montero, H. Knobel, S. Mojal, P. Saballs,
E. Salas (Barcelona, ES)
Background: Antimicrobial stewardship includes several strategies to
improve antimicrobial use and prevent emergence of antibiotic
resistance. Computer-assisted programs have been related to achieve
these goals. Antibiotic Committee team designed a new computer
program integrated in the computerized order entry. The objective is to
assess the impact of this implementation by comparing characteristics,
infections and clinical evolution of patients who receive interventions in
their antimicrobial therapy vs. those in whom interventions were not
considered.
Methods: Prospective cohort study at a 400-bed hospital in Barcelona,
Spain between June and September 2011. Monitorized antimicrobials
(MA): carbapenemics, linezolid, daptomycin, linezolid, tigecycline and
voriconazole, echinocandins and amphotericins. Patients receiving a
MA were included. All consecutive MA prescribed were assessed. A
ﬁrst assessment was done the initial day of therapy and a second
assessment 72 hour later. Prescriptions were classiﬁed: with
intervention and without intervention. Data collected: demographics,
SAPS-II at admission (SAPS-II-A) and at antibiotic prescription
(SAPS-II-AP), MA, infection related to MA, clinical evolution,
microbiological data, length of hospital stay (LOS) and global and
attributable mortality. Chi square and Fischer exact test for dichotomic
variables and t-Student and ‘‘U’’ Mann–Whitney test for continuous
variables were employed.
Results: Patients included: 100, man 61, mean age 66.8 years. UTI 26,
Pneumonia 24, IAI 23, CNS 6, unknown origin sepsis 6, other 7. Main
interventions: other alternatives with narrow spectrum of activity (43%)
and changes in dosage schedule (27%). Intervention vs. non-
intervention treatments: neither differences were found in origin and
type of infection nor in cause of treatment discontinuation.
Conclusions: Computer program has shown to be a good tool for
improving antimicrobial prescription. Almost 50% of prescriptions
were related to an intervention carried out by Antibiotic Committee.
Although interventions were performed in patients with higher severity,
they showed a reduction in lenght of hospital stay and in the days of
antimicrobial therapy without impairment in clinical outcomes.
R2577 Antibiotic consumption among six general hospitals:
results from a Greek surveillance network
A. Markogiannakis*, D. Gennimata, V. Goulas, K. Tzortzopoulou,
V. Aggelopoulou, D. Makridaki (Athens, Agrinio, Messologi, GR)
Objectives: To analyze data on antimicrobial consumption (AC)
originated from Internal Medicine (IM), Surgical (S) and Intensive
Care Units (ICU) departments of six general hospitals of Greece (four
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from the region of Athens and two from the Western Greece) in order to
provide a clear picture of the proﬁle of hospital antibiotic usage.
Methods: Data on AC of systemic antibiotics in Anatomic Therapeutic
Chemical (ATC) class J01 were obtained from the hospital pharmacy
department records during the ﬁrst sixmonths of 2011 andwere expresses
in deﬁned daily doses (DDDs) per 100 patient days (PDs) (ABC calc. vs.
3.1). Differences between compared hospital departments were accepted
as statistically signiﬁcantwhen p < 0.05, counting Pearson’s ·2 or Fisher
exact tests for proportions (GraphPad Prism vs. 5.04).
Results: A higher AC was noticed among the three big hospitals of
400–550 beds (Laiko, Red Cross and Sismanoglio General Hospitals),
especially in the IM departments, with mean AC (MAC): 87.2 DDDs/
100 PDs and in the ICU departments with MAC: 128.4 DDDs/100
PDs). The comparison with the MAC of the other three hospitals of
120–150 beds (Polycliniki, Agrinio and Messologi General Hospitals)
was statistically signiﬁcant between the corresponding groups of IM
and ICU departments. The highest AC was observed among the classes
of carbapenems (J01DH), penicillins with b-lactamase inhibitor
(J01CR) and ﬂuroquinolones (J01MA), especially among the three
big hospitals, while the AC in the other antibiotic classes as was
signiﬁcantly lower. The AC in S departments was generally limited
among all hospitals.
Conclusion: A higher AC was noticed in the hospitals with more than
400 beds especially in IM and ICU departments. The carbapenem
consumption in these hospitals is worrying. The collaboration among
the six hospitals was an attempt for the creation of a surveillance
network for AC among the hospital pharmacy departments in national
level, aiming to collect reliable and comparable data of AC in Greece.
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R2578 Prevalence of plasmid-mediated quinolone resistance
determinants in Enterobacteriaceae
O. Oncul, Z. Aktas*, M. Ozyurt, A. Acar, C. Kayacan, V. Turhan,
L. Gorenek (Istanbul, TR)
Objectives: The presence of plasmid-mediated quinolone resistance
determinants was investigated in quinolone-resistant enterobacterial
isolates.
Methods: We tested a total of 136 norﬂoxacin, ciproﬂoxacin-resistant
isolates of Enterobacteriaceae which were collected at the GATA from
January to December 2009. The presence and identity of ESBL and the
qnrA, qnrB, qnrS, aac(6¢)-Ib-cr and qepA genes genes were screened by
a multiplex PCR-based technique. Plasmid analysis was carried out by
Kado-Lui method and the genetic relationships among the strains were
determined by ERIC-PCR.
Results: All isolates were resistant to norﬂoxacine and ciproﬂoxacine
by disk diffusion test. Of the 136 collected isolates, 106 isolates were E.
coli, 29 isolates were K. pneumoniae and two isolates were K. oytoca.
Prevalence of ESBLs was 42.4% of E. coli, 65.5% of K. pneumoniae
and 50% of K. oxytoca. Ten percent of those isolates carried qnr genes
encoding the qnrA, qnrB, qnrS or aac(6¢)-Ib-cr determinants. Most
aac(6¢)-Ib-cr-positive isolates (n = 6) were ESBL producers, Among
these isolates, qnrB were detected in two K. pneumoniae and one E. coli
isolates, whereas qnrA was detected only one K. pneumoniae isolate.
qnrS was detected in two isolates; one K. pneumoniae and one K.
oxytoca. aac(6¢)-Ib-cr was detected seven isolates of E. coli, whereas no
qepA-positive isolates were detected. Two qnrB-positive K.
pneumoniae isolates also had blaTEM and blaSHV genes. Plasmid
DNA ﬁngerprinting revealed the presence of approximately 80 and
130 kb in K. pneumoniae isolates; 80, 130 and >200 kb plasmids were
detected in qnrB gene harboured E. coli. ERIC-PCR results revealed
that the strains carried qnr genes were not clonally related. Two qnrB-
positive K. pneumoniae isolates also had blaTEM and blaSHV genes.
Conclusion: This is the ﬁrst study of qnr genes in Enterobacteriaceae
isolates from our hospital. qnrB was the most frequently encountered
gene in K. pneumoniae and E. coli, aac(6¢)-Ib-cr gene among ESBL-
producing E. coli was identiﬁed.
R2579 MALDI-TOF mass spectrometry in a paediatric clinic’s
microbiology laboratory everyday work
N. Mayanskiy*, A. Kalakutskaya, O. Motuzova, G. Lominadze,
L. Katosova (Moscow, RU)
Objectives: Matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF MS) has been recently introduced in
microbiological laboratories for the identiﬁcation of microorganisms
with proteomics approaches. Hereby, we report the performance of
MALDI-TOF MS identiﬁcation of clinical microbial isolates from the
microbiology laboratory serving for a pediatric hospital in comparison
to conventional microbiological methods.
Methods: We performed MALDI-TOF MS by means of a Microﬂex
mass spectrometer (Bruker Daltonics, Germany). Colonies from the
culture dishes were directly deposited on the target plate without any
pretreatment. Conventional identiﬁcation was performed by routine
phenotypic and immunological methods.
Results: In total, by means of MALDI-TOF MS we analyzed 1810
isolates obtained from pediatric patients. Score values of (1.700 that
were used as a minimum cut-off for genus identiﬁcation were observed
for 1447 isolates (79.9%). These included 30 bacterial species from 16
genus and two fungi species from Candida genus. For isolates with
score (1.700, MALDI-TOF MS genus identiﬁcation was in complete
agreement with conventional methods (100%), whereas correct species
identiﬁcation was found for 1428 isolates (98.7%). All discordant
results were associated with Streptococcus pneumoniae identiﬁcation.
MALDI-TOF MS correctly identiﬁed S. pneumoniae in 20 from 39
isolates (51%), the rest of isolates was misidentiﬁed according to results
of speciﬁc pneumococcal latex agglutination.
Conclusion: Thus, MALDI-TOF MS is a reliable and rapid method for
identiﬁcation of microbes isolated from clinical samples that may in
many instances substitute classical laboratory methods. Moreover,
accurate MALDI-TOF MS identiﬁcation at the species level of all
microbes having score (1.700 (except S. pneumoniae) substantiates the
use of the score value (1.700 as a reliable cut-off for species
identiﬁcation of the microbes studied in the present work.
R2580 Comparison of four commercial molecular methods for
the diagnosis of Clostridium difﬁcile infection
C. Holmstro¨m, H. Huang, S. Falklind Jerke´rus, M.U. Rashid, H. Fang,
C.E. Nord, A. Weintraub* (Huddinge, SE)
Objectives: Clostridium difﬁcile infection (CDI) is the major cause of
health care-associated diarrhoea. Rapid and accurate microbiological
diagnosis of CDI is urgently needed. Toxigenic C. difﬁcile detection by
the cell culture neutralization assay (CCNA) is considered to be the
gold standard. However, this procedure is time and labour intensive.
The purpose of the present study was to compare four different
commercial molecular methods (Cepheid XpertTM C. difﬁcile assay,
Illumigene C. difﬁcile test, RIDAGENE method and Duplica alpha)
using the CCNA as the reference method.
Methods: The Cepheid method was tested with 220 faecal samples.
The Illumigene with 263, the RIDAGENE as well as the Duplica
alpha with 181 samples each. In all investigations consecutive, non-
repetitive fresh unformed stool specimens from patients older than
2 years of age were analysed. All four methods were compared with the
standard laboratory diagnosis method i.e. CCNA and culture.
Results: In a comparison with the CCNA reference method the
sensitivities ranged from 90% to 97% and speciﬁcities from 93% to
99%. The methods except Illumigene are based on RT-PCR. The
Illumigene uses a Loop-mediated isothermal ampliﬁcation (LAMP)
technology. The major difference between the methods was the pre-
analyses time and the reaction time. The fastest method was that from
Cepheid. In average it took 65 minute from the arrival of the sample
until the ﬁnal result. For the Illumigene method, the corresponding time
was 75 minute. Both the RIDAGENE as well as the Duplica alpha
methods the overall time was 2.5 hour. The tested methods, except
Cepheid, were run in batches. The Cepheid method has been run
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continuously since every sample could be run independently of each
other. The Cepheid method targets the genes for the toxin B, the binary
toxin as well as the deletion in the regulatory TcdC gene. The
Illumigene targets a conservative region in the toxin A gene. The
RIDAGENE targets both the toxin A and toxin B genes and the
Duplica alpha targets the toxin B gene.
Conclusion: The four methods have high sensitivities and speciﬁcities.
The methods except the Cepheid XpertTM C. difﬁcile assay, required a
separate step of DNA extraction and were run in batches. The Cepheid
method has the fastest turn around time of 65 minute followed by
Illumigene (75 minute). With the Cepheid Xpert TM C. difﬁcile assay it
is possible to run each sample independently.
R2581 GeneXpert MTB/RIF system in pulmonary and
extrapulmonary specimens: comparison with other
nucleic acid technologies
A. Barreales-Fonseca, D. Garcia-Martinez De Artola, I. Hernandez-
Caceres, J. Alcoba-Florez (Santa Cruz de Tenerife, ES)
Objectives: New techniques for rapid diagnosis of TB and drug
resistance have been used in hospitals to facilitate critical decisions.
One of the latest systems, the GeneXpertTM MTB/RIF (Xpert). The
Xpert assay integrates DNA extraction, genomic ampliﬁcation,
semiquantitative detection of M. tuberculosis complex, and rifampin
(RIF) resistance determination in a single cartridge, for DNA extraction
and ampliﬁcation of a 192-bp segment of the rpoB gene. The aim of the
present study was to evaluated the effectiveness of the Xpert system for
the detection of TB in respiratory and non-respiratory specimens and to
compare with conventional culture methods and reverse hybridation
assay.
Methods: Between February 2010 and October 2011, 90 specimens
ordered for routine mycobacterial testing were prospectively studied.
Samples were processed by standard procedures: microscopic
examination for acid-fast organisms (Ziehl-Neelsen stain) and
mycobacterial culture using Lowenstein-Jensen and BacT/ALERT
(bioMe´rieux). Mycobacterium isolates were identiﬁed by AccuProbe
(Gen-Probe Inc./bioMe´rieux) and sensibility were tested using
Genotype MTBDR plus (Hain Lifescience). The GeneXpert assay
was run according to the manufacturer’s instructions on all 90 samples.
Results: Of the 90 specimens tested 50 were respiratory and 40 non-
respiratory samples (11 acid-fast smear positive and 79 smear negative).
The Xpert assay detected 100% smear-positive, culture-positive cases
and smear-negative culture-positive cases, as determined by growth on
solid medium or on both solid and liquid media. M. tuberculosis was
not detected in all of the culture-negative samples. One specimen
yielded false positive result with Xpert MTB/RIF when compared to the
reference method. No resistance were detected for the tested isolates.
No crossed-contamination was detected with other mycobacteria in any
sample. No uninterpretable results were described in this study.
Conclusion: Xpert is a useful and easy-to-apply test for the rapid
diagnostic of TB. In this study we demonstrate that Xpert is highly
sensitive and speciﬁc for TB detection.
The MTB/RIF assay is simple to perform with minimal training, is not
prone to facilities, and has a high sensitivity in smear-negative
tuberculosis. Xpert is a platform that detects a relatively small number
of mutations and in population with high prevalence of RIF resistance
more studies are required in order to assess the performance of this test.
R2582 Evaluation of a triple molecular genetic test for the
diagnosis of Helicobacter pylori infection and its resistance
to clarithromycin and ﬂuoroquinolones in clinical practice
N. Mathou, S. Likousi, O. Kordanouli, J. Karagiannis,
E. Platsouka* (Athens, GR)
Objectives: To assess the applicability, efﬁcacy and accuracy of a
triple molecular genetic test for identiﬁcation of Helicobacter pylori
(HP) infection and its resistance to clarithromycin and ﬂuoroquinolones
in every day clinical practice.
Patients and Methods: Forty consecutive patients undergone upper
gastrointestinal (Gl) endoscopy due to various upper GI tract symptoms.
HP infection was assessed by a RUT test (CLO) and/or histology of
gastric biopsies (two antral and two corpus specimens) and one sample
for the molecular genetic test. (GenoType Helico DR test- Hain). It was
analyzed into three steps. Multiplex PCR and DNA strip hybridization
were performed for identiﬁcation of HP. The determination of its
resistance to clarithromycin was made by the detection of the most
signiﬁcant mutations of 23S gene (positions 2146 and 2147) and its
resistance to ﬂuoroquinolones from the examination of gyrA gene
(codons 87 and 91).
Results: There was concordance in positivity of HP, with at least one
of the applicable HP detection tests (CLO and/or histology) in all
patients (100%) found positive for HP (19/40, 47.5%). In four patients
CLO test was positive while histology and the molecular genetic test
were negative, so concordance to negativity of HP was 81%(4/21).
Resistance to clarithromycin was detected in 6/19 (31.5%) patients but
1/19 (5.2%) was found resistant to ﬂuoroquinolones. Total resistance to
antibiotics was high enough reaching 36.7% of the HP+ population.
Eradication HP regimes, selected according to resistance, succeeded in
100% of HP+ patients, as conﬁrmed with one month later, breath test.
Conclusion: The use of the molecular genetic test is proved easily
applicable and highly sensitive in the detection of HP infection and it
deﬁnes the resistance of clarithromycin and/or ﬂuoroquinolones. The
progressive increase of antibiotics resistance should be controlled
with targeted treatment, so that clarithromycin will continue to be a
useful tool.
R2583 Determination of bacterial DNA in clinical blood samples:
volume matters
M. van den Brand*, R.P.H. Peters, A. Beishuizen, R.K. Riezebos,
A. Rubenjan, L.C. Smeets, M.A. van Agtmael, J.T.M. van der Meer,
R.P. Schade, P.H.M. Savelkoul (Amsterdam, NL; Tzaneen, ZA; Delft,
NL)
Objectives: The molecular detection of bacteria in blood may provide
a rapid tool for diagnosis of bloodstream infections since this omits
culturing. A major drawback to date is the limited clinical sensitivity,
mainly caused by the limited volume of blood used. In this study we
investigated the inﬂuence on clinical sensitivity of increased blood
volume from patients with proven bloodstream infection. For this
purpose we used a new rapid method (Polaris) that is in development
within Biocartis which claims to selectively remove human DNA prior
to the extraction of bacterial DNA enabling higher blood volume input
in the PCR. Preclinical results revealed a sensitivity of up to 1 CFU/
mL. This method was compared to a reference method in patients with
bacteremia & endocarditis.
Methods: Whole blood samples (6 mL EDTA) from patients (n = 9)
with positive blood cultures with Enterococcus faecalis (n = 3) or
Staphylococcus aureus (n = 6) were analysed. Samples were processed
using the Polaris method (5 mL) and the reference method (0.2 mL).
The reference method achieves bacterial lysis with Triton-Tris-EDTA
for E. faecalis and lysostaphine for S. aureus. DNA was extracted with
the EasyMag system and quantiﬁed with a speciﬁc real-time PCR
assay (Lightcycler 480). Additionally, serial measurements during
treatment for culture-proven endocarditis were performed in three
patients.
Results: Bacterial DNA was detected in 8/9 patients with the Polaris
method and in 6/9 with the reference method; the signal in the other
samples did not cross the detection limit. The Polaris method had a
median cycle threshold (CT) value of 35.2 (range 29.7–>42) compared
to 36.7 (range 32.7–>42) with the reference method. A Wilcoxon
signed rank test showed a signiﬁcant difference between both methods
(p = 0.04). In three endocarditis patients of whom follow up samples
were available, bacterial DNA remained longer detectable with Polaris
than with the reference method.
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Conclusion: The Polaris method has a higher sensitivity than the
reference method in clinical samples and provides more possibilities for
serial measurements in clinical blood specimen during treatment. The
larger volume that can be processed with this method is likely an
important factor for clinical usage. This method may provide the step
that increases sensitivity required to make the molecular detection of
bloodstream infections clinically applicable.
R2584 Development of rapid point-of-care tests for the detection
of bacteria implicated in surgical site infections and the
determination of their antibiotic resistance proﬁle
O. Diribe*, S. North, N. Fitzpatrick, L. Roberts, J. Sawyer, M. AbuOun,
R. La Ragione (Surrey, UK)
Objectives: Surgical site infections (SSI), particularly those
complicated by antibiotic resistance can be a problem in human and
veterinary medicine. In view of the wellbeing and economic cost of
SSIs on the patient and practice involved, it is imperative that the
causative agent(s) of an SSI and their antibiotic resistance proﬁle are
rapidly identiﬁed to aid rapid and targeted treatment. With the advent of
rapid isothermal DNA ampliﬁcation technology, the opportunity exists
to develop rapid in-practice diagnostic tests to facilitate pre and post
operative diagnostic microbiology and subsequent treatment regimes.
The work described here aimed to develop rapid diagnostic tests to
evaluate the type of organisms involved in surgical site infections and
their antibiotic resistance gene proﬁles.
Methods: The isothermal ampliﬁcation technique – Loop mediated
Isothermal Ampliﬁcation (LAMP) originally described by Notomi et al.
was used as the basis of the rapid diagnostic tests in the work reported
here. For each of the designed assays, a set of six primers speciﬁc to an
organism speciﬁc gene or antibiotic resistance gene were designed,
using – LAMP designer software i.e. PrimerExplorer V4 by Eiken
Chemical Co. ltd. or Manually under speciﬁed conditions.
Results: To date, LAMP assays have been developed for the
identiﬁcation of Staphylococcus aureus, Pseudomonas aeruginosa,
Escherichia coli/Shigella, Enterococcus faecalis, Enterococcus
faecium and Staphylococcus pseudintermedius, as well as the
detection of the Chloramphenicol AcetylTransferase (cat) gene in
Gram negative bacteria. These assays have been validated using crude
DNA lysates from positive control strains, and detection has been
determined within 15 minute in all assays. Upon testing against a panel
of 28 different bacterial species, the majority of the assays have shown
no cross-reactivity.
Conclusion: The preliminary results obtained hitherto for the assays
show that they are both speciﬁc and rapid in detecting their target. In
addition to this, the relative inexpensive nature (no thermocycler
required) and simplicity (can be used with simple laboratory heating
equipment such as a heat block) of carrying out the reactions, makes
LAMP a suitable alternative to conventional PCR and culture-based
methods of bacteria and antimicrobial resistance identiﬁcation, as well
as a prime candidate for the development of rapid and cost efﬁcient
diagnostic tests.
R2585 Evaluation of the Cepheid GeneXpert vanA/vanB assay
J. Shone*, J. Adam, N. Parsons, D. Yirrell, G. Phillips (Dundee, UK)
Objectives: Rapid identiﬁcation of vancomycin resistant enterococci
(VRE) carriage may be useful in the clinical setting, with faster
identiﬁcation of VRE positive patients allowing prompt infection
control strategies to be implemented. As such, we investigated the turn-
around-time (TAT), sensitivity and speciﬁcity of the Cepheid
GeneXpert vanA/vanB rapid PCR assay, when compared to culture
using selective chromogenic agar, for the detection of VRE.
Methods: Patients (n = 89) from two wards were screened for VRE
carriage by two commercial methods. Rectal and perianal swabs were
taken simultaneously. Rectal swabs were cultured on BrillianceTM VRE
agar. Perianal swabs were subjected to PCR using the vanA/vanB assay
according to the manufacturer’s instructions. Patient samples yielding
discrepant results were investigated further using EnterococcoselTM
broth enrichment of the perianal swab, followed by culture on
BrillianceTM VRE agar. TAT was noted for each sample. The
sensitivity and speciﬁcity of the PCR assay was calculated through
comparison with the results obtained by culture (±enrichment).
Results: In our hands, samples processed by PCR had a mean TAT of
26 hours 30 minutes, representing an average reduction in TAT of
44 hours 18 minutes when compared to culture. The sensitivity and
speciﬁcity of the vanA/vanB PCR assay was 94% and 70%
respectively. Taken alone, analysis of the vanA component of the
PCR reaction resulted in a sensitivity of 94% and speciﬁcity of 89%.
The sensitivity and speciﬁcity of the vanB PCR was 11% and 80%
respectively.
Conclusion: The Cepheid GeneXpert vanA/vanB assay is a sensitive
test for the detection of VRE, yielding results faster than culture on
chromogenic agar. A number of false positive results were observed
using the assay. A large proportion of the false positives were attributed
to the presence of the vanB gene, which is found in a number of non-
enterococcal species. In our hands, the relatively low speciﬁcity of the
PCR assay would require all samples positive by PCR to be conﬁrmed
by culture or an alternative method. Nevertheless, the assay could
provide a useful tool for the rapid screening out of negative patients.
R2586 Assessment of Neisseria gonorrhoeae Chlamydia
trachomatis simultaneous detection by real-time PCR
according to the care unit
N. Bourgeois-Nicolaos*, S. Pozzi-Gaudin, A. Levy, C. Guillet-Caruba,
J. Decousser, A. Benachi, F. Doucet-Populaire (Clamart, FR)
Objectives: Chlamydia trachomatis (CT) and Neisseria gonorrhoeae
(NG) are the two most important agents of sexually transmitted
bacterial infections (STI). These infections if untreated can be at the
origin of serious complications. The objective of our study was to
estimate the relevance of the systematic simultaneous detection of these
two bacteria by real time PCR on urogenital specimens colleted from
women or men consulting in different care units either for a screening
test or based on symptomatic suspicion.
Method: From November 1st, 2010 to August 31st, 2011, Abbott Real
Time CT/NG assay was systematically performed on all urogenital
specimens sent to diagnose STI. Endocervical swabs were collected
from female of the Family Planning clinic (FP) and the Department of
Obstetrics and Gynecology (OG), self-collected vaginal swab was
collected from female subjects of STI Screening Center (SC) and urine
sample was collected from male subjects of SC.
Results: A total of 1861 CT/NG PCR were performed during this
period (sex-ratio M/F: 0.25). Of 58.8% were prescribed by FP, 28.5%
(SC) and 10.1% by OG. Of 161 specimens were positive for CT (M/F:
0.15) and 32 for NG (M/F: 0.23). Of 20 specimens were positive for
both (M/F: 0.18). The prevalence of CT was 8.2% in FP, 8.5% in SC
and 11.7% in OG. Medium age was 22 years for women and 25 years
for men. CT infections were asymptomatic in 81% of cases. The
prevalence of NG was 1.5% in FP, 0.7% in SC and 4.2% in OG.
Medium age was 23 years for women and 24 years for men. A total of
7 NG salpingitidis were diagnosed of which 4 were co-infected with
CT.
Conclusion: CT/NG multiplex PCR is a fast, practical technique,
easily completed on urines and more sensitive than culture. It allowed
us to increase the number of NG biological diagnosis especially on
woman specimens in all care units. CT/NG PCR is a useful tool for STI
diagnosis and treatment especially asymptomatic patients.
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R2587 DNA extraction from broad range of micro-organisms for
molecular diagnosis
C. Disque´*, S. Keim, H. Mu¨hl, M.G. Lorenz (Bremen, DE)
Molecular analysis has proven as a valuable tool in the timely diagnosis
of the aetiological agents of infectious diseases such as sepsis,
endocarditis and meningitis. DNA extraction from a wide variety of
microorganisms is a key issue for their detection at high analytical
sensitivity and precise sequence-based identiﬁcation. The aim was to
test the broad-range lysing capability of a reagent included in the
diagnostic kit, UMDTM Universal, using a variety of clinical material
coming in for routine molecular analysis.
Methods: Clinical material from patients under suspect of an infection
included liquid and tissue specimens from different body sites. The
specimens were extracted according to protocols supplied with UMDTM
Universal (Molzym, Bremen, Germany). This kit includes universal
rRNA gene PCR assays for the detection of bacteria and fungi. If the
assay was positive, amplicons were sequenced and analysed using
NCBI BLAST and SepsiTest-BLAST to identify the organisms.
Results: In total, 404 clinical specimens were extracted and PCR-
analysed, including whole blood, synovial ﬂuid, swabs taken from
wounds, prostheses, pus and bones, liquor, and heart valve and aortal
tissues. The organisms identiﬁed included typical pathogens and strains
which are commensal as well as aetiological (e.g. CoNS, viridans
streptococci). Among typical pathogens, S. aureus, E. faecalis, E. coli,
and C. albicans were the most prominent. Rare aetiologies comprised
taxonomically diverse strains, including, among others, Bacteroides
fragilis, Bartonella quintana, Borrelia graninii, Coxiella burnetii,
Listeria monocytogenes, Providencia stuartii, and Tropheryma
whippleii. One blood sample was positive for the aetiological agent
of malaria, Plasmodium falciparum (speciﬁc assay).
Conclusion: During the pre-analytical processing of clinical material
by UMDTM Universal, a reagent is applied for the destruction of
microbial cell walls. The chemical composition and thus the rigidity of
cell walls is very different among the microbiota. The data from
randomly collected, diverse material indicated that the reagent can lyse
a broad range of microorganisms, including Gram-positive and Gram-
negative bacteria, yeasts, other fungi and a protist. This character of the
reagent greatly supports the precise molecular identiﬁcation of common
and rare aetiologies.
R2588 Multiplex-PCR for the rapid detection of clinically
relevant antibiotic resistance genes
M.M. D’Andrea, N. Ciacci, D. Iodice, G.M. Rossolini* (Siena, IT)
Objectives: Spreading of antibiotic resistance determinants in clinical
isolates is worrisome, limiting antibiotic usage and their effectiveness.
Early detection of these genes in such isolates is therefore crucial, not
only for the choice of an effective antibiotic therapy, but also for to
establish appropriate infection control strategies. Here we describe a
novel multiplex-PCR (mP) method for the rapid detection of a number
of clinically relevant resistance genes directly from bacterial colonies.
Methods: Allelic variants of selected gene families of beta-lactams,
aminoglycoside and glycopeptide resistant genes were retrieved from
the REDDB database and used to identify primer sequences. Oligos
were synthesized by MWG Biotech and used for the optimization of six
distinct mP reactions. Inoculated agar plates were grown O/N at 37C
and used to prepare a standardized bacterial suspension (SBS). An
aliquot of the obtained suspension was centrifuged and the pellet was
resuspended in a previously described lysis buffer. After an incubation
of 2 hours at 60C, the sample was heated at 95C for 15 minutes then
pelleted by centrifugation. 1 lL of the obtained sample was used as
template for mP reactions in a total volume of 12.5 lL using the GoTaq
polymerase (Promega) and a MgCl2 ﬁnal concentrations of 50 mM.
Cycling conditions were as follows: 5 minute at 94C, 35 cycles of
30 seconds at 94C, 40 seconds at 54C, and 1 minute at 72C, and a
ﬁnal extension step of 5 minute at 72C. Ampliﬁcation products were
resolved by gel electrophoresis and eventually analysed by enzymatic
restriction for the discrimination of amplicons.
Results: Positive control strains (n = 30) (used separately or mixed)
yielded expected amplicons, thus validating the mP protocol. The use of
SBSs gave highly reproducible results, even when used 4 weeks after
preparation. Speciﬁcity of each mP was excellent, with any unattended
amplicons in the range of expected products. Restriction of ambiguous
fragments allowed the discrimination of ampliﬁed product.
Conclusions: In this work a mP based approach for the detection of
resistance determinants starting from isolated colonies was set-up and
optimized. Ampliﬁcation from SBS instead of puriﬁed genomic DNA
allows a considerable reduction of time necessary for the detection of
resistance genes.
R2589 Quantiﬁcation on the BD MAXTM System with BD
MAXTM MRSA assay
B. Dore´*, V. Jean, S. Le´tourneau, B. Leclerc, M.-E. Rochette, C. Roger-
Dalbert, C. Me´nard (Quebec, CA)
Introduction: The BD MAXTM System is a next-generation
automated workstation for molecular testing. BD MAXTM System is
designed to standardize and streamline workﬂow and offer full walk-
away automation, the system accommodates varying workloads for
enhanced laboratory efﬁciency and ﬂexibility.
Objectives: (i) Determine if the BD MAXTM System could be used to
perform quantitative analysis. (ii) Determine the Sample Preparation
efﬁciency of the BD MAXTM System.
Methods: BD MAXTM MRSA Assay1 has been used as the model
assay. A simulated MRSA target has been genetically inserted into the
genome of a Bacillus subtilis strain (BSgm). Puriﬁed genomic DNA
(gDNA) and ﬁxed BSgm cells were used to evaluate the performances
of the BD MAXTM System using the MRSA Assay. Serial dilutions of
BSgm gDNA were analyzed in PCR-only mode on the BD MAXTM
System with the BD MAXTM MRSA Assay. Fixed BSgm cells were
analyzed in full-process mode (automated Sample preparation and real-
time PCR) on the BD MAXTM System with the BD MAXTM MRSA
Assay. The statistical analyses were focused on the second derivative
peak apex (SDPA) PCR parameter.
Results: The statistical analysis showed a dynamic range over six
orders of magnitude with the BD MAXTM MRSA Assay on the BD
MAXTM System. Analysis comparing the PCR only to the full process
results with the BD MAXTM MRSA Assay on the BD MAXTM System
showed efﬁcient Sample Preparation with the automated in vitro
diagnostic system. The statistical analysis showed that the BD MAXTM
MRSA Assay and System could be effective in quantiﬁcation studies
for concentration of cells higher or equal to 1.23 cells/mL .
Conclusion: Quantiﬁcation studies can be performed on the BD
MAXTM System using BD MAXTM MRSA Assay for MRSA
infection levels higher than 1.23 cells/mL.
1The BD MAXTM MRSA Assay is not available for sale or use in the
U.S.
R2590 Carbapenem-resistant Serratia marcescens and
Enterobacter cloacae isolates harbouring OXA-48
carbapenemase, Turkey
Z. Aktas*, L. Poirel, O. Oncul, N. Gurler, P. Nordmann (Istanbul, TR;
Paris, FR)
Objectives: The frequency of carbapenem resistance due to class-D
OXA-48 type beta-lactamase in Enterobacteriaceae is increasing. We
report the identiﬁcation and characterization of three carbapenem-
resistant isolates (two Serratia marcescens and one Enterobacter
cloacae)
Methods: These isolates recovered from three patients hospitalized in
two different hospitals in Istanbul in 2010, S. marcescens isolates
recovered from blood samples and E. cloacae recovered from rectal
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swab. Minimum inhibitory concentrations were determined using agar
dilution and E-test, beta-lactamase production by phenotypic tests (E-
test MBL, ESBL and MHT) PCR and sequencing were used to search
for bla(VIM), bla(IMP), bla(SPM), bla (KPC), bla(CTX-M-1 group),
bla(OXA-48), bla(TEM), bla(SHV), bla (PER), plasmid encoded
AmpC and the quinolone resistance genes Qnr A, B, S.
Results: The three isolates were resistant ((4 mgl/L) to imipenem,
meropenem and ertapenem all harbored the blaOXA-48 gene. The E.
cloacae isolate also harbored blaIMP-1 and qnrA genes. S. marcescens
isolates were also resistant to tigecycline (3 mg/L). S. marcescens 2 and
E. cloacae were resistant to ceftazidime, cefotaxime, piperacillin/
tazobactam, cefoperazone/sulbactam, and gentamicin; S. marcescens 1
was resistant to piperacillin/tazobactam and cefoperazone/sulbactam.
Conclusion: This is the ﬁrst report of OXA-48 – producing S.
marcescens and it is important that surveillance studies be undertaken
in hospitals to limit the nosocomial spread of these strains.
R2591 Evaluation of four commercial assays for rapid detection
of Clostridium difﬁcile toxin in stool samples
S. Ferreira, S. Fernandes, C. Araujo, A.C. Mendes*, K. Rodrigues,
A. Castro, H. Ramos (Porto, PT)
Objective: The aim of this study was to evaluate four available
commercial assays for C. difﬁcile toxin detection: Vidas C. difﬁcile
Tox A/B (bioMe´rieux, Clinical Diagnostics), Xpert C. difﬁcile
(Cepheid), Illumigene C. difﬁcile (Meridian Bioscience, Inc), and
SimplexaTM C. difﬁcile Universal Direct (Focus Diagnostics)
Methods: A total of 48 clinical stool samples were tested by selected
methodologies, with the exception of Simplexa TM C. difﬁcile used to
test only 36 of these samples. Vidas and Xpert were performed on
fresh stool samples. Illumigene and SimplexaTM were executed in
stored samples (-20C). The true positives and negatives were
established in accordance with a consensus result, based on the
results of at least two methods. An in-house PCR was used for
conﬁrmation and identiﬁcation of toxin A and B Clostridium genes.
Results: Consensus results were positive in 60% (n = 29) of samples
and negative in 40% (n = 19). Equivocal results were found in 27%
(n = 13) of Vidas and 4% (n = 2) of Illumigene results. Sensitivity,
speciﬁcity, PPV and NPV were as follows: Vidas – 72%, 89%, 91%,
68%; Xpert – 100%, 84%, 90%, 100%; Illumigene – 79%, 100%,
100%, 76%; SimplexaTM – 82%, 100%, 100%, 76%. Binary toxin was
identiﬁed by Xpert in 6% samples (n = 3), always in association with
toxin B. QCMD 2011 Clostridium difﬁcile DNA EQA samples were
tested with SimplexaTM, correctly identifying the complete panel.
Conclusion: We found the high percentage of equivocal results by
Vidas to be a problem, together with its low sensitivity. Xpert
showed the best sensitivity, however, Illumigene and SimplexaTM had
a better speciﬁcity and NPV, but were executed after sample storage,
which can contribute to the poorer performance, as conﬁrmed by
QCMD results.
R2592 Detection of Staphylococcus aureus multiclonality in
screening samples using spa gene denaturing gradient gel
electrophoresis
L. Stark*, F. Hammarskjo¨ld, P. Lindgren, S. Lo¨fgren,
A. Matussek (Jo¨nko¨ping, Linko¨ping, SE)
Objectives: Staphylococcus aureus is responsible for a wide range of
infections. The understanding of the biological nature of S. aureus
colonization is still limited, and virtually all studies of the nasal carriage
presume that individuals are colonized by a single isolate. However, the
issue of multiclonality is clinically important since screening of a single
isolate from patients infected with S. aureus may identify an antibiotic-
susceptible strain rather than a second, more resistant strain.
Furthermore, data regarding colonization is also based on culture of a
low number (1–3) of colonies from each sampling site. Recently, a
molecular method based on the S. aureus protein A gene (spa) was
developed to characterize multiclonality. In this study, we investigated
screening samples from 31 individuals hospitalized at the intensive care
unit (ICU) in Jo¨nko¨ping, Sweden, for possible multiple colonization of
S. aureus using spa-DGGE.
Methods: Swabs from throat, nares and in some cases groin were
cultured on blood agar plates. Conﬁrmation of S. aureus was performed
by DNase testing and growth of pink colonies on BD BBLTM
CHROMagarTM Staph aureus plates (Becton Dickinson). Prior to DNA
extraction total growth of each agar plate was harvested in 700 ll 0.9%
NaCl. Bacterial DNA was extracted from the suspension using the EZ1
DNA Tissue Kit on BioRobot EZ1 (Qiagen, Hilden, Germany).
Extracted DNA was ampliﬁed in 50 ll reactions and PCR-products
were analyzed by DGGE using a Bio-Rad Dcode Universal Mutation
Detection System (Bio-Rad Laboratories, Hercules, CA).
Results: In total 15 out of 31 patients were colonized with S. aureus at
least once during the ICU stay. This revealed twentyﬁve S. aureus
positive samples out of in total 181 collected samples. Using spa-
DGGE two samples from one patient revealed colonization with two
different spa-types. Hence, one out of 15 patients (7%) showed dual
colonization with S. aureus and two out of 25 samples (8%) contained
two strains, respectively.
Conclusions: In this study, we detected dual colonization of S.
aureus in screening samples from a patient at the local ICU using spa-
DGGE. This powerful molecular method can separate strains differing
only in one base in the PCR-product obtained, and colonization and
possible infections caused by more than one isolate can be revealed.
New insights into S. aureus epidemiology using spa-DGGE may
optimize infection control measures and treatment options for infected
patients.
Molecular virology
R2593 High occurrence of Epstein-Barr virus infection during
exacerbations of inﬂammatory bowel disease
E. Dimitroulia, N. Spanakis, V. Pitiriga, E.-T. Piperaki,
A. Konstandinidou, A. Tsakris* (Athens, GR)
Background: Although Epstein-Barr (EBV) infection has been linked
to the pathogenesis of inﬂammatory bowel disease (IBD), the virus
participation as an exacerbating factor remains unclear. The aim of this
study was to clarify the clinical signiﬁcance of EBV infection
complicating IBD exacerbation and to correlate EBV detection with
various clinical characteristics in IBD patients.
Methods: The study was performed in a cohort of 94 IBD patients (63
with ulcerative colitis and 31 with Crohn’s disease) (mean age
47.7 ± 18.3) selected from two adult gastrointestinal referral centers
in Athens, Greece. The presence of EBV was examined in blood and
intestinal tissue samples by molecular assays and comparisons were
made among patients with disease exacerbation and those with
remission. Demographic and clinical characteristics of all participants
were also recorded.
Results: Among IBD patients, 67 and 27 were in a disease state of
exacerbation and remission respectively. The mean age of groups of
IBD exacerbation and IBD remission were 46.4 ± 18.7 and
51.52 ± 18 years respectively. Six (8.9%) patients with exacerbation
and 2 (7.4%) patients with remission had EBV genome in both the
intestinal tissue and blood detected by PCR. In addition, 32 (47.7%)
patients with exacerbation and 4 (14.8%) patients with remission had
detectable EBV genome only in their intestinal mucosa, while 9
(13.4%) patients with exacerbation and 7 (25.9%) patients with
remission had positive EBV PCR only in blood. Detectable EBV
genome in the intestine was identiﬁed in 38 (56.7%) patients with
exacerbation and in 6 (22.2%) patients with remission (p = 0.001). No
difference in prevalence of EBV genome in blood was indicated among
the groups.
Conclusion: Patients with IBD exacerbation had higher frequency of
EBV infection in their inﬂamed intestine when compared with patients
776 Abstracts accepted for publication only
with IBD remission, implying a potential involvement of the virus to
the onset or the severity of IBD exacerbation. Further research is
required to elucidate possible underlying mechanisms of pathogenesis.
R2594 Dobrava virus detection in a patient with haemorrhagic
fever with renal syndrome: a case report and review
N. Kalvatchev, I. Christova* (Soﬁa, BG)
Objectives: Haemorrhagic fever with renal syndrome (HFRS) is an
acute infectious disease, caused by different viruses from the
Bunyaviridae family. In the Balkan region, some of the cases emerge
with severe general status, haemorrhagic syndrome, and particular
damage of kidney function. In Bulgaria, HFRS is registered since 1953.
Prevalence of different hantaviruses causing HFRS in Bulgaria is not
clear.
Case report: A man residing in a town near the northeastern city of
Bulgaria, Shumen, reported to have a direct contact with rats in his
farm. After sudden onset of illness (temperature, headache, nausea,
vomiting, abdominal pain and myalgia) he was admitted to the regional
hospital. Physical examination revealed oliguria, haematuria, acute
renal dysfunction, bradycardia and petechiae on the body. Blood
samples from the patient were used to perform real-time RT-PCR, while
serum samples were tested by ELISA for antibodies against
hantaviruses. Dobrava virus was detected in this patient conﬁrmed by
Taqman and SYBR Green I real-time assays and serologically by high
titer of IgM speciﬁc antibodies.
Conclusion: Distribution of different hantaviruses in Bulgaria needs
elucidation. By mapping hantavirus infections using molecular
methods, this severe viral hemorrhagic fever will presumably be
detected in new areas.
R2595 Evaluation of two new commercial cytomegalovirus real-
time PCR quantitation assays
M.A. Iborra, C. Salvador*, A. Moreno, M.A. Garcia, J. Sanz,
P. Martinez, M. Segovia (Murcia, ES)
Automated real-time PCR systems have become the most common
method in the quantitation of viral load during cytomegalovirus (CMV)
infection in immuno-compromised patients. The aim of this study was
to evaluate the clinical application of two news commercial quantitative
CMV PCR assays (COBAS Ampliprep/COBAS Taqman CMV
Test, Roche Diagnostics, Germany and REALQUALITY RQ-CMV,
AB Analitica, Italy), in solid organ and stem cell transplant patients.
CMV R-geneTM (Argene, France) was compared to the COBAS
Ampliprep/COBAS Taqman CMV Test and REALQUALITY RQ-
CMV for the detection and quantitation of CMV load in plasma
samples. A total of 56 plasma specimens collected into potassium
EDTA tubes were quantiﬁed. DNA was automatically isolated from
200 lL of plasma using a NucliSENS easyMAG system (Biomerieux,
France) and the Generic 2.0.1 protocol according to the manufacturer’s
instructions. Total DNA was eluted in a ﬁnal volume of 50 lL. All
three tests were carried out according to the manufacturer’s instructions.
Inhibitors of PCR were detected in DNA extracts thanks to the use of an
inhibition control included in the ampliﬁcation premix. Fifty six
samples of plasma were tested in parallel with CMV R-gene and with
one of the two commercial kits. Results are summarised in Table 1.
Eleven (19.6%) discordant results were obtained. All discrepant
samples had a low viral load. All samples that gave positive results
in both tests were analysed by the Spearman’s rank test (n: 12 for
COBAS, n: 17 for RQ-CMV). A good correlation between the two
commercial kits and the CMV R-gene was obtained. The Spearman¢s
correlation coefﬁcient was 0.90 and 0.89, respectively. Our study
showed that COBAS Ampliprep/COBAS Taqman CMV Test and
REALQUALITY RQ-CMV are accurate, efﬁcient, reliable and versa-
tile tools for rapid diagnosis and monitoring of CMV disease in
transplantation recipients.
R2596 Standardisation of a PCR assay for the detection of
Bocavirus using a synthetic control
A.M. Paez*, C. Jaramillo, M. del, P. Delgado (Bogota, CO)
Introduction: Acute Respiratory Infections (ARI) are respiratory tract
pathologies which constitute a major public health problem because
they cause high morbidity and mortality rates in the population
worldwide. In 2005, Swedish scientists ﬁrst detected in nasopharyngeal
aspirates, a virus that had not previously been reported. Given its
relatively recent discovery, little is known about this agent, so its role as
a possible causative agent in ARIs is uncertain. The Polymerase Chain
Reaction (PCR) has been proposed as an alternative to conventional
diagnostic methods because it provides better results in terms of speed,
simplicity, sensitivity and speciﬁcity. Despite this, its main
disadvantage is its high costs in viral positive controls. For this
reason, to standardize a PCR assay for detection of Bocavirus using a
synthetic control was the aim of this project.
Objective: Standardization of a PCR assay for the detection of
Bocavirus using an in vitro synthesized control.
Methods: We designed a primer (INTF) that together with the primer
542R reported by Allander et al. (2005), ampliﬁed a 100 bp sequence
speciﬁc to Bocavirus. NCBI bioinformatics tools were used to
approximate prior PCR results and to conﬁrm that this sequence
corresponded to the desired region. A PCR temperature gradient from
50 to 60C was done to determine an appropriate annealing
temperature. Also, a titration of the synthetic control between 2 and
4 lL per reaction was performed, as well as a modiﬁcation of the ﬁnal
concentration of this sequence, carrying out serial dilutions of the stock.
Similarly, a titration of magnesium chloride concentration was done
between 1 and 4 mM. Finally, a comparison between the protocol with
no modiﬁcations and a reaction mixture ready to use suggested by a
commercial manufacturer was done.
Results: After performing various tests, it was determined that the
conditions that could be modiﬁed were the primers concentration to
0.1 pmol/lL each, the magnesium chloride concentration to 3 mM and
the annealing temperature to 52C. The ﬁnal assay was carried out with
all the proposed modiﬁcations, which showed a brighter and clearer
band compared to the band obtained in the ﬁrst PCR assay.
Conclusions: Implementing all the variations made to the protocol, it
was possible to afﬁrm that these modiﬁcations were useful for an
adequate standardization of the test and that the implementation of this
synthetic control is a possible solution to the lack of controls for PCR.
Molecular mycology
R2597 Initial treament as consequence of using PNA-FISH for
yeast in blood cultures
R.R. Laub*, J.D. Knudsen (Hvidovre, DK)
Objectives: The clinical guidance from microbiologists following
blood cultures (BC) with yeast depends on patient history and the
pathogen retrieved. C. albicans has a high grade of susceptibility to
ﬂuconazole. Other species have a low grade of susceptibility to
ﬂuconazole and should be treated with other antifungals. PNA-FISH
(peptide nucleic acid ﬂuorescence in situ hybridization) identiﬁes
pathogens within 90 minute. The clinical consequences of early species
detection were studied.
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Methods: In November 2009, PNA-FISH was implemented for
examination of yeast directly from positive BC. Records of BC
containing yeast from January 2010–September 2011 were reviewed,
and the guidance given was recorded.
Results: We identiﬁed 103 patients having BC with yeast (51 C.
albicans and 52 non-C. albicans). PNA-FISH was used to identify the
pathogen of 53 cases; 28 C. albicans and 25 non-C. albicans. Patients
with C. albicans: of 28 cases identiﬁed PNA-FISH, 5 (18%) patients
were dead or transferred to other hospitals. Of the 23 patients
available for evaluation, 15 (65%) were treated with ﬂuconazole and 8
(35%) received caspofungin or amphotericine B. For patients with C
albicans fungaemia, where PNA-FISH was not used, 8 (42%) patients
received ﬂuconazole and 11 (58%) got either caspofungin or
amphotericine B. Patients with non-C. albicans: of 25 cases
identiﬁed with PNA-FISH, 19 were available for evaluation. Of 16
(84%) received caspofungin or amphotericine B and 3 (16%) got
ﬂuconazole. Of 17 cases not identiﬁed with PNA-FISH, 10 (59%)
received caspofungin or amphotericine B and 7 (41%) got
ﬂuconazole. Given that ﬂuconazole is the right treatment for C.
albicans, and for other yeasts caspofungin or amphotericine B should
be used, 31 of 41 (74%) patients got correct treatment in the PNA-
FISH group compared to 18 of 36 (50%) patients in the group not
examined by PNA-FISH (p = 0.037).
Conclusions: PNA-FISH was able to improve guidance from clinical
microbiologist to clinical doctors. The beneﬁts were early diagnosis and
early appropriate treatment. Obviously, these improvements in patients
care also hold economic beneﬁts.
R2598 Upregulation of the ERG11 gene in Candida krusei by
Azoles
M. Tavakoli*, M. Heidari, F. Zaini (Ahvaz, IR)
Background and the purpose of the study: Candida species (spp.)
are the agents of local and systemic opportunistic infections have
become a major cause of morbidity and mortality in the last few
decades. Azole resistance in Candida krusei (C. krusei) species appears
to be the result of gene alterations in relation to the ergosterol
biosynthetic pathway, as well as efﬂux pumps. The main aim of this
study was to examine the RNA expression of ERG11 in C. krusei which
had been identiﬁed to be resistance to azoles.
Method: The ERG11 mRNA expression was investigated in four
Iranian clinical isolates of C. krusei, which were resistant to ﬂuconazole
and itraconazole by a semiquantitative RT-PCR.
Results: The mRNA expression levels were observed in four out of
four isolates by this technique. Furthermore, we found the variation in
ERG11 expression levels among four representative isolates of C.
krusei. Although DNA sequencing revealed no signiﬁcant genetic
alteration in the ERG11 gene, one heterozygous polymorphism was
observed in two isolates, but not in others. This polymorphism was
found in the third base of codon 313 for Thr (ACT>ACC).
Major conclusion: Even though such a polymorphism creates a new
Ear1 restriction site, we considered it to have no signiﬁcant effect on the
resistance of C. krusei to azoles. Our results are consistent with
previous studies and may provide further evidence for the genetic
heterogeneity and complexity of the ergosterol biosynthetic pathway or
efﬂux pumps.
R2599 Outbreak of neonatal invasive candidiasis due to Candida
albicans invetigated by molecular typing
J. Ben Abdeljelil*, F. Saghrouni, S. Gheith, I. Khammari, M. Ben Said,
A. Fathallah (Sousse, TN)
Objective: Invasive candidiasis (IC) has emerged as a major problem
in neonatal intensive care units (NICUs). We investigated herein the
temporal clustering of six cases of neonatal IC due to Candida albicans
in the NICU of Farhat Hached teaching Hospital at Sousse City,
Tunisia.
Methods: Eighteen isolates obtained from six infected neonates
(eleven isolates were collected from blood and deep-site samples, six
isolates from implanted medical devices and one isolate from a urine
sample) and two isolates from two nurses working at the same unit and
suffering from ﬁngers’ onychomycosis were genotyped by
electrophoretic karyotyping (EK) and restriction endonuclease
analysis of genomic DNA by using Sﬁ I (PFGE-Sﬁ I).
Results: The 20 tested isolates generated nine different PFGE-Sﬁ I
patterns but only four different karyotypes. PFGE-Sﬁ I was more
effective in discriminating between the temporally related isolates. It
showed that: (i) Both HCWs had speciﬁc strains excluding them as
source of infections in neonates. (ii) Isolates collected from three
neonates were identical providing evidence of their clonal origin and
the occurrence of a horizontal transmission of C. albicans in the unit.
(iii) The three remaining neonates had speciﬁc strains conﬁrming that
the IC cases were coincidental. (iv) Microevolution occurred in one
catheter-related candidemia case.
Conclusion: Our results illustrate the relevance of the molecular
approach to investigate suspected outbreaks in hospital surveys and the
effectiveness of PFGE-Sﬁ I for the typing of epidemiologically related
C. albicans isolates.
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R2600 MIRU-VNTR genotyping of human Mycobacterium bovis
strains in Tunisia
A. Ghariani*, E. Mehiri, S. Sanakli, H. Draoui, L. Essalah, F. Messadi-
Akrout, L. Slim-Saidi (Ariana, Sfax, TN)
Introduction: Advances in molecular typing, particularly with the
developing MIRU-VNTR technique, have improved the ability to
distinguish among strains of Mycobacterium bovis.
Objective: The discriminatory power of MIRU-VNTR to typing based
on the standardized 15 loci was assessed for 23 human strains of M.
bovis collected at the laboratory of microbiology of the Pneumology
Hospital of Tunis
Materials and Methods: From 2000 to 2010, 23 human M. bovis
strains were isolated, 13 were isolated from extrapulmonary samples
and two from sputa. Genotyping was performed using the 15 MIRU-
VNTR set. PCR products were analyzed by gel electrophoresis. The
allelic diversity (h) was calculated.
Results: Molecular evidence demonstrated that M. bovis isolates are
not related even though between cases occurring in the same area and
the same place. Only two of the 23 M. bovis strains were clustered.
Allelic diversity was calculated (h) and we deﬁned: 12 loci as highly
discriminative (h ( 0, 5): MIRU 4, MIRU 10, Miru26, Miru 31, ETR C
Mtub 21Mtub 4, QUB11b, ETR A, Mtub39 QUB 26 and QUB4156.
Three loci as moderately discriminative (0.2 < h £ 0.5): MIRU 16,
MIRU 40, Mtub39
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With the nine most polymorphic loci, we obtained the same initial result
that with the 15. We consider that these nine loci are distinctive enough
for initial epidemiological studies and allow us to save time and
minimize expenses.
Conclusion: Analysis of allelic diversity is a powerful tool to deﬁne a
ﬁrst line set that will be discriminative for M. bovis strains in Tunisia.
Improved discrimination between isolates is needed for better tracing of
epidemiological links and identifying the source of contamination.
R2601 Comparison of AMOS, MLVA and Bruce-Ladder assays
for typing of Brucella spp.
M. Weiner*, W. Iwaniak, K. Szulowski (Pulawy, PL)
Brucellae are intracellular bacteria that are pathogenic for humans and
animals. The infection generally results from transmission via the
gastrointestinal route by the consumption of unpasteurised dairy
products. A genus-speciﬁc PCR assay is sufﬁcient in diagnosis of
human brucellosis or contamination of food products. However, the
species-speciﬁc differential assays are needed for epidemiological
investigation and ﬁnding the source of infection. The ﬁrst assay, based
on the polymorphism of IS711 region was AMOS PCR. Then, Bruce-
ladder which allowed molecular typing of all Brucella species was
proposed as ofﬁcial in OIE Manual. Parallely, a new ‘‘ﬁngerprinting’’
approach, multiple-locus variable-number tandem repeat (VNTR)
analysis (MLVA) was described. The aim of the study was to perform
a comparisonal study of AMOS, Bruce-ladder and MLVA for typing of
Brucella spp. The Brucella reference strains: B. abortus bv. 1, 2, 3, 4, 5,
6, 9, B. melitensis bv. 1, 2, 3, B. suis bv. 1, 2, 3, 4, 5, B. ovis, B. canis
and B. neotomae strain were used. Moreover, 138 the Brucella clinical
isolates were examined. We observed that AMOS PCR could correctly
identify only B. abortus bv1, bv2, and bv4, B. suis bv1, three biovars of
B. melitensis (bv1, bv2, and bv3) and B. ovis. A major advantage of the
Bruce-ladder PCR assay was that it could identify and differentiate for
the ﬁrst time all of the Brucella species and the vaccine strains in the
same test. In contrast to AMOS PCR, Bruce-ladder PCR was also able
to detect DNA from B. canis, B. neotomae, B. abortus biovars 3, 5, 6,
and 9, and B. suis biovars 2, 3, 4, and 5. The only one disadvantage of
this assay is that the high quality DNA polymerase should be used.
MLVA analysis has been developed for molecular typing of Brucella.
In our study we could correctly recognise the species among B. aborus,
B. melitensis, B. ovis and B. neotomae using VNTR6, VNTR8,
VNTR11, VNTR12, VNTR42, VNTR43, VNTR 45 and VNTR55.
Using the reference strains of B. abortus bv5 we observed the same
VNTR proﬁle as B. abortus bv9. Using MLVA we could not
differentiate B. canis from B. suis bv4. Only Bruce-ladder correctly
identiﬁed the species of all Brucella strains tested. Moreover, this assay
is performed in one step, comparing to the MLVA which needs at least
eight separated PCR ampliﬁcations. In conclusion, Bruce-ladder PCR
can be a useful tool for the rapid species identiﬁcation of Brucella
strains.
R2602 An outbreak of multidrug-resistant Acinetobacter
baumannii producing the carbapenem hydrolysing
oxacillinases in an intensive are unit in Turkey
A. Basustaoglu*, A. Uskudar Guclu, O. Bedir, A. Kilic (Ankara, TR)
Objectives: We aimed to analyse the spread of Acinetobacter
baumannii in the intensive care unit of Gulhane Military Medical
Academy (GMMA) Hospital from march to may 2010. Outbreak
investigation based on a prospective ICU surveillance.
Methods: GMMA Hospital is a 1500-bed teaching hospital in Ankara,
Turkey. Two doctors, ﬁve nurses work in the 11-bed Intensive Care
Unit. Twelve clinical A. baumannii isolates from seven patients and
eight A. baumannii isolates from 51 environmental specimens were
investigated. Identiﬁcation and antimicrobial susceptibility testing were
performed by both conventional methods and Phoenix System. The
presence of carbapenemase was tested by Modiﬁed Hodge test (MHT).
To determine the cause of carbapenem resistance, four groups of OXA
carbapenemase genes (OXA-23, OXA-24, OXA-51 and OXA-58) were
searched by multiplex PCR, metallo beta -lactamase (MBL) presence
was investigated by MBL E-test. Pulsed-ﬁeld gel electrophoresis
(PFGE) using ApaI restriction endonuclease was performed for
genotyping.
Results: Twenty multidrug resistant A. baumannii isolates were
recovered: six from catheter, four surgical wounds, one blood, one
pleural effusion and eight from environmental samples. All A.
baumannii isolates were resistant to gentamicin, cefotaxime,
ceftazidime, cefepime, imipenem, meropenem, piperacillin-
tazobactam, and cotrimoxazole. Resistance rate to amikacin was 70%.
All isolates were susceptible to colistin. MHT was positive for all
strains. There was no MBL activity. All of the isolates had blaOXA-51,
15 isolates had blaOXA-23, and ﬁve isolates had blaOXA-58 genes.
PFGE analysis of outbreak-isolates indicated the presence of two
clones. Nine isolates from four patients and six environmental strains
had similar PFGE patterns and three clinical isolates and two
environmental strains had another clone. The ﬁrst clone was ﬁrst
isolated from pleural effusion of patient transfered to ICU. This clone
was also isolated from the emergency trolley and from drug trolley of
the second patients. The second clone was spread from medicine
trolley.
Conclusion: OXA-23 and OXA-58 were the source of carbapenem
resistance in our A. baumannii isolates. The clonal dissemination of A.
baumannii strains in ICU was conﬁrmed by molecular method.
Environmental contamination, close contact patients and health care
workers, and widespread imipenem use were the important factors that
lead rapid clonal spread of multi-drug resistant A. baumannii.
R2603 Phylogenetic analysis of b-lactamases
C. Stein*, O. Makarewicz, P.M. Keller, M.W. Pletz (Jena, DE)
Objectives: Recently, the number of annually identiﬁed b-lactamases
with extended spectrum activity (ESBL) against cephalosporins (ESBL)
or activity against carbapenems (etc. NDM-1, VIM) has been
dynamically increasing. In contrast to MRSA, an overall rapid and
reliable PCR-based test to detect the presence of all ESBL- and other
clinically relevant beta-lactamase (i.e. KPC, VIM etc.) in clinical
samples is difﬁcult to develop because of the high sequence diversity of
different beta-lactamase-subtypes. In preparation to develop such a test
we analyzed all amino acid sequences of b-lactamases available from
NCBI data base by performing an overall phylogenetic analysis and
correlation to substrate-inhibitor proﬁles.
Methods: In total, 643 sequences with at least 200 residues could be
aligned and analyzed using DS Gene 1.5 software (Accelrys Ltd) with
the phylogenetic method by neighbor joininging. The resulting
phylogenetic tree was correlated to the functional properties proposed
by Bush and Jacoby in 2010 [1] and analyzed in detail.
Results: As expected, the sequence alignment reﬂected the differences
in substrate patterns of the b-lactamases. Closer relationships were
found for AmpC and OXA types, whereas GES, CTX-M, IMI and KPC
formed another phylogenetic group. Moreover, we indentiﬁed mutation
hot spots, which are responsible for speciﬁc changes of the phenotype.
Conclusion: We identiﬁed some unique amino acid substitutions that
cause speciﬁc changes in the phenotype of TEM indicating that better
understanding of substitution’s dynamics within the types might
simplify the prediction of the phenotype by SNP typing. We focus on
the validation of such unique substitutions within the other molecular
classes that exhibit much higher sequence variation compared to TEM.
1. Bush, K. and G.A. Jacoby, Updated functional classiﬁcation of b-
lactamases. Antimicrob Agents Chemother, 2010 54(3): 969–76.
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R2604 Phylogenetic analysis with Multi Locus sequence typing
reveals a potential new clade of Clostridium difﬁcile
E.M. Terveer*, C.W. Knetsch, D.W. Notermans, H.C. van Leeuwen,
E.J. Kuijper (Leiden, Bilthoven, NL)
Objectives: Clostridium difﬁcile is the most frequent cause of
nosocomial diarrhoea worldwide. Since 2004, the reported incidence
of this disease has increased signiﬁcantly, particularly of the notorious
‘‘hypervirulent’’ PCR ribotypes 027 (RT027) and RT078. Recently,
PCR ribotypes that are closely related to RT 027 and RT 078 have been
identiﬁed, representing a 027 lineage and a 078 lineage, respectively.
However, little is known about their phylogenetic classiﬁcation.
Currently, a large variety of typing techniques is in use for C.
difﬁcile. This can be confusing, especially when typing techniques
contradict each other. For example one PCR RT122 isolate belonged to
the above mentioned 027 lineage, while several other PCR RT122
isolates did not. Since Multi Locus Sequence Typing (MLST) is a
technique suitable for studying the phylogenetic relationships, this
technique was applied to analyze potential relationships of various C.
difﬁcile RTs within the 027 lineage and the 078 lineage as well as
several controversies of C. difﬁcile strain typing.
Methods: MLST was performed using the method described by
Grifﬁths et al. The concatenated MLST sequences were used to
construct a phylogenetic neighbour-joining tree with MAFFT. All C.
difﬁcile isolates included in the study are derived from the National
Reference Laboratory (RIVM, LUMC)
Results: In total, 94 C. difﬁcile isolates belonging to 75 different PCR
ribotypes were investigated using MLST. In addition to the already
described ﬁve evident clades of C. difﬁcile, a potential sixth clade was
discovered. This clade comprises of one sequence type, ST-122
associated with RT131. This type is found in humans, although
infrequently. Furthermore, it was observed that the hypervirulent PCR
ribotypes 027 and 078 are present within two distinct clades, which also
harbour several other PCR ribotypes that are highly related to RT027
and RT078. Analysis of the posed controversy showed that C. difﬁcile
RT122 with the 027 marker is typed as a different sequence type
located in a divergent clade as RT122 not containing the marker.
Conclusion: PCR ribotyping is a less effective typing method for
studying close phylogenetic relations. MLST can accurately link groups
of isolates and thereby appears to be an appropriate method for
recognition and classiﬁcation of potential hypervirulent strains.
Furthermore, a new sixth clade is identiﬁed, of which the clinical and
epidemiological relevance is under study.
R2605 Culture-independent detection of Mycobacterium
marinum: the cause of cutaneous infections in humans
M. Slany*, P. Jezek, M. Bodnarova, I. Pavlik (Brno, Pribram, Prague,
CZ)
Objectives: The low frequency of infection caused by non-tuberculous
mycobacteria (NTM), non speciﬁc symptoms and requirements of
speciﬁc cultivation approaches could detract from a correct diagnosis.
Infections caused by NTMs are increasing nowadays because of living
style, environment and other factors affecting human’ susceptibility to
diseases. In the Czech Republic is reported each year around 100 cases
of conﬁrmed NTM infections (source: U´ZIS). The most frequently
isolated agents are: MAC (50%), M. kansasii (20%), M. xenopi (12%)
and other PPM (18%, M. marinum, M. malmoense and others). M.
marinum, the cause of chronic systemic infections in ﬁsh, occasionally
causes granulomatous skin lesions involving the hands, forearms,
elbows and knees in humans reporting contact with water environment.
Methods: Rapid, sensitive and speciﬁc method for the detection of M.
marinum in human and animal samples was set up in this study. The
duplex real-time PCR assays (erp) described here provides a fast,
sensitive and speciﬁc diagnosis of M. marinum, in comparison to more
time-consuming conventional PCR and DNA hybridization methods.
Results: We developed a quick and sufﬁciently sensitive system for
the detection of M. marinum in tissue samples. Developed qPCR
system was successfully used for detection of M. marinum infection in
four humans. Interestingly, one of the patients was previously
misdiagnosed and treated with methylprednisolone for period of
3 month, which resulted in a rare systemic spread of M. marinum
into the testis and epidimidis. Simultaneously, the screening for M.
marinum presence in all patients’ aquaria revealed positive ﬁsh.
Conclusion: The protocol used enabled us to complete analysis of
sample, including controls, in approximately 6 hour; including
extraction and assay time, and is suitable for implementation in
routine laboratory diagnostics. To our best knowledge, this is the ﬁrst
report of detection and quantiﬁcation of M. marinum directly from
infected human tissue. This approach could also be beneﬁcial for
detection of mycobacterioses in ﬁsh aquaculture, where M. marinum
infections results in economic losses.
This work was supported by Grants Nos. MZE0002716202 and
QH91240 from the Ministry of Agriculture and Grant ‘‘AdmireVet’’
No. CZ 1.05/2.1.00/01.0006-ED0006/01/01 from the Ministry of
Education, Youth and Sports of the Czech Republic.
R2606 Concordance between pulsed ﬁeld gel electrophoresis and
sequence-based typing techniques in the study of
legionnaires’ disease outbreaks
M. Garcia-Nun˜ez*, M.L. Pedro-Botet, A. Serrano, S. Quero,
L. Millares, S. Catini, M. Farras, L. Mateu, M. Sabria
Leal (Barcelona, ES)
Objectives: To evaluate the concordance between the Pulsed Field Gel
Electrophoresis (PFGE) and Sequence-Based Typing (SBT) techniques
in the study of Legionnaires’disease (LD) outbreaks.
Methods: We included six outbreaks of LD according to
epidemiological surveillance and PFGE results that occurred in the
Catalan Autonomous Community. We analyzed nine clinical and 39
environmental Legionella pneumophila isolates. The strains were typed
by Sﬁ I-PFGE and by SBT method according to the European Working
Group for Legionella Infections (EWGLI) standard protocol (7 genes)
and database.
Results: SBT method showed an 83.3% (5/6) concordance with the
PFGE method in identifying the source of the outbreak. In the non-
concordant outbreak clinical and environmental strains showed the
same ST proﬁle and one band difference in the PFGE proﬁle. Other data
should be noted: (i) Some environmental epidemiologically related
strains with minor molecular differences such as only 1–2 bands in the
ﬁngerprinting PFGE proﬁle were indistinguishable by SBT method,
although different from the epidemic strain, and (ii) In one case, two
molecularly different (four bands) environmental isolates corresponding
to the same outbreak were identical by SBT.
Conclusions: Although preliminary, the results of this study show that
SBT has a good concordance with PFGE method in identifying the
source of a LD outbreak. Nevertheless, some discordances observed
between both methods, lead us to consider SBT, if conﬁrmed in a larger
number of outbreaks, as a screening technique in epidemiological
molecular studies of LD outbreaks. In order to achieve a cost-effective
screening tool, a proposal would be to analyze some of the seven genes.
Currently, we are analyzing more isolates to know the true role of SBT
technique in the investigation of the source of LD outbreaks.
Funded by FIS 10/0191.
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R2607 From manual to automated processes in molecular
diagnostics of infectious diseases
J.W.A. Rossen*, J.M. Verbakel, P.C. van Esch, W. Ritmeester,
L.P.J. Broers, A.G. Buiting (Tilburg, NL)
In a therapy-based setting fast reporting of diagnostic results is key. The
laboratory equipment must support this ‘‘need for speed’’. But what
criteria does this exactly include? We run a multitude of laboratory-
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developed and commercial assays, plus we receive samples throughout
the day from many sources. Also the kind of biological material varies,
as well as the tube formats. All these factors are quite a challenge when
it comes to quick reporting of the results. Therefore, we decided to
evaluate our workﬂow, identify potential for improvement, and deﬁne
the ‘‘must haves’’ for new equipment accordingly.
It appeared that the reduction of administrative tasks was crucial for a
workﬂow improvement in our lab. If the workﬂow involves creating the
plate setup, looking at controls manually, typing results into LIS, or
analyzing PCR curves, then all of this is much too time-consuming and
also prone to errors, which could put patient results at risk.
So any new equipment would need to provide automated solutions for
the test setup and reporting. It should follow lean principles like less
waste and one-piece ﬂow. A connection with the LIS would be utmost
important.
Here, we evaluate our new automated workﬂow solution, following the
criteria deﬁned earlier. For many criteria the newly purchased
QIAsymphony RGQ provided what we were looking for — ﬂexible
throughput, in process loading, no reagent waste, and the possibility to
load different input and output tubes. The only thing we were missing
was the integration with our existing LIS, but we solved this by
developing the middleware in cooperation with a Dutch company
(Bode´gro) specializing in software development for laboratory auto-
mation. Here we present the results of the evaluation of the old
workﬂow, the steps we took to improve it and the middleware solution
we developed.
R2608 The protective effect of speciﬁc blocking TREM-1 on
endotoxin-induced acute lung injury in mice
G. Qin*, L. Ning (Nanjing, CN)
Objective: To explore the protective effect and its mechanism of LP17
for speciﬁc blocking TREM-1 on endotoxin-induced acute lung injury
in mice.
Methods: 36 BALB/C mice were randomly divided into three groups:
control group, ALI group and LP17 group, intraperitoneal injection of
lipopolysaccharide (LPS) to establish a mouse model of ALI,
intravenous injection of LP17 (3.5 mg/kg) to establish LP17 group,
comparing the groups 6, 12, 24, 48 hours lung pathology Smith score
using enzyme-linked immunosorbent assay (ELISA) determination of
the point in the lung tissue and serum tumor necrosis factor-a (TNF-a),
interleukin -10 (IL-10), TREM-1, sTREM-1 levels. At the same time,
using ﬂuorescence quantitative RT-PCR to detect the expression of
TREM-1mRNA point.
Results: (i) The lung pathology showed, LP17 makes 12, 24, 48 hours
lung pathology Smith score decreased signiﬁcantly (p < 0.05). (ii)
TNF-a of lung tissue homogenate showed, LP17 group’s TNF-a levels
decreased gradually with time changing, and TNF-a of 12, 24 hours
point lower than the same time point of ALI group (p < 0.05); TNF-a of
serum showed, TNF-a of 24, 48 hours-point lower than the same time
point of ALI group (p < 0.05). IL-10 concentrations of lung
homogenates and serum have been maintaining at a high level,
48 hours was signiﬁcantly higher than ALI group’s (p < 0.05). (ii)
TREM-1 of lung tissue homogenate showed, TREM-1 concentrations
of 12, 24 hours point lower than the same time point of ALI group
(p < 0.05); Blood and lung tissue expression of TREM-1mRNA results
showed, TREM-1mRNA expression in blood of LP17 group in the 12,
48 hours were lower than ALI group at the samt time point (p < 0.05),
TREM-1mRNA expression in lung tissue of LP17 group in the 12,
48 hours were lower than ALI group at the samt time point (p < 0.05).
Conclusion: LP17 lung tissue by blocking TREM-1 signiﬁcantly
reduced LPS-induced ALI in mice lung tissue inﬂammation, improved
inﬂammatory imbalance, the protection does not depend on the gene
level.
R2609 Infections as factors of genome destabilisation and
manifestation of hereditary diseases
O. Grechanina, J. Grechanina, O. Vasylieva* (Kharkiv, UA)
The importance of methylation in the etiopathogenesis of hereditary
diseases can open new possibilities of their therapy. It is known that in
human cells viral DNA sequences can be methylated, which leads to
blockage of transcription and subsequent elimination of the virus. But
in a genetically determined deﬁciency of enzymes folate cycle (DEFC)
is an infringement of these processes. Therefore, to study the role of
DNA methylation as a component of the cell ‘‘immune system’’ in
DEFC is an urgent problem.
Objective: To investigate the relationship DEFC with carriage
TORCH and urogenital infections (UGI) in maniﬁstetion of
hereditary diseases.
Methods: Molecular study of 62 patients with various forms of
hereditary diseases and clinical manifestations of DEFC. By PCR
method investigated polymorphisms of folate cycle genes C677T
MTHFR and A66G MTRR, DNA study of UGI and TORCH: Herpes
simplex virus I, II (HSV), Cytomegalovirus (CMV), Chlamydia
trachomatis (Chl.tr.), Toxoplasma gondii (Toxo), Mycoplasma
hominis (M.h.), Mycoplasma genitalium (M.g.), Ureaplasma
urealiticum (Ur.ur.).
Results: In 58 (93.5%) of patients identiﬁed the presence of
polymorphisms C677T MTHFR and/or the A66G MTRR.
Compounds alleles MTHFR/MTRR were follows: hmzg/hmzg – 6
(9.7%); htrzg/htrzg – 11 (17.7%); htrzg/hmzg – 13 (21.0%); hmzg/htrzg
2 (3.2%); N/hmzg – 15 (24.2%); N/htrzg – 6 (9.7%); hmzg/N – 0; htrzg/
N – 5 (8.1%); N/N – 4 (6.4%). In 51 (82.3%) patients were identiﬁed
carrier of UGI and/or TORCH. The most frequently identiﬁed carrier of
CMV – 18 (29%) and Ur.ur. – 17 (27.4%) patients. The analysis of
infections combination with the presence of MTHFR/MTRR
polymorphisms: most common carriers of HSV were detected by a
genetic compound htrzg/hmzg – in 30.8%, CMV – with htrzg/htrzg in
36.4% and htrzg/hmzg in 23.1%, Chl.tr. – with htrzg/htrzg in 27.3%,
M.h. and M.g. – with N hmzg in 20%, Ur.ur. – with htrzg/htrzg in
36.4% and htrzg/hmzg – in 30.8%.
Conclusions: The most frequently carrier TORCH and UGI associated
with compound heterozygous MTHFR/MTRR, wich corresponded with
severe hereditary diseases clinic. Therefore we can assume that with a
decrease in methylation in the cells can be observed an increased
activation of infectious factors leading to the launch mechanism of
genome destabilization and manifestation of hereditary diseases. Diet
and cofactor therapy are an integral part of the pathogenetic therapy of
these disorders, wich can improve the condition of patients with DEFC.
R2610 The contribution of a multiplex real-time PCR to detect
bacterial and fungal bloodstream infections in a cohort of
thoracic allograft recipients
A. Chaidaroglou*, E. Manoli, D. Aggelaki, P. Gourzi, M. Pantou,
V. Kolovou, G. Saroglou, D. Degiannis (Kallithea, GR)
Objectives: Bloodstream infections (BSIs) are a major cause of
morbidity and mortality in thoracic allograft recipients. The early and
accurate identiﬁcation of the responsible pathogen and the
administration of the appropriate treatment are of critical importance
for improved patient survival. In the early post-transplant (Tx) period
(0–2 months post-Tx) when recipients are receiving empirical antibiotic
treatment, detection of pathogens by the conventional blood culture
(BC) methodology may be hindered by the empirical broad-spectrum
antibiotic therapy administered for preventing post-transplant
infections. In the present study we investigated the potential clinical
utility of a multiplex real-time PCR system (SeptiFast, Roche
Diagnostics) to detect BSIs infections in a cohort of thoracic allograft.
Methods: The study included the analysis of 130 blood samples from
30 thoracic allograft recipients (23 heart and seven lung) using
SeptiFast in parallel with BC. Samples were drawn when there were
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clinical and laboratory signs of a BSI. The applied multiplex real-time
PCR assay allowed the detection of a wide panel of Gram-positive and
Gram-negative bacteria and fungi in 6 hours and was performed
according to manufacturer’s guidelines.
Results: Real-time PCR yielded concurrent negative and positive
results with BC methodology in 113 (86.9%) and 5 (3.9%) samples,
respectively, with 100% concordance in species identiﬁcation. Diverging
results were obtained in 9 (6.9%) samples, where only real-time PCRwas
positive and in 3 (2.3%) samples, where only blood cultures were
positive. Eight of the PCR-only positive samples were drawn from
patients during the early post-transplant period when they were under
empirical antibiotic treatment. The combined use of SeptiFast and BC
increased the number of positive samples detected to 17 (13.1%) from 14
(10.8%) detected with SeptiFast alone or from 8 (6.1%) detected with
BC alone. In cases of concurrent positivity, SeptiFast results were
available on average 1.5 days earlier than BC results.
Conclusion: The PCR-based SeptiFast test is a valuable add-on to the
traditional BC method for the rapid etiological diagnosis of BSIs in
thoracic transplant recipients, especially during the immediate post-
transplant period when empirical antimicrobial therapy is also
administered to the recipients.
R2611 Association of tumour necrosis factor–alpha gene
polymorphisms with susceptibility to respiratory virus
infection
M.K. Lee*, T.H. Kim, B.S. Shim (Seoul, KR)
Objectives: Tumor necrosis factor-alpha (TNF-a) is a proinﬂammatory
cytokine that is important in the innate host defense and thus in the
defense of infectious agents. It has been known that several TNF-alpha
gene polymorphisms in a promoter region are related to TNF-alpha
production. Among them, the G to A substitution at the position 308
(TNF-alpha 308 A) and at the position 238 (TNF-alpha 238 A) in the
TNF-alpha promoter are associated with the high or low production of
TNF-alpha .The aim of this study was to investigate whether these
genetic variants of TNF-a were associated with susceptibility to
respiratory virus infection.
Methods: This study included 183 children hospitalized as a result of
respiratory symptom. DNA was extracted from nasopharyngeal
aspirates and tested several times (more than two times) with Seeplex
TM RV detection kit. Susceptible group consisted of 137 patients with
more than 50% positive ratio in test and non-susceptible group
consisted of 46 patients without any positive results. We used ﬁve
primers and two separate polymerase chain reaction (PCR) to detect the
TNF-polymorphism by the multiplex ampliﬁcation refractory mutation
system (ARMS) technique.
Results: No statistically signiﬁcant difference in the -308 and -238 A
allele frequencies was found between two group.
Conclusions: These ﬁndings suggest that TNF-alpha polymorphism
did not show genetic predisposition with regard to susceptibility to
respiratory virus infection.
R2612 Performance of a commercial real-time PCR test in the
diagnosis of toxoplasmosis
V. Meroni*, A. Vola, F. Genco (Pavia, IT)
Objectives: PCR test is widely employed in the diagnosis of
congenital, ocular and in immunosuppressed patients toxoplasmosis.
Most laboratories use in house PCR either conventional or Real Time.
In the last report of Quality Control for Molecular Diagnostics 2010
External quality assessment programme (QCMD2010 Toxoplasma
gondii EQA Programme) 77% of the data came from in house PCR
which continues to be the dominant technology. We aimed evaluating
the performance of TOXOPLASMA Q-PCR Alert Kit (Nanogen
Advanced Diagnostics S.p.A Buttigliera Alta, Italy) a commercial Real
Time PCR assay.
Methods: From October 2009 to October 2011 we tested 309
samples:173 amniotic ﬂuid (AF) from treated mothers with
toxoplasmic infection,69 peripheral blood (PB), 57 cerebrospinal ﬂuid
(CSF), seven aqueous (HA) and one Vitreous humor from
immunocompromised patients (HIV positive and transplanted. DNA
was extracted from all the samples with NucliSENS EasyMAG
(BIOMERIEUX Marcy l’Etoile, France) according to manufacturer’s
instruction and kept frozen until used. Real Time PCR were performed
with the TOXOPLASMA Q-PCR Alert Kit onan ABIPRISM 7300
(Applied Biosystem Carlsbad, USA) following the manufacturer’s
instructions. The gene target is rep 529. All the samples were run in
triplicate and an internal control (beta Globin gene) and positive and
negative samples were included.
Results: Three out of the 173 amniotic sample tested positive and the
newborn resulted infected at birth in two cases; the third one is on
follow up. One hundred and three newborns completed follow up and
the negativity of PCR test was conﬁrmed by anti Toxoplasma antibody
absence at 1 year. The two positive PCR on CSF, (one of these patients
was positive also for PB) became negative after 1 month treatment. We
had also a PCR positive result in a vitreous sample. All the patients
improved after treatment. We detected with this kit all the positive
samples, even at the lowest concentration, of QCMD Toxoplasma
gondii EQA Programme.
Conclusions: All the 103 newborns from mother whose AF was
negative that completed the follow-up resulted not infected, the other
two with positive PCR had congenital infection. In immunosuppressed
patients diagnosis was quicker and made an early therapy possible.
Control 1 month later showed the therapy efﬁcacy. Sensitivity
compared to other in house methods seems to be the same. Real
Time Alert Q-PCR test seems to be very useful in the diagnosis of
toxoplasmosis on any biological sample.
R2613 Evaluation of the xTAG stool sample pretreatment pack
using the xTAG gastrointestinal pathogen panel
S. Morrison*, M. Shennan, H. Zhang (Toronto, CA)
Objectives: To achieve optimal nucleic acid extraction efﬁcacy,
especially for parasites, pretreating stool samples prior to nucleic acid
extraction is recommended when using the xTAG Gastrointestinal
Pathogen Panel (xTAG GPP). Here we describe the use and
performance of the xTAG Stool Sample Pretreatment Pack under
development for the pretreatment of stool samples prior to nucleic acid
extraction and subsequent testing with xTAG GPP.
Methods: Eighteen stool samples (from de-identiﬁed subjects with
gastroenteritis and asymptomatic subjects in which a cultured pathogen
was added to the stool) were used for a side-by-side comparison study.
One aliquot of each sample was pretreated with the procedure as
outlined in the xTAG GPP package insert using Bertin SK38 Soil Kit
bead tubes with NucliSENS easyMAG Lysis Buffer. The other
aliquot from the same sample was pretreated with xTAG Stool Sample
Pretreatment Pack under development which contains pretreatment
bead tubes and pretreatment buffer. All pretreated samples were
extracted with easyMAG. Aliquots from additional four samples that
were pretreated with xTAG Stool Sample Pretreatment Pack were used
to assess the compatibility of the pretreated material with four different
nucleic acid extraction platforms including QIAamp MinElute Virus
spin kits, the QIAsymphony, the Roche MagNA pure and
BioMerieux easyMAG systems. All extracted nucleic acid was
analyzed with xTAG GPP on a Luminex 200TM system running
xPONENT 3.1 software.
Results: All 18 samples prepared with the xTAG Stool Sample
Pretreatment Pack gave the correct calls when assessed with xTAG
GPP. Speciﬁc MFIs were mostly comparable between samples treated
with the xTAG Stool Sample Pretreatment Pack and the NucliSENS
buffer and Bertin beads. Interestingly, samples treated with the xTAG
Stool Sample Pretreatment Pack showed relatively lower rate of PCR
inhibition (0/45 for 15 samples in triplicate) than samples treated with
NucliSENS easyMAG Lysis Buffer (3/45) as indicated by failure of
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internal control detection. In addition, samples processed with the
xTAG Stool Sample Pretreatment Pack were compatible with the four
nucleic acid extraction platforms evaluated.
Conclusions: The study showed that xTAG Stool Sample pretreatment
pack under development is a promising solution for stool sample
preparation prior to nucleic acid extraction and molecular testing.
Further evaluation of this pretreatment pack with a larger sample set is
warranted.
Diagnostic/laboratory methods (other than
molecular)
R2614 Comparison of cattle blood with sheep, rabbit and human
blood in blood supplemented media
K. Jayatilleke*, N.J. Pitigalage (Sri Jayewardenapura, LK)
Objective: Isolation of bacterial pathogens from clinical specimens is
still the ‘‘Gold Standard’’ in diagnosing infectious diseases. Isolation
of fastidious groups such as Streptococci, Neisseria and Haemophilus
species require blood supplemented media for their growth. Due to
lack of availability of recommended type of animal blood such as
sheep and horse blood, expired banked human blood is widely used in
developing countries. According to our experience and the experience
of previous workers, human blood agar shows poor haemolysis
pattern causing difﬁculty in identiﬁcation. Considering the wide
availability and dispersion of cattle throughout Sri Lanka, we are
assessing the overall suitability of cattle blood as an enrichment
substance in agar media in this study. We could not ﬁnd any
published studies determining the suitability of cattle blood for the
above purpose.
Methods: We performed a descriptive, laboratory based study from 1st
January to 30th April 2010. In this study, we tested the suitability of
cattle blood enriched media for growth, identiﬁcation, isolation from
clinical specimens and antibiotic sensitivity testing for a selected group
of bacteria. At the same time, we compared sheep, rabbit and human
blood which are being used in microbiology laboratories in Sri Lanka
currently for isolation of bacteria.
Results: Both deﬁbrinated and citrated forms of cattle blood gave
similar results for growth, identiﬁcation, isolation of bacteria from
clinical specimens and antibiotic sensitivity testing. Cattle blood gives
synergistic haemolysis in CAMP test for identiﬁcation of Group B
streptococci. Haemolysis patterns and degree of haemolysis is very
similar in sheep and cattle blood Haemolysis produced in human blood
agar was minimal when compared to animal blood agar. Results for the
disk diffusion antibiotic sensitivity testing were similar on sheep blood
enriched Mueller Hinton agar and cattle blood enriched Mueller Hinton
agar for the strains tested in the study.
Conclusion: Either deﬁbrinated or citrated cattle blood can be used to
enrich bacterial culture media for growth, identiﬁcation and isolation of
bacteria from clinical specimens. Further studies are necessary to
recommend cattle blood as an enrichment substance in antibiotic
sensitivity testing.
R2615 Gray-scale and Doppler ultrasonographic evaluation of
chronic osteomyelitis in clinical practice
F. Baziaka, V. Sakka, A. Balanika, I. Karaiskos, L. Galani,
A. Mpournazos, C. Baltas, P. Koutoukas, H. Giamarellou* (Athens,
GR)
Background: Chronic osteomyelitis (COM) in adults remains a
difﬁcult to treat disease. The key to successful management is early
diagnosis as well as targeted and long lasting antimicrobial therapy. Our
study aimed to carry out a useful framework for planning treatment of
the patients with COM using ultrasonography. Furthermore, we
evaluated how Color Doppler ultrasonography might be useful in
detecting and monitoring resolution of COM.
Methods: Patients with COM were evaluated over a 2 years period
(2009–2011). All patients were examined clinically for signs of
infection (pain, erythema, edema and present of a ﬁstula) at baseline
and after 3, 6 and 12 months. In parallel, a gray-scale and color Doppler
ultrasonography was performed for evaluation of progression of
treatment.
Results: A total of 45 patients (28 male, 17 female) with an average
period from initial diagnosis of COM of 23.3 months were included.
There were 11 infections regarding the upper body and 34 involving the
lower body, with the knee joint and the tibia representing the most
affected sites. Fifteen COM were post-traumatic, 24 were post-
operative, two were related to diabetic foot and four were primary. In
addition, 26 patients had opthopaedic devices and 29 were free of
foreign bodies. In 36 patients, a positive culture was identiﬁed (gram
positive in 18, gram negative in 10 and polymicrobial in 8. Upon
baseline evaluation, 39 patients had signs of infection and 18 had a
ﬁstula. Regarding ultrasonography, 35 patients had increased periosteal
vascularity, low-resistance arterial ﬂow, periosteal thickening,
discontinuity of the cortex with or without a ﬁstulous tract at
baseline, ﬁndings consistent with COM. After 3, 6 and 12 months of
treatment, 43% (15), 20% (7) and 26% (9) patients, respectively, had
shown improvement. Four patients were lost during follow-up. Finally,
a correlation between clinical and imaging ﬁndings was observed.
Conclusion: A gray-scale and color Doppler ultrasonography is a
useful, rapid and cheap tool for the guidance of treatment in chronic
osteomyelitis and of particular value in patients with metallic implants.
R2616 Serum procalcitonin increase in earthquake victims
associated with sepsis
L. Guo*, Y. Xie, M. Xiong, X. Lv, H. Fan, M. Kang, C. Tao,
Z. Chen (Chengdu, CN)
Objective: Procalcitonin (PCT) as the biologically active precursor of
calcitonin, had shown closely correlation with outcome of critically ill
patients. Serum concentration of PCT was rapid rising during bacterial
infections.
Methods: The PCT was assessed with C-reactive protein (CRP), Acute
Physiology and Chronic Health Evaluation II (APACHE II) and result
of blood cluture in rescuing earthquake vitims after Wenchuan
earthquake.
Results: A prospective, population-based investigation of sepsis was
conducted over a 7-month period. The trial was a prospective clinical
study with sepsis group and control group. The changing of serum PCT
were detected with ﬁrst, third and ﬁfth day after patients admitted in our
hospital. The sersum PCT was a marked increase in death group, while
CRP was slightly decline. In invalid group and improve group, sersum
PCT was rising with illness progresses and decreasing with
improvement, but CRP value was changed unconspicuously. The
mean value of PCT was signiﬁcantly different in gram-positive cocci,
gram negative bacilli and candida infection (p < 0.05). But in terms of
level of CRP and APACHE-II, no difference was found between
patients with sepsis (p = 0.551 and 0.733).
Conclusions: PCT is a very valuable diagnostic indicator of infection
and the advantage of PCT is supporting rapid diagnosis. Furthermore,
serum PCT levels increase more in patients with sepsis by GN than the
GP of fungi.
R2617 Evaluation of the new Vidas Lyme IgM and Vidas
Lyme IgG kits as screening test for the serological
diagnosis of Lyme borreliosis
B. Van Meensel*, M. Lontie (Leuven, BE)
Objectives: CDC currently recommends a two-tier testing algorithm
for Lyme disease: an enzyme immunoassay as a screening test,
followed by an immunoblot if the result is positive. We evaluated the
performance of the new generation Vidas Lyme IgM and Vidas
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Lyme IgG kits (Vidas LYM and Vidas LYG) as a screening test for
Lyme disease and compared it to the former Vidas Lyme test (Vidas
LYT – total antibodies). A commercial immunoblot (Borrelia Europe
plus TpN17, Virotech) was used as a conﬁrmation test.
Methods: A total of 143 frozen retrospective serum samples were
tested. All samples were already tested by the Vidas LYT assay using
an immunoblot to conﬁrm all positive results. The samples were
divided into four categories. Cat. I: 41 patients: Vidas LYT positive –
blot negative (false-positives)
Cat. II: 30 patients: Vidas LYT positive – blot positive (true-positives)
Cat. III: 21 patients: Vidas LYT positive – blot undetermined Cat. IV:
51 patients: Vidas LYT negative. All sera were then tested with
Vidas LYM and LYG assays.
Results: Cat. I: of the 41 samples, only nine had a positive Vidas
LYM and/or Vidas LYG result (78% less false positive results). Cat.
II: of the 30 samples, 28 were positive with the Vidas LYM and/or
Vidas LYG test. We noted a very good correlation between the IgM
and IgG results of the Vidas test and the IgM and IgG results of the
immunoblot (96% and 93% respectively). Cat. III: of the 21 samples, 11
were negative with the Vidas LYM and/or Vidas LYG test. In seven
of these 11 cases, we noted a discordance between the results of the
immunoblot and the clinical picture (erythema migrans-like vs. IgG blot
undetermined/IgM blot negative), so we can’t exclude the possibility of
false positive IgG immunoblots. Cat. IV: of the 51 samples, two were
positive with the Vidas LYG test (index 0.21/0.31). Both samples
were tested with immunoblot: one sample was negative; the other
sample had an undetermined blot IgG. No clinical information was
available.
Conclusion: The new generation Vidas LYM and Vidas LYG test,
based on recombinant protein technology, demonstrated a signiﬁcant
better speciﬁcity (78% less false positives) compared to the former
Vidas LYT test which is based on the native antigen. The sensitivity
seemed comparable between the two tests.
R2618 Controlling quality of blood culture’s preanalytical phase:
a benchmark of KPI’s
E. Willems*, A. Smismans, R. Cartuyvels, G. Coppens, K. Van
Vaerenbergh, A. Van den Abeele, J. Frans on behalf of the Bilulu Study
Group
Objectives and Methods: Blood cultures remain the most important
diagnostic tool for the detection of blood stream infections (BSI). Blood
culture yield can be improved by optimizing several factors in the
analytical phase but depends also on the quality of the preanalytical
phase. Quality control on blood cultures preanalytical phase can be
performed by measuring key performance indicators (KPI) and setting
thresholds for acceptable proﬁciency. Corrective actions should be
ensued to improve diagnostic accuracy when these limits are exceeded.
In ﬁve Belgian hospitals, a benchmark of the quality of blood cultures
preanalytical phase was performed by comparing the results of the
following KPI’s: the true positive rate, the contamination rate, and the
collected blood volume.
Results: In all ﬁve hospitals, the true positive blood culture rate fell
within the predeﬁned acceptation criterion of 5–15% (Baron et al.,
2005), whereas the contamination rate exceeded the target value (of
3%) in four locations. Most unexpected, more than one third of the
blood culture bottles was incorrectly ﬁlled, and this irrespective of the
manufacturer of the blood culture vials (Becton Dickinson [BD] and
bioMe´rieux). The main reason of this unexpected result is the lack of
correlation between the vacuum in the vials and the optimal blood
volume that needs to be collected. Therefore, it should be mandatory for
a laboratory to check the ﬁlling of their blood culture bottles regularly
and to provide feedback to their clinical staff. As a consequence of this
shortcoming, one manufacturer recently developed an automatic blood
volume monitoring system.
Conclusion: This study shows that quality control of blood cultures
preanalytical phase can reveal critical shortcomings in the preanalytical
process and ultimately leads to diagnostic improvement.
R2619 Stable combination discs of imipenem and dipicolinic acid,
for phenotypic detection of metallo-beta-lactamases in
Pseudomonas aeruginosa and Acinetobacter spp
J. Bou Casals* (Roskilde, DK)
Objectives: Inhibitor-based methods are used to detect metallo-beta-
lactamases (MBL) in Enterobacteriaceae, P. aeruginosa and
Acinetobacter spp. Combined discs with EDTA may show false
positive results with Acinetobacter and P. aeruginosa, due to the
intrinsic antibacterial activity of EDTA against these microorganisms.
Dipicolinic acid a potent inhibitor of IMP-1, VIM-1, VIM-2 and SIM-1
MBL has no intrinsic antibacterial effect against P. aeruginosa or
Acinetobacter spp. Imipenem + Dipicolinic acid combined disc is
expected to detect MBL in P. aeruginosa and Acinetobacter spp. A
comparative study was performed against Meropenem
10 lg + dipicolinic acid (DPA), which has shown its effectivity in
detecting MBL in isolates of Enterobacteriaceae.
Methods: Ten isolates of P. aeruginosa possessing either IMP-1 or
VIM-2 and 10 isolates of Acinetobacter spp. possessing either IMP-1,
VIM-2 or SIM-1 MBL were tested against Imipenem 10 lg and
Imipenem 10 lg + Dipicolinic acid as well as Meropenem 10 lg and
Meropenem 10 lg + Dipicolinic acid on MH agar with Mc Farland 0.5
inoculum. Zones of inhibition ‡5 mm larger with the combination discs
compared to the single discs, indicates the presence of a MBL.
Results: (i) Pseudomonas aeruginosa: 10 out of 10 MBL were
detected using Imipenem + DPA, while the Meropenem + DPA
combination detected 90% of the VIM-2, but only 40% of the IMP-1
producing isolates. (ii) Acinetobacter spp. The Imipenem 10 lg + DPA
combined disc detected 10 out of 10 MBL, while the Meropenem +
DPA disc detected nine out of 10 MBL.
Conclusion: Combination discs of Imipenem 10 lg and Dipicolinic
acid are very effective in detecting MBL in both Pseudomonas
aeruginosa and Acinetobacter spp. Sensitivity and speciﬁcity were
100%. nd speciﬁcity were 100%.
R2620 Diagnosis of intestinal parasitic infections using
ﬂuorescence microscopy
L.K. Nono*, L.G. Lehman, C.F.B. Bilong (Yaounde, Douala, CM)
Objective: Intestinal parasites are a real public health problem in
developing countries. They are generally responsible for many
symptoms among which malabsorption, anemia, abdominal pain and
diarrhea. The ﬁght against intestinal parasites requires multifaceted
approaches with prior identiﬁcation of the parasite species involved.
Diagnostic methods based on microscopic identiﬁcation of parasites
remain common in developing countries, despite their low sensitivity.
Recently, new ﬂuorescent microscopes with light emitting diodes have
improved the diagnosis of other protozoan parasites such as malaria
using a DNA-speciﬁc dye DAPI (4¢,6-diamidino-2-phenylindole. This
study was designed to compare a rapid ﬂuorescence microscopy –
based method for diagnosis of intestinal parasites to classical
microscopy and to collect epidemiological data in rural and urban
settings to Cameroon.
Methods: From september 2009 to march 2010, 583 stool samples
from outclinic patients were analyzed, including 300 in the city of
Douala and 283 in the rural area of Njombe. Each sample was
submitted to direct microscopic examination and formalin-ether
concentration technique. The observation under ﬂuorescence after
staining with DAPI and white light was made using a ﬂuorescence
microscope CyScope (Partec GmbH, Go¨rlitz, Germany). Statistical
analysis were done on SPSS statistics version 17 (SPSS Science Inc,
USA).
Results: Stool samples had less visible artifacts under ﬂuorescence and
helminth eggs were very clearly observed. In opposite, protozoa were
better distinguished using white light. The search for parasites was
positive in 155 (26.6%) of the 583 patients in the study. The prevalence
in Njombe was signiﬁcantly higher than Douala (39.2% against 14.7%,
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p < 0.001). The most common prevalent species in Douala was
Entamoeba histolytica (10.3%), while in Njombe, Schistosoma mansoni
dominated 13.1%.
Conclusion: This work has conﬁrmed a high prevalence of intestinal
parasites in a rural area of Cameroon and has also shown that the
simultaneous use of white and ﬂuorescence lights for stool exams could
help to better observe parasites. Thus, the use of ﬂuorescence
microscopy for routine diagnosis of intestinal parasites deserves
further investigation.
R2621 Comparison of different methods for the detection of
Clostridium difﬁcile and its toxins A/B in stool samples
S. Petersdorf*, B. Hornei, T. Hoppe (Bonn, Leverkusen, Cologne, DE)
Objectives: Clostridium difﬁcile associated diarrhea (CDAD) is the
most prevalent reason for nosocomial diarrhea and the incidence of
CDAD is increasing worldwide. Rapid and effective testing is
mandatory for optimal patient care and to stop transmission. We
evaluated the performance of various currently available ELISA and
rapid tests in comparison to the cell cytotoxicity neutralization assay
(CCNA) and culture.
Methods: Five hundred and two stool specimens from hospitalized
patients suspected of having CDI were included. All samples were
homogenized and tested by CCNA and culture, all further tests were
performed in parallel from the same sample. The following tests were
performed: ELISA: C. difﬁcile Toxin A+B (Seramun), Premier Toxin
A&B (Meridian), ProSpect C. difﬁcile Toxin A/B (Oxoid) and
RIDASCREEN C. difﬁcile Toxin A/B (R-Biopharm); rapid tests:
RIDAQUICKC. difﬁcile Toxin A/B (R-Biopharm) RIDAQUICKC.
difﬁcile Toxin A/B (R-Biopharm) and Xpect C. diff ToxA/B (Oxoid).
All tests were performed according to manufacturer¢s instructions.
Results: Among the 502 stool samples 108 (21.5%) were positive by
culture, 68 (14%) were positive by CCNA and 51 (12%) were positive
by CCNA and culture. For the ELISAs, we found a sensitivity,
speciﬁcity, positive and negative predictive value of 66%, 97%, 74%
95% respectively for C. difﬁcile Toxin A+B (Seramun), 82%, 98%,
85%, 97% for C. DIFF QUIK CHEK COMPLETE (Wampole), 81%,
98%, 85% and 95% for Premier Toxin A&B (Meridian), 87%, 96%,
78%, 98% for ProSpect C. difﬁcile Toxin A/B (Oxoid) and 90%, 97%,
81% and 98% for RIDASCREEN C. difﬁcile Toxin A/B (R-
Biopharm), respectively. The rapid tests revealed sensitivities,
speciﬁcities, PPVs and NPVs 85%, 99%, 92%, 98% for C. diff.
QUICK CHEK COMPLETE (Wampole), 94%, 97%, 83% and 99% for
RIDA QUICK C. difﬁcile Toxin A/B (R-Biopharm) and 72%, 94%,
66%, 96% for Xpect C. diff ToxA/B (Oxoid).
Conclusions: In contrast to CCNA, ELISA based tests can be
performed easily and render reliable results within a few hours. They
have become the method of choice for routine testing in many
laboratories. The RIDA QUICK C. difﬁcile Toxin A/B (R-Biopharm)
detecting toxin A/B reached the highest combined value (sensitivity +
speciﬁcity) and therefore performed even better than C. diff. QUICK
CHEK COMPLETE (Wampole) test, which consists of combined
GDH (glutamate dehydrogenase) + toxin A/B detection.
R2622 Validation of new liquid faecal swab for the detection of
Clostridium difﬁcile from faecal specimens with multiple
diagnostic assays
J.B. Laughlin*, K. Khan (Wexham, UK)
Objective: Pathology labs are being faced with the challenge of doing
more with less money. This has led to a dramatic surge in innovative
ideas and products. The pre-analytical process has been targeted
particularly as signiﬁcant improvements in efﬁciencies can be made
here. The majority of front-end solutions require liquid base approach to
the collection of samples which has led to the marketing of various
forms of liquid swabs. The latest foray into liquid based microbiology
comes from MW&E and its new liquid medium faecal swab. The goal
was an innovative specimen collection device that would automatically
transform the sample into liquid in standardized containers containing
medium speciﬁc for enteric pathogens. This study was carried out to
determine the compatibility of the liquid faecal swab with assays which
detect C. difﬁcile toxins A/B via an ELISA approach, GDH (Glutamate
Dehyrogenase) and a molecular test.
Methods:
• Fifty faecal specimens, of which 49 had tested positive previously for
C. difﬁcile direct from a faecal pot were used to validate the liquid
faecal swab device.
• The foam tipped swab of the collection kit was used to sample the
clinical material.
• The commercial kits used in the validation were: C.DIFF QUIK
CHEK by TechLab (A rapid test for the detection of C. difﬁcile
Glutamate Dehyrogenase); VIDAS C. difﬁcile Toxin A & B by
Biomerieux and the BD GeneOhmTM real time PCR assay by Becton
Dickinson.
• Testing of the commercial kits where according to manufacturer’s
protocols.
• A negative faecal liquid swab was tested for each kit as a control and
to determine if there was any interference from the liquid medium
(modiﬁed Cary Blair).
Results:
• Of the 50 samples tested 49 were positive utilizing all the above
named kits whether the sample was taken from the liquid faecal swab
or direct from a traditional stool container.
• The foam swab collected on average 136 mg of faecal material.
Conclusion:
• The dilution factor introduced by the liquid medium had no effect on
the result. There was a 100% correlation from doing the assay direct
from the stool or performing it from the faecal liquid medium.
• The Cary Blair medium had no effect on the PCR method. There was
a 100% correlation between doing the PCR direct on the stool sample
or straight from the inoculated Cary Blair.
R2623 Evaluation of a new chromogenic medium for isolation of
Clostridium difﬁcile
C. Eckert*, P. Schaaf, C. Me´nard, C. Elias, B. Burghoffer, V. Lalande,
F. Barbut (Paris, FR)
Objective: Rapid and effective methods for the isolation of
Clostridium difﬁcile are necessary to obtain isolates for typing and to
facilitate diagnosis of C. difﬁcile infections (CDI). chromID C. difﬁcile
agar (bioMe´rieux) is a new chromogenic medium for the isolation of C.
difﬁcile in 24 hours which recently came to the market. The objective of
the study was to assess the performances of this new selective medium.
chromID C. difﬁcile agar was compared to the CLO (bioMe´rieux) and
TCCA (Taurocholate Cycloserine Cefoxitin agar) media.
Methods: Four hundred and six untreated diarrheic stools from
patients suspected of CDI were plated on the three media and
incubated anaerobically at 37C. Cultures were read after 24 and
48 hours of incubation for chromID C. difﬁcile agar medium and after
48 hours for CLO and TCCA media. Suspensions of stools were
inoculated on media according to a standardized procedure in order to
perform a semi-quantiﬁcation of the endogenous ﬂora and C. difﬁcile
colonies. Identiﬁcation of C. difﬁcile was based on morphological
criteria (black and irregular colonies on chromID C. difﬁcile agar),
Gram stain and RapID 32 A galleries (bioMe´rieux).
Results: C. difﬁcile was recovered from 55 stools (13.5%) using a
combination of all the media. Forty (72.7%), 47 (85.5%), 46 (83.6%)
and 39 (70.9%) stools were positive on chromID C. difﬁcile agar in 24
and 48 hours, CLO and TCCA, respectively. Endogenous ﬂora was
absent in 67.7% 30.8%, 16.5% and 3.9% on chromID C. difﬁcile agar
24, 48 hours, CLO and TCCA respectively. Conversely, 3.9% of
chromID C. difﬁcile agar 24 hours, 15% of chromID C. difﬁcile agar
48 hours, 15.3% of CLO and 59.1% of TCCA showed abondant
endogenous ﬂora.
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Conclusion: Identiﬁcation of C. difﬁcile on chromID C. difﬁcile agar
in 24 hours is easy and sensitive. Moreover, this new chromogenic
culture medium appears to be highly selective.
R2624 Evaluation a chromogenic culture medium for isolation of
Clostridium difﬁcile from stool samples
J. Van Broeck*, C. Laurenzano, S. Dilmi, M. Delme´e (Brussels, BE)
Introduction: Culture of Clostridium difﬁcile from stool specimens
remains a gold standard in the diagnosis of C. difﬁcile infections (CDI).
By comparison with other rapid tests the delay to obtain a result is a
major drawback. CHROM ID CD TM (bio-Me´rieux, Lyon, France) is a
transparent chromogenic medium for the detection of C. difﬁcile.
Colonies grow black within 24 hours. We evaluated this medium
against our homemade CCFA medium and the commercial CLO-
medium TM (bio-Me´rieux, Lyon, France).
Materials and Methods: Stools were from adult inpatients of the St
Luc-UCL University hospital (890 beds) suffering from diarrhoea.
Stool samples, diluted in Cary-Blair medium (Copan) were inoculated
on CCFA, CLO and CHROM ID CD using a 30 lL loop. The CCFA
and CLO media were read after 48 hours, the CHROM ID CD after
24 hours. Identiﬁcation was conﬁrmed by MALDI-TOF (Bruker) mass
spectrometer. Cell cytotoxicity assay on MRC5 cells (CTA) and the
combined GDH-TOX A&B immunoassay (C. diff Quik Chek Complete
TM) were performed for toxin detection. PCR-ribotyping was
performed on all isolates using capillary gel electrophoresis. Toxin
detection on colonies was performed using CTA and a molecular assay,
illumigene (Meridian).
Results: A total of 86 stool specimens from 70 patients (36 F/50 M)
collected in May 2011 were tested. C. difﬁcile was isolated in 23
samples (27%). The strain was toxigenic in 15/23 cases. Results are
given in the Table: Culture was positive in 21/23 samples on CHROM
ID CD TM (against 18 on CCFA and 20 on CLO) and all isolates were
identiﬁed within 24 hours. However, in three cases, colonies did not
appear black but were easily recognized by binocular examination. Two
of these three isolates were toxigenic and belonged to the same
ribotype. The toxigenic status of the isolates was correctly identiﬁed by
illumigene applied on colonies from 24 hours cultures. GDH
correlated very well with positive cultures. Toxin EIA was positive in
8/15 stools with toxigenic isolates and CTA in 9/15.
Conclusion: The CHROM ID CD is a very sensitive medium for the
isolation of C. difﬁcile in stools in 24 hours.
R2625 Comparative study of Access immunoassay for the
detection of HIV antibody and antigen
S.B. Jørgensen*, B.C.T. Trinh, L.B.K. Steffarud,
T.M. Leegaard (Lørenskog, NO)
Objective: Access HIV combo is a new diagnostic paramagnetic–
particle chemiluminiscent immunoassay for the qualitative detection of
anti-HIV antibodies and antigen in human serum or plasma. The aim of
this study was to evaluate the performance of this assay in terms of
sensitivity, speciﬁcity and precision in our routine laboratory.
Method: Access HIV combo assay was evaluated on UniCel DxI 800
immunoassay system and compared to the Architect HIV Ab/Ag assay.
For the performance studies, we used 122 unselected serum samples
from blood donors, pregnant women and hospital patients. We used 55
reactive patient samples and seven quality control samples.
Results: Unselected serum samples tested on both Access and
Architect assays were all negative. The agreement between Access
and Architect assays was 100%. Among the 55 samples previously
reactive in the Architect assay, three tested negative in the Access assay.
Samples from these patients, and one sample that was reactive in both
assays, were negative when tested with a HIV RNA PCR and Western
Blot. The clinical speciﬁcity for Access HIV combo was 99.2% and the
sensitivity was 100% in this study. For the two assays precision was
equivocal.
Conclusions: Access HIV combo assay performance was very close to
the Architect assay. The performance obtained was excellent in terms of
clinical speciﬁcity and clinical sensitivity. Access HIV combo assay
used on UniCel DxI 800 is well suited for routine use in a hospital
laboratory with a high volume of HIV screening tests.
R2626 The Lean Six Sigma approach to improving patient
management cycle
P. Cichero*, C. Ossi, H. Palumbo, C. Brovero (Milan, IT; Marcy-
l’Etoile, FR; Firenze, IT)
Objectives: In challenging times where the containment of costs is
becoming a critical success factor, microbiology laboratories are under
pressure to continue delivering high quality results with an increased
focus on timings while optimizing the available resources. San Raffaele
Microbiology Lab had to reallocate 1 Full Time Equivalent employee
(FTE) to manage the increasing workload in the Mycobacteria and
Moleculare Biology Services. The main challenge was to make the
most of already available automated solutions in the lab by reorganizing
the current workﬂow.
Methods: Lean and Six Sigma are the two most powerful strategies to
achieve operational and service excellence in any organization today.
The Lab Performance Assessment was performed by two ‘‘Green belt
Lean Six Sigma’’ specialists and a Microbiology Application Specialist
in two main phases. The ﬁrst phase was performed in May 2011 with
the collection of all necessary indicators, the second phase, performed
in July 2011, was based on a 4-day observation at the lab with ﬁnal
recommendations. The roadmap obtained outlined how the lab could
improve procedures such as reducing time waste and enhance
efﬁciency, while simultaneously increasing results quality and
reducing errors.
Results: The current routine in the microbiology lab is performed
within 40 working hours per day with the existing dedicated resources.
The analysis has shown the possibility to save 10 working hours which
are equivalent to either 37% of productivity gained, or the reallocation
of 1.4 FTE to different activities. It was highlighted the management of
urines, which is 38% of the total number of specimens and 40% of the
total workload, resulted to be the main area for improvement. TAT was
70 hours which could be reduced by 50% (35, 5 hours) through the
new suggested workﬂow. These results were achievable through the full
integration of automated solutions, PREVITM Isola, PREVITM Color
Gram, VITEK 2, VITEK MS, together with the reorganization of the
workﬂow.
Conclusion: The purpose of the new workﬂow for the management of
the urines greatly improves the TAT and allows for the reallocation of
1.4 FTE to the Services with a high added value for patients. These
potential improvements will enable the lab to optimize the workload/
capacity ratio and manage the increasing activity in the near future.
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R2627 Evaluation of Sigma VCMTM for detection of Bordetella
pertussis and H1N1 (2009) inﬂuenza virus by real-time
PCR
I. Pedrosa-Corral, E. Cuadros-Moronta, S. Sanbonmatsu-Ga´mez,
M. Pe´rez-Ruiz*, J.M. Navarro-Marı´, D. Shedden (Granada, ES;
Corsham, UK)
Laboratory testing of pathogens involved in respiratory tract infections
require an appropriate sampling and transport medium to preserve
microorganisms. Nasopharyngeal swabs are usually collected for the
investigation of respiratory viruses and Bordetella pertussis infection.
Sigma VCMTM (SVCM) is a universal medium combined with swabs,
for collection and transport of viruses, Mycoplasma, Chlamydia,
Ureaplasma and Neisseria gonorrhoeae.
Objective: We evaluated the utility of SVCM for detection of B.
pertussis (BP) and H1N1 (2009) inﬂuenza virus (Flu-H1N1), compared
with conventional/routine transport media.
Methods: A total of 50 nasopharyngeal aspirates previously positive
for BP (n = 25) or Flu-H1N1 (n = 25) in 2011 (real-time PCR) were
used. Samples had been frozen at -80C. For BP investigation, two
aliquots of 200 lL of each thawed sample were placed in a sterile tube
and Sigma swabs and conventional swabs were introduced in each tube
and subsequently in SVCM or Amies transport (A) medium,
respectively. The same procedure was carried out for Flu-H1N1
investigation, SVCM was compared with in-house viral transport (B)
medium (Eagle’s MEM plus 1% bovine albumin and antibiotics). Tubes
were refrigerated at 4C for 24 hours. A-swabs were resuspended in
1 mL of sterile saline solution prior to molecular testing. Nucleic acids
were extracted from 200 lL of each sample, and speciﬁc real-time PCR
was carried out in parallel.
Results: BP DNA was detected in 23 (92%) cases in SVCM and B
medium (100% concordant), although increased recovery of DNA was
observed with SVCM (lower Cp in 21 samples, 91.3%). Cp difference
between the SVCM and the fresh sample (FS) ranged from -0.7 to 1.76,
and from 0.36 to 3.08 between A and FS (p < 0.05). SVCM was better
than B, qualitative and quantitatively, for Flu-H1N1 detection. Positive
results were obtained in 19 (76%) SVCM and in 17 (68%) B samples,
respectively; and increased recovery of viral RNA was observed with
SVCM (lower Cp in 15 samples, 79%). Cp difference between SVCM
and FS ranged from 2.79 to 5.53, and from 4.29 to 7.31 between B and
FS (p < 0.05).
Conclusion: SVCM is better than conventional transport media for the
investigation of Flu-H1N1 and BP in nasopharyngeal specimens.
SVCM avoids the need of several sampling from the same anatomic
site, since bacteria and viruses preserve efﬁciently in the same transport
medium.
R2628 Compare HBsAg cutoff index values of initially borderline
or weakly reactive samples with neutralisation results for
electrochemiluminescence immunoassay in China
D.D. Li*, T.T. Wang, H.X. Ning, C.M. Tao, X.H. Bi,
L.L. Wang (Chengdu, CN)
Objective: Hepatitis B surface antigen (HBsAg) is an important
serological marker for diagnosis of hepatitis B virus (HBV) infection.
The usual criteria for analysis of HBsAg are detection of HBsAg and
result conﬁrmation by antibody neutralization. We observed a relatively
high proportion of weakly reactive samples were false positive with
electrochemiluminescence immunoassay (ECLIA). In this study, we
compared cutoff index (COI) values of the borderline or initially
reactive samples (COI < 7.0) with HBsAg conﬁrmation test in order to
set up modiﬁed cutoff with an expectation of a decrease in complexity,
improved turnaround time, and decreased expense.
Methods: Two hundred and thirty-eight HBsAg initially borderline or
reactive sera or plasma with COI <7 were collected in West China
Hospital of Sichuan University. Each sample must be re-determined in
duplicate with Elecsys HBsAg II assay according to manufacturers’
instructions. All repeated reactive samples were conﬁrmed with HBsAg
neutralization assay.
Results: 48.7% (116 out of 238) samples, deemed as weakly reactive
(WR) samples, were found COIs < 2. Up to 12.1% (11 out of 91)
repeated WR samples didn’t pass conﬁrmation. Statistical analysis
indicated that more weakly reactive (WR) samples (100%) were found in
HBsAg negative group than those (42.7%) in repeatedly reactive group
(p < 0.05). There were 25 HBsAg negative samples and 11 samples
which didn’t pass the neutralization. And one of them was found HBV
DNA existed. All these samples were found with anti-HBc and anti-HBe.
In our study, we could improve the PPV from 95.2% to 99.4% and to
100% by setting up mortiﬁed cutoff values of 1.455 and 1.785.
Conclusion: It was the ﬁrst report of evaluation of ECLIA with
HBsAg conﬁrmatory test in lower COIs samples. Evaluation of HBsAg
prevalence through Elecsys HBsAg II will overestimate the true
positive, especially in WR samples. When interpreting WR samples,
one should look at the whole proﬁle of HBV tests and viral loads, in
addition to HBsAg neutralization test. Besides, arbitrary revised COIs
may decreased the need of HBsAg neutralization test.
R2629 Streptococcal Lanceﬁeld grouping using Thermo
Scientiﬁc PathoDxtra strep grouping kit
J. Beaves*, E. Scopes (Basingstoke, UK)
Objectives: Thermo Scientiﬁc PathoDxtraTM Strep Grouping Kit
(Thermo Fisher Scientiﬁc) and ProlexTM Streptococcal Grouping
Latex Kit (Pro-Lab Diagnostics) were evaluated to compare the
ability of the kits to accurately identify Lanceﬁeld grouped streptococci.
Methods: Three hundred and eleven Lanceﬁeld grouped streptococci
(56 group A [GAS], 85 group B [GBS], 30 group C [GCS], 93 group D
[GDS], 10 group F [GFS] and 37 group G [GGS]), 79 non-groupable
streptococci/enterococci and 29 non-streptococci isolates (including
Staphylococcus species) were inoculated onto Columbia Horse Blood
agar and incubated at 36 ± 1C overnight. Colonies were tested using
PathoDxtra Strep Grouping Kit and Prolex Streptococcal Grouping
Latex Kit according to manufacturer’s instructions for use. All isolates
had previously been identiﬁed using MALDI-TOF mass spectrometry
and sodA sequencing.
Results: Sensitivity of PathoDxtra Strep Grouping Kit when testing
individual streptococcal Lanceﬁeld groups was comparable to or greater
than Prolex Streptococcal Grouping Latex Kit: GAS 100% and 98.2%,
GBS 96.5% and 97.6%, GCS 100% and 86.7%, GDS 66.7% and
59.1%, GFS 100% and 90%, GGS 100% and 100% for PathoDxtra and
Prolex kits, respectively. Overall, sensitivity of PathoDxtra Strep
Grouping Kit (89.1%) was higher than Prolex Streptococcal Grouping
Latex Kit (85.2%). Speciﬁcities of PathoDxtra Strep Grouping Kit and
Prolex Streptococcal Grouping Latex Kit were comparable: 97.8% and
97.5%, respectively.
Conclusion: Overall, performance of PathoDxtra Strep Grouping Kit
was better than Prolex Streptococcal Grouping Latex Kit, especially in
detection of GCS and GDS. PathoDxtra Strep Grouping Kit showed
fewer cross reactions from both Lanceﬁeld groupable and non-
groupable streptococci isolates compared to Prolex Streptococcal
Grouping Latex Kit. Incorporating a vivid blue latex, PathoDxtra
Strep Grouping Kit gave clear, easily readable agglutination reactions
within 60 seconds.
R2630 Performance evaluation of multianalyte mariPOC
respiratory infection test for adenovirus types 1–8, 14, 19
and 21
H. Toivola, J.M. Koskinen, M. Lappalainen, R. Ruonamo,
P. Antikainen, J.O. Koskinen* (Turku, Helsinki, FI)
Objective: Multianalyte mariPOC test system allows efﬁcient point-
of-care testing of respiratory tract infections (CE marked). It applies a
fully automated random-access ﬂuorescent analyser and antigen
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detection. The coverage exceeds the test selection available as lateral
ﬂow rapid tests or immunoﬂuorescence assay kits (Figure). Both
pharyngitis, upper, and lower respiratory infections can be detected.
Sampling is done by a swab either from the nasopharynx or from the
throat. The test is extremely simple to operate and hands-on-time is less
than a minute per sample. It reports positive samples after 20 minutes,
while low positive and negative samples are reported in 2 hours. The
objective was to study mariPOC’s performance for the detection of
adenovirus types 1–8, 14, 19 and 21. A highly sensitive laboratory
method based on DELFIA technique was used as a reference test.
Methods: Heat inactivated adenovirus preparations of types 1, 3, 4, 5,
6 and 7 were purchased from the Department of Virology, Turku,
Finland as solutions of similar viral titres. Puriﬁed adenovirus hexon
protein of type 2 was from the same source. Adenovirus preparations of
types 14, 19 and 21, and positive clinical samples of types 2 and 8 were
from HUSLAB, Finland. The viral preparations were diluted with
mariPOC RTI sample buffer and analysed with the automated analyser.
Results: The analytical detection sensitivity of the mariPOC
adenovirus-speciﬁc method is 2 pM (0.7 ng/mL of antigen). This
level of sensitivity is among the best in the current mariPOC menu of
tested pathogens. The mariPOC detected all studied adenovirus types.
Preparations of types 1, and 3–7 had been produced by a similar
process and they were of similar titre. Preparations of types 2, 8, 14,
19 and 21 were produced by varying processes or were clinical
samples, and thus they were of varying viral titres. There was a high
correlation of signals between the mariPOC and the reference
DELFIA method (p = 0.84).
Conclusions: mariPOC detected all studied adenovirus types with high
sensitivity. These types cause most respiratory tract infections
associated with adenoviruses. The mariPOC is expected to be well
suited for rapid diagnostic testing of adenovirus infections. It has
potentially superior clinical speciﬁcity in etiological diagnosis
compared to PCR. Antigen testing ﬁnds better clinically meaningful
infections while PCR (especially of DNA) will also detect subclinical
infections, contamination and carriership.
R2631 The Modiﬁed Hodge Test negative predictive value among
carbapenem-resistant isolates in a Brazilian university
hospital
F. Rossi*, A.P. Cury, M.R. Franco, M. Maffucci, H. Caiaffa (Sao
Paulo, BR)
Objectives: Evaluate the Modiﬁed Hodge Test (MHT) performance to
rule out KPC in a Brazilian University Hospital.
Methods: From April 2009 to July 2011, 1521 Enterobacteriaceae
isolates not susceptible to ertapenem (ENSE), i.e. MIC > 0.5 mg/L,
were submitted to MHT. All the positive MHT isolates and 36% of the
negative MHT were also PCR tested for blaKPC2. Susceptibility Tests
were done by Vitek2  (AST-105 and 104) and the carbapenens drugs
were also tested by disk-diffusion and interpretation according to CLSI
M100-S11.
Results: Sixty-four percentage of the ENSE isolates were MHT
negative, 35.6% MHT positive and 0.4% MHT undetermined.
Among 541 MHT positive 84% were KPC and among 354 MHT
negative 100% was not KPC. Overall 30% (456) of the ENSE were
positive for gene blaKPC2 being 93% K. pneumoniae; 2% E. cloacae;
1.8% E. coli, 1.1% Serratia spp. and 2.1% other species. Of those
99.8% were MHT positive and only one isolate was undetermined.
KPC isolates antibiogram showed very high resistance rates among
distinct classes but aminoglycosides (amikacin 5%, gentamicin 12%
susceptible) and tygacil (25%). Colistin had an MIC50/90 of 0.5 and
16 mg/L respectively. KPC isolates had 69.8% resistant rate to
imipenem and 49.6% to meropenem by Vitek2 . Meropenem had a
30% of Very Major Error by the Vitek2. Among ENSE isolates the
MHT had 100% Sensitivity, 80% Speciﬁcity, 84% Positive Predictive
Value and 100% Negative Predictive Value (NPV).
Conclusion: MHT results had very good correlation with molecular
KPC and NPV was excellent. MHT is a good alternative phenotypic
tool for routine and low resource laboratories to easily rule out
carbapenemase isolates.
R2632 An investigation of the suitability of liquid transport
medium for recovery of enteric pathogens from faecal
specimens
K. Khan*, J. Laughlin (Slough, UK)
In recent years a number of automated processing systems have been
introduced into clinical microbiology laboratories. These systems
require a liquid specimen such as blood or urine as the matrix for
processing. Transport swabs are also available with liquid medium for
respiratory, urogenital, and wound specimens. Faecal specimens,
however, which account for a considerable proportion of specimens
in a routine clinical laboratory, could not be processed unless ﬁrst
emulsiﬁed and suspended in a broth. Recently a transport swab for
faecal specimens (Faecal Transwab) has been developed which at the
time of collection converts faecal specimens into a liquid specimens;
suitable for direct processing on automated platforms. The present study
was devised to investigate the performance over typical transport
periods of this new device with a range of important enteric pathogens.
Methods: The Clinical and Laboratory Standards Institute standard
M40-A describes methods for assessing the ability of transport devices
to maintain various microorganisms in a viable condition for up to
48 hours during transport at ambient or refrigerated temperatures. The
standard, however, does not include any enteric pathogens. The present
study used the principles and methods of CLSI M40-A to evaluate the
new device, adapted for the enteric microorganisms which are the target
for faecal swabs. Stock Test suspensions were prepared for Eschericia
coli 0157, Campylobacter spp., Shigella dysenteriae, Shigella ﬂexneri,
Shigella boydii, Shigella sonni, Vibrio cholerae, Salmonella typhi,
Salmonella typhimurium, and Salmonella enteritidis. Swabs in triplicate
were inoculated with dilutions of each microorganism, and held for 0,
24 and 48 hours at ambient temperature and refrigerated temperature.
After the holding period aliquots of the transport medium were
inoculated on to plates of the appropriate agar medium, incubated, and
any colonies were counted.
Results: Acceptable recoveries within the parameters for CLSI M40-A
were recorded for all organisms at refrigerated temperature, at the
ambient temperature over the 48 hours period a decline in the number
of colonies was observed.
Conclusion: This investigation has shown that Fecal Transwab
device can efﬁciently recover a range of enteric pathogens at
refrigerated temperature during simulated transport conditions over a
48 hours period, in compliance with the principles of CLSI standard
M40-A.
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R2633 Group B streptococcus carriage screening using direct
latex agglutination on selective broth
F. Ferrer*, M. Martı´nez, L. Robles, M.D. Crespo (Albacete, ES)
Objectives: Group B streptococcus (GBS) is a leading bacterial cause
of neonatal disease worldwide. CDC recommends a method to detect
GBS carriage in all pregnant women. The aim of the study was to
evaluate direct latex agglutination on incubated selective broth as a
screening method.
Methods: Two hundred and forty-ﬁve vaginorectal swabs submitted to
our laboratory during 1 month were tested by both methods. They were
immersed in SBM broth (Todd-Hewitt with gentamicin, nalidixic acid,
5% blood; Biomedics) and incubated at 35C overnight. Subcultures
onto 5% blood agar were incubated 24 hours at 35C with 5% CO2.
GBS suspected colonies were conﬁrmed by catalase reaction, Gram
stain and latex assay (also hippurate hydrolysis test when colonies were
non-hemolytic). Negative plates were reincubated and examined on the
following day. In addition, groups B and D latex testing (Slidex
Strepto Plus, bioMe´rieux) was performed on all SBM adapting the
protocol to broth. Samples were considered positive when B+D-,
negative when B-D+ or B-D- and undetermined when B+D+.
Results: Results are shown in Table 1. We found 40 specimens
positive and 134 negative by both methods. Culture method gave nine
more positive specimens which tested B+D+. We also found four
samples B+D- but negative with CDC method. Repeated subcultures in
those cases conﬁrmed the presence of GBS, giving a total of 53 true
positive specimens (21.6%). Another 58 B+D+ samples were negative
by standard method. As we lack a molecular method to further
investigate the B+D+ samples in those 67 (27.3%) cases subculture
remains necessary. For the positive and negative results the method had
a sensitivity, speciﬁcity and predictive values of 100%.
Conclusions: In a previous study using only group B latex test on
incubated broth we found some positive results in samples which
contained polyagglutinating strains (usually non-hemolytic
streptococci) and were negative for GBS by CDC method. It is
possible however that some of them were true positive as GBS could
have been masked in subcultures. Unfortunately we could not conﬁrm
this. Using both B and D groups it is possible to give reliable positive
and negative results on the ﬁrst day and select which samples need to be
subcultured. Direct latex agglutination on overnight incubated selective
broth is a good ﬁrst step screening method for GBS carriage detection
and it decreases the turnaround time and the laboratory workload.
R2634 Evaluation of phenotypic methods to detect ESBL-
producing Enterobacteriaceae, in Coimbra, Portugal
A. Rodrigues*, H. Oliveira, H. Pereira, I. Henriques,
S. Ferreira (Coimbra, Aveiro, PT)
The increase of resistance to antibiotics caused by the production of
Extended Spectrum beta-lactamases (ESBL) among Enterobacteriaceae
can be a serious problem. The aim of the present study was to compare
different methodologies to screen for ESBL-producers among Entero-
bacteriaceae isolates recovered from patients in Centro Hospitalar de
Coimbra-Portugal.
Methods: From September 2011 until October 2011 ESBL-producing
isolates were collected in the Centro Hospitalar de Coimbra, EPE,
central Portugal. Isolates were identiﬁed by Walkaway Systems
(Siemens, USA). ESBL producers were conﬁrmed using the
following methodologies: Etest (BioMe´rieux, France) ESBL with
Cefotaxime/Cefotaxime + Clavulanic acid, Ceftazidime/
Ceftazidime + Clavulanic acid and Cefepime/Cefepime + Clavulanic
acid strips; CicaBeta test (MAST, UK) and Disc test (MAST, UK)
according to manufacturer’s instructions.
Results: From total of 498 Enterobacteriaceae isolates, the Walkaway
system identiﬁed 50 isolates with an ESBL-positive phenotype, which
were included in this study. The isolates belonged to Escherichia coli
(25), Klebsiella pneumoniae (24) and Klebsiella oxytoca (1) species and
were collected mainly from urine, but also sputum and blood cultures.
Thirty-two isolates were isolated from samples collected from patients
in the Emergency Room (ER) and 18 were from inpatients. These
results were compared to the CicaBeta test results and it failed to
identify ﬁve isolates as ESBL-producers. The same isolates were used
to compare the performance of the Etest strips and Disc test (MAST).
Etest strips identiﬁed 48 isolates as ESBL producers and two gave an
inconclusive result, whereas 47 isolates were identiﬁed by the Disc test
as ESBL producers and three were negative.
Conclusions: The number of ESBL producing isolates collected from
the ER is considerable and requires surveillance since it indicates that
ESBL producers are spreading to the community settings. These
ﬁndings highlight the importance of routine detection of ESBL
producers. Although phenotypic methods for determination of ESBL
production have been widely used in routine microbiology laboratories,
they have certain limitations. The results in this study favour the use of
automated antimicrobial susceptibility system for this purpose,
nevertheless CLSI phenotypic conﬁrmation increase the reliability.
R2635 MALDI-TOF – to early goal-directed antibiotic treatment
H. Glans*, B. Claesson, E. Backhaus (Sko¨vde, SE)
Objectives: Without loss of speciﬁcity, MALDI-TOF (Matrix-assisted
laser desorption/ionization – time of ﬂight) mass spectrometry provides
faster species determination in the microbiological routine lab than do
conventional methods. The aim of this study was to evaluate whether
the introduction of Maldi-Tof in septic patients would shorten the
duration of empiric broad-spectrum antibiotics and favour a faster shift
to antibiotics with a more narrow spectrum.
Methods: We compared data concerning the antibiotic regimen in
inpatients with positive blood cultures (BacT/ALERTR, bioMe´rieux)
from two periods, November-December 2010 and May-August 2011,
before and after the introduction of MALDI-TOF (MALDI Biotyper
2.0, Bruker Daltronics) in the laboratory routine. During the ﬁrst period,
60 positive blood cultures from 42 patients were analysed with Gram
stain followed by biochemical tests and susceptibility testing. During
the second period, 80 positive blood cultures from 57 patients were
analyzed with the same methods together with MALDI-TOF.
Results: Most patients started empiric treatment with a broad-spectrum
antibiotic. The time from positive blood culture to the switch from
empiric to goal-directed antibiotic treatment was several hours longer
before compared to after introduction of MALDI-TOF in the routine.
With MALDI-TOF, species identiﬁcation was completed already 4–
6 hours after a positive blood culture, and this often lead to a change of
antibiotic regimen. MALDI-TOF seemed to shorten the time with
broad-spectrum antibiotic treatment in patients with gram-positive
bacteria but not with gram-negatives. In infections with gram-positive
bacteria there was a reduction from 18.6 to 10.5 hours. MALDI-TOF
also led to a quicker decision whether or not a gram-positive
bacteraemia was a contamination, sometimes leading to earlier
termination of treatment.
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Conclusion: MALDI-TOF in routine diagnostics of positive blood
cultures may lead to an earlier switch from empiric to directed antibiotic
treatment, and sometimes termination of treatment, thereby reducing the
amount of broad-spectrum antibiotics used, especially for gram-positive
bacteraemia.
R2636 Validation of Eswab for the detection of urogenital
mycoplasma from endocervical specimens using the
Mycoplasma Duo test
J.-F. Carod*, A. Bechara (Saint-Claude, FR)
Objectives: Ureaplasma urealyticum (Uu) and Mycoplasma hominis
(Mh) are commensal organisms which colonize the urogenital tract
mucosa and under some circumstances multiply excessively giving rise
to a number of diseases including: prostatitis, epididymitis,
chorioamniotis, endomitritis, salpingitis and vaginitis. A liquid and
universal transport medium storable at room temperature would be
beneﬁcial. This study compares endocervical specimens collected by
Eswab to specimens preserved in Mycoplasma Duo suspension
Medium (MDSM) for the detection of Uu and Mh.
Methods: Eswab is a tube with 2 mL Liquid Amies transport medium
and a ﬂocked swab for sample collection and transportation.
Endocervical specimens (n = 30) were used for this evaluation.
Innoculation of both Eswab and MDSM was freshly carried out of
after sample collection and Mycoplasma Duo microplate was seeded
according to the manufacturer procedure either with Eswab liquid or
MDSM. Final results were given after 48 hours of incubation at 37C
and expressed as follow: negative: Uu and Mh <10 exp.4 positive: Uu
or Mh >10 exp.4.
Results: Eswab collected samples showed 92% positive concordance
(n = 10 Uu and n = 2 Mh + Uu) and 94% negative concordance with
MDSM collected samples (n = 18). One Eswab collected samples was
positive for Uu but was found negative with the MDSM sample. At
24 hours, 11 Eswab samples were already positive after 24 hours vs. 8
using the MDSM.
Conclusion: Eswab is compatible with the performance of
Mycoplasma Duo. Using Eswab liquid instead of MDSM leads to the
detection of more than 92% of both negative or positive samples tested
with MDSM, with however the ability to detect earlier positivity for Uu/
Mh and to detect positive samples undected using MDSM. Therefore,
due to some discrepancies, further validation should be carried out
including more Mh positive samples.
R2637 Rapid and accurate identiﬁcation of alpha haemolytic
streptococci using the Vitek MS MALDI-TOF system
A. Symonds*, N.P. Reading, H.M. Kilgariff (Birmingham, UK)
Objectives: The alpha haemolytic streptococci are an important group
of clinically signiﬁcant bacteria and their correct identiﬁcation can prove
problematic, inaccurate and time consuming when traditional phenotypic
methods are used. The objective of this study was to show the easy, rapid
and accurate identiﬁcation of alpha haemolytic streptococci including
Streptococcus pneumoniae the recently launched Vitek MS
(Biomerieux, France) matrix assisted laser desorption/ionisation time
of ﬂight (MALDI-TOF) mass spectrometry system.
Method: One hundred and forty-eight previously characterised strains
of alpha haemolytic streptococci were cultured onto Columbia Horse
Blood Agar. Disposable target slides were inoculated with a small
amount of a single bacterial colony to provide a thin layer of bacterial
growth. This was then overlaid with 1 lL of matrix solution and air
dried. The resulting slide was then processed in the Vitek MS
instrument with automatic database analysis of resulting mass spectra.
A second target spot was analysed if no spectra or identiﬁcation were
obtained. Discordant isolates were subsequently identiﬁed using the GP
–ID Card on a Vitek 2 (Biomerieux, France) system and were
considered to be the reference identiﬁcation.
Results: Of 148 strains of alpha haemolytic streptococci tested by the
Vitek MS, 34/35 (97.1%) of Streptococcus pneumoniae isolates
identiﬁed correctly to species. 90/113 (79.6%) of other alpha haemolytic
streptococci strains gave good identiﬁcation to species level. 112/113
(99.1%) of other alpha haemolytic streptococci strains identiﬁed to the
correct group. 147/148 (98.6%) of the total isolates provided an
identiﬁcation correct to genus level. One Streptococcus pneumoniae
strain failed to give any identiﬁcation using the Vitek MS system.
Conclusions: The Vitek MS MALDI-TOF system provides an easy,
speciﬁc, accurate and importantly rapid identiﬁcation of alpha
haemolytic streptococci and signiﬁcantly Streptococcus pneumoniae.
Although the Vitek MS is unable to differentiate between strains of S.
mitis and S. oralis, all isolates were correctly identiﬁed into the S. mitis
group.
R2638 Typing of Propionibacterium acnes by MALDI-TOF MS
E. Urban*, M. Kostrzewa, I. Nagy, E. Nagy (Szeged, HU; Bremen, DE)
Objectives: P. acnes has been considered traditionally as a non-
pathogenic member of the skin ﬂora, however today it is accepted as an
opportunistic pathogen associated with several diseases such as severe
acne vulgaris, corneal ulceration, endophtalmitis, endocarditis, late-
stage prostatic joint infection, and shunt-associated central nervous
system infection. The aim of the present study was to evaluate the
possibility to use MS-based typing for this important anaerobic species
after routine identiﬁcation by MALDI-TOF MS.
Methods: P. acnes strains obtained from patients with severe acne,
blood, joint infection or skin, were identiﬁed by conventional methods
and by MALDI-TOF MS. After acquisition the mass spectra of P. acnes
strains (MS Bruker Biotyper 2.0), the type of which were determined
earlier as type I, II and III, mass spectrum sets were imported in the
ClinProTools 2.2 software. Spectra were normalized and recalibrated
using the respective functionalities of the software. Type characteristic
peaks and peak shifts were searched. In addition, peak variations
between the different types of P. acnes were investigated by using our
FlexAnalysis 3.3 software. Out of the main spectra (MSP) of strains
with known types, differentiating library was created for P. acnes type I
(IA and IB), II and III and this library was challenged with spectra of
further 60 P. acnes isolates with different origins. MLST analysis of the
strains was also carried out.
Results: By careful analyses of the mass spectra of seven strains with
known types of P. acnes, speciﬁc peaks and peak shifts were found in
the range of 6800 and 7400 Da, which could be selected as
characteristic peaks for type I, II and III. Even differentiation of types
IA and IB was possible with a characteristic peak with 9950 Da present
in type 1 A P. acnes and missing in type IB strain. Using this approach
out of the further 60 clinical P. acnes isolates 52 (86%) could be typed
after identiﬁcation by MALDI-TOF MS. MLST results were compared
with the MS-based typing results.
Conclusion: Since the introduction of MALDI-TOF MS for
microbiological application, it has evolved from an experimental tool
to a technology with signiﬁcant beneﬁt for routine microbiological
laboratories ﬁrst of all for the identiﬁcation of bacteria and fungi.
However careful evaluation of the MSP of well known bacteria may
give a possibility to use this technique also for typing of bacteria such
as presented here.
R2639 Tuberculosis laboratory diagnosis: compliance with UK
national guidance
J. Conlon, R. Burnell, M.M. Raza* (Milton Keynes, UK)
Objectives: The UK Department of Health (DH) has provided
guidance for laboratories that provide diagnostic services for
tuberculosis (TB). A retrospective study was carried out to examine
laboratory practices and turnaround times, supported by the reference
laboratory, for processing respiratory specimens only.
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Method: Data on respiratory specimens for TB investigations for a
period of 1 year (January 2010–December 2010) was collected from the
laboratory information system (LIMS). Turnaround times were
determined for reporting acid-alcohol fast bacilli (AAFB) microscopy.
All specimens were cultured using a liquid culture analyser and all
positive cultures were referred to the reference laboratory. Turnaround
times for culture identiﬁcation and susceptibility results were
determined.
Results: A total of 1037 respiratory specimens were received. 749
(72.2%) of these specimens had AAFB microscopy reported within the
recommended 1 day period. 112 (10.8%) specimens were reported
within 2 days, 107 (10.3%) within 3 days and 53 (5.1%) within 4 days.
The average time to result of AAFB microscopy was 1.39 days. Of the
1037 respiratory specimens, 77 (7%) were culture positive but only
eight grew Mycobacterium tuberculosis. The average time for the
reference laboratory to report identiﬁcation was 13.30 days but the
average time for reporting identiﬁcation of the 77 positive samples was
38.86 days. Only ﬁve specimens were reported within the target
21 days (6.5%) which included one of 6 (16.6%) isolates identiﬁed as
M. tuberculosis for whom the average time was 31.5 days. The average
time to return susceptibility results on these isolates to ﬁrst-line agents
was 55.7 days.
Discussion & Conclusion: This laboratory provides a 5 days service
for routine requests. Investigation of AAFB microscopy revealed that
the non-compliance with the 24 hours target is because of samples
arriving late in the laboratory, out of hours or over the weekend .The
study shows that compliance to meet the 21 days guideline for
reporting identiﬁcation is poor. Again factors contributing to this
included delays in setting up the culture, taking off a positive culture
from the machine, transport to the reference laboratory and time taken
by the reference laboratory to report identiﬁcation and need for repeat
specimen due to contamination. These factors also contribute to delayed
reporting of susceptibility results and thus time taken for ﬁnal reporting
is well outside the recommended 30 days.
R2640 Evaluation of optimal neutrophil gelatinase-associated
lipocalin value as a screening biomarker for urinary tract
infections in children
T.H. Kim*, B.H. Kim, H.R. Kim, M.K. Lee, B.S. Shim (Seoul, KR)
Objectives: Neutrophil gelatinase-associated lipocalin (NGAL) is
identiﬁed as a 25-kDa protein that is a promising biomarker for
detecting kidney injury. Urinary tract infection (UTI) is one of the most
common bacterial infections in children. Although urine culture is the
gold standard for the diagnosis of UTI, positive culture results require
2–3 days for complete bacterial identiﬁcation. Currently, urine pH,
leukocyte esterase, nitrite levels, etc., are used to screen for UTI, but
these tests have sensitivities of about 70–80%. Recently, several studies
have suggested that urine NGAL (uNGAL) may be used as a novel
biomarker to predict UTI in children. The aim of this study was to
assess whether uNGAL and serum NGAL (sNGAL) represent reliable
markers of UTI in children, and to evaluate the appropriate levels of
NGAL for the screening of UTI.
Methods: We analyzed 375 and 760 samples from UTI and non-UTI
patients, respectively. If the culture showed more than 105 CFU/mL of
a single pathogen, or if the child was symptomatic with the culture
showing more than 104 CFU/mL, the child was diagnosed as having a
UTI. sNGAL and uNGAL levels were measured by using enzyme-
linked immunosorbent assay (Bioporto, Denmark). The sensitivity,
speciﬁcity, and optimal cut-off values of NGAL for UTI screening were
calculated using the receiver operating characteristic (ROC) curves
formed using NGAL values and the number of UTI and non-UTI cases.
Results: sNGAL and uNGAL levels were more elevated in the UTI
cases than in the non-UTI cases, but the differences in levels were not
statistically signiﬁcant (p > 0.005). The optimal cut-off values of
sNGAL and uNGAL for UTI screening were 65.25 ng/mL and 5.65 ng/
mL, respectively, with sensitivities of 70% each, which was similar to
the corresponding sensitivities of other conventional screening tests.
These values were lower than the proposed cut-off values of sNGAL
and uNGAL by the manufacturers, which were 106 ng/mL and 9.8 ng/
mL, respectively.
Conclusions: sNGAL and uNGAL are not the only markers for an
early prediction of UTI. If NGAL levels are considered for the
screening of UTI, the cut-off levels lower than those recommended by
the manufacturer will have to be used. Therefore, further investigations,
for example, comparison of NGALs with other markers for the
screening of UTI, are required to evaluate the exact cut-off values of
NGAL for UTI in children.
R2641 Comparison of EUCAST and CLSI cephalosporin discs to
detect ESBL phenotype in Enterobacteriaceae at a
university hospital in Poland
A. Piorkowska*, L. Naumiuk, R. Torunska, M. Bronk (Gdansk, PL)
Objectives: The aim of the study was to compare low cephalosporin
content discs (EUCAST) to high cephalosporin content discs (CLSI)
with addtition of cefepime disc in detecting ESBL phenotype in
Enterobacteriaceae. EUCAST was introduced in Poland in 2011
however ESBL detection is still recommended to be done with CLSI
cephalosporin discs.
Methods: Thirty one consecutive one per patient isolates of
Enterobacteriaceae with ESBL phenotype were subjected to
additional testing with cefotaxime (5 and 30 lg), ceftazidime (10 and
30 lg), cefepime (30 lg) and amoxicillin/clavulanate (20/10 lg) discs.
Existence of zone enlargement between different cephalosporins and
clavulanate containing discs was recorded.
Results: There were 12 Klebsiella paneumoniae, seven Enterobacter
cloacae, six Escherichia coli, ﬁve K. oxytoca and one Citrobacter
koseri isolates identiﬁed by conventional and WalkAway Microscan
(Siemens) method. All isolates demonstrated presence of inhibition
zone enlargement between cephalosporin and clavulanate containing
discs with exception of two K. oxytoca and their both ceftazidime
containing discs, one K. oxytoca and ceftazidime 10 lg and cefepime
30 lg discs and another K. pneumoniae ceftazidime 10 lg.
Conclusion: Low (EUCAST) and high (CLSI) cephalosporin content
discs were equally good at detecting ESBL phenotype in our isolates.
This could result in using only EUCAST discs for both susceptibility
testing and ESBL phenotype detection. Combination of cefotaxime
(5 lg) and cefepime (30 ug) seems most appropriate in our setting as it
ensures ESBL observation even in AmpC derepressed isolates
sometimes encountered in our patients.
R2642 EBV tests performance on DiaSorin’s newly launched
LIAISON XL
M. Barak*, R. Daniel, M. Grinberg, C. Henig, O. Rozenberg (Haifa,
IL)
Objective: The aim of the present study was to evaluate the EBV
(EBNA, VCA-IGG and IGM) kits panel on the LIAISON XL,
DiaSorin’s next generation analyzer, against the performance of the
well established LIAISON platform.
Methods: One hundred and twenty routine samples were collected and
used in the evaluation for the EBNA performance while 112 and 98
were assayed also for VCA-IGG and IGM. A proportion of 40%, 20%
and 60% the samples chosen were below or around EBNA, VCA-IGG
and IGM cut-offs, respectively. Samples were run on the LIAISON
and LIAISON XL analyzers, on the same day. We checked the
concordance between the two analyzers, and discrepant samples were
rechecked in another lab or conﬁrmed by blotting.
Results: The overall correlation between the two analyzers results was
96.9%. The concordance in the EBNA assay was 94.6% Among the
seven discrepant results it seems that the LIAISON XL had two FP and
four FN and one result was inconclusive. The concordance in the VCA-
IGG assay was 98.2%. Among the three discrepant results it seems that
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the LIAISON had one FP, one FN and one result was inconclusive. The
concordance in the IGM assay was 96.9%. Among the three discrepant
results it seems that the LIAISON XL had three FP. In view of the
algorithm adopted at our institution (initially performing EBNA and
only if negative continuing to perform VCA-IGG and IGM), most of
the discrepant results (borderline levels) will not affect the diagnosis.
However, adjusting the lower cut-off of the EBNA assay to 6 U/mL
instead of 5 U/mL renders similar clinical outcome between the
analyzers. Using ﬁne tuning of cut-offs, the overall correlation between
the two analyzers was 98.8%.
Conclusion: The LIAISON XL offers higher throughput, long walk-
away time and improved instrument reliability. The performance of the
EBV panel was comparable between the two platforms.
R2643 Evaluation of an anti-listeriolysin O ELISA on the
diagnosis of intra-uterine infections with Listeria
monocytogenes
D.L.J. Hess*, C.W. Ang (Amsterdam, NL)
Objectives: Listeria monocytogenes is a foodborne pathogen with
mortality up to 30%. Listeriosis has particular predilection for pregnant
women and can cause severe complications like spontaneous abortion,
stillbirth and preterm labour. According to literature, detection of anti-
listeriolysin O (LLO) might be useful for serodiagnosis of listeriosis,
especially when cultures stay negative. The aims of our study were to
investigate the seroprevalence of anti-LLO in women of childbearing
age and examine if detection of anti-LLO IgG in serum could contribute
to diagnosis of listeriosis in pregnancy.
Methods: We used a commercially available ELISA for the detection
of anti-LLO IgG in human serum and plasma (Diatheva). A collection
of 176 sera from 83 admitted pregnant women (nine spontaneous
abortions, 39 stillbirths and 35 preterm labours, respectively), nine
culture positive listeriosis patients and 84 control sera (women visiting
our fertility clinic) was tested.
Results: An optical density (OD) of 0.650 was determined as optimal
cutoff value. The results showed that 5.6% (5/84) of the controls had
IgG antibodies toward LLO. Positive serology was present in one
pregnant woman (1/83, 0.8%) with a stillbirth due to massive feto-
maternal transfusion. Cultures from this patient were negative for
Listeria. All nine Listeria culture-positive patients tested negative for
anti-LLO antibodies.
Conclusion: Production of anti-LLO in the control group indicates the
possibility of previous or current (subclinical) listeriosis in this group.
Lower prevalence of anti-LLO in pregnant women may be due to
nutritional restrictions during pregnancy. None of the nine culture
positive listeriosis patients showed an anti-LLO response.
Seroprevalence of anti-LLO in women of childbearing age is very
low. This test is not suitable for detecting culture-negative listeriosis.
R2644 Added value of selective broth enrichment for the
detection of rectal carriage of extended-spectrum beta-
lactamase producing Enterobacteriaceae in hospitalised
patients
M.F.Q. Kluytmans – van den Bergh*, L.E. Willemsen, R. Punselie,
C. Verhulst, J.A.J.W. Kluytmans (Breda, NL)
Objectives: Adequate laboratory methods for the detection of
extended-spectrum beta-lactamase producing Enterobacteriaceae
(ESBL-E) are crucial in the prevention of nosocomial transmission of
ESBL-E and appropriate antimicrobial therapy for ESBL-E infections.
The use of broth enrichment in the laboratory detection of ESBL-E has
been an unresolved issue. This study aimed to evaluate the added value
of selective broth enrichment for the detection of rectal carriage of
ESBL-E in hospitalised patients.
Methods: In October 2011 an ESBL-E prevalence survey was
performed in a Dutch teaching hospital. Rectal swabs were taken
from all patients hospitalised on the day of the survey. Swabs were
directly plated on a selective ESBL screening agar plate (EbSA,
Cepheid), and subsequently placed in a selective tryptic soy broth,
containing cefotaxime (0.25 mg/L) and vancomycin (8 mg/L) (TSB-
VC). After 18–24 hours incubation (35–37C) the EbSA agar plate
was read and the TSB-VC was subcultured on an EbSA agar plate that
was read after 18–24 hours incubation (35–37C). Species
identiﬁcation and susceptibility testing was performed for all isolates
that grew on either one of the EbSA agar plates using VITEK 2
(bioMe´rieux). For suspected isolates (MIC ceftazidime and/or MIC
cefotaxime >1 mg/L) the presence of ESBL was phenotypically
conﬁrmed with the combination disk diffusion method for cefotaxime,
ceftazidime, and cefepime, both alone and with clavulanic acid
(Rosco). Test results were considered positive if the inhibition zone
around the disk was ‡5 mm increased for the combination with
clavulanic acid.
Results: Rectal swabs were obtained from 556 patients. ESBL-E was
cultured in 38 (6.8%) patients. Direct EbSA culture detected ESBL-E in
swabs from 22 (4.0%) patients. TSB-VC subculture increased the
number of ESBL-E positive cultures to 37 (6.7%) (McNemar
Chisquare=10.56, p = 0.0012). Only one of 38 (2.6%) ESBL-E
positive patients was not detected after TSB-VC enrichment.
Escherichia coli was the predominant ESBL-positive species
identiﬁed (26/38; 68%)
Conclusions: The use of selective broth enrichment resulted in a
substantial and statistically signiﬁcant increase in the yield of ESBL-E
screening in hospitalised patients. Broth enrichment is, therefore,
considered indispensable for the reliable detection of ESBL-E.
R2645 PNA FISH (AdvanDx, Vedbaek, DK) for rapid
identiﬁcation of Staphylococcus aureus and Coagulase-
negative staphylococci directly from positive blood
cultures
I.K. Hosein*, T. Asseez, J. Silles, G. Benge (London, UK)
Objectives: Staphylococcus aureus bacteremia is associated with high
mortality and requires prompt and aggressive antibiotic therapy whereas
the presence of coagulase-negative staphylococci (CNS) in a blood
culture often is due to contamination. Routine pathogen identiﬁcation in
positive blood cultures showing ‘‘Gram-positive cocci in clusters’’ is
unavailable on a same-day basis. This could lead to patients with S.
aureus bacteraemia receiving inadequate therapy and/or patients with
CNS getting unnecessary antibiotics until standard, next-day species
identiﬁcation. The S. aureus/CNS PNA FISH (Peptide nucleic acid
ﬂuorescence in-situ hybridization- AdvanDx, Vedbaek, DK) system
claims to differentiate between S. aureus and CNS in 90 minutes which
could have immediate clinical and therapeutic implications. In addition,
the system should permit identiﬁcation of each in mixed cultures of S.
aureus and CNS that can be challenging by conventional methods. We
studied the performance of the S. aureus/CNS PNA FISH system
compared to our routine culture-based method for pathogen
identiﬁcation in positive blood cultures.
Methods: PNA FISH was performed directly on smears from 75 blood
cultures ﬂagged as being positive by the Bactec 9240 (Becton
Dickinson) during a 14-week validation period. The assay uses
ﬂuorophore-labeled dual probes which stain S. aureus green and CNS
red under UV light microscopy. Pathogen identiﬁcation by PNA FISH
and our routine culture-based method were compared.
Results: Among 54 showing Gram positive cocci in clusters (GPCCL)
20 S. aureus, 31 CNS and two mixed S. aureus/CNS cultures were
identiﬁed by both PNA FISH and standard culture and identiﬁcation.
However, routine culture missed the CNS that was covered with a
heavy growth of S. aureus in one of the mixed cultures. One GPCCL
identiﬁed as Micrococcus spp by culture was appropriately negative by
PNA FISH. As expected, PNA FISH was also negative when performed
on 16 Gram negative rods (GNR) and ﬁve other Gram positive bacterial
species. Overall test sensitivity and speciﬁcity were 100% (53 of 53)
and 100% (22 of 22), respectively.
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Conclusions: PNA FISH accurately identiﬁed S. aureus and CNS in
blood cultures with gram stain showing GPCCL including two with
mixed S. aureus and CNS cultures. Reporting PNA FISH results soon
after the Gram stain may have positive clinical, therapeutic and
economic implications.
R2646 Evaluation of Britania kit based on novel meropenem/
inhibitor combination disks for the detection of
contemporary carbapenemases in Enterobacteriaceae: a
reliable approach for KPC, MBLs and OXA-48/163
recognition
F. Pasteran*, O. Veliz, C. Lucero, L. Icardi, L. Guerriero, M. Mira,
C. Guardiano, A. Corso (Buenos Aires, AR)
Phenotypic detection of carbapenemase producers remains a challenge
for the routine microbiology lab. and is important to guide the
appropriate antimicrobial therapy and to prevent nosocomial spread.
Combinations of meropenem (MER) with boronic acid (APB), EDTA
and cloxacillin (CLO) may be used to detect KPC, MBL or AmpC
hyperproducers, respectively. The major limitation of these combina-
tions is that they did not include strategies for the detection of other
carbapenemases as oxacillinases or for the discrimination of other
frequent interfering mechanism as CTX-M plus porins loss.
Aim: Here we tested a kit produced by Laboratorios Britania,
Argentina, based on reported MER (10 lg) disk combinations (APB
600 lg/disk, CLO 3000 lg/disk, EDTA 750 lg/disk) and the
innovative incorporation of tazobactam (TZ 100 lg/disk) designed for
the detection of carbapenem-resistance strains with ESBLs plus porins
loss.
Methods: A panel of 132 Enterobacteriaceae was assessed (n): KPC,
20; MBL (IMP-1, IMP-8, VIM-2, NDM-1) 16; OXA-48/163, 15; Sme,
8; NMC-A/IMI, 2; GES-5, 2; CTX-M plus porin loss, 26; AmpC
hyperproducers, 24; other mechanisms, 19. Disk diffusion was carried
out following CLSI recommendations.
Results: Cutoff values were selected to provide the best sensitivity
(Sn) and speciﬁcity (Sp) (increments in mm): APB ‡4; TZ and EDTA
‡5: CLOX ‡7. The Sn and Sp for predicting KPC (APB +ve, CLO -ve)
was 95% and 98%, respectively (one E. coli KPC was miss detected).
All KPCs tested negative for TZ. The remaining class A
carbapenemases were detected with a Sn and Sp of 92% and 97%,
respectively. The Sn and Sp for predicting MBL (EDTA +ve) was 91%
and 90%, respectively. Interfering AmpC strains (APB +ve, CLO +ve,
TZ -ve) were differentiated from carbapenemase producers with 92%
and 97% of Sn and Sp. The Sn and Sp for predicting the other
interfering mechanism, CTX-M plus porin loss (APB -ve, CLO -ve, TZ
+ve), was achieved with a Sn of 91% and Sp of 90%. Those strains with
APB -ve, CLO -ve and TZ -ve results were considered suspicious of
OXA production. With this strategy OXA-48/163 was inferred with a
high Sn (90%).
Conclusions: The kit was able to identify class A and B
carbapenemases and also to differentiate all the interfering
mechanisms, allowing the inclusion for the ﬁrst time, of a phenotypic
approach for oxacillinases detection. The MER/Inhibitor combinations
kit permitted the differentiation of all major carbapenemases KPC,
MBL or OXA-48/163 with high performance.
R2647 Evaluation of the vaginal ecosystem status in women with
pre-term delivery
E. Shopova*, R. Rousseva (Soﬁa, BG)
Objectives: To determine the signiﬁcance of the state of the vaginal
ecosystem in women with preterm delivery.
Methods: Ninety three pregnant women were examined – 60 women
with preterm delivery/I – group/and 33 pregnant women at term/II-
group/. Vaginal smears were examinated by Nugent. Score 0–3 normal,
4–6 intermediate/clue cells not present/ – smear not consistent with BV/
bacterial vaginosis/. Score 4–6/clue cells are present/ and score ‡7–
smear consistent with BV. HP /+/ hydrogen peroxide producing
Lactobacillus spp., U. urealyticum, Candida spp. and other associated
with genital infections aerobic microorganisms/S. agalactiae GBS, S.
aureus, E. coli/were determined by cultural methods.
Results: In the group I with preterm delivery 43% were with normal
score, 54% with intermediate smears – 31% clue cells not present –
smears not consistent with BV and 23% clue cells are present – smears
consistent with BV; 3% with bacterial vaginosis. In the group II of
pregnant women at term vaginal smears were determined as normal
ﬂora in 84%, 16% intermediate – 7% of them with clue cells – smears
consistent with BV. HP/+/Lactobacillus spp. were isolated in 13%
group I and 81% in group II. U. urealyticum were positive in 17%
group I and 12% in group II. Candida spp. were isolated in 10% group I
and 33% group II. GBS /17% group I and 7% group II, S. aureus 3%
group I-5% group II, E. coli 14% group I-6% group II.
Conclusion: More than 50% of the preterm delivery connected with
desordered vaginal ecosystem. Twenty six percent of vaginal smears
were determined as consistent with BV. HP/+/Lactobacillus spp. were
isolated only in 13% in group I, while in group II they were
predominant – 81%. U. urealyticum and other associated with genital
infections aerobic microorganisms / GBS, S. aureus, E. coli/more often
been isolated in group I, while Candida spp. prevalent in women at
term.
R2648 Comparison of the the Copan LIM broth to the BHI broth
for the isolation of GBS-colonised women prior delivery
V. Cristea*, G. Neacsu, M. Duta (Bucarest, RO)
Objective: Currently vaginal specimens for the detection of antenatal
colonization status of B Streptococcus (GBS) in women are collected
with traditional transystem gel and swabs are incubated in BHI (Brain
Heart Infusion) enrichment broth. Since the implementation of the
WASP automation (Copan Italia) in our laboratory, traditional swabs in
gel transystem were replaced with the Copan liquid base microbiology
(LBM) device for the collection and transport of all clinical specimens.
Copan LIM broth (Todd Hewitt with CNA), is a tube with 2 mL of
selective enrichment medium speciﬁc for the incubation of vaginal
swabs from pregnant women prior delivery for the detection of GBS.
The objective of this study is to compare vaginal specimens, collected
with Amies Gel transystem in primary culture and after incubation in
BHI broth, to vaginal specimen’s primary culture and after incubation
in Copan LIM broth for detection of GBS for prenatal screening.
Methods: For this validation 252 consecutive combined vaginal
specimens were collected from women for GBS prenatal screening
using a Copan dual swab Amies Gel Transystem. One swab was ﬁrst
used for primary culture in a Columbia Agar plate then incubated inside
a tube of BHI (Oxoid); the other swab plated as per current laboratory
procedure, but incubated in a tube of LIM broth. Columbia Agar plates
and both broths were incubated 35–37C. After 18–24 hours BHI and
the LIM broths were checked for turbidity and an aliquot was seeded on
Columbia agar. All culture results from original and broths inoculations
for both swabs were recorded.
Results: In the 252 patients 68 (26.9%) were positive for GBS and 184
were negative. Forty patients were positive in both primary culture and
both BHI and LIM broths. 28 patients were positive only after
inoculation from the enrichment broths, 18 were positive in both broth,
nine were positive only in the LIM broth and one only in the BHI broth.
Turbidity was present in all positive broths.
Conclusions: The Copan LIM broth detected more Streptococcus B
positive patients compared to the BHI broth. The LIM broth, a liquid
base microbiology device, facilitates the implementation of the WASP
automation in our laboratory and is improving the detection of GBS
colonized pre-labor women allowing treatment for the prevention of
neonatal GBS disease.
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R2649 Can we refer to previous isolates with acceptable
conﬁdence? A ﬁrst evidence-based approach
S. Nickmans*, A. Boel, K. Van Vaerenbergh, H. De
Beenhouwer (Aalst, BE)
Objectives: When a micro-organism is repeatedly isolated in the same
patient from the same sample source within a limited time frame, this
repeated isolation might be identical to the prior isolation, especially
when similarity can be conﬁrmed by morphological and enzymatic
characteristics. The term ‘identical’ here covers identiﬁcation as well as
susceptibility features. Prominent institutions e.g. CLSI, Garcia et al.
have suggested the use of a referral strategy for the work up of such
repetitive isolations that consent with speciﬁc conditions for the
referring procedure. In spite of these guidelines, no evidence-based
studies have been published yet to justify this strategy which could
imply faster turn-around-times and lower the work load for laboratory
staff.
Materials and Methods: In a prospective study, 100 gram-negative
isolates from urinary, respiratory and other human sample sources were
included. At the time of primary assessment of culture media, these
isolations showed a presumptive identiﬁcation similar to a recently
(<1 week) isolated micro-organism and also met the other inclusion
criteria (originating from the same patient andthe same sample source).
These repetitive isolations were subjected to fully automated analysis
(ID and AST) by means of Phoenix instrument (BD, Eucast vs. 2010).
Based on FDA criteria for comparison of automatic ID and AST test
instruments, acceptance criteria were preconceived. For identiﬁcation,
the aim was an agreement of at least 95%. Susceptibility results were
compared based on categorical (dis) agreements. Criteria for major
errors were <3%, very major errors <1.5%.
Results: Regarding identiﬁcation, an agreement of 97% was achieved.
For the AST results, a total of 1094 categorical results were compared
(restraining all antibiotics subject to intrinsic resistances as summarized
by EUCAST [versie…]). Categorical agreement was 97.27%: 1.37%
minor errors were observed, 0.27% major errors, 1.09% very major
errors. In the subgroup ‘‘categorical results obtained from cultures
isolated under antibiotic therapy (n = 426)’’, the increase of categorical
disagreements was statistically signiﬁcant compared to those in the
subgroup without antibiotic therapy. (McNemar, p < 0.01) However,
these results still met our criteria.
Conclusion: Our strategy for referring duplicate isolates meets the
FDA based preconceived criteria and therefore supports expert-opinions
(CLSI, Garcia et al).
R2650 Ability of BacT/ALERT FAN plus blood-culture bottles
to detect bacterial pathogens in samples containing
therapeutic levels of antimicrobials
W. McNamara*, M. Adamik, L. Barton, L. Borzhemskaya, A. Bowen,
A. Gates, D. Helms, B. Katzin, E. Miller, Z. O’Neal, J. Spontak,
P. Deol (Durham, NC)
Objectives: BacT/ALERT Microbial Detection System is an
automated blood culture system that allows for the growth and
detection of microorganisms commonly encountered in patients with
bacteremia and or fungemia. This system contains the BacT/ALERT
incubator and culture media. In order to maximize recovery,
antimicrobial agents in the blood sample must be reduced below
inhibitory concentrations. BacT/ALERT Aerobic FA Plus, Aerobic PF
Plus, and Anaerobic FN Plus blood culture bottles contain polymeric
adsorbent beads that adsorb and neutralize many antimicrobial agents.
This study was designed to evaluate the performance of the beads for
recovery of susceptible organisms in the presence of inhibitory levels of
antimicrobial agents.
Methods: Organism recovery was evaluated by combining the test
organism, along with 10 mL of buffer or whole blood containing 100–
120% peak serum levels (PSL) of the target antimicrobial agent, in FA
Plus or FN Plus culture bottles. Test organisms included a panel of
susceptible ATCC strains. Inoculated bottles were then incubated in
BacT/ALERT 3D instruments and examined for growth over a 5 days
incubation cycle.
Results: FA Plus bottles yielded 100% recovery of test organisms
when evaluated with 120% PSL of vancomycin, piperacillin,
piperacillin-tazobactam, amikacin, ﬂuconazole, and amphotericin B.
One hundred percent recovery was also achieved at 100% PSL
ampicillin. FN Plus bottles yielded 100% recovery when tested with
120% peak PSL of clindamycin, cefoxitin, oxacillin, and imipenem.
One hundred percent recovery was also achieved at 100% PSL
vancomycin, moxiﬂoxacin, and piperacillin-tazobactam. Recovery in
the presence of ertapenem and meropenem is organism dependent.
Conclusion: This study demonstrates that the presence of adsorbent
polymer beads in BacT/ALERT FAN Plus blood culture bottles allows
for the recovery of susceptible test organisms in the presence of
effective antimicrobial agents at elevated PSL.
R2651 Comparison of pre-treatment of sputum and endotracheal
aspirate samples with SL-Solution (Copan) or Digest-
EUR (Eurobio)
V. Cocquerelle*, C. Koebel, F. Stempfer, C. Graefﬂy, F. Jehl,
B. Jaulhac (Strasbourg, FR)
Objectives: Lower respiratory tract infections are frequent. Some
respiratory samples require ﬂuidiﬁcation before culture. SL-Solution
and Digest’Eur are two commercially available pre-treatment reagents
for liquefying thick or mucous specimens. The aim of this study was to
compare them in terms of efﬁciency.
Methods: A total of 56 consecutive sputum and tracheal aspirates was
collected from daily routine in our university hospital laboratory and
treated as follows. All were ﬂuidiﬁed by both SL-solution and Digest-
Eur, according to the manufacturer’s instructions. Each digested sample
was 1000-fold diluted and 10 lL were inoculated on four culture agar
media: Columbia blood1, nalidixic acid-colistin2, Drigalski2 and
Haemophilus medium1 (BioMe´rieux) for 24 hours at 37C under
aerobic conditions with one or without two 10% CO2.
Microscopic examination after Gram staining was also compared for 10
samples before and after SL-solution pre-treatment.
Results: Cultures were qualitatively and quantitatively equal in 66% of
the cases (37/56). No culture was negative with one reagent and
positive with the other. Culture after SL-solution pre-treatment was
more powerful in 29% of cases (16/56), with a higher colony count (9/
56, up to 10-fold higher), or due to detection of an additional bacterial
species (7/56). In this latter situation, potential pathogens
(Enterobacteria or S. maltophilia) were observed in four samples,
while oropharyngeal ﬂora bacteria, coagulase negative Staphylococci or
Candida were detected in the three others. Culture after Digest’Eur pre-
treatment was more relevant in 5% of the cases (3/56). One sample
showed a difference with a H. inﬂuenzae count higher than the
signiﬁcative threshold. The two other discrepancies were qualitative
(growth of beta-hemolytic Streptococcus or Enterobacteria) but culture
counts were under the signiﬁcative threshold in both cases. Microscopic
examination after ﬂuidiﬁcation by SL-Solution was the same as without
in six out of 10 cases.
Conclusion: SL-solution is at least as good as Digest’Eur for sputum
pre-treatment. Fluidiﬁcation by SL-Solution was found equivalent or
more relevant (Gram negative bacteria) in 95% of the cases. When less
performing, differences were minimal and with no consequences. SL-
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solution pre-treatment is not adequate for microscopic examination that
must be made directly on the sample. SL-solution is a rapid, practical
and ready-to-use system to calibrate and ﬂuidify lower respiratory
samples.
R2652 An investigation into the use of Kiestra Lab Automation
and Vision technology for the analysis of disc diffusion
antimicrobial susceptibility testing plates
C. Malone*, H. Gough (Brighton, Stevenage, UK)
Objective: To evaluate the results produced by Vision analysis of
digital susceptibility plate images when compared to the results
recorded by HPC registered Biomedical Scientists (BMS) at the
Lister Hospital, Stevenage, UK.
Method: Routine plates cultured in the laboratory, according to the
British Society of Antimicrobial Chemotherapy (BSAC) guidelines for
organisms grown on Iso-sensitest agar (Oxoid) at 35C in atmospheric
air, were used in this investigation. For analysis of these images, several
pre-deﬁned tools within Vision software were linked. By adjusting light
and shutter speed settings, a true representation of each plate was
captured. Images were then processed through the Vision method. Each
tool within the Vision method was then adjusted to detect a speciﬁc area
of the plate, i.e. the antimicrobial discs or the zone of inhibition. The
images created by each tool were then merged to produce one image,
displaying all three components. Results were then compared to those
recorded by BMS. This process was repeated for the different genus of
organisms; Staphylococcus species, Enterococci species, Pseudomonas
species and the family, Enterobacteriaceae.
Results: In total 238 images were analysed, 44 Staphylococcus spp.,
50 Pseudomonas spp., 45 Enterococci spp. and 99 Enterobacteriaceae
from urine, blood and swab cultures. 1428 antimicrobial discs were
present and Vision detected 1424 discs, 99.7% detected. All four
missed discs had two discs present, overlaying each other resulting in
an irregular, larger shape. Vision results showed 12% minor errors, the
different zone size is reported as the same result, 2.5% false resistance
and 0 false sensitive results when compared to BMS results.
Conclusion: This new technology produces accurate, reproducible
results for measuring zones of inhibition on disc diffusion antimicrobial
susceptibility plates. This technology has no associated additional
reagent cost and reduces the amount of time required by BMS staff to
interpret these images. Additional technology can recognise the
antimicrobial discs, and combined these results could be linked to
software capable of interpretation according to published zone sizes and
rules for the identiﬁcation of resistance mechanisms. At this time BMS
are still required to validate the Vision results before reporting.
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R2653 Comparative evaluation of three automated systems for
detection of different mechanisms of resistance in
bacteria: results gathered in an ESCMID Postgraduate
Technical Workshop in Izmir, Turkey
Z. Gulay, M. Bicmen*, A. Sari on behalf of invited faculty for practical
sessions and participants at the ESCMID PGTW (Izmir, Turkey)
Comparative evaluation of the results for microorganisms with special
resistance mechanisms analysed by different commercial systems in
PGTW on ‘‘Clinical Implications of Antimicrobial Susceptibility
Testing’’ which took place at the Department of Medical Microbiology
of DEU, Faculty of Medicine (Izmir, Turkey) between March 11 and
13, 2011 was intended.
Four Gram negative clinical isolates (Amp-C positive E. cloacae,
GSBL positive E. coli, OXA-48 and GSBL positive K. pneumoniae and
NDM-1 positive K. pneumoniae) and three Gram positive cocci (a
penicillin resistant S. pneumoniae clinical isolate, a vanB positive E.
faecium and heteroVISA Mu3) of which resistance mechanisms were
deﬁned completely by disk diffusion, E test, and molecular methods,
were studied by two different groups of participants and by three
different automated systems (BD Phoenix, VITEK 2 and MicroScan).
The results obtained by Vitek 2 were the same in both of the groups
whereas reproducibility for BD Phoenix and MicroScan was found as
96.9% and 95.8%, respectively. Categorical agreement for Vitek 2, BD
Phoenix and MicroScan was calculated as 95.8%, 90.6% and 88.5%
and the error rates in the same order were 1.1%, 4.2% and 5.2%, for
very major errors, 1.1%, 2.1% and 2.1%, for major errors, and 2.1%,
3.1% and 4.2% for minor errors, respectively.
All resistance mechanisms were determined by Vitek 2 accurately.
Phoenix failed to detect vancomycin heteroresistance in S. aureus and
MicroScan both Va heteroresistance and AmpC production in Ente-
robacter. For the two carbapenemase positive isolates, the results for the
carbapenems (imipenem and meropenem) were in a total inagreement
(S vs. R; very major error) by the disk diffusion and the Vitek 2 system.
Nevertheless, the strains were reported as resistant by Vitek 2 as
detected a carbapenemase ‘‘KPC or Metallo-beta-lactamase’’.
In conclusion, it was seen that Vitek-2 was the most successful system
in comparison with the other systems in reproducibility and detection
of the resistance mechanisms present. However, in spite of changing
susceptible results to resistant for IMP and MEM (MIC £1 lg/mL) in
the two carbapenemase positive strains which were obviously resistant
by disk diffusion (inhibition zone=6 mm), has caused suspicions
about the reliability of this system as current recommendations by
EUCAST and CLSI do not include changing susceptibility results
according to the resistance mechanism. This was also criticised by the
participants.
R2654 Standardising a procedure for the evaluation of
antimicrobial activity of wound dressings and assessment
of three wound dressings
O. Tkachenko*, J.A. Karas (Cambridge, UK)
Objectives: A wide selection of wound dressings is available on the
market with varying claims of antimicrobial efﬁcacy. A valid standard
method for evaluation of their antimicrobial activity has not been
established. In this study we suggest a standardised time kill assay
procedure for antimicrobial activity evaluation of wound dressings in
order to make studies more comparable and reproducible. We also
tested two silver-containing and one propolis-containing dressing
against S. aureus, S. pyogenes, E. coli and P. aeruginosa using our
proposed procedure.
Methods: The following dressings were tested: silver-containing
dressings Aquacel Ag (Conva Tec Inc., Uxbridge UK), Acticoat
(Smith & Nephew, Hull, UK) and a propolis-containing dressing (PCD)
that is in development. Sterile gauze was used as a negative control.
Squares of 1 cm2 of each dressing were placed in a suspension of each
organism in the peptone water and either Brain Heart Infusion broth or
Mueller-Hinton broth (Oxoid Ltd., Basingstoke, UK) was added to each
dressing. After incubation at 37C for 48 hours aliquots of bacterial
broth were taken from each vial at speciﬁc time intervals and spread on
to plates with Iso Sensitivity agar (Oxoid Ltd.). The plates were
incubated overnight at 37C and bacterial counts (CFU/mL) were
performed.
Results: Acticoat exhibited the most potent antibacterial activity
against all organisms. Aquacel Ag also demonstrated good
antibacterial activity although inferior to Acticoat. Propolis-containing
dressing did not show bactericidal effect, only marginally slowing
down growth of S. aureus and S. pyogenes compared to the sterile
gauze.
Conclusion: We suggest a standardised time kill assay for evaluation
of the antimicrobial activity of wound dressings. The dressings should
be exposed to a standardised inoculum of approximately
1–1.5 · 106 CFU/mL which is consistent with that used for antibiotic
sensitivity testing in laboratories. Mueller-Hinton broth is the most
appropriate medium for this assay as it supports the growth of most
Methods for antibacterial susceptibility testing 795
common wound pathogens and does not contain inhibitors. A 1 cm2 is
the most suitable and practical size of dressing. Acticoat was the most
active dressing of those tested using this method.
R2655 Evaluation of a Gram-negative EUCAST panel (NBC46)
on the Siemens MicroScan WalkAway-96 Plus system
W. Vandewal*, K. Flore´, J. Robbrecht (Brugge, BE)
Objectives: The aim of this study was to evaluate the gram negative
EUCAST panel (NBC46) for identiﬁcation (ID) and antimicrobial
susceptibility testing (AST) of gram negative rods on the Siemens
MicroScan WalkAway-96 Plus System (Microscan) and to
investigate the impact on susceptibility reporting due to the shift of
MIC breakpoints from CLSI to EUCAST.
Methods: During 1 month, all gram negative rods isolated from
clinical samples in daily routine were examined using both the CLSI
panel (NBC42) and the EUCAST panel (NBC46) on Microscan for ID
as well as for AST.
Results: Of the 173 isolates (159 fermenters and 14 non-fermenters) all
identiﬁcations were identical at species level, using the two different
panels. The identiﬁcation of fermenters resulted in 62% Escherichia
coli, 11% Proteus sp., 9% Enterobacter sp., 7% Klebsiella sp., 4%
Citrobacter sp., 4%Morganella morganii and 2% Serratia marcescens.
All non-fermenters were Pseudomonas aeruginosa. In order to
emphasize true interpretation differences between CLSI and
EUCAST, 34 of 1919 (1.8%) AST results with signiﬁcant discrepant
MIC values were discarded. A discrepant MIC value was deﬁned as
having a difference of more than one dilution. In the group of
fermenters the major differences in interpretation were found with
Amoxicillin-clavulanic acid (AMC): 37% were resistant using
EUCAST and 27% using CLSI. An impact on susceptibility was also
observed for Cefepime, Piperacillin-Tazobactam, Levoﬂoxacin,
Meropenem and Amikacin. These antibiotics showed a reduction in
susceptibility from respectively 3.8%, 3.3%, 2.5%, 1.3% and 1.3% (see
results table 1).
Keeping in mind the low total number of non-fermenters, the greatest
differences in AST interpretation using EUCAST were found for the
following antibiotics (less susceptible): Piperacillin-Tazobactam
(14.3%), Levoﬂoxacin (14.3%) and Amikacin (7.1%).
Conclusion: We evaluated a new EUCAST panel on Microscan for ID
and AST of gram negative rods. Ten percent of our routine cultured
Enterobacteriaceae now reported non-resistant for AMC, would be
reported resistant using EUCAST. These ﬁndings combined with the
facts that AMC is the most prescribed antibiotic in our hospital and that
EUCAST offers no breakpoints for S or I for this antibiotic, highlights
the necessity to inform our medical staff of the impact of
implementation of EUCAST guidelines.
R2656 Antimicrobial combination testing of MDR cystic ﬁbrosis
isolates of B. cepacia: comparison between FICI and SBPI
K. Milne, A. Kumar*, I. Gould (Aberdeen, UK)
Objectives: The Cystic Fibrosis Antibiotic Susceptibility Testing
Service (CFASS) based at Aberdeen Royal Inﬁrmary provides an
extended susceptibility testing service for multidrug-resistant non-
fermenting Gram negative bacterial isolates from the respiratory
secretions of Scottish individuals with cystic ﬁbrosis. CFASS aims to
offer useful antimicrobial combinations to assist clinicians in making
appropriate treatment decisions in problematic individuals.
Methods: Two hundred and thirty-three isolates which were
phenotypically identiﬁed as Burkholderia cepacia/B. cepacia complex
were submitted to CFASS over a 10 year period. E test was used to
facilitate MIC and combination testing of the isolates. MICs of up to 21
antimicrobials were determined and interpreted as per CLSI guidelines.
Usually six antimicrobial pairs were tested in combination per isolate and
the results interpreted by fractional inhibitory concentration index (FICI)
and also by Susceptible Breakpoint Index (SBPI) which allows easy
ranking of the antimicrobial combinations by their in-vitro effectiveness.
Results: Number of isolates: 233 MIC: Number 4259% Susceptible
15.7% Intermediate 4.8% Resistant 79.5. Most susceptible co-
trimoxazole (54.5%) minocycline (48.1%) doxycycline (47.2%).
Antimicrobial Combinations: Number 1595% Synergy 9.2% Non-
interactive 89.3% Antagonism 1.5 Median SBPI 2.7 FICI for
combinations tested ‡10 times (N = 35): Most synergy tobramycin +
ceftazidime (33.3%) tobramycin + meropenem (28.6%) ciproﬂoxacin +
piperacillin/tazobactam (25.0%). Most antagonism piperacillin/
tazobactam + co-trimoxazole (11.1%) piperacillin/tazobactam +
ciproﬂoxacin (10.0%) meropenem + co-trimoxazole (4.5%). Median
SBPI for combinations tested ‡10 times (N = 35): Best combination
doxycycline + meropenem (9.3) doxycycline + piperacillin/tazobactam
(9.3) levoﬂoxacin + minocycline (7.6). Worst combination ticarcillin/
clavulanate + co-trimoxazole (0.5) ciproﬂoxacin + imipenem (0.8)
chloramphenicol + levoﬂoxacin (0.8).
Conclusions: The antimicrobial combinations which were most
effective by SBPI in comparison to the ones which were most
synergistic by FICI were altogether different. The SBPI is calculated
based on the MIC of the antimicrobials in combination to their
susceptible breakpoints and, therefore, might possibly be more
discriminatory than the FICI in determining the effectiveness of the
antimicrobial combinations in vitro and likely to have some clinical
relevance in vivo.
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R2657 Comparison of antimicrobial susceptibility testing by
Etest, Kirby-Bauer disc method and Microscan for
Pseudomonas aeruginosa isolates from cystic ﬁbrosis
patients
E. Leung*, K. Singh, C. Crank, S. Wang (Chicago, US)
Background: P. aeruginosa is a major pathogen in cystic ﬁbrosis
(CF), contributing to CF exacerbations, pneumonia and ultimately
respiratory failure. Treatment is frequently complicated by development
of antibiotic resistance which limits therapeutic options and often
restricts treatment to intravenous antibiotics; susceptibility results
provide valuable information used to tailor empiric therapy to
targeted antimicrobial therapy. However, regarding P. aeruginosa
isolates from CF patients, there are many conﬂicting data concerning
the consistency and accuracy of susceptibility results obtained from
commonly used laboratory methods of susceptibility testing.
Methods: P. aeruginosa isolates (mucoid and non-mucoid) from CF
surveillance sputum cultures were identiﬁed and tested using three
different methods of susceptibility testing: E-test (ET) and Kirby-Bauer
(KB) disk methods using cation adjusted Mueller-Hinton agar; and
Microscan (MS) microdilutional broth method. For each method, each
isolate was tested against a pre-speciﬁed panel of antibiotics including
antibiotics from the ﬂuoroquinolone, aminoglycoside and beta-lactam
classes. Susceptibilities were compared by error analysis as deﬁned by
the Clinical and Laboratory Standards Institute (CLSI) to identify and
classify discrepancies between the three methods of susceptibility
testing.
Results: Twenty-four P. aeruginosa isolates were tested. Among
susceptibilities reported for ET vs. KB and ET vs. MS, all major errors
observed were in the aminoglycoside group with one exception
occurring in the piperacillin-tazobactam group; however, no very
major errors were identiﬁed. Overall discrepancy rates between all tests
were highest for aminoglycosides (21–37.5%) followed by beta-lactam
antibiotics (4–16%). Overall, mucoid isolates of P. aeruginosa
contributed to three major errors.
Conclusions: Discrepancies between susceptibility results obtained by
commonly used testing methods varied widely, with the highest rate of
discrepancies seen among aminoglycosides. In contrast to previous
data, mucoid isolates were not associated with a greater number of
major errors in this study. These discrepancies in susceptibility results
have the potential to signiﬁcantly impact therapeutic drug and dosing
decisions, especially in the CF population. Further study is needed to
characterize if a lower MIC among susceptible isolates is associated
with better clinical outcomes in CF patients.
R2658 Comparison of antibiotic resistance patterns of group G
streptococci in Austria using disc diffusion and the new
AST-ST01 card on the Vitek II instrument
E. Leitner*, G. Feierl, A.J. Grisold, L. Masoud-Landgraf, J. Posch,
U. Wagner-Eibel, G. Zarfel, E. Marth (Graz, AT)
Objectives: There is an increase of severe infections caused by group
G steptococci (GGS). Therefore antibiotic resistance patterns of GGS
are of interest. Aim of this study was to investigate the antimicrobial
susceptibility and to compare the disc diffusion method with the new
AST-ST01 card on the VITEK II instrument (bioMe´rieux).
Methods: From July 2008 to July 2010, 108 nonduplicate GGS
isolates were collected at the Institute of Hygiene, Medical University
of Graz. 24 GGS were isolated from the respiratory tract and 84 from
other body sites (e.g. wounds, blood, genital tract). The isolates were
characterised according their morphology and with the Streptex GGS-
speciﬁc antiserum (remel). For species identiﬁcation the ID-GP card
(bioMe´rieux) was used; resistance testing was performed by disc
diffusion and with the new AST-ST01 card (bioMe´rieux). The AST-
ST01 card includes ampicilin, benzylpenicillin, cefotaxime, ceftriaxone,
clindamycin, erythromycin, levoﬂoxacin, linezolid, tetracycline,
trimethoprim/sulfamethoxazole, vancomycin and detection of
inducible MLSB resistance. The antibiotic susceptibility results were
interpreted according to EUCAST guidelines.
Results: All GGS isolates were identiﬁed on species level as
Streptococcus dysgalactiae subspecies equisimilis. For susceptibility
testing disc diffusion method and AST-ST01 card showed 100%
consistence. All 108 GGS isolates were susceptible to ampicilin,
benzylpenicillin, cefotaxime, ceftriaxone, linezolid, trimethoprim/
sulfamethoxazole and vancomycin. Resistance rates were highest for
tetracycline with 63% (68/108). Resistance rate for erythromycin was
14% (15/108) with only one isolate showing an M phenotype, six
isolates with a consistent MLSB resistance and eight isolates with an
inducible MLSB resistance leading to a resistance rate for clindamycin
of 13% (14/108). Resistance to levoﬂoxacin was found in a single GGS
isolate only.
Discussion: For resistance testing of GGS the disc diffusion test and
the AST-ST01 card gave identical results. The GGS isolates from
Austria shows a high resistance rate to tetracycline, followed by a low
resistance to erythromycin and clindamycin. Resistance to chinolones is
rare.
R2659 CLSI and EUCAST: comparison of clinical breakpoints
in bacterial strains isolated in paediatric haematological
patients
M. Perotti, L. Pescetto, L. Ricagni, R. Bandettini* (Genoa, IT)
Objectives: It is important to analyse the impact of changes in
breakpoints suggested by CLSI and EUCAST because it could be
signiﬁcant for the surveillance of antimicrobial resistance.
In our institute CLSI breakpoints have been used until the beginning of
2011, then we passed to EUCAST. We made a retrospective study
(from 2004) to estimate how the antibiotic resistance incidence would
have been if we had used EUCAST breakpoints in gram negative
bacteria isolated from bloodcultures of pediatric haematological
patients.
Methods: We evaluated 97 antimicrobial reports performed from 2004
to 2010 analysing MIC values of ceftazidime, meropenem,
ciproﬂoxacin and amikacin got with automatised system Phoenix 100
(Becton Dickinson) in 30 Escherichia coli, 29 Pseudomonas aeruginosa
and 27 KES group (Klebsiella, Enterobacter, Serratia) isolated from
bloodcultures. We compared the interpretation by CLSI 2010 and by
EUCAST.
Results: The data obtained are summarized in the Table1.
Conclusion: From the evaluation of our results there is not any
discrepancies regarding the interpretation of the MIC of ceftazidime
for all bacteria groups. We had changes for ciproﬂoxacin in only one
strain of E. coli and one of P. aeruginosa. In KES group we had
one discrepancy regarding meropenem and two for amikacin.
Applying EUCAST breakpoints we had a little increase of
antibiotic resistance incidence and this fact could have protected
by therapeutic failures.
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R2660 Emerging Klebsiella pneumoniae isolates producing KPC-
2 and VIM-1 carbapenemases in a Greek hospital
N. Charalambakis, A. Kyratsa, I. Grafakos, P. Giakkoupi,
K. Tryﬁnopoulou, P. Giannopoulou, A. Vatopoulos, E. Trikka-
Graphakos* (Athens, GR)
Worldwide increase in the occurrence and dissemination of KPC beta-
lactamases among Gram (-) pathogens makes critical the early detection
of these enzymes.
Objectives: Accurate detection of production or co-production of class
A KPC and class B metallo –beta-lactamase (MBL) Klebsiella
pneumoniae clinical isolates.
Methods: From November 2010 – November 2011, 30 K. pneumoniae
ICU blood isolates with reduced susceptibility to carbapenemes
(MIC > 1 lg/mL) were detected. Antibiotic susceptibility to several
antibiotics was estimated by Kirby-Bauer method, MIC determination
by automated system (Phoenix, BD) and E-test (Biomerieux SA,
France), according to CLSI standards. The isolates were submitted to
phenotypic combined disk test by both EDTA and boronic acid –
meropenem for the differentiation of KPC and MBL enzymes.
Genotypic conﬁrmation for the presence of carbapenemase genes was
carried out by PCR and molecular typing was performed by PFGE in 11
representative isolates.
Results: The clinical isolates were mulltidrug resistant with an MIC
range to meropenem (<1 to ‡2), while colistin (£0.5–‡4), gentamicin
(2–8), tigecycline (£2–‡8) and fosfomycin (£16–128) were the most
active agents. Twenty isolates produced KPC carbapenemases, seven
isolates only VIM while four produced both KPC and VIM
carbapenemases. Five isolates produced ESBL additionally. Pulsed
ﬁeld typing gathered ﬁve isolates into subtype A1 and one in subtype
A2, which is the most common type producing KPC-2 in Greece. Three
isolates were included in sybtype B, the second most common type of
KPC in Greece which produced both KPC and VIM . Two isolates were
not genetically related.
Conclusion: Dissemination of bla KPC is mainly due to certain K.
pneumoniae types. Fosfomycin, colistin and tigecyclin remain among
the therapeutic options for KPC infections. Phenotypic and molecular
tests were in accordance for detection of KPC, MBL producers and
coproducers in the majority of isolates. They are proved useful tools in
the clinical laboratory especially in regions were MBL and KPC
represent a potential source of clinical failure in patients treated with
carbapenemes.
Public health and community-acquired
infections
R2661 Vaginal trichomoniasis among HIV patients attending
primary health care centres of Jos, Nigeria
I. Nwadioha*, P. Nwokedi, I. Bako, I. Onwuezobe (Makurdi, NG)
Aims/Objectives: To determine the prevalence of trichomonal
infection in HIV/AIDS and non-HIV control group of patients in a
population of women with abnormal vaginal discharge.
Study Design: We conducted a simple cross-sectional study.
Place and Duration of Study: Primary health care centres in Jos
metropolis and Jos University Teaching Hospital, during December
2006 to December 2007.
Methods: Seven hundred high vaginal swabs were collected; 350 from
HIV positive and another 350 from HIV-negative control group of
patients with abnormal vaginal discharge attending primary health care
centres in Jos metropolis and analysed for microscopy and culture in Jos
University Teaching Hospital. Data on epidemiologic indices from the
patients, using structured interviewer-administered questionnaires were
collected.
Results: The rate of trichomoniasis among all participants in the study
was17% (n = 120/700). The prevalence rate of trichomoniasis among
persons with HIV was 24% while it was found to be 10.3% among HIV
negative controls. The difference was statistically signiﬁcant
(· 2 = 23.172; df = 1; p < 0.05). The rate of co-infection of T.
vaginalis in Bacterial vaginosis was 42%(n = 50/120), while it was
24%(n = 29/120) in candidiasis. The singles had a 35% high rate of
trichomonal infection. The infected women had a median age of
26 years, and a median number of 3 intra-vaginal sex partners per week.
Conclusion: There was a signiﬁcant statistical difference in prevalence
of Trichomonas vaginalis between HIV/AIDS group and non-HIV
(control) group of patients in the study (p < 0.05). Local HIV prevention
strategies should target such women with trichomonal infection for
intervention efforts, especially in HIV endemic area of sub-continent of
Africa to further reduce the burden of HIV in the population.
R2662 Detection of inﬂuenza virus A and B in stools of adult
patients reporting acute diarrhoea in general practice
C. Arena*, J.P. Amoros, V. Vaillant, K. Balay, R. Chikhi-Brachet,
J. Arrighi, T. Blanchon, F. Carrat, T. Hanslik, A. Falchi (Paris, Dijon,
Ajaccio, FR)
Background: Little is known about presence of inﬂuenza in
gastroenteric tract of patients suffering from acute diarrhea (AD) and
during a period when enteric and respiratory viruses are circulating.
Objectives: The aim of this study was to determine the presence of
inﬂuenza virus A (A/H1N1 2009, A/H3N2) and B in stools of patients
consulting their GP for AD.
Methods: A case-control study was performed from December 2010 to
April 2011. French Sentinel GPs collected a stool sample from adult
patients consulting for AD and from control patients matched on sex
and age. All stool specimens were tested for inﬂuenza virus A (A/H1N1
2009 and A/H3N2) and inﬂuenza B, and also for ﬁve enteric viruses
usually associated with AD (Astrovirus, Group A Rotavirus, Enteric
Adenovirus 40 and 41, Norovirus-GI and Norovirus-GII).
Results: GPs enrolled 138 cases and 93 controls. Ten (7.2%,
CI95%=[2.9; 11.6]) cases tested positive for inﬂuenza viruses: eight
for inﬂuenza virus B, and two for inﬂuenza virus A (1 A/H1N12009
and 1 A/H3N2). Among the 10 patients, ﬁve were positive only for an
inﬂuenza virus while ﬁve were co-infected with inﬂuenza and enteric
viruses. None of the 93 controls tested positive for inﬂuenza or enteric
viruses.
Conclusions: This study showed that the presence of inﬂuenza viruses
in stools, especially inﬂuenza virus B, is not unusual among GPs’
patients suffering from AD. Simultaneous investigations of enteric and
respiratory viruses in patients complaining of AD, could be useful for
next studies to better identify the agents responsible for AD and to
understand the potential mode of transmission and interaction of these
viruses during epidemic Inﬂuenza Like Illness and AD outbreaks.
R2663 Mortality and associated risk factors of Escherichia coli
bacteraemia in a prospective cohort of young, old and
very old patients
C. Roubaud-Baudron*, X. Panhard, F. Mentre´, B. Fantin, E. Denamur,
A. Lefort on behalf of the COLIBAFI Group
Few data are available about the characteristics and risk factors for
death of E. coli bacteremia in the elderly.
Objectives: To compare demographic, clinical, microbiological
characteristics and risk factors for in-hospital death of E. coli
bloodstream infections between young (18–64 years), old (65–
79 years) and very old (‡80 years) patients.
Methods: French prospective multicenter cohort study (n = 1051
patients). Comorbidities (immunosuppression, organ insufﬁciencies
and cancer), clinical (nosocomial/health care-related, portal of entry,
treatment) and microbiological (drug resistance, 18 different virulence
factors, phylogenetic groups) characteristics and outcome were
compared between the three age groups. Chi-squared or Fisher test
were used to compare qualitative variable when appropriate and
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quantitative variables were compared with t test when ANOVA was
signiﬁcant. Host and bacterial factors associated with in-hospital death
(up to 28 days) were identiﬁed by a binary logistic regression for
multivariate analysis for each age group.
Results: Six hundred ﬁfty six (62%) patients were over 65 years (372
old and 284 very old). Overall, 43.5% of young and 42.5% of old
patients were immunocompromised and heart failure concerned 25.1%
of the very old patients. Young and old patients’ comorbidities scores
were higher than that of very old patients (1.49 ± 1.26 and 1.55 ±
1.22 vs. 1.15 ± 1.15, p < 0.0001). Very old patients infections were
more often health care associated (p = 0.013), of pulmonary origin
(p = 0.027), and caused by less resistant isolates (p = 0.011). Presence
of E. coli virulence factors did not differ between groups, except for
iroN, more prevalent in the young group (p = 0.007). Mortality was
higher in old patients than in the other two groups (10.4% vs. 16.4%
and 12.0%, respectively; p = 0.039). Multivariate analysis of risk
factors for death according to the age is shown in Table 1.
Discussion: E. coli bacteremia is a frequent disease in the elderly
population. Prognosis is poorer in old patients (65–79 years), as a
consequence of the age itself and numerous comorbidities. Risk factors
for death are age group speciﬁc.
R2664 Stroke-associated pneumonia in a rural general hospital
T. Exiara*, S. Saridou, M. Filippidou, E. Gidaris, K. Nikolaou,
L. Simoglou, A. Konstantis, A. Risggits, M. Kouroupi, E. Pigkal,
V. Dendrinos, M. Memet, L. Papazoglou (Komotini, Didimoteixo,
Alexandroupolis, GR)
Objectives: Stroke is the main cause of disability in high-income
countries and ranks second as a cause of death worldwide. Stroke-
associated pneumonia (SAP) constitutes a clinically relevant
complication of stroke, because it increases the mortality and has a
negative impact on the neurological prognosis of the patient. The aim of
this study was to determine the incident of SAP and the microbiological
data and outcome of patients with SAP in our Internal Medicine Ward.
Methods: We retrospectively investigated the medical ﬁles of all
patients admitted to our Internal Medicine Ward, over a period of
5 years, with acute stroke. Patients who developed pneumonia were
identiﬁed and divided into two groups: group 1 patients who developed
pneumonia within the ﬁrst 72 hours of admission and group 2 patients
who developed pneumonia after 72 of admission. The demographical,
laboratory, radiological, microbiological data and outcome at discharge
of patients with SAP were registered and analyzed. Patients who had
dysphagia and fever before stroke onset and those who required
mechanical ventilation during hospitalization, were excluded.
Results: Three hundred and eighty-nine patients with stroke were
registered, 112 (28.8%) had SAP and 64 (57.1%) of them registered at
the group1. Sixty-nine (61.6%) patients were male and 43 (38.4%)
female with mean age of 64 ± 13.4 years. Fifty-one (45.5%) patients
had positive cultures of tracheal aspirates and 32 (28.7%) had inﬁltrates
on their chest radiographs. The microorganisms identiﬁed in group 1
and group 2 were: Staphylococcus aureus 10 (15.6%) vs. 6 (12.5%),
Pseudomonas aeruginosa 9 (14.1%) vs. 8 (16.7%), Klebsiella
pneumoniae 0 (0%) vs. 4 (8.4%), Streptococcus pneumoniae 6
(9.4%) vs. 3 (6.25%), Candida albicans 1 (1.6%) vs. 4 (8.4%),
respectively. Median length of stay was 12 days compared to 6 days for
all stroke patients and the mortality rate was 36.6%. However, the
mortality rate was not affected by age, gender, time of onset and results
of cultures. Patients in group 2 tended to be older and had higher
frequency of positive cultures of tracheal aspirate and chest radiography
with inﬁltrates, as compared to patients in group1.
Conclusions: Pneumonia is a common complication after acute stroke
and it is associated with a high mortality and prolongs the hospital stay.
Pseudomonas aeruginosa and Staphylococcus aureus are most
common organisms in stroke-associated pneumonia both of groups.
R2665 Evaluation of epidemiological, clinical and laboratory
characteristics of patients with spondylodiscitis in a
tertiary care hospital in Turkey
C. Ataman Hatipoglu*, K. Arslan, C. Bulut, Z. Kocak Tufan,
Y. Kurtoglu Gul, S. Kinikli, A.P. Demiroz (Ankara, TR)
Objectives: Spondylodiscitis is the infection of the intervertebral disc
and the adjacent vertebrae and is hematogenous in origin in most cases.
It can also occur postoperatively. In this report, we present
epidemiological, clinical and laboratory data of patients with
spondylodiscitis admitted in our clinic.
Methods: Epidemiologic, clinical and laboratory data of patients with
spondylodiscitis were evaluated retrospectively according to hospital
records.
Results: Totally 24 patients followed due to spondylodiscitis were
evaluated. Two patients who had cancer metastasis to lumber vertebrae
were excluded. Of the study patients, 16 were male (72.7%) and mean
age of patients was 54 ± 16.3 years. There was history of fresh cheese
consumption in eight patients (36.4%) and animal husbandry in 7
(31.8%). None of patients had trauma, steroid therapy or tuberculosis
history. Eight patients (36.4%) had concomitant systemic diseases and
three (13.6%) had malignancy. Of patients, 17 (77.3%) had undergo
various operations; among them, in nine patients the operation region
was vertebrae and intervertebral disc. On admission, most common
symptoms were backache, difﬁculty in walking, pain in legs, sweating,
fever and numbness in toes (100%, 40.9%, 27.3%, 22.7%, 18.2% and
18.2%, respectively). In the laboratory investigations; WBC, CRP and
sedimentation rate were high in 22.7%, 63.6% and 77.3% of patients,
respectively. Brucella agglutination test was positive in eight patients
(36.4%). Blood and tuberculosis cultures were remained negative but
ARB was found positive in the abscess material of one patient.
Escherichia coli and Bacillus pumilus were isolated from cultures of
abscess material in two other patients. Radiological investigations
including vertebral tomography, magnetic resonance imaging and
sintigraphy were compatible with spondylodiscitis, one patient’s
ﬁndings were resemble to tuberculosis. So, eight patients were
diagnosed as brucellar spondylodiscitis, two as tuberculous and nine
as postoperative spondylodiscitis. Eleven patients (50%) received
ampicillin sulbactam, eight patients (36.4%) received treatment for
brucellosis, two (9.1%) for tuberculosis and one (4.5%) meropenem for
ESBL positive E. coli. Duration of the therapy was 6 weeks in 16
patients, 3 months in four and 6 months in two.
Conclusion: Operation is the main cause of spondylodiscitis. But
tuberculosis and brucellosis should always be in mind as a cause of
spondylodiscitis in endemic regions.
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R2666 Community-acquired urinary tract infection: prevalence
and resistence – a 1 year experience
A. Guerreiro*, A. Duarte, A. Ramalheiro (Lisbon, Alverca do Ribatejo,
PT)
Objectives: The aim of this study was to evaluate the prevalence of the
community-acquired UTI and the antibiotic resistance of the bacteria
involved.
Methods: Eight thousand eight hundred and twenty-eight urine
samples were analyzed from January 2010 until December 2010.
Urine samples were cultured in CPS ID3 and incubated at 37C for
24 hours. Identiﬁcation and antibiotic susceptibility tests were made by
the automated system Vitek 2 Compact (Biome´rieux). Susceptibility to
16 antibiotics commonly used in UTIs was evaluated: amoxicillin,
amoxicillin/clavulanic acid, cephalothin, cefuroxime, ceftazidime,
ceftriaxone, cefoxitin, cefepime, norﬂoxacin, ciproﬂoxacin,
fosfomycin, gentamicin, tobramycin, amikacin, trimethoprim/
sulfamethoxazole and nitrofurantoin.
Results: According to guidelines 1594 urines (18.1%) were associated
to UTI. Urinary isolates were collected from patients £50 years 37.8%,
(602/1594), >50 years 62.2%, (992/1594). The prevalence of
Escherichia coli was 64.9% (1034/1594) and for other Gram negative
bacteria 23.6% (376/1594). Klebsiella pneumoniae were identiﬁed from
168 urines (10.5%) while for Proteus mirabilis 145 urines (9.1%).
Among the Gram positive bacteria 10.4% (166/1594), Enterococcus
faecalis was the predominant species 6.3% (101/1594) followed by
Streptococcus agalactiae 2% (32/1594) and Staphylococcus
saprophyticus 1% (16/1594). For E. coli, K. pneumoniae, P. mirabilis
the antibiotics with higher frequency of resistance were ciproﬂoxacin
(10%, 11.3%, 10.3%) in association to trimethoprim/sulfamethoxazole
(27.3%, 19.6%, 29.7%), respectively. Fosfomycin showed more
efﬁcacy than others antibiotics with frequency of 1.5% (E. coli),
2.4% (K. pneumoniae) and 2.8% (P. mirabilis). Among E. coli isolates
the frequency of resistant strains were less than for K. pneumoniae and
P. mirabilis isolates.
Conclusion: This study shows that E. coli is involved in 64.9% of
the community-acquired UTI, a number lower than expected, followed
by other Gram negative bacteria like K. pneumoniae and P. mirabilis.
S. saprophyticus represents only 1% of the UTI, much lower than the
value described in literature where it is considered the second main
agent of UTI. High resistance rates were obtained for amoxicillin,
quinolones and trimethoprim-sulfamethoxazol. These antibiotics
should not be used for the empiric treatment of community-acquired
UTI. Low resistance rates are shown for fosfomycin and
nitrofurantoin. These two antibiotics may be a good option for the
empiric treatment of UTI.
R2667 Prevalence and sensitivity of viral and bacterial
enteropathogens in a local hospital in Spain (2004–2010)
J. Pe´rez, A. Sa´nchez-Maroto*, L. Garcı´a-Agudo,
S. Illescas (Manzanares, Tomelloso, Ciudad Real, ES)
Objectives: The aim of this study was to establish the prevalence
and sensitivity of isolated bacterial and viral enteric pathogens in the
Health Care Area of Manzanares (Ciudad Real, Spain) from 2004 to
2010.
Materials and Methods: We studied all stool samples received from
patients with suspected gastroenteritis and were processed for
Salmonella spp., Shigella spp., Yersinia spp., Aeromonas spp. and
Campylobacter spp. Suspected cases of Campylobacter spp. were
identiﬁcated using API Campy (bioMe´rieux, France). In other cases,
identiﬁcation and susceptibility testing were carried out in the WIDER
automated system (Soria Melguizo, Spain). We used speciﬁc antisera
(Bio-Rad, Spain) for the serotyping of Salmonella spp. All samples
from patients younger than 5 years were tested for viral pathogens
(Rotavirus and Adenovirus species) by inmunocromatographic methods
(Rota/Adenoscreen Dipstick, Microgen Bioproducts, UK).
Results: We isolated 764 bacterial pathogens from 3287 stool samples
(23.2%). We observed 437 (21%) positive samples to Rotavirus and 96
(5%) to Adenovirus from 2069 and 1870 stool samples analyzed
respectively. From bacterial pathogens, 326 isolates were Salmonella
spp. (42.7%), 297 Campylobacter spp. (38.9%), 101 Aeromonas spp.
(13.2%), 28 Yersinia enterocolitica (3.7%), 11 Shigella spp. (1.4%) and
10 Vibrio spp. (1.3%). The most prevalent Salmonella spp. serogroups
were B (43.6%) and D (41.7%). Campylobacter jejuni was identiﬁed in
the majority of Campylobacter spp. cultures. We found 73 bacterial
mixed infections, 71 double and two triple and 67 (91.8%) occurred in
children under 12 years. The sensitivity percentage of Salmonella spp.
to nalidixic acid and ciproﬂoxacin was 61.9% and 91.9%. In
Salmonella spp. serogroup B, the sensitivity to amoxicillin and
nalidixic acid was 34.4% and 92.6% and in serogroup D of 72.6%
and 52.2% respectively. We isolated three ESBL producing Salmonella
spp. As for Campylobacter spp. 98.2% of isolates were sensitive to
erythromycin and 12.2% to ciproﬂoxacin.
Conclusions: (i) The most prevalent enteropathogens in our area were
Rotavirus, Salmonella spp. and Campylobacter spp. among the
investigated pathogens. (ii) Salmonella spp., Aeromonas spp. and Y.
enterocolitica had high sensitivity to ciproﬂoxacin and 3rd generation
cephalosporins. (iii) The frequency of bacterial mixed infections was
high in our Area, and were more common in children. (iv) Rotavirus
infection was more prevalent than Adenovirus infection.
R2668 Improvement of CRB-65 as a prognostic scoring system in
adult patients with community-acquired pneumonia
R.P. Dwyer*, J. Hedlund, B. Henriques-Normark, G. Hoffman,
M. Kalin (Stockholm, SE)
Objectives: Community-acquired pneumonia (CAP) is the leading
cause of hospitalisation among infectious diseases. In accordance
with the work by Dwyer et al. (Scand J. Infect. Dis. 2011; 43: 448–
455) modiﬁcations were tested to improve the accuracy of CRB-65
(DS CRB-65) as a simple, but useful bedside scoring system, and to
compare it with three established severity scoring systems (PSI,
CURB-65 and CRB-65) to estimate risk of death within 30 days of
ER assessment in patients with CAP. DS CRB-65 implies adding
coexisting conditions deﬁned according to the pneumonia severity
index (PSI) rule (malignancy, liver, cerebrovascular, and renal
disease and congestive heart failure), as well as peripherally
measured oxygen saturation (SpO2) < 90% to the four parameters
of CRB-65.
Methods: For the period December 2008 through March 2010
patients, 18 years or older with CAP, were retrospectively included
from an inner city hospital. Age, gender, ICU-treatment, underlying
conditions, and 30-day mortality were recorded. Patients had not been
admitted to hospital during the preceding 2 weeks before enrolment.
PSI, CURB-65, CRB-65 and DS CRB-65 were calculated from
information given by the patient, the patient ﬁles, and laboratory
databases on day of admission. Receiver operating characteristic (ROC)
curves were constructed and the area under the curve (AUC) was
measured to compare accuracy of the scoring systems prediction of 30-
day mortality.
Results: A total of 1077 patients were included (67.9% admitted to
hospital, 32.1% treated on an outpatient basis), mean age was
64.3 years, overall mortality was 5.8%, and 50.7% were male. Of the
admitted patients 11.4% received ICU-treatment. The AUC, standard
error, Z-value, and 95% conﬁdence interval according to the ROC-
curves of the different scoring systems were as follows – PSI (0.82,
0.02, 15.6, 0.77–0.85), CURB-65 (0.80, 0.02, 12.5, 0.75–0.85), CRB-
65 (0.78, 0.03, 11.3, 0.73–0.83), DS CRB-65 (0.82, 0.02, 14.1, 0.77–
0.86). There was a signiﬁcant statistical difference between the ROC
curve AUCs of CRB-65 and DS CRB-65 (p = 0.004).
Conclusion: Modiﬁcation of CRB-65 (DS CRB-65), according to the
PSI rule, with addition of one point for the presence of any underlying
disease, and with one point if SpO2 was <90%, increased its prognostic
accuracy in CAP with retained independence of laboratory data. The
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modiﬁed CRB-65 may have potential to be used in ERs and outpatient
clinics for assessment of prognosis in patients with CAP.
R2669 Identiﬁcation of a human strain of Streptococcus
dysgalactiae subsp. equisimilis in a dog: a new zoonosis?
S. Preziuso*, A.R. Attili, M. Moriconi, A. Fruganti,
V. Cuteri (Matelica, IT)
Objectives: Streptococcus dysgalactiae subsp. equisimilis (SDSE) is
an important and sometimes lethal pathogen in humans, while it has
been considered mainly as opportunistic in animals. Very limited cases
of SDSE diseases have been described in dogs so far. Several zoonoses
are caused by a close contact between humans and animals. Recently, a
PCR protocol for distinction between SDSE of human (hSDSE) and
equine origin has been optimised. The objective of this work was to
evaluate if dogs may harbour human SDSE, with consequent potential
impact on human health.
Methods: Forty-seven beta-haemolytic streptococci isolated from
different clinical specimens from dogs have been identiﬁed by PCR.
The four strains identiﬁed as S. dysgalactiae have been tested by PCR
for identifying the subspecies and for detecting a sequence of the
streptokinase (skc) precursor gene of hSDSE.
Results: Forty-one out of 47 streptococci strains have been identiﬁed
as Streptococcus canis and four strains were S. dysgalactiae. One S.
dysgalactiae strain resulted positive for the skc precursor gene speciﬁc
of hSDSE, while the other three strains were negative. The dog had
fever, was lacking appetite, had enlarged and painful retro-pharyngeal
lymph nodes and signiﬁcant increase of the tonsillar volume
Conclusion: This is the ﬁrst detection of a SDSE strain of human
origin in dogs. Dogs infected by hSDSE might represent a potential risk
for human health. This risk should be better investigated because of the
close contact between pets and humans, including children. Species
identiﬁcation of beta-haemolytic streptococci isolated from dogs is
usually not requested in veterinary clinical microbiology for economic
reasons. If SDSE transmission between dogs and humans will be
conﬁrmed, a rapid identiﬁcation of hSDSE in infected dogs could be
useful for preventing the bacterial transmission to humans, with
particular attention to children and immunocompromised people.
R2670 Commonality among CTX-M-15-producing ST131-O25b
uropathogenic Escherichia coli isolates from companion
animals and humans in Portugal
C. Pomba*, L. Fernandes, A. Belas, N. Couto, R. Dias, P. Cavaco-
Silva (Lisbon, PT)
Objectives: To assess similarities by PFGE analysis of E. coli isolates
from the sequence type 131 serotype O25-variant b worldwide
pandemic clone among companion animal and human urinary tract
infection in Portugal and its association with ﬂuoroquinolone-resistance
and ESBL production.
Methods: All isolates were previously identiﬁed as ST131-O25b by
PCR. The veterinary community E. coli isolates (n = 44, 36 from dogs
and eight from cats), were collected from 2004 until 2009 at the
Veterinary Teaching Hospital of the FVM and at private practices in the
Lisbon area. Human strains (n = 41) were isolated in hospitals and in a
community Diagnostic Laboratory in the Lisbon area, during 2005 and
2006. Of these, 15 were from hospitalized and 26 from ambulatory
patients. The subset of ST131-O25b isolates underwent susceptibility
testing by disk diffusion, ESBL phenotyping and genotyping and PFGE
analysis. PFGE digital images were analyzed using Bionumerics
software version 6.6. Similarities were calculated using the Dice
coefﬁcient, with 0.5% optimization, a maximum position tolerance of
1.0%, and clustered by UPGMA.
Results: Thirteen (31.7%) ST131 human isolates were CTX-M-15
beta-lactamase producers (seven E. coli isolates from community-
associated UTI and six from hospitalized patients). Five (11%) CTX-M
producer E. coli isolates were isolated from three dogs (2 CTX-M-15
and 1 CTX-M-32) and two cats respectively (1 CTX-M-15 and 1 CTX-
M-32). All human and animal ESBL-producer isolates were also
ciproﬂoxacin-resistant. The ESBL-producer isolates also harboured
simultaneously the blaTEM and blaOXA-1 genes (nine human and two
animal isolates). PFGE analysis showed 100% similarity between one
human nosocomial and a dog community both CTX-M-15-producer
isolates and these clustered (>85% similarity) with two other human
nosocomial and cat CTX-M-15-producer isolates.
Conclusions: We had previously demonstrated that the ST131-O25b
pandemic E. coli clone is a prevalent clone in the Lisbon area in
Portugal and that the majority of these isolates lack ESBL genes.
Nevertheless, the present study shows the similarity of CTX-M-15-
producer E. coli ST131-O25b clone across host species. Our ﬁndings
conﬁrm that the transfer of resistance markers and resistance isolates
between animals and owners/caretakers is a strong possibility either by
infection or direct contact. Companion animals may play an important
role in the dissemination of the ST131-O25b pandemic E. coli clone in
the community.
R2671 Community-aquired urinary tract infections: spectrum of
causative agents and susceptibility to common
antimicrobials. A 4-year study
N. Skarmoutsou*, D. Dimitriadi, P. Katsika, V. Mitraj,
S. Konstantopoulou, G. Kasdaglis, M. Martsoukou,
M.E. Fakiri (Athens, GR)
Objectives: This study was performed to investigate the spectrum of
bacteria associated with community-acquired bacteriuria and their
resistance patterns to antibiotics commonly used as empirical therapy.
Methods: During a 4 years period (September 2007–September 2011)
a total of 3.126 urine samples from outpatients with urinary tract
infection (UTI) symptoms were submitted in our laboratory and
cultured by conventional methods. Species identiﬁcation and
susceptibility testing was performed with the Wider system (Soria),
while the phenotypic detection of the production of extended spectrum
b-lactamases (ESBL) was performed by the double disk synergy test,
the combined disk test and the two-sided E-test, when necessary, on M.
H. agar according to CLSI criteria.
Results: Bacterial pathogens were identiﬁed in 1.236 samples (39.5%).
E. coli encountered more frequently (73%), followed by P. mirabilis
(6.4%), K. pneumoniae (5.3%), several Gram negative bacteria (5.7%),
E. faecalis (4.5%) and S. saprophyticus (1.9%). ESBL were detected in
15.3% of K. pneumoniae strains, 6.3% of P. mirabilis and 2.1% of E.
coli. Susceptibility testing of Gram (–) isolates to most commonly used
per-os antimicrobials Ampicillin, Amoxicillin/clavulanic, Cefuroxime,
Trimethoprime/sulfamethoxazole and Norﬂoxacin revealed resistance
44.6%, 9.5%, 9.2%, 26.7% and 8.7%, respectively. Enterococci
exhibited resistance to Norﬂoxacin 8.9%, while all S. saprophyticus
strains were susceptible at Trimethoprime/sulfamethoxazole and
Norﬂoxacin.
Conclusions: E. coli remains the most prevalent causative agent of
community-acquired UTI (73%). Resistance rates to quinolones,
amoxiccilin/clavulanic and per-os cephalosporines remained low and
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it seems that these agents can still be used in empirical antimicrobial
therapy of uncomplicated UTI. On the other hand, high resistance rates
to trimethoprime/sulfamethoxazole and ampicillin indicates that their
use in therapy of UTI may lead to treatment failure.
R2672 Absence of faecal shedding of Listeria monocytogenes in
the Netherlands
D.L.J. Hess*, P.H.M. Savelkoul, C.J.C.M. Hamilton,
P.M. Schneeberger, C.W. Ang (Amsterdam, ‘s-Hertogenbosch, NL)
Objectives: In the Netherlands, Listeria monocytogenes faecal carriage
of up to 70% has been described. Listeria is usually acquired by
consuming food contaminated with L. monocytogenes. Because of its
high mortality (up to 30%), listeriosis is a major public health concern
and the Community legislation lays down food safety criteria for
Listeria in risk products.
The aim of this study was to determine faecal shedding of L.
monocytogenes using culture and PCR.
Methods: A total of 437 stool specimens was collected from four
different patient groups (267 gastro-enteritis patients, 91
immunocompromised patients, 45 pregnant women and 35 chronic
bowel disease patients, respectively). Culture was performed using cold
enrichment and PALCAM selective agar plates. PCR was performed
using a primer-probe combination as described by Oravcova´ et al.,
targeting the actA gene.
Results: None of the faecal samples was L. monocytogenes positive,
neither culture nor PCR positive. 4.8% (20/437) of the samples could
not be assessed using PCR due to inhibition of the PCR reaction.
Conclusion: Compared to previous Dutch reports in the seventies of
the last century, faecal shedding of Listeria has dramatically declined in
the Netherlands. Since publication of these reports there have been
major changes in regulations on food safety. Our data suggest that the
current food safety policy in the Netherlands regarding L.
monocytogenes control is highly successful.
R2673 Prevalence and risk factors of HIV, hepatitis B virus and
syphilis among pregnant women on Mayotte Island,
Indian Ocean, 2008–2009
M. Saindou, T. Be´net, D. Troalen, A. Abaine, N. Voirin, M. Giard,
P. Vanhems* (Lyon, Mamoudzou, Mayotte, FR)
Objectives: Indian Ocean’s Islands have been described as areas with a
high prevalence of sexually-transmitted infections (STIs) except human
immunodeﬁciency virus (HIV) infection. The objective was to assess
the prevalence of infection by HIV, hepatitis B virus (HBV) and
syphilis and their risk factors among pregnant women (PW) of Mayotte
Island, Indian Ocean.
Methods: A cross-sectional study was conducted at 11 antenatal clinic
centers of Mayotte Island’s from September 2008 to September 2009.
All PW attending for their pregnancies in the participating centers were
eligible if they conformed to the following inclusion criteria: a screening
at consultation done for HIV, HBV, and syphilis, and provide written
informed consent. Among the 13 antenatal clinic centre, two were not
included for practical reason. One because of a very low activity and the
other because it was located on another island. Socio-demographic and
behavioral characteristics were collected by interviewer-administered
questionnaire. Blood samples were obtained for testing HIV, HBV, and
syphilis. Risk factors were analyzed by logistic regression.
Results: Of the 708 eligible PW, 671 (94.5%) consented to participate.
No prevalent case of HIV infection was detected. The prevalences of
hepatitis B surface antigen (HBsAg), active syphilis (RPR+TPHA+)
and any sexually transmitted infection (STIs) (at least one selected STIs
marker) were 3.4%, 2.1%, and 5.4%, respectively. HBsAg positive test
was associated with being born in Madagascar, and having a casual
partner. Lack of education, partner’s refusal to use condom and history
of STIs were associated with active syphilis. STI pathogens were
associated with lack of education, age 15 years or over at ﬁrst sexual
intercourse, having a casual partner and a history of STI.
Conclusions: The continuing low prevalence of HIV and high
incidence of STIs conﬁrmed the Indian Ocean situation with HIV/
STIs. Identifying the factors associated with this phenomenon could
help to prevent an HIV epidemic in low HIV transmission areas such as
Mayotte Island.
R2674 Impact of changes in the surveillance system on the
epidemiology of pertussis over 20 years in Catalonia,
Spain
I. Crespo*, N. Soldevila, P. Godoy, G. Carmona,
A. Domı´nguez (Barcelona, ES)
Objectives: Pertussis is an infectious disease that causes important
morbidity in developed countries. In Catalonia, a region in the
Northeast of Spain with 7.5 million inhabitants, organized in 41
counties, pertussis surveillance began in 1980, when notiﬁcation was by
numerical report. Since then, the surveillance system has undergone
various changes. In 1997, there was a change from numerical to
individual report, with physicians being required to complete a report
form for each case. In 2003, a program aimed at increasing laboratory
diagnosis of pertussis was begun. The aim of this study was to analyse
the changes in pertussis surveillance in Catalonia and their impact on
reported disease incidence in rural and urban areas.
Methods: The 20-year study period (1990–2009) was divided into
three periods: 1990–1996; 1997–2002; and 2003–2009. Rural and
urban counties were deﬁned according to population density. The mean
population density of Catalonia was calculated. Counties with a density
above the mean (‡201 inhab/km2) were considered as urban areas and
counties below the mean (<201 inhab/km2) as rural. The incidence rate
of pertussis was estimated for each period. The RR between rural and
urban areas and the 95% CI were calculated, with rural areas taken as
the reference value. Statistical signiﬁcance was established at an alpha
level of 0.05.
Results: A total of 7251 cases were reported to the Department of
Health during 1990–2009. In 1990–1996, 5064 cases were reported
with an incidence rate of 11.92 · 10.5 persons-year. In 1997–2002,
425 cases were reported with an incidence rate of 1.13 · 10.5 persons-
year. In 2003–2009, 1762 cases were reported with an incidence rate of
3.52 · 10.5 persons-year. The RR obtained comparing the rates of
urban and rural counties in 1990–1996 was 1.43 (95% CI 1.34–1.54;
p < 0.001). In 1997–2002, there were no differences between urban and
rural counties (RR:1.10; 95% CI 0.89–1.37, p < 0.358). Rates were
again higher in urban compared to rural counties in 2003–2009
(RR:1.36; 95% CI 1.20–1.53; p < 0.001).
Conclusions: The change from numerical to individual report was
associated with a reduction reported cases. However, when laboratory
facilities were introduced, the detection of incidence increased. In the
periods when high incidence was observed, urban areas showed higher
rates than rural areas. This underlines the importance of taking into
account the surveillance system when changes in the epidemiology of
pertussis are observed.
R2675 Laboratory surveillance of polio and other enteroviruses
circulation in Latvia
L. Firstova, N. Zamiatina, G. Ryazantseva, S. Nikishin, L. Metlova,
Y. Storozenko*, B. Rozentale (Riga, LV)
Objectives: Latvia had been recognized by WHO as polio free country
in 2002, but the possibility to import wild polio virus from endemic
countries or vaccine-derived poliovirus (VDPV) with regained
neurovirulence, can become new challenge for the eradication of
polio. Laboratory surveillance revealing of enteroviruses in clinical
materials, especially from patient with acute ﬂaccid paralysis as well as
virus ﬁndings in environmental samples is background for completing
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WHO programme and the main control procedure for polio circulation
in Latvia.
Methods: Clinical materials as faeces, CSF, pharyngeal swabs, post
mortem collected specimens, sewage were collected and analysed in
according to the WHO recommendation. Three different cell lines: L-
20B, Hep-2C, RD (A) were used for enterovirus isolation. Isolated
polio and enteroviruses strains were characterized for serotype on the
base of neutralization reaction with speciﬁc antisera. Intratyping
diagnostics have been completed at the National Institute of Health
and Welfare, Helsinki-Collaborating Center of WHO Global Polio
Laboratory Net.
Results: The last wild polio virus in Latvia had been detected in 1965.
It was WPV1 isolated from sewage. Since this year only polio vaccine
associated viruses have been detected in Latvia. From 2000 to
2008 years 11569 samples were laboratory examined. Polioviruses
were found in 152 samples of sewage water (Sabin PV1- 54, PV2-48,
PV3-50) and in 29 ones of faeces (Sabin PV1-14, PV2-5, PV3-10). The
last polio vaccine associated viruses were detected in 2008. No one
Poliovirus was found in 2009 and 2010 years. In September of 2011
PV1 has been isolated from RIGA international airport’s sewage water
and characterized as polio vaccine associated virus in WHO CC
laboratory. Intensiﬁed sewage sampling and diagnostics weekly from
the airport and main Riga city water reﬁne buildings no one poliovirus
was detected. Active circulation of others enteroviruses was detected in
all years. From last events, in 2010 dominated Echo 30 (104 cases) and
Coxackie A9 (70 cases), that was the main cause of the big aseptic
meningitis outbreak in south-eastern Latvia.
Conclusions: During 2 years period, after introducing inactivated polio
vaccine in Latvia in 2006, laboratory detected only sporadic polio
vaccine associated viruses and no one in 2009–10 years. The source of
PV1 Sabin, isolated in 2011 from the airport’s sewage, is unknown;
rather it was imported from countries, using oral polio vaccine.
R2676 The evaluation of 46 cases presenting with rare adherence
and complications due to brucellosis
T. Turunc*, Y. Demiroglu, E. Kursun (Adana, TR)
Objectives: The study was established in order to take care of the
physicians from all departments rather than Infection Diseases about
diffential diagnosis of brucellosis that can present atypical adherence
and complications, also imitate other infectious and non-infectious
diseases.
Methods: Between January 2002 and October 2011, totally 487 cases
with brucellosis were followed and treated prospectively in our clinics.
Forty-six of these cases who did not have spesiﬁc sign, symptoms and/
or laboratuary ﬁndings about brucellosis and also presented unexpected
adherence and complications were included to study.
Results: Seventeen of the 46 cases were female and 29 of them were
male. The mean age was calculated as 40.8 years. Thirty-six of the
cases were detected as acute, while nine of them subacute and one of
them chronical brucellosis. Brucella melitensis was isolated in blood
samples of 17 cases, urine sample of one case, both urine and blood
samples of one case, abcess samples of four cases, blood sample and
mitral valv of one case, pleural and peritoneal ﬂuid samples of one case.
The distribution patern of the patients due to affected systems and
organs with symptoms at application time was presented in Table 1.
Also, it was detected that 37 (80.4%) of the cases were initially
evaluated by different clinics rather than Infection Diseases.
Conclusion: As seen in our study, an important proportion that can not
be underestimated (9.4%) of brucellosis might progress with atypical
clinics and be evaluated by different clinics rather than Infection
Diseases. The treatable disease can be easily overlooked if it is not
mentioned in differantial diagnosis in endemic regions. Therefore, we
think that the differantial diagnosis of brucellosis might be kept in mind
by not only the specialists of Infection Diseases but also the physicians
of other branches, too.
R2677 Evaluation of 89 cases of Brucellar spondylodiscitis
T. Turunc*, E. Kursun, Y. Demiroglu (Adana, TR)
Objective: Spondylodiscitis due to brucellosis as well as longer
duration of treatment required during the diagnosis and computed
tomography with magnetic resonance imaging examinations such as the
use of advanced disease with focal organ involvement is one of the
most troublesome. In our study, we followed the patients were
evaluated with brucellar spondylodiscitis.
Methods: Our clinic between March 2004-October 2011 total of 487
cases of brucellosis were monitored prospectively, and these patients 89
(18.2%) cases were identiﬁed spondylodiscitis The diagnosis of
spondilodiscitis was established by physical examination and
radiological ﬁndings obtained by diagnosting imaging tools.
Results: Total 89 cases, while 49 men and 40 women mean age 58.02
(age range:26–86 years), respectively. Fifty one cases (57.3%) acute,
subacute, 34 (38.2%) and 4 (4.4%) were considered chronic. Three
patients (3.3%) relapsed with a spondylodiscitis is determined. The
most common site of lumbar spine involvement in 64 (71.9%),
respectively, while the thoracic and cervical spine involvement was
found to be 25.8% and 2.2%. Thirty-six cases of blood culture both
yielded Brucella spp. In addition to the twenty-eight cases of
paravertebral abscess, spondylodiscitis, 20 cases of epidural abscess
and one patient was found intraosseous abscess. In two patients with
neurological deﬁcits due to surgical treatment is applied to identify
other medical treatment was performed in all cases. Medical treatment
was performed at least 4 months. All patients had healed without
sequelae.
Conclusion: In our study, approximately one ﬁfth of spondylodiscitis
seen almost all cases of brucellosis with the most common cause of
focal involvemed organ. Contrary to expectations, a large portion of
patients diagnosed with acute or subacute period, and again a large part
of the paravertebral and epidural abscess has been identiﬁed as a serious
involvemed. Spondylodiscitis due to other factors in different cases of
epidural and paravertebral abscess is improved with medical treatment
without the need for surgical treatment. This is so serious, especially in
endemic areas, brucellosis should be considered in the differential
diagnosis of vertebral involvement in cases of spondylodiscitis.
R2678 Measles epidemic in Istanbul – a measles-free
metropolitan area for the past 5 years
F. Pehlivanoglu, G. Sengoz*, K.K. Yasar (Istanbul, TR)
Objectives: Annual average of measles cases reported in Istanbul with
a total population of 13 million people was 500 cases whereas
approximately 3000 cases were reported in the epidemic years. A
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pleasant successful point has been achieved in the elimination of
measles disease due to the continuous vaccination process that has been
performed in the children between ages of 0–14 years and has reached
the rates over 95%. Only seven imported cases have been reported in
this notiﬁable disease during the 5-years term since 2006 in Istanbul.
However, a measles epidemic has been observed in Istanbul at the
beginning of the year 2011 that has affected the adults around 30-ages.
The conﬁrmed 42 (including nine medical staff), 14 and 38 cases were
between 19–35 ages interval, below 1-year of age and in childhood,
respectively.
Cases: The six cases followed in our hospital ranged between 22–32
ages and four cases were female (including one case with 33 weeks
gestational age). All of the patients were clustered in the same region
however there was no association. Their application dates were between
19th February and 25th March. While all the patients were found to
have typical maculopapular rash, fever, measles IgM positivity,
elevated ALT and AST values; Koplik’s spots were found in four
patients. Of the patients, three of the patients were evaluated to have
allergic eruption at the ﬁrst hospital admission. While pneumonia was
detected clinically and radiologically in four patients, H. inﬂuenzae was
isolated from sputum in one patient. Of the three cases that were
medical staff, one has shown disease symptoms 7 days after the
vaccination and bilateral viral pneumonia developed in the patient.
Conclusions: Measles is a vaccine-preventable disease. However,
some problems have been experienced in the diagnosis of the recent
cases in Istanbul and the patients could have been diagnosed only after
they have received several treatments for different diseases since
awareness and familiarness level of the disease decreased between
people and medical staff by the years. The presence of the susceptible
cohorts of the people complicates the elimination of the disease.
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R2679 Ongoing circulation of a novel sandﬂy fever virus variant,
sandﬂy fever Turkish virus in Ankara province, Turkey
Z.K. Tufan*, K. Ergunay, C. Bulut, S. Bakkal, S. Kinikli,
A. Demiroz (Ankara, TR)
Objectives: Sandﬂy Fever Turkish Virus (SFTV), a variant of Sandﬂy
Fever Virus (SFV) Sicilian serotype, was identiﬁed in Turkey during an
investigation of an outbreak of a febrile disease of unknown origin.
SFTV is associated with sandﬂy fever, a self-limited febrile disease
common in Mediterranean basin, but with a severe clinical picture with
elevated liver enzymes and thrombocytopenia and requiring up to
30 days for complete recovery. The objective of this study was to
identify the acute infections with SFTV at a research and training
hospital in Ankara Province, Turkey, where cases had been observed
previously between 2007 and 2009. West Nile virus (WNV) infections,
which was responsible for an outbreak in Turkey in 2010 and has to be
considered in the differential diagnosis of sandﬂy fever, were also
investigated.
Methods: A total of 16 serum and plasma pairs from patients with
suspected SFTV during July-August 2011 were included in the study
with informed consent. Inclusion criteria were deﬁned as fever,
accompanied by any of the following: malaise, abdominal discomfort,
photophobia, headache plus leukopenia, thrombocytopenia and elevated
liver enzymes. For the detection of SFTV and other SFVs, a nested
PCR with Phlebovirus consensus primers, targeting the viral
polymerase (L segment) were employed. Amplicons from the PCR
were subjected to cycle sequencing for identiﬁcation. SFV IgM
antibodies were detected via a commercial immunoﬂuorescence assay
(IFA, Sandﬂy fever virus IgM mosaic I, EuroImmun, Germany). All
sera were also evaluated in parallel for WNV using a commercial assay
(West Nile virus IgM IIFT, EuroImmun, Germany) for antibodies and
an in-house reverse transcription real-time PCR for viral RNA.
Results: All samples were negative for WNV RNA or IgM. A total of
four samples (4/16, 25%) were reactive in Phlebovirus consensus PCR.
Sequencing of the amplicons revealed sequences similar to previously
published SFTV L segment, distinct from other SFV types. In eight
sera, SFV IgMs were identiﬁed. In three PCR positive samples (3/
4,75%), IgM antibodies to Sicilian, Cyprus or Toscana serotypes were
detected via the commercial IFA.
Conclusions: Symptomatic cases due to acute SFTV infections were
demonstrated in this study via generic PCR and cycle sequencing.
These ﬁndings conﬁrm the ongoing circulation of this novel SFV in the
region where it was originally identiﬁed.
R2680 Burkholderia cepacia complex in adult cystic ﬁbrosis
patients: species, sensibility and other micro-organisms
associated
A. Correa*, B. Buendia, A. Somodevilla, M. Espı´nola, C. Cisneros,
R. Go´mez-Punter, R. Giro´n (Madrid, ES)
Objectives: The Burkholdderia cepacia complex (Bcc) species are
important opportunistic pathogens with intrinsic antibiotic resistance.
They cause devastating infections in patients with cystic ﬁbrosis (CF)
and other vulnerable individuals. The aim of this study was to describe
the distribution of species, Bcc antimicrobial susceptibility proﬁles and
its relation with other microorganisms isolated in sputum sample
isolated from adult CF patients examined in a cystic ﬁbrosis unit at
Hospital Universitario de La Princesa (Madrid).
Methods: From March 2009 to June 2011, all sputum samples from
CF patients were cultivated following standard procedures for these
samples. Bcc was isolated in the BCSA (B cepacia selective agar)
medium. The identiﬁcation and susceptibility was performed by Walk
away (SIEMENS). The determination of the species status of B. cepacia
complex strains was carried in a reference laboratory (Carlos III,
Majadahonda) by sequentiation ribosomal 16S. The susceptibility break
points cosidered were according to the Clinical Laboratory Estandar
Institute guideless (CLSI).
Results: Bcc was isolated from eight out of 70 patients (11.4%), one of
them Bcc was eradicated. 62.5% were women and 37.5% were men.
The average age was 26 years old and pulmonary function expressed in
FEV1 in average was 64.6%. Four patients (50%) had B. cenocepacia,
one patient had B. cepacia, other one had B. multivorans, other one had
B. vietnamiensis, other one had B. stabilis and other one patient had B.
contaminans. One of them had two different species (cenocepacia and
contaminans). 40% of Bcc was susceptible to ceftazidime, 20% to
levoﬂoxacin, 87.5% to meropenem and 72.5% to cotrimoxazol. Three
patients who were colonized by Bcc were also colonized by
Staphylococcus aureus.
Conclusions: We found a high rate of patients colonized by Bcc. The
B. cenocepacia was the most prevalent among the Bcc isolated in CF
adult patients. Meropenem and cotrimoxazol showed the best activity
and levoﬂoxacin was the less active one against our strains. In this
study, we concluded that there is a certain grade of co-colonization by
Bcc and S. aureus.
R2681 Six cases of human intestinal spirochetosis
A. Gil-Setas*, J.M. Martinez-Pen˜uela, R. Escudero, P. Anda,
I. Tordoya, C. Ezpeleta (Pamplona, Madrid, ES)
Objective: Human intestinal spirochetosis (HIS) has been associated
with two species of Brachyspira: Brachyspira aalborgi and Brachyspira
pilosicoli. B aalborgi has been isolated mostly from human and B
pilosicoli from animals. Prevalence rates of HIS are variable, being
higher in poorly developed areas or in patients infected with HIV.
Although HIS is usually an incidental ﬁnding there is strong evidence to
be a cause of diarrhea, diffuse abdominal pain or gastrointestinal
bleeding. Our aim in this work was to identify to species level the cases
of HIS that were diagnosed in our Hospital by the Pathology laboratory
and compare them with previous papers.
Methods: From 2002 to 2011 six cases of heavy colonization with
spirochetes were diagnosed in the Pathology laboratories of our
Hospitals. The stains used in the diagnosis were Hematoxylin-eosin in a
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ﬁrst step and Warthin-Starry for conﬁrmation of cases of typical
hematoxyphilic fringe on the brush border. The extraction of the DNA
from the samples ﬁxed in formalin and embedded in paraﬁnn wax was
performed following the protocol of the Instituto de Salud Carlos III by
using QIAamp DNA mini kit. Generic primers for all Brachyspira
species were designed targeting the NADH-oxidase (nox) gene for the
ampliﬁcation of a 776 bp fragment Positive samples were then
sequenced and analyzed. Data of age, sex, HIV serology and clinical
symptoms were collected from medical records.
Results: Five of the six samples were positive to the PCR and four of
them identiﬁed to species level after nox gene sequencing. Three of
the samples were identiﬁed as Brachyspira aalborgi, one as
Brachyspira pilosicoli; the remaining sample yielded a positive
result by PCR and it is being sequencing at time to writing this
abstract. All the patients were older than 60 years and only one of
them was female. Except for one case that was unknown HIV
serology, all were negative. Four of the patients had symptoms of
diarrhea, one was asymptomatic at the time of discovery IS and for the
other one there was not medical record.
Conclusion: As in previous reports, most of the diagnosis of HIS were
due to B aalborgi and B pilosicoli.
None of our patients were HIV infected although is the high rate of
colonization in this population. Four of our cases had symptoms
compatible with the disease but despite of this none of them received
speciﬁc treatment. HIS is a condition with a non difﬁcult microbiolog-
ical diagnosis, although clinical awareness can be low.
R2682 Different pathogenicity among Corynebacterium species
isolated from clinical specimens
M.I. Ferna´ndez-Natal*, J.A. Sa´ez-Nieto, S. Valdezate-Ramos,
M.D. Ruiz de Villa, S. Lapen˜a, F.S. Garcı´a (Leo´n, Madrid, ES)
Objectives: To evaluate the pathogenicity among Corynebacterium
species isolated from clinical specimens.
Methods: During a 5 years period, we recovered 252 isolates of
Corynebacterium species (mostly from blood cultures) from 223 in-
patients. All isolates were identiﬁed by phenotypic studies including
API CoryneTM V2.0 and Biolog GP2TM. 16S rDNA and rpoB
ampliﬁcation and sequencing were also performed. Resulting sequences
were BLAST compared with the deposited GeneBank sequences.
Patients were grouped according with the Corynebacterium specie
isolated. Only groups with more than ﬁve patients-same specie involved
were further analysed. The clinical signiﬁcance of each isolate was
categorized by means of clinical and epidemiological data as deﬁnitive,
probable, possible or indeterminate. Species with more than 50% of the
cases involved in deﬁnitive or probable clinical infections (group A)
were compared with those involved in <50% (group B). The difference
between both groups was compared by the EPIDAT program.
Results: Table shows the results with eight species responsible of
deﬁnitive or probable clinical signiﬁcance (between 25.0 and 84.2% of
the cases). In group A we have included species highly involved in true
clinical infections (between 57.1 and 84.2%) while in group B species
less involved in true clinical infections are included (between 25.0 and
50.0%). The difference between both groups were highly signiﬁcant:
p < 0.0001; OR: 3.71; (IC95:1.92–7.15).
Conclusions: The isolation of any Corynebacterium species from
clinical samples must be evaluated taking into account clinical and
microbiological data to consider them as true responsible for an
infection. However, our study suggests that some species as C.
jeikeium, C. ureicelerivorans, and C. urealyticum are more frequently
responsible of clinical infections while C. aurimucosum, and C.
amycolatum are less. Studies on pathogenicity and virulence of the
genus are merited. Once considered any isolate as clinical signiﬁcant,
antimicrobial susceptibility data must be provided as antibiotic
resistance varies but it is particularly high in C. jeikeium, C.
urealyticum, C. striatum, and C. amycolatum.
R2683 Infectious spondylodiscitis: clinical-epidemiological
features and therapeutic management
T. Tieghi, V. Belvisi, C. Del Borgo, R. Citton, A. Vetica, P. Fabietti,
V. Mercurio, R. Marocco, M. Lichtner, C. Mastroianni* (Latina, IT)
Objective: Spinal infections are an emerging problem, representing 3–
5% of all cases of osteomyelitis. The aim of this study was the analysis
of clinical and epidemiological features of a cohort of patients with
infectious spondylodiscitis.
Methods: All patients with spondylodiscitis admitted at the S. M.
Goretti Hospital of Latina, Italy were included and followed up for at
least 6 months. The diagnosis of spondylodiscitis was made according
to clinical, radiological and microbiological criteria. All cases were
classiﬁed into community-acquired (CA) and hospital-acquired (HA)
spondylodiscitis; the latter were subdivided into non post-operative and
post-operative, when the onset of symptoms was within 1 year from
spinal surgery. For every patient, the following data were recorded:
demographic characteristics, comorbidities, clinical features, laboratory
data, imaging, antimicrobial and surgical treatment, outcome and
complications at follow-up.
Results: The study included 32 patients (66% M and 34% F, mean age
of 58 years. Twenty-one patients had CA- spondylodiscitis, seven
experienced post-operative HA-spondylodiscitis and four non post-
operative spondylodiscitis. Five patients suffered from TB spondylitis.
Spondylodiscitis affected more often the lumbar spine (78%) and four
people had also endocarditis. Unremitting pain was the initial complaint
of all patients, whereas fever was reported in 69% of people. At
baseline blood tests showed raised ESR and CRP in all cases, while the
leucocyte count was elevated in 26%. At 6 weeks follow-up, CRP
returned to normal in 29 patients, whereas ESR persisted elevated in the
majority of cases. Pathogens were identiﬁed in 50% of patients. Blood
cultures grew bacteria in nine cases and 11 patients (34%) underwent
spinal biopsy, that detected microbes in three cases. MRI was
performed in all patient. The mean time to repeat MRI was 34 days
and the second MRI images demonstrated worsening changes in 40% of
patients, despite clinical improvement. Antimicrobial therapy was
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administered parenterally for a mean of 37 days and combinations of
beta-lactams and glycopeptides or beta-lactams and a quinolone were
used. Clinical improvement and dropping of inﬂammatory markers
were observed in all patients, and no recrudescence of infection
occurred within 6 months.
Conclusions: Infectious spondylodiscitis represents an emerging
infection at community and hospital setting. The appropriate lenght
of therapy could be addressed with comparative trials.
R2684 Infective endocarditis complications during evaluation of
fever of unknown origin
G. Stevanovic*, M. Pelemis, L. Lavadinovic, M. Pavlovic, J. Poluga,
S. Nikolic, J. Nikolic, M. Jovanovic, T. Tosovic (Belgrade, RS)
Introduction: Infective endocarditis is inﬂammatory process localized
on valves. Intracardial complications: miocarditis, myocardial abscess,
valvular ring abscess, purulent pericarditis, chord rupture, papillary
muscle or septum, ﬁstulas, rhythm disorders are common. Septic
embolizations with infarcts are also possible. Neurological
complications: meningitis, meningoencephalitis, brain abscess are rare.
Aim: Research frequency of single complications seen in our patients,
and established association of these complications with risk factors,
during evaluation of fever of unknown origin.
Material and Methods: All patients admitted with presentation of
fever of unknown origin in which endocarditis was established in
period 2005–2010. We diagnosed 52 patients as endocarditis, age 18–
73 in the Department of clinical pharmacotherapy, Clinic for infectious
and tropical diseases, Belgrade.
Results: Risk factors are previous cardiology disease and congenital
cardiology defects and cardiac surgical interventions at 27.08% (cardiac
surgery 12.5%). The most frequent causative microorganisms are
Staphylococci (32.3%), Streptococci (26.5%) and Enterococci (26.5%).
Neurological complications was observed in 41.67% of the cases, 35%
of them had headache, conscious crisis 45%, cranial nerves disorders –
lesions of facial nerve 5%, disphagia 10%, 5% with speech problems.
Septic thromboses in central nerve system are diagnosed at 5% of
patients. Of them, meningoencephalitis had 10%, cerebritis 25%,
purulent meningitis 5%, other had minor singes. Symptoms by the CNS
were marked at 90% of the patients who had neurological
complications, and they appeared before infective endocarditis
diagnosed. Cardiology complications detected at 25% (of them mitral
valves defect 25%, aorta valves defect 58.33%, thricuspid valves defect
8.33%, rhythm disorders 8.33%, chord rupture 25%, aneurysm aorta
8.33%). Spleen abscess and cardiac abscess 2.08%.
Conclusion: Major clinical manifestation was fever, without other
symptoms. Patients with neurological complications had neurological
manifestations before endocarditis diagnosis were established.
Cardiological and other complications are developed and diagnosed
later. The appearance of neurological complications is relevant for the
course, treatment and the outcome of the disease.
R2685 The results of the deep tissue culture test for diabetic foot
F. Pehlivanoglu, G. Sengoz*, K. Kart Yasar (Istanbul, TR)
Objectives: Diabetes mellitus is a prevalent disease in all ages that
may have long-term effects over all body organs. Diabetic foot (DF) is a
clinical entity associated with orthopedic, neurologic and the vascular
structures that may be frequently complicated with infection. In this
study, it has been aimed to determine and to evaluate the agents isolated
via deep tissue cultures from the DF and to assess the antibiotic
susceptibilities.
Methods: In 6-month period, 112 samples of deep tissue cultures for
DF were sent to our laboratory for investigation. The identiﬁcation of
the bacteria was performed via conventional biochemical methods and
Vitek Compact Systems 2 (Biomerieux, France) while their sensitivity
to antibiotics was assessed via disc diffusion method accordingly with
the recommendations of Clinical and Laboratory Standards Institute.
Results: Of the cases followed-up during 6 months; isolation rate of
responsible agents was 10% in ones below 50 years old whereas this
ratio was 31% in those above 50 years old. The 42 (37.5%) of the
investigated 112 deep tissue cultures were polimicrobial materials with
two different isolates. Of the determined bacteria; 24% were Gram
positive cocci whereas 76% were Gram negative enteric bacilli.
Antibiotic resistance rates were found 5%, 22%, 12%, 11%, 2%, 3%,
2%, and 5% in Pseudomonas strains against ceftazidime, aztreonam,
amikasin, ciproﬂoxacin, cefepime and piperacillin-tazobactam,
cefoperazone-sulbactam and imipenem, respectively.
Conclusions: Antibiotic resistance rates against the commonly used
antibiotics were not found high in Pseudomonas strains that have been
most frequently isolated from the cases followed-up with diagnosis of
DF infection. Therefore, treatment failure of DF infection infections
may depend on different factors such as adaptation of the patient and
foot care, regulation of diabetes, comorbid diseases, sufﬁcient
revitalization of foot with respect to vascular aspects rather than the
resistance to the applied antibiotics. The treatment of DF must be
performed via multidisciplinary approach.
R2686 Two oropharyngeal tularaemia cases with pregnancy
G.R. Yilmaz*, T. Guven, R. Guner, T. Aslan Gulen, F. Civelek,
M.A. Tasyaran (Ankara, TR)
Introduction: Tularemia cases have been reported since 1930 in
Turkey. Oropharyngeal tularemia is the most common type of the
disease and transmission route is generally through contact with
contaminated water. The number of human tularemia cases have
increased over the past 20 years. Here we discuss two cases of pregnant
women diagnosed and followed as oropharyngeal tularemia in our
department.
Cases: The ﬁrst case was a 23 years old woman who applied to
outpatient department. She was 4 weeks pregnant and complained of
high fever, chills, malaise and swelling on neck for 2 months. In
physical examination, the fever was 37.5C and oropharynx was
hyperemic. There was a 2 · 1 cm size adenopathy on the right cervical
region of the neck. The antibody against tularemia was detected as
positive 1/320 dilution in micro-agglutination test. The patient did not
accept gentamicin therapy. In the follow-up, adenopathy were distinctly
decreased, body fever was getting normal and malaise was recovered.
The patient and the baby were normal during and after delivery. The
second case was a 33 years old woman who applied with high fever,
throat pain, chills, malaise, myalgia, arthralgia and swelling on
submandibular region of the neck for 3 days. She was 22 weeks
pregnant. In physical examination the fever was 37C. There was a
5 · 5 cm, tender and hyperemic adenopathy on right submandibular
region. The antibody against tularemia was detected as positive 1/
320 dilution in micro-agglutination test. The patient did not accept
gentamicin therapy either. In the follow-up, adenopathy had suppurated
spontaneously, and high fever and other complaints resolved after
1 month. After delivery the baby was also normal and the patient only
had a small size adenopathy.
Conclusion: There is no anti-microbial drug in group B to treat
tularemia in pregnancy. Gentamicin is recommended by guidelines.
World Health Organization also recommends gentamicin or
ciproﬂoxacin. Our patients did not accept treatment. In conclusion,
two cases of pregnant women with oropharyngeal tularemia recovered
without speciﬁc therapy. The recovery of these two cases could have
been due to the low virulence of F. Tularensis subspecies holarctica
which is common in Turkey.
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R2687 Oral syphilis: a review of literature and the description of
ﬁve unusual clinical case
S. Martina*, S. Leuci, M. Mignogna (Napoli, IT)
Objectives: To review the literature about oral lesions in syphilis and
to analyze and compare clinical cases followed in the recent clinical
practice.
Methods: All studies were abstracted from PUBMED using key
words matched in different ways. We selected the studies where oral
lesions were present in the three stages (primary, secondary, tertiary).
From our clinical practice in the last 3 years we retrospectively
selected and analyzed clinical data of syphilis patients with oral
lesions who underwent the outpatient clinic of our unit. We performed
diagnostic biopsy on the oral mucosa with immunohistochemical
staining for Treponema pallidum, VDRL and FTA-abs serological
tests.
Results: The analysis of literature revealed twenty-one articles of oral
syphilis concerning oral lesions in thirty patients from 1954 to August
2011 of which ten cases of primary stage (33%), sixteen of secondary
stage (53%) and four cases of tertiary stage (13%). The primary lesions
were always represented by ulcers, of which eight were asymptomatic
and two were painful. The secondary lesions were represented by an
heterogeneous pattern: solitary or multiple ulcerations (six cases),
mucous patches (three cases), leukoplakia-like lesions (two cases),
erosive lesions (one case), aphtae (one case) and tonsillar swelling (one
case). All tertiary lesions are gumma, of which two were on the hard
palate, one on the soft palate and one on the gingiva. Our cases had all
secondary syphilis with an unusual clinical aspect: one with keratotic,
bilateral plaques of the hard palate, one with heritematous, bilateral
lesions of the hard palate, one with an ulcer with neoplastic aspect, one
polymorph keratotic lesions with reticular lichenoid-like pattern on the
buccal mucosa, one with vesciculo-bullous lesions on the gingiva and
tongue. All the diagnostic tests performed were positive for the
diagnosis of syphilis.
Conclusion: As shown by the review of literature, syphilis rates have
increased dramatically in recent years. Data are in line with our clinical
experience in the last years showing clearly the increasing of rates
together with the difﬁculties in differential diagnosis. Because of the
ability of syphilis to imitate many different diseases as oral cancer,
immuno-bullous diseases, lichenoid lesions, leukoplakia and
eritroplakia, clinicians must be aware, having in their mind that in
case of atypical clinical presentations or poor response to therapy
syphilis must be considered.
Infection control
R2688 Barrier from patient empowerment in hand hygiene
programme: from different point of views of patients/
family members, health care workers, and general
population in Asian culture
S.-C. Pan*, Y.-C. Chen, M.-C. Yang, Y.-L. Yang, M.-J. Wang, S.-
C. Chang (Taipei, TW)
Background: ‘‘Patient empowerment’’ is a component of hand
hygiene promotion programs of the World Health Organization, but
little is known about the perceptions of patients/families, health care
workers’ (HCW) and the general population.
Methods: To assess patients/families, HCWs and the general
population, a cross-sectional survey using questionnaires was
conducted in a tertiary teaching hospital in Taiwan to determine
attitudes about hand hygiene.
Results: A total of 1492 questionnaires were analyzed from three
groups. Responses related to patient empowerment showed that 97.1%
(333/336) of patients/families agreed with the concept, but only 67.8%
(232/342) stated they would remind HCWs to perform hand hygiene.
Responses of HCWs indicated,553 (553/880, 62.8%) would be willing
to be reminded of hand hygiene by the patient/family while 151 (151/
880, 17.2%) would not. Of the general population participants, 234
(234/245, 95.5%) would be willing to remind HCWs of hand hygiene,
while 3 (3/245, 1.2%) said they would not.
Conclusions: The attitude toward patient empowerment in hand
hygiene differed among HCWs, patients/families and the general
population. Further studies exploring the perception of patient
empowerment from the HCWs point of view may provide beneﬁt in
designing future education programs and promotion methods related to
enhanced hand hygiene.
R2689 Faecal carriage of extended-spectrum beta-lactamase-
producing Enterobacteriaceae in Korean community and
hospital settings
Y.-J. Ko*, H.-W. Moon, M. Hur, S.E. Cho (Seoul, KR)
Background: The production of extended-spectrum beta-lactamases
(ESBLs) by Enterobacteriaceae has been a great health concern in
hospitals and long-term care facilities. Recently, ESBL-producing
Enterobacteriaceae (ESBL-E) were identiﬁed as important causes of
community-onset infections as well as nosocomial infections. Previous
studies on fecal carriage of ESBL-E were conducted in high-risk
patients in the hospital setting and only a few reports evaluated fecal
carriage of ESBL-E in the community setting.
Methods: A total of 384 samples from healthy individuals and high-
risk patients were collected. Screening was performed using
commercial chromogenic medium (ChromID ESBL agar; bioMe´rieux,
Marcy l’Etoile, France). Identiﬁcation and antimicrobial susceptibility
testing were performed using the Vitek 2 system (bioMe´rieux).
Susceptibility was determined using the new CLSI break points, and
the presence of ESBLs of grown isolates were conﬁrmed by CLSI
guidelines (CLSI, 2011).
Results: The prevalence of ESBL-E carriage among high-risk patients
was 55.0%, which was signiﬁcantly higher than that among healthy
individuals (20.3%; p < 0.0001). A large majority (96.6%) of the
isolates from healthy individuals were E. coli, but K. pneumoniae was
more commonly detected (45.0%) in high-risk patients than in healthy
individuals (p < 0.0001). K. pneumoniae isolates exhibited signiﬁcantly
higher non-susceptibility (intermediate and resistant) than E. coli to
CAZ (70.0% vs. 30.4%; p = 0.002), AMC (70.0% vs. 39.4%;
p = 0.022), IPM (15.0% vs. 1.3%; p = 0.025), and MEM (10.0% vs.
0.0%; p = 0.039). In contrast, E. coli exhibited higher non-
susceptibility to CTX compared to K. pneumoniae (100.0% vs.
85.0%; p = 0.039). The minimal inhibitory concentrations (MICs) for
CAZ, LVX, ATM, FEP, and NN were higher for E. coli from high-risk
patients than for those from healthy individuals. E. coli from high-risk
patients exhibited signiﬁcantly higher non-susceptibility to LVX
(95.5% vs. 42.1%; p = 0.000) and FEP (27.3% vs. 3.5%; p = 0.005).
Conclusion: The prevalence of ESBL-E carriage was higher in Korea
than that reported previously in other countries. The distribution and
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antibiotic susceptibility of colonized ESBL-E were different between
healthy-individuals and high-risk patients. Active surveillance of
ESBL-E carriage is suggested for infection control and epidemiologic
purposes, and the use of chromogenic agar appears to be an efﬁcient
and reliable method.
R2690 Clinical application of a molecular method based on real-
time RT-PCR in epidemiological detection of the inﬂuenza
A/H1N1 virus
A. Pierro*, P. Gaibani, G. Rossini, F. Cavrini, M. Landini,
V. Sambri (Bologna, IT)
Objectives: Between late March and early April 2009, a swine origin
of a novel inﬂuenza A/H1N1 was identiﬁed and it spread rapidly in
many countries via human-to-human transmission. The next 2 years, in
Italy, the diagnosis of pandemic (H1N1) 2009 was continued for
epidemiological purposes. Regional Reference Centre for
Microbiological Emergencies (CRREM) in Bologna compared two
molecular methods based on Real Time RT-PCR. Establishment of
adequate methods for the diagnosis of emerging viruses with the
potential of spreading rapidly is necessary for the timely identiﬁcation
of cases and for implementation of public health measures to limit their
spread.
Methods: In this study two Real-Time RT-PCR were compared: the
PCR based kit established by the Centers for Disease Control and
prevention (CDC) speciﬁc for detection and characterization of A/
H1N1 that ampliﬁed four different targets (InfA, SwInfA, SwH1N1,
RNAseP), considered as the reference standard, and a new kit Xpert
Flu (Cepheid) that ampliﬁed FluA, 2009 H1N1 and FluB targets.
Results: On the whole, samples from 60 potential 2009 H1N1 cases
have been screened from December 2010 to March 2011 at the our
center using the the two methods in parallel. Among these, 47 cases
(78.3%) gave the same result for both methods: 3 (6.4%) were positive
for InfA, 18 (38.3%) were positive both for InfA and for SwH1N1 and
26 (55.3%) resulted negative. Methods gave different results for 13
sample: 10 samples were positive for CDC PCR and negative for
Xpert Flu kit, two samples were positive for Xpert Flu kit and
negative for CDC PCR, one samples resulted invalid with Xpert Flu
kit and positive with CDC PCR. In addition 66 potential 2009 H1N1
cases were screened only with the new kit Xpert Flu: 5 (7.6%) resulted
positive for FluA and 2009 H1N1, 2 (3.0%) for FluA, 8 (12.1%) for Flu
B and 1 (1.5%) sample was positive both for FluA and for H1N1 and
for FluB.
Conclusion: The new kit Xpert Flu (Cepheid) allows the rapid
identiﬁcation in 70 minutes not only of FluA and 2009 H1N1 but also
of FluB and this reduces the need for additional or conﬁrmatory testing.
The novel method is suitable for the diagnosis of pandemic (H1N1)
2009 virus and, although less sensitive than PCR established by CDC,
could be used as a screening test of inﬂuenza virus during the epidemic
season. This can allow rapid results (TAT 3 hours) for a rapid
therapeutic treatment and management of the patient and limiting the
spread of the virus.
R2691 Quantitative adenosine tri-phosphate detection to aid
infection control
L.S.P. Moore*, S.J. Barnass, M. Kyi (London, UK)
Objective: Time trend analysis observing the integration of
quantitative adenosine tri-phosphate detection into routine infection
control surveillance at an NHS University Hospital.
Background: Decontamination of environment and of equipment is
central to infection control, and the framework for setting and
measuring performance outcomes is derived from the National Patient
Safety Agency. Audits are routinely carried out using visible
contamination as an indication of cleanliness; however this does not
necessarily represent absence of transmissible pathogens.
Microbiological settle plates or environmental swabbing both delay
audit feedback and have poor reproducibility. ATP detection uses
quantitative bioluminescence to measure the levels of organic material
on a surface, providing a monitoring tool that can be used at both
technical and managerial levels of audit.
Methods: Internal validation and implementation of standardised
sampling with a commercially available device (Systemsure Plus )
with subsequent hospital wide roll out by the Infection Control Team.
Monthly audits of ﬁxed assets, close contact and direct contact items in
all clinical areas with immediate feedback to ward managers and annual
reporting to Infection Control Committee and Patient Environment
Action Team (PEAT).
Results: Quantitative ATP detection identiﬁed speciﬁc areas with high
levels of organic material which appeared clean at the macroscopic
level. Identiﬁcation of poorly decontaminated ﬁxed assets included door
plates (832 units pre targeted clean, <100 units post) and ward phones
(553 units pre targeted clean, <100 units post) and of direct contact
items including commodes. For this latter item use of the ATP device
allowed pinpointing of subsections of the commode that had been
repeatedly poorly decontaminated including the commode arms
(169 units pre targeted clean, <100 units post). Targeted resources
and training were then allocated to improve decontamination
techniques. This resulted in a decrease in ATP detection over
repeated audits.
Conclusion: Quantitative ATP detection adds a focused tool to the
infection control armamentarium to identify poorly decontaminated
items that may contribute to onward transmission of infective
pathogens. This tool allows immediate feedback at clinician level as
well as providing data allowing time trend analysis to identify particular
clinical areas that need additional training or particular items that are
poorly decontaminated.
R2692 An investigation into the source of a strain of
Burkholderia cepacia (genomovar I) isolated from
multiple patients and hospitals over a period of 19 months
D. Kenna*, C. Perry, C. Hird, K. Martin, N. Mustafa, R. Pike,
K. Patabendige, E. Sheridan, J. Turton (London, UK)
Objectives: Our laboratory routinely performs national surveillance of
the Burkholderia cepacia complex (Bcc) because of the association of
certain strains with poor outcome and transmissibility among Cystic
Fibrosis (CF) patients. Common in the environment and intrinsically
resistant to many antibacterial agents, these organisms have also been
described as contaminants of various medical products, including nasal
spray, nebulization solution, mouthwash, ultrasound gel, ophthalmic
solutions and chlorhexidine. During 2010/2011 we received substantial
numbers of isolates of B. cepacia (genomovar I) from non-CF patients,
prompting an investigation into the nature and possible source of these
cases.
Methods: Identiﬁcation of the isolates to species level was by recA
sequence cluster analysis and molecular comparison was conducted
using pulsed-ﬁeld gel electrophoresis. MICs were determined by agar
dilution.
Results: Molecular analyses revealed that isolates from 28 non-CF
patients from 19 hospitals across the UK, received between March 2010
and October 2011, represented a single strain. Of the eleven isolates
screened all had similar antibiograms, with susceptibility to
meropenem, co-trimoxazole and ceftazidime. A questionnaire,
collecting clinical information including signiﬁcance of infection,
exposure to various products and procedures, antibiotic usage and
details of specimen collection was sent to clinical microbiologists in the
hospitals involved to generate a hypothesis for a potential common
source. Resulting data revealed that most isolates were from blood. The
clinical signiﬁcance was generally uncertain, but there was evidence of
at least one conﬁrmed intra-venous line infection.
Conclusion: No potential source of this common strain has been
identiﬁed, highlighting the difﬁculty in investigating an outbreak spread
over time and place. The use of chlorhexidine-containing products in
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both the disinfection of medical devices and patient’s skin was the most
common shared factor between hospitals, though this may reﬂect
widespread use rather than an association with infection.
R2693 The missing link in the health-care associated infection
acquisition cycle: an innovative patient hand-hygiene
audit led by doctors at a tertiary cardiac centre in
northwestern England
K. Mattam*, T. Al-Badawi, S. King, A. Guleri (Blackpool, UK)
Background: Handhygiene compliance in healthcare settings is
acknowledged as the single most important infection prevention
intervention to reduce healthcare associated infections [HAI].
Department of Health guidance has made HHA results a mandatory
item of agenda at trust board, divisional, hospital infection control
committee, care quality inspection, etc. Blackpool Teaching Hospitals
[BTH], winner of HAI technology innovation team award 2009,
operates a most successful HAI programme with high emphasis on
antibiotic stewardship and handhygiene compliance. CEO of the trust
recently led a system change of HHA within the trust from conventional
dedicated staff conducting HHA, to a secret shopper style conduct of
HHA by a variety of trained HC professionals visiting the clinical area.
We present ﬁndings from an innovative HHA project led by junior
doctors [JD]. The aim of this project was to explore the missing link in
the HAI acquisition cycle – the patient HH.
Methods: Prospective audit of patient hand hygiene before meals over
2-weeks of October2011 in the Lancashire cardiac unit. The standard
was the hospital policy requiring healthcare assistants [HCA] to explain
HH to patients and offer HH wipes before meals. The audit was a joint
microbiology – JDs in cardiac surgery project. Data was covertly
collected during each meal distribution time by JDs/HCAs and analysed
by JDs and microbiologist.
Results: Key ﬁndings from 76 patient included in HHA over 2-weeks
included 471 observations during breakfast, lunch and dinner. Male:
Female ratio of 2.5:1. Overall Hand hygiene compliance was observed
in 73% (344/471). HHcompliance was not always consistent between
three meals in some patients. Details of compliance variation between
gender; during different meals to be presented.
Conclusions: Poor hand hygiene compliance can potentially
undermine the hospital HAI program. The focus of hand hygiene has
consistently been on healthcare staff specially the doctors and nursing
staff. The microbiology – infection control – JD alliance at BTH are
constantly working to improve the awareness and standards of
HHcompliance. The Phase 1 of this project conducted in 2009/10 by
JDs [supervised by microbiologist and using identical HHA tool as IC
nurses] highlighted similar and poor [37%] compliance within all health
professionals. This phase 2 patient HHA results will be used to inform
the trust wide enhanced hand hygiene programme launched in 2011.
Details of programme to be presented.
R2694 Increased risk of surgical site infection in older patients in
a cohort survey: targets for quality improvement in
antibiotic prophylaxis
A. Agodi, A. Quattrocchi*, M. Barchitta, A. Cocuzza, R. Latino,
S. Sciacca, A. Di Cataldo (Catania, IT)
Objectives: Surgical site infections (SSIs) remain a major issue of
patient safety despite improvements in surgical practice and infection
control techniques. Although the effect of SSI on mortality, duration of
hospitalization, and hospital costs has been well described in the
general population, these data are limited in older operative patients.
The objectives of our study were: i) to describe SSI risk in older
operative patients and ii) to evaluate compliance with guidelines for
antimicrobial prophylaxis.
Methods: A 12-months cohort study was performed in accordance
with the methods, protocols and deﬁnitions of the HELICS. For SSIs,
rates were calculated by operative procedure and risk index category.
The compliance of current prophylactic antibiotic practices in the ward
with the published national guidelines (SNLG 17, 2008) was assessed.
Results: A total of 250 patients were enrolled and 253 surgical
procedures were included. An increase of the incidence of SSI was
observed comparing the older operative patients (‡65 years) with the
younger group, from 6.1 per 100 surgical procedures to 2.2 per 100
surgical procedures. Furthermore, the older patients were less likely to
be subjected to laparoscopic procedures (18.2% vs. 33.3%) and more
likely to undergo emergency surgery than the younger one (10.6% vs.
1.6%, p < 0.05). The mean length of stay and the mean duration of the
surgical procedure were signiﬁcantly higher in the older operative
patients group (6.6 days vs. 3.5 days and 127 minutes vs. 99 minutes,
p < 0.05). Antibiotic was administered peri-operatively for 98.8% of
surgical procedures and post-operatively in 98.4% of them. The most
frequently prescribed category of antibiotics was cephalosporins
(79.6%). The single most frequently used drug was ceftriaxone
(46.4%). Antibiotic prophylaxis was indicated in 35.2% of surgical
procedures in our survey, as from national guidelines, and it was
appropriately administered in 36.1% of surgical procedures.
Conclusions: Results of this study let us identify older patients at
higher risk of infection and can be used to design and implement
strategies directed toward the prevention of SSIs. Furthermore, our
study underlines the need to develop multimodal intervention programs
to improve compliance with antimicrobial prophylaxis practices and
ﬁnally decrease SSI rates.
R2695 Assessment of the rate of environmental recolonisation
after manual and airborne decontamination in an ICU of
a tertiary hospital
P. Thomaidis, A. Stylianakis*, S. Tsiplakou, V. Papaioannou,
S. Katara, A. Vergaki, I. Alamanos, K. Mouta (Athens, GR)
Objectives: The hospital environment is a major source of infections.
In the present study the extent of the environmental contamination of a
7-bed ICU, the impact of manual and airborne decontamination as well
as the rate of recolonization was investigated.
Methods: The ICU was emptied and not in use for 13 days. Sampling
was conducted before any type of cleaning, after manual cleaning, after
airborne decontamination and on the 3rd, 9th and 16th day after
patients’ admission. Samples were taken from 21 standard sites using
moistened swabs. The samples were cultured directly and after
incubation in nutrient broth, on blood, MacConkey and Sabouraud
agar. All strains isolated were identiﬁed using microscopy, Gram
staining and biochemical methods. Susceptibility testing of selected
strains was performed using the VITEK II automated system
(biomerieux, France). At the same time all causative agents of
infections occurring in the ICU during the last year were
systematically recorded.
Results: Direct plating has shown 15 sites (71%) to be contaminated
before any cleaning, while the number of contaminated sites was 11
(52%) after both cleaning procedures (p = 0.34). The third day after
patient admission the contaminated sites were found to be 19 (90%)
(p = 0.017). After incubation in nutrient broth the contaminated sites
were 90%, 81% and 95% respectively. Results are shown in the table
below. The strains most commonly isolated were Acinetobacter spp.,
Klebsiella spp., Pseudomonas spp. and CN Staphylococci. These
bacteria were also the causative agents of the majority of infections
occurring in the ICU patients during last year.
Conclusion: Extensive contamination was demonstrated in the ICU.
The majority of the contaminating bacteria was the same and had the
same antimicrobial susceptibilities as the pathogens causing infections
in the ICU patients’ population. Airborne decontamination, in addition
to manual cleaning, can reduce in some extend environmental
contamination but cannot eliminate it. The almost immediate
recontamination towards pre-cleaning levels is suggestive of a more
frequent implementation of environmental decontamination. The
compliance of the cleaning personnel to the decontamination
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protocols is mandatory. More studies are needed in order to determine
the optimal schedule of cleaning procedures.
R2696 Inﬂuenza vaccination uptake among health care workers
after a multimodal educational campaign in the post
pandemic year
A. Sangil*, S. Gonzalez, M. Riera, V. Pascual, S. Sallent, L. Gomez,
O. Monistrol, I. Romero, H. Monzon, M. Tortajada, E. Calbo,
J. Garau (Terrassa, ES)
Background: ESCMID guidelines recommend that health care
workers should be vaccinated annually against inﬂuenza. Despite this,
vaccination rates have been low in our hospital and they worsened after
the H1N1 pandemic in 2009. Our aim was to evaluate the impact of a
multimodal educational campaign over the vaccination uptake among
health care workers (HCW) in our centre.
Methods: During the 2011–2012 vaccination programme a
multimodal educational and motivational campaign was applied in a
University Hospital of 500 beds, serving a population circa
350 000 hours. The campaign included: management and staff
commitment in order to create an institutional climate favoring
vaccination practices, educational seminars, widely distributed
motivational posters and informative leaﬂets, adaptation of
vaccination schedules for all shifts with special interest in areas of
high risk patients (ICU, NICU, and the onco-hematology ward). All
employees of the Hospital (n = 1672) were asked to ﬁll in anonymously
a self-administered questionnaire. It inquired about attitudes,
perceptions, acceptance of the vaccination and reasons of their
choice. Informative leaﬂets were based on the most common
problems detected in the questionnaire. Annual vaccination rates
since 2007 were calculated.
Results: Thirty posters and 300 leaﬂets were distributed throughout the
hospital. 428 HCW (25.6%), full ﬁlled the questionnaire. 72.05% were
females, 34.6% were nurses and 30.7% were physicians. The main
reason given for not being immunized was fear of the adverse effects of
the inﬂuenza vaccine. Healthcare workers trivalent inactivated vaccine
uptake ranged from 27.34% in 2007 to 28.4% in 2008 and 27.21% in
2009. In 2009–2010, the uptake rate for trivalent vaccine was 16.3%
and for monovalent pandemic H1N1 vaccine was 12.8%. After the
multimodal interventional campaign, the global rates of vaccination
reached 30.6%. Vaccination rates in high-risk units were: 38.9% in
ICU, 62.9% in NICU and 68.7% in the onco-hematology ward.
Conclusions: Despite the improvement in the coverage rate of
inﬂuenza vaccination in our study, we would expect a higher rate
because of wide vaccine availability. The results indicate the need for
on-going education of inﬂuenza disease among HCWs to increase
vaccination rates.
R2698 Sexually tnsmitted infections in women attending the
obstetrics and gynaecologic unit of a university hospital in
the north of Milan: prevalence and risk behaviours
C. Pagani*, S.G. Rimoldi, L.L. Chenal, N. Zanchetta, E.O. Zorini,
F. Stefani, M.R. Gismondo (Milan, IT)
Objectives: Sexually transmitted infections (STIs) are a large group of
human infections worldwide widespread in people of reproductive age.
In a group of HIV-1 negative women the prevalence of different
sexually transmitted pathogens (Human papillomavirus, Neisseria
gonorrhoeae, Chlamidia trachomatis, Mycoplasma hominis/
genitalium, Ureaplasma urealyticum/parvum, Trichomonas vaginalis)
and their risk factors were evaluated.
Methods: A retrospective 36 months study (January 2008-December
2010) was managed with 233 women (200/233 Italians, 15/233
European, 3/233 Africans, 10/233 South Americans, 5/233 Asians) in
the age range from 15 to 70 years (median age 38 years) attending the
Obstetrics and Gynaecologic Unit of L. Sacco University Hospital. For
each patient cervical sample was collected (PreservCyt; Thin Prep,
UK) for the detection of HPV (Inno-Lipa HPV genotyping Extra;
Innogenetics, Belgium) and bacteria infections (Multiplex PCR;
Seeplex STI Master ACE detection, Seegene, Korea). Demographic
(nationality, age and sex) and clinical data (age of ﬁrst intercourse,
multiple sexual partners, use of intrauterine device, pregnancy) were
recorded in 132 out of 233 patients. Statistical analysis were evaluated
with CCA-software X1Stat 4.0.
Results: The overall prevalence of STIs was 80.7% (188/233): 49%
(92/188) were co-infections, 51% (96/188) were due to a single agent.
The most common agent detected in total population was HPV, 68.7%
(160/233), followed by U. urealitycum/parvum 44.6% (104/233), M.
hominis 13.3% (31/233), C. trachomatis 2.6% (6/233), T. vaginalis and
N. gonorrhoeae 1.3% each one (3/233), and M. genytalium 0.8% (2/
233). Correspondence analysis worked out between pathogens and risk
factors showed that younger women with high risk factors (early age of
ﬁrst intercourse, >5 partners) are most affected by N. gonorrheae. A
signiﬁcant statistically high prevalence rate with U. urealyticum/parvum
or HPV were reported in all women.
Conclusion: Epidemiological studies have demonstrated the role of
screening for genital infection, essential to reveal the presence of the
different sexually transmitted infectious agents. The presence of HPV
may have an inﬂuence in vaginal ﬂora, but in our ﬁndings bacterial
infections are not statistically associated with HPV and behavioural
risks.
R2699 Filamentous fungi in hydroponic plants for decoration in
a university hospital
V. Spertini*, L.S. Lusignani, M. Diab-Elschahawi, B. Parschalk,
B. Willinger, E. Presterl (Vienna, AT)
Objectives: Nosocomial infections caused by ﬁlamentous fungi are ill
deﬁned and thus a challenge for infection control. Commonly detected
in severely immunocompromised patients these infections may be
acquired ubiquitously from the environment in and outside the hospital.
Decoration plants are meant to embellish the in-hospital areas and make
them more homely and agreeable to long-term patients. Hydroponic
plants using clay pebbles as potting medium are generally preferred in
hospitals as the pebbles are thought to be clean and therefore not
contaminated by spores.
Methods: After an outbreak of Fusarium infections at the burns
intensive care unit involving two patients we tested hydroponic plants at
sites of the hospital for the presence of ﬁlamentous fungi. Apart from
the burns intensive care unit we randomly chose nine wards, three staff
rooms and three public areas within the hospital. In each of the sites we
collected 1–2 clay pebbles of hydroponic plants and enriched them in
Sabouraud-Bouillon. Turbid turned bouillons were cultured using
Sabouraud agar. Identiﬁcation of the fungi was achieved by standard
macro- and micromorphological criteria. Typing of Fusarium species
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was done using the DiversiLabTM kit (bioMe´rieux). Retrospective chart
review was performed to detect invasive hyphomycetal fungal
infections.
Results: In hydroponics clay pebbles of 22 plants we found 11 fungal
species in all specimens (Table). Scanning the hospital records for
invasive fungal infections caused by these species did not reveal
associated infections in the past. Comparing environmental and
patients’ isolates of Fusarium species by genotyping showed no
similarity.
Conclusion: Hydroponic decoration plants are colonized with multiple
fungal species that might cause invasive fungal infections in severely
immunocompromised patients. Thus surveillance of invasive fungal
infections should be done in a tertiary care hospital with patients with
hemato-oncological malignancies, transplantation and
immunomodulation. Hydroponic plants should not be present in these
high risk areas.
R2700 Effectiveness of an educational programme to reduce
catheter-related blood stream infections in a tertiary
paediatric hospital
K. Dzierzanowska-Fangrat*, K. Semczuk, M. Grochowska,
W. Rostkowska (Warsaw, PL)
Objectives: Central venous catheters are widely used in hospital
practice. However, they are the leading source of bloodstream
infections in hospitalised patients. The aim of this study was to
assess the effectiveness of an educational programme to prevent
catheter-related blood stream infections (CRBSI).
Methods: Between June and December 2010 the Hospital Infection
Control Team of the Children’s Memorial Health Institute (400-bed
tertiary paediatric hospital in Warsaw) performed an educational
training programme involving physicians and nurses on diagnosis and
prevention of CRBSI. The programme included lectures and practical
demonstrations. The standard of care of central venous catheter (CVC)
was implemented in all hospital wards. To assess the effectiveness of
these measures the rate of CRBSI was determined in a 6-month period
before (January – June 2010) and after (January – June 2011) the
intervention.
Preliminary Results: Before the intervention there were 11 CRBSI
diagnosed in 427 CVC insertions (2.6%). After the intervention the rate
of CRBSI increased to 6.4% (25 infections in 388 CVC insertions. The
rate of CRBSI per 1000 catheter-days was higher after the intervention.
Additionally, after the intervention the frequency of blood cultures
performed in patients with CVCs increased by 47%.
Conclusions: The implementation of the educational programme was
associated with an increased number of blood cultures performed in
CVC patients and a higher frequency of CRBSI diagnosed within the
ﬁrst 6 months after the intervention. These partly unexpected ﬁndings
result probably from better diagnosis and reporting of CBRSI after the
intervention.
R2701 A junior doctor’s change management and leadership
project: hand-hygiene compliance audit programme at a
teaching hospital in northwestern England
M. Przybylo*, R. Sharma, L. Moorhouse, S. Staff,
A. Guleri (Blackpool, UK)
Background: According to CDC, people don’t wash their hands as
often they say they do or as often as they should’’. Hand washing is the
single most effective way to prevent spread of infections. We present a
summary from a junior doctor’s change management and leadership
project – hand hygiene [HH] audit programme at Blackpool Teaching
Hospitals.
Methods: Review of conventional HH audit rates when conducted by
clipboard bearing dedicated nurses; Review of results of HH audit
[2009] and re-audit [2010] conducted by JDs using identical HH audit
tool as nurses, but large number of observations and un-disclosed
observational audit. Presentation of results to trust executive directors,
hospital infection control committee and CEO.
Results: Conventional dedicated nurse conducted HHA results above
90% compliance, JDs conducted HHAs included 3060 minutes [2009]
and 1840 minutes [2010] of observations with compliance rates of 37%
and 35% [p > 0.05] respectively. Introduction of new secret shopper
style HHA programme [based on Royal Devon and Exeter risk based
criteria]. Refer attached picture. Details to be presented.
Conclusions: Poor HH compliance can potentially undermine trust
HAI programme. The value of ﬁndings from a conventional dedicated
nurse led HHA may be limited by bias, hawthorne effect and
complacent behaviour from high (>90%) HHA rates. The JD led
HHA, supervised by microbiologist, was part of a change management
and leadership project. This involved studying the conventional HHA
system, planning the project, leading and supervising a group of JDs;
analyzing and presenting ﬁndings at hospital committees and to CEO;
discussing validity of ﬁndings amidst resistance; leading up to CEO led
decision to change the HHA programme from the conventional
dedicated nurse led HHA system to a secret shopper style HHA
conducted by a variety of trained healthcare professionals visiting the
clinical areas. This study has revealed a detailed picture regarding hand
hygiene compliance and auditing methods. Unbiased compliance results
are needed for an effective infection control programme.
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R2702 Epidemiological and laboratory investigation and
effective control of a nosocomial outbreak of
gastroenteritis due to Norovirus
O. Zarkotou*, D. Karageorgopoulos, E. Kousouli, N. Spanakis,
G. Vrioni, G. Chrysos, S. Drimis, T. Grivas, K. Chrysou, D. Voutsinas,
A. Tsakris, K. Themeli-Digalaki (Piraeus, Athens, GR)
Objectives: We aim to describe the epidemiological and laboratory
investigation of a nosocomial outbreak of gastroenteritis and the
effectiveness measures taken for its containment.
Methods: In April 3, 2011, an outbreak of gastroenteritis occurred in
patients and personnel of the Orthopedic Department of Tzaneio
General Hospital of Piraeus, Greece, a 450-bed, tertiary-care center.
The hospital infection control committee was notiﬁed. Cases were
deﬁned as patients, visitors or hospital personnel with symptoms of
vomiting and/or diarrhea. Clinical and epidemiological information was
collected from cases and all patients hospitalized in the speciﬁc
department. Investigation for similar cases was made to other hospital
departments. Instructions for strict hand hygiene and contact
precautions were given. Hospital surfaces in the vicinity of the
affected patients were cleaned with hypochlorite solution and the rooms
were aerated. Visits to the patients were discouraged. All affected
hospital staff was asked to refrain from work until symptom resolution.
Stool samples from select cases were sent for routine culture,
Clostridium difﬁcile toxin assay, and detection of viral antigens.
Results: The outbreak lasted for 10 days and it was contained within
the hospital department of origin. A total of 21 cases were identiﬁed
(81.0% female). Ten (47.6%) were inpatients, 3 (14.3%) were patient
visitors, and 8 (38.1%) were hospital personnel. The attack rate was 10/
36 (27.8%) for inpatients and 6/11 (54.5%) for the nursing staff. The 10
hospitalized case-patients were located in seven different rooms. All
cases had diarrhea, 6 (28.6%) had vomiting and 1 (4.8%) had fever.
Symptoms lasted for 1–3 days and were generally mild. A common
food- or water-borne source was not identiﬁed. The case patient was
infected from a visitor. Stool cultures were negative. The antigen
immunoassays were positive for Norovirus. This was conﬁrmed with
polymerase chain reaction.
Conclusion: A Norovirus outbreak was introduced to a hospital
department from the community. The outbreak quickly spread among
inpatients, possibly via infected healthcare professionals, who had a
high attack rate. This could compromise the implementation of proper
infection control measures due to required absence from work. The
prompt response to the outbreak prevented the spread to other hospital
departments.
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R2704 High mortality in bacteraemia and candidaemia in
critically ill patients – report from Swedish Intensive Care
Registry
G. Fransson*, M. Edstro¨m, L.E. Nilsson, S. Walther,
H. Hanberger (Kalmar, Linko¨ping, SE)
Objective: Increasing prevalence of bacteremia and candidemia with
signiﬁcant resistance to antimicrobial agents is an increasing concern
among ICU patients. The objective of this report from Swedish Registry
of Intensive care (SIR) was to study the frequency and cause of culture
veriﬁed sepsis in critically ill patients and to analyse mortality in sepsis
caused by Candida albicans, Candida non albicans and bacteria.
Methods: Setting: Starting 10 years ago an increasing number of ICU:
s in Sweden reports each episode of care (EOC) to the Swedish
Intensive care Registry (SIR). Mortality is followed weekly for all
patients by link to the Swedish population registry. A speciﬁc routine
for collection of microbial data directly from the laboratories connected
individually to each EOC has been tested and implemented for
laboratories covering 1/3 of the Swedish population.
Participants: 47 ICU: s reported 1540 EOC: s during the period January
2005 to November 2011, with a diagnosis of sepsis (ICD10: A419,
R572 or R651) and a positive blood culture within 14 days before
admission until discharge. For patients with more than one EOC was
only the last EOC included which reduced the number of observations
included in mortality calculations to 1416.
Variables: Primary outcome was 30 day mortality calculated from
admission to ICU.
Results: Thousand four hundred and sixteen patients met inclusion
criteria and were included in the analysis. The most common causes of
sepsis were: E. coli (24%) followed by Coagulase Negative
Staphylococci (CoNS) (21%), Streptococcus spp. (19%), S. aureus
(14%), Klebsiella spp. (8%) and Candida spp. (6%) [Candida albicans
4% and Candida non albicans 2%]. The 30-day crude mortality was
34% for patients with sepsis caused by S. aureus. Correspondingly
30 days mortality was for Candida non albicans 34%, Candida albicans
31%, Klebsiella spp. 26%, CoNS 25%, E. coli 22%. Distribution of
species in blood cultures from the 87 patients with candidemia were: C.
albicans 62, C. glabrata 11, C. krusei 1, C. tropicalis 4, C. other 4, C.
non speciﬁed 9.
Conclusion: The highest (>30%) crude mortality in critically ill
patients with sepsis was seen in patients with S. aureus and Candida
infections. Further analysis of independent risk factors for mortality in
sepsis caused by different pathogens are warranted.
R2705 Hospital-acquired infections in patients with acute
ischaemic stroke
N. Popovic*, J. Nikolic, N. Mitrovic, M. Budimkic,
D. Jovanovic (Belgrade, RS)
Objectives: Hospital-acquired infections represent a signiﬁcant
problem during hospitalization of patients with acute ischemic stroke
and occur in 15–65% of patients. The aim of this study was to assess the
rate of nosocomial infections in patients with acute ischemic stroke,
their risk factors, most common pathogens and inﬂuence on patients’
outcome.
Methods: We analyzed patients with the diagnosis of acute ischemic
stroke who were treated in the Department for emergency neurology in
the Clinic for Neurology, Clinical Center Serbia, from October the 1st
2009 till the 31st of September 2010. Patients who had fever or other
signs of infection on admission and those transferred from another
hospital were excluded from the study.
Results: We analyzed 133 patients, with the average age of
58.4 ± 15.5 years. Hospital-acquired infection occurred in 63 (47.4%)
patients. The most frequent were urinary tract infections in 27 (20.3%)
and pneumonia which was present in 19 (14.3%) patients. Nine patients
had primary blood stream infection. Pneumonia was the cause of
secondary blood stream infection in four patients while urinary tract
was the origin of sepsis in two patients. Severe neurological deﬁcit on
admission (p = 0.001, adjusted odds ratio OR [CI] 4.02 [1.05–15.41]),
severe movement impairment (p = 0.000, adjusted OR [CI] 3.41 [1.01–
11.51]) and the presence of urinary catheter (p = 0.000, adjusted OR
[CI] 8.81 [1.25–61.84]) were found to be independent predictors for
infection in ischemic stroke. The most commonly isolated pathogens
were Pseudomonas sp. in 20 (20.8%), Klebsiella sp. in 19 (19.8%) and
Acinetobacter in 13 (13.6%) cases. Gram positive bacteria
Staphylococcus aureus, Coagulase-negative Staphylococcus and
Enterococcus sp. were the major causes of primary sepsis. The rate
of carbapenem, cefepim and ciproﬂoxacin resistance of Pseudomonas
was 67.5%, 80%, and 100%, Acinetobacter 69.3%, 84.6% and 92.3%,
and Klebsiella 0%, 80% and 89.5%. The presence of infection in stroke
patients was associated with longer hospital stay and was found to be an
independent predictor for poor functional outcome (p < 0.0001,
adjusted OR [CI] 7.81 [1.04–58.82]).
Conclusion: Hospital acquired infections in stroke patients are very
frequent. They are caused by resistant microorganisms and are
associated with poor functional outcome. Prevention and adequate
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initial therapy of these infections based on the prevalent pathogens are
important for ﬁnal outcome of stroke patients.
R2706 Infections in patients who undergo craniotomy: a
prospective study
I. Kourbeti*, P. Ziakas, S. Christou, S. Maraki, D. Karabetsos,
A. Vakis, G. Samonis (Chalkida, Athens, GR; Nicosia, CY; Heraklion,
GR)
Objectives: To identify the prevalence and the microbiology of
infections in patients who undergo craniotomy and to determine the
risk factors for post-craniotomy meningitis (PCM) in Greece.
Methods: Prospective study in patients >18 years old who underwent
craniotomy between 2006 and 2008 in the University Hospital of
Heraklion.
Results: Three hundred and thirty-four patients were analyzed. Their
median age was 51. 65.6% of the patients were men. 50% of the
surgeries were emergency procedures and 18.7% were revision
surgeries. Traumatic brain injury was the most common cause for
craniotomy. The most common infection in this population was
ventilator associated pneumonia (VAP) (22.5%). The most common
VAP pathogen was Acinetobacter spp. (44%). They were 100%
sensitive to colistin but only 30% sensitive to imipenem. The pathogens
were 100% resistant to ticarcillin/clavunate, piperacillin/tazobactam,
cefepime, aztreonam and ciproﬂoxacin. Surgical site infections (SSIs)
and urine tract infections were encountered in 9% of the patients.
Meningitis was noted in 4.8%. Acinetobacter spp. were the most
common pathogens in PCM. They also were 100% sensitive to colistin
but 100% resistant to piperacillin/tazobactam, cefepime, aztreonam,
aminoglycosides and ciproﬂoxacin. Other pathogens involved in PCM
included Klebsiella spp., P. aeruginosa, S. aureus, E. cloacae and P.
mirabilis (6% each). PCM was culture-proven in 100%. Perioperative
steroid use (OR 11.5), CSF leak (OR 48) and ventricular drain use (OR
70) were independently associated with PCM use. Internal Medicine
Unit (ICU) admission was associated with PCM (p < 0.001). There was
no difference in survival between patients who developed and did not
develop meningitis.
Conclusion: VAP was the most common infection in people who
undergo craniotomy. PCM developed in 4.8% which was similar to
rates reported before. Multiresistant Acinetobacter spp were the main
pathogens. Communication between CSF and environment, CSF leak
and perioperative steroid administration were independently associated
with PCM in this prospective study.
R2707 Clostridium difﬁcile health care and community-associated
infection: a cross-sectional study in a hospital for tropical
diseases
P. Trevisi*, C. Toro, B. Lo´pez, N. Iglesias, M. Baquero (Madrid, ES)
Objective: Spreading of virulent C. difﬁcile by ribotype 027 infection
is increasing in Europe but with an unequal distribution. Up to now,
only two cases by ribotype 027 strains have been reported in Spain. The
aim of this study was to determine the prevalence in hospitalized and
non-hospitalized patients and the epidemiology associated to C. difﬁcile
infection (CDI) in a Hospital specialized on Tropical Medicine.
Methods: From October 2009 to October 2011, stool samples from
patients with clinical suspicion of CDI were examined. Subjects were
classiﬁed in two groups, hospitalized patients and outpatients, and a
different diagnostic algorithm was performed. In the ﬁrst group,
detection was made by a real-time PCR which includes detection of
ribotype 027 (Xpert; C. difﬁcile). In outpatients, a two-step algorithm
was used: screening with a rapid test (Techlab C. difﬁcile Quik Chek
Complete) and positive cases were conﬁrmed by real-time PCR.
Results: A total of 690 specimens from 582 patients (279 male and
303 women) were studied. 343 corresponding to hospitalized patients,
most of them natives (87.2%), and the rest immigrants (7.3%) and
travellers (5.5%). Among 239 outpatients, the majority were travellers
(76.6%) followed by Spaniards (19.2%) and immigrants (4.2%). A total
of 40 patients were positive for CDI, 33 hospitalized patients
(prevalence=9.6%) and seven outpatients (prevalence=2.9%). Most of
cases detected with CDI in hospitalized patients were >70 years old
(median age, 81; interquartile range [IQR], 75.5–88.5), in contrast to
outpatients (median age, 40; IQR, 33–65; p = 0.005). Out of 33 CDI-
positive inpatients, 31 were native and three immigrants. One of the
immigrants was positive for 027 strain. She was a Portuguese female
who had been operated in her country less than a month ago. Among
seven outpatients positive for CDI, three were travelers and two of them
have developed diarrhea after antibiotic treatment for traveller’s
diarrhea. The remaining outpatients were immigrants and natives who
had previously taken antibiotics or proton pump inhibitors.
Conclusion: A high prevalence of CDI infection in hospitalized
patients with detection ribotype 027 was observed. In addition, the
prevalence obtained in outpatients, notably in those with antibiotic
treatment after traveller’s diarrhea, is far from negligible. These data
suggest the need of diagnosis of ribotype 027 in hospitalized patients
and the screening of CDI out of the traditional risk groups.
R2708 Mathematical modelling of health-care- associated
infections – a systematic review
E. van Kleef*, J.V. Robotham, M. Jit, B. Cookson,
W.J. Edmunds (London, UK)
Objectives: In the mid-90 seconds, the ﬁrst mathematical models
addressing healthcare-associated infections (HCAI) were introduced.
Since then, these models have contributed to an increased
understanding of hospital epidemiology. We conducted a systematic
review in order to establish 1) how mathematical models have been
applied in the ﬁeld of HCAI, 2) how the methods and model structures
have developed over time and 3) what the results of these models have
shown. This was done in order to synthesise key lessons learnt from
these models and provide directions for future research in the area of
modelling HCAI.
Methods: We searched MEDLINE, EMBASE, CINAHL plus and the
grey literature using search terms for mathematical modelling, HCAI
and relevant organisms.
Results: The ﬁrst mathematical models of HCAI aimed at
conceptualising transmission dynamics in single wards using
deterministic approaches. Following this, stochastic models began to
include chance due to its importance to the transmission process
(particularly in small patient populations). The dominant pathogen
studied is methicillin resistant Staphylococcus aureus. Others include
vancomycin resistant enterococci and Clostridium difﬁcile. Models
have explored a multitude of factors important to HCAI transmission
and control, for example, antibiotic effects and the development of
resistance, variability in transmission routes, effectiveness of
interventions and differences in transmission between strains or
settings (including community transmission). Higher awareness of the
signiﬁcance of HCAI has lead to improved national and international
surveillance systems, leading in turn to greater availability of data to
inform modelling studies. This has been coupled with the development
of more sophisticated methods e.g. for model parameterisation (e.g.
Markov Chain Monte Carlo methods) and characterising uncertainty,
and has led to improved model validation.
Conclusion: The ecology and epidemiology of HCAI can be complex.
Mathematical models have proved to be useful tools to aid our
understanding of the spread of these infections and the likely impact of
control measures. Improved national and international data collection
initiatives have enabled development of more realistic models, however
new insights and questions facing the ﬁeld call for further elaboration
and collaboration.
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R2709 Breast implant associated-infection conservative
treatment. Implant exposure is highly predictive of failure
E. Mauleon, J. Buendia, J.R. Yuste, J.L. Del Pozo* (Pamplona, ES)
Objective: Breast implants are used for breast augmentation and
reconstruction after mastectomy. Infection is one of the leading causes
of morbidity that occurs after breast implantation, and complicates
around 2% of interventions in most case series. Surgical removal of the
implant is mandatory in most cases. The goal of the present study was
to retrospectively analyze if a conservative treatment based on long-
term antimicrobial use could be a sure and effective alternative.
Methods: Study location: Clı´nica Universidad de Navarra, a 300-bed
University Hospital in Pamplona, Spain. Dates: January 2000 to
October 2011. Study design and patients: A retrospective review of all
consecutive patients diagnosed with breast implant associated infection
that were treated in a conservative way was conducted. Demographic,
clinical, microbiological, antimicrobial treatment and outcome data
were collected. Cure was deﬁned as clinical infection disappearance and
implant retention.
Results: Eighteen patients were identiﬁed. Median age at the time of
infection was 46 years (interquartilic range: 40–53). Thirteen patients
had a reconstructive and ﬁve an augmentation surgery. Median implant
life span from placement to removal was 307 days (interquartilic range:
20–337). Clinical picture included fever (88%), local pain (83%),
erythema (77%) and swelling (50%). Implant was exposed at diagnosis
in six patients. Cultures were performed in nine patients (50%). Most
common isolated microorganism was methicillin-susceptible
Staphylococcus aureus (44%). E. coli, Corynebacterium jeikeium,
Corynebacterium pseudodiphtericum, Staphylococcus epidermidis,
Prevotella bivia and Abiothroﬁa adjacens were involved in the other
episodes. All patients were started on IV (13) or oral (5) antimicrobial
therapy. Antimicrobials were administered for a mean of 89 days
(interquartilic range: 48–98). Breast implants had to be surgically
removed in eight patients (44%) because of treatment failure. Clinical
cure with breast implant retention was achieved in 84% of the patients
with a non-exposed implant, while 100% of the patients with implant
exposure required removal.
Conclusion: Not all breast implant associated infections mandate
implant removal. Breast implant exposure is highly predictive of failure
if a conservative treatment is intended. If implant is not exposed a
conservative treatment based in long-term administration of
antimicrobials could be a valuable therapeutic option.
R2710 Impact of inappropriate initial empiric antibiotic therapy
and antimicrobial resistance on outcome of patients with
complicated intra-abdominal infections requiring
surgery: a propective cohort study in Italy
L. Signorini*, E. Van Hauwermeiren, S. Magri, S. Piva, S. Garilli,
G. Moioli, M. Rosina, F. Ragni, S.M. Giulini, A. Matteelli, G. Sganga,
R. Cauda, B. Salerni, R. Stellini, G. Paraninfo, G. Carosi (Brescia,
Roma, IT)
Study Design: Multicenter prospective observational cohort study.
Objective: To evaluate the impact of inappropriate empiric therapy in
patients undergoing surgery for complicated intra-abdominal infections
(cIAI).
Methods: Setting: accrual at two clinical centres in Italy, from October
2009 to May 2011.
Participants inclusion criteria were: (i) age >18 years, (ii) complicated
intra-abdominal infection (iii) requiring surgery (iv) fever or leukocy-
tosis. Patients with underlying immunodeﬁciency or with life expec-
tancy <30 days were excluded.
Variables: the primary outcome was clinical success, deﬁned as
infection cure in response to combined initial antibiotic therapy plus
surgery.
Statistical Methods: Univariable analysis was performed using the
Chi square test for categorical variables and the Student’s t test for
continuous ones. Logistic regression models were used to identify the
variables independently associated with clinical success. The chosen
level of signiﬁcance was 5% and the p values reported were two tailed.
Results: Participants: 107 eligible patients had a mean age of 53 years
(SD + 18.8), 63% were male. Most patients had complicated
appendicitis (24%), or intra-abdominal abscess (21%). Eighty-two
pathogens were isolated from 38 patients (35.5%). Escherichia coli was
the most frequently identiﬁed pathogen (21%).
Main Results: In 82 cases (77%) the initial antibiotic therapy was
appropriate. Clinical success was observed in 74% (79/107) of the
cases. Patients with appropriate initial antibiotic therapy had clinical
success in 77% vs. 64% in the inappropriate therapy group (OR 1.87,
95% CI 0.64–5.41; p = 0.2). At multivariable analysis among those
with initial appropriate antibiotic therapy, clinical success was
signiﬁcantly associated with younger patient age (OR 1.1; 95% CI
1.0–1.3; p = 0.02); localised cIAI (OR 10.0; 95% CI 1.0–50; p = 0.05);
and shorter duration of ﬁrst line antibiotic treatment (OR 1.43; 95% CI
1.11–2.0; p = 0.04). Patients with resistant isolates (n = 17) had a
longer mean duration of antibiotic therapy (19 vs. 12, p = 0.04) and
longer hospital stay compared with patients with sensitive strains (23
vs. 15, p = 0.08).
Conclusions: We report the results of the ﬁrst prospective study on
inappropriate antibiotic therapy and outcome of cIAI. A trend towards a
better outcome in cIAI patients with appropriate initial therapy was
observed. cIAI due to resistant strains required longer duration of
therapy and hospital stay.
R2711 Clinical epidemiology of nosocomial candidaemia among
non-neutropenic adult patients
S. Cavinato, G. Grana`, M.L. Deiana, A. Maggiore, G. Boscaro,
F. Barbone, R. Luzzati* (Trieste, Verona, Padua, Udine, IT)
Objectives: To evaluate incidence, causative Candida species, risk
factors, treatment and outcome of nosocomial candidemia.
Methods: Retrospective study of nosocomial candidemia observed
from January 2008 to June 2011 at an italian tertiary care hospital with
no pediatric and transplantation departments.
Results: One hundred forty-ﬁve episodes of candidemia occurred in 139
patients (52% males). Median age was 81 years (range 14–98 years). At
diagnosis of candidemia, 70% of patients were hospitalized in medical
wards, 17% in surgical wards, 13% in intensive care units (ICUs).
Overall hospital incidence was 1.56 episodes per 10 000 patient-days
(1.90 in 2008, 1.57 in 2009, 1.20 in 2010, 1.57 in 2011). The incidence
was 4.28 episodes per 10 000 patient-days in ICUs, 1.69 in medical
wards and 0.89 in surgical wards. The most frequent Candida species
isolated was C. albicans (55%), followed by C. parapsilosis (24%), C.
glabrata (10%), C. tropicalis (4%) and other Candida species (7%).
Underlying diseases were: solid cancer (39%), diabetes mellitus (25%),
surgery (27%), autoimmune disease (5%), hematological malignancy
(3%), HIV (1%). Potential risk factors for candidemia were: antibiotic
therapy (93%), urinary catheter (75%), total parenteral nutrition (TPN)
(60%), surgery (27%), mechanical ventilation (18%), dialysis (9%),
corticosteroid therapy (8%).
A central venous catheter (CVC) ‡48 hours before candidemia was
present in 53% of patients; of them, 39% had CVC-related candidemia.
CVCs were removed in 71% of patients, with median removal time of
2 days (range 0–19 days). Systemic antifungals for at least 7 days were
given to 69% of patients. Considering all treated patients, ﬂuconazole
and caspofungin were administered to 85% and 12% of cases,
respectively. The overall crude mortality at discharge was 52%.
Mortality rate was associated to hospitalization in medical wards (p
.018), CVC retention (p .003) and inadequate antifungal therapy
(p < 0.001). The presence of CVC, CVC timing removal (£3 days vs.
>3 days) and Candida species were not signiﬁcantly associated with
crude mortality.
Conclusion: This study shows high incidence of nosocomial
candidemia, especially in very elderly patients admitted in medical
wards. Only about one fourth of patients had CVC-related candidemia.
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Mortality rate was highest in medical wards and associated to
inadequate antifungal therapy and CVC retention.
R2712 Comparison of genetic and resistance properties of
Clostridium difﬁcile isolates collected from clinical
specimens from a large urban area in Germany
V. Miller*, R. Guadarrama, B. Lamik-Wolters, B. Henrich,
C. Mackenzie (Du¨sseldorf, DE)
Objective: The Clostridium difﬁcile ‘‘epidemic strain’’ BNAP-1/
027causing severe disease in North America and parts of Europe is
not prevalent in Germany although the incidence of CDAD has greatly
increased. Characteristics of a large collection of Clostridium difﬁcile
isolates from patients in a densely populated urban area may provide
useful data concerning local epidemiology.
Methods: In the period from 2007 to 2011 a large number of isolates
has been collected from the greater Du¨sseldorf area and subjected to
ribotyping, PCR analysis of the presence of the toxin genes; tcdA, tcdB
and cdtB and mutation causing truncation of the tcdC gene as well as
resistance to erythromycin and moxiﬂoxacin.
Results: A total of 392 isolates have been analysed to date. Most of the
isolates (376 [95.9%]) possessed both tcdA and tcdB genes and 16
[4.1%] possessed neither toxin gene. No isolate carried only tcdA or
tcdB. The binary toxin gene, cdtB was found in only 52 [13.3%]
isolates, all of which possessed cdtA and cdtB genes. A mutation of the
tcdC gene leading to the expression of a truncated protein was found in
62 [16.5%] of the toxin-gene carrying isolates. All isolates possessing
the cdtB gene also carried a mutation of the tcdC gene. Ribotyping
displayed a large spread of different ribotypes. The ribotype with the
most isolates contained 68 members; unfortunately the classiﬁcation is
still unknown. Only 27 isolates were type 027. All other clusters
contained <20 isolates, most <10, per cluster. A total of 201 [51.3%]
isolates were resistant to both erythromycin and moxiﬂoxacin, 66
[16.8%] sensitive to both, 108 [27.6%] sensitive to erythromycin only
and 17 [4.3%] to moxiﬂoxacin only.
Conclusion: The isolates investigated so far show a wide diversity and
no single ribotype or molecular type appears to be predominant in the
area studied. This correlates with the epidemiological data obtained
from the largest hospital in the collection area, in which nosocomial
spread of clones is rare. In addition the ribotype 027, as in other studies
in Germany does not appear to be common. Ribotyping a large number
of isolates is technically demanding and thus alternative methods will
be included in the ongoing study. A very small number of clinical
Clostridium difﬁcile isolates (all from patients with diarrhoea)
possessed no toxin gene, a fact that has relevance for the use of PCR
as a diagnostic method.
R2713 High rates of carbapenem resistance and mortality in
patients with nosocomial Pseudomonas putida
bacteraemia
H. Jang*, S. Park, S. Kang, K. Park, S. Kim, S. Jung,
J. Shin (Gwangju, KR)
Objectives: Pseudomonas putida belongs to the ﬂuorescent group of
Pseudomonas species and has been recognized as a rare cause of
bacteremia. This organism was considered to be a lower virulent
pathogen. But, recently, multi-drug resistant and carbapenem-resistant
P. putida have been emerged which caused difﬁcult-to-treat nosocomial
infections in seriously ill patients. However, the clinical data on the
prevalence and mortality rates of carbapenem resistant P. putida
infections are still lacking. Here, we investigated the antibiotic
resistance rates of nosocomial P. putida blood isolates and clinical
characteristics and mortality of P. putida bacteremia.
Methods: From January 2006 through September 2010 the cases of
nosocomial P. putida bacteremia were collected by review of Clinical
Microbiology Laboratory Records at Chonnam National University
Hospital (1000-bedded) and Chonnam National University Hwasun
Hospital (700-bedded). During the study period four cases of P. putida
bacteremia outbreak related to contaminated infusion ﬂuid were
conﬁrmed, and this cases were excluded in this study. Medical
records were retrospectively reviewed. Species identiﬁcation and
antibiotic susceptibility was determined by the VITEK 2 system
(bioMe´rieux Inc., Hazelwood, MO, USA).
Results: Four (31%) and ﬁve (39%) of 13 P. putida isolates were
resistant to imipenem and meropenem, respectively. All of 13 P. putida
isolates were susceptible to colistimethate. Eleven (84.6%) patients had
indwelling devices related to primary infections. Common primary
infection sites were ventilator-related pneumonia (6.55%) and biliary
tract (2.18%). Single cases of necrotizing fasciitis, surgical site
infection, peritonitis and central venous catheter-related infection
were observed. Thirty-day mortality in patients with P. putida
bacteremia was 54% (7/13): 60% (3/5) in patients with carbapenem-
resistant P. putida bacteremia, but 50% (4/8) in patients with
carbapenem-susceptible isolates. Three patients who received
inappropriate antibiotic treatment because of carbapenem resistance
were all died.
Conclusion: Nosocomial infection of P. putida could show high rate
of resistance to most potent beta-lactams, carbapenems, and it can cause
signiﬁcant morbidity and mortality for infected patients. So it is
necessary to aware the fatality of nosocomia P. putida bacteremia and
consider the early initiation of the susceptible antibiotic regimen such as
colistimethate.
Travel medicine, tropical and parasitic
diseases
R2714 Prevalence of intestinal parasitic infections among
suspected referred patients to a reference laboratory in
Ilam, Iran
N. Sadeghifard*, S. Ghafourian, A. Maleki, R. Mohebi (Ilam, IR)
Objectives: The aim of the present study was to estimate the
prevalence of intestinal parasitic infections among suspected referred
patients to Reference laboratory of Ilam in the west of Iran during the
period March 2010 to April 2010.
Methods: Samples were collected from stool of 1600 suspected
referred patients to Reference laboratory of Ilam in the west of Iran
during the period March 2010 to April 2010.
The stool samples were examined for intestinal parasites by direct
microscopic.
Results: The results indicated that intestinal parasitic infections among
patients in the study area are mainly water-borne. Intestinal parasites
were detected by direct smear in 154 of 1600 (9.6%) suspected referred
patients to the laboratory. At least one intestinal parasite was found in
stool samples from 124 patients, two parasites in 27, and mixed
infections with three or more parasites were seen in stool samples of
three patients. The parasites were Giardia intestinalis 77 (50%),
Entamoeba histolytica/E. dispar 19 (12.3%), Entamoeba coli 36
(23.3%).
Conclusion: The prevalence of E. histolytica/E. dispar in the present
study to base on microscopy examination was 1.18%. Presumably, the
number of E. histolytica positive cases would be higher if all samples
were tested by Molecular methods. The ratio of E. histolytica to E.
dispar found in this study was 1–3.5 is higher than the estimated global
ratio of 1–10.
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R2715 Case report: prolonged multiple paralysis after
rattlesnake bite in Brazil
P.P.Q. Torrez, M.R. Duarte, A. Nicoletti, C.R. Medeiros,
C.M.S. Malaque, F.H. Wen, J.J.B. Ferreira, J.Y. Risk, R. Lobo,
J.L.C. Cardozo, F.O.S. Franca* (Sa˜o Paulo, BR)
Objectives: Report a case of a man that was bitten by a rattlesnake in
Brazil with compromised the activities of several cranial nerves and
muscle groups for an unusual period of time.
Methods: Review of clinical record from Hospital Vital Brazil,
Butantan Institute, Brazil.
Results: In April, 2009, a 42 years old Brazilian man, previously
health, natural of Santana de Parnaı´ba was admitted to Vital Brazil
Hospital, Butantan Institute (Sa˜o Paulo, SP, Brazil) 1 hour and
:20 minutes after been beaten by a Crotalus durissus terriﬁcus (total
length 101 cm) identiﬁed by the Herpetology Laboratory of the
Butantan Institute, Sa˜o Paulo. The patient was drunk and tried to
capture the snake and reporting many bites on both hands. The bite sites
presented pain, bleeding and swelling. In the Hospital admission he was
conscious and hypotense. The pacient was classiﬁed as moderate and
received ten vials of anti-crotalic antivenom. Five hours later after the
admission, he developed myalgia associated with change of visual
acuity, bilateral ptosis. Coagulation tests was incoagulable, and a
peripheral blood ﬁlm revealed white blood cells: 11 200/mm3 (4400–
11 300/mm3) with neutrophilia, urea: 41 mg/dL (10–50 mg/dL);
creatinine: 1.5 mg/dL (0.4–1.3 mg/dL), creatine kinase: 1095 U/l
(38–174 U/L). On the third day of hospitalization, the patient
remained with blurred vision, bilateral ptosis, complete
ophthalmoplegia with mild anisocoria, tearing, conjunctival
hyperemia, hiccups that only improved after the use of
chlorpromazine hydrochloride, salivation, difﬁculty chewing,
swallowing food solid, refers bitter taste (change in taste), decreased
olfaction and difﬁculty walking. He developed non dialytic acute renal
failure and evolved with remission of myalgia. Kept bilateral ptosis
with ophthalmoplegia, mild anisocoria and tearing for more than
2 months after the snakebite.
Conclusion: Accidents caused by rattlesnakes are responsible for
approximately 9% of venomous snake bites in Brazil (in 2009 were
reported 2211 cases). The South American rattlesnake venom has
neurotoxic, coagulant and myotoxic activities. The myotoxic activity
can cause severe rhabdomyolysis and acute renal failure. The
neurotoxic activity can cause cranial nerve involvement and paralysis
of skeletal muscles that usually regress within a few days. It is very
unusual reports in the literature with compromise many cranial nerves
and muscle groups lasting months after snake bites.
R2716 Requests for malaria prevention advice to the HPA
Malaria Reference Laboratory
G.S. Godbole*, P.L. Chiodini (London, UK)
Objectives: The Malaria Reference Laboratory (MRL), Health
Protection Agency (HPA), UK regularly gets requests for advice
about malaria prophylaxis for overseas travellers and provides a
specialist advisory service for complex queries from medical
practitioners. This audit was conducted to look at types of queries
with an aim to improve quality of service.
Methods: All requests for advice are sent on a proforma faxed to the
MRL. We reviewed all the faxed requests received over a period of
6 months in 2011. The information was collated and the number and
types of queries were scrutinised.
Results: There were a total of 450 requests over a period of 6 months.
98% requests were from general practitioners. Median age of travellers
was 33 years, 58% were females. 70% travellers were visiting single
destinations and 75% were visiting both rural and urban areas. The
commonest reason for travelling was visiting family. The most common
queries were about prophylaxis for travellers to multiple destinations
with a mix of high and low risk of malaria (93, 21%). Others included
prophylaxis for a prolonged duration (80, 18%), antimalarial
prophylaxis for the immunosuppressed (35.8%), drug interactions
between antimalarials and other drugs like warfarin, oral contraceptives
and antiarrhythmic drugs (26, 6%) and speciﬁc questions about
prophylaxis for children (61, 14%), women who were pregnant or
planning pregnancy (36, 8%). The MRL has a dedicated website with
guidance for health professionals regarding antimalarial prophylaxis
which could have been used for 27% of the enquiries, however a
substantial number of questions were related to patients with multiple
problems (100/450, 22%), eg pregnancy with epilepsy and long term
stay in a high risk area.
Conclusion: Malaria prevention enquiries which are not readily
resolved by consulting written guidelines can be answered by a fax
back service which has the additional beneﬁt of providing a written
record of advice given.
R2717 Prevalence of Chlamydia trachomatis infection in male
population
I.H.-P. Meloska*, B.C. Trajkovska, B. Jaglikovski, D. Cvetkovik, A.H.-
P. Jankijevic (Skopje, MK)
Introduction: Chlamydia trachomatis (CT) is more common than any
other male sexually transmitted disease with millions of new reported
cases each year. The bacteria are found in the urethral swab, urine and
sperm, and can ba transferred through genital ﬂuids from one partner to
the other. Men, especially under 25 who have had more than one
partner within the last year, should have regular Chlamydia tests even
there are no symptoms present. The symptoms vary in both type and
severity; from discharge, irritation of oriﬁcium urethrae, painful and
frequent urination, to orchitis with subsequent infertility. Asymptomatic
men with chlamydial infections are under-identiﬁed and probably play
an important role in sustaining the epidemic.
Aim: The objective of this study was to measure the prevalence of
Chlamydia trachomatis infection among men using direct
immunoﬂuorescent assay.
Method: A total of 450 male samples (435 urethral swabs and 15 ﬁrst
void urine specimens) in a period of 2 years were enrolled in this study.
The patients were on age between 17 and 69, all sexually active. A
direct immunoﬂuorescent assay – Patho DX (Oxoid, UK) was
performed for diagnosis of CT.
Results: The positivity of the samples was 21.1% (95/450). The
majority of positive patients were on age 21–50 years, median age 32.
Symptoms with different severity were reported in half (45) of positive
and 78 of Chlamydia negative patients. The most frequently reported
symptom in 95 CT positive patients was white watery discharge – noted
in 87%, and in only 10 of the negative patients. Risk biheiviour with
multiple sex partners during the evaluated period was noted in 85
patients, 52 of them being CT positive. One month post therapy follow
up was performed on 40 of the positive patients, 34 being CT negative,
and the rest needed further antibiotic administration.
Conclusion: Chlamydia positivity is rather high in the evaluated
population especially in the age around 30, implicating the need of
regular screening. The screening for Chlamydia should enroll all
sexyally active men, not only those with symptoms. CT investigations
needed are as well in the evaluation of the antibiotic therapy success.
R2718 Prevalence of Strongyloidosis and Chagas’ disease co-
infection in Latin-American migrants in a tertiary
hospital in Spain
M. Alvarez-Martinez*, M.E. Valls, E. Aldasoro, J. Mun˜oz, R. Ferre´,
J. Pardos, M. Navarro, E. Rodrı´guez, J. Gasco´n, J. Mas (Barcelona,
Madrid, ES)
Objectives: Strongyloidosis (St), produced by the geo-helminth
Strongyloides stercoralis, is worldwide distributed and endemic to
warm and humid areas. Chagas disease (CD), caused by Trypanosoma
816 Abstracts accepted for publication only
cruzi, is endemic to Latin America, and of emerging importance in non-
endemic countries because of migration of people infected with T.
cruzi. St and CD are neglected tropical diseases (NTDs) presenting
common features, long-life persistance, pauci-symptoms, prolonged
morbidity and potential mortaliy. The objective of this study was to
determine the prevalence of St and CD co-infection in Latin-American
migrants in our hospital.
Methods: One hundred sixty-four patients attending to our tropical
medicine unit were screened for St in our lab between January 2010 and
October 2011 by at least one of these techniques (i) microscopic
examination of fresh and concentrated faeces; (ii) culture of faecal
specimens or (iii) ELISA test (Strongyloides Serology Microwell
ELISA kit, DRG-International). Four hundred ninety-one patients were
screened for CD at the same period of time by two ELISA tests (i)
BIOELISA, Biokit and (ii) ELISA-Ortho. Indirect
immunoﬂuorescence-IFI (Inmunoﬂuor Chagas-Biocientı´ﬁca) was
performed if any discordant result was found. Screening of St was
performed in all patients presenting eosinophilia, screening of CD was
performed in all patients from CD endemic areas that showed
eosinophilia.
Results: Seventy-two out of 164 (44%) screened patients were
diagnosed of St, 39 (54%) were male, mean age (38). Origin of
patients was as follows, Bolivia (58), Democratic Republic of Congo
(1) Ecuador (2), Equatorial Guinea (7), Honduras (2), India (1) Sierra
Leone (1). All patients, except two, presented eosinophilia at the
moment of diagnosis. Thirty-ﬁve of these 72 patients (49%) were found
co-infected with CD. Co-infected patients were all Bolivian, 19 (54%)
male, mean age (37). All, except one, showed eosinophilia. T. cruzi
infection was conﬁrmed in 71 patients by the two described ELISA
tests, only in one patient discordant results were found between ELISA
tests, and infection was conﬁrmed by IFI.
Conclusions: We have found a high prevalence of co-infection of St
and CD in patients from Latin-America attending to our clinic. Bolivian
patients are the most important group, at the presence of eosinophilia,
the screening for St and CD is strongly recommended. Taking into
account the nature of these NTDs, their burden could be underestimated
in non-endemic areas.
R2719 Short-term medical response in Haiti: epidemiology and
model for delivery of care
K. Prentiss, S. Arshad, T. Prentiss, T. Zervos, S. King,
M. Zervos* (Denver, Detroit, US)
Objectives: This report describes an acute care medical mission clinic
model and data collected on diseases seen during a trip organised by
International Medical Relief (IMR) during the period from July 2–10,
2011 in Haiti.
Methods: The team consisted of 40 members including medical, dental
and community education professionals in 7 locations within and
around the capital, Port au Prince.
Results: Over an 8-day period, 1696 patients were seen, 641 male and
1042 female. Mean age was 24.6 years (range 30-days to 94 years). All
patients sought medical attention and 254 patients also sought dental
care. All patients and providers participated in the community education
sessions. For women, number of pregnancies, live births and children
currently was 3.38, 3.08 and 2.86 mean. The most common presenting
complaint was fever, in 304 patients. Gastrointestinal illness was
observed in 222 patients, which included gastrointestinal reﬂux,
parasitosis, and acute diarrhoeal illness. One hundred and sixty-nine
patients had respiratory illnesses, mostly upper respiratory illness,
pharyngitis and otitis in children. Eye dryness occurred in 162 patients,
and was related to dust and smoke in the air. Skin rashes including
infections (wound infection, cellulitis, impetigo, ringworm and scabies)
occurred in 153 patients. 151 patients complained of pain and malaise.
Vaginal symptoms related to fungal, bacterial vaginosis and likely
sexually transmitted illness was present in 118 patients. Post-traumatic
stress related symptoms were common, often presenting as pain, vague
abdominal complaints, anxiety and difﬁculty sleeping. Clinical
presentations typical of tuberculosis, advanced AIDS, and severe
cholera were uncommon. Mumps was suspected in one patient, there
were no diagnosed cases of measles or rubella. Three patients were
transferred to acute care hospitals, one for refractory seizures, a second
for diarrhoea refractory to oral rehydration likely secondary to cholera
and the third for a large intra oral, retropharyngeal abscess. 83% of
patients said they had seen a provider in the past. 16% were previously
diagnosed with a condition including malaria, TB or HIV. 45% had
received prior immunizations; 58% of children had received polio
immunization and 55% stated they slept with bed nets.
Conclusion: The intervention bundle described in this report of an
acute care clinic staffed by short term medical and education workers
provides a useful model for acute care in developing countries.
R2720 Evaluation of Toxoplasma gondii Liaison IgG and IgM
assay
M. Skvarc*, B. Soba (Ljubljana, SI)
Objectives: The serological diagnosis of toxoplasmosis is very
complex. Diagnosis is especially difﬁcult for pregnant women. In
Slovenia we have established screening programme in 1995 to prevent
congenital toxoplasmosis. We are testing pregnant women three times
during the pregnancy. The purpose of this study was to evaluate the
analytical performance of the Cobas Toxo IgG and IgM (Roche, USA)
immunoassays and compare the results with those of the Liaison Toxo
IgG and IgM (Dia-Sorin, Italy) assays.
Methods: We have done prospective study for T. gondii. IgG and IgM.
In May and June, a total of 870 samples were collected from 870
pregnant women. Serums for Toxoplasma IgG and IgM testing were
stored at 4C until use. Each sample was tested on both machines in
parallel. To conﬁrm positive IgM cases we used ISAGA IgM assay
(bioMerieux, France). To conﬁrm acute toxoplasmosis we used testing
of second serum that was taken 3–4 weeks after ﬁrst serum.
Results: We detected two cases of acute toxoplasmosis. One was
woman was infected early in ﬁrst trimester. She had a rise in the values
of IgG in the second serum sample. The second woman seroconverted
in second trimester of pregnancy. The Cobas IgM values were all the
time negative in the second case. The detection of IgG was not
problematic in both assays. In seven cases we found false positive IgM
with Cobas assay and four cases of false positive IgM with Liaison
assay. In both of the cases of acute toxoplasmosis we could not detect
IgM with Cobas assay.
Conclusion: In our opinion the Liaison assay is more reliable than
Cobas assay. We discovered less false positive IgM with Liaison. Any
false positive result on T. gondii testing presents great psychological
burden for pregnant women. On the other hand we would miss acute
infection, if we would use only Cobas assay.
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R2721 Can PCR provide the clue to a diagnosis of swine
cysticercosis?
J.-F. Carod*, M. Rakotondrazaka, R. Jambou,
R.M. Ramahefarisoa (Antananarivo, MG)
Introduction: Cysticercosis is a zoonotic disease due to Taenia
solium, which involves pork as intermediate host. It is endemic in
Madagascar, however very few data has been reported concerning
porcine cysticercosis prevalence. Lack of ante-mortem diagnostic tools
makes the prevalence evaluation difﬁcult. Tongue palpation is very
speciﬁc but of poor sensitivity. Serological tests detecting antigen or
antibodies are sensitive for human cysticercosis diagnosis but are not
yet considered as a gold standard in swine ante-mortem examination.
PCR are wildly used to detect pathogens but poorly evaluated for the
diagnosis of cysticercosis.
Methods: We compare the performance of PCR and ELISA assays on
sixty seven pig serums: 22 from cysticercosis positive pigs (meat
inspection) and 45 from cysticercosis negative animals (originating
from a non-endemic country or grown in industrial and well isolated
pigsties). Among the negative samples 19 were collected from pigs with
trichinellosis and four from pigs with toxoplasmosis.
Results: Results indicate that ELISA assay showed high sensitivity
and good speciﬁcity while the PCR assays showed high speciﬁcity but a
low sensitivity.
R2722 Post-malaria neurologic syndrome in falciparum malaria
case
M. Sonmezoglu*, B.C. Yalcinkaya (Istanbul, TR)
Infection with Plasmodium falciparum is known to cause several
neurological complications. The most deleterious presentation is
cerebral malaria, carrying a mortality of 10–50% in treated patients.
Patients can experience a neurological syndrome following successful
treatment rarely. The syndrome has been deﬁned as the acute onset of
neurological or neuropsychiatric symptoms in patients recently recov-
ered from Plasmodium falciparum malaria who have negative blood
ﬁlms at the time of onset.
We report a case of PMNS after successful treatment for Plasmodium
falciparum malaria. He was travelled to Equatorial Guinea 2 weeks
before admission and referred to a hospital with fever and fatigue. After
referral to our hospital 6 days later with no diagnosis, he had taken to
intensive care unit with cerebral malarial clinical presentation. Blood
smears revealed Plasmodium falciparum parasites. He was put on
quinine and tetracycline and improved in 2 days. Two weeks after
discharge, he began to experience headache, mild hand tremor,
psychosis and strange behavior. He readmitted to the hospital, and
presented with irritability, visual hallucination. Blood smears showed
no parasites. Blood biochemistry was normal. Neurologic examination
and electroencelaphalography was normal. Cranial MRI was also
normal except T2 hyperintensity in proximity of right trigeminal nerve.
He improved with anti-psychotic medication (Olanzapin) and had no
complaints in a week.
The ﬁrst description of PMNS was a large case series from Vietnam and
Thailand. Of 1176 patients with severe falciparum malaria, 21 (1.8%)
developed PMNS. PMNS usually occurs in adults after recovery from
severe falciparum malaria. Median onset was 4 days in the Vietnamese
study and 15 days for the other cases. It is a postinfectious diffuse
encephalopathy, characterized by >1 of the following: impaired
consciousness, confusion, aphasia, seizure, tremor, psychosis, and in
severe cases, ataxia. Patients often are febrile at presentation. PMNSis
self-limited, lasting 2–14 days, and requires no speciﬁc treatment.
Resistance and mechanisms of action of
antifungals
R2723 Antifungal susceptibility proﬁle of bloodstream Candida
isolates in an intensive care unit of a tertiary hospital
B. Mete, N. Saltoglu*, E. Zerdali, G. Aygun, T. Utku, S. Urkmez,
R. Ozaras, A. Mert, F. Tabak, R. Ozturk (Istanbul, TR)
Introduction: Incidence of nosocomial fungal infections have been
increased in intensive care unit (ICU), especially in patients who
underwent surgery. In recent years, azole prophylaxis, have led to
change in the distribution of Candida albicans and non-albicans
Candida species. Our objective is to evaluate the resistance proﬁle of
Candida spp. isolated from candidemic patiens followed-up in ICU of
our hospital.
Materials and Methods: The patients are consulted by infectious
diseases and clinical microbiology consultants daily in our 13 bed
medical/surgical ICU. The patients with positive peripheral blood
cultures for Candida species was evaluated from January 1st 2005 to
December 31st, 2007. Stored Candida spp. at -70C were subcultured
onto Sabouraud dextrose agar and Candida spp. grown in cultures were
evaluated by germ-tube test, according to the morphological
characteristics of colonies in Sabouraud dextrose agar and
CHROMagar, and has been identiﬁed by the commercial
identiﬁcation system API 32C. Antifungal susceptibility was
performed by E-test method according to the manufacturer’s
instructions. Interpretations of minimal inhibitory concentration
(MIC) levels for ﬂuconazole, itraconazole, voriconazole, caspofungin
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and anidulafungin were evaluated according to Clinical Laboratory
Standards Institute. As there are no established breakpoints for
amphotericin B, breakpoints proposed by Nguyen et al. were used.
Results: Thirty-two candidemia episodes were identiﬁed in 32
patients. Incidence of candidemia was 22 per 1000 admissions. The
most frequent species were C. albicans (41%), followed by C.
parapsilosis (19%), C. glabrata (19%), C. tropicalis (9%) and C.
dubliniensis (9%). Overall susceptibility to amphotericin B,
voriconazole and caspofungin were 100% among all Candida
species. Although 100% of C. albicans, C. parapsilosis, C. tropicalis
and C. dubliniensis were susceptible to anidulafungin, only 33% of C.
parapsilosis were susceptible. Susceptibility to ﬂuconazole were 100%
among all Candida spp. except C. glabrata (83% susceptible).
Posaconazole exhibited low MICs for all isolates, except three in C.
glabrata (MIC >1 lg/mL). MIC50 and MIC90 levels of the Candida
spp.are demonstrated in table.
Conclusion: In recent years, the distribution of Candida spp. has been
shifted towards non-albicans Candida spp. But antifungal susceptibility
results have demonstrated that ﬂuconazole may be still used as a ﬁrst
choice in empirical therapy in our unit.
R2724 In vitro synergism of nine antifungal combinations against
bloodstream Fusarium solani and Fusarium oxysporum
isolates
H.M. Morales*, M. Rinaldi, C. Sanders, D. McCarthy, T.F. Patterson,
A.W. Fothergill (Sao Paulo, BR; San Antonio, TX)
Objectives: Fusarial infections have both high mortality and morbidity
rates among immunosupressed populations. Treatment is a major
problem since two of the most prevalent species – Fusarium solani and
Fusarium oxysporum- are usually resistant to antifungals. Therefore, the
present study aimed to evaluate synergism of antifungals combinations
against bloodstream Fusarium solani and Fusarium oxysporum isolates.
Methods: The clinical isolates were all from blood source. These were
previously identiﬁed by the University of Texas Health Science Center
at San Antonio University of Texas Health Science Center Fungus
Testing Laboratory. Susceptibility was determined according to
methods outlined in Clinical and Laboratory Standards Institute
document M38-A2. Drug interactions were tested using the
checkerboard microdilution method. Interaction was determined by
calculating the fractional inhibitory concentration index (FICI) with
standard deﬁnitions: synergy FICI £0.5, indifference FICI >0.5 and = 4,
and antagonism FICI >4. The in vitro activities of Amphotericin B
(AMB), Caspofungin (CAS), Poscanazole (POS), Voriconazole (VOR)
and Terbinaﬁne (TER) alone and in the following combinations
AMB + CAS, TER + CAS, TER + AMB, POS + AMB, TER + POS,
CAS + POS, AMB + VOR, CAS + VOR, TER + VOR were
evaluated. Identiﬁcation was based on morphology and Paecilomyces
variotii ATCC 3257 was included as quality control strains for
minimum inhibitory concentration (MIC) determination. The MIC50
and MIC90 were calculated using Microsoft Excel 14.0.
Results: We analyzed 14 Fusarium solani isolates and ﬁve Fusarium
oxysporum isolates. Synergy was observed for the combination
VOR+TER against 14/19 isolates (F. solani 9/14 and F. oxysporum
5/5). The MIC50 and MIC90 against TER alone (>4 lg/mL, >4 lg/
mL) and VOR alone (4 lg/mL, >4 lg/mL) were higher than in
combination (TER=2 lg/mL, 4 lg/mL and VOR = 1 lg/mL, 4 lg/
mL). The following combinations had synergism against F solani
isolates: AMB + CAS 2/14, TER + CAS 0/14 and TER + AMB 1/14.
Synergy was noted fot the following combinations against F
oxysporum: AMB + CAS 1/5, TER + CAS 1/5 TER + AMB 1/5,
CAS + VOR 1/5 and TER + VOR 5/5.
Conclusion: The combination VOR + TER showed synergism against
73.7% of bloodstream fusarial isolates while the common used
combination AMB + VOR was indifferent against all isolates. There
were no antagonism.
Fungal infections
R2725 Epidemiology and outcome of invasive candidiasis in an
intensive care unit of a central hospital in Lisbon
A. Paro´la*, I. Carvalho, E. Monteiro, G. Freitas, M. Lopes (Lisbon,
PT)
Objective: To determine the incidence of invasive candidiasis, factors
associated with risk of infection, and to identify the main infectious
Candida species in the Intensive Care Unit (ICU) of the Hospital Egas
Moniz.
Methods: A prospective observational study was conducted from May
to December 2009 in ICU of Hospital Egas Moniz. Demographic
information, risk factors, therapy and outcome of all patients in the ICU
were reviewed. Statistical analyses were performed using Epi Info 2000
and SPSS 5.3, 18.0 Statistic PAWS. Mean ± SD was determined for
quantitative data, and frequency was determined for categorical
variables.
Results: During this period, 28 episodes of invasive candidiasis (IC)
were reported in 26 patients, accounting for an overall incidence of
12.8% and for a candidemia incidence of 0.46%. In the ﬁve death cases
associated with IC, ﬁve were due to C. albicans, from which two were
mixed infections with C. glabrata or C. parapsilosis, accounting for
19.2% of mortality rate and a proportional mortality ratio of 11.1%.
Patients with IC had mean age of 72.3 years, and patients hospitalized
longer than 21 days accounted for 46% of the cases. In all age groups,
IC occurred more frequently in males (73.1%). Hypertension (69.2%),
chronic obstructive pulmonary disease (46.2%), heart failure (42.3%),
diabetes mellitus (30.8%), central venous catheter (100%), and
mechanical ventilation (88.5%) were the major underlying conditions.
The use of broad-spectrum antibiotics, namely carbapenems (n = 22)
and piperacilin+tazobactan (n = 12), was prevalent in patients with IC.
In patients with previous quinolones use, a trend for the isolation of
non-albicans species was noticed.
The most common pathogen was C. albicans (59.3%), followed by C.
glabrata (15.5%), C. krusei (12.4%), C. tropicalis (9.7%) and C.
parapsilosis (3.1%). 40% of IC was due to non-albicans species. Mixed
infections due to two species were recorded in six cases (21.4%).
Conclusions: Candida species are an important cause of invasive
infection in patients with co-morbidities and extremes of age are at
highest risk. These results help to establish epidemiological measures
for the control of IC. In addition, these ﬁndings reinforce the need for
continued and active surveillance programs to address the changes in
the species distribution which will help to develop effective, preventive
and therapeutic strategies.
R2726 Detection of Aspergillus antigen galactomannan in
diagnosis and follow-up of the Aspergillus infections
P. Kazila*, I. Diamanti, E. Sotiriadou, V. Anagnostou, X. Meleti,
S. Kostopoulou, S. Karampa, E. Kaitsa (Thessaloniki, GR)
Objectives: The invasive aspergillosis (IA) remains a common cause
of morbidity and mortality in immunocompromised patients, although
there is a lot of progress in diagnosis and therapeutic management. Aim
of our study is to evaluate the detection of Aspergillus antigen
galactomannan (GM) in diagnosis and following up in infected patients
of our hospital.
Methods: During the period 2008–2010, 2499 clinical samples were
examined for the detection of GM antigen. Samples (1–8/patient) were
from 422 immunocompromised hospitalized patients. Patients were
mostly neutrophenic with symptoms of infection. GM antigen was
detected by Platelia Aspergillus EIA method (Biorad, Marnes-La-
Coquette, France). Samples that had ratio (r) >0.5 were rated as
positive. Statistical analysis was made using SPSS (paired samples t-
test).
Results: The positive samples were 133/2499 (5.32%). These samples
were from 71/422 (16.8%) patients. Apart from GM there were other
clinical and laboratory ﬁndings that conﬁrmed aspergillosis. Fifty-eight
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patients were from the hematological clinic, eight from the intensive
care unit, four from the pathological clinic and one from the surgical
clinic. One hundred and eight from the 133 positive samples were blood
samples, 12 were bronchoalveolar lavage (BAL) and 13 were
cerebrospinal ﬂuid (CSF). During the weekly detection of the GM
antigen titer, r was 0.5–5.6 in blood samples and 0.8–6.7 in the rest of
the samples. In infections of the central nervous system, levels of r were
statistically higher (p < 0.05) in CSF (mean 4.76 ± 0.36) than in blood
(mean 1.76 ± 0.64). A difference between levels of BAL and blood in
the infection of the respiratory system was not statistically signiﬁcant
(p > 0.05). Levels of r correlated well with response to therapy.
Conclusions: Detection of GM antigen is a reliable marker for early
diagnosis of IA and therapeutic management of high risk patients such
as immunocompromised patients.
R2727 A fungi as a cause of hospital infection: the results of
2 years of active surveillance in a tertiary care hospital
Z. Karacaer, O. O¨ncu¨l, V. Turhan, M. O¨zyurt, L. Go¨renek (Istanbul,
TR)
Background: It was aimed to investigate the frequency of fungal
infections (FI), to determine typing of fungi that were isolated from
patients and to evaluate risk factors associated with FI and mortality.
Methods: This study was carried out between Jan1, 2009 and Dec 31,
2010 as prospective and controlled in intensive care units (ICU), and
the patients were observed with active surveillance. Colony
morphology, and germ tube formation methods, and VITEK 2
Compact System kits were used for the identiﬁcation of isolates.
Results: In this study, 2362 patients were followed for 16 135 patient
days of hospitalization. During the study, 63 (27.5%) of 229 patients
who developed nosocomial infection (NI) 77 episodes of FI were
observed. Patients of 54% were male, 46% were women. Hospital stay
(OR = 1.03, p = 0.007), hyperglycemia (OR = 17.93, p = 0.009), and
accompanied by other infections (OR = 3.98, p = 0.001) were
identiﬁed as independent risk factors for FI. Candida spp. were
determined the only as cause of FI. 77 of 135 candida strains was
isolated as causative pathogens. The distribution of isolates were 63.6%
C. albicans, 14.2% C. tropicalis, 6.4% C. glabrata, 6.4% C.
parapsilosis, 3.8% C. kefyr, 3.8% C. dubliniensis and 1.2% C.
zeylanoides. High APACHE II scores (OR = 1.37; p = 0.002), and the
use of central venous catheter (OR = 9.01; p = 0.04) were assigned as
independent risk factors for mortality. The rates of mortality
attiributable to candida infection and candidemia were 27%, and
18.3% respectively. The mortality rate related C. albicans and C.
tropicalis was 12.2%.
Conclusions: As a result, FI rate is increasing in our hospital. FI and
mortality can be prevented by controlling of some risk factors as well as
length of hospital stay and hyperglycemia. Typing of fungi should be
done routinely to treat FI successfully.
R2728 Species distribution and antifungal susceptibilities of yeast
isolated from catheterised urine specimen
T.H. Kim*, M.K. Lee, B.S. Shim (Seoul, KR)
Objectives: The aim of the present study was to evaluate the effect of
urinary catheter on species distribution and susceptibilities of
antifungals against clinical isolates of yeasts from catheter-associated
urinary tract infection (CAUTI).
Methods: A total 281 yeast isolates from catheterized urine in a
medical and surgical ward were collected. Species identiﬁcation and
antifungal susceptibulity test to amphotericin B, ﬂuconazole,
voriconazole and ﬂucytosine were performed by VITEK 2 system
(bioMe´rieux Inc., Hazelwood, MO, USA).
Results: The most frequent species was Candida tropicalis (48.8%),
followed by C. albicans (24.6%), C. glabrata (15.7%) and
Trichosporon asahii (5.0%). C. tropicalis and T. asahii were more
frequently isolated in a surgical ward than medical ward (P < 0.05).
Decreased susceptibilities to amphotericin B were observed in C.
albicans and T. asahii. All isolates except C. glabrata and C. krusei
were susceptible to ﬂuconazole and voriconazole.
Conclusions: The results of this study suggest the possibility that
urinary catheter may lead to inﬂuence on species distribution of yeast of
CAUTI. There is an need for continuous surveillance of CAUTI by
yeast for the control of CAUTI.
R2729 Fungal infections diagnosed in patients of haematological
department
U. Nawrot*, L. Usnarska-Zubkiewicz, K. Wlodarczyk, M. Wrobel,
K. Kuliczkowski, G. Gosciniak (Wroclaw, PL)
The aim of this study was to test the utility of the detection of
Aspergillus GM and fungal DNA in blood samples from patients with
clinical signs of infection.
Methods: Within the period of 3 years 80 patients of the Department
of Haematology who were treated with conventional chemotherapy due
to leukaemia (40), lymphoma (7), multiple myeloma (8) or other
malignancies: CLL (17) MDS (8) were examined for the presence of
fungal biomarkers in the blood. The patients showed FUO or
abnormalities in respiratory tract and/or central nervous system
demonstrated in radiological examination. The laboratory
examinations included testing of Aspergillus galactomannan (GM) by
PlateliaTMAspergillus (BioRad, France) and investigation of fungal
DNA by previously described universal primers and Aspergillus- and
Candida- speciﬁc TaqMan probes (White et al., CID 2006; Khlif et al.
CMI 2009). DNA from EDTA-blood samples was extracted by
mechanical cell disruption and commercial test QIAmp DNA Mini
kit (Qiagen. The presence of PCR inhibitors was tested using the
TaqMan Exogenous IPC Reagents (Applied Biosystem).
Results: The multiple positive results of GM blood testing were
obtained in two patients with ALL, of them one was also positive for
Aspergillus DNA. Next three patients (two with ALL and one with MM
were positive in Aspergillus TaqMan, despite of negative GM results,
however clinical and radiological picture were in agreement with
positive TaqMan sample.
Candida DNA was detected in the blood from seven patients, no one of
them showed positive blood cultures, however in some patients
pneumonia was diagnosed based on clinical and radiological ﬁndings.
The patients were treated empirically with ketokonazol and voriconazol
with good outcome. The blood culture positive for fungi were found in
one patient with negative results of tested biomarkers. The causative
organism was identiﬁed biochemically and by sequencing of ribosomal
DNA as Trichosporon asahi. In the another patient (AML) the
mucormycosis was detected by the culture of Absidia corymbifera
from the respiratory tract. Applying the PCR with universal primers
followed by sequencing of PCR product enabled to detect the DNA of
this microorganism in patient’s blood sample.
Conclusion: Molecular examination of blood samples together with
molecular identiﬁcation of cultured microorganisms seems to be an
useful tool improving the diagnosis of IFI in haematological patients.
R2731 Candida blood infections in a 5-year period
M.P. Palacia´n, M.I. Cameo, C. Villuendas, A. Rojo, M.L. Marco,
A. Rezusta* (Zaragoza, ES)
Objective: Candida species are a common cause of nosocomial
bloodstream infections and are associated with a signiﬁcant morbidity
and mortality. The aim of this study is to determine the epidemiology of
candidemia in our hospital over a 5 years period.
Methods: Retrospective study of candids isolates from blood samples
of patients attended in the Hospital Universitario Miguel Servet from
2005 to 2010. Isolates were identiﬁed using chromogenic agar
(CHROMagar) and API 20C AUX (bioMe`rieux)
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Results: A total of 186 candidemia cases were identiﬁed among
28 480 patients with blood sample studied in this period. The
candidemia cases in adults were isolated in 94 patients in adults in
critical units care. 61.16% were male, age range 16–95 years old with a
mean age of 63 years old. Isolation was most frequent in patients
hospitalized in intensive care units (32.23%). The most frequent isolates
are shown on table 1. Forty-four cases were isolated in children in
critical care units under 14 years old (male 58.49%; age range: 1 day–
13 years old). The most frequently isolated species were C. albicans
(43.39%) and C. parapsilosis (28.30%) and Candida guilliermondii
(13.20%). The pair urine-blood culture was obtained in 15 adult
patients. In 10 (66.67%) cases, the urine and blood culture isolates
belonged to same specie and the Candida isolates from urine and blood
were different in ﬁve patients (33.33%).
Conclusion: Candida albicans remains the most common isolated
specie.
The critical unit pediatric had experiment an important decrease in the
candidemia in the last 3 years. Further studies are obliged to ﬁnd out the
predisponent factors of bacteremia.
R2732 Rare tropical fungi in Madagascar. When should we think
of them?
J.-F. Carod*, L. Ramarozatovo, M. San Lorenzo,
P. Grosjean (Antananarivo, Isoanala, MG; Monte´limar, FR)
Emergent, unknown, misdiagnosed may qualify two type of fungal
infection in Madagascar: sporotrichosis and chromoblastomycosis.
The aim for this topic is to summarize and illustrate the current
localization of both diseases with updated data, the clinical patterns of
the infection and the laboratory procedures to recover the pathogens;
therepeutic options are also noted. Sporotrichosis is a subcutaneous
disease due to Sporotriochosis schenkii, an environmental dimorphic
agent that typically causes lymphnode enlargement following a
lymphatic pathway, ulceration may occurs and can lead to secondary
bacterial infections. The disease is currently found in the Malagasy
highlands: with a fairly cold and dry weather and is directly related to
the injure of wood splinters or plant thorns. Treatment is based on
Potassium Iodine or Itraconazole. Pro and cons are listed.
Chromoblastomycosis occurs mainly in the dry and hot South-East of
Madagascar where deamacious fungi harboured by cactuses and dry
plants thorns are said to be responsible of this chronic subcutaneous
disease displaying many kind of clinical lesions (displayed). pathology
is the base of its diagnosis, fungi are hard to isolate thanks to the
overgrowth of other environmental moulds. Its treatment relies mostly
on terbinaﬁne, even though a combination of antifungal agents is
strongly advised.
Surgery may be used for limited lesions and relapses may occur due to a
default of patient compliance or treatment inefﬁciency.
R2733 Invasive pulmonary aspergillosis and zygomycosis in an
AIDS patient
P. Pacheco*, A. Ventura, T. Branco, C. Carvalho, L. Gonçalves,
C. Ferreira (Amadora, Lisbon, PT)
Introduction: Fungal Invasive ﬁlamentous lung infections are very
rare conditions in AIDS but must be considered in patients with
profound immune suppression.
Clinical Case: A 34-year-old female was admitted to our Unit in
January 2010 with Listeria monocytogenes meningitis. She had a
known history of AIDS and a plasmablastic lymphoma of the oral
cavity diagnosed 1 month before admission and was on antiretrovirals
and chemotherapy since then. She improved under antibiotic therapy
but after the third week in hospital, she developed persistent cough, low
grade fever, dyspneia and hypoxemia. The thoracic CT scan revealed
interstitial inﬁltrates and cavitation on the upper right lobe. A
bronchoﬁbroscopy revealed a grayish lesion on the wall of the main
right bronchus, macroscopically described as ‘‘caseous granulomas’’.
Microbiological examination of BAL was negative. Antituberculous
therapy was started without improvement. Histology of bronchial
mucosa revealed extensive necrosis with fungal hyphae suggestive of
Mucor. Another bronchoscopy was done and histology conﬁrmed
aspects of Mucor and CMV infection. The patient started liposomal
amphotericin B and valganciclovir for pulmonary mucormycosis and
CMV peumonia with clinical and radiological improvement. She
completed 3 weeks on amphotericin B and switched to posaconazole
due to hypokalaemia and to enable oral dosing. Despite a reduction of
the cavitation and improvement of lung inﬁltrates, it was considered
wiser to do a lobar lung resection that was performed on the 36th day of
antifungal therapy. Histology revealed a cavitation containing grayish
white material, with extensive necrosis and numerous hyphae
compatible with Aspergillus and Mucor. Oral posaconazole was
maintained for 2 months and she resumed treatment for lymphoma
with local radiotherapy. She remains without evidence of lymphoma or
fungal lung infection.
Discussion: The clinical presentation of fever and prolonged
respiratory symptoms with pulmonary cavitation suggested
tuberculosis. The endobronchial mucous material described as
‘‘caseous granulomas’’ was in fact endobronchial mucormycosis.
Surgical approach was essential, in spite of clinical improvement with
antifungal therapy. The concomitant ﬁnding of pulmonary aspergillosis
and zygomycosis in the surgical specimen conﬁrms the profound
delicateness of patients with severely compromised immune systems.
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R2734 Prevalence of QTc prolongation among HIV-infected
patients: a clinical prediction tool to determine high-risk
patients
N. Patel*, M. Veve, C. Miller (Albany, US)
Objectives: The objectives of this study were to (i) quantify prevalence
of QTc prolongation and (ii) determine the predictors of QTc
prolongation among HIV-infected patients.
Methods: A cross-sectional study was performed among HIV-infected
patients receiving care at the Albany Medical Center between Jan 2007
and Jul 2011. A random sample of these patients was selected for
screening. Inclusion criteria were: (i) age ‡18 years, (ii) documented
HIV-infection, and (iii) availability of at least one echocardiogram
(EKG) test in the patients’ medical record. Trained reviewers extracted
the following from the patients’ medical records: demographics, co-
morbid conditions associated with QTc-prolongation, EKG test results,
and medication histories. Normal QT interval was deﬁned as
£430 milliseconds among men and £450 milliseconds among women.
Results above these thresholds were considered abnormal. Logistic
regression was utilized to determine the variables independently
associated with QTc prolongation. Signiﬁcant variables in the logistic
regression analyses were used to determine the predicted probabilities
of the outcome.
Results: There were 138 patients that met inclusion criteria. The mean
(SD) QT interval was 420 (25.9) ms. Abnormal QT intervals were
observed in 38 (27.5%) patients. The distribution of concomitant
comorbidities differed signiﬁcantly between patients with abnormal and
normal QT intervals. The frequency of cardiac, hepatic and renal
comorbidities were higher among patients with abnormal QT intervals
compared to patients with normal QT intervals. Known medications
with a high risk of causing QT prolongation were more prevalent
among patients with an abnormal QT than patients with a normal QT
interval. In multivariate analyses, the only variable to be independently
associated with abnormal QT interval was the number of comorbidities
(OR = 2.9, 95% conﬁdence interval 1.81–4.66, p < 0.001). The
observed and predicted probabilities of abnormal QT, stratiﬁed by
number of comorbidities, are displayed in Table 1. Overall, there was
good concordance between observed and predicted probabilities and the
risk of abnormal QT interval increased monotonically.
Conclusion: This study included patients with an available EKG
readings and demonstrated a high prevalence of HIV-infected patients
with an abnormal QT interval. The number of comorbidities was the
only variable independently associated with an abnormal QT interval.
R2735 Quantifying the incidence and severity of acute renal
failure among HIV-infected adults receiving tenofovir-
based antiretroviral therapy
N. Patel*, V. Tizzano, E. Bruni, M. Veve, C. Miller (Albany, US)
Objectives: (i) Quantify incidence of acute renal failure (ARF), (ii)
Classify severity of ARF & (iii) Determine predictors of ARF.
Methods: A retrospective cohort study was performed among patients
receiving tenofovir (TDF) at the Albany Medical Center between Jan
2007 and Jul 2011. Inclusion criteria were: (i) age‡18 years, (ii) HIV-
infection, (iii) receipt of TDF for ‡1 month, and (iv) availability of
laboratory results to classify outcome status. Trained reviewers
extracted the following from the patients’ medical records:
demographics, co-morbid conditions associated with chronic kidney
disease (CKD), serum creatinine (SCr), CD4 count, HIVRNA, and
medication histories. Creatinine clearance (CLCR) was calculated using
the Cockroft-Gault method. ARF was deﬁned and classiﬁed using
criteria proposed by the Acute Dialysis Quality Initiative Group as
follows: Risk (SCr increase · 1.5 or CLCR decrease >25%), Injury
(SCr increase · 2 or CLCR decrease >50%) and Failure (SCr
increase · 3 or CLCR decrease >75%). Logistic regression was
utilized to determine the variables independently associated with each
ARF classiﬁcation.
Results: There were 298 patients that met inclusion criteria. There
were 173 (58.1%) males. The mean (SD) age at the start of TDF was
48.5 (9.0) years. The median (IQR) SCr and CLCR values were 0.9
(0.8–1.1) mg/dL and 95 (78–110) mL/minute, respectively.
Concomitant nephrotoxins were used in 71 (23.8%) patients. The
incidence of ARF was 22.8% during the study period. The number of
patients that satisﬁed the Risk, Injury and Failure classiﬁcation criteria
were 68 (22.8%), 21 (7.0%) and 12 (4.0%), respectively. In bivariate
analyses, variables associated with ARF-Risk were underlying CKD,
concomitant abacavir use, and duration of TDF. Variable associated
with ARF-Injury classiﬁcation are displayed in Table 1. There were no
variables signiﬁcantly associated with the Failure classiﬁcation. In
multivariate (MV) analyses assessing ARF-Risk as the outcome of
interest, underlying CKD was the only independent predictor variable
(OR = 3.93, 95% CI: 1.44–10.73, p = 0.008) after adjusting for
duration of TDF use. In MV analyses assessing ARF-Injury as the
outcome, independent predictor were CKD (OR = 4.38, 95% CI: 1.31–
14.62, p = 0.02) and hypertension (OR = 3.69, 95% CI: 1.34–10.13,
p = 0.01).
Conclusion: The incidence of ARF varies as a function of severity.
Underlying CKD and hypertension are important variables when
predicting severity of ARF.
R2736 QTc interval prolongation in HIV-infected patients: a
case-control study
P. Chinello, N. Petrosillo*, A. Di Stefano, S. Cicalini, L. Borgognoni,
E. Boumis, L. Tubani, A. Fiorentini (Rome, IT)
Objectives: QTc interval prolongation in HIV-infected patients has
been associated with several drugs, autonomic dysfunction, and HCV
coinfection. Since the duration of ventricular repolarization can change
during the day, we assessed QTc interval by a 24-hour ECG recording.
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Aim of the study was to evaluate the risk factors associated with QTc
prolongation and the indices of cardiovascular autonomic control.
Methods: Twenty-seven consecutive HIV+ patients (group I) with
known prolonged (>440 milliseconds) QTc interval as assessed by
standard ECG, and 54 HIV+ patients with normal QTc interval at
standard ECG (group II) matched 1:2 with group I individuals by
gender and age (±5 years) underwent 24-hour Holter ECG. A case-
control study was performed using as cases the patients of both group I
and II with prolonged QTc interval as assessed by Holter ECG (mean
QTc >440 milliseconds), and as controls (1:2) HIV+ subjects with
normal QTc interval as assessed by Holter ECG, matched by gender
and age. Autonomic nervous system function was evaluated by heart
rate variability (HRV) analysis during 24-hour ECG recording.
Results: Eighteen out of the 27 group I patients (67%) had QTc
interval prolongation conﬁrmed by Holter ECG. Fourty of the 54 group
II patients (74%) had a normal QTc interval at Holter ECG. Overall, 32
patients from both group I and II had a prolonged QTc interval (mean
475 ± 33 milliseconds) assessed by Holter ECG and were considered
cases. They were matched by gender and age (±5 years) with 64
controls exhibiting a normal QTc interval assessed by Holter ECG.
Duration of HIV disease was signiﬁcantly longer among cases than
among controls (10.9 ± 7.1 years vs. 7.8 ± 6.4 years; p = 0.04). Waist/
hip ratio was higher among cases than among controls (0.93 ± 0.07 vs.
0.90 ± 0.07; p = 0.05). Antiretroviral drugs were not associated with
QTc prolongation at a statistically signiﬁcant level. HRV analysis
showed the absence of physiologic decrease of low frequency (LF) in
the night period in both cases and controls. The LF night in cases
showed a statistically signiﬁcant reduction when compared with
controls (p = 0.007).
Conclusions: In our study group the QTc interval prolongation was
associated with a longer duration of HIV infection and with a greater
waist/hip ratio. HIV-infected patients with QTc interval prolongation
and with a longer duration of HIV infection were more likely to have an
impairment of parasympathetic and sympathetic cardiac component.
R2737 Assessment of factors inﬂuencing health-related quality of
life in HIV-infected patients: the era of co-morbidities
I. Katsarolis*, K. Protopapas, D. Kavatha, P. Panagopoulos,
G. Poulakou, A. Papadopoulos, A. Papadopoulos, D. Niakas,
G. Petrikkos, A. Antoniadou (Haidari, Patras, GR)
Objectives: To determine factors inﬂuencing health-related quality of
life (HRQL) in a cohort of HIV-infected pts.
Methods: This was a single-center cross-sectional study in pts
attending the outpatient clinic during a 3-month period in 2011.
Exclusion criteria were: age <18 years, seropositivity diagnosis <3 mos,
illiteracy, lack of print informed consent and acute disease. MOS-HIV
questionnaire was used. Treatment adherence was assessed with SMAQ
(Simpliﬁed Medication Adherence Questionnaire). Demographic,
clinical and laboratory data were retrieved from the medical records.
Co morbidities included dyslipidaemia, hypertension, diabetes mellitus,
COPD, hepatitis B/C, psychiatric illness. Logistic regression models
were used to identify HRQL determining factors.
Results: A total of 144 pts were enrolled (91% men, mean age
37.6 years, median time from seroconversion 5.5 years, actively on
HAART 86.8%, CD4 > 500 61.8%, undetectable viral load 81.9%).
Stage-distribution was: A-73.6%, B-15.3%, C-11.1%. Co morbidities
were recorded in 32.6% (4.2% psychiatric illness). Adherence rate was
63.2%, signiﬁcantly improved in non-experienced pts (p = 0.03) and
negatively associated with the number of pills daily (p = 0.05). MOS-
HIV domains did not differ by gender, stage, immunological status,
treatment status, antiretroviral regimen type and past regimens. Co
morbidities in total (and psychiatric illness in particular) were
negatively associated with most MOS-HIV domains (excluding social
functioning and health transition), as well as the Physical Health
Summary score (PHS) and the Mental Health Summary score (MHS).
PHS was also negatively associated with increasing age and
unemployment. Treatment adherence was signiﬁcantly associated
with better scores in cognitive function, pain, quality of life and MHS.
Conclusions: In a patient cohort with stable HIV disease, the existence
of co morbidities was a consistent and independent aggravating factor
for most HRQL domains. Reinforcing treatment adherence and dealing
effectively with coexisting chronic conditions (age or disease-related)
may help in improving HRQL in HIV pts.
R2738 Epstein-Barr virus–associated smooth-muscle tumours in
AIDS patients: the largest case series
R. Issarachaikul*, S. Shuangshoti, C. Suankratay (Bangkok, TH)
Objectives: Our previous report described the association of Epstein-
Barr virus (EBV) and smooth-muscle tumors (SMTs) in AIDS patients.
Most patients without immunological response had fatal outcomes
despite complete tumor removal. The present study was thus aimed to
determine the outcome of EBV-associated SMTs in higher number of
AIDS patients receiving highly active antiretroviral therapy (HAART)
with longer follow-up period.
Methods: Seventeen AIDS patients with SMTs were analyzed at King
Chulalongkorn Memorial Hospital, Thailand from 2001 to 2011. All
tissues were tested for SMTs and EBV by standard
immunohistochemistry and in situ hybridization, and blood samples
were assayed for EBV by real-time quantitative PCR.
Results: Of 17 study patients, there were 5 (29.4%) males and 12
females with the mean age of 34 + 9.2 years. Apart from two patients
with SMTs as the ﬁrst presentation, the median duration of diagnosis of
HIV infection before SMTs diagnosis was 4 years with interquartile
range (IQR) of 2–6.5 years. At the time of SMTs diagnosis, the median
CD4 count was 26 cells/lL with IQR of 9.75–154.5 cells/lL and four
patients had undetectable of HIV viral load. 8 (47.1%) patients had
received HAART. There were eight and nine patients with single and
multiple sites of tumor. The most common site was the cranial epidura
(10 patients, 58.8%), followed by spinal epidura (7, 41.2%), lung, liver,
vocal cord, abdominal wall, and adrenal gland (two patients each),
pleura, kidney, thigh, orbit, and iris (one patient each). Of nine patients
with multicentric SMTs, there were 3 (33.3%), 4 (44.5%), and 2
(22.2%) patients with central nervous system (CNS) only, CNS and
extra-CNS, and extra-CNS only. All patients had evidence of EBV
infection in the tumor, and two patients had detectable blood EBV viral
load. Seven (41.2%), 7 (41.2%), and 3 (17.6%) patients received
surgery, both surgery and radiotherapy, and neither surgery nor
radiotherapy. The median follow-up duration was 1 year with IQR of
0.5–5.5 years. Overall mortality rate was 41.2%; all seven patients with
detectable HIV viral load died. In contrast, all 10 patients with
undetectable HIV viral load and immunologic improvement survived
despite incomplete tumor removal in some patients.
Conclusion: The improvement of immune status by HAART, in
analogy with treatment of EBV-associated posttranplantation
lymphoproliferative disorder, will result in better outcome of EBV-
associated SMTs in patients with AIDS.
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R2739 Changes in the metabolic status and the liver function
tests in a cohort of newborns exposed in utero to
antiretroviral agents
R. Figueroa*, N. Plazola (Mexico City, MX)
Objective: To describe the metabolic characteristics and results of the
liver function tests of a cohort of neonates born to HIV positive
mothers, who were exposed in utero to different scheme of
antiretroviral agents (ARVs).
Methods: The study was conduced at the Instituto Nacional de
Perinatologı´a, Mexico, city, during the period of January 2008 to May
2011. This was a cohort study that evaluated the metabolic condition
and results of renal and liver function tests (LFT) at born in infants
exposed in utero to ARVs. A comparison was made of the results
observed in the neonates born to HIV positive mothers, who received
HIV treatment during their gestation, against the normal newborns data
described at the literature. The infants were included in different
comparison groups according to the following variables: (i) initiation of
ARV treatment in the mother before 20 weeks of gestation, (ii) if the
scheme included a protease inhibitor, (iii) if scheme included lopinavir-
ritonavir, and (iv) if the scheme contained tenofovir-emtricitabine.
Descriptive statistics were used, and the comparison between groups
was made by Student’s t test.
Results: The cohort consisted in 58 newborns. The average value of
the components of LFTs, and serum glucose, cholesterol and
triglycerides were statistically higher among newborns exposed to
ARV that the normal newborn data described at the literature. The
average value of serum urea and creatinine was similar to normal. No
signiﬁcant differences was observed in the laboratory results between
cases of newborns whose mothers received ARV scheme that included
a PI, lopinavir/ritonavir, tenofovir/emtricitabine or that the treatment
was started before the 20 SDG, with the exception of an increase
statistically signiﬁcant in the serum creatinine of newborns exposed in
utero to tenfovir/emtricitabine.
Conclusions: ARV treatment during pregnancy increases the values
of LFTs, glucose, cholesterol and triglycerides in the newborn.
Tenfovir/emtricitabine increase the newborn serum creatinine. It is
important to monitor laboratory parameters in newborns exposed in
utero to ARV.
Hepatitis
R2740 The correlation between baseline biochemical and
virological parameters with viral replication and liver
ﬁbrosis in patients with chronic hepatitis B infection
H. Leblebicioglu*, O. Aydogdu, S. Akhan, H. Tarakci, R. Guner,
N. Demirturk, M. Candan, H. Turgut, E. Sehmen, S. Kilic, E. Tutuncu,
D. Inan, A. Kaya, Z. Kuruuzum, M. Parlak, M. Geyik, S. Barut,
Z. Yulugkural, A. Gokal, S. Kinikli, I. Koksal, N. Beslen, T. Yamazhan,
O. Kokoglu, O. Dagli, S. Esen, M. Namiduru, F. Bostanci, C. Gul,
D. Midikli, F. Tabak, A. Akbulut, O. Ural, M. Akkus, Y. Onlen, S. Kaya,
F. Ozdener, S. Erdogan (Samsun, Kocaeli, Izmir, Ankara, Afyon,
Gaziantep, Denizli, Elazig, Antalya, Mersin, Erzurum, Duzce, Tokat,
Edirne, Giresun, Trabzon, Kayseri, Kahramanmaras, Kilis, Ordu,
Adana, Istanbul, Konya, Antakya, TR)
Objective: To evaluate the relation of biochemical liver function
parameters with pathologically diagnosed liver ﬁbrosis in treatment-
naı¨ve chronic hepatitis B (CHB) patients. Change in HBV-DNA,
HBsAg and HBeAg during the 12 months (mo) of antiviral treatment
were also evaluated.
Methods: This is a non-interventional, multicenter study was
conducted at 34 centers in Turkey in 289 patients with CHB (67.7%
males; mean (standard deviation; SD) age: 36.5 (10.7) years). After
baseline data collection, 143 (92.3%), 138 (89.0%) and 148 (95.5%)
patients were evaluated at the 3rd, 6th and 12th months (mo) of follow-
up.
Results: HBeAg positivity was identiﬁed in 25.5% of the patients at
the initiation, in 20.7% at the 3rd and 6th month and 19.0% at the 12th
month. Reduction in baseline HBeAg titers was determined in 47.1 and
in 62.5% of these patients at the 3rd and 6th month. Mean (SD) HBsAg
titers were 277.2 (77.0) IU/mL at baseline 305.2 (201.7) IU/mL at
3 months and 313.0 (193.6) IU/mL) at the 6th month. Mean (SD)
HBV-DNA (IU/mL) levels were signiﬁcantly higher in HBe (+)
patients compared to HBe (-) patients at baseline (7.7 (0.7) vs. 5.3
(5.1)), 3rd month (6.0 (2.2) vs. 2.9 (2.3)), 6th month (5.4 (4.6) vs. 2.4
(1.7)) and 12th month (4.1 (3.7) vs. 2.1 (1.7)) (p < 0.001 for each).
Baseline mean (SD) AST level was 61.2 (46.8) U/L, ALT 97.3 (79.6)
U/L, alpha-2 macroglobulin 265.5 (83.4) mg/dL, haptoglobulin 70.3
(39.6) mg/dL, apolipoprotein A1 145.8 (33.6) mg/dL, and Knodell
score 7.6 (4.5) in the overall population. There was no difference
between HBe (+) and HBe (-) patients in terms of baseline levels of
AST (59.8 (39.1) vs. 61.9 (49.7) U/L), ALT (101.0 (57.5) vs. 96.4
(86.8) U/L) and total Knodell score (7.1 (4.5) vs. 7.8 (4.5)). Baseline
HBsAg titer was negatively correlated with 3rd month (r=-0.265;
p < 0.001) and 6th month titers (r=-0.287; p < 0.001) of HBV-DNA.
No correlation between baseline AST and ALT levels and Knodell
scores was found. Baseline HBeAg titer was positively correlated with
baseline (r = 0.488; p < 0.001), 3rd month (r = 0.393; p < 0.001) and
6th month (r = 0.579; p < 0.001) HBV-DNA titers. Positive correlation
of ALT (r = 0.381 and r = 0.283) and AST (r = 0.334 and r = 0.267)
were determined with baseline and 3rd month HBV-DNA (p < 0.001
for each).
Conclusion: In conclusion, no direct relation between baseline
biochemical liver function test results with Knodell scores showing in
patients with CHB was detected. HBsAg and HBeAg titers were
signiﬁcantly related to HBV-DNA titers during the course of treatment.
R2741 A case of hepatitis B virus reactivation with a mutant
HBsAg virus in a renal dialysis unit: infection control and
public health implications
F.M. Awadel-Kariem*, S. Ijaz, S. Chandna, K. Farrington, C. Yates,
R. Hodges, P. Sheridan, R. Tedder (Stevenage, London, Letchworth,
UK)
Blood borne viruses (BBVs) are a recognised risk in renal dialysis units
(RDU). Hepatitis B virus is the most infectious of the BBVs. Patients
who are HBV uninfected are immunised against the virus prior to
commencing on haemodialysis. We report a case of a successfully
immunised patient whose low level HBV infection was missed who
then went on to reactivate her infection with a virus bearing HBsAg
mutants while undergoing dialysis.
Objectives: To report this unusual case of HBV in RDU and to propose
ways to prevent similar cases occurring in other RDUs.
Methods: Case history: A 71-year old Bangladeshi lady was admitted
with ESRF in February 2009 and commenced on dialysis in March
2009. Testing for HBV markers on March 2009 was negative for HBV
surface antigen (HBsAg). She received three doses of immunisation
between April to November 2009 and mounted a good antibody
response. A routine sample taken in January 2010 showed a BsAb titre
of 228 mIU/mL) but also a total anti-core (Anti-Core Ab) positive
signal considered at the time to be of doubtful signiﬁcance. The patient
continued haemodialysis and samples taken on 3 monthly bases
continued to be negative for HBsAg with ‘‘protective’’ HBsAb levels.
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However, routine testing in July 2011 was positive for both HBsAg &
Anti-Core Ab with undetectable levels of HBsAb. This remarkable
change in the immune status of the patient (from immune to highly
infectious) triggered an immediate investigation and the implementation
of strict infection control measures.
Results: HBV DNA was detectable at 240 IU/mL in the January 2010
sample when low level anti-HBc was ﬁrst detected. By the time routine
testing ﬁrst detected HBsAg, HBV DNA levels had increased to
>108 IU/mL. The virus was shown to be genotype D with mutation
analysis indicating the presence of multiple amino acid substitutions in
the a determinant. Additional phenotyping analysis conﬁrmed the
deletion of HBsAg antigenicity. The patient to date remains HBsAg,
HBeAg and HBV DNA positive. Comprehensive testing over a period
of 2 months found no further cases.
Conclusion: This unusual case emphasised the need for more frequent
testing of dialysis patients (4 weekly rather than 3 monthly). The
implementation of strict infection control measures ensured no further
transmission. The role of immunisation in selecting HBsAg mutants in
this patient’s virus remains speculative but individuals with positive
anti-core Ab should be reviewed carefully before immunisation.
R2742 Seroprevalence of hepatitis E virus infection among HIV-
infected men who have sex with men in Taiwan
T. Yang*, Y. Su, W. Liu, C. Lu, C. Wu, M. Huang, B. Wu, C. Hsieh,
P. Wu, C. Hung, S. Chang, N. Xia, P. Chen (Taipei, Hsin-Chu, TW;
Xiamen, CN)
Objectives: Men who have sex with men (MSM) are at increased risk
for infections with viruses that are transmitted through fecal-oral route,
such as hepatitis A and hepatitis E virus (HEV). In this study, we aimed
to investigate the seroprevalence of HEV infection among human
immunodeﬁciency virus type 1 (HIV-1)-infected MSM who sought
HIV care at a major university hospital in Taiwan.
Methods: Between 1 April 2011 and 30 September, 2011, blood
samples were collected from HIV-infected MSM. A standardized
computerized data record form was used to collect information on
demographics, and clinical, virologic and immunologic characteristics
of the subjects. Antibodies against HEV, HEV-speciﬁc IgG and IgM,
were determined with the use of commercial kits by following the
instructions of the manufacturer (Beijing Wantai Biological Pharmacy,
Beijing, China).
Results: During the 6-month study period, 1260 HIV-infected MSM
were enrolled, and 969 (76.1%) were receiving combination
antiretroviral therapy. The median CD4 lymphocyte counts and
plasma HIV RNA load for the study subjects were 478 cells per
cubic millimeter (range, 0–2862) and 3.75 log10 copies/mL (range,
1.60–6.99), respectively. Overall, 83 subjects (6.6%) were seropositive
for HEV-speciﬁc IgG and 5 (0.4%) tested positive for HEV-speciﬁc
IgM. When the patients were stratiﬁed according to the age group, an
increasing trend of seropositivity for HEV-speciﬁc IgG was observed,
from 1.6% (5/307) in subjects aged between 20 and 29 years, to 25.5%
(27/106) in those aged 50 years or greater. Compared with the subjects
who were seronegative for HEV-speciﬁc IgG, subjects who were
seropositive for HEV-speciﬁc IgG were older (median, 35 vs. 44 years),
had a lower median CD4 count (483 vs. 421 cells per cubic millimeter),
and lower plasma HIV RNA load (3.88 vs. 2.88 log10 copies/mL) in
univariate analysis. In multiple logistic regression, age (per 1-year
increase) and CD4 (per 1-cell per cubic millimeter increase) were
independently associated with seropositivity for HEV-speciﬁc IgG,
with odds ratio of 1.086 (95% conﬁdence interval [CI], 1.063–1.111)
and 0.999 (95% CI, 0.998–1.0), respectively.
Conclusions: We concluded that the HEV seroprevalence of HIV-
infected MSM in Taiwan was estimated 6.6%, which increased with
age.
R2743 Hepatitis B virus infection in Chinese population living in
Barcelona, Spain
E. Dopico*, I. Ubillos, E. Grenzner, L. Guerrero, R. Navarro,
A. Casanova (Barcelona, ES)
Objective: To understand the main characteristics of hepatitis B virus
infection in the Chinese population living in Baix Llobregat area
(Barcelona).
Material and Methods: A retrospective study was performed among
Chinese patients consulting in Primary Care centre from January 2008
to June 2011 and tested at the Clinical Laboratory of l’Hospitalet
(Catalan Institute of Health). The Hepatitis B virus (HBV) infection was
screened analysing the Hepatitis B surface antigen (HBsAg) and
subsequently the hepatitis B e antigen (HBeAg) and HBV-DNA PCR
was performed. We assayed HBsAg, HBeAg, anti-HBe and HB anti-
core (anti-HBc) by chemiluminescent immunoassay (Vitros
Johnson&Johnson) and the Hepatitis B DNA viral load was
quantiﬁed by Abbott Real Time HBV DNA Assay. The immune
tolerant phase was deﬁned by HBeAg presence, HBV-DNA >106 UI/
mL and normal ALT levels (<40 UI/mL), the immune reactive phase
was determinated by HBeAg positive or negative with abnormal levels
of ALT and the non replicative or low replicative phase by HBeAg
negative and normal ALT levels.
Results: A total of 68 patients tested positive to HBsAg and were
included in this study, the median age was 35 years and 42.6% (29)
were women. HBeAg was positive in 30 (44.1%) patients and negative
in 38 (55.9%). Of the total, eight (11.8%) were considered to be in the
immune tolerance phase, 24 (35.3%) were deﬁned as immune reactive
patients and ﬁnally, 28 (41.2%) patients were included in non
replicative or low replicative phase. Amongst the immune tolerance
phase, six patients were women in childbearing age. Five (7.3%)
patients from the total, were anti-HBc negative and presented DNA
viral loads >106 UI/mL, reﬂecting extreme immune tolerance.
Conclusions: Chinese population living in Barcelona presents chronic
HBV infection with similar characteristics to the country of origin.
Some of them had an elevated replicative activity and therefore a high
HBV-DNA viral load which is associated to high risk of sexual and
perinatal transmission. Additionally, we found an atypical serological
pattern with absence of anti-HBc and high levels of HBV-DNA in
serum that might be associated to congenital infection.
R2744 Evaluation of the determination of the core antigen of the
hepatitis C virus as a direct scoreboard for diagnosis of
the infection
M.D. Ocete*, N. Tormo, M.T. Fraile, M.R. Guna, D. Navalpotro,
R. Medina, A. de Miguel, C. Gimeno (Valencia, ES)
Introduction: The diagnosis of infection by the virus of the hepatitis C
(VHC) is based on the direct detection of antibodies (AB) against VHC
(AcVHC) and on nucleic acid detection tests (NAT). A positive low or
indeterminate result in the AcVHC’s detection screening tests needs to
be conﬁrmed, which can be performed by means of immunoblot (BB)
and / or viral replication tests. The AB’s conﬁrmation tests are poorly
sensitive, costly in time and money and provide scarce information
about the diagnostic value. The NAT tests are expensive and need more
technology than the serologic tests. The majority of the studies done up
to the moment have correlated the levels of Ag VHC with ARN-VHC’s
quantiﬁcation, showing top levels of correlation to 0.75. The cost for
determination of Ag VHC is four times lower than that of the ARN-
VHC and two than that of BB.
Objective: To evaluate the determination of the AgVHC as a direct
marker of infection in patients with AcVHC’s results £3 times the
cutoff of the test, which supposes about the 20% of the total of reactive
samples analyzed for AcVHC screening.
Material and Methods: The VHC Ag quantiﬁcation carried out in 33
samples of serum and plasma by means of chemiluminescent
immunoassay using the ARCHITECTi2000 autoanalyzer (Abbott
Hepatitis 825
Diagnostic), sent to the Laboratory for VHC infection screening. The
selected samples had an AcVHC with S/CO’s result £3. A conﬁrmation
test was performed on all the samples using the BB (Chiron RIBA HCV
3.0 Strip Immunoblot Assay) and the determination of VHC’s viral load
(CV-VHC) in the system COBAS Taqman (Roche Diagnostic).
Results: Of the 33 samples analyzed with a positive serology, negative
or indeterminate AcVHC, the result of the BB was negative in six of
them, indeterminate in 21 and positive in 6. Whereas the result of the
AgVHC was negative (<0.04 pg/mL) in 31 of the samples and in two
positive (>0.13 pg/mL). All the samples with negative VHC Ag, the
VHC viral load was <15 copias/mL. In two samples with values of
positive AgVHC the viral load was positive.
Conclusions: Ag’s determination VHC might be considered a direct
serological marker, easy to perform, with a short time of response and
costs-safe, to evaluate the replication activity of the VHC and based in
our results, it would allow us to classify the patients with AB levels of
VHC with cutoff values £3 and negative VHC Antigen as not
infectious.
R2745 Presence of the Toll-like receptor 8 A1G polymorphism
affects the severity of liver histopathological hhanges in
males with chronic HCV infection
D. Oh*, A. Storek, E. Schott, L. Hamann, M. Eisenblaetter,
K. Neumann, R. Ignatius, R. Schumann, T. Berg (Berlin, Leipzig, DE)
Background/Objectives: Toll-like Receptor 7 and 8 (TLR7 and
TLR8) are key mediators of the innate immune response to RNA
viral infections. The clinical impact of genetic TLR7/8 variation,
however, is not well studied yet. We have previously shown that
polymorphisms of the TLR7 gene inﬂuence the development of ﬁbrosis
and the therapy response in patients with chronic hepatitis C virus
(HCV) infection. This study tests the hypothesis that the course of
chronic hepatitis C is also affected by genetic variation of TLR8.
Methods: Nine hundred and eighty-six patients with chronic HCV
infection and 809 HCV negative controls were genotyped for the
TLR8A1G polymorphism. The association with the persistence of HCV
infection and with the histological severity of chronic infection was
analyzed. In addition, TLR8 speciﬁc stimulation of monocyte-derived
dendritic cells (DCs) differing in their TLR8A1G genotype was
performed for ex vivo functional analysis.
Results: The TLR8 A1G polymorphism was signiﬁcantly related to
higher stage liver ﬁbrosis (p = 0.009) and inﬂammation (p = 0.004) in
male but not female patients (table 1). Cytokine proﬁles of cells derived
from hemizygous TLR8 mutation carriers equalled those observed of
cells from wildtype hemizygotes.
Conclusion: This analysis suggests that the TLR8A1G polymorphism
predisposes male patients to higher-grade hepatic inﬂammation and
ﬁbrosis. Since this polymorphism is also relevant for the course of HIV
infection and pulmonary tuberculosis, further analysis of its functional
impact is of major interest.
R2746 The ‘‘protective’’ role of high-dose intravenous
immunoglobulin therapy in two patients with pemphigus
vulgaris in clinical remission affected by hepatitis C virus-
chronic liver disease
S. Leuci*, F. Minervini, M. Mignogna (Naples, IT)
Objectives: Pemphigus vulgaris (PV) is an autoimmune blistering
disease rarely associated with hepatitis C virus (HCV). Among the most
common side effects (asthenia, fatigue, anorexia, bone marrow
suppression), the antiviral therapy include the unmasking or
exacerbation of autoimmune disease. This report was performed to
investigate the favorable outcome of two PV-patients in clinical
remission with chronic liver disease associated with HCV treated with a
combined protocol of pegylated interferon alfa-2a (PEG-IFN alfa-2a)
plus ribavirin (RBV) and high-dose intravenous immunoglobulins
(IVIg). Methods: Patients had a similar history of severe and recalcitrant
mucocutaneous PV with excellent outcome to previous IVIg therapy at
2 g/kg/cycle. To be recruited, patients were both in complete clinical
and partial immune-serological remission. One patient was genotype
1b-related and one patient 2a; both with HCV-RNA PCR positive. The
routine blood tests and the thyroid function were determined before,
during and post-treatment. The combined protocol with PEG-IFN alfa-2
plus RBV and IVIg was as follows: one dose of IVIg at 3gr/kg/cycle
divided in three consecutive days 30 days before the ﬁrst dose of PEG-
IFN (1.5 mg/kg) plus RBV (400 mg twice a day) and performed one
time a month for 12 months. The PEG-IFN and RBV were
administered totally for 12 months, 1 time/week and daily respectively.
Results: Patients presented a clinical remission during the antiviral
therapy with no bullous lesions on skin and mucosal sites and no
serological PV antibodies. At the third month after the beginning of the
antiviral therapy, patients were negative on HCV-RNA PCR and these
data were substained until the end of the protocol. During the therapy
we did not observe any major side effects, while asthenia and weight
loss were reported for both patients.
Conclusion: Despite the immunomodulation of PEG-IFN, patients
obtained a sustained clinical remission of PV without any ﬂare during
the follow-up period (18 months). We suggest a protective role of the
IVIg therapy administered at 3 g/kg when a PV patient with an active
chronic liver disease undergoes an antiviral therapy. We believe that the
natural history of the two diseases is not been modiﬁed when they are
present simultaneously in terms of clinical outcomes and prognosis.
Further researches on a large number of patients are needed and the role
of HCV virus in the autoimmune blistering diseases needs to be
clariﬁed.
R2747 Materno-foetal transmision of B viral hepatitis in
Constanta
C. Cambrea*, E. Dumea, S. Halichidis, D. Carp (Constanta, RO)
Aim: To evaluate transmission of B hepatitis virus from mother to
child in Constanta County during a period of 30 months (January
2009–June 2011).
Methods: Retrospective and prospective study on a group of 35
HbsAg positive pregnant women and their babies.
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Results: Age of patients ranged from 1 to 38 years, average
25.07 years, eight women were HbeAg positive. Alaninamino-
transferases (ALT) in 14 patients were within normal limits, the
maximum value 3.5 · normal. HBV-DNA viremia was performed
(method TaqMan) during pregnancy in 19 patients, with average
49000 IU/mL (limits: 28–23 500 000 IU/mL). 18 of the women had C-
section and 20 didn’t brestfeed. Five women were coinfected HBV and
HIV. Fourteen children had speciﬁc prophylaxis with immunoglobulin
anti hepatitis B in doses of 30–50 IU/bw, and vaccination with
EngerixB was performed in all infants (schedule 0-2-6 months of age).
Two infants were found HbsAg positive; they were born from mothers
with high viral load (over 100 000 IU/mL), one from a HbeAg positive
mother. All children borne from mothers with HIV and HBV
coinfection present anti HBs after 1 year of age.
Conclusion: Rate of transmission for B virus was low (8.57%) in our
group of patients. Careful monitoring of pregnant women limitted
materno –fetal transmission of B virus infection. We do not register
transmission of HBV or HIV in coinfected mothers to their children.
Virology non-HIV/non-hepatitis
R2748 Detection of Norovirus acute gastroenteritis in two
hospitals in Soﬁa, Bulgaria
A. Stoyanova*, A. Dikova, Z. Mladenova (Soﬁa, BG)
Objectives: Noroviruses are considered as a global leading cause of
non-bacterial gastroenteritis outbreaks, as well as being an important
cause of sporadic cases. The aim of the prospective study was to
evaluate the contribution of noroviruses to morbidity of sporadic acute
gastroenteritis among children <10 years of age admitted for treatment
in two infectious wards in Soﬁa, Bulgaria.
Methods: For 2-years period (2010–2011), a total of 280 stool samples
were collected from children aged 45 days–10 years. All the patients
were suffering from 2 to 10 episodes of vomiting and/or watery
diarrhoea. The samples were screened for bacterial pathogens and
rotavirus group A by standard bacterial methods and rotavirus antigen
ELISA. Only rotavirus-negative samples were taken for norovirus
detection through RT-PCR using primers toward norovirus polymerase
region (JV12Y-JV13I, NI+E3). Amplicons of norovirus genogroup I
and II capside region were obtained using primers G1SKF+R/
G2SKF+R, and norovirus strain characterization was performed
through sequence and phylogenetic analysis.
Results: Results revealed that all stool samples were negative for
bacterial agents, and noroviruses were found in 48 (17.1%) of the
samples tested. Thirty (62.4%) isolates were successfully ampliﬁed
using G2SKF+R primer set and three (6.3%) using primers G1SKF+R
toward noroviruses genogroup I, and 15 norovirus isolates (31.3%)
could not ampliﬁed with the genotype-speciﬁc primers used. Sequence
analysis of 23 norovirus isolates showed that norovirus GII.4 was the
cause of most acute gastroenteritis cases, and norovirus GII.4/2006 and
GII.4/2010 variants were the pre-dominant.
Conclusion: Norovirus-related gastroenteritis is responsible for a
signiﬁcant morbidity in Bulgaria. Implementation of routine norovirus
testing among hospitalized patients of different age groups will help
health authorities to estimate the real burden of norovirus
gastroenteritis. In addition, it can complement the routine rotavirus
surveillance system helping the epidemiology authorities to take
preventive measures for control of norovirus spread.
R2749 Evaluation of 3151 cases applied to rabies vaccination
centre, Istanbul
B. Dede, A. Kadanali*, G. Karagoz, M. Bektasoglu,
A.B. Fetvaci (Istanbul, TR)
Objectives: Rabies is aviral disease that produced almost uniformly
fatal encephalitis in human and most other mammals. Every year, more
than 15 million people worldwide receive a post-exposure preventive
regimen to avert the disease. In this study, we aim to emphasize that
rabies risk-contact cases are important public healthproblems for our
region and importance of effective, accurate prophylaxies.
Methods: In this study; 3151 cases applied to rabies vaccination center
of Umraniye Training and Research Hospital between January 2009 and
July 2011 were evaluated.
Results: A total of 2242 (71%) cases were male, while 909 (29%) were
female with an average age of 26.6 years. It was determined that 63.6%
of the cases were bitten by dogs, 28% scratch by cats. The sites of injury
were head-neck in 173 cases (%5.5), body in 189 cases (%6) cases, foot
in 267 cases (8.5), arm in 315 cases (%10), leg in 773 cases (%24.5) and
hand in 1434 cases (%45.5) cases. Three doses of protective vaccines
were administered to 1470 (%46.7) of the cases and ﬁve doses to1516
(%48.1) of the cases. Additionally, 31 of the cases were treated with
rabies immune globulin. Only wound care was performed in 91 cases.
No rabies infections developed in any of the cases included into the
vaccination program. Due to high mortality rate is almost %100
prophylactic measured are of utmost importance in rabies.
Conclusion: In conclusion, public education programmes and stray-
animals control programmes are important to prevent rabies in our
country and they might have an impact on unnecessary treatment costs.
Mycobacterial infections (including
diagnosis)
R2750 Molecular detection of isoniazid and rifampicin-resistant
Mycobacterium tuberculosis
A.M. Hefnawy, S.M. Ahmed*, H.A. Okasha (Alexandria, EG)
Background: Presently, tuberculosis (TB) reemergence and spread are
of worldwide concern. The situation is aggravated by the increasing
circulation of multidrug resistant (MDR) Mycobacterium tuberculosis
strains that are deﬁned as resistant to at least rifampicin (RIF) and
isoniazid (INH), which comprise the back-bone of antitubercular
chemotherapy.
Objectives: The aim of the present study was to test a simple and rapid
PCR assay for detecting INH and RIF resistance in M. tuberculosis
clinical isolates.
Methods: In this study, Twenty-ﬁve strains of M. tuberculosis were
tested for their susceptibility to two antituberculous drugs (isoniazid and
rifampicin) by proportion method and PCR. The strains were tested by
PCR procedures for mutation detection. Multiplex PCR (MPCR) was
used to detect mutation in codon 315 of katG gene denoting INH
resistance. Ampliﬁcation Refractory Mutation System (ARMS PCR)
was used to detect mutation in codons 516, 531 and 526 of rpoB gene
denoting RIF resistance.
Results: Susceptibility results for the 25 tested strains by proportion
method, detected 7 (28%) strains resistant to INH. While for RIF 5
(20%) were found to be resistant. While out of the seven strains found
to be INH resistant by the proportion method, of these, six strains were
resistant by both the proportion method and by MPCR. Similarly, out of
ﬁve strains found to be resistant to RIF by the proportion method, four
were found to be resistant by ARMS. The sensitivity of the PCR
compared to the proportion dilution method in testing susceptibility to
INH was 85.71%, the speciﬁcity of the PCR was 100%. Reﬂecting a
very good agreement of the PCR with the proportion method for INH
susceptibility testing. The sensitivity of the PCR compared to the
proportion dilution method in testing susceptibility to RIF was 80%, the
speciﬁcity of the PCR was 100%. Reﬂecting a very good agreement of
the PCR with the proportion method for RIF susceptibility testing.
Conculsion: The molecular method tested in the present study cannot
completely substitute the proportion method for detecting INH and RIF
sensitivity. Yet the described procedure may be used to detect a
considerable proportion of INH and RIF resistant isolates, as it is rapid,
easy to perform and interpret and its implementation would be useful
for timely delivery of adequate antituberculous therapy.
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R2751 Aetiological diagnostics of tuberculous spondylitis in HIV-
positive and HIV-negative patients
N. Solovieva, E. Reshetneva, V. Zhuravlev*, G. Vasilieva,
A. Vishnevskiy, B. Vishnevskiy, P. Yablonskiy (St.Petersburg, RU)
Purpose: Veriﬁcation of tuberculous spondylitis (TS) diagnosis by
bacteriological (B) and molecular-genetic methods (MG) in patients
with HIV-infection and without it.
Methods: Purulence, granulations, caseous masses, bone and disk
fragments were simultaneously analyzed using (MG) methods and (B)
method by inoculation in Levenstein-Jensen (LJ) liquid culture medium
(CM) (BACTEC MGIT 960) with determination of drug resistant (DR)
of mycobacterium tuberculosis (MBT) using absolute concentration
method. The material analyzed was carefully regrind and subjected to
triple washing in order to eliminate erythrocytes to prevent growth
inhibition in BACTEC system. Isolation of DNA and ampliﬁcation of
nucleotide sequence IS6110 – marker of MBT was carried out using
test systems manufactured by ‘‘DNA-Technologia’’ (Russia) by real
time PCR method (RT-PCR) using analyzer iCyclerQ, Bio-Rad (USA).
Accelerated evaluation of MBT DR in surgical material was carried out
using ‘‘TB-BIOCHIP’’ (TBch) system. This method helps identify
IS6110 sequence in the sample and simultaneously identify mutations
associated with DR in rpoB genes in rifampicin-(R)-resistant strains,
katG, inhA and interregulatory area of ahpC-oxyR genes in isoniazid-
(H)- resistant strains.
Results: First group included 26 HIV-infected patients. MBT was
isolated by the way (B) in 15 cases of 26 (57.5%), (MG) method – 20 of
23 (86.0%). Nine MBT cultures had multidrug-resistant (MDR-TB), 1 –
extensively drug resistant (XDR-TB) that in total has made 66.0%.
Second group – 155 HIV-negative patients operated for TS. Among
155 samples – 51 were isolated by (B) and MBT was identiﬁed, that has
made 32.9%, (MG) methods were used to receive DNA MBT – 92
positive tests (59.3%). Twenty-four cultures had MDR, 2 – XDR that in
total has made 50.0%. DR to H was presented by gene katG mutations
in codon 315 (50.0%). DR to R was determined by gene rpoB
mutations in codons 531 (44%), 526, 516. Comparison of the results of
DR determination by microbiological methods and using (TBch)
technology has shown 100.0% conformity of the results.
Conclusion: Isolation of MBT in HIV-infected patients, operated for
TS, using (B) methods (57.5%) is higher than in patients without HIV-
infection (32.9%) (X2 = 4884; Er = 0.027). The result was conﬁrmed
by (MG) methods: ﬁrst group – 86%, second group – 59.3%
(X2 = 5411; Er = 0.02). There were no DR differences, but in both
groups DR degree was high which is adverse prognostic factor.
R2752 Comparison of Helicobacter pylori diagnosis techniques:
Moroccan prospective study
S. Alaoui*, A. Amarti, M. Mahmoud, K. El Ghazi, C. Nejjari,
D. Benajah, M. Lahbabi, M. El Abkari, A. Ibrahimi, A. Souleimani,
B. Bennani (Fe`s, MA)
Objective: The aim of our study is to compare rapid urease test (RUT),
histology and PCR in Helicobacter pylori (H. pylori) diagnosis.
Methods: A prospective and randomized study has been conducted in
the gastroenterology department of University Hospital Hassan II of Fez
from May 2009 to July 2011. Consenting patients with abdominal pain
or gastric discomfort and undergoing endoscopy has been enrolled in
the study. For each patient, four biopsies (three antrum and one corpus)
were collected and used for H. pylori detection by rapid urease test,
PCR and histological examination (1antrum and one corpus). The
comparison of different techniques was done using SPSS.
Results: During the 26 months of this study, 486 patients have been
recruited. The mean age of the participants was 49 years (16–90 years).
The prevalence of H. pylori varies according to the diagnosis technique
with rates of 50%, 68.5% and 65% using RUT, Histology and PCR
respectively. The concordance between pairwise techniques has been
determined using Kappa coefﬁcient. This coefﬁcient show that the
result obtained with RUT was more concordant with those obtained
with PCR (0.362) than with histology (0.252). Then, PCR and histology
gives the best rate of complementarities (87.4%). Among biopsies
classiﬁed as positive by PCR, sensitivity of histology and RUT were
71.01% and 63.92% respectively.
Conclusion: PCR and Histology may be used as complementary
techniques in H. pylori detection and therefore in better therapeutic
management. Effectively, the PCR was more speciﬁc than histology
however histological examination still essential to detect gastric lesions
and to conﬁrm gastric cancer diagnosis.
R2753 Optimisation of sputum microscopy with use of Naoh/
centrifugation method for the diagnosis of tuberculous
and non-tuberculous mycobacterial pulmonary infections
J. Couto, J. Barelli, E. Picoli, P.C. Panunto, M. de Carvalho
Ramos* (Campinas, BR)
Objectives: Descriptive study of a collection of Acid-Fast Bacilli
(AFB) smears optimized by the NaOH/centrifugation method, and
isolation of Mycobacteria.
Methods: Direct examination and concentration of sputum or
respiratory secretions with NaOH/centrifugation and direct
visualization by Ziehl-Neelsen method in specimens sent to the
mycobacterial laboratory from 2006 through 2010. Cultures were
done with the use of MGIT 960. Isolates grown in liquid cultures were
identiﬁed to the complex, and to the species levels with a modiﬁed
IS6110/hsp65 multiplexPCR and PRA-PCR.
Results: During the study period 12 473 clinical respiratory specimens
were examined. AFB smears performed in the non-concentrated
materials yielded 487 positive tests. An additional 127 cases were
found after concentration of the material. 5.25% of the samples showed
a positive AFB smear. When compared to culture as the gold standard,
the sensitivity for non-concentrated material was 33%, and 39% for the
concentrated material. Positive predictive ratio was 74%, and 69% for
the non-concentrated, and concentrated materials. 87% of Mycobacteria
grown were identiﬁed as M. tuberculosis. When grown from positive-
only AFBs made with concentrated materials, isolates had a higher
chance of belonging to the Non-tuberculous mycobacteria group.
Another 662 isolates were grown from materials that had
simultaneously AFB negative smears made from non-concentrated
and concentrated materials.
Discussion: AFB smear is a mainstay for the diagnosis of respiratory
mycobaterial infections. Concentration of respiratory materials can add
new cases of both MTC, and NTM infections. The low sensitivity of
non-concentrated and concentrated AFB smears observed strongly
indicates that mycobacterium culture plays an essential role in the
diagnosis of tuberculosis. Semi-automated liquid cultivation techniques
have improved the recovery of mycobacterium not detected by AFB
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smears in paucibacillary materials. Concentration of sputum or
respiratory secretion, and universal mycobacterium cultures have to
be mandatory in order to diminish the burden of tuberculosis among
affected countries. There is a signiﬁcant higher chance of growing non-
tuberculous mycobacteria from only positive AFBs from concentrated
respiratory secretions. Fast and simple identiﬁcation techniques must be
done in all mycobacterial laboratories to distinguish M. tuberculosis
complex isolates from Non-tuberculous mycobacteria.
R2754 The genetic diversity of Mycobacterium tuberculosis
complex in Azerbaijan by 24 MIRU-VNTR loci
genotyping in association with susceptibility testing by
conventional and molecular methods
L. Gkaravela*, A. Foka, M. Athanassiou, N. Lazarou, F. Kontos,
V. Mollaki, R. Abuzarov, L. Ibragimkhalilov, I. Akhundova,
E. Mammadbaynov, L. Zerba, I. Spiliopoulou (Rion, Kavala, Athens,
GR; Baku, Sheki, AZ)
Objective: Tuberculosis (TB) is still a serious public health problem in
Azerbaijan. According to the most recent World Health Organization
(WHO) global TB drug resistance surveillance report, high multidrug-
resistant (MDR) TB rate was recorded in Baku. The spread of the
disease is also complicated by the emergence of hyper virulent strains
from the Beijing/W lineage. We report an epidemiological surveillance
study performed in the region of Sheki in Azerbaijan under a program
supported by the Hellenic Ministry of Foreign Affairs.
Methods: Sixty-two Mycobacterium tuberculosis complex (MTB)
clinical isolates were isolated from 182 patients during 7 months (9/
3/10–17/10/10). Ziehl-Neelsen (ZN) staining was performed in all
sputum samples, inoculation onto Lo¨wenstein-Jensen slants (LJ,
bioMe´rieux) and into Bactec/9000 MB culture vials (Becton
Dickinson) was carried out. Susceptibility testing was performed by
phenotypic and genotypic methods (MGIT, Becton Dickinson and
GenoType MTBDRplus/GenoType MTBsl, Hain, respectively).
Molecular typing was based on 24 loci including variable numbers of
tandem repeats of mycobacterial interspersed repetitive units (MIRU-
VNTR).
Results: Phenotypic susceptibility testing of 62 MTB showed that 14
were XDR, 24 MDR and among the remaining, 15 were sensitive to
isoniazid, 23 to rifampicin, 22 to ethambutol and 12 to streptomycin.
The molecular method showed that all XDRs were isoniazid/rifampicin/
aminoglycosides/ﬂuoroquinolones-resistant and 13/14 additionally
ethambutol-resistant, while MDRs carried at least one mutation in
inhA/katG and rpoB genes. Among the 15 phenotypicaly isoniazid-
sensitive isolates, 10 carried the wild types and one mutation either in
katG or in inhA genes, while 16 out of 23 rifampicin-susceptible
isolates carried one mutation of the rpoB gene and two were identiﬁed
as resistant. The 24 loci internationally-agreed MIRU-VNTR typing
scheme classiﬁed the 62 isolates into four clusters: 52 strains belonged
to Beijing family, four to LAM (Latin-American and Mediterranean),
four to H37RV and two to Harlem lineages.
Conclusions: The MDR-MTB clinical isolates belonged to two
lineages LAM and H37RV, while all the XDR-MTB clinical isolates
to the Beijing family. Drug resistance among tuberculosis patients in the
region of Sheki in Azerbaijan, could be associated with the spread of
Beijing family strains.
R2755 A ﬁne line between a major surgery and oral drug
therapy: the diagnosis of sternal tuberculosis
A. Yesilkaya*, O. Kurt Azap, D. Kilic, H. Arslan, H. Uner (Ankara, TR)
Case: A 53-year-old man presented with a 1-month history of chest
pain and two distinct palpable masses on his lower sternal part of chest.
He was a teacher and was living in a village. He denied cough, night
sweating, loss of appetite, loss of weight, fever and any trauma. He had
a history of pulmonary tuberculosis which occured 36 years ago.
Previously when he had admitted with those complaints to a local
hospital, ultrasound revealed 4 · 2 cm hypoechoic septated abscess
formation localised near to the left of distal sternum and non-contrast
enhanced computed tomography of thorax demonstrated a 6.7 · 4.2 cm
lobulated soft tissue mass eroding the sternum (Figure 1). Ultrasound-
guided ﬁne needle aspiration yielded no microorganism and the
cytology revealed polymorphonuclear leucocytes. When he was
admitted to our hospital for an extensive surgery fort he removal of
the mass, a pus drainage from the needle insertion area was seen on
examination. The remaining systemic examination was normal.
Anteroposterior chest radiograph showed no abnormalities with the
lung parenchyma and bone structures. Sternal tuberculosis was
suspected of ﬁrst priority in differential diagnosis. Local debridement
of infected tissue and punch biopsies from sternum was done under
local anesthesia. Amoxicilin-clavulonate was given for 10 days because
of the growth of methicillin-sensitive Staphylococcus epidermidis and
he was discharged from hospital on the third day of the operation.
Isoniazide, rifampin, ethambutol and pyrazinamide were started after
the necrotising granulomatous inﬂammation was reported.
Mycobacterium tuberculosis, that was not seen with acid-fast staining
microscopically, was cultured from biopsy specimen on the 15th day
with Bactec 460 TB system. By the end of 2 months of treatment, the
masses were reduced in size and there was no drainage. The four-drug
antitubercular treatment was switched to two-drug treatment. Isoniazid
and rifampin was planned to be completed to 1 year.
Conclusion: Tuberculous osteomyelitis of sternum comprises <%1
tuberculous osteomyelitis. Of today, fewer than 40 cases of sternal
tuberculosis were reported. Sternal tuberculosis, should be kept in mind
in the differential diagnosis of mass involving the chest wall particularly
in the endemic areas. This approach will prevent patients with sternal
tuberculosis-but mimicking a tumoral lesion- undergoing a major
surgery.
R2756 Early detection of genotypic resistance of Mycobacterium
tuberculosis in direct specimen
N.M. Quezel-Guerraz*, P.B. Ruiz, E.C. Frutos, F.F. Sa´nchez,
A.S. Porto, J.C. Gallardo, A.D.A. Jime´nez (Marbella, Ma´laga, La
Lı´nea de la Concepcio´n, ES)
Objectives: The aim of this study was to determine the genotypic
resistance pattern of Mycobacterium tuberculosis complex directly in
Mycobacterial infections (including diagnosis) 829
clinical samples to improve the response time of the laboratory and to
optimize the treatment for tuberculosis patients.
Material and Methods: We studied 61 respiratory samples of
different patients with tuberculosis diagnostic in Malaga province. All
the samples were processed for cultivation and stains. Theses samples
were selected for giving positive with Auramine-Rodamine. The M.
tuberculosis complex strains were performed to study of sensitivity
with the ﬁrst-line anti-tuberculosis drugs. The clinical samples were
worked following the manufacturer’s instruction with the kit
MTBDRplus (Hain LifeScience, Germany) for detection of genotypic
resistance to Isoniazid and Rifampicim (detection of gen katG, inhA
and rpoB).
Results: We obtained a total of 32 (52.46%) isoniazid-resistant strains,
which have mutations in the katG gene in 13 (40.62%) and in the inhA
in 6 (18.75%), which represents 59.37% of the clinical samples we ﬁnd
a mutation associated with resistance to isoniazid. Of all the strains, we
have obtained a phenotypic resistance to rifampicin in 14 (22.95%),
which detected 13 (92.86%) clinical samples with mutations in the rpoB
gene. We have not found any resistance mutations with phenotypic
sensitive strains.
Conclusions: The study of genotypic resistance to Isoniazid and
Rifampicin in clinical samples has a good correlation with phenotypic
sensitivity studies, especially to rifampicin. This facilitates clinical
decision when managing a patient with tuberculosis, by decreasing the
response time of 30–40 days to 24–48 hours. The conventional
susceptibility testing cannot yet be replaced by genotypic study to
interpret the behaviour of Mycobacterium tuberculosis complex against
Isoniazid, because it does not detect all mutations involved in
resistance.
R2757 Risk factors associated with surgical site infection caused
by Mycobacterium massiliense in abdominal
videolaparoscopies
M. Conceiça˜o*, M. Perez, A. Baptista, C. Romero, L. Galva˜o,
M. Lourenço, R. Duarte, S. Nouer (Rio de Janeiro, BR)
In Brazil, Mycobacterium massiliense infections after surgery have
been described since 2004, mainly due to contamination of surgical
materials. The purpose of this study was to identify risk factors
associated with surgical infection after abdominal video surgery in a
hospital of Rio de Janeiro and describe their clinical presentation. In a
case-control study, controls were patients undergoing the same
procedure in this hospital during the period. The classiﬁcation and
treatment were established by the Brazilian Health Department. Strains
were tested by PRA-hsp65 and gen rpoB sequency. Forty nine (29%)
patients: 13 proven, three probable and 33 possible were compared to
119 controls. Probable and possible were similar to proven (conﬁrmed)
cases. Conﬁrmed cases had lower incubation time (14 and 27.5 days,
p = 0.001) and greater local hyperthermia (77 and 25%, p < 0.001)
than non conﬁrmed ones (possible and probable). Pancreatitis
(p = 0.05) and sterilization procedure (p = 0.02) were associated with
this infection. At logistic regression, only sterilization was associated to
infection (OR=2.31; 95% IC: 1.10–4.87; p = 0.03). All cases were
submitted to surgical debridement followed by monotherapy or
combination therapy (45% and 55%). Two patients died during
treatment (4%). Success was observed at 10 (conﬁrmed) and
12 months (not conﬁrmed). About 90% of patients had an adverse
reaction, digeus was the most frequent (71%), and 4% were severe. All
the strains were identiﬁed as M. massiliensis. Conclusion:
Despite the low mortality, the incidence of this infection was high and it
should be remind as a differential diagnosis of surgical infections.
Infection in the immunocompromised host
and transplant recipients
R2758 Seroprevalence of hepatitis E among Iranian renal
transplant recipients
Z. Rostamzadeh*, S. Masoodi, N. Sepehrvand, K. Houman,
Z. Shirmohamadi (Urmia, IR)
Background: Renal transplant recipients are known to be susceptible
for viral infections with more severe clinical presentations compared to
healthy persons. Hepatitis E is generally a self-limited disease which is
caused by Hepatitis E virus. Recently, Hepatitis E becomes more
important in organ transplant recipients, because of new ﬁndings
regarding the chronicity potential in this patient group. This study was
aimed to evaluate the seroprevalence of anti-HEV IgG among kidney
transplant recipients of Urmia in the north-west region of Iran.
Methods: Ninety one patients were selected randomly among patients
who underwent kidney transplantation in Urmia, Iran. Each patient was
experimented for anti-HEV IgG using ELISA method (Diapro, Italy).
Results: Twenty eight subjects (30.8%) were seropositive for anti-
HEV IgG. Seropositive cases are generally older than seronegative
cases (p = 0.009). There was no correlation between HEV infection and
the level of education (p = 0.206), the history of blood transfusion
(p = 0.164), history of pre-transplantation hemodialysis (p = 0.228).
There was not signiﬁcant difference among the serum ALT level of
anti-HEV seropositive and seronegative cases. Multinomial logistic
regression indicated no signiﬁcant relationship between HEV infection
and increase in ALT levels, even when controlled for the treatment with
azathioprine (p = 0.79, OR=1.12; 95% CI: 0.45–2.76).
Conclusion: The anti-HEV IgG has a high prevalence in Iranian
kidney transplant recipients, and it is signiﬁcantly higher in comparison
with previous studies in general population or HD patients. This could
be of great clinical importance considering the probable persistent HEV
infection in the setting of graft recipients suggested in the literature.
R2759 Iron overload is a major risk factor for infectious
complications in kidney transplant recipients
M. Ferna´ndez-Ruiz*, F. Lo´pez-Medrano, A. Garcı´a-Reyne,
J.M. Herrero, E. Gonza´lez, N. Polanco, R.S. Juan, C. Lumbreras,
A. Andre´s, J.M. Morales, J.M. Aguado (Madrid, ES)
Objectives: The impact of iron overload on the pathogenesis and
outcome of infections has been documented in various patient
populations but, to our knowledge, it has never been assessed in
kidney transplant (KT) recipients.
Methods: In this observational cohort study we prospectively analyzed
159 patients (102 males; mean age: 53.6 ± 14.9 years) who underwent
KT at our institution from November 2008 to August 2010. Serum iron
markers (iron level, ferritin level, total iron-binding capacity [TIBC],
and transferrin saturation) were measured within the ﬁrst month after
transplantation before any infectious event had occurred. Primary
outcome was the occurrence of any episode of infection in the ﬁrst
6 months post-transplant. Secondary outcome included all-cause
mortality at the end of follow-up. Multivariate adjusted odds ratios
(ORs) were calculated using those covariates that were found to be
signiﬁcant at p < 0.10 by univariate analysis. We compared Kaplan–
Meier survival curves with the log rank test.
Results: During the ﬁrst 6-month follow-up period, 95 (59.7%)
recipients developed at least one episode of infection (bacterial in
44.7%, cytomegalovirus [CMV] in 23.9%, viral non-CMV in 8.2%,
and fungal in 6.3%). Serum iron markers were assessed in samples
taken at a median interval of 2 days after KT (interquartile range, 1–
5 days) and a median interval of 24 days before any infectious event
occurred (interquartile range, 12–64 days). Mean ferritin levels were
signiﬁcantly higher in those patients who developed any episode of
infection (540.8 vs. 391.0 ng/mL; p = 0.024), as compared to the rest
of the cohort. As an inverse marker of iron status, TIBC was lower in
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the group with any infection (213.1 vs. 229.0 lg/dL; p = 0.048).
After adjustment for other factors (including age, pre-transplant
comorbidities, number of red blood cells transfused intraoperatively,
and induction therapy), a ferritin level >600 ng/mL (above percentile
75) emerged as an independent risk factor for any infection (OR =
4.61; 95% conﬁdence interval = 1.89–11.23; p = 0.001). Overall
mortality at the end of follow-up (median 544 days) was 5.0%
(infection-related mortality of 2.5%). Patients with ferritin levels
>600 ng/mL exhibited a nearly signiﬁcant trend towards a worse
survival (p = 0.088).
Conclusion: Our results suggest that iron overload plays an important
role on the risk of infectious complications after KT and may be
considered as a potential marker of poor outcome.
R2760 Pulmonary infection caused by non-tuberculous
mycobacteria in cancer patients: is treatment always
necessary?
K.V. Rolston*, C.N. Mihu, J.A. Adachi (Houston, US)
Objectives: Cancer patients frequently undergo pulmonary imaging
(usually chest CT) to monitor for recurrent or metastatic disease.
Occasionally lesions seen on CT represent infection (predominantly
fungal or mycobacterial). Many patients with Non-Tuberculous
Mycobacteria (NTM) isolated from BAL are asymptomatic. Our
objective was to determine whether antimicrobial therapy was
necessary in such patients, and to assess treatment outcomes when it
was deemed necessary.
Methods: Retrospective case review of 33 cancer patients with
documented microbiologically NTM pulmonary infection.
Results: Twenty-two patients (67%) were women. The median age of
patients was 69 years (range 35–82). Lymphoma, lung, and breast
cancer were the most common underlying tumors. Nine patients were
actively receiving chemotherapy when the infection was diagnosed. The
NTM isolated were M. avium-complex in 26 patients (79%), M.
gordonae in 2, and M. abscessus, M. chelonae, M. fortuitum, M.
kansasii andM. sculgai in one patient each. Twenty one pts (64%) were
asymptomatic. Sixteen of these (76%) chose not to, or were
recommended not to, receive any anti-mycobacterial therapy. All
have remained asymptomatic despite radiographic waxing and waning
with a median follow-up of 48 months. Seventeen patients received
standard therapy for the NTM isolated. Five (29%) discontinued
therapy within 4–20 weeks due to serious side effects (intractable
vomiting, rash, C. difﬁcile colitis, tendinitis). Seven were able to
complete 18 months of therapy. All have remained clinically stable
after discontinuation of therapy (any length) despite persistent
radiographic changes in most, and repeat positive cultures for NTM
in ﬁve patients.
Conclusion: Therapy for NTM infections in asymptomatic cancer
patients is not indicated. In patients who do need treatment, it can be
quite toxic and may not lead to the eradication of the NTM in those who
are able to tolerate a full course.
R2761 Bloodstream infection among bone marrow transplant
outpatients: risk factors for hospitalisation and death
R. Russo, F. Dulley, R. Saboya, M. Shikanai-Yasuda, S. Costa* (Sa˜o
Paulo, BR)
Introduction: Bloodstream infection (BSI) is one of the most common
medical complications in bone marrow transplanted patients. A few
studies, however, evaluate the treatment of BSI among bone marrow
transplated outpatients.
Objectives: Describe the bloodstream infection agents identiﬁed
among bone marrow transplanted outpatients at HCFMUSP. Evaluate
the proportion and risk factors associated with hospitalization and death
of such patients.
Method: Retrospective analysis on patients’ records of the Bone
Marrow Transplant¢s clinics that presents positive blood culture
gathered between January 2004 and December 2008. All the data
was analyzed using the software Epi Info version 3.5.1, the signiﬁcance
level adopted was of 5%. Hospitalization and death in 30 days were the
outcomes evaluated and which the risk factors associated were
calculated and compared through the analysis bivariate and
multivariate.
Results: A total of 743 patients were evaluated of which blood cultures
were positive during the clinic follow up in 172 pts, the records of 146
were evaluated, with a total of 235 bloodstream infection episodes,
being 207 (88%) monomicrobial episodes and 28 (12%) polimicrobial
in both the occurrence of gram-negatives was predominant. The
episodes were more frequent during the ﬁrst 100 days after the
transplant. The most important agents isolated were S. maltophilia
(15%), SCN (12%), Acinectobacter spp (9%). The average age of the
patients was 32 years old (range of 2–68 years), being 90 (61.6%) male
and 87 (59.6%) allogeneic transplant. The hospitalization occurred in
26% of the episodes. Autologous transplant was found as protect for
hospitalization on both analyses, bivariate and multivariate. Death in
30 days occurred only in 10% of the cases. BSI due to Gram-negative
and presence of serious neutropenia were found as independent risk
factor for death. The multivariate analysis found as protection factor for
death in 30 days only MASCC score.
Conclusion: The gram-negatives were the most important agents
isolated in our bone marrow transplat outpatients unit, highlighting the
isolation of Stenotrophomonas maltophilia. The occurrence of
hospitalization and death wasn’t high. MASCC score could be a
good predictor for death and the treatment of autologous outpatients
with bloodstream infections seems to be safe.
R2763 Derivation and validation of a scoring system to identify
patients with bacterial bloodstream infection and
haematological malignancies at higher risk for mortality:
He.M.A.B.I.S. (Hematological Malignancies Associated
Bloodstream Infections Surveillance)
E.M. Trecarichi*, M. Tumbarello, M. Caira, A. Candoni, D. Pastore,
C. Cattaneo, R. Fanci, A. Nosari, A. Spadea, A. Busca, N. Vianelli,
L. Pagano (Rome, Udine, Bari, Brescia, Firenze, Milan, Torino,
Bologna, IT)
Objectives: The aim of the present study, conducted in nine Italian
large hospitals, was to develop and validate a reliable, easy-to-use
clinical prediction rule that could be employed to identify patients with
higher likelihood of mortality among those with hematological
malignancies (HM) and bacterial bloodstream infections (BBSIs).
Methods: To identify risk factors for mortality in adult patients with
HM and BSI, we conducted a cohort study in nine Italian
haematological units. The derivation cohort consisted of adult
patients with BBSI and HM admitted to the Catholic University
Hospital (Rome), between January 2002 and December 2008. The
outcome measured was mortality 30 days after BBSI onset. Survivors
and nonsurvivors were compared to identify predictors of 30-day
mortality. The validation cohort consisted of patients hospitalized with
BBSI and HM, prospectively enrolled in eight other Italian
hematological units between January 2009 and December 2010.
Inclusion and exclusion criteria were identical to those used for the
derivation cohort; patients included in the validation set were matched
with those in the derivation set according to type and stage of HM
(match ratio, 1:1).
Results: In the derivation set (247 episodes), the multivariate analysis
(after excluding variables not evaluable at BBSI onset) yielded the
following signiﬁcant mortality-related risk factors: acute renal failure
(Odds Ratio [OR] 6.44, 95% conﬁdence interval [CI], 2.36–17.57);
severe neutropenia (<100/mm3) (OR 4.38, 95% CI, 2.04–9.43);
nosocomial infection (OR 3.73, 95% CI, 1.36–10.22); age ‡65 years
(OR 3.42, 95% CI, 1.49–7.80), Charlson Comorbidity Index >= 4 (OR
3.01, 95% CI, 1.36–6.65). The equal-weight risk score model, which
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signed one point to each risk factor, yielded good-excellent
discrimination in both cohorts with areas under the receiver operating
curve (AUROCs) of 0.83 vs. 0.93 (derivation vs. validation). The
model was well calibrated in both derivation and validation sets
(Hosmer-Lemshow p = 0.16 and 0.75, respectively).
Conclusion: The risk index accurately identiﬁes patients with HMs
and BBSIs at high risk for mortality; a better initial predictive approach
may allow better therapeutic decisions for these patients, with an
eventual impact on reducing mortality.
R2764 Epidemiology of Candida species in critically ill patients in
ICUs in a multi-speciality hospital in India
R. Bagga*, U. Baveja, A. Rattan, S. Sharma (Gurgaon, IN)
Aim: To study the epidemiology of Candida isolates in critically ill
patients, its risk factors and their antifungal susceptibility pattern.
Methods: Retrospective study was conducted at a 650 bedded tertiary
care centre: Medanta – The Medicity, Gurgaon, India between
November 2009-October 2011. Data of 5456 samples from patients
admitted in ICUs (from November 2009 – October 2011) was analyzed.
Identiﬁcation of the isolates and their antifungal susceptibility testing
was done using VITEK 2 (bio Merieux).
Results: Out of 5456 clinical specimens 295 samples (5.4%) grew
Candida Species. Candida was isolated from104 blood samples,115
from respiratory specimens (ET, sputum, BAL), 22 from body ﬂuids
(pleural, ascitic,) and 54 from urine.
Non albicans Candida (71.6%) was more frequent than C. albicans
(29.4%). C. tropicalis (39.3%) was the most frequent isolate followed
by C. albicans (29.4%) and C. haemulonii (8%). According to our
results, Candida infections were nosocomially acquired in 83.7% of
cases and patients frequently had severe co morbidities. Liver
transplant, CVC, Neutropenia & Liver cirrhosis were associated risk
factors. During the 2 years of the study, a fall in Candida associated
BSIs was seen after implementation of CLABSI bundle. C. tropicalis
was the most predominant species followed by C. albicans. Suscep-
tibilty to routine antifungal agents varied according to the species .92%
of isolates were susceptible to Voriconazole, 86.4% to Amphotericin B,
82.03% to Fluconazole, with variable sensitivity according to species.
All C. krusei were resistant to ﬂuconazole . 63% of C. hemulonii were
resistant to Amphotericin B and ~50% were resistant to Fluconazole
and Voriconazole.
Candidial infections were found to be more common in men (70.5%),
those above 45 years of age (76.27%), those with hospital stay of more
than 9 days and patients from gastroenterology ICU (24.4%).
Conclusion: Epidemiological studies including early identiﬁcation,
speciation and antifungal therapy are critically important in Candidial
infections. Epidemiological data helps in risk assessment of cases and
initiation of empirical treatment. Hence it is imperative to know the
epidemiology of Candida spp. in one’s own setup. New subsets of Non
albicans Candida like C. haemulonii are emerging. Current antifungal
agents have inadequate activity against current and emerging fungal
pathogens. Use of newer generation antifungals like echinocandins
improve outcomes in serious fungal infections.
R2765 Adult lung cancer complicated with invasive pulmonary
aspergillosis
M. Peghin*, I. Ruiz, E. Rossello, J. Andreu, A. Curran, A. Martinez,
P. Martinez, E. Zamora, F.J. Jimenez, E. Felip, A. Pahissa (Barcelona,
ES)
Objectives: Aspergillus spp. can cause acute invasive disease in
severely immunocompromised patients. However there are few cases
reported of lung cancer complicated by invasive pulmonary
aspergillosis (IPA) at the same site.
Methods: A retrospective review of all consecutive episodes of adult
lung cancer complicated by IPA diagnosed in a hospital, from January
2009 to October 2011. A combination of socio-demographic
characteristics, underlying diseases, clinical features, microbiological
results, radiological ﬁndings, treatment and outcome were recorded.
Results: During the study period 856 patients with lung cancer were
treated and 10 episodes (1.16%) of probable IPA were diagnosed. Eight
episodes occurred in men and two in women, mean age 63 years. The
most common underlying oncological disease was non-small cell lung
cancer (eight patients). Clinical stages were III (3) or IV (7). Chronic
lung disease was a co-existing illness in ﬁve persons, but none had
previous Aspergillus colonization. Median time between cancer
diagnosis and Aspergillus detection was 5 months. One episode
occurred during neutropenia. Within 30 days prior to the diagnosis of
IPA, ﬁve patients were receiving systemic steroids therapy and two
chemotherapy. Two patients had received previous chest radiotherapy.
The most common clinical presentations were fever (4), hemoptysis (4),
dyspnoea (3), chest pain (3) cough (2) and distress syndrome (2).
Aspergillus was detected in four sputum samples, three bronchoalveolar
lavages, two tracheal aspirates and one percutaneous lung puncture. A.
fumigatus (6) was the most frequently isolated, followed by A. terreus
(3) and A. ﬂavus (1). Nine patients had concomitant bacterial isolation.
At time of Aspergillus detection, the most common radiological
ﬁndings in thoracic computed tomography (TCT) were cavities (5),
consolidation (3), nodular inﬁltrates (1) and air crescent signs (1). Since
Aspergillus detection, TCT controls showed that all cavitary lesions
expanded over time. All patients were treated with azoles (voriconazole
or itraconazole) and one underwent surgical resection. Eight persons
died after Aspergillus detection (average time 11 weeks) with two IPA
related death.
Conclusions: The presence of lung cancer seems to be a factor
triggering Aspergillus implantation, predisposing to IPA. Once
localized in the damaged lung, the mould can grow and cause or
expand cavities. In lung cancer patients Aspergillus detection entails a
very poor prognosis.
R2766 An outbreak of Burkholderia cepacia bacteraemia in
hospitalised haematological patients in northern Greece
M. Kachrimanidou*, E. Katsifa, A. Vardi, M. Alexandridou,
S. Kyriakidou, M. Vlaxou, E. Tsorlini (Thessaloniki, GR)
Objectives: Burkholderia cepacia (Bcc) is a common environmental
bacterium that is resistant to disinfectants, and therefore is often
encountered as a hospital-acquired pathogen. We describe a 3-month
hospital outbreak of Bcc bacteremia among hospitalized hematological
patients.
Methods: The study included nine hematological patients hospitalized
between December 16, 2009 and March 13, 2010 who had blood
culture positive for Bcc. Environmental samples were collected from
benches, sinks, drains, bed rails, ﬂoors, refrigerators, bathroom
surfaces, stethoscopes, distilled water, sterile saline and intravenous
ﬂuids. All positive blood culture isolates were identiﬁed to the species
level and tested for antimicrobial susceptibilities by a commercial
system Vitek 2 (AST-N093 bioMerieux, France).
Results: During the period of the outbreak 102 patients were
hospitalized in the Hematology Department and 28.4% (29) of them
suffered from acute myeloid leukemia (AML). Over the 3-months
outbreak period, a total of nine patients with Bcc bacteremia were
identiﬁed. Notably, all patients infected with Bcc suffered from AML
and were neutropenic. Of them, 5 (55.5%) were men and the ages
ranged from 43 to 75 years. Bcc was repeatedly isolated from the blood
of the above nine patients. Four patients (4/9) had signs of pneumonia,
but Bcc was never recovered from sputum and the rest of the index
cases (5/9) had no other documented infection site but Bcc bacteremia.
Three cases developed septic shock and died. All isolates were sensitive
to ceftazidime and resistant to amikacin, gentamycin, tobramycin,
imipeneme and colistin. The rates of susceptibility for the nine Bcc
isolates to cefepime, ciproﬂoxacin, cotrimoxazole, piperacillin-
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tazobactam and minocycline were 73%, 82%, 59%, 61% and 64%
respectively. All environmental cultures did not grow Bcc. A point
source was not identiﬁed and horizontal spread was suspected. Strict
infection control measures terminated the outbreak.
Conclusions: B. cepacia is an opportunistic pathogen which can cause
life-threatening disease to haematological malignancy patients and can
produce a serious outbreak. Infection control measures, including
contact isolation, are of outmost importance in containing the spread of
Bcc among patients.
R2767 Surveillance of catheter-related bloodstream infections in
a haemodialysis centre
A. Radulescu*, A. Slavcovici, S. Racasan, I. Patiu (Cluj-Napoca, RO)
Objectives: To evaluate the frequency, risk factors, severity and the
etiology of catheter-related bloodstream infections (BSI) in
hemodialysis patients.
Methods: We reviewed the records of patients receiving maintenance
hemodialysis three times per week in the period 2008–2011, the
capacity of the dialysis center being 160–170 patients. Catheter-related
BSIs were diagnosed if at least one positive blood culture, clinical
manifestations of infection were present and positive semi quantitative
or quantitative cultures from the segment of the removed catheter. The
outcome measures were number of BSI per patient catheter- days,
hospitalizations and deaths, comorbidity scores, and correlations with
hospitalization and infection as the cause of deaths.
Results: Among the 165 hemodialysis patients currently cared, 47
(28%) have a tunneled catheter in place due to no other vascular access.
Infection control interventions for the prevention of BSIs were folowed.
The mean age was 64.7 ± 13.45 years, the dialysis duration
4.22 ± 3.71 years, the vascular-catheter in place 1.52 ± 0.84 years
with 1.68 ± 1.86 infections/patient, catheter-related BSI rate was 3.16
per 1000 catheter-days. The infection death rate/year was between 22
and 25%. Most of the patients with BSIs were treated with systemic
antibiotic alone in the dialysis center (4 weeks) and only critical
patients or infective endocarditis were considered for hospitalization.
The clinical picture was very similar in all patients and severe sepsis
was rarely observed. The need of hospitalization was not signiﬁcantly
increased depending on the number of infections (‡2), OR 1.83 (95%
CI 0.26–13.36), the duration of catheter in place for >1 year was
signiﬁcantly associated with increased number of infections, OR 5
(95% CI 1.16–23.8). The Comorbidity Charlson Index was signiﬁcantly
associated with hospital admissions and deaths (>3), OR 5.27 (95% CI
1.37–21.14). There was a predominance of staphylococci – 61%
(meticillin resistant) and polymicrobial infections 26% (multidrug
resistant). High procalcitonin levels were not clinical and statistical
signiﬁcantly associated with hospital admission or death OR 1.9 (95%
CI 0.32–11.31).
Conclusion: The increased need for vascular access through vascular
catheter was associated with excessively high number of BSIs. The risk
of severe sepsis and deaths were mainly related to comorbidities than to
the etiology or resistance pattern.
Community-acquired infections including
CAP, sepsis, STD
R2768 The investigation of risk factors of patients with urinary
tract infections due to Escherichia coli
C. Buke*, A. Nazli, E.E. Kivrak, H. Kahraman, F. Cilli (Izmir, TR)
Objectives: To assess the relationship between community acquired
urinary tract infection (CA-UTI) due to extended-spectrum beta-
lactamase producing Escherichia coli (ESBL-E. coli) and
demographic characteristics and risk factors.
Methods: Between 2009 and 2010, 100 outpatients diagnosed with E.
coli urinary tract infection (UTI) were included in this study.
Demographic characteristics, risk factors such as; hospitalization,
antecedent UTI, urinary tract stone and anomalies, diabetes mellitus,
pregnancy, invasive procedures were recorded in a form. Antimicrobial
susceptibility test results were evaluated.
Results: Mean age of 100 patients was 47.4 ± 18.8. The rate of ESBL-
E. coli among CA-UTI was 25%. There were no relationships between
the number of people living at home, antecedent UTI, urinary tract
stone, diabetes mellitus, pregnancy, renal insufﬁciency, invasive
procedures in the last 3 months and ESBL-E. coli (p > 0.05). In
contrast hospitalization (p < 0.01) and antibiotic use (p < 0.009) in the
last 3 months were statistically signiﬁcant with ESBL-E. coli. Rates (%)
of resistance to gentamicin, levoﬂoxacin and trimethoprim/
sulphametoxazole were respectively 31, 43 and 40.
Conclusions: We show that ESBL-E. coli in patients with CA-UTI
was high. Inappropriate antibiotic use, especially irrational use of
levoﬂoxacin in patients with CA-UTI and hospitalization in the last
3 months can be the factors predisposing ESBL production.
R2769 Body mass index as prognostic factor in community-
acquired pneumonia
M. Falguera*, A. Ruiz-Gonza´lez, I. Chica, P. Cabezas, G. Cao,
M. Badia, E. Polverino, J. Pe´rez-Mur, M. Vila`, R. Pifarre´, A. Torres,
J. Porcel (Lleida, Barcelona, ES)
Objective: Underweight and/or obesity have been associated with poor
prognosis in many pathological processes including some infectious
diseases. We aimed to evaluate the impact of body mass index (BMI)
and waist circumference on mortality, other outcome parameters and
etiology in patients admitted with community-acquired pneumonia.
Methods: A prospective observational study was conducted in two
university hospitals in Spain between January 2008 and December
2010. In addition to epidemiological parameters, clinical and laboratory
data, we collected weight, height, BMI and waist circumference in all
patients with community-acquired pneumonia. According to BMI,
subjects were stratiﬁed into ﬁve subgroups: underweight (BMI < 18.5),
normal weight (BMI 18.5–24.9), overweight (BMI 25.0–29.9), obesity
(BMI 30.0–39.9) and morbid obesity (BMI > 39.9). Association
between anthropometric parameters and outcome (mortality during
hospitalization, mortality post-discharge, morbid complications,
admission to ICU, readmission, length of hospital stay, duration of
fever and time to reach clinical stability) were evaluated in univariate
and multivariate analyses.
Results: A total of 514 patients were enrolled in the study. Distribution
of patients according to BMI subgroups were: 3% had underweight,
33% normal weight, 42% overweight, 20% obesity and 3% morbid
obesity. Morbid obesity was associated with some poor prognostic
indicators: mortality during admission (15% vs. 3%; p = 0.014),
readmission at 30 days (18% vs. 4%, p = 0.029), duration of fever
(5.8 vs. 2.4 days; p = 0.010) and time to reach clinical stability (8.3 vs.
3.5 days; p = 0.004). This relation was particularly evident among
patients classiﬁed at admission as low-risk patients (PSI groups I/II/III)
and among females. Multivariate analysis selected morbid obesity
(OR:68.13; 95% IC:2.08-904-67), in addition to prior cerebrovascular
diseases (OR:32.72; 95% IC:1.48–647.46), altered mental status
(OR:18.94; 95% IC:2.49–95.60), tachypnea (OR:1.10; 95% IC:1.01–
1.27) and low oxygen saturation levels (OR:0.91; 95% IC:0.86–0.96) as
independent risk factors for in-hospital mortality. No associations were
found between other BMI subgroups or waist circumference and
outcome. Similarly, no associations were found between BMI
subgroups and etiologies.
Conclusion: Our study suggests that among anthropometric
parameters only morbid obesity could have a signiﬁcant prognostic
impact in patients with community-acquired pneumonia.
Community-acquired infections including CAP, sepsis, STD 833
R2770 Effect of adjuvant therapy in pneumococcal meningitis:
seizures and mortality
I. Pelegrin*, R. Verdaguer, J. Ariza, P.F. Viladrich,
C. Cabellos (Barcelona, ES)
Objectives: To evaluate the occurrence and prognostic relevance of
seizures in pneumococcal meningitis (PM) and to compare clinical
outcomes of pts treated with different strategies.
Methods: This is a cohort study of pts with community-acquired
bacterial meningitis (CABM) 1977 to 2009 in a tertiary care hospital.
Since 1987 all pts with PM were systematically treated with anti
intracranial hypertension prophylaxis (Dexamethasone (DXM) for
48 h, a single dose of mannitol (MAN) and prophylactic phenytoin
(PHT) in order to avoid seizures and other neurological complications.
We considered three groups for analysis: Group 1 (G1) (1977–1986
without any prophylaxis); Group 2 (G2) (1987–2009 with DXM ±
MAN prophylaxis and prophylactic PHT). Group 3 (G3) (1987–2009
with DXM ± MAN without prophylactic PHT due to
contraindications). Forty-ﬁve points from G1 received DXM as
treatment due to poor prognosis.
Results: Two hundred and sixty-three episodes of PM, mainly in adults,
110 W/153 M, mean age 53 years (7–93) have been treated. Seizures
occurred in 75/263 pts (28%), 33 of them (12%) prehospital. Seizures in
pts with CABM due to other etiologies was 62/729 (8.5%) p < 0.05.
Time point of seizures was before arriving to the hospital in 33 pts
(44%), ﬁrst 24 hours in 19 (25%), 24–72 hours in 12 (16%), between
72 hours and 1 week in 7 (9%) and >1 week in 4 (5%). In PM overall
mortality was 52 (20%). Mortality in pts presenting seizures was 29/75
(39%) vs. 23/188 (12%) in pts without seizures (p < 0.05). Mortality in
pts with prehospital seizures was 3/33 (9%) while in pts with in-hospital
seizures was 26/42 (62%) (p < 0.05). Among pts from G1 (n = 110), in-
hospital seizures were present in 27/97 (28%), overall mortality was 40/
110 (36%) and mortality among patients presenting seizures was 20/27
(74%). Among pts from G2 (n = 132), in-hospital seizures were present
in 13/122 (10%) (p < 0.05 vs. G1), overall mortality was 18/132 (14%)
(p < 0.05 vs. G1) and mortality among pts presenting seizures was 5/13
(38%) (p < 0.05 vs. G1). Among pts from G3 (n = 21), in-hospital
seizures were present in 2/11 (18%) overall mortality was 2/21 (9%) and
mortality among pts presenting seizures was 1/2 (50%).
Conclusion: Seizures in PM is related to a worse prognosis.
Introduction of prophylaxis with DXM ± MAN and PHT has been
effective. The exact role of PHT in avoiding seizures in PM is not clear
besides the improvement due to DEX ± MAN, so a randomized clinical
trial should be performed.
R2771 Clinical presentations of invasive pneumococcal disease
and associated co-morbidities in adults in Spain
E. Polverino*, M. Rodriguez-Creixems, I. Grau, L. Molinos, O. Rajas,
P. Llinares, J.L. De la Cruz, A. Fenoll, I. Cifuentes and the ODIN
Study Group
Objectives: To analyse clinical presentations, associated
comorbidities, and clinical outcome of invasive pneumococcal disease
(IPD) in adults.
Methods: A prospective, active, hospital-based surveillance of all
culture-conﬁrmed IPDs in adults (‡18 years) was performed in seven
Spanish hospitals (August 2010-June 2011). IPD was considered
isolation of S. pneumoniae from normally sterile ﬂuids. Clinical
presentations were classiﬁed as complicated pneumonia -CP-
(pneumonia with pleural effusion and/or empyema and/or multilobar
presentation), non-complicated pneumonia (N-CP), meningitis (M),
primary bacteremia (PB), sepsis (S), peritonitis (P) and others (O).
Results: One hundred and ninety-one cases (mean age
62.2 ± 17.8 years, 58.1% males) were included. Table shows by
clinical presentation (with ‡8 cases) percentage of patients with
comorbidities (present in at least 9% total patients), history of
vaccination and outcome. The most frequent presentation was
pneumonia (71.2%), with previous pneumonia as main comorbidity.
Malignancies were mainly associated with PB and S (both accounting
for 12.0% cases and showing the highest Charlson index) while chronic
liver disease was the main comorbidity in patients with peritonitis
(4.2% cases) and meningitis (9.9% cases).
Conclusions: Previous pneumonia has been identiﬁed as one of the
most frequent risk factor for IPD that represents a great burden of
disease. Facing limitations of the 23-valent polysaccharide (21.9% total
population had been vaccinated, reaching >36% patients presenting N-
CP or PB), vaccination with conjugate vaccines could be a better
strategy.
R2772 Seven-years retrospective epidemiological survey of
uncomplicated community urinary tract infections in a
tertiary hospital
E. Sideris, D. Paisis, A. Tsakalos, M. Orfanidou, E. Vagiakou*,
E. Malamou-Lada (Athens, GR)
Objectives: To investigate the pathogens causing community-acquired
acute uncomplicated urinary tract infections (UTIs) and their resistance
during 7 years period (2004–2010) in a tertiary hospital of Athens,
Greece.
Methods: Midstream urine samples were taken for culture and testing
for the presence of leucocytes and /or bacteriuria from 30 106
community patients presenting with symptoms of acute UTI. The
identiﬁcation of isolated bacteria performed with established techniques
and their antibiotic resistance by Kirby- Bauer method and MICs by
VITEK-II system, E-test. Only patients with urine cultures yielding
growth of pathogens ‡105 cfu/mL were included in the study.
Results: Recognized urinary tract pathogens were present in 9278
(31%) patients. The ﬁrst group of isolated bacteria was
Enterobacteriaceae (84%), followed by Gram positive cocci (9%) and
Gram negative non fermentans (3.6%). The commonest isolated
organisms were Escherichia coli (67%), Klebsiella spp. (6.7%),
Proteus spp. (7%), Enterococcus faecalis (4.6%), Coagulase- negative
staphylococci (CoNS) (2%), Staphylococcus saprophyticus (1.47%).
Resistance of E. coli was most common to ampicillin (43%),
co-trimoxazole (23%), followed by quinolones (6.8%) while to co-
amoxiclav, cefuroxime, nitrofurantoin, gentamicin was <3%. Proteus
mirabilis was resistant to ampicillin in 50% and co-trimoxazole in 29%,
while Klebsiella spp was resistant to co-trimoxazole, quinolones more
than 29% .In P. aeruginosa the resistance to carbapenemes, quinolones
was 14% and 31% respectively. S. saprophyticus resistance to
quinolones, co-trimoxazole was <3%. CoNS were resistant to
quinolones (23%), co-trimoxazole (21%), methicillin (26%). The
resistance of E. faecalis to quinolones was 27%.
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Conclusions: The frequence of uncomplicated community urinary
tract infections was 31% during 7 years period. Enterobacteriaceae was
the most frequently isolated group organism (84%) with E. coli
accounting for 67% of isolates. E. coli was resistant to ampicillin and
co-trimoxazole more than 23%. So the most effective antibiotics for the
empirical treatment of acute community-acquired urinary tract
infections seems to be nitrofurantoin, co-amoxiclav, cefuroxime.
R2773 Elevated venous lactate levels predict mortality in
community-onset norovirus enteritis – a retrospective
cohort study
L. Gustavsson*, L.-M. Andersson, M. Brink, M. Lindh,
J. Westin (Go¨teborg, SE)
Objective: Serum lactate levels measured in the emergency department
(ED) detect occult hypoperfusion and are associated with mortality.
Since norovirus enteritis (NVE) causes ﬂuid losses and has been
associated with increased mortality, we hypothesised that lactate levels
can be used to identify high-risk patients with norovirus (NoV)
infection who require hospitalisation. The objective was to describe the
association, in patients with community-onset NVE, between lactate
levels on admission and 30-day mortality.
Methods: This was a retrospective cohort study set at the Sahlgrenska
University Hospital, Gothenburg, Sweden during the NoV-season
august 2008- june 2009. All hospitalised adult (>18 years) patients,
admitted via the ED of the hospital, with a stool sample positive by
PCR for NoV and community onset of gastroenteritis symptoms were
included. Patients with concomitant serious bacterial infections,
hypovolemic shock or surgical abdominal emergencies were
excluded. Vital signs and venous lactate on arrival, co-morbid
conditions, diagnosis at discharge and time of death were registered.
The primary outcome was 30-day all-cause mortality. Chi-square test
was used for comparisons of proportions, and Mann-Whitney U-test for
continuous variables. One-step logistic regression was used for
multivariate analysis.
Results: We included 82 patients with a median age of 77 years (IQR
53–86), of whom 47 (57%) were female and 49 (60%) had at least one
major co-morbid condition. Lactate levels were above the upper limit of
normal (ULN) 1.6 mM in 45 patients (55%). The overall 30-day
mortality rate was 7.3% (6/82). Mortality was higher in patients with
lactate >2.4 mM (>50% above the ULN) on admission (18% vs. 2%,
p < 0.05). Higher lactate levels were associated with higher mortality
(see ﬁgure). Patients who died had a higher median lactate compared to
survivors, 4.5 (IQR 2.7–7.9) mM vs. 1.7 (IQR 1.2–2.6) mM,
respectively (p < 0.01). After adjusting for other variables associated
with mortality, the adjusted odds ratio for death within 30 days of a
1 mM increase in lactate was 3.4 (95% CI 1.05–11.1, p = 0.041).
Conclusions: Measurements of serum lactate may be a valuable tool in
the clinical assessment of suspected NoV-infection.
R2774 Is bacterial vaginosis associated with the presence of
Candida albicans and Ureaplasma urealyticum in
reproductive-age women with vulvovaginitis?
I. Tsirmpa, E. Kouskouni*, I. Tsouma, S. Baka (Athens, GR)
Objectives: At present, it is accepted that low acidity and a healthy
appearing lactobacillary ﬂora is typical for Candida vulvovaginitis,
while bacterial vaginosis (BV), with decreased lactobacilli and
increased vaginal pH levels, protects against Candida growth. In
other words, it is suggested that the growth requirements of Candida
and BV are completely opposite to each other. However, it has been
reported that 6% of women with symptomatic Candida vaginitis had
simultaneously BV and that a different proteolytic activity in the
vaginas of women with BV can be involved in the pathogenesis of
concomitant infection with Candida. Furthermore, women with BV
were more likely to have a genetic polymorphism of the innate
immune response. On the other hand, Ureaplasma urealyticum (UU)
appears to be an important factor that enhances the virulence
commonly associated with BV and was detected more often in
women with BV than in those without BV. For the diagnosis of BV
usually a Gram stain is used. Since genital mycoplasmas lack a cell
wall and are thus resistant to Gram stain, their presence in studies that
rely on Gram stain criteria can easily be missed. We aimed to assess
the potential association of bacterial vaginosis with the presence of
UU and Candida species in a group of symptomatic reproductive age
women.
Methods: We examined 3648 vaginal and cervical specimens from an
equal number of reproductive age women presenting to our hospital
with signs and symptoms of vulvovaginitis during April 2009 to April
2011. Only 284 women with BV were tested simultaneously for
mycoplasmas and this population was included in the present study.
Gram stain preparations were examined from all specimens and Nugent
criteria were applied for the diagnosis of BV. Vaginal and cervical
cultures were performed under standard conditions. For the isolation of
mycoplasmas the Mycoplasma IST2 (BioMe`rieux, France) was used.
Results: Out of the 284 women with BV, 39 (13.7%) had vaginal
candidiasis, too, while UU was isolated in 88 (31.0%) cases. Lastly, in
15 (5.3%) women BV was simultaneously present with UU and
Candida.
Conclusions: BV was associated with UU in one third of the cases and
in 5% with both UU and Candida. However, given the complexity of
the vaginal ﬂora and our relatively limited understanding of lower
genital tract infections, further studies are needed to understand the role
these pathogens play in causing disease.
R2775 Analysis of cases of infective endocarditis at Barts and the
London NHS Trust over 1 year: clinical features,
investigations and outcome
A. Sivaramakrishnan*, S. Warwick, S. Das (London, UK)
Infective endocarditis (IE) is an important and challenging illness.
Recent studies have reported a changing epidemiology related to
increasing nosocomial IE with Staphylococcal aetiology. However, we
are not aware of any recent published studies from the UK.
Objectives: To study the clinical features, microbial aetiology,
management and outcome of all cases of IE admitted to Barts and the
London NHS Trust (BLT) over 1 year. BLT receives direct inpatient
admissions and is also a tertiary level referral centre for Cardiology and
Cardiothoracic surgery.
Methods: All patients with clinical deﬁnite endocarditis (as per
modiﬁed Duke’s criteria) admitted from December 2009 to January
2011 were included. Demographic, clinical and laboratory data were
collected prospectively.
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Results: Thirty patients were studied. The age range was 19–85 years
(73% were above 60 years). Sixteen patients (53%) had no
comorbidities. Twenty four patients had native valve endocarditis and
six had endocarditis of a prosthetic valve. Fever and respiratory
symptoms were the commonest presentation and 10 (33%) patients
were admitted within a week of symptom onset. Fourteen patients
(47%) were admitted directly from the community (emergency
admissions or GP referrals), and 16 (53%) were transferred from
district hospitals for specialist care. Twenty six patients (86%) had
community acquired IE and 3 (10%) had nosocomial IE. Blood cultures
were positive in 24 (80%) patients. The most frequent organisms
isolated were Viridians streptococci (7/24:29%), Staphylococcus aureus
(6/24:25%) and Enterococcus faecalis (5/24:20%). Blood cultures were
negative in 7 (29%) patients. Streptococci were identiﬁed in 6/10 (60%)
patients presenting with acute IE. All patients underwent valve surgery.
Twelve (40%) valve samples were culture positive, and 19 (63%) were
PCR positive. A good outcome was observed in 29 (96%) patients, with
a median follow up period of 3–6 months post discharge.
Conclusions: IE presenting to our centre occurred predominantly in
elderly individuals with no obvious pre-existing valvular heart disease.
Against expectations, Viridians streptococci were a signiﬁcant cause of
acute endocarditis. Earlier presentation, timely surgical intervention and
predominance of Streptococcal aetiology might have contributed to the
overall favourable outcome. Despite the limitation of an inherent
selection bias, important conclusions about patients with IE presenting
to a UK tertiary level service can be made.
R2776 Interventions for preventing recurrent urinary tract
infection during pregnancy: a Cochrane review
C. Schneeberger*, S.E. Geerlings, P. Middleton,
C.A. Crowther (Groningen, Amsterdam, NL; Adelaide, AU)
Objectives: Recurrent urinary tract infections (RUTI) are common in
women who are pregnant and may cause serious adverse pregnancy
outcomes for both mother and child including preterm birth and small
for gestational age babies. Interventions used to prevent RUTI in
women who are pregnant can be pharmacological (antibiotics) or non-
pharmacological (cranberry products, acupuncture, probiotics and
behavioural modiﬁcations). So far little is known about the best way
to prevent RUTI in pregnant women.
Methods: We used standard Cochrane methodology (last search
February 2011). The primary maternal outcomes were (recurrent)
urinary tract infection before birth (variously deﬁned) and preterm birth
(<37 weeks). The primary infant outcomes were small-for-gestational
age and total mortality.
Results: The review included one trial involving 200 women. This trial
compared a daily dose of nitrofurantoin and close surveillance with
close surveillance only. No signiﬁcant differences were found for the
described primary outcomes: recurrent pyelonephritis (risk ratio (RR)
0.89, 95% conﬁdence interval (CI) 0.31–2.53), urinary tract infection
before birth (RR 0.30 95% CI 0.06–1.38) and preterm birth
(<37 weeks) (RR 1.18 95% CI 0.42–3.35). The incidence of
asymptomatic bacteriuria (ASB) (‡103 colonies per milliliter)
(secondary outcome), only reported in women with a clinic
attendance rate of >90% (RR 0.55, 95% CI 0.34–0.89), was
signiﬁcantly reduced in women who received nitrofurantoin and close
surveillance.
Conclusion: Daily dose of nitrofurantoin and close surveillance has
not been shown to prevent RUTI compared with close surveillance
alone, although a signiﬁcant reduction of ASB was found in women
with a clinic attendance rate of > 90% and who received nitrofurantoin
and close surveillance. Furthermore, there is limited reporting of both
primary and secondary outcomes for both women and infants. Due to
lack of RCT, no conclusions can be drawn regarding the optimal
intervention to prevent RUTI in women who are pregnant. RCT
comparing different pharmacological and non-pharmacological
interventions are necessary to investigate potentially effective
interventions to prevent RUTI in women who are pregnant.
R2777 Severe community-acquired pneumonia
O. Gorbich, Y. Gorbich*, I. Karpov (Minsk, BY)
Objective: This study was designed to identify etiological agents of
severe community-acquired pneumonia (CAP) in patients who require
admission to an intensive care unit (ICU).
Material and Methods: A multicenter, retrospective study of 12
hospitals in the Republic of Belarus was undertaken. Two hundred
thirty-three patients with severe CAP were enrolled in the study during
the period from March, 2009, to May, 2011. The diagnosis of CAP was
based on the combination of chest radiograph ﬁndings, clinical signs
and laboratory data (sputum specimens – 85.4%, bronchial aspirate –
12.9%, pleural ﬂuid – 1.7%). We analyzed four age groups (15–
29 years; 30–49 years; 50–69 years; more than 70 years). The ﬁrst
group included 45 patients with severe CAP (19.3%), the second group
included 66 patients (28.3%), the third group included 78 patients
(33.5%), and the fourth group included 31 patients (13.3%). Data was
stored and analyzed using Microsoft Excel software (Microsoft, USA).
Results: During the study period, a total of 233 nonimmunosuppressed
adult patients with severe CAP were admitted to ICUs, of whom 164
were men and 69 were women (mean patient age, 48 years; range, 15–
91 years). Etiologic diagnoses were established in all cases. The most
frequently identiﬁed pathogens were Klebsiella pneumoniae (61.8%),
Staphylococcus aureus (34.8%), Streptococcus pneumoniae (2.6%) and
Haemophilus inﬂuenzae (0.9%). All patients received antibiotic
therapy.
Conclusion: The results of this study have stated a remarkable role of
Klebsiella pneumoniae (61.8%) and Staphylococcus aureus (34.8%) in
severe adult CAP.
R2778 Community-acquired pneumonia in an internal medicine
service
C. Armin˜anzas*, L. Velasco, N. Calvo, R. Portilla, J. Riancho,
C. Valero (Santander, Torrelavega, ES)
Objective: Community-acquired pneumonia (CAP) is a leading cause
of death from infectious disease in western countries. The mortality is
reported to be about 10%. The aim of this study was to analyze
mortality in patients with CAP admitted to an Internal Medicine service
and to study the value of the CURB-65 score as a prognostic tool.
Methods: The prospective cohort study was conducted at Hospital
Sierrallana (Torrelavega, Spain) from March to October 2010. All
patients admitted with CAP to the Internal Medicine Service were
prospectively recorded. Clinical and epidemiological data and
laboratory ﬁndings were examined. The CURB-65 score and the
Charlson Cormobidity Index were calculated. Sensitivity, speciﬁcity,
positive predictive value and negative predictive value were assessed.
All data were analysed and processed with the SPSS version 15.0.
Results are expressed as frequencies or as mean ± standard desviation.
Results: During the study period, there were 539 in-patients admitted
to the Internal Medicine service, 39 (7%) with CAP (64% men and 36%
women). The mean age was 78 ± 11 years and the mean duration of
stay was 7 ± 6 days. One patient was admitted to Intensive Care Unit
(ICU). According to CURB-65 criteria on admission, ﬁve patients
presented low risk (13%); 15 intermediate risk (38%) and 19 high risk
(49%), without signiﬁcant sex-related differences. According to the
Charlson Comobidity Index on admission, 13 patients (33%) presented
high risk (44% men; p < 0.01). The most common chronic diseases
causing comorbidity were pulmonary disease (31%) and dementia
(28%). Overall, 30-day mortality was 20%. The mean age of patients
who died was 82 ± 2 years, 50% were men. The CURB-65 score was
signiﬁcantly associated with the risk of death. The positive predictive
value for a fatal outcome of high risk CURB-65 was 40%.
Conclusions: Seven percent of patients admitted to the Internal
Medicine service presented CAP. Mortality was higher than in
previous studies, which could be associated with the older age and
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comorbidity of our patients. The CURB-65 score can also be used in
these patients to assess pneumonia severity and the risk of death.
Lyme borreliosis, toxoplasmosis
R2779 Molecular identiﬁcation of Borrelia spirochetes isolated
from skin biopsies of patients characterised with an
unusual dermal manifestation (prurigo pigmentosa) in
Taiwan
L.L. Chao, C.F. Lu, C.M. Shih* (Taipei, TW)
Objectives: To identify the genetic identity of Borrelia spirochetes
isolated from skin biopsies of patients characterized with an unusual
skin manifestation in Taiwan.
Methods: Serum samples and skin biopsy specimens were collected
from patients in Taiwan. Serodiagnosis was performed by Western
immunoblot assay and Borrelia spirochetes were isolated by culturing
of skin biopsies. Total genomic DNA was extracted from individual
culture by using DNeasy Tissue Kit (Qiagen). The genetic identity of
Borrelia spirochetes were determined by analyzing the gene sequences
ampliﬁed by a genospecies-speciﬁc polymerase chain reaction (PCR)
assay based on the 5S-23S intergenic spacer amplicon gene of Borrelia
spirochetes. Aligned sequences were analyzed by neighbor-joining (NJ)
compared with maximum parsimony (MP) methods to estimate the
phylogenetic relationships of these detected spirochetes.
Results: Serological evidence ofB. burgdorferi infectionwas conﬁrmed
by elevated IgG and IgM antibodies against protein antigens of B.
burgdorferi. A total of 10 patients were examined by Borrelia cultures
and tested by PCR assay. Phylogenetic analysis reveals that all those
detected spirochetes constitute two major separate clades distinguished
from other Borrelia genospecies in both NJ and MP methods. Within
these clades, two isolates of Borrelia spirochetes detected in skin cultures
were closely related to the genospecies of B. garinii and one isolate were
closely related to the genospecies of B. afzelii.
Conclusion: Our results describe the ﬁrst identiﬁcation of B. garinii
and B. afzelii spirochetes isolated from skin biopsies of patients
characterized with an unusual skin lesion of prurigo pigmentosa in
Taiwan. Further investigations on Borrelia spirochetes detected in
patients with various clinical manifestations would beneﬁcial to the
better understanding of genetic diversity of Borrelia spirochetes in
Taiwan.
R2780 Detection of Borrelia burgdorferi sensu lato in urine
specimens from patients with early and late Lyme
borreliosis
T. Gladnishka, E. Tasseva, I. Trifonova, V. Ivanova,
I. Christova* (Soﬁa, BG)
Objectives: Detection of Borrelia burgdorferi by polymerase chain
reaction (PCR) in blood from patients with Lyme disease is often not
enough effective to ensure reliable diagnosis. The aim of this study was
to investigate appropriateness of urine and blood specimens for
diagnosis of Lyme disease by PCR.
Methods: Urine and blood samples from 228 patients with symptoms
attributable to Lyme disease were investigated by PCR. Of them, 81
patients were with typical erythema migrans and were not treated with
antibiotics, 92 were with treated with antibiotics erythema migrans and
55 presented with symptoms of early disseminated and late Lyme
borreliosis.
Results: B. burgdorferi was detected only in patients with untreated
erythema migrans. The diagnosis was conﬁrmed in 10 (12.3%) of 81
patients. The etiologic agent was detected in urine of 4/59 (6.8%)
patients and in blood plasma of 6/81 (7.4%) patients.
Conclusion: Our results demonstrated that B. burgdorferi could be
detected by PCR before speciﬁc IgM antibodies appearance and that
PCR testing of urine samples may add to effectiveness of this diagnostic
method in Lyme disease conﬁrmation.
R2781 Lyme borreliosis and tick-borne encephalitis in Latvia: a
comparative study of cases reported in 2007–2010
I. Lucenko*, F. Arsa, A. Bormane, J. Perevoscikovs, L. Rohlina,
J. Storozenko, J. Troﬁmova, B. Rozentale, L. Viksna, G. Brigis,
A. Krumina (Riga, LV)
Background: Tick-borne encephalitis (TBE) has been registered in
Latvia since 1955, Lyme borreliosis (LB) – since 1986. The annual
incidence rate during 2001–2010 ranged from 21.5 to 36.9 per 100 000
population for LB and from 7.5 to 22.0 – for TBE with the highest
incidence rates in 2010. The objective of the study was to describe main
epidemiological and some clinical characteristics of LB and TBE in
order to improve public health advice.
Materials and Methods: Reports for notiﬁed individual cases of LB
and TBE were analyzed for 2007–2010 with EpiInfo software.
Retrospective epidemiological analysis covered incidence rates by
territories, age and gender groups, seasonality, data on exposures,
hospital admission rates and length of hospital admission, data on
laboratory conﬁrmed diagnosis, as well data on tick activity and
pathogen prevalence.
Results: Altogether, 2664 cases of LB and 1177 cases of TBE were
reported during the study period, including 75 co-infection cases with
TBE and LB. The total number of LB cases 2.3 times exceeded the
number of TBE cases, ranging from 3.7 in 2007 to 1.7 in 2010. The
incidence rates of LB, TBE and co-infection varied by territories.
Male/female ratio was 0.53 for LB and 1 – for TBE patients. Mean
age of LB patients was 47.4 years (SD ± 18.2, range from 15 months
to 88 years); mean age of TBE patients was 46.6 years (SD ± 18.2,
range from 14 months to 87 years). Proportion of cases occurred
outside of tick activity season was higher in LB cases. 67.3% (95%
CI: 65.5–69.1%) of LB patients and 63.5% (95% CI: 60.7–66.3%) of
TBE patients reported tick bite prior to disease onset. TBE patients
were more likely to be hospitalized than LB patients (RR 28.9; 95%
CI: 21.5–38.8, p < 0.05). On average, patients with single LB or TBE
infection were hospitalized for accordingly 11.9 and 12.7 days.
Comparing to LB cases, patients with LB/TBE co-infection were
older, had higher hospitalization rate and stayed in hospital on average
3 days longer.
Conclusions: The results of the study revealed more or less similar
trend in age distribution and hospitalization lengths; differences
included unequal territorial distribution, higher hospitalization rate for
TBE patients, and much higher proportion of LB women patients. Due
to growing relevance of tick borne infections in Latvia it is necessary to
sustain physicians and public awareness at high level for early
diagnostic measures, as well conduct regular monitoring of disease
careers and pathogens.
R2783 A rifampicin-containing antibiotic regimen is associated
with better outcome in vascular graft infections
S. Erb*, L. Elzi, J. Sidler, L. Gu¨rke, M. Battegay, A.F. Widmer,
W. Maja (Basel, CH)
Background: Vascular graft infection is a life-threatening
complication after vascular surgery. Little is known about the optimal
antibiotic management.
Methods: Ten-year retrospective analysis of all patients (pts) with
vascular graft infection in a tertiary hospital between 2001 and 2011.
Treatment failure was deﬁned as death from graft infection and/or
persistence of clinical or radiological signs compatible with vascular
infection at 1 year after diagnosis. Cox proportional hazard models
were used to estimate the hazard ratios (HR) of treatment failure at
1 year.
Results: Sixty-one points were included in this preliminary analysis.
Characteristics: 52 males (85%), median age 65 years (IQR 57–70),
cardiovascular comorbidity in 90% and diabetes in 16% of pts. Most pts
(84%) received an aortic graft due to aneurysm, combined with valve
replacement in 15 pts, and 16% received peripheral vascular graft due to
Lyme borreliosis, toxoplasmosis 837
occlusive arterial disease. The median time to vascular graft infection
was 37 days (IQR 9–267) after surgery. Wound secretion and fever
were observed in 18% and 49% of pts, respectively. Coagulase-negative
staphylococci and Staphylococcus aureus were the most frequent
microorganisms (40%). Polymicrobial infections were found in 34% of
pts. All pts were treated with antibiotics and 74% underwent surgical
revision with graft replacement in 9 pts and extra-anatomical bypass in
8 pts. The median antibiotic therapy was 41 days (IQR 17–78). During
the follow-up, 17 pts experienced treatment failure, 10 of those died
from graft infection with a median time to death of 20 days (IQR 12–
59) after diagnosis, i.e. 1-year success rate was 72%. In univariate
analysis, risk factors of treatment failure at 1 year were older age (HR
2.0, 95% CI 1.2–3.3, p = 0.004, per 10 years increase), high C-reactive
protein (HR 1.3, 95% CI 1.1–1.6, p = 0.013, per 50 mg/L increase),
whereas infection with gram positive microorganisms (HR 0.2, 95% CI
0.1–0.6, p = 0.007) and a rifampicin-containing antibiotic regimen (HR
0.1, 95% CI 0.05–0.5, p = 0.009) were associated with better outcome.
In multivariate analysis, after adjustment for age, vascular graft, C-
reactive protein, microorganism and surgical treatment, an antibiotic
regimen containing rifampicin was associated with lower risk of
treatment failure (HR 0.1, 95% CI 0.1–0.8, p = 0.028).
Conclusions: Rifampicin-containing regimen signiﬁcantly improved
outcome in vascular graft infections in this study, as previously
observed in orthopedic implant-associated infections.
R2784 Can bacterial infection be predicted in clinical trials on
acute exacerbations of chronic obstructive pulmonary
disease (AECOPD)? A retrospective analysis from the
MAESTRAL patient cohort
R. Wilson*, S. Sethi, M. Miravitlles, A. Anzueto, J. Alder,
D. Haverstock, P. Arvis, A. Shorr (London, UK; Buffalo, NY;
Barcelona, ES; San Antonio, TX; Monteville, CT; Loos, FR;
Washington, US)
Objective: Acute exacerbations of chronic obstructive pulmonary
disease (AECOPD) studies with improved design and modern methods
have established that approximately 50% of exacerbations are caused
by bacterial infection. In the MAESTRAL study, enrolling 1492
chronic bronchitis outpatients with moderate-to-severe COPD and an
Anthonisen type 1 exacerbation, bacteria were isolated from sputum in
49% of the patients at enrolment. Using the MAESTRAL database, the
objective of this analysis was to build up a scoring system that was easy
for physicians to use, which could help predict bacterial infection in
AECOPD patients.
Methods: This analysis ﬁrst identiﬁed independent predictors
associated with the presence of bacteria at baseline using a
multivariate logistic regression method. These independent predictors
were evaluated in terms of their frequency.
Results: The following factors were found to be independently
associated with the presence of bacteria at enrolment: age ‡65 years/
<65 years (51.6%/42.0%), history of cardiopulmonary disease (yes/no)
(58.6%/47.7%), FEV1 predicted (‡30%/<30%) (50.6%/44.0%), sputum
viscosity (very thick/not very thick) (55.6%/48.1%), colour of purulent/
mucopurulent phlegm at AECB-SS (green or brown/other colours)
(54.4%/47.0%), wheeze at enrolment (yes/no) (50.4%/43.0%), anti-
cholinergics use (yes/no) (57.9%/47.7%). Although these were all
statistically signiﬁcant effects, the actual difference between categories
did not exceed 10.9% and there was no category with an organism rate
higher than 58.6%. When these factors were pooled and at least four of
them were present, the probability of the presence of bacteria was
60.9% (Table). With ﬁve or more factors simultaneously occurring in
patients, the rate was 68.2%, but only a few patients had all these
factors. There were no patients with all seven factors present
simultaneously.
Conclusion: This analysis suggests that using the combined
independent factors listed above would have increased the proportion
of bacterial infections in patients with an Anthonisen type 1
exacerbation, by only 10% in the MAESTRAL study. Applying
additional risk factors to deﬁne a patient population would provide little
beneﬁt on increasing the proportion of patients with bacteria and would
be too restrictive during enrolment.
R2785 A comparative randomised clinical trial against semi-
synthetic penicillins and glycopeptides supports the use of
daptomycin as ﬁrst-line treatment of complicated skin and
soft-tissue infections in the elderly
A. Konychev*, M. Heep, R.K.C. Moritz, A. Kreuter, A. Shulutko,
G. Fierlbeck, K. Bouylout, R. Pathan, R. Chaves (St. Petersburg, RU;
Basel, CH; Bochum, DE; Moscow, RU; Tu¨bingen, DE; Hyderabad, IN)
Objectives: Staphylococcus aureus is the leading pathogen in skin and
soft tissue infections (SSTIs). In comparison to anti-methicillin resistant
S. aureus (MRSA) agents, including linezolid/tigecycline/
glycopeptides, daptomycin has the most potent in-vitro activity
against Gram-positives causing complicated SSTI, including
methicillin susceptible S. aureus /MRSA. As therapy is initiated
before availability of culture data, antibiotic coverage equally active
against MSSA and MRSA is advantageous. Daptomycin’s superior
potency is a strong rationale for its use in empirical treatment,
especially in the elderly. The objective of this study was to assess the
effectiveness of daptomycin in the elderly.
Methods: Phase IIIb open label multicentre randomised study to assess
safety/efﬁcacy of i.v. daptomycin (4 or 6 mg/kg q24 hours) vs. pooled
i.v. comparators (semi-synthetic penicillin 2 g q4 hours/6 hours or
vancomycin 1 g q12 hours). Patients aged ‡65 years with cSSTIs with
or without bacteraemia, treated for 14–28 days (stratiﬁed by baseline
CrCl). The primary objective was to descriptively compare clinical
success at the test of cure (TOC) 7–14 days after the end of treatment in
the clinically evaluable (CE) set. Secondary objectives were
microbiological outcome and safety.
Results: One hundred and twenty patients were randomised (81 to
daptomycin; 39 to comparator) and 102 completed the study. Baseline
characteristics were comparable in both groups. The most common
infection was cellulitis; other common infections were ulcers and
abscesses. Six patients had bacteraemia (daptomycin 4, comparator 2).
Clinical success at TOC was numerically higher for daptomycin vs.
comparator in the overall CE population (89% 65/73 vs. 83% 25/30,
blinded) and in patients with S. aureus (90% 35/39 vs. 69% 9/13). In the
full analysis set (nonevaluable response = failure) the clinical success
was 82% for daptomycin and 72% for comparator. Rates of adverse
events (AEs) and serious AEs were similar (respectively, 63% and 9%
for daptomycin vs. 65% and 10% pooled comparator), rates of
discontinuation due to signiﬁcant AEs or SAEs were lower for
daptomycin (4% vs. 10%).
Conclusion: Further studies are warranted to determine whether early
use of anti-MRSA treatment in SSTI in settings with elevated MRSA
rates may result in improved outcomes such as lower mortality, shorter
length of hospital stay and lower total treatment costs. Results of the
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present study support the use of daptomycin as ﬁrst-line treatment of
cSSTIs in elderly.
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R2786 Childhood brucellosis-osteoarticular manifestations
E. Dimitrovska*, D. Balalovski, D. Galovska, B. Velova (Bitola, MK)
Objectives: Since 1980, brucellosis in Macedonia has persisted as an
endemic and epidemic infectious disease of cattle and people too. The
aim of this paper is to show the osteoarticular manifestations of human
brucellosis in children.
Methods: This paper is a retrospective study of patients under 14 years
of age, infected with brucellosis with predominant damages of the
osteoarticular system. We have been working with a group of 49
children between 3 and 14 years of age. Nineteen patients were from
Bitola, and 30 from its surrounding villages. 23 patients were female,
and 26 male. The diagnosis was set according to the serum parameters
(Rose-Bengal, Wright, Coombs, RVK Brucellae, ELISA), Rtg,
scannographic, and KTM.
Results: Predominant symptoms were: fever (in 100% of the patients),
sweating (85%), exhaustion (80%). Osteoarticular symptoms were
evident in 64% of the patients: pain, limited mobility, almost
immobility, with or without swollen joints. In 67%, the big joints of
the lower limbs were infected, in 29% the joints of the upper limb, and
in 4% the spinal and pelvic joints. Monoarticular form was present in
41%, and poliarticular in 59% of the children. All of the children had
arthralgia, and complete immobility was present in 12%. The treatment
lasted between 30 and 42 days; streptomycin and cotrimoxasol,
rifampiciyn and cotrimoxasol were used, and also doxicycline was
used in the treatment of children over 8 years of age. Relapse of the
infection was registered in 6.3%, whereas sequel in a form of aseptic
necrosis was registered in only one of the patients.
Conclusion: Human brucellosis is a grate health problem in the region
of Bitola, R. Macedonia. It is important to organize more serious health
education and very severe sanitary and veterinary control of the cattle,
meat, milk and dairy products in order to eradicate the disease.
R2787 Urinary tract infection in a paediatric hospital in southern
Iran
A. Zare*, F. Emamghoreishi, F. Navabi, S. Zare,
F. Nikoosefat (Bandar Abbas, IR)
Objectives: Urinary tract infections (UTI) are the most common
infections in children and their complications result in signiﬁcant
morbidity and mortality and consume resources. The aim of this study
was to ﬁnd out the incidence and distribution of urinary tract infections
in childhood in south of Iran and analysis their clinical presentation.
Methods: In this cross sectional study, during a 6-month period, 125
children who admitted to the pediatric hospital for treatment were
prospectively investigated. Demographic characteristics, clinical and
paraclinical ﬁndings, organism type, their sensitivity and drug
resistance based on antibiogram were recorded in a pre-designed
checklist. UTI was deﬁned by >10 organisms/mL on laboratory culture
of urine.
Results: Of 125 children, UTI rate in female children was signiﬁcantly
higher than that in male children (55% vs. 45%, p < 0.05). The greatest
proportion of the patients was in 1–12 months age group (33%, n = 41)
and then in 5–9 years age group (26%, n = 32). The most common
symptom was fever, which was found in 79% of the cases. Some of
non-speciﬁc symptoms were found in 75% of the children, with the
highest rate in <2 years old children. Speciﬁc symptoms were mostly in
older children. There was a signiﬁcant relationship between age and the
symptoms (p < 0.05). Most common causative organism for both
genders and in all age groups was E-coli (74%). Klebsiella was
common organism in both genders, but more prevalent in under 2 years
old children. There was no signiﬁcant relationship between organism
type and gender, but it was signiﬁcant in different age groups. The
greatest susceptibility of E-coli and Klebsiella was to ampicillin, septrin
and gentamicin and Proteus showed susceptibility to septrin. Kidney
sonography of 42 children showed abnormalities such grade four reﬂux,
urinary stone and hydronephrosis in seven children.
Conclusion: The main objectives in childhood urinary tract infections
are rapid recovery from complaints and prevention of infection-related
complications. Predominant organisms causing the infection were E-
coli, Klebsiella and Proteus, whereas they show susceptibility to
ampicillin, septrin and gentamicin. Consequently, further studies should
be conducted to establish a guideline for management of these
infections and to recognize innovative practical approaches in order
to control the infections.
R2788 Two year study of neonatal intensive care unit blood
cultures in a Greek maternity hospital
A. Varvaressou, A. Dimitroulea*, A. Stamnidi, D. Konstantinou,
E. Charvalos (Athens, GR)
Objectives: The purpose of this study was the assessment of blood
culture isolates and their antibiotic sensitivities in the neonatal intensive
care clinic of the IASO Maternity hospital.
Material and Methods: The study concerns the blood cultures of two
ntensive care unit (ICUs) out of four of the IASO Maternity Hospital.
Blood cultures have been performed by the Bactec system. Antibiotic
sensitivity was accomplished by the Kirby Bauer method on Mueller
Hinton agar.
Results: Out of 8224, four hundred ninety one (491) blood cultures
were positive. The pathogenic microorganisms isolated were as follows:
75.4% Staphylococcus epidermidis, 5.3% Escherichia coli, 4.5%
Enterococcus, 3.6% Streptococcus group B, 3% Enterobacter
cloacae, 1.4% Serratia marcescens, 0.4% Klebsiella pneumoniae,
0.4% Pseudomonas aeruginosa and 6% Candida spp. (Candida
albicans and Candida krusei). Penicillin G, exhibited the lowest
percentage of sensitivity among both Gram positive and Gram negative
species. Imipenem was the most efﬁcient antibiotic with the highest
percentage of sensitivity among gram negative. Most of the isolates
(100% gram + and 90% gram-) showed a b-lactamase activity which
was reversed in the presence of clavulanic acid. Resistance to second
generation cephalosporins was highly prevalent for Gram positive, but
90% of Gram negative isolates were sensitive. Resistance to third
generation cephalosporins was prevalent in 50% of gram positive
strains, and about to 10% of gram negative with the exception of one
strain of Serratia marscecens which was highly resistant to most of the
b-lactam antibiotics. Gram negative strains showed 100% and gram
positive strains showed 80% sensitivity respectively to ciproﬂoxacin.
Resistance to vancomycin was shown in only 1% and to teicoplanin to
7% respectively of the S. epidermidis isolates. Among the
aminoglycosides, netilmicin showed the highest percentage of
sensitivity both for gram positive and gram negative strains.
Conclusions: We conclude that the most common microorganism
isolated in blood cultures of our neonate ICU is Staph. epidermidis and
that the most resistant phenotype was shown in only one Serratia
marcescens isolate. About 95% of Candida spp. were sensitive to the
azoles. Until now the management of ICU neonates with positive blood
cultures was efﬁcient and without treatment failure. We however are
vigilant and we accomplish a monthly protocol for the survey of
microbial carriage and antibiotic sensitivity in the ICU.
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R2789 Effects of usage of immunomodulators of different
pharmacological groups on eradication and immune
indexes in Helicobacter pylori induced peptic ulcer disease
V.B. Kuzin, V.V. Dugina, G. Kughan* (Nizhny Novgorod, RU)
Objectives: 1 To investigate inﬂuence of immunomodulators Licopid
(synthetic bacterial preparation) and Derinat (nucleic acid preparation)
in combination with antihelicobacter ‘‘quadro-scheme’’ therapy (QST)
on efﬁciency of eradication in patients with peptic ulcer disease (PUD)
caused by H. Pylori (HP).
2 To reveal interrelation of changes of intensity of speciﬁc (levels of
Immunoglobulins and population T-lymphocytes) and non-speciﬁc
immunity (lysozyme activity in saliva and gastric juice).
Methods: 1 This research is carried out on 75 patients within the age
range of 20–55 years with PUD of stomach caused by HP.
2 Depending on types of received therapy, three groups of patients have
been allocated:-
(i) Group A (control group) consisting of 25 patients receiving
‘‘quadro-scheme’’ therapy (QST) consisting of bismuth colloidal
subcitrate, omeprazole, amoxicillin and clarithromycin.
(ii) Group B of 25 patients receiving QST with Licopid
(iii) Group C of 25 patients receiving QST with Derinat
3 Before and 6 weeks after treatment, the histomorphological tests of
biopsy material taken endoscopically from stomach, blood immune test
and nephelometric test of saliva and gastric juice from patients are done.
Results: Six weeks after treatment, cytological tests revealed that in
Group A, parameter of eradication (percentage of absence of H. Pylori
on biopsy samples) is essentially higher in Group B and C (p < 0.01)
compared to Group A. Presence of coccal (resistant) forms are noted in
Group A but are absent in Group B and C. Blood immune test revealed
that levels of CD-3, -4 and -8 T-lymphocytes and Immunoglobulin A,
M and G are increased in Group B and C (p < 0.01 compared to initial
level). In contrast, their levels are decreased in control Group A. The
maximal authentic increase of lyzosymal activity in saliva and gastric
juice is observed in Group B (p < 0.01 compared to initial level)
whereas in Group C its activity reliably increases (p < 0.05). In Group
A, the lowest increase in lyzosymal activity of saliva and gastric juice is
obtained (p > 0.05).
Conclusion: Usage of immunomodulators in combination with QST
leads to increased eradication of HP and improvement of immune
indexes, more pronounced at application Licopid. In this connection,
combination of immunomodulators with QST can be recommended for
effective eradication of H. Pylori in patients with secondary
immunedeﬁciency and prevention of serious complications of PUD
(malignancy, bleeding, perforation, etc).
R2790 Varicella zoster antibodies among patients with chronic
renal failure candidate for renal transplantation in a
referral teaching hospital, Tehran, Iran
M. Talebi-Taher*, S.H. Osareh, T. Hassanzadeh (Tehran, IR)
Objectives: This study was designed to evaluate the immune status of
patients with chronic renal failure (CRF) candidate for renal
transplantation in a referral teaching hospital, Tehran, Iran, and to
compare the history of chickenpox infection with the presence of
varicella antibodies in this population.
Methods: In this cross-sectional prevalence study serologic testing for
varicella zoster was performed for 187 patients with CRF between
January and May 2010. A checklist was completed including
demographic data and the history of varicella. Individuals with acute
varicella infection, those under immunosuppressive therapy, or those
having blood transfusion during the year 2009, were excluded from the
study. Blood samples were collected from each individual and the
separated serum was stored at -20 centigrade prior to testing. EIA for
varicella-speciﬁc IgG was performed using commercial virus-speciﬁc
IgG EIA kits (varicella IgG EIA well, RADIM, Italy; sensitivity 100%,
speciﬁcity 88%). Statistical analysis was performed using the spss 15
software. The p value of <0.05 was considered statistically signiﬁcant.
We compared the history of varicella infection in patients with the
results of testing for antibody against varicella zoster antigen to assess
the reliability of the history of varicella in this population. Sensitivity,
speciﬁcity, positive predictive value (PPV), and negative predictive
value (NPV) were calculated.
Results: One hundred and eighty seven patients evaluated in this
study, 49.2% were female and 50.8% were male. Mean age was
57.51 ± 16.17 years. One hundred and thirteen (60.42%) patients
didn’t have any history of varicella disease. One hundred and eighty
three patients (97.86%) had positive antibody titers. Mean age of
seronegative patients was signiﬁcantly lower than seropositive patients
(29.50 ± 10.41 vs. 58.13 ± 15.74, p value<0.001). Logistic regression
reveals correlation between age and antibody titer (B = 0.132, p
value<0.001). Sensitivity, speciﬁcity, PPV, and NPV of the history of
varicella for the seropositivity were 39%, 50%, 97%, 1.7%
respectively.
Conclusion: Most of kidney transplantation candidate in our study
were seropositive and patients age was correlated to seropositivity,
nevertheless the vzv antibody titer evaluating seams necessary in these
patients. Negative history for varicalla zoster infection is not reliable to
consider patients as seronegative.
R2791 Immune response to Cryptosporidium parvum in immuno-
competent mice
V. Codices*, C. Martins, C. Novo, M. Pinho, B. de Sousa, Aˆ. Mendes,
M. Borrego, O. Matos (Lisbon, PT)
Objectives: Cryptosporidium parvum is an intracellular parasite
causing enteritis which can become life-threatening in
immunocompromised host. Immunoregulatory T cells (Tregs) play a
central role in the regulatory network of the host. Speciﬁc therapeutic or
preventive interventions are not yet available so understanding the
immune response to the parasite is required. In this study, we propose to
characterize cell composition in peripheral blood and spleen through
infection and reinfection with C. parvum.
Methods: Speciﬁc-pathogen-free BALB/C mice were inoculated with
1 · 106 oocysts of C. parvum at days 0 and 22. Fecal and blood
samples, spleens and small intestines were collected for analysis on
speciﬁc days. Immune cells were characterized, by ﬂow cytometry, in
peripheral blood and spleen samples.
Results: The presence of gDNA of C. parvum in feces was conﬁrmed
after a nested PCR of the gp60. Small intestine sections from infected
mice were screened for intracellular stages of the parasite, which could
be observed in the villi of the intestine, although no evidence of
pathology has been observed. After infection, mice presented higher
values of neutrophils, eosinophils, NK cells and CD4 + CD25high T
cells (days 0–21) in peripheral blood. After reinoculation, this upward
tendency was maintained in the following days in infected mice, for all
the four populations. At day 35, the values observed in infected mice
were close to the control group values, except for CD4 + CD25high,
which maintained higher values in infected mice. Statistical analysis
using the nonparametric Mann–Whitney test showed a greater
variability after reinfection stage. Despite the small sample size, the
greater variability observed after reinfection stage might be age-related,
which is particularly relevant in conditions of disease, and probably due
to the different maturation of the immune system.
Conclusion: Our data presents preliminary information which seems to
be important for the knowledgment of the speciﬁc cell-mediated
response to the infection by C. parvum in immunocompetent mice.
These data it is expected to contribute for a better understanding of the
role of innate and Treg cells in the initial clearance process of this
parasite. Complementary studies are needed to clarify the role of innate
immune response in the context of C. parvum infection, and to
corroborate the results presented in this work.
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R2792 Luminex xMAP: high-throughput technology for
quantiﬁcation of cytokines and immunoglobulins in
Cryptosporidium parvum infection
V. Codices*, C. Martins, C. Novo, B. de Sousa, M. Borrego,
O. Matos (Lisbon, PT)
Objectives: Cryptosporidium parvum is the enteric parasite most
frequently associated with diarrhea outbreaks. Infection with this
organism triggers a complex array of innate and cell mediated immune
response. To date, there are no studies applying the Luminex
technology to determine proﬁles of cytokines and immunoglobulins
in the context of an infection by C. parvum. In this study, we intent to
analyze these immune mediators in serum of mice inoculated with C.
parvum oocysts, using a Luminex xMAP technology.
Methods: Speciﬁc-pathogen-free BALB/C mice were inoculated with
1 · 106 oocysts of C. parvum at day 0 and re-challenged at day 22.
Peripheral blood was aseptically collected from mice euthanized, on
speciﬁc days, and serum was obtained after centrifugation. Two kits
were used to assess and quantify mouse cytokines and
immunoglobulins in serum, respectively: the Bio-Plex ProTM Mouse
Cytokine Standard Group I 23-Plex and the Milliplex MAP Mouse
Immunoglobulin Isotyping, using the xMAP technology. Both assays
were performed according to the manufacturer’s instructions.
Results: Infection was conﬁrmed by the presence of C. parvum DNA
in feces, collected from each group of mice, by a nested PCR of the 60-
kDa glycoprotein. The preliminary analysis showed a signiﬁcant
increase of IgM during the primary infection and a decrease after
reinfection as expected. A signiﬁcant rise of IgA and IgG2a was
observed after reinoculation. The analysis of the produced cytokines
suggests a preferential Th1 over the Th2 response, with the consequent
production of IFN-gamma, TNF-alfa and IL-12 over IL-5 and IL-10.
Conclusion: This work aims to understand how the immune system
responds to an infection by C. parvum. In this context, the greatest
advantage of using Luminex xMAP technology is allowing the
quantiﬁcation of the small amounts of immunoglobulins and cytokines
produced during this infection in an animal model, from a single small
volume sample.
R2793 Impaired early intravaginal cell recruitment in response
to Chlamydia muridarum in mice pretreated with
progesterone
N. Kobets, E. Koroleva, N. Zigangirova* (Moscow, RU)
Objectives: Chlamydia is a widely spread chronic urogenital infection
that essentially affects reproduction health worldwide. There is well
acknowledged evidence that Chlamydia infection induces a range of
immunopathological reactions, while the components of early immune
response that might lead to protection from re-infection require further
elucidation. It is also well established that progesterone treatment can
boost the host susceptibility to Chlamydia and increases its acute
infectivity and shedding. However, the effects of progesterone
treatment on long lasting immunity to the pathogen and control of re-
infection has not been assessed. In this study we are analyzing the early
local responses to intravaginal C. muridarum primary infection in mice
treated with covinan (progesterone analogue) and their responses to the
secondary infectious challenge.
Methods: Mice were infected intravaginally with 106 IFU of
Chlamydia and numbers and phenotypes of cells from vaginal washes
were analyzed 24 hours post infection (PI) by ﬂow cytometry.
Results: We have found that Chlamydia intravaginal infection induced
very robust cell recruitment in mice untreated with progesterone
24 hours post infection (10-fold increase compared to uninfected
controls and 30-fold increase compared to covinan-treated mice).
Interestingly, uninfected but covinan-treated mice had increased
numbers of recruited cells compared to intact control. Phenotype
study of cells from vaginal washes revealed the increase in percentage
of Gr-1+ cells (neutrophils) and CD11c+CD86+ (activated dendritic
cells) in infected but covinan-untreated compared to intact controls.
Covinan-pretreated infected mice had decreased levels Gr-1+ cells and
completely none of CD11c+ cells, while covinan-pretreated uninfected
control had apparent CD11c+CD86+ cell population (none of these
cells were found in intact control) We also observed an increase in
CD8 + T cells in both infected groups (slightly higher in covinan-
untreated mice) compared to uninfected controls. Cytokine proﬁles and
responses to secondary infectious challenge of covinan pretreated mice
are currently under the study.
Conclusion: Our preliminary results demonstrate that early
introvaginal recruitment of neutrophils and dendritic cells seems to be
impaired in Chlamydia infected progesterone pretreated mice, while T
cells are still recruited. Whether this affects the ability to control re-
infection in our model needs further investigation.
R2794 Tumour necrosis factor -308 G/A and 238 G/A
polymorphism: has it any role in the course of infective
endocarditis?
E. Giannitsioti*, G. Damoraki, C. Rokkas, A. Fragou, M. Mouktaroudi,
T. Tsaganos, S. Kanellaki, E. Giamarellos-Bourboulis (Athens, GR)
Objectives: The role of single nucleotide polymorphisms (SNPs) of
the TNF gene in infective endocarditis (IE) remains unknown. The
impact of SNPs at the promoter regions -308 (G/A) and -238 (G/A) of
the Tumour necrosis factor (TNF) gene in the physical course of IE was
studied.
Methods: Sampling was done from 82 patients with deﬁnite IE and
from 108 healthy Greek individuals. Genomic DNA was extracted from
whole blood by the Puregene kit. The TNF 308G/A and 238 G/A SNPs
were detected by polymerase chain reaction, incubation with the
enzyme NcoI and electrophoresis of the restriction fragments. Clinical
data were recorded.
Results: For the 308 SNP, 67 patients were carriers of both wild-type
G alleles; 13 patients were heterozygotes for the SNP A allele; and two
patients was homozygous for both SNP A alleles. Respective
frequencies within the 108 controls were 92, 14 and two patients
(pNS) For the 238 SNP, 68 patients were carriers of both wild-type G
alleles; and 14 patients were heterozygotes for the SNP A allele.
Respective frequencies within the 108 healthy controls were 104 and 4
(p: 0.003 vs. patients). Double SNP phenotype (-308 and -238) was
associated with death (OR: 7.0, 95% CI 1.0–48, p = 0.05) in a
multivariate logistic regression model adjusted for diabetes mellitus,
female gender and persistent bacteremia.
Conclusions: These results denote for the ﬁrst time a role of SNPs of
genes related with the immune function in the physical course of IE.
R2795 IgG antibody response to Plasmodium falciparum schizont
extract
A. Khosravi*, E. Asadollahy (Ilam, IR)
Background: Schizont extract can be obtained from malaria culture
using each plasmodium falciparum isolate and also can be used as a fast
and easy method to evaluate the immune response against malaria. The
current study aimed to evaluate the age dependent immune response
against crude shizont extract.
Materials and Methods: Age-dependent immunity was analysed
testing the sera of 179 individuals, randomly selected from the
Keneba Serum Collection using crude schizont extract. Cultivation of
the erythrocyte stages of P. falciparum was done according to the
technique of Trager and Jensen. Crude schizont extract was obtained
using centrifugation methods. Schizonts were concentrated from culture
either by using the plasmagel ﬂotation technique or the Percoll gradient
technique according to modiﬁcation of methods described by Kramer
and Lambros & Vanderberg. Total IgG and IgG subclasses was
measured using ELISA. Data were analyzed using Spearman
correlation method, ANOVA and Post hoc analyses methods.
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Results: About 78% of the individuals within all age groups had IgG
responses to schizont extract with the mean OD values above the cut-
off. 66% of individuals whose IgG responses to the schizont extract
were below the cut-off belonged to the 0–5 year ages and only 2.5%
belonged to the age group 51+. About all individuals in age group 16–
30 and 91% of those in age group 51+ showed IgG responses higher
than background to schizont extract. The correlation between age and
OD values to schizont extract was positively signiﬁcant (r = 0.296 and
p < 0.01).
Conclusion: Most sera strongly recognized the crude schizont extract
in an age dependent manner while these responses were associated with
an increase in haemoglobin levels and a decrease in parasitaemia,
suggesting that IgG response to crude schizont extract may be a useful
mean for further studies of protective immunity against plasmodium
falciparum.
Vaccines
R2796 Efﬁcacy of hepatitis B vaccination in Iranian thalassaemic
patients
S. Zare*, A. Nazemi gheshmi, A. Zare on behalf of the Hormozgan
infectious and tropical diseases research centre
Objectives: Thalassemia is still a major health problem in south of Iran
and thalassemic patients are at risk of transmission infection diseases
such as hepatitis B. The aim of the present study was to examine the
efﬁcacy of vaccination against hepatitis B in thalassemic patient in a
thalassemia centre in south of Iran.
Methods: A random sample of 406 thalassemic patients including
major thalassemia, sickle thalassemia, intermediate thalassemia who
had regular blood transfusion and had received a full course of vaccine
against hepatitis B were investigated. Antibody levels after vaccination
were measured by an enzyme immunoassay method. Levels >10 mIU/
mL were considered to show a positive response.
Results: Of 406 patients, 69.70% of the cases were with major
thalassemia, 19.46% intermediate thalassemia and 10.84% sickle
thalassemia. One hundred and ninety-six cases (48.28%) were male
with mean age of 13.3 years (SD=7.3) and 210 cases (51.72%) were
female with mean age of 12.27 years (SD = 6.8). 61 cases had booster
dose and 23 cases had three more doses in addition to routine
vaccination. HBsAb in 79.2% of the cases with routine vaccination was
positive. It was positive in 86.89% of the cases with booster dose and in
86.96% of the cases with three extra doses. Overall, 78 of the 406
individuals in the study (19.21%) showed no antibody at all or had
levels <10 mIU/mL. The response rate was signiﬁcantly different in
those who received routine vaccine and those who received a
combination of routine vaccine and booster dose or three extra doses.
There seemed to be no demographic characteristics that signiﬁcantly
distinguish responders from the non-responders. Moreover, thalassemia
type, frequency of blood transfusion per month and duration between
the vaccination and serology did not have signiﬁcant effect on antibody
response.
Conclusions: Despite this fact in the literature that hepatitis B
vaccination is effective in raising antibody level in general
population, this study almost conﬁrm that it cannot be effective in
thalassemic patients. It seems that for these patients routine antibody
screening must be called every 4–5 years and accordingly advice
booster dose or extra three doses.
R2797 Antibody response to hepatitis B vaccination in health
care workers
S. Zare*, P. Davoodian, H. Moshtaghzadeh, F. Nikoosefat on behalf of
the Hormozgan infectious and tropical diseases research centre
Objectives: Hepatitis B is an important cause of acute and chronic
hepatitis, cirrhosis and hepatocellular carcinoma. This disease is 10
times more prevalent among health care workers. At present,
vaccination is the most effective and cost saving means of prevention
of hepatitis B virus infection. The main aim of this study was
determining hepatitis B surface antibody (HBsAb) level following
vaccination and examining the relationship between HBsAb level with
age, sex, body mass index, Anti-HBV titre, time elapsed since last dose
of vaccination and vaccine combination.
Methods: This cross sectional study was performed among 165 health
care workers in a main general hospital in south of Iran, who had a full
course of vaccination against hepatitis B virus. Data on Anti-HBV titer,
combined vaccination history, body mass index and time elapsed since
last dose of vaccination were collected retrospectively by reviewing
their medical records. Antibody levels after vaccination were measured
by an enzyme-linked immunoadsorbent assay (ELISA) method and the
results expressed in mIU/mL. levels <10 mIU/mL were considered
negative, 10–100 mIU/mL relative responses and more than 100 mIU/
mL full responses.
Results: According to the results, 92% (152 individuals) of the health
workers showed a complete immune response, 8% (13 individuals) had
partial immunity. The response rate did not differ appreciably
whichever combination of vaccine was given. There was no
signiﬁcant relationship between Anti-HBV titer, age, sex, body mass
index and duration between the vaccinations with antibody level.
Conclusions: The results conﬁrm that hepatitis B vaccination is
effective in raising antibody level in health care worker. Given the
relatively high cost in both time and labour that vaccination
programmes entail, routine antibody screening after vaccination must
be called into question except perhaps for those who are at highest risk,
such as those who work in renal or drug addiction units.
R2798 Vaccination rates among adult cancer patients at a
comprehensive cancer centre
S. Wattari*, T.N. Johnson, C. Gonzalez, K. Rolston (Houston, US)
Adult patients with cancer are at a high risk for pneumonia from both
inﬂuenza and pneumococcal infections. The risk increases in patients
that are still smoking. Mortality rates from pneumonia can be seen as
high as 33%. The CDC recommends all individuals at high risk
including immunocompromised patients to receive both vaccines.
Objective: Our primary objective was to determine our inﬂuenza and
pneumococcal vaccination rates in adult solid tumor cancer patients
diagnosed with pneumonia in the Emergency Center (EC) at a
comprehensive cancer center.
Methods: A retrospective chart review was completed over a 5 month
period in 2010.
Results: A total of 157 solid tumor cancer patients [median age:
61 years (range 18–91), 87 males (55%)] were included. Inﬂuenza
vaccines were screened in 123 patients (78%). This is an improvement
from 65% in 2008. Nurses screened 118 patients while physicians
screened 22. There were 42 patients that received the vaccine prior to
their EC visit. Seventy-four patients qualiﬁed to receive vaccines upon
EC discharge. None of these patients received vaccines or a
recommendation if they were admitted. Four patients received
vaccination prior to discharge from their primary team. Pneumococcal
vaccines were screened in 112 (71%) patients out of the 157. This
number is slightly up from 67% in 2008. Nurses screened more often
than physicians, 107 vs. 21 patients. Thirty-three patients received
pneumococcal vaccines prior to their EC visit. Again, no
recommendations were made for vaccination and none were given
prior to EC discharge. Fifty-seven (36%) patients were 65 years old or
older. Of these patients, 40 patients were screened. Sixteen (28%)
patients received vaccines prior to their EC visit. No recommendations
or vaccines were given in the EC. Of the 157 patients that were
diagnosed with pneumonia only 37% were screened for smoking.
Twenty-one of the patients were considered active smokers. Four of the
active smokers were screened and one recommended to be seen by the
Tobacco Smoking Cessation Program.
Conclusion: More education is needed to all healthcare providers
associated with cancer patients about the importance of inﬂuenza and
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pneumococcal vaccines. A new nurse driven program is needed to
ensure that our patients receive the appropriate vaccines prior to
discharge from the clinic, EC and/or hospital.
R2799 Astragalus adscendens extract is a novel adjuvant
increasing the immune responses in mice compared to
Quil A and Allum
A. Khosravi*, A. Abdolkarimi, S. Alizadeh (Ilam, IR)
Objectives: Astragalus adscendens is a perennial plant of family
astragalus that its polysaccharide extract is usually used as a popular
sweetie in Iran for years called GAS ANGABIN. Several studies
demonstrated that Astragalus membraneous extracts could be safely
used as an adjuvant with low or non-haemolytic effect. As there is no
study assessing such potential ability in A. Adscendens the current
study was designed to evaluate the hemolytic and adjuvant activities of
this plant in mice.
Materials and Methods: Four groups of ICR mice were
subcutaneously immunized with OVA 100 lg alone or OVA and
Astragalus extract (ASE as a new adjuvant), QuilA and Allum on Day 1
and 15. Two weeks later (Day 28), concanavalin A (Con A)-,
lipopolysaccharide (LPS)- and OVA-stimulated splenocyte
proliferation and OVA-speciﬁc antibodies in serum were measured.
Haemolytic activities of ASE was evaluated using 0.5% rabbit red
blood together with its adjuvant potentials on the cellular and humoral
immune responses at both 100 and 200 lg/mL doses.
Results: ASE showed no haemolytic effect, at the concentration of 100
and 200 lg/mL. ASE signiﬁcantly enhanced the Con A-, LPS-, and
OVA-induced splenocyte proliferation in the OVA-immunized mice at
both doses of 100 and 200 lg. The IgG total and IgG sub-class
responses in the serum of mice were signiﬁcantly higher using ASE as
adjuvant compared with QuilA, Allum and control group.
Conclusion: This study demonstrated that ASE has a considerable
adjuvant activity with non-haemolytic effect at both 100 and 200 lg/
mL doses superior to Allum and QuilA.
Internet and electronic resources
R2800 Management of infective endocarditis: an innovative
multidisciplinary pathway to manage a complex disease –
clinical experience from a Lancashire cardiac centre
A. Guleri*, R. More, D. Roberts, A. Tang, J. Zacharis, T. Morris,
S. Rogers, M. Purohit, N. Waddington, A. Jones (Blackpool, Old
Malton, UK)
Infective endocarditis (IE) is a complex disease with poor prognosis and
high mortality. Cardiologists, cardiac surgeons and the microbiologists
from Lancashire Cardiac Centre collaborated and reviewed the practical
limitations of identiﬁcation and referral of IE and the available
guidelines to set up an IE care-pathway (Endocarditis Pathway-EP). We
present data and clinical experience from the use of EP over a 12-month
pilot.
Methods: Analysis of database (55 patients). Patients with suspected
IE are e-logged (intranet based registration of patients on EP) and paper
copy is added to the notes and completed during patients’ hospital stay.
Results: Mean age: Fifty-eight years; 67% Males; Mean weight
72 kg; 95% Caucasian. Forty patients had an initial diagnosis by
echocardiogram of IE (transthoracic: 38; transesophageal: 14); 62%
(34/55) with left-sided IE; 4% (2/55) right-sided and 7%(4/55) both
sided IE; indeterminate 20% (11/55). Valve involvement: aortic 18;
mitral 9; aortic+mitral 7; mitral+tricuspid 4; tricuspid 2.
Echocardiography was not recorded for three patients. Thirty-nine
patients had positive blood cultures. IE speciﬁc isolates: Meticillin-
sensitive Staphylococcus aureus (MSSA), 13; Streptococcus spp., 11;
Enterococcus spp., 6; HACEK group, 3; S. epidermidis, 3; meticillin-
resistant S. aureus, 2; MSSA + Strep, 1. Two patients were also culture-
positive for Candida albicans. Thirty-three patients underwent surgical
procedures. Antibiotics: gentamicin in combination 35%; rifampicin in
combination 32%; ﬂucloxacillin 35%; daptomycin 27%; benzyl-
penicillin 23%; vancomycin 15%. Six patients required continuous
veno-venous haemodialysis (CVVHD). Outcome was cured or
improved in 42 patients (76%). Mortality was 23% (13/55), of which
10 patients died from complications or conditions other than IE.
Conclusions: The EP was piloted at the Lancashire Cardiac Centre
with plans to extend it for consultation of the regional cardiac network
with an aim to standardise care throughout the region. The
multidisciplinary input from cardiologist, cardiac surgeon and
microbiologist prevents delay and optimises management. Results and
clinical experience from this pilot have been used to inform revised
user-friendly version of the EP to be available on the new trust
electronic patient record system. Details to be presented.
R2801 Colony Morphology Ontology (CMO): a standard
nomenclature for the classiﬁcation of human pathogenic
bacteria colony morphology
A.M. Sousa, A. Lourenço, M.O. Pereira* (Braga, PT)
Phenotypic and genetic variations are the most important mechanisms
adopted by microorganisms to survive adverse stress conditions.
Bacteria persistence is a noteworthy downside in clinical settings
(even after disinfection and antibiotic procedures) and studies have
pointed out that colony morphology variations are a key factor
motivating pathogenicity, virulence and resistance of infection-causing
microorganisms.
Ongoing studies on colony morphology switching aim to apply colony
observation mechanisms to medical diagnose and clinical decision
making. Colony observation approaches share a common principle, but
they lack standard laboratorial guidelines and consensual criteria to
identify the morphological characteristics of the colonies. Clearly, the
comparison of colony morphologies is only possible under similar
experimental conditions and nomenclature standardisation is recom-
mended to avoid ambiguity or misinterpretation. Particularly, visually
observed phenotypes, which cannot be directly measured quantitatively,
are often in the form of free text descriptions plagued by semantic
ambiguity (i.e. a single concept has different meanings, though
sometimes the differences can be very subtle), heterogeneity (i.e. the
same visually observed phenotype is described with different concepts),
and low granularity (i.e. the level of detail used in concept deﬁnition).
Standardisation efforts are thus needed to ensure the understanding of
the annotations and large-scale phenotype comparison in real-time
clinical decision making.
Till date, no ontology covers for the annotation of colony morpholog-
ies. This work aims to ﬁll in this gap, proposing the Colony
Morphology Ontology (CMO). CMO considers the following top
annotation classes: microorganisms (e.g. identiﬁcation, source), culture
conditions (e.g. culture type, growth mode), plating conditions (e.g.
media, incubation time), stress conditions (e.g. physical, chemical
stressors), susceptibility proﬁles (e.g. antibiotics, disinfectants) and
morphological characterisation (e.g. shape, size, colour). The ability to
search for and compare similar phenotypic appearances within and
across species is believed to have vast potential in bioﬁlm-associated
infection research. Therefore, CMO is made publicly available at http://
193.137.90.5/morphocol/. In the future, we envision the development of
a framework suitable for the modelling and analysis of the computable
representation of bioﬁlm phenotypic signatures.
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R2802 BiofOmics: a database on high-throughput bioﬁlm
susceptibility and resistance tests
A. Lourenço, A. Ferreira, M.O. Pereira*, N.F. Azevedo (Braga, Porto,
PT)
Bioﬁlms are structured communities of bacteria that are able to survive
virtually everywhere in Nature because of their ability to adhere to a
surface and embed in a protecting, self-produced matrix of extracellular
polymeric substances. Due to their persistence and resistance to
antimicrobials, including clinically relevant antibiotics, bioﬁlm-associ-
ated infections are at the basis of a range of problems in clinical
settings. Much research has been devoted to the understanding of
bioﬁlm-growing bacteria susceptibility and resistance in the last
decades.
Similarly to what has happen in other research domains, bioﬁlm
research has beneﬁted from technological evolution. The development
of high-throughput bioﬁlm-forming devices (e.g. the 96-well microtiter
plate and the calgary device) has enabled the simultaneous testing of
large sets of conditions. The implementation of automated spectropho-
tometry and microscopy systems allow addressing different features of
bioﬁlms in a large scale. Furthermore, the so-called ‘‘omics’’ platforms
are enabling the disclosure of the transcriptome proteome and
metabolome of bioﬁlms.
As bioﬁlm research grows to be a data-intensive discipline, the need for
suitable bioinformatics approaches becomes compelling. The large
amount of results being generated claims for proper means of data
organization, normalisation and storage. Also, in order to convert the
large sets of data into valuable and interchangeable knowledge,
researchers are in need of analytical tools, capable of dealing with the
ever growing size of the data as well as supporting advanced statistics
and, eventually, data mining. However, our analysis of current
procedures in bioﬁlm research shows that no real effort has been
made to introduce bioinformatics into the community.
The purpose of this work is thus to describe a novel approach to the
large-scale, standardized and systematic documentation of published
evaluations on bioﬁlm-growing bacteria susceptibility and resistance.
Speciﬁcally, we establish the basic requirements in terms of data
normalisation and describe a systematic and computer-amenable
approach to data organisation. The approach has been validated using
our laboratories’ experiments and it is already in practice, supporting
the operation of the BiofOmics database (publicly accessible at http://
biofomics.org). This new resource provides the means for large-scale
study comparison and interchange, promoting inter-laboratory collab-
orations.
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